{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "qwen3-32b",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions_in_experiment": 1000
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for LMT's nonqualified defined benefit pension plans increased slightly from $1.0 billion as of December 31, 2023, to $905 million as of December 31, 2024. Additionally, the actuarial losses and unrecognized prior service credits related to these plans decreased from $347 million at the end of 2023 to $303 million at the end of 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in describing the change in gross benefit obligation. While the reported values of $1.0 billion in 2023 and $905 million in 2024 are correct, the LLM incorrectly states that the obligation 'increased slightly' when in fact it decreased (from $1.0B to $905M). This misrepresents the direction of change, which is central to the question. Actuarial losses are correctly reported as decreasing from $347M to $303M, which is accurate. (2) Quantitatively, the dollar amounts and years are correct, earning partial credit. However, the interpretation of the trend for the gross benefit obligation is wrong, which undermines the quantitative reasoning. (3) The multi-hop reasoning fails because the model does not correctly synthesize the evolution between the two years—it mischaracterizes a decrease as an increase. Additionally, the mention of 'unrecognized prior service credits' introduces an element not asked for and not present in the ground truth, adding irrelevant detail. (4) Despite accurate raw numbers, the incorrect directional analysis and flawed conclusion significantly reduce correctness. Contextual relevance is high because the answer addresses the right plans, company (LMT), and time frame, and covers both required metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 364,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "General Motors' long-term rate of return assumptions on U.S. pension plan assets increased from 5.4% at December 31, 2022, to 6.5% at December 31, 2024. This upward adjustment indicates a strategic shift in asset mix, with a higher allocation to alternative investments (29%) and a reduced emphasis on debt (60%) in 2024 compared to 2022, reflecting a focus on diversification and potentially higher-yielding assets to improve funded positions and manage risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and dates. According to the ground truth, the 5.4% rate was for December 31, 2021 (not 2022), and the increase to 6.5% occurred by December 31, 2024, based on a prior 6.3% in 2023. The LLM incorrectly states the starting point as 5.4% at December 31, 2022, which misaligns the timeline and omits the actual 2021–2023 progression. Additionally, the LLM introduces specific asset allocation figures (29% alternatives, 60% debt) that are not present in the original answer and cannot be verified from the provided ground truth. (2) The calculation of the rate change is partially correct in direction (increase from ~5.4% to 6.5%) but uses incorrect time anchors, undermining quantitative accuracy. The original answer shows a drop to 5.4% in 2021 and a rise to 6.5% in 2024, but the LLM misrepresents the starting year and omits the intermediate 6.3% in 2023. (3) The reasoning about strategic asset mix shift is plausible and aligns with the general interpretation in the original answer, but it adds unsupported specifics (exact allocation percentages) not found in the source, weakening the multi-hop synthesis. The conclusion about diversification and higher-yielding assets is contextually reasonable but extrapolated beyond the evidence. (4) Scores reflect major quantitative errors (3/10), partial qualitative accuracy due to correct directional interpretation but unsupported details (5/10), high contextual relevance as it addresses both parts of the question (8/10), and an overall correctness score of 4 due to critical factual inaccuracies despite some logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 454,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly between 2023 and 2024, as PDC was acquired by Chevron in a business combination during 2023. In 2024, this acquisition contributed to increased U.S. upstream earnings by $3.5 billion, driven by higher sales volumes from legacy PDC assets and the absence of decommissioning charges related to previously divested Gulf of America assets. Operationally, the acquisition added approximately 250,000 barrels per day to net oil-equivalent production, primarily due to the full-year inclusion of PDC's production and growth in the Permian Basin.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the acquisition of PDC Energy by Chevron in 2023 and the operational integration by 2024, which aligns with the ground truth. However, key quantitative figures are incorrect. The LLM states a $3.5 billion increase in U.S. upstream earnings, whereas the ground truth reports $2.2 billion—this is a significant factual error. Additionally, the LLM claims an increase of 'approximately 250,000 barrels per day' in production, but the ground truth specifies a 19% increase in net oil-equivalent production (not a volume figure), making the LLM's number both numerically and metrically inaccurate. The mention of 'absence of decommissioning charges related to previously divested Gulf of America assets' introduces information not present in the ground truth and appears fabricated or misattributed. (2) Quantitative accuracy is low: $3.5B vs $2.2B is a 59% overstatement; 250,000 bbl/day is a volume, while the truth reports a percentage change (19%), so no direct comparison is valid. The model invents metrics not in the source. (3) Qualitatively, the reasoning structure is sound—acquisition in 2023 leading to operational and financial impacts in 2024—but fails in accurate synthesis. The model incorrectly attributes earnings drivers and invents operational details (Permian Basin growth, decommissioning charges). It captures the multi-hop nature (acquisition → integration → financial impact) but uses incorrect data. (4) Contextual relevance is high as the answer addresses the evolution of the relationship and attempts to report operational and financial impacts. However, due to major numerical inaccuracies and fabricated details, the correctness score is low despite correct high-level narrative flow.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 477,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "Between 2022 and 2024, Southern Company's treatment and valuation of energy-related derivatives remained largely consistent in terms of accounting methods (regulatory hedges, cash flow hedges, and not designated hedges), but the presentation and magnitude of unrealized gains (losses) changed. In 2022, unrealized gains (losses) from energy-related derivatives designated as regulatory hedges were deferred in regulatory assets and liabilities, with a total of $155 million in gains at year-end. By 2024, the presentation shifted to a more detailed breakdown of derivative balances by current and non-current classifications, with a net liability position of $554 million for Southern Company, reflecting a significant unrealized loss position compared to the net asset position in 2022. The change highlights a shift from regulatory deferrals to a more direct balance sheet presentation of derivative fair values.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$155 million in gains in 2022 and a $554 million net liability in 2024—that are not present in the original ground truth answer and cannot be verified against it. Since the ground truth does not mention any dollar amounts or quantitative figures related to unrealized gains or losses, the inclusion of these numbers significantly undermines factual accuracy. There is no confirmation from the original answer that such figures exist or are correctly reported, making the quantitative claims unsupported and potentially misleading. (2) The ground truth emphasizes a shift in disclosure focus—from deferring unrealized gains (losses) for regulatory hedging instruments (as of 2020 and 2021) in the 2022 report, to presenting fair values of various derivatives (energy, interest rate, foreign currency) on the balance sheet under specific line items by 2024. The LLM correctly identifies a shift in presentation from deferral to balance sheet recognition, which aligns with the qualitative direction of the original answer. However, it incorrectly implies that the change occurred between 2022 and 2024 financial statements based on year-end positions, while the original answer references disclosures as of December 31, 2021 and 2020 being reported in the 2022 filing, suggesting the timeline comparison is between earlier periods disclosed in later reports. (3) The multi-hop reasoning is partially sound—the model infers a change in presentation and links it to regulatory versus fair value accounting. However, it fabricates precise financial figures without source support, fails to mention the inclusion of interest rate and foreign currency derivatives in the 2024 disclosures (a key point in the original), and misrepresents the time frame of the data being discussed. (4) The contextual relevance is high because the answer addresses the core theme: changes in treatment and presentation of energy-related derivatives. But due to unsupported numerical claims and misaligned timelines, the correctness score is low. The qualitative accuracy is moderate because the conceptual shift is recognized, but the reasoning lacks fidelity to the source data. Quantitative accuracy is poor due to invented figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 607,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Chevron's investment carrying value in Tengizchevroil increased from $23,727 in 2021 to $27,368 in 2024, reflecting a $3,641 increase over the period. Additionally, Chevron's equity earnings from Tengizchevroil declined from $4,386 in 2022 to $3,033 in 2024, indicating a reduction in profitability from this joint venture during the specified timeframe.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in equity earnings from $4,386 million in 2022 to $3,033 million in 2024, matching the ground truth. However, it introduces a carrying value of $23,727 million in 2021, which is not mentioned in the original answer and is outside the requested 2022–2024 timeframe. The ground truth states that in 2022, Chevron's carrying value was about $100 higher than its equity in net assets and highlights a $4,500 million loan related to FGP/WPMP, which the LLM omits entirely. The LLM does correctly report the $27,368 million investment and advances in 2024, and implies growth, but incorrectly frames the comparison starting from 2021 instead of 2022 or 2023. The ground truth provides 2023 data ($26,954 million), which the LLM fails to include, missing a key point about year-over-year growth. (2) The equity earnings numbers are accurate and correctly attributed to 2022 and 2024. However, the $23,727 million figure for 2021 is unsupported by the original answer and introduces a factual inconsistency, even if it may be true in external data. The increase of $3,641 is based on this unsupported 2021 figure and thus misleading. The correct comparison from ground truth is between $26,954 million (2023) and $27,368 million (2024), a $414 increase, which the LLM fails to report. (3) The reasoning partially captures the evolution in investment value and correctly identifies declining profitability, satisfying the multi-hop requirement to connect investment value and earnings over time. However, it misses the nuance about the $4.5 billion loan and the $100 million excess carrying value in 2022, which are important aspects of the financial relationship. (4) The contextual relevance is high as it directly addresses the evolution of carrying value and equity earnings. Qualitative accuracy is good due to correct entity identification and logical flow, but quantitative accuracy is reduced due to incorrect baseline data and omission of intermediate year (2023) figures. Correctness score is 7 due to accurate core facts on earnings and 2024 investment value, but docked for introducing unsupported data and missing key details from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 592,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart acquired a 100% ownership stake in Alert Innovation during fiscal 2023 by completing a $0.4 billion acquisition. This entity was previously consolidated as a variable interest entity. However, it was subsequently sold and deconsolidated in fiscal 2025, meaning Walmart no longer held any ownership stake in Alert Innovation by the end of fiscal 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Walmart acquired a 100% stake in Alert Innovation for $0.4 billion in fiscal 2023 and later sold and deconsolidated the entity, resulting in no ownership. These core facts and financial figures are accurate. However, the LLM incorrectly states the sale occurred in 'fiscal 2025', whereas the ground truth specifies the deconsolidation occurred by fiscal 2024, meaning the transaction must have taken place during or before fiscal 2024. This misstatement of the timeline affects the factual accuracy of the temporal evolution. (2) Quantitatively, the $0.4 billion acquisition amount and 100% ownership are correct. The error lies in the timing, not the numbers. Fiscal year misalignment is a significant but not catastrophic error in quantitative accuracy. (3) The multi-hop reasoning is mostly sound—Walmart went from VIE to full ownership to complete exit. The model captures this transformation correctly in essence but fails on the precise fiscal year of the sale, undermining the accuracy of the 'evolution between fiscal 2023 and 2024' timeline. (4) Contextual relevance is perfect—the answer directly addresses the ownership evolution and transaction type. Due to the fiscal year error, the correctness score is reduced to 7, as the core facts are right but the key temporal detail is off, affecting the overall narrative of the ownership change within the specified period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 396,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "Starbucks' foreign currency - other derivative asset positions increased significantly from $1,009 million in fiscal 2022 to $1,164 million in fiscal 2023, while liability positions remained relatively stable. This indicates an expanded use of hedging instruments to manage foreign currency exposure, reflecting the company's proactive strategy to mitigate risks arising from currency fluctuations in its international operations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both quantitative and qualitative aspects. The reported asset values of $1,009 million in 2022 and $1,164 million in 2023 are completely inaccurate and do not match the ground truth. According to the original answer, Starbucks had a foreign currency - other derivative asset of $55.3 million in AOCI in 2022, not over $1 billion. In 2023, the asset positions were $1.9 million (current) and $1.7 million (long-term), totaling $3.6 million—far below the LLM's claim. The LLM also falsely states that liabilities remained stable, while the ground truth shows a new liability structure of $4.7 million (current) and $4.1 million (long-term) in 2023, indicating a shift from prior year's asset-heavy position. (2) The numbers are off by orders of magnitude—$55.3 million vs $1,009 million is a 17x difference. There is no indication in the ground truth of assets exceeding $1 billion. Calculations and comparisons are therefore fundamentally flawed. (3) The multi-hop reasoning failed completely: the model did not recognize the shift from AOCI-based unrealized gains in 2022 to realized short- and long-term asset/liability positions in 2023. Instead, it invented a narrative of increasing hedging activity, while the truth indicates a significant reduction in exposure. (4) The contextual relevance is low because the answer discusses hedging strategy but misrepresents the underlying data, leading to an incorrect interpretation. The qualitative reasoning is unsound due to incorrect entity mapping (confusing derivative categories or misplacing values across years). Only minimal credit is given for addressing the general topic of foreign currency derivatives and strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 472,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Between fiscal years 2022 and 2024, Medtronic's A Preferred Shares were consistently not issued or outstanding. In 2022, the company redeemed the previously outstanding 1,872 A Preferred Shares for $0.075 million, leaving no A Preferred Shares outstanding as of April 29, 2022. This status remained unchanged through fiscal year 2024, with no A Preferred Shares issued or outstanding as of April 26, 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Medtronic redeemed 1,872 A Preferred Shares for $0.075 million in fiscal year 2022, with no shares outstanding as of April 29, 2022. The status remained unchanged through fiscal year 2024. (2) Quantitative accuracy is perfect: the number of shares (1,872), dollar amount ($0.075 million), and dates (April 29, 2022, and April 26, 2024) match the original answer. The dollar amount is correctly formatted and consistent. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across fiscal years 2022 and 2024, noting both the redemption event and the continued absence of shares, leading to the conclusion of discontinuation. (4) The answer addresses both parts of the question: the evolution over time and the specific 2022 action. Wording differs slightly but conveys the same factual content with no omissions or inaccuracies. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 286,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Comcast's financial relationship with Atairos evolved significantly between 2022 and 2023 in terms of equity income (losses) driven by fair value adjustments on underlying investments. In 2022, Atairos contributed a loss of $434 million, while in 2023, it generated income of $1.1 billion, reflecting substantial positive changes in the fair value of its underlying investments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: in 2022, Atairos contributed a loss of $434 million due to fair value adjustments, and in 2023, it generated income of $1.1 billion. These figures match the original answer exactly, with acceptable formatting ($434 million vs $(434) million — the parentheses in the original denote a loss, which is correctly interpreted as a negative value and expressed as a loss in the LLM response). (2) Quantitative accuracy is perfect: both years' figures are correct, and the directional change (from loss to significant gain) is properly highlighted. (3) The multi-hop reasoning is sound — the answer synthesizes Comcast's equity income from Atairos across two years, correctly attributing the changes to fair value adjustments on underlying investments. (4) The response is contextually relevant, directly addressing the evolution of the financial relationship in terms of equity income driven by fair value changes. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 308,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region remained at zero for both 2023 and 2024, as indicated in the reserve tables for both years. This suggests that the company does not hold any direct natural gas reserves in this region, though it does have equity affiliate reserves located there. The absence of direct reserves indicates that COP's strategic positioning in the Asia Pacific/Middle East region is likely focused on equity partnerships and operations rather than direct natural gas production in the area.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claims. According to the ground truth, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region in 2023 and 296 billion cubic feet in 2024, indicating a slight decline. The LLM incorrectly states that reserves were zero in both years, which directly contradicts the verified data. This error invalidates the entire response, as the core factual basis is false. The reasoning and strategic interpretation in the LLM answer—focusing on equity affiliates and lack of direct reserves—are speculative and unsupported by the provided ground truth, which makes no mention of equity affiliates or operational strategy beyond the numerical trend. While the question asks about evolution and strategic implications, the LLM fails to correctly identify the primary fact (non-zero reserves) and thus cannot provide valid multi-hop reasoning. The contextual relevance is moderate because it attempts to address the region and strategic positioning, but the factual foundation is entirely flawed. No acceptable number format variation can justify reporting 0 instead of 312 or 296 billion cubic feet. Therefore, the correctness and quantitative accuracy scores are very low, with only minimal credit for attempting the right question scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 368,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL's revenue in Canada declined significantly between 2022 and 2024, dropping from $73 million in 2022 to $47 million in 2023 and further to $28 million in 2024, representing declines of 36% and 40%, respectively. This steep decline indicates a deteriorating market trajectory for ENBREL in Canada, driven primarily by lower net selling prices and likely increased competition or market pressures. The continued erosion in sales suggests a challenging outlook for the product in this region.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the declining revenue trend of ENBREL in Canada from 2022 to 2024 and accurately reports the $47 million (2023) and $28 million (2024) figures. However, it incorrectly states the 2022 revenue as $73 million instead of the ground truth $113 million, which is a significant factual error. This affects the accuracy of the calculated declines: the LLM reports a 36% drop from 2022 to 2023 and 40% from 2023 to 2024. While the 2023-to-2024 drop of $19 million from $47M to $28M is indeed ~40%, the 2022-to-2023 decline from $113M to $47M is actually ~58%, not 36%. Thus, both the initial value and the first percentage decline are incorrect. (2) The entity (ENBREL), country (Canada), and time periods (2022–2024) are correctly identified. The metric (revenue) is appropriate and consistent with the question. (3) The reasoning about market trajectory—declining sales indicating a deteriorating market position—is logically sound and consistent with the actual trend. The addition of potential causes (lower net selling prices, competition) goes beyond the ground truth but is plausible and contextually reasonable, though not verifiable from the provided data. (4) The answer is contextually relevant and addresses both parts of the question: revenue evolution and market trajectory. However, the incorrect 2022 revenue figure undermines quantitative accuracy. Despite correct directional interpretation, the factual inaccuracy in a key data point limits the correctness score. The qualitative and contextual scores are higher due to sound logic and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 440,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "Qualcomm's approach to linking human capital advancements with executive compensation in fiscal 2024 involved using progress toward human capital advancements as a non-financial performance modifier for executives' bonuses. Specifically, for fiscal 2024, this modifier could adjust the executives' bonus payout by a multiple ranging from 0.9 to 1.1. This reflects a continued emphasis on aligning executive compensation with diversity, equity, and inclusion goals, as well as other human capital initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in Qualcomm's executive compensation approach for fiscal 2024, stating that progress toward human capital advancements served as a non-financial performance modifier with a multiplier range of 0.9 to 1.1, which matches the ground truth exactly. All quantitative elements (the 0.9 to 1.1 range) are accurate and properly contextualized. The answer addresses the specific performance modifier range applied in fiscal 2024 correctly. However, while the LLM mentions the continued emphasis on human capital, it does not explicitly contrast the fiscal 2023 approach (where human capital was a general consideration) with the more structured, quantified fiscal 2024 approach, which is a key part of the multi-hop reasoning required by the question. This omission slightly weakens the qualitative accuracy, though the core facts are correct. The answer remains semantically aligned with the ground truth and highly relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 283,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "Between 2022 and 2024, the therapeutic scope of Breyanzi expanded significantly. In 2022, Breyanzi was approved for specific B-cell malignancies, but by 2024, it received FDA approvals for additional indications, including relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and follicular lymphoma (FL), as well as mantle cell lymphoma (MCL). These approvals broadened Breyanzi's application to treat a wider range of B-cell malignancies, making it the CAR-T cell therapy with the broadest array of approved indications in this category.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but introduces significant errors. (1) It incorrectly states that Breyanzi was already approved for specific B-cell malignancies in 2022, while the ground truth indicates it was still in late-stage trials (TRANSCEND-CLL-004 and TRANSCEND-FL) with expected timing in 2023/24—no approvals were documented in 2022. (2) The LLM claims approvals for three indications by 2024, including mantle cell lymphoma (MCL), which is not supported by the ground truth; only two approvals are documented: relapsed/refractory FL (May 2024) and CLL/SLL (March 2024). MCL is not mentioned in the original answer. (3) The statement that Breyanzi became 'the CAR-T cell therapy with the broadest array of approved indications' is an unsupported comparative claim not present in the original data and cannot be verified from the provided information. (4) While the core idea of expansion from trials to approvals is correct, the LLM misrepresents the 2022 status and overstates the 2024 approvals. Dates (March and May 2024) are not mentioned in the LLM answer, reducing quantitative precision. The reasoning is partially sound in identifying expansion but fails in accurate synthesis across years and indications. Contextually, the answer addresses the evolution of therapeutic scope, so relevance is moderate to high, but factual inaccuracies severely limit correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 385,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "Disney's Resorts and Vacations segment revenue increased by 5% from 2023 to 2024, driven by higher average ticket prices for cruise line sailings, increased hotel room rates, and more occupied hotel room nights. This growth in the Resorts and Vacations segment aligns with the overall 5% revenue growth of the broader Parks & Experiences segment, which was fueled by higher theme park admissions, merchandise sales, and food and beverage revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the Resorts and Vacations segment grew by 5% from 2023 to 2024, which matches the ground truth calculation based on $7,949 million to $8,375 million (a 5.36% increase, rounded to 5%). However, the LLM claims this 5% growth 'aligns with' the overall Parks & Experiences segment growth of 5%, but the ground truth specifies that Parks & Experiences grew from $32,549 million to $34,151 million, which is a 4.92% increase—also rounded to 5%. While the percentages are both approximately 5%, the original answer notes that Resorts and Vacations growth was 'slightly below' overall segment growth, implying a nuanced difference in exact rates that the LLM overlooks. The LLM incorrectly frames the growth as perfectly aligned rather than slightly lagging. (2) The dollar amounts are missing in the LLM answer, which reduces quantitative completeness. While percentages are approximately correct, the absence of revenue figures limits full verification and weakens multi-hop transparency. (3) The reasoning is logically sound and reflects plausible drivers (e.g., higher room rates, occupancy, ticket prices), but these qualitative drivers are not present in the ground truth and cannot be verified from the provided knowledge graph. The multi-hop synthesis between Resorts and Vacations and the broader Parks & Experiences segment is attempted but slightly mischaracterized due to the incorrect equivalence claim. (4) The contextual relevance is high—the answer directly addresses both parts of the question and uses appropriate terminology. However, the correctness score is reduced due to the misrepresentation of the comparative growth relationship and missing numerical data, despite the general directional accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 479,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "Between 2023 and 2024, the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved in terms of notional amounts and share allocations. In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., receiving 80% of the shares upfront (17.4 million shares) and the remaining 20% (5.4 million shares) later in the year. In 2024, the Company executed a larger $3.0 billion ASR with Morgan Stanley, receiving 85% of the shares upfront (31.4 million shares) and the remaining 15% (8.3 million shares) in March 2024. This indicates an increase in the scale of ASR activity and a shift in the percentage of shares delivered upfront.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the correct ASR amounts ($2.0 billion in 2023, $3.0 billion in 2024), counterparties (Citibank, N.A. and Morgan Stanley), and the general structure of upfront and delayed share delivery. It correctly notes the shift from 80% to 85% upfront delivery and the receipt of remaining shares in March 2024. However, it introduces specific share counts (17.4M, 5.4M, 31.4M, 8.3M) that are not present in the original answer and cannot be verified from the ground truth, making them potentially inaccurate. (2) The original answer emphasizes that the forward contract value remained constant at $0.4 billion in both years despite the larger ASR in 2024, which is a key point about the evolution of the contract structure. The LLM answer omits any mention of the $0.4 billion forward contract value, its classification as an equity instrument, or its recording in capital surplus—critical details about the financial structure and accounting treatment. This omission significantly undermines quantitative and qualitative accuracy. (3) While the LLM correctly identifies the increase in ASR scale and the shift in upfront share percentage, it fails to synthesize the multi-hop insight that the forward contract value did not increase proportionally with the ASR size, which is the core analytical point in the original answer. (4) The contextual relevance is high because the response addresses the evolution of ASR transactions and forward contracts. However, the absence of forward contract valuation and incorrect introduction of unverified share numbers reduce correctness. The answer is partially correct but misses key financial details necessary for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 463,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "From 2023 to 2024, Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology showed increased transparency around fair value categorization. In 2023, the disclosure included fair value measurements by asset class with Level 1, Level 2, Level 3, and \"Not Categorized\" designations, but did not elaborate on the reasons for certain assets being uncategorized. By 2024, the disclosures maintained the same structure but provided more clarity by explicitly stating that certain investments measured using the net asset value per share practical expedient were not categorized in the fair value hierarchy. This enhancement improved transparency by explaining the exclusion of specific assets from the standard fair value hierarchy.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Duke Energy and the relevant years (2023–2024), satisfying entity accuracy and contextual relevance. It also correctly notes that certain investments using the net asset value (NAV) per share practical expedient were not categorized in the fair value hierarchy — a detail present in the 2023 disclosure. However, the core evolution in transparency described in the LLM answer is factually incorrect: it claims that the 2024 filing improved transparency by 'explicitly stating' the reason for non-categorization, implying this explanation was new in 2024. In reality, the 2023 filing already contained that explanation. The actual new disclosure in 2024 — a reconciliation of beginning and ending balances for Level 3 assets in the Master Retirement Trust — is entirely missing from the LLM response. This is a critical omission, as it represents the true increase in transparency. The LLM instead fabricates a qualitative improvement (added explanation) that did not occur. While the structure of fair value hierarchy disclosures (Level 1/2/3, 'Not Categorized') may be descriptively accurate, the central claim about the nature of increased transparency is wrong, undermining the multi-hop reasoning and factual correctness. Therefore, despite some accurate contextual elements, the answer fails on the key factual development between years, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 389,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial obligations and revenue recognition related to Paxlovid shifted significantly due to the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile (SNS). In 2023, a non-cash revenue reversal of $3.5 billion was recorded due to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses by the U.S. government. By 2024, a favorable final adjustment of $771 million was recorded after 5.1 million courses were returned, and an additional $442 million in revenue was recognized for supplying 1.0 million NDA-labeled Paxlovid treatment courses to create the U.S. SNS. This transition marked a shift from government contracts to commercial market sales, with deferred Paxlovid revenues decreasing from $3.4 billion in 2023 to $2.2 billion in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key financial figures and events from the ground truth: the $3.5 billion non-cash revenue reversal in 2023 due to the expected return of 6.5 million EUA-labeled Paxlovid courses, the $771 million favorable adjustment in 2024 based on the actual return of 5.1 million courses, and the $442 million revenue recognized in 2024 for supplying 1.0 million NDA-labeled courses to the U.S. Strategic National Stockpile. All numbers match exactly and are contextually accurate. (2) Quantitative accuracy is perfect: all dollar amounts ($3.5B, $771M, $442M) and units (6.5M, 5.1M, 1.0M treatment courses) are correct, and no calculation errors are present. The mention of deferred revenues decreasing from $3.4B to $2.2B is additional context not in the ground truth but does not contradict it and may reflect broader financial trends; however, since this specific detail isn't in the original answer, it slightly affects qualitative precision. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across two years, two distinct U.S. government-related events (inventory return and SNS creation), and links them to changes in revenue recognition and financial obligations. The characterization of a shift from government contracts to commercial sales is a reasonable inference. (4) The answer is highly relevant, directly addressing the question about changes between 2023 and 2024. The only minor deviation is the inclusion of the deferred revenue figures not present in the ground truth, which, while plausible, introduces unverified information. This prevents a perfect 10 but does not undermine the core correctness. Overall, the answer is factually accurate, well-structured, and semantically equivalent to the original answer with excellent contextual and quantitative fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 501,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA's financial performance improved significantly between 2022 and 2023, with sales increasing by 26.9% to $2.387 billion from $1.881 billion, driven by continued share gains and market growth in metastatic castration-resistant prostate cancer. This strong growth highlights ERLEADA's growing importance within J&J's oncology portfolio, reflecting its effectiveness in capturing market share and contributing to the segment's overall 10.5% revenue increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: ERLEADA sales increased from $1.881 billion in 2022 to $2.387 billion in 2023, representing a 26.9% growth. These figures match the ground truth exactly, with acceptable format variation ($1,881 million = $1.881 billion). The overall oncology segment growth of 10.5% is also accurately cited. (2) Calculations are correct: (2,387 - 1,881) / 1,881 ≈ 26.9%, confirming the percentage growth is accurate. (3) The reasoning is sound and captures the core implication—that ERLEADA is becoming more important in J&J's oncology portfolio due to its strong growth. However, the LLM answer omits a key comparative insight present in the ground truth: the contrast with declining sales of other oncology products like IMBRUVICA and ZYTIGA. This context strengthens the conclusion about ERLEADA's increasing strategic role, and its absence represents a minor but notable gap in completeness. (4) Despite this omission, the answer is factually correct, well-reasoned, and highly relevant. The missing comparison slightly reduces qualitative accuracy but does not undermine the overall correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 365,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA's global sales increased by 26.9% in 2023 compared to 2022, driven by continued share gains and market growth in Metastatic Castration-Resistant Prostate Cancer. This significant growth indicates a strong market trajectory for ERLEADA, reflecting its expanding adoption and effectiveness in its target indication.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 26.9% growth in ERLEADA's global sales from 2022 to 2023, which matches the ground truth. However, it omits the actual sales figures for both years ($1,291 million in 2022 and $2,387 million in 2023), which are key quantitative details required for a complete response. Additionally, the LLM fails to mention the 70.0% growth in 2022 compared to 2021, which is a critical part of the multi-year performance analysis and context for understanding the deceleration in growth. (2) While the 26.9% growth rate is accurate, the absence of absolute sales numbers reduces quantitative completeness. The calculation implied (growth from 2022 to 2023) is correct as stated, but without the base and final values, full verification by the reader is not possible. (3) The reasoning about strong market trajectory and expanding adoption is logically sound and aligns with the ground truth; however, the conclusion lacks the nuance that growth is slowing compared to the prior year’s 70% surge, which the original answer highlights as indicative of a maturing growth phase. This missing comparative insight weakens the multi-hop synthesis across years. (4) The answer is contextually relevant and addresses the market trajectory aspect well, with appropriate clinical context (Metastatic Castration-Resistant Prostate Cancer). However, due to significant omissions in quantitative data and incomplete temporal analysis, the overall correctness is reduced to a 6—partially correct but missing key facts needed for a comprehensive evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 434,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "Between fiscal years 2023 and 2024, NVDA's debt management strategy regarding the 0.584% Notes Due 2024 evolved from holding the debt until its maturity in 2024 to repaying it in fiscal year 2025. In 2023 and 2024, the notes had a remaining term of 0.4 years and were listed with a carrying value of $1,250 million. However, in fiscal year 2025, NVDA repaid the 0.584% Notes Due 2024, removing them from its outstanding debt. This repayment reflects a proactive approach to managing short-term obligations and optimizing the company's debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1,250 million carrying value of the 0.584% Notes Due 2024 in fiscal years 2023 and 2024, matching the ground truth. It accurately states that NVDA repaid the notes in fiscal year 2025, resulting in no remaining balance as of January 26, 2025. The effective interest rate (0.66%) is not mentioned in the LLM answer, which is a minor omission but does not affect the core debt management narrative. (2) All numeric values—$1,250 million, fiscal years 2023–2025, and the note's maturity—are factually correct and consistent with the original answer. The mention of a 'remaining term of 0.4 years' is a reasonable inference given the timing relative to maturity and does not contradict the data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across fiscal years and filings to conclude that NVDA retired the debt rather than refinancing it, indicating a strategic shift. The characterization of this as a 'proactive approach' aligns semantically with the ground truth's 'shift in debt management strategy.' (4) The answer is highly relevant, directly addressing how the strategy evolved. The only minor gap is the omission of the effective interest rate, which slightly affects completeness but not the overall correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 397,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Honeywell's investment in Mortgage/Asset-backed securities decreased between 2022 and 2023. In 2022, the amount was $31 million (Non-U.S. plans) and $1,119 million (U.S. plans), totaling $1,150 million. In 2023, the amount was $10 million (Non-U.S. plans) and $676 million (U.S. plans), totaling $686 million. This represents a decrease of $464 million, or 40.3%, in the total investment in Mortgage/Asset-backed securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Honeywell reported $982 million in Mortgage/Asset-backed securities under U.S. Plans in 2022 and only $10 million under Non-U.S. Plans in 2023. However, the LLM incorrectly states that in 2022, the amount was $31 million (Non-U.S.) and $1,119 million (U.S.), totaling $1,150 million—both figures are wrong. Similarly, for 2023, the LLM reports $676 million under U.S. Plans and $10 million under Non-U.S., totaling $686 million, which contradicts the ground truth that all $10 million was under Non-U.S. Plans and implies a continued U.S. investment not present in the original data. (2) The calculation of a $464 million decrease (40.3%) is based on incorrect totals. The correct change is a reduction from $982 million to $10 million, which is a $972 million decrease, or approximately 98.98%. The LLM’s calculation is mathematically correct only relative to its own incorrect inputs. (3) The multi-hop reasoning is flawed because the model fails to correctly identify and synthesize the relevant data points across years and plan types. It incorrectly attributes large investments in both U.S. and Non-U.S. plans in both years, whereas the ground truth shows a complete shift from U.S. to Non-U.S. with near-total divestment. The model does not reflect the strategic shift accurately. (4) Despite the incorrect numbers and synthesis, the answer is contextually relevant—it addresses the evolution and magnitude of change in Honeywell's investment as asked. However, due to major quantitative and qualitative errors, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 456,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations remained relatively stable in its funding mix, with a carrying value of $16,973 million in 2022 and $18,043 million in 2023. These obligations were classified as Level 2 in the fair value hierarchy for both years, indicating they were valued using observable market inputs. The slight increase in securitized debt obligations reflects continued reliance on this funding source, though no significant shifts in their role or valuation methodology were observed during the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 carrying value of securitized debt obligations, stating $16,973 million, which is not supported by the ground truth. The original answer does not provide a 2022 carrying value, only a qualitative description of the role of securitized debt in the funding mix. By fabricating this number, the LLM introduces a false data point, undermining quantitative accuracy. The 2023 carrying value ($18,043 million) and fair value ($18,067 million) are correctly reported, as is the Level 2 classification. (2) The calculation of a 'slight increase' is based on an incorrect 2022 figure, making the comparison invalid. While the direction of change (increase) may be accurate, the magnitude and basis are not verifiable and likely misleading. (3) The reasoning partially captures the continuity in use and classification of securitized debt obligations but misses the key qualitative evolution highlighted in the ground truth: the shift toward more detailed disclosure and transparency in 2023, particularly around fair value and hierarchy classification. The original answer interprets the increased specificity in 2023 as indicative of improved risk management reporting, a nuance absent in the LLM response. (4) The LLM answer is contextually relevant and addresses the funding mix and fair value classification, but fails on completeness and reasoning due to the invented 2022 number and omission of the disclosure evolution. Correctness is penalized heavily due to the unsupported quantitative claim, despite correct 2023 data and proper entity and year identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 449,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "From 2023 to 2024, JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolved as the CECL-related capital benefit was phased in. Specifically, the CECL benefit in CET1 capital decreased from $1.4 billion as of December 31, 2023, to $720 million as of December 31, 2024, with the remaining benefit fully phased in by January 1, 2025. This represents a quantitative reduction of $680 million in the CECL-related capital benefit during the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1.4 billion (2023) and $720 million (2024) are accurately reported, and the reduction of $680 million ($1.4B - $720M = $680M) is correctly calculated. (2) The dates—December 31, 2023, December 31, 2024, and January 1, 2025—are consistent with the original answer and reflect the correct timeline for the phase-in period. (3) The reasoning is sound: the decrease in the CECL-related capital benefit reflects the phased transition under U.S. capital rules, and the full phase-in by January 1, 2025, is correctly noted. (4) All entities—JPMorgan, CECL capital transition provisions, CET1 capital—are accurately identified and contextually used. The answer addresses both parts of the question: the evolution of treatment (phased reduction) and the quantitative change ($680 million decrease). Semantic equivalence is maintained with precise factual alignment. No errors in multi-hop synthesis; information across time points and regulatory context is correctly integrated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 306,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolved as follows: \n\nIn fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Prior Credit Agreement, which was set to mature on December 23, 2025. By fiscal 2024, Salesforce replaced the Prior Credit Agreement with a new Revolving Loan Credit Agreement in October 2024, increasing the borrowing capacity to $5.0 billion and extending the maturity date to October 2029. The new agreement provides for an unsecured revolving credit facility that can be used for general corporate purposes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $3.0 billion facility in fiscal 2023 maturing in December 2025, the replacement with a $5.0 billion facility in fiscal 2024, and the new maturity date of October 2029. The increase in capacity and extension of maturity are correctly highlighted. (2) Quantitative accuracy is perfect: dollar amounts ($3.0B and $5.0B), and dates (December 2025 and October 2029) match the ground truth. The mention of 'October 2024' as the replacement date is plausible context not contradicted by the original answer. (3) Multi-hop reasoning is sound—correctly comparing two fiscal years' credit agreements and synthesizing changes in terms and capacity. (4) The only minor deviation is the use of 'Prior Credit Agreement' and specifying 'October 2024' for the new agreement, which adds detail not in the original but does not conflict; the original simply states 'by fiscal 2024'. This does not affect factual correctness but slightly exceeds the provided information. Overall, the answer is semantically equivalent, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 328,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "Between 2022 and 2024, UPS's relationship with Coyote evolved from operating it as part of its Supply Chain Solutions segment to divesting the business. In 2022, Coyote was described as a key part of UPS's truckload brokerage services in the U.S. and Europe. However, by 2024, UPS completed the divestiture of Coyote, as noted in the third quarter of 2024. This divestiture resulted in a pre-tax gain of $156 million ($152 million after tax) for UPS in 2024, which was recorded as part of other expenses in the consolidated income statement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: UPS operated Coyote as a subsidiary in 2022 providing truckload brokerage services in the U.S. and Europe, and by 2024 had completed its divestiture. The financial impact—a pre-tax gain of $156 million ($152 million after tax)—is accurately reported. (2) Quantitative accuracy is perfect: both dollar amounts match the original answer exactly, and the timing (third quarter of 2024) is consistent with the knowledge graph. Format variations are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the answer synthesizes information across time (2022 to 2024), entities (UPS and Coyote), and financial outcomes (divestiture gain), correctly identifying the strategic shift and its accounting treatment. (4) The answer is contextually relevant, directly addressing both parts of the question—evolution of the relationship and financial impact—without extraneous information. Wording differs slightly but maintains semantic equivalence. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 308,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "Between 2023 and 2024, Union Pacific's relationship with chassis showed a significant shift in both total units and ownership structure. In 2023, the company owned 30,635 chassis and leased 17,705, totaling 48,340 units with an average age of 13.2 years. By 2024, the total number of chassis dropped to 5,553, with a marked decrease in leased units to 1,197 and owned units to 4,356, representing an average age of 11.6 years. This indicates a substantial reduction in chassis volume and a shift toward greater ownership relative to leasing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: 2023 owned (30,635), leased (17,705), and total (48,340) chassis units; 2024 owned (4,356), leased (1,197), and total (5,553) units. These match exactly with the original answer, confirming full quantitative accuracy. (2) The LLM adds average age data (13.2 years in 2023, 11.6 in 2024), which is not present in the ground truth. While this does not contradict the original answer, it introduces unverified information not supported by the provided knowledge graph, slightly affecting qualitative accuracy. However, since the core facts and calculations are correct and the added detail does not distort the meaning, the impact is minor. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in total units and ownership structure across two years and draws a valid conclusion about a strategic shift toward reduced reliance on chassis and a relatively higher ownership share. The observation about increased ownership proportion (from ~63% to ~78% owned) is accurate and insightful. (4) The answer is fully contextually relevant, addressing both parts of the question—evolution in total units and ownership structure—and provides a coherent interpretation. The only deviation is the inclusion of unsupported average age figures, which prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 407,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "Between 2022 and 2024, Boeing has consistently classified its aluminum agreements as derivative instruments for accounting purposes but has not designated them for hedge accounting treatment. In 2022, these agreements were described as addressing \"long-term strategic sourcing objectives and non-U.S. business requirements,\" with changes in fair value recorded directly in earnings. By 2024, the description remained largely unchanged, with the agreements still being treated as derivatives not designated for hedge accounting. Additionally, the time horizon for these agreements has extended, as Boeing's commodity contracts now hedge forecasted transactions through 2028, compared to earlier periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Boeing classified aluminum agreements as derivatives not designated for hedge accounting in both 2022 and 2024, with fair value changes recorded in earnings. The 2022 rationale (strategic sourcing and non-U.S. business needs) is accurately reported. The 2024 evolution—linking these agreements to a broader hedging program covering forecasted transactions through 2028—is correctly identified, including the specific time horizon of 2028. (2) There are no numeric or date inaccuracies; 'through 2028' matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in disclosure tone and intent—from strategic sourcing to structured hedging—across years. (4) The only minor shortcoming is the phrase 'description remained largely unchanged,' which slightly understates the significance of the shift toward framing the agreements as part of a formal hedging strategy. While the classification treatment didn't change, the strategic context did evolve meaningfully, which the LLM downplays slightly. However, the core factual and conceptual content is correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 344,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble's exposure to currency rate risk remained relatively stable between the fiscal years ended June 30, 2023, and June 30, 2024. The company primarily manages its currency rate risk through operational hedging and the use of forward contracts and currency swaps with maturities of less than 18 months. In both years, P&G stated that near-term changes in currency rates would not materially affect its financial statements, based on a 95% confidence level using historical data. Additionally, the company emphasized its confidence in mitigating near-term exchange rate fluctuations through its diversified portfolio and hedging strategies. There was no significant change in the nature or extent of hedging instruments used during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: P&G's currency risk exposure remained stable between FY2023 and FY2024; the company used forward contracts and currency swaps with maturities under 18 months; and it maintained a 95% confidence level that near-term exchange rate fluctuations would not materially affect financial statements. These points match the original answer exactly. (2) Quantitative elements—'95% confidence level', 'less than 18 months', and 'fiscal years ended June 30, 2023 and 2024'—are all factually correct and consistent with the ground truth. No calculations were required, but temporal and statistical data are precise. (3) The multi-hop reasoning is sound: the answer synthesizes information about risk exposure, hedging instruments, and confidence assessments across two fiscal years. The only minor deviation is the mention of 'operational hedging' and 'diversified portfolio', which are not present in the original answer. While these may reflect general knowledge about P&G’s strategy, they introduce slight overreach beyond the provided ground truth, slightly reducing qualitative accuracy. However, they do not contradict the facts. (4) The response is fully contextually relevant, addressing all parts of the question—evolution of risk exposure, hedging instruments, and confidence in mitigation—without introducing irrelevant information. Overall, the answer is semantically equivalent to the ground truth with high completeness and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 422,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "Between 2022 and 2024, Adobe has expanded Frame.io's functional scope and deepened its integration with other Adobe products. In 2022, Frame.io was described as a cloud-native collaboration platform supporting video and design workflows with integrations into Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. By 2024, Frame.io's integration has expanded further, with enhanced support for video workflows beyond post-production (e.g., casting, location scouting, marketing campaign management) and direct integration with additional Adobe tools. It is also highlighted as part of Adobe GenStudio, enabling scalable content production and emphasizing its role in Adobe's broader creative ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Frame.io between 2022 and 2024 and its integration into Adobe's ecosystem. However, there is a factual inaccuracy regarding the 2022 description: the ground truth states that in 2022, Frame.io was only listed as a trademark with no functional description, whereas the LLM claims it was already described as a 'cloud-native collaboration platform' with specific integrations—this level of detail did not appear until 2024. This misrepresents the timeline and overstates the integration depth in 2022. The 2024 details are mostly accurate: Frame.io is correctly described as part of Adobe GenStudio and having expanded functionality and integrations, including with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. The mention of expanded use cases like casting and location scouting is plausible but not explicitly confirmed in the ground truth, which focuses on real-time upload, review, frame-accurate commenting, and Camera to Cloud. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—scored 10 by default as no errors exist. (3) The multi-hop reasoning is partially sound: the model correctly infers increased integration and broader functional scope over time, but fails to accurately represent the starting point in 2022, weakening the comparative analysis. (4) The contextual relevance is high because the answer addresses the question’s focus on functional scope and integration evolution. The qualitative accuracy is reduced due to the incorrect attribution of 2024-level detail to 2022, which affects the fidelity of the evolution narrative. Overall, the answer captures the direction and general trajectory correctly but lacks precision in the historical state, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 502,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "Between the 2022 and 2023 fiscal years, AMD's carrying value of its investment in the ATMP JV increased from $69 million to $99 million, reflecting a $30 million growth. Financial disclosures related to the ATMP JV became more detailed in 2023, with expanded reporting of purchases and payables, which rose from $1.1 billion in 2022 to $1.7 billion in 2023, and payables increasing from $85 million to $363 million. The nature of disclosures also included clearer descriptions of the joint venture's role in providing ATMP services and AMD's inventory management involvement.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both quantitative and qualitative aspects. According to the ground truth, in the 2022 filing, AMD reported a carrying value of $69 million as of December 25, 2021, and $63 million as of December 26, 2020 — there is no mention of a $99 million carrying value in 2023, nor any indication of an increase. In fact, the 2023 filing omits the carrying value entirely, which the LLM incorrectly states as having risen to $99 million. Similarly, the LLM claims purchases from the JV increased from $1.1 billion in 2022 to $1.7 billion in 2023, but the ground truth states that transaction figures were only disclosed for 2020 and 2021 ($831M and $1.1B respectively) in the 2022 filing, and were omitted entirely in 2023 — not expanded. Payables figures ($85M to $363M) are entirely fabricated with no support in the original answer. (2) All numeric values in the LLM response are factually wrong and contradict the ground truth. The direction of change (increased disclosure, increased investment value) is the opposite of the truth (reduced disclosure, no updated carrying value). (3) The multi-hop reasoning is fundamentally flawed: instead of recognizing that AMD stopped disclosing specific financials in 2023 (a reduction in transparency), the model falsely asserts increased detail and new figures. It fails to recognize that the absence of data in the 2023 filing is a key part of the evolution. (4) The contextual relevance is moderate because the answer addresses the right topic (AMD's relationship with ATMP JV) and mentions relevant aspects like disclosures and financial figures, but the factual inaccuracies render it misleading. Correctness and quantitative accuracy are extremely low due to complete inversion of facts and invention of unsupported numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 495,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a potential weakening in demand for new aircraft equipment, which could indicate challenges in the aerospace sector, such as reduced OEM production or market saturation. However, the overall Aerospace Technologies segment still showed growth in total sales, driven by higher Commercial Aviation Aftermarket and Defense and Space revenues, highlighting Honeywell's diversified position in the aerospace industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for Commercial Aviation Original Equipment—$2,397 million in 2023 and $2,223 million in 2024—matching the ground truth exactly. The decrease is accurately implied, and no calculation is required beyond this comparison. (2) All numeric values are correct and presented in a consistent format; minor phrasing differences (e.g., 'decreased from...to...') do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies the decline in Original Equipment revenue while contextualizing it within broader growth in the Aerospace Technologies segment, citing Commercial Aviation Aftermarket and Defense and Space as drivers. This synthesis aligns with the ground truth’s implication that overall division growth occurred despite this segment's contraction. (4) The LLM adds slightly more context than the original answer—mentioning aftermarket and defense growth as offsetting factors—which is factually plausible and enhances the explanation without contradicting the ground truth. The only minor difference is that the original emphasizes 'supply constraints' as a possible cause, while the LLM focuses on 'demand' and 'market saturation.' However, both are reasonable interpretations, and the LLM does not contradict the original; it complements it. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 421,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The global revenue contribution from Heart Failure Devices increased by 10.3% in 2024, excluding the effect of foreign exchange, primarily driven by growth in heart assist devices. In 2023, the segment's revenue grew by 12.0% under similar conditions. This indicates a slight deceleration in growth from 2023 to 2024, with a 1.7 percentage point decrease in the growth rate.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative facts. The ground truth states that Heart Failure Devices revenue increased from $1,161 million in 2023 to $1,279 million in 2024, representing a 10.2% increase. The LLM incorrectly reports a 10.3% growth but does not provide the actual revenue figures, which are essential to fully answer the question. More critically, the LLM introduces a claim that 2023 revenue grew by 12.0%, which is not supported by the original answer and is factually incorrect—no growth rate for 2023 is given in the ground truth, only the absolute revenue. (2) The percentage calculation in the ground truth is correct: (1,279 - 1,161) / 1,161 ≈ 10.16%, rounded to 10.2%. The LLM’s 10.3% is close but inaccurate, and without showing base-year revenues, it fails the completeness and accuracy test. (3) The reasoning is flawed: the LLM attempts a multi-hop comparison between 2023 and 2024 growth rates, but the original data does not provide 2023 growth rate—only absolute revenue. Thus, the conclusion about 'deceleration' and '1.7 percentage point decrease' is fabricated and reflects incorrect synthesis. (4) Contextual relevance is moderate—the answer discusses the correct segment and general trend (growth in revenue), but introduces unsupported metrics and misrepresents the data. The mention of 'heart assist devices' as a driver is not in the original and adds unverified detail. Overall, major factual and quantitative errors lead to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 419,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "Between the 2022 and 2023 filings, IBM's treatment of the 0.300% Notes due 2028 remains consistent, as both filings list the notes under the company's registered securities. In the 2022 filing (page 28), the 0.300% Notes due 2028 are listed as \"IBM 28B\" and traded on the New York Stock Exchange. In the 2023 filing (page 1), the same note is again listed with identical terms and trading details, indicating no material change in its classification or status.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim that IBM's treatment of the 0.300% Notes due 2028 remained consistent between the 2022 and 2023 filings. The ground truth states that in the 2022 filing, the notes were only referenced by incorporation by reference via Exhibit 4.1 to a Form 8-K from February 10, 2020, and were not explicitly listed in a table of registered securities with a trading symbol. However, the LLM incorrectly asserts that in the 2022 filing (page 28), the notes were already listed as 'IBM 28B' and traded on the NYSE—this contradicts the ground truth. In reality, it was only in the 2023 filing that the notes were formally listed with the symbol IBM 28B and explicitly registered on the NYSE. Therefore, there was a material change in disclosure practice—from incorporation by reference to explicit registration and listing—which the LLM completely misses. The answer falsely claims consistency where there was evolution. Quantitatively, the percentage (0.300%) and maturity year (2028) are correct, but the claim about the 2022 listing with a trading symbol is factually wrong. The reasoning is flawed because it fails the multi-hop requirement: comparing the nature of disclosure across two filings. While the entities (IBM, 0.300% Notes due 2028) are correct, the synthesis across years is incorrect. Contextually, the answer addresses the right topic but draws the opposite conclusion of the ground truth, making it misleading despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 410,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple's financial performance in the Rest of Asia Pacific region from 2022 to 2023 showed a modest increase in net sales, rising from $29,375 million in 2022 to $29,615 million in 2023, and further to $30,658 million in 2024. Operating income also improved during this period, increasing from $11,569 million in 2022 to $12,066 million in 2023 and reaching $13,062 million in 2024, indicating a positive trend in both revenue and profitability for the region.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly reports Apple's 2022 and 2023 net sales ($29,375M and $29,615M) and operating income ($11,569M and $12,066M), it incorrectly introduces 2024 data ($30,658M net sales, $13,062M operating income) which is not part of the question or ground truth. The question only asks about 2022 to 2023 performance. (2) The quantitative accuracy is partially correct for 2022–2023 figures, but the inclusion of fabricated 2024 numbers severely undermines correctness. The ground truth reports a $240M (0.8%) increase in net sales and $497M (4.3%) increase in operating income—calculations the LLM does not explicitly make, nor confirm. (3) The multi-hop reasoning is flawed because the model extrapolates beyond the provided data, introducing non-existent future-year figures instead of analyzing the requested 2022–2023 evolution. It fails to compute or mention the percentage growth rates, which are key to assessing performance trends. (4) Contextual relevance is moderate because the answer discusses the correct company, region, and metrics, and correctly identifies a positive trend, but the inclusion of false data and omission of calculated changes significantly reduces its reliability. The core facts for 2022–2023 are present but overshadowed by inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 375,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The vesting period for stock options issued under the 2007 Omnibus Incentive Plan changed between grants made prior to 2022 and those made after December 31, 2021. Stock options granted prior to 2022 generally vested pro rata over a five-year period, while stock options granted subsequent to December 31, 2021 generally vest pro rata over a four-year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and matches the ground truth in all key aspects: (1) It accurately states that stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, and those granted after December 31, 2021, vest over a four-year period—this aligns with both the 2022 and 2024 10-K disclosures. (2) All dates and time periods (pre-2022 vs. post-December 31, 2021) are correctly referenced, and the vesting durations (5-year vs. 4-year) are quantitatively accurate. (3) The reasoning correctly captures the structural change in the plan, showing a reduction in vesting period after the amendment. (4) The only minor shortcoming is completeness: while the LLM answer correctly describes the change, it does not explicitly mention that the 2024 10-K confirms the continuation of these terms, which adds longitudinal validation. However, this omission does not undermine the core factual accuracy. The answer is semantically equivalent to the ground truth and fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 301,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "From 2022 to 2023, CVS maintained a consistent approach to validating fair value estimates for its Level 2 debt securities, with no adjustments made to the prices obtained in either year. The Company continued to review prices for observable market inputs and compared primary source prices to secondary sources quarterly, examining variances above a specified threshold. Additionally, the internal investment team consistently compared prices to its own independent fair value estimates. No changes in methodology or increased reliance on secondary source comparisons were noted in the 2023 disclosures compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CVS obtained one price per Level 2 debt security in both 2022 and 2023, made no price adjustments at year-end (specifically December 31, 2022 and 2023, and also referenced 2020/2021 in original), and continued quarterly comparisons to secondary sources with threshold-based variance reviews. (2) Quantitative accuracy is perfect: no numerical errors, correct years, and proper representation of the unchanged methodology. (3) The multi-hop reasoning is sound—synthesizing information across years and validation steps (primary vs. secondary sources, internal team review). The only minor gap is that the LLM mentions the investment team comparing prices to 'independent fair value estimates,' which is slightly more specific than the original's 'emphasis on consistent internal validation,' though this is a reasonable inference and not factually incorrect. (4) The answer fully addresses the question about evolution (or lack thereof) in approach, price adjustments, and secondary source comparisons. Wording differs slightly but maintains semantic equivalence. No irrelevant content; highly contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 342,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "Between 2022 and 2023, CVS maintained its classification of privately-placed equity securities in Level 3 of the fair value hierarchy due to the absence of an active market. The valuation methodology for these securities remained consistent, relying on internal analysis of each investment's financial statements and cash flow projections. Unobservable inputs such as earnings and revenue multiples, discounts for lack of marketability, and comparability adjustments continued to be significant in determining fair value. However, in 2023, the fair value of privately-placed equity securities increased from $60 million to $79 million, reflecting changes in the underlying assumptions or investment performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that CVS classified privately-placed equity securities as Level 3 in both years and used internal financial analysis and cash flow projections for fair value determination. It accurately lists the unobservable inputs (earnings and revenue multiples, discount for lack of marketability, comparability adjustments), which matches the ground truth. However, the LLM introduces a specific quantitative claim—'fair value increased from $60 million to $79 million'—that is not present in the original answer and cannot be verified from the provided ground truth. This number is likely fabricated or misattributed, as the ground truth does not mention any dollar values for the securities in either year. (2) The quantitative inaccuracy is significant: the introduction of unsupported dollar figures ($60M to $79M) undermines factual reliability, even if the direction of change (increase) might align with some external data. Since the ground truth contains no such numbers, this represents a clear hallucination or data error. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes the consistent classification, methodology, and inputs across 2022 and 2023, and notes a qualitative shift in emphasis in 2023. However, it fails to mention the key evolution highlighted in the ground truth—the increased emphasis on sensitivity analysis or scrutiny of unobservable inputs' impact on fair value—which is a critical qualitative development. Instead, it substitutes this with a numerical change that wasn't asked for and isn't supported. (4) The correctness score is 6 due to partially correct information: core classification and inputs are right, but missing the key 2023 enhancement in methodology emphasis and introducing false quantitative data. Quantitative accuracy is low (4) due to unsupported numbers. Qualitative accuracy is high (8) because the reasoning framework is solid, and contextual relevance is strong (9) as the response stays focused on the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 550,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue from Alphagan/Combigan decreased by 8.8% between 2023 and 2024. In terms of international revenue, it increased by 1.5% in 2024 compared to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that total net revenue from Alphagan/Combigan decreased by 8.8% from 2023 to 2024 and that international revenue increased by 1.5%, which matches the ground truth. All percentages are accurate. (2) The ground truth specifies the dollar amounts: $272M (2023) to $248M (2024) for total net revenue (an 8.8% decline), and $151M to $153M for international revenue (a 1.5% increase). While the LLM does not include the exact dollar figures, the percentage changes are calculated correctly and match the ground truth. (3) The multi-hop reasoning is sound—the model correctly synthesizes the trend across two years and two revenue segments (total and international). It correctly infers the direction and magnitude of change. (4) The answer is contextually complete and relevant, though slightly less detailed than the original answer due to omission of absolute values. However, since the question only asks for the change and trend, the percentage-based response suffices. The correctness score is 9 instead of 10 due to the missing dollar amounts, which add context but are not strictly required for answering the question as posed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 333,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly from 2023 to 2024, as PDC was acquired by Chevron in a business combination during 2023. This acquisition contributed to Chevron's production performance in 2024, with the full-year inclusion of legacy PDC production being a primary driver for the seven percent increase in worldwide oil-equivalent production compared to 2023. Specifically, the United States production saw a notable increase, attributed in part to PDC's operations, with net daily oil-equivalent production in the Permian Basin benefiting from PDC's assets and strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Chevron acquired PDC Energy in 2023 and that the full-year contribution from legacy PDC operations in 2024 contributed to a 7% increase in worldwide oil-equivalent production, which matches the ground truth. The percentage (7%), the year-over-year comparison (2023 to 2024), and the causal link between the acquisition and production growth are all factually accurate. (2) Quantitative accuracy is perfect: the 7% production increase is correctly cited, and no other numerical inaccuracies are present. Format and units are consistent with the original answer. (3) The multi-hop reasoning is sound—linking the 2023 acquisition to the 2024 production impact demonstrates synthesis across time and entities. The LLM adds contextual detail about the Permian Basin and U.S. production, which is plausible and consistent with PDC’s operational focus, though not explicitly stated in the ground truth. This addition does not contradict but slightly extends the original answer, which is acceptable. (4) The only minor shortcoming is that the original answer specifically notes PDC was excluded from internal control assessment in 2023 due to the acquisition timing—a detail omitted in the LLM response. However, this does not affect the core question about operational impact on production. Thus, while highly accurate and complete on the main points, a score of 9 is justified due to this minor omission in completeness. All other aspects—contextual relevance, reasoning, and factual accuracy—are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 428,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "From 2023 to 2024, UPS enhanced its cold-chain logistics capabilities through strategic acquisitions. In 2023, the acquisitions of MNX Global Logistics and Bomi Group expanded UPS's global time-critical and temperature-sensitive logistics services, particularly in healthcare and international markets. In 2024, UPS further strengthened its cold-chain logistics by acquiring Frigo-Trans and Biotech & Pharma Logistics, a leading healthcare logistics provider in Germany, for approximately $440 million. These acquisitions contributed to UPS's growth in complex cold-chain logistics capabilities both domestically and internationally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2023 acquisitions of Bomi Group and MNX Global Logistics, and the 2024 acquisitions of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million are accurately reported. The dollar amount and years are correct, satisfying quantitative accuracy. (2) The answer correctly identifies the purpose of the acquisitions—enhancing cold-chain and healthcare logistics—both globally and specifically in Germany. (3) The multi-hop reasoning is sound: it connects UPS’s strategic evolution from 2023 to 2024, showing a progression in cold-chain investment. (4) The only minor shortcoming is that the LLM does not explicitly characterize the shift from general expansion to targeted, high-value international acquisitions, which is a nuanced but important point in the original answer. However, the implication is present through the description of the German acquisitions as significant. Wording differs slightly but maintains semantic equivalence. No factual errors or omissions affect the core correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 320,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "Between 2022 and 2024, Linde plc's non-employee director restricted stock unit (RSU) award program has evolved to enhance governance and long-term shareholder alignment. In 2022, the program was governed under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan, with awards structured to align director compensation with company performance and shareholder returns. By 2024, the program transitioned under the 2021 Linde plc Long Term Incentive Plan, reflecting a more updated governance framework. Additionally, in 2024, Linde introduced the Linde plc Non-employee Director Deferral Program, adopted on July 30, 2024, which allows directors to defer compensation, further aligning their interests with long-term shareholder value.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and captures the key evolution of Linde plc's non-employee director RSU program between 2022 and 2024, particularly the introduction of the deferral program on July 30, 2024, which aligns with the ground truth. The date of adoption (July 30, 2024) is accurate, and the existence of the Linde plc Non-employee Director Deferral Program is correctly identified, supporting strong quantitative and contextual accuracy. However, there is a significant factual error in the governance structure timeline: the LLM claims that in 2022, the program was governed under the 'Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan.' This contradicts the ground truth, which states that the 2022 program was established under the '2021 Linde plc Long Term Incentive Plan.' This misrepresentation of the foundational plan undermines the qualitative accuracy, as it misattributes the governance framework during the initial phase of the program. The evolution narrative—transitioning from an older plan to the 2021 plan by 2024—is factually incorrect; the 2021 plan was already in place in 2022. Despite this, the core multi-hop synthesis (linking the 2022 RSU framework to the 2024 deferral expansion) is logically sound and contextually relevant. The answer correctly identifies the purpose of these mechanisms—long-term shareholder alignment and enhanced governance—even if the underlying entity (the incentive plan) is misstated. Therefore, while the reasoning and intent are well-conveyed, the error in plan identification reduces the correctness and qualitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 446,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "Between 2022 and 2024, General Motors' financial and legal relationship with Stellantis primarily revolved around indemnification obligations stemming from the 2017 sale of the Opel/Vauxhall business to PSA Group (now Stellantis). GM agreed to indemnify Stellantis for certain losses related to emissions claims, product liabilities, and recalls for vehicles sold before the sale. As of December 31, 2024, GM had accrued an immaterial amount for these obligations, as it was unable to estimate any reasonably possible material loss or range of loss. Additionally, GM indemnified Stellantis for an immaterial amount related to Takata inflator recalls in legacy Opel vehicles, though further indemnification for such matters was considered remote. There were no notable investment gains reported in the provided documents regarding this relationship.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the indemnification obligations from GM to Stellantis related to the 2017 Opel/Vauxhall sale, including emissions claims, product liabilities, and recalls, which aligns with the ground truth. It also accurately notes that GM accrued an immaterial amount and could not estimate a material loss, which is consistent with disclosures. However, it fails to mention the key positive financial event in 2022 — the $0.2 billion gain from Stellantis warrants — which is a major component of the question about the evolution of the financial relationship. This omission significantly undermines completeness and correctness. (2) Quantitatively, the LLM does not contradict any numbers; it correctly states that accruals were immaterial and avoids fabricating figures. However, it omits the $0.2 billion gain, a critical quantitative fact. The absence of this number results in a partial failure in quantitative accuracy despite no incorrect numbers being presented. (3) The reasoning is sound in describing the indemnification obligations and their legal basis, showing correct multi-hop synthesis between the 2017 sale and later liabilities. However, the failure to incorporate the 2022 gain breaks the narrative of evolution 'between 2022 and 2024', weakening the multi-hop analysis. The answer presents only one side (liabilities in 2024) without contrasting it with the earlier financial benefit. (4) Contextual relevance is high because the answer focuses on the right companies, time frame, and transaction (Opel sale), and addresses indemnification thoroughly. But due to the missing 2022 gain — a central element of the financial evolution — the overall correctness score is reduced to 6, reflecting partial accuracy with a significant factual omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 489,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "From 2022 to 2024, Southern Company's treatment and disclosure of energy-related derivatives evolved in terms of financial presentation and categorization by providing more detailed breakdowns of derivative positions and their fair value impacts. In 2024, the company presented a more granular categorization of derivatives, including energy-related derivatives designated as hedging instruments for regulatory purposes and those in cash flow and fair value hedges, with separate disclosures for current and non-current positions. Additionally, the 2024 disclosures included more specific information on netting arrangements, collateral, and the fair value gains or losses for various derivative types, reflecting a more transparent and structured approach to financial reporting compared to 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but diverges from the ground truth in key aspects. While it correctly identifies a shift toward more detailed disclosure by 2024, it introduces specifics not present in the original answer—such as derivatives designated for 'regulatory purposes', 'cash flow and fair value hedges', 'netting arrangements', and 'collateral'—which are not mentioned in the ground truth. The original answer emphasizes a shift from income statement presentation (2022) to balance sheet categorization under 'Other' or 'Risk Management Activities' (2024), which the LLM answer omits or reinterprets. (2) There are no explicit numbers, dollar amounts, or percentages in either answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct and consistently used. (3) The multi-hop reasoning is partially sound: the model infers increased transparency over time, which aligns with the ground truth, but fails to accurately represent the nature of the evolution—shifting from income statement focus to balance sheet classification. Instead, it fabricates a more complex categorization structure not supported by the original. (4) The contextual relevance is high because the response addresses the evolution of derivative disclosures and stays within the timeframe and topic. However, the qualitative accuracy is reduced due to incorrect synthesis—adding unsupported details and missing the core shift from income to balance sheet reporting. Correctness score is moderate because the general direction of increased transparency is correct, but the specific evolution described is factually misaligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 450,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "Between 2023 and 2024, GILD's strategic relationship with Arcus evolved significantly in terms of equity ownership and governance influence. In 2023, GILD owned approximately 19.9% of Arcus' voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment, increasing its ownership to 33%, and expanded its board representation to three designees. This marked a substantial increase in both equity ownership and governance influence over Arcus.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All key facts are accurately reported: GILD's initial 19.9% ownership in Arcus in 2023, two board designees, the January 2024 $320 million equity investment, the increase in ownership to 33%, and the expansion of board representation to three designees. (2) Quantitative accuracy is perfect: percentages (19.9% → 33%), dollar amount ($320 million), and timing (January 2024) are all correct. No calculations are required beyond the stated increase, which is factually sound. (3) The multi-hop reasoning is sound—information is synthesized across two time points (2023 and 2024) and two dimensions (equity ownership and governance), correctly showing an evolution in the strategic relationship. (4) The answer is semantically equivalent to the original, with no omissions or distortions, and directly addresses the question’s focus on changes in ownership and governance. All entities (GILD, Arcus) and time periods are correctly identified. No errors or inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 302,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "The maturity date of the 2021 Multicurrency Credit Facility was extended from July 1, 2026, in 2022 to July 1, 2026, in 2023, remaining unchanged. The borrowing capacity also remained the same at $6.0 billion between 2022 and 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the maturity date for 2022. According to the ground truth, the 2021 Multicurrency Credit Facility had a maturity date of June 30, 2025, in 2022, not July 1, 2026. The LLM incorrectly states that the maturity date was already July 1, 2026, in 2022 and remained unchanged in 2023, which contradicts the ground truth that the date was extended *to* July 1, 2026, in 2023. The borrowing capacity of $6.0 billion is correctly reported for both years. (2) Quantitative accuracy is low because the key date (maturity in 2022) is wrong. The correct evolution is from June 30, 2025, to July 1, 2026 — a one-year extension — but the LLM falsely implies no change occurred. (3) The multi-hop reasoning is flawed: the model failed to correctly synthesize the change over time, misrepresenting the direction and nature of the maturity date update. It incorrectly suggests stability when there was a clear extension. (4) Contextual relevance is high because the answer addresses both parts of the question (maturity date and borrowing capacity) and focuses on the correct financial instrument and time frame. However, due to the major factual inaccuracy in dates, the overall correctness score is low despite correct mention of the unchanged borrowing capacity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 367,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron's utilization of imported crude oil in U.S. refining operations remained stable at approximately 60% of total refinery inputs in both 2023 and 2024. However, refinery capacity utilization in the U.S. declined slightly, averaging 86.6% in 2024 compared to 90.8% in 2023. This decrease in utilization was accompanied by ongoing projects to enhance refinery flexibility and throughput capacity, such as the completion of the Pasadena Refinery upgrade in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron's reliance on imported crude oil remained stable at approximately 60% in both 2023 and 2024, matching the ground truth. It also accurately reports the refinery capacity utilization figures: 90.8% in 2023 and 86.6% in 2024, reflecting the decline. All quantitative data are factually correct. (2) Numeric values are precise and consistent with the original answer; no calculation errors are present. The comparison between years is accurate. (3) The multi-hop reasoning is sound—linking imported crude oil usage with refinery utilization trends across two years. However, the mention of 'ongoing projects to enhance refinery flexibility' and the 'completion of the Pasadena Refinery upgrade in 2024' introduces information not present in the ground truth, which does not mention any such projects or upgrades. While this addition does not contradict the core facts, it adds unsupported context, slightly reducing qualitative accuracy. (4) Despite the minor addition of unverified details, the answer remains highly accurate, complete, and relevant to the question. The core facts, numbers, and synthesis are correct, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 343,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS's hedging position in British Pound Sterling decreased from £856 million in 2022 to £663 million in 2023 and further to £536 million in 2024, as reflected in the notional amounts of outstanding derivative positions. This reduction indicates a strategic adjustment in UPS's currency risk management, potentially reflecting a lower exposure to GBP-denominated cash flows or a shift in focus to other currencies like the Chinese Renminbi, which appeared in 2024. The shift suggests a more dynamic and responsive approach to managing foreign currency risks based on evolving operational and financial exposures.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 and 2024 GBP hedging positions as £663 million and £536 million, matching the ground truth. However, it introduces a 2022 figure (£856 million) not present in the original question or ground truth, which is extraneous and unverified. The reduction from 663M to 536M is accurate (127M decrease, ~19.15%), but the LLM does not explicitly calculate or mention the percentage change, slightly reducing quantitative completeness. (2) The numbers for 2023 and 2024 are correct and match the ground truth; however, the inclusion of a 2022 value introduces a factual element outside the scope of the provided data, which risks misleading the user. Calculations implied by the decrease are directionally correct but not explicitly verified in the response. (3) The reasoning about UPS adjusting its currency risk strategy is sound and aligns with the ground truth’s interpretation. The mention of a shift toward other currencies like Chinese Renminbi (RMB) in 2024 adds context not in the original answer; while plausible, it is not supported by the ground truth and represents an unsupported inference. Still, the core multi-hop reasoning—linking decreasing hedge notional to strategic risk management—is valid. (4) The answer is highly relevant to the question, addressing both the evolution of the hedging position and its strategic implications. Despite minor inaccuracies and additions, the central facts and interpretation are aligned with the ground truth. The score reflects high qualitative and contextual accuracy but a moderate deduction in quantitative accuracy due to the inclusion of unverified data and lack of explicit calculation verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 466,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at the end of 2023 to $1.3 billion at the end of 2024. This slight increase suggests a modest shift in the company's short-term investment strategy, potentially reflecting efforts to maintain or slightly expand its liquidity position amid evolving market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the fair value of money market investments increased from $1.2 billion at the end of 2023 to $1.3 billion at the end of 2024, matching the ground truth exactly in both values and time periods. There are no numerical or date inaccuracies. (2) All numeric values are accurate and properly formatted; the increase of $0.1 billion (or $100 million) is implied and consistent with the data. No calculations were required beyond recognition of the change, which is correctly interpreted as an increase. (3) The reasoning is sound: the LLM correctly infers that the increase suggests a modest shift in short-term investment strategy, aligning with the ground truth's interpretation of 'modest growth' and 'slight expansion in liquidity management.' While the original answer explicitly mentions 'liquidity management or short-term capital deployment,' the LLM's phrasing—'maintain or slightly expand its liquidity position amid evolving market conditions'—is semantically equivalent and contextually reasonable, though slightly less specific. (4) The answer fully addresses both parts of the question: the evolution of fair value and its implication for strategy. The contextual relevance is perfect, and the qualitative accuracy is very high, warranting a 9/10 due to minor softening of specificity in strategic interpretation. Overall, this is a factually correct, complete, and well-reasoned response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 401,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas subject to physical supply contracts with sell-back options for Southern Company decreased from 26 million mmBtu in 2022 to 15 million mmBtu in 2024. Specifically, Alabama Power's volume decreased from 6 million mmBtu to 4 million mmBtu, Georgia Power's from 8 million mmBtu to 6 million mmBtu, Mississippi Power's from 4 million mmBtu to 2 million mmBtu, and Southern Power's from 8 million mmBtu to 3 million mmBtu.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values for both 2022 and 2024 are accurate: company-wide totals (26 million mmBtu to 15 million mmBtu), and subsidiary-specific volumes (Alabama Power: 6 to 4, Georgia Power: 8 to 6, Mississippi Power: 4 to 2, Southern Power: 8 to 3 million mmBtu) are exactly correct. (2) Quantitative accuracy is perfect—no calculation errors, and the reductions are correctly implied. (3) The multi-hop reasoning is sound: the model correctly synthesized data across Southern Company and its four subsidiaries over two years, capturing the consistent downward trend. (4) The answer is semantically equivalent to the original, conveying the same core conclusion—a company-wide and subsidiary-level reduction—without any omissions or distortions. All entities, metrics, and time periods are correctly identified. The response is concise but complete, directly addressing the change in volume over time across all relevant entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 289,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "Between 2023 and 2024, the integration and application of the Firefly Vector Model across Adobe's product suite expanded significantly. In 2023, Firefly Vector Model was introduced as part of Adobe Firefly, enabling users to generate fully editable vector graphics from text prompts. By 2024, the model was more deeply integrated into core creative tools like Adobe Illustrator and Adobe Express, allowing for enhanced generative design capabilities such as Generative Recolor and streamlined workflows for creating vector-based content. Additionally, Firefly Vector Model became part of Adobe Firefly Services and Custom Models, offering enterprises scalable solutions for brand-specific content generation. This evolution reflects Adobe's focus on embedding generative AI into its ecosystem to boost creativity and productivity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of the Firefly Vector Model from 2023 to 2024 across Adobe's product suite. It accurately notes the 2023 introduction involving text-to-vector generation and the 2024 integration into Adobe Illustrator and Adobe Express with features like Generative Recolor. However, it slightly misrepresents the 2023 integration by stating it was introduced as part of 'Adobe Firefly' broadly, whereas the ground truth specifies it was integrated into Adobe Express specifically. Additionally, the mention of 'Adobe Firefly Services and Custom Models' and 'enterprises scalable solutions' is not present in the ground truth and introduces unverified details about enterprise offerings. (2) There are no numeric values, dates, or calculations in the question or answers that conflict—dates (2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is mostly sound: the model correctly infers progression in integration across time and products, linking Firefly’s evolution from initial to expanded use. However, the addition of unsupported enterprise applications weakens the fidelity of the synthesis. (4) Despite minor overreach in scope, the core facts—timeline, product integrations (Illustrator, Express), and key features like Generative Recolor—are accurate and contextually relevant. The answer captures the essence of the evolution, warranting a high correctness score with a small deduction for unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 412,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "Based on the data from the GILD_10k_2023.pdf and GILD_10k_2024.pdf, Biktarvy's commercial significance for Gilead has grown from 2023 to 2024. In 2023, Biktarvy generated $11,850 million in total product sales, increasing to $12,130 million in 2024. This growth reflects its continued dominance in Gilead's HIV portfolio. The increase in sales suggests that Biktarvy remains a cornerstone of Gilead's HIV business strategy, helping to offset potential revenue declines from other HIV products due to competition and patent expirations. However, the company must continue to innovate and expand indications for existing products to maintain its market position in the competitive HIV treatment landscape.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2024 sales figure for Biktarvy. The ground truth states that the 2024 data reflects increased risks and strategic concerns but does not report $12,130 million in sales for 2024—this number is fabricated or incorrectly sourced. The original answer only provides 2023 sales ($11,850 million) and notes growing risks in 2024, with no indication of sales growth. Thus, the claim of an increase to $12,130 million is unsupported and incorrect. (2) Quantitative accuracy is low because the core financial data for 2024 is wrong. While the 2023 figure ($11,850 million) is correctly stated, the 2024 figure is not present in the ground truth, making the comparison and implied growth false. There is no calculation error per se, but the input data is invalid. (3) The reasoning is partially sound in recognizing Biktarvy's strategic importance and the need for innovation, but it misrepresents the trend by asserting continued growth when the ground truth signals heightened risk and potential decline due to generic competition and treatment shifts. The multi-hop synthesis fails because it does not correctly integrate the 2024 risk narrative with the 2023 performance data. Instead of highlighting strategic vulnerability, it portrays ongoing commercial expansion. (4) Contextual relevance is high because the answer addresses both parts of the question—commercial significance and strategic implications—and discusses relevant themes like competition and innovation. However, due to the incorrect sales figure and resulting misinterpretation of Biktarvy’s trajectory, the qualitative and overall correctness scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 466,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "The Series 2018-1A Securities had an outstanding principal amount of $496.8 million as of December 31, 2023, compared to $496.1 million as of December 31, 2022, indicating a slight increase in the outstanding principal. The interest rate for the Series 2018-1A Securities remained consistent at 3.652% during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported principal amounts. According to the ground truth, the outstanding principal in 2022 was $500.0 million, not $496.1 million as stated by the LLM. In 2023, the principal was $496.8 million, which the LLM correctly reports. However, the LLM incorrectly states that the principal increased from 2022 to 2023, when in fact it decreased from $500.0 million to $496.8 million. The interest rate of 3.652% is correctly reported as unchanged, which is accurate. (2) The quantitative inaccuracies are critical: the 2022 principal is off by over $3 million, and the direction of change (increase vs. decrease) is wrong, leading to an incorrect conclusion. (3) The reasoning is flawed because the model fails to correctly retrieve and compare the two principal values across years, undermining the multi-hop synthesis required to assess evolution over time. While it identifies the correct security and metric, the incorrect data leads to faulty inference. (4) Scores reflect major quantitative errors (3/10), partially sound reasoning but with incorrect inputs (4/10), and high contextual relevance as the answer addresses the right securities, time frame, and metrics, just with wrong numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 355,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "UPS's relationship with Coyote evolved significantly from 2023 to 2024, both financially and strategically. In 2023, UPS recorded a $111 million impairment charge for the Coyote trade name due to declining business performance and challenging market conditions. By 2024, UPS completed the strategic divestiture of Coyote in September, which led to a $156 million gain on the divestiture and significantly reduced operating expenses in the Forwarding segment by $949 million due to lower activity levels. This reflects a shift from impairment and underperformance in 2023 to a strategic exit and financial benefit in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $111 million impairment charge in 2023 related to the Coyote trade name, it fabricates a $156 million gain on divestiture and a $949 million reduction in operating expenses in the Forwarding segment—neither of which appear in the ground truth. These numbers are not supported by the original answer and represent major quantitative errors. The September 2024 divestiture date is correctly mentioned, aligning with the strategic timeline. (2) The original answer states that Coyote's exit contributed to a decrease in Supply Chain Solutions revenue, but does not mention any gain from divestiture or specific operating expense reductions. Thus, the LLM introduces false financial impacts not present in the source. (3) The multi-hop reasoning is partially sound in that it connects 2023 impairment to 2024 divestiture as a strategic evolution, which matches the original narrative. However, the synthesis fails when introducing non-existent financial gains and cost savings, indicating a failure to accurately retrieve or interpret the downstream financial effects. (4) The contextual relevance is high because the answer addresses the evolution of the relationship in both financial and strategic terms as asked. However, due to the inclusion of fabricated quantitative data, the correctness and quantitative accuracy scores are severely penalized. The qualitative accuracy is moderate because the direction of the strategic shift is correctly interpreted, but key financial outcomes are misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 441,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "Linde plc's Performance Share Unit Awards for grants beginning in 2019, as outlined in both the 2022 and 2024 10-K filings, utilized two primary performance metrics: Return on Capital and Total Shareholder Return. These metrics were specified in the forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan. There is no indication of a change in these metrics between 2022 and 2024 for grants starting in 2019.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies that Linde plc used two performance metrics—Return on Capital and Total Shareholder Return—for Performance Share Unit Awards related to grants beginning in 2019, under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan. It correctly states that there was no change in these metrics between the 2022 and 2024 10-K filings. The answer captures the core conclusion from the original answer: the structure remained consistent over time for the 2019 grants. While the LLM does not explicitly reference the exhibit numbers (e.g., Exhibit 10.11k, 10.11l, 10.10l, 10.10m), this detail is ancillary and does not affect the factual correctness of the response, as the question focuses on the evolution of the structure and metrics rather than document-level citations. All entities (company, plan name, metrics, time frame) are accurate. The reasoning is sound, demonstrating proper synthesis across years (2022 to 2024) and consistency in treatment of 2019 grants. There are no calculation errors or date inaccuracies. The answer is semantically equivalent to the original, though slightly less detailed in documentary references. Hence, a high score of 9 is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 373,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "Between 2023 and 2024, Trodelvy's regulatory status evolved with the FDA granting it Breakthrough Therapy designation in 2024 for the treatment of extensive-stage small cell lung cancer, following its 2023 approval for HR+/HER2- breast cancer and metastatic urothelial cancer. This indicates a positive development trajectory, with Trodelvy being recognized for its potential to significantly improve outcomes in serious conditions, thereby accelerating its regulatory review and expanding its therapeutic applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2024, the FDA granted Trodelvy Breakthrough Therapy designation for extensive-stage small cell lung cancer, which matches the original answer. It also correctly references its 2023 approvals for HR+/HER2-negative breast cancer and urothelial cancer. The mention of 'metastatic urothelial cancer' is consistent with the original answer's 'urothelial cancer' indication. (2) All dates (2023, 2024) and regulatory actions (Breakthrough Therapy designation) are factually correct. No numerical values require calculation, but the temporal and regulatory milestones are accurately presented. (3) The multi-hop reasoning is sound: the model synthesizes Trodelvy’s 2023 indications with its 2024 regulatory update and infers a positive development trajectory, correctly interpreting the strategic expansion into new oncology areas with high unmet need. (4) The only minor omission is that the original answer also lists 'unresectable locally advanced or metastatic triple-negative breast cancer' as a 2023 indication, which the LLM answer does not mention. While this doesn't invalidate the core correctness, it represents a slight incompleteness in the full scope of 2023 indications. Otherwise, the reasoning, entity accuracy (FDA, Trodelvy, cancer types), and contextual relevance are excellent. The conclusion about accelerated review and expanding therapeutic applications is semantically equivalent to the original's 'strategic expansion... high unmet medical need.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 430,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "The Vertex AI platform within Google Cloud has evolved significantly from 2023 to 2024 in terms of its capabilities and integration with generative AI models. In 2023, Vertex AI enabled developers to train, tune, augment, and deploy applications using generative AI models. By 2024, Vertex AI had expanded to include training, tuning, augmenting, testing, and deploying applications using Gemini, Imagen, Veo, and other generative AI models. Additionally, Gemini for Google Cloud was introduced, offering pre-packaged AI agents to assist developers in writing, documenting, testing, and operating software, as well as supporting cybersecurity teams in threat analysis and response.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of Vertex AI from 2023 to 2024, noting its initial capabilities in training, tuning, augmenting, and deploying generative AI applications. The 2024 enhancements are accurately described, including expanded functionality (testing), support for Gemini and other models (specifically naming Imagen and Veo, which are consistent with Google's generative AI suite), and the addition of new services like pre-packaged AI agents via Gemini for Google Cloud. While the original answer emphasizes vector search, grounding, and distillation for cost and quality improvement, the LLM answer substitutes this with specific use cases of Gemini agents in software development and cybersecurity—details not present in the ground truth but plausible and contextually relevant. These additions do not contradict the original but extend it slightly beyond the documented scope. All entities (Vertex AI, Google Cloud, Gemini, 2023–2024 timeline) are correct. No numerical inaccuracies exist (dates are correct, no erroneous figures). The reasoning is sound, demonstrating multi-hop synthesis across time and capabilities. The answer is semantically equivalent with minor expansion. Deduction of 1 point due to inclusion of details (cybersecurity agents) not confirmed in ground truth, slightly exceeding verified information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 390,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "From 2022 to 2024, the treatment and valuation of weather derivatives in SO's financial disclosures indicate that amounts associated with weather derivatives have consistently been deemed immaterial and excluded from derivative valuations. In both the 2022 and 2024 filings, the disclosures explicitly state that immaterial premium and intrinsic value associated with weather derivatives are excluded from the net amounts recognized in the balance sheets. However, in 2024, there is a slight increase in specificity, as the exclusion of weather derivative values is mentioned in the context of both current and deferred regulatory assets and liabilities, suggesting a more detailed breakdown of immaterial items. Overall, the materiality threshold for weather derivatives has remained low and consistent across the two periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that weather derivatives were consistently treated as immaterial in both 2022 and 2024, and that their premium and intrinsic value were excluded from derivative valuations—this aligns with the ground truth. However, it fails to include the key quantitative disclosures from 2024: the $17 million and $62 million in cash collateral held in broker margin accounts at the end of 2024 and 2023, respectively. These specific figures are central to the evolution in SO’s disclosure practices and were explicitly mentioned in the original answer. The LLM instead introduces a detail not present in the ground truth—mentioning that weather derivative exclusions were discussed in the context of 'current and deferred regulatory assets and liabilities'—which is unsupported by the provided truth. (2) Quantitative accuracy is low because the only numbers in the ground truth (the $17M and $62M collateral amounts) are entirely missing from the LLM response. No incorrect numbers are stated, but the omission of these critical figures significantly undermines the quantitative completeness. (3) The reasoning is partially sound: the model correctly infers consistency in immateriality treatment and detects increased specificity in 2024, but it misattributes that specificity to regulatory assets/liabilities rather than the new collateral disclosures, indicating a flawed multi-hop synthesis. (4) Contextual relevance is high because the answer stays focused on the question about changes in treatment and valuation, and correctly frames the narrative around immateriality and disclosure evolution, even if key data points are missing or misdirected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 461,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "Between 2023 and 2024, Biktarvy's regulatory and market positioning evolved through an expanded FDA-approved indication to treat people with HIV who have suppressed viral loads and known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the label was updated with new safety and efficacy data supporting its use in pregnant individuals with HIV-1. These updates reinforced Biktarvy's role as a versatile and reliable treatment option in managing HIV, particularly in complex patient scenarios.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory developments for Biktarvy in 2024—expanded indication for patients with suppressed viral loads and M184V/I resistance, and updated labeling for use in pregnant individuals with HIV-1. These are accurately drawn from GILD's 2024 disclosures and represent a shift toward broader therapeutic application. However, the LLM omits the 2023 patent expiration detail (2033 U.S. patent expiry), which is a key part of the original answer and important for understanding the market exclusivity positioning in 2023. This omission reduces completeness. (2) There are no numerical values, dates, or calculations in the LLM answer that conflict with the ground truth. The absence of the 2033 patent date is a missing fact, not an incorrect one, so quantitative accuracy remains high. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the 2024 regulatory updates and their implications. However, it fails to contrast 2023 (patent protection focus) with 2024 (expanded indications), which is central to the question about evolution between years. This weakens the qualitative reasoning. (4) Despite the omission, the answer is highly relevant and accurately reflects important aspects of Biktarvy’s 2024 regulatory evolution. Scores reflect strong performance with a moderate deduction for missing a key comparative element from 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 393,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "AMT's utilization of the 2021 Multicurrency Credit Facility changed significantly between 2022 and 2023. In 2023, AMT borrowed an aggregate of $3.0 billion and repaid $6.1 billion, including 842.6 million EUR ($919.1 million), under the facility, primarily to repay existing indebtedness and for general corporate purposes. Additionally, the facility was amended in June 2023, extending its maturity date to July 1, 2026, and replacing the LIBOR pricing benchmark with an Adjusted Term SOFR benchmark.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: $3.0 billion borrowed and $6.1 billion repaid in 2023, including the 842.6 million EUR (converted to $919.1 million), and the June 2023 amendment extending maturity to July 1, 2026, replacing LIBOR with SOFR. These match the ground truth exactly. However, the LLM omits the 2022 net borrowings of $850.0 million, which is a key part of the question asking for changes *between* 2022 and 2023. This omission reduces completeness but does not introduce inaccuracy. (2) All numbers and dates are factually correct and match the original answer. The EUR-to-USD conversion is accurately reflected. (3) The reasoning correctly identifies the structural changes in 2023 (amendments, benchmark shift) and the scale of borrowing/repayment, but fails to fully synthesize the multi-hop comparison by leaving out the 2022 borrowing activity, which is essential for assessing the change over time. (4) Scores reflect high factual accuracy and relevance, with a minor deduction in correctness and qualitative accuracy due to the omission of the 2022 borrowing detail, which weakens the comparative analysis the question demands.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 336,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "Between 2023 and 2024, Google Ad Manager remained a key platform for advertising inventory purchases, but there is no specific mention of a strategic evolution in its role within Alphabet's revenue recognition model. The integration with revenue reporting models continued to reflect gross reporting for ads placed on Google Network properties, where Alphabet acts as the principal, recognizing revenues billed to customers and recording payments to partners as cost of revenues. No material changes in this approach were disclosed in the provided pages.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that there was no strategic evolution or material change in Google Ad Manager's role in revenue recognition between 2023 and 2024. The ground truth explicitly states a shift from a transactional gross reporting model to a more control-based justification for gross revenue recognition, emphasizing Alphabet's role as principal with control over inventory, responsibility to customers, and pricing discretion. This evolution reflects a strategic refinement in accounting policy rationale, even if the outcome (gross reporting) remained the same. The LLM incorrectly concludes no change occurred based on lack of 'material changes disclosed,' which contradicts the documented shift in language and reasoning. (2) There are no numeric values in this question, so quantitative accuracy is not applicable—score of 10 is appropriate as no numbers were misstated. (3) The multi-hop reasoning failed: the model should have synthesized changes in narrative disclosures around control criteria (principal vs agent considerations) from 2023 to 2024, which indicate a strategic evolution in justification for revenue recognition, even if the accounting outcome was consistent. The LLM missed this qualitative shift, indicating poor reasoning. (4) Contextual relevance is moderate because the answer discusses the correct entities (Google Ad Manager, Alphabet, revenue recognition on gross basis) and correctly describes the general model, but fails to capture the key evolution in strategy, making it partially relevant but ultimately misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 439,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "Between 2023 and 2024, UPS's financial exposure and strategic positioning regarding Roadie evolved as follows: In 2023, UPS recorded a $56 million goodwill impairment charge for Roadie, indicating a decline in its fair value relative to carrying value. By 2024, Roadie was among three reporting units (alongside Global Freight Forwarding and Global Logistics and Distribution) identified as having limited excess fair value over carrying value, exposing it to a higher risk of future impairment. Although no impairment was recorded in 2024, the company noted that a 100 basis point increase in cost of capital or a 10% reduction in projected cash flows could reasonably lead to impairment for these units. This reflects a continued strategic focus on monitoring Roadie's performance and financial risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $56 million goodwill impairment in 2023 is accurately reported, and the 2024 status—no new impairment but Roadie being among units with limited excess fair value over carrying value—is correctly stated. The additional context about a 100 bps increase in cost of capital or 10% reduction in cash flows triggering potential impairment is factually consistent with typical SEC disclosures and enhances the answer without contradicting the original. (2) Quantitative accuracy is perfect: the $56 million figure, 100 basis points, and 10% thresholds are all correctly presented and logically tied to risk exposure. (3) Multi-hop reasoning is sound: the answer synthesizes information across years (2023 vs 2024), entities (Roadie within UPS’s reporting units), and financial concepts (goodwill impairment, fair value sensitivity), correctly inferring continued risk despite no new charge. (4) The only minor shortcoming is that the original answer emphasizes the strategic shift from active impairment to cautious monitoring, which is slightly more nuanced than the LLM’s focus on risk exposure. However, the LLM still captures the essence of ongoing monitoring through sensitivity analysis. The mention of the other two reporting units (Global Freight Forwarding and GLD) is an acceptable addition from broader context and does not detract from accuracy. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 430,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "Linde's global helium operations, which are part of the \"Other\" segment, experienced a decline in volumes in 2024 compared to 2023, contributing to a $32 million decrease in sales for the segment. Despite this, operating profit in the Other segment increased by $19 million, or 44%, largely due to insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher helium-related costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that helium caused a 2% underlying sales decrease in the 'Other' segment due to lower volumes, but the LLM fabricates a specific $32 million sales decrease, which is not present in the original answer. Similarly, the LLM claims a $19 million (44%) increase in operating profit, but the original answer does not provide specific dollar figures for profit changes—only that operating profit saw increased costs related to helium, partially offset by an insurance recovery. These specific numbers are unsupported and incorrect. (2) The qualitative aspects are partially correct: the LLM correctly identifies that helium volumes declined and that insurance recovery for LAMT helped offset helium-related costs. It also correctly situates helium within the 'Other' segment. However, it fails to capture the evolution from 2022 to 2024—specifically, that helium shifted from being a supply component (neutral/positive) in 2022 to a cost pressure in 2024. This key multi-hop insight is missing. (3) The reasoning is partially sound in linking helium volumes to sales impact and insurance recovery to profit, but it invents precise financial figures not present in the source, undermining the multi-hop synthesis. The model also omits the comparative timeline (2022 vs 2024), focusing only on 2024 vs 2023, which misaligns with the question's scope. (4) Contextual relevance is high because the answer addresses Linde, helium, sales, and operating profit in the correct segment. However, the invented numbers and incomplete temporal analysis reduce correctness significantly. Quantitative accuracy is low due to fabricated dollar amounts; qualitative accuracy is moderate due to correct identification of trends and entities but missing key comparative insight; contextual relevance remains strong as the response stays on-topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 519,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The total value of loans covered under long-term credit protection agreements with FNMA and FHLMC decreased from $8.7 billion in 2023 to $8.0 billion in 2024. This reduction indicates that the Corporation's credit risk exposure on residential mortgage loans has slightly decreased, as fewer loans are now protected under these agreements. However, since all these loans are individually insured, the Corporation does not record an allowance for credit losses related to them, suggesting continued low credit risk for these specific loans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the quantitative evolution of loans covered under credit protection agreements—$8.7 billion in 2023 decreasing to $8.0 billion in 2024—matching the ground truth exactly. There are no errors in numbers, dates, or formatting. (2) The calculation of a $0.7 billion decrease is implied and accurate. All financial figures are presented correctly. (3) The reasoning is largely sound: the answer correctly infers that the decline suggests reduced credit risk exposure and notes the Corporation does not record an allowance for credit losses due to full protection. However, it slightly misses the nuance in the original answer that the reduction reflects a decreased reliance on full credit protection, which may indicate a strategic or portfolio shift away from high-risk residential mortgage loans. Instead, the LLM focuses on 'slightly decreased' risk exposure without fully capturing the implication about changing risk management strategy or loan composition. (4) Despite this minor gap in depth of interpretation, the answer is factually correct, contextually appropriate, and synthesizes the required multi-hop information (values across years and their risk implications). Thus, correctness is high but not perfect due to slightly less precise qualitative inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 368,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "Between 2023 and 2024, Adobe Firefly evolved as a core component of Adobe's generative AI strategy, enhancing competitive differentiation by offering natively integrated, commercially safe AI capabilities across Creative Cloud, Adobe Express, and other tools. In 2023, Firefly was positioned as a standalone web app with AI-assisted creative expression, while in 2024, it expanded into enterprise offerings with intellectual property indemnification and deeper integration into workflows. Regulatory risks increased due to evolving AI regulations, such as the EU AI Act, which could impose compliance costs, alter monetization strategies, and require costly changes to Firefly's deployment and governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe Firefly was positioned in 2023 as a competitive differentiator with commercial safety and native integration, and by 2024, regulatory risks—especially from the EU AI Act—were explicitly acknowledged. The LLM correctly identifies the shift in strategic positioning from competitive emphasis to inclusion of risk awareness. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2023, 2024) and regulatory references (EU AI Act) are accurate. (3) Multi-hop reasoning is sound: the model synthesizes Firefly’s evolving role across time, product integration, and regulatory context across both years. It adds contextual detail (e.g., IP indemnification, enterprise expansion) that is consistent with and enriches the ground truth without introducing inaccuracies. (4) The only minor deviation is that the original answer emphasizes the 'shift from purely competitive emphasis to risk-aware positioning' more explicitly, while the LLM frames it as an expansion rather than a strategic pivot. However, this does not undermine factual correctness. Overall, the answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 371,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "Between 2023 and 2024, Trodelvy's financial performance and regulatory trajectory showed notable progress. In 2023, Trodelvy's product sales increased by 56% to $1.1 billion compared to 2022, driven by higher demand in new and existing geographies. By 2024, the drug received Breakthrough Therapy designation from the FDA for the treatment of adult patients with extensive-stage small cell lung cancer whose disease has progressed on or after platinum-based chemotherapy, marking a significant regulatory milestone. This designation aims to expedite development and regulatory review, reflecting the potential of Trodelvy to improve clinical outcomes for this serious condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the financial performance and regulatory developments for Trodelvy between 2023 and 2024. The 56% sales increase in 2023 is accurately reported, and the $1.1 billion figure is a rounded version of the exact $1,063 million stated in the ground truth. This minor rounding is acceptable under semantic equivalence. The 2024 FDA Breakthrough Therapy designation for extensive-stage small cell lung cancer after platinum-based chemotherapy is correctly identified, including the appropriate patient population and clinical context. (2) Quantitatively, the 56% growth and $1.1 billion (vs $1,063 million) are within acceptable variance; no calculation errors are present. The year-over-year comparison correctly references 2022 as the prior year, which aligns with the ground truth’s implied comparison. (3) The multi-hop reasoning is sound: the model synthesizes financial data from 2023 and regulatory developments in 2024, correctly attributing each to the right year and context. The explanation of the Breakthrough Therapy designation’s significance shows accurate qualitative understanding. (4) Scores reflect near-perfect factual alignment, with only a negligible rounding difference in the sales figure preventing a full 10 on correctness and quantitative accuracy. Qualitative accuracy is high due to correct entity and context identification. Contextual relevance is perfect—the response directly and fully addresses the evolution of both financial and regulatory aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 420,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "Chevron's financial involvement in Angola LNG, as disclosed in its equity investments, decreased from 2022 to 2024. In 2022, Chevron reported equity in earnings from Angola LNG of $1,857 million, which dropped significantly to $405 million in 2024. Additionally, the carrying value of Chevron's investment in Angola LNG was $1,665 million in 2024, down from $1,762 million in 2023, indicating a reduction in its financial commitment. These figures suggest a strategic shift or potential challenges in the performance of the Angola LNG project during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both quantitative and qualitative aspects. The ground truth states that in 2022, Chevron reported total income from equity affiliates as $5,657 million, which included earnings from Angola LNG among other affiliates—but it does not specify the exact amount attributable solely to Angola LNG. The LLM incorrectly claims Chevron reported $1,857 million in equity earnings specifically from Angola LNG in 2022 and $405 million in 2024, which is not supported by the original answer or known disclosures. Additionally, the LLM introduces a carrying value of $1,665 million in 2024 and $1,762 million in 2023—figures absent from the ground truth and unverified. (2) The original answer makes no mention of year-over-year declines, specific earnings from Angola LNG, or carrying values; instead, it highlights Chevron’s 36.4% ownership stake in Angola LNG Limited in 2024 and references upstream-related earnings contributions in 2022 without quantifying them separately. The LLM fabricates precise numbers and trends not present in the source. (3) The multi-hop reasoning is flawed: rather than synthesizing the evolution from general earnings mention (2022) to specific ownership stake disclosure (2024), the model invents a narrative of declining financial performance based on non-existent data. This reflects a failure to correctly interpret or retrieve the actual disclosures. (4) While the LLM attempts to address Chevron’s strategic positioning in Angola LNG over time, its reliance on fabricated financials severely undermines correctness. The contextual relevance is moderate because it engages with the right topic and timeframe, but the factual foundation is entirely incorrect, warranting a very low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 483,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "From 2023 to 2024, the value of META's Fixed-Rate Senior Unsecured Notes increased significantly from $18.50 billion to $29.0 billion. This increase was primarily driven by the issuance of $10.50 billion in new Notes in August 2024. The Notes have varying maturity dates from 2027 to 2064, with stated interest rates ranging from 4.30% to 5.55% and effective interest rates from 4.42% to 5.60%. The total fair value of the Notes also rose from $18.48 billion in 2023 to $27.83 billion in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in the total value of META's Fixed-Rate Senior Unsecured Notes from $18.50 billion at the end of 2023 to $29.0 billion at the end of 2024, and attributes this to a $10.50 billion issuance in August 2024, which aligns with the ground truth. However, it omits the 2023 issuance of $8.46 billion in net proceeds from May, which is a key part of the 'issuance activity' asked in the question. This omission reduces completeness. (2) All provided numbers are accurate: $18.50 billion (2023), $29.0 billion (2024), $10.50 billion (August 2024 issuance), and fair values ($18.48B to $27.83B) are correctly stated. The interest rate ranges and maturity dates are consistent with typical disclosures but were not in the original answer, so they are considered extra detail rather than error. (3) The multi-hop reasoning is sound—correctly linking the increase in total value to new issuance and tracking changes over time. However, the failure to mention the 2023 issuance means the full evolution of issuance activity is not captured, weakening the synthesis. (4) Scores reflect high accuracy in numbers and reasoning, with a moderate deduction for missing key issuance data from 2023. Contextual relevance is perfect as all included information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 372,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "LIN's financial exposure to helium as a raw material increased from 2023 to 2024, as reflected in the shift from categorizing helium as a \"supply\" to a \"dependency.\" In 2023, raw materials and supplies were valued at $614 million, while in 2024, this figure decreased to $529 million. This decline in raw material inventory, combined with the increased classification of helium as a critical dependency, suggests a higher reliance on helium sourcing, potentially leading to greater exposure to price volatility and supply chain disruptions. The change indicates a strategic or operational shift in helium sourcing or cost management practices, emphasizing its critical role in LIN's operations in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the shift in categorization from 'supply' in 2023 to 'dependency' in 2024, it introduces incorrect financial figures—$614 million and $529 million for raw materials and supplies—which are not present in the ground truth and contradict the actual metric provided (helium as a percentage of raw material expenses). The ground truth specifies that helium costs were 4.2% of total raw material expenses in 2023 and increased to 6.8% in 2024, but the LLM fails to mention these percentages entirely. Instead, it fabricates inventory values that do not address the actual cost exposure metric. (2) The quantitative inaccuracies are severe: no dollar amounts for raw materials were provided in the original data, and the LLM invents numbers without basis. There is no verification or alignment with the actual percentage-based cost exposure disclosed. Calculations are not attempted, and the introduced figures misrepresent the nature of the financial exposure. (3) The reasoning partially captures the qualitative shift in helium's strategic importance due to the categorization change, which shows some correct multi-hop synthesis between classification and operational significance. However, it fails to link the increased dependency to the specific rise in cost proportion, which is the core of the financial exposure change. The conclusion about increased exposure to price volatility is reasonable but unsupported by the actual data presented. (4) The contextual relevance is moderate because the answer addresses the shift in helium's role and attempts to interpret its implications. However, due to the absence of correct metrics and introduction of false data, the qualitative accuracy is limited, and the correctness score is low. The answer misses the key financial insight—increased cost burden as a percentage of inputs—which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 529,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "Between 2022 and 2023, PayPal reduced the amount of European customer balances approved for credit activities from $3.8 billion to $3.0 billion. This represents a decrease of $0.8 billion, or a 21.1% reduction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative facts: PayPal reduced the approved amount for European customer balances used in credit activities from $3.8 billion in 2022 to $3.0 billion in 2023, a $0.8 billion decrease. The calculated percentage change (21.1%) is accurate: (0.8 / 3.8) ≈ 21.05%, which rounds to 21.1%. All numeric values and dates match the ground truth. (2) The calculation is correct and clearly presented. The LLM accurately computes the percentage reduction, which was not explicitly stated in the original answer but is a valid derivation. (3) The multi-hop reasoning is sound—comparing two years of data involving dollar amounts and deriving a trend. However, the LLM omits the contextual nuance about the percentage of total European balances increasing slightly from 37% to 39%, which provides important insight into the relative utilization despite the drop in absolute terms. This qualitative context helps explain that while the absolute amount decreased, the proportion of available balances used increased, indicating a more conservative but still active use. (4) The answer is factually correct and highly relevant, earning full marks for quantitative accuracy and contextual relevance. The qualitative accuracy is slightly reduced due to the missing interpretive layer about the percentage of balances, but the core multi-hop synthesis is correct. Thus, the overall correctness score is 9—excellent but not fully complete in conveying all dimensions of the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 422,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Starbucks' exposure to foreign currency - other instruments decreased significantly between 2023 and 2024 in terms of fair value. As of September 29, 2024, the fair value of foreign currency - other derivative assets was $1.9 million, down from $32.0 million as of October 1, 2023. Additionally, the fair value of related derivative liabilities for foreign currency - other was $4.7 million in 2024, compared to $2.0 million in 2023. The expected reclassification impact on earnings for foreign currency - other was $9.5 million in 2024, compared to $39.6 million in 2023, indicating a notable reduction in the anticipated impact on earnings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Starbucks reported a fair value of $1,164 million in 2023 and $920 million in 2024 for foreign currency - other instruments. However, the LLM states the fair value of derivative assets was $32.0 million in 2023 and $1.9 million in 2024, and liabilities were $2.0 million and $4.7 million, respectively—these figures are off by orders of magnitude and do not align with the total fair value reported in the original answer. The only correct number is the expected reclassification impact in 2024 ($9.5 million), but it incorrectly states the 2023 reclassification as $39.6 million, which in the ground truth is the net gain in AOCI, not the reclassification amount. The correct 2023 reclassification amount is $55.3 million, which the LLM omits entirely. (2) Multiple numeric values are incorrect: fair values are misrepresented as single-digit millions instead of nearly $1.2 billion and $920 million; the 2023 reclassification figure is wrong (uses AOCI gain instead of reclassification); only the 2024 reclassification is correct. (3) The reasoning is flawed—while the LLM correctly infers a reduction in earnings impact due to declining reclassification amounts, it fails to synthesize the correct multi-hop data: the fair value and AOCI components must come from the same instrument category and year, but the LLM appears to conflate derivative assets/liabilities with the total instrument value and misattributes AOCI gains as reclassification expectations. (4) The contextual relevance is moderate because the answer addresses the right topic (evolution of foreign currency instruments and earnings impact), but the severe quantitative errors and misidentification of key metrics drastically undermine factual correctness, warranting a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 504,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives for Alabama Power increased from $15 million to $15 million (no change), while for Georgia Power, it increased from $13 million to $13 million (also no change). However, the directional change in their asset versus liability positions shows that Alabama Power's energy-related derivative liabilities increased from $11 million in 2022 to $110 million in 2023, and Georgia Power's liabilities increased from $8 million in 2022 to $124 million in 2023. This indicates a significant shift from asset positions to liability positions for both companies.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the asset values for both companies in 2022. It incorrectly states that Alabama Power's energy-related derivative assets were $15 million in 2022, when the ground truth is $55 million. Similarly, it claims Georgia Power had $13 million in assets in 2022, but the correct value is $75 million. The 2023 asset values ($15M for Alabama Power, $13M for Georgia Power) are correct. Liability values for both companies in both years are accurate: Alabama Power’s liabilities increased from $11M to $110M, and Georgia Power’s from $8M to $124M. (2) Calculations are not required beyond directional changes, but the misrepresentation of starting asset values severely undermines quantitative accuracy. The claim of 'no change' in fair value is incorrect and contradicts the actual substantial declines in asset values. (3) The reasoning correctly identifies the directional shift from net asset to net liability positions and synthesizes the liability increases across both companies, showing partial multi-hop understanding. However, the failure to report correct 2022 asset values breaks the full synthesis needed for accurate evolution analysis. (4) Scores reflect major factual inaccuracies in core numbers (quantitative accuracy penalized heavily), partial correct reasoning and entity identification (moderate qualitative score), and relevance to the question’s structure despite errors (solid contextual relevance).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 409,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "The asset allocation strategy for the U.S. Retiree Health Care Plan shifted from 2022 to 2023, with the percentage of fixed income securities increasing from 65% to 80%, while the percentage of equity securities decreased from 35% to 20%. This change aligns with the plan's target allocation ranges, which emphasize a higher proportion of fixed income to better match the interest rate sensitivity of liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentage distribution for fixed income and equity securities in both 2022 and 2023: 65% fixed income and 35% equity in 2022, shifting to 80% fixed income and 20% equity in 2023. These values match the ground truth exactly. (2) All numeric values are accurate, and the directional change (increase in fixed income, decrease in equity) is correctly described. There are no calculation errors. (3) The reasoning is sound and captures the multi-hop nature of the question by comparing allocations across two years and identifying the strategic shift. The LLM adds contextual insight about 'target allocation ranges' and 'interest rate sensitivity of liabilities,' which, while not present in the original answer, is plausible and does not contradict the ground truth. However, this additional rationale is not confirmed by the provided ground truth, slightly reducing qualitative accuracy. (4) The answer is semantically equivalent to the original in terms of factual content and directly addresses the question about evolution in asset allocation. The extra detail enhances relevance without introducing error, but since it goes beyond the verified facts, it prevents a perfect qualitative score. Overall, the response is factually correct, complete, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 369,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "Between 2022 and 2023, Trodelvy received new regulatory approvals for additional indications. In 2023, the FDA approved Trodelvy for the treatment of adult patients with unresectable locally advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. Additionally, the European Commission approved Trodelvy as monotherapy for the treatment of adult patients with unresectable or metastatic HR+/HER2- breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the advanced setting.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly identifies the 2023 regulatory approvals for Trodelvy by both the FDA and the European Commission (EC), specifying the new indication for HR+/HER2- breast cancer. (2) The dates (2022 to 2023) and approval bodies (FDA, EC) are correct, with no numeric or date inaccuracies. While the original answer mentions the 2022 indications (TNBC and urothelial cancer), the LLM focuses on the evolution and new 2023 approvals, which directly addresses the question about how the status evolved and what new indications were granted. (3) The multi-hop reasoning is sound: the model correctly infers that the key development between 2022 and 2023 was the expansion into HR+/HER2- breast cancer with approvals in both the U.S. and Europe. (4) The LLM omits the 2022 indications but this does not detract from correctness since the question emphasizes the evolution and new 2023 approvals. The answer is semantically equivalent, using slightly different phrasing (e.g., 'advanced setting' vs 'metastatic setting') but conveying the same clinical and regulatory meaning. All entities (FDA, EC, HR+/HER2-, endocrine-based therapy, systemic therapies) are accurate. Thus, all scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 353,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "Between 2023 and 2024, Meta's disclosure regarding user perception as a risk factor evolved to emphasize the impact of regulatory and policy changes on user behavior and engagement. In 2023, the focus was on factors like geopolitical events, user sentiment, and platform integrity affecting user growth and engagement. By 2024, Meta highlighted more specific regulatory-driven risks, such as limitations on data use for advertising due to laws like the GDPR and DMA, and the introduction of user alternatives like \"subscription for no ads\" in Europe. Additionally, 2024 emphasized the potential for user disengagement due to changes in platform policies and enforcement decisions, including those from the Oversight Board, reflecting a broader concern about compliance and its indirect impact on user perception and business operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges from the ground truth in key aspects of Meta's risk disclosure evolution between 2023 and 2024. (1) Correct elements: The answer accurately identifies that in 2023, Meta highlighted user sentiment, platform integrity, and external factors (e.g., geopolitical events) as affecting user engagement. It also correctly notes that in 2024, regulatory constraints like GDPR and DMA were emphasized, along with product changes such as ad-free subscriptions in Europe—these reflect real developments. (2) Quantitative accuracy: There are no numerical values in the question or answers, so this dimension is neutral; no errors present. (3) Multi-hop reasoning assessment: The LLM synthesizes plausible regulatory and policy shifts but misrepresents the core evolution. The ground truth states that Meta *reduced* explicit mention of user perception as a risk factor in 2024, shifting focus to operational and financial risks (e.g., acquisition integration, tax liabilities, investor sentiment). In contrast, the LLM suggests an increased focus on regulatory impacts *on user perception*, implying continuity or deepening of user perception as a central risk—this contradicts the documented strategic shift. (4) The answer remains contextually relevant and well-structured, addressing risk evolution and business impact, but misses the key point about de-emphasizing user perception in favor of broader financial/operational risks in 2024. Thus, while some accurate details are included, the overall qualitative interpretation is misaligned with the ground truth, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 447,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "The notional amount of Lockheed Martin's variable interest rate swaps increased from $500 million in 2021 to $1.3 billion in 2024. This increase indicates that the company has expanded its use of interest rate derivatives to hedge against interest rate fluctuations, reflecting a proactive approach to managing its interest rate risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the notional amounts of $500 million in 2021 and $1.3 billion in 2024, matching the ground truth exactly. These figures are quantitatively accurate with correct formatting and time periods. (2) All numbers and dates are correct—there are no calculation errors or misstatements. The increase from $500M to $1.3B is accurately represented. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift in interest rate risk management based on the increase in swap notional amounts. While the LLM attributes the increase to a general 'proactive approach to managing interest rate risk,' it does not explicitly mention the key nuance from the ground truth—that the strategy involves converting fixed-rate borrowings to variable-rate borrowings. This omission slightly weakens the qualitative accuracy, as it misses a specific directional insight about the company's hedging objective. (4) Despite this, the answer remains factually correct, contextually relevant, and captures the core implication of increased derivative usage. The scores reflect high accuracy with a minor deduction in qualitative reasoning for missing the precise nature of the strategy shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 346,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "PayPal's allowance for transaction losses slightly decreased between 2022 and 2023, from $66 million to $64 million. The allowance for negative customer balances remained relatively stable, at $218 million in 2023 compared to $212 million in 2022. The provision for transaction losses increased slightly from $1,170 million in 2022 to $1,192 million in 2023, while realized losses decreased from $1,417 million to $1,313 million. This suggests a more cautious approach in 2023, with higher provisions set aside for potential transaction losses, potentially reflecting increased risk management efforts or changes in fraud patterns.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct numbers but introduces several metrics not present in the original answer or question focus, such as 'allowance for negative customer balances' ($218M/$212M), 'provision for transaction losses' ($1,170M/$1,192M), and 'realized losses' ($1,417M/$1,313M), which are not mentioned in the ground truth and appear to be fabricated or misattributed. Only the allowance for transaction losses ($66M in 2022, $64M in 2023) matches the ground truth and is correctly stated. (2) The quantitative accuracy is partially correct on the allowance figure but fails on all other introduced numbers, which cannot be verified and are irrelevant to the original answer. There is no mention in the ground truth of provisions or realized losses, so these figures undermine accuracy. (3) The multi-hop reasoning is flawed: while the LLM correctly notes a decrease in allowance from $66M to $64M, it incorrectly interprets this alongside an increase in 'provision' to suggest a 'more cautious approach', which contradicts the ground truth interpretation that PayPal adopted a more structured and defined disclosure approach in 2023. The original answer emphasizes a shift from qualitative risk discussion in 2022 to quantified disclosures in 2023, which the LLM fails to capture. (4) The contextual relevance is moderate because the answer addresses financial provisions for transaction losses and the time frame, but it adds extraneous, unverified data that distracts from the actual evolution described in the ground truth. The core insight about a more defined financial disclosure approach in 2023 is missing, replaced by an incorrect narrative about increased provisioning. Thus, while some numbers are accurate, the overall factual and reasoning accuracy is significantly compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 494,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "Starbucks' derivative positions for foreign currency - other changed from fiscal year 2023 to 2024 as follows: derivative assets decreased from $32.0 million to $1.9 million (current assets) and from $22.9 million to $1.7 million (long-term assets), while derivative liabilities increased from $2.0 million to $4.7 million (current liabilities) and from $- to $4.1 million (long-term liabilities). The overall magnitude of the change on the balance sheet was a reduction in net derivative positions for foreign currency - other by approximately $50.3 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numbers. According to the ground truth, Starbucks reported a derivative asset of $1,164 million in 2023 under 'Foreign currency - other,' but the LLM claims it was $32.0 million (current) + $22.9 million (long-term) = $54.9 million, which is drastically incorrect. The 2024 asset value of $1.9 million matches the ground truth, but the LLM incorrectly splits it into current and long-term components ($1.9M and $1.7M), which contradicts the source. The liability increase from $2.0M to $4.7M in current liabilities matches the ground truth, but the LLM adds a new long-term liability of $4.1 million in 2024 with no prior value, which is not supported by the original answer and introduces data not present in the truth. (2) Calculations are also flawed: the claimed 'reduction in net derivative positions by approximately $50.3 million' is based on incorrect inputs. Using the LLM's numbers: decrease in assets = ($32.0 + $22.9) - ($1.9 + $1.7) = $51.3M reduction; increase in liabilities = ($2.0 → $4.7 and $0 → $4.1) = $6.8M increase; net change would be roughly $51.3M (asset decrease) - $6.8M (liability increase) = ~$44.5M reduction in net position, not $50.3M. Moreover, the ground truth shows a much larger asset reduction: from $1,164M to $1.9M, or ~$1,162.1M decrease, making the LLM's magnitude estimate off by over two orders of magnitude. (3) The multi-hop reasoning is partially sound in structure—comparing year-over-year changes in assets and liabilities across categories—but fails in execution due to reliance on incorrect underlying data. The model appears to synthesize across balance sheet categories (current vs long-term), but the original answer does not provide such a breakdown, suggesting the LLM hallucinated granular data. (4) Contextual relevance is high—the answer addresses the question format correctly, discussing changes in both assets and liabilities and attempting to quantify the balance sheet impact. However, due to severe quantitative errors and unsupported details, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the direction of change (decreasing assets, increasing liabilities) aligns with the truth, but the magnitude and specifics do not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 618,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "From 2022 to 2023, the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions shifted from a gain of $37 million in 2022 to a loss of $44 million in 2023 for Southern Company and Southern Company Gas. This indicates a negative change in the effectiveness or market conditions of these hedging positions during the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that in 2022, derivatives had a $117 million negative impact on natural gas revenues and a $27 million negative impact on costs, while in 2023, there was a $59 million gain on cost and $0 impact on revenue. The LLM instead claims a 'gain of $37 million in 2022' and a 'loss of $44 million in 2023', which does not match any sum or interpretation of the actual figures. (2) The numbers are completely wrong—there was no $37 million gain or $44 million loss in the provided data. Additionally, the LLM introduces 'Southern Company and Southern Company Gas' which are not mentioned in the original answer or question, adding unsupported entities. (3) The multi-hop reasoning is flawed: the model fails to correctly extract, let alone synthesize, the separate impacts on cost and revenue across years. Instead, it collapses them into a single net figure that is both miscalculated and mischaracterized. (4) The contextual relevance is slightly preserved because the answer addresses the general topic of change in derivative impact over time, but the factual inaccuracies and invented data render the response misleading. Due to total failure in quantitative and qualitative accuracy, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 370,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "Between the 2023 and 2024 10-K filings, Walmart's Deferred Compensation Matching Plan was amended and restated, with the effective date of the amendment changing from February 1, 2023, in 2023 to November 8, 2023, in 2024. Additionally, in 2024, the plan was documented and incorporated by reference to the 2024 10-K filing, indicating updated documentation status.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding dates and the nature of the plan's evolution. (1) The effective date in the 2023 filing was already November 8, 2023, not February 1, 2023 as claimed—this is a critical error. The LLM incorrectly states that the effective date changed between filings, when the ground truth confirms it remained unchanged. (2) The documentation status shift—from newly introduced in 2023 to incorporated by reference in 2024—is partially correct, but the LLM misrepresents the 2023 status by implying an earlier effective date. (3) The multi-hop reasoning is flawed: the model fails to recognize that the plan was introduced *as amended and restated effective November 8, 2023* in the 2023 filing itself, not updated later. Thus, there was no change in effective date between years. (4) While the mention of 'incorporated by reference' in 2024 aligns with the ground truth and shows some understanding of documentation evolution, the incorrect timeline undermines the core accuracy. The answer addresses the question's scope (documentation status and effective date) but with major factual errors, warranting a low correctness score despite partial relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 341,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Between 2023 and 2024, the disclosure and treatment of LTIP Units remained consistent in terms of their dilutive effect, as no securities had a material dilutive impact in either year. Both years stated that potentially dilutive securities included LTIP Units, but no adjustments were made to net income or weighted average shares/outstanding units due to the absence of material dilution. Regarding accrual policy, the company continued to accrue dividends or distributions when they were declared in both periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core information from the ground truth. (1) All factual elements are correct: LTIP Units are consistently described as potentially dilutive with no material dilutive effect in both 2023 and 2024; no adjustments to net income or weighted average shares are made due to lack of material impact; and the accrual policy remains unchanged—distributions are accrued when declared. (2) There are no numeric values requiring calculation, but the years referenced (2023, 2024, and prior years) are correctly aligned with the disclosures. (3) The multi-hop reasoning is sound—information is synthesized across two reporting years and consistent treatment is correctly inferred. (4) The only minor shortcoming is that the LLM does not explicitly mention the simplification of disclosure in 2024 noted in the original answer (i.e., that the 2024 filing streamlined the language compared to 2023), which slightly reduces completeness. However, this does not affect the core accuracy of the treatment or policy. Overall, the answer is semantically equivalent and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 317,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved significantly between 2023 and 2024 in response to regulatory actions and decisions. In 2023, the EU-U.S. DPF was established as a replacement for the invalidated Privacy Shield, with the European Commission issuing an adequacy decision in July 2023. Meta implemented steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a fine and orders to suspend data transfers. By 2024, Meta continued to engage with regulators to ensure compliance with the EU-U.S. DPF and the GDPR, including addressing concerns around its \"subscription for no ads\" model under the Digital Markets Act (DMA). The company also faced formal proceedings from the European Commission regarding this model, indicating an ongoing effort to adapt its compliance practices to evolving regulatory expectations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Meta's compliance approach between 2023 and 2024. It correctly identifies the establishment of the EU-U.S. DPF in 2023 with the European Commission's adequacy decision in July 2023, which aligns with the ground truth. It accurately notes Meta's implementation of corrective actions following the IDPC's orders and the context of the €1.2 billion fine (though the fine amount is omitted, which is a minor gap). The answer correctly references the 'subscription for no ads' model and the European Commission's formal proceedings under the DMA in 2024, including the July 2024 timeline for preliminary findings. However, it does not explicitly state that the subscription model was introduced in November 2023, which is a relevant detail for tracking the timeline of compliance evolution. Additionally, while it mentions ongoing engagement and formal proceedings, it softens the ground truth's stronger conclusion that regulators found preliminary evidence of non-compliance, which slightly weakens the precision of the regulatory outcome. There are no numerical inaccuracies—dates and events are correctly framed, and no incorrect figures are introduced. The reasoning is sound and synthesizes multi-hop elements: regulatory actions (IDPC fine), framework adoption (EU-U.S. DPF), and new scrutiny under DMA. The answer is contextually highly relevant, directly addressing the evolution in Meta's compliance posture. The minor omissions and slightly less precise characterization of the DMA findings prevent a top score, but the overall factual and conceptual accuracy is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 447,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "Between 2023 and 2024, Linde has increased its emphasis on green hydrogen production by expanding its technologies for renewable hydrogen generation. In 2023, Linde described green hydrogen as being produced by electrolysis using renewable energy or from the steam methane reformation of biomethane. By 2024, the company highlighted its state-of-the-art sustainable technologies in its Engineering business, which support the transition to clean energy and cover the entire hydrogen value chain, including production, liquefaction, storage, and distribution. This evolution reflects a stronger focus on renewable energy sources and the broader adoption of green hydrogen as part of Linde's clean energy strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Linde's 2023 production methods for green hydrogen—electrolysis using renewable energy and steam methane reforming of biomethane—which matches the original answer. It also accurately notes the increased emphasis on green hydrogen in 2024 and references sustainable technologies in Linde’s Engineering business. However, it omits key details from the ground truth: the rebranding of green hydrogen as 'renewable hydrogen' in 2024, the explicit differentiation from blue hydrogen, and the introduction of carbon intensity as a metric to distinguish production methods. These omissions reduce completeness and qualitative accuracy. (2) There are no numerical values, dates, or calculations in the response, so quantitative accuracy is not applicable—no errors present, hence a score of 10. (3) The reasoning is sound in identifying an evolution in Linde’s approach and linking it to broader clean energy strategy, but it fails to fully synthesize the multi-hop nuance of how the framing and differentiation of green hydrogen evolved strategically in 2024. The answer generalizes the shift without capturing the specific conceptual refinement (e.g., carbon intensity, terminology shift). (4) Correctness is scored 7 because core facts are accurate but important qualitative distinctions are missing. Qualitative accuracy is 7 due to incomplete synthesis. Contextual relevance is high (9) as the response stays focused and relevant to the question’s scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 414,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company completed the sale of Sequent to Williams Field Services Group on July 1, 2021, resulting in a pre-tax gain of approximately $121 million ($92 million after tax). The sale removed Sequent as a reportable segment under Southern Company Gas, as noted in the 2023 10-K. Financially, the transaction also led to $85 million in additional tax expense due to changes in state apportionment rates. Thus, between 2022 and 2023, Southern Company no longer maintained a relationship with Sequent, and the financial impact was fully realized in 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several key factual inaccuracies, most critically the sale date. The ground truth states the sale occurred in 2022, but the LLM claims it happened on July 1, 2021—this misalignment undermines the core of the question, which asks about the evolution between 2022 and 2023. Since the divestiture is portrayed as occurring before 2022, the LLM incorrectly implies no relationship change occurred during the specified period, contradicting the ground truth that the sale and its financial impacts were realized in 2022, with full separation evident by 2023. (2) Quantitatively, the $121 million pre-tax gain and $85 million additional tax expense are correctly reported, as is the $92 million after-tax figure (implied by $121M gain minus $85M tax impact). These numbers match the ground truth and are accurately presented, earning partial credit. However, the incorrect timing affects the interpretation of when these figures were recognized. (3) The reasoning is partially sound in that the LLM correctly identifies the divestiture, the buyer (Williams Field Services Group), the financial impact, and the removal of Sequent as a reportable segment. However, the multi-hop synthesis fails on temporal logic: the evolution from ownership to divestiture between 2022 and 2023 is misrepresented because the sale is placed in 2021. This breaks the causal timeline required by the question. (4) Contextual relevance is high—the answer addresses the relationship change and financial implications directly and uses appropriate financial terminology. However, due to the incorrect year, the answer fails to accurately describe the evolution during the specified period, resulting in a moderate correctness score. Minor flexibility is allowed for stating after-tax gain, which is not in the original but can be inferred, but the date error is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 509,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Between 2023 and 2024, Walmart's relationship with the Allswell brand remained consistent within its private brand portfolio, as Allswell was listed among the private brands marketed by Walmart U.S. in both years. In 2023, Allswell was included in the list of private brands such as \"Equate,\" \"George,\" and \"Great Value,\" and in 2024, it was similarly mentioned without any indication of removal or reduced emphasis. This consistency suggests that Allswell continues to be a strategic component of Walmart's private label strategy, aimed at offering high-quality, low-priced products to customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a key factual inaccuracy: it states that Allswell was already part of Walmart's private brand portfolio in 2023 alongside brands like 'George' and 'Equate', implying it was an established brand at that time. However, the ground truth indicates that 2023 marked the *introduction* of Allswell, meaning it was a new addition, not a pre-existing brand. This misrepresents the evolution of the relationship. Additionally, the LLM claims consistency between years, but the ground truth emphasizes a transition from new to established status by 2024, which the LLM fails to capture. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is flawed: the question asks how the relationship *evolved*, requiring recognition of Allswell’s introduction in 2023 and maturation by 2024. The LLM instead asserts continuity, missing the developmental trajectory. It also incorrectly lists 'George' as a co-branded example in 2023, which is not in the original answer. (4) While the LLM correctly identifies Allswell as part of Walmart’s private brand strategy in both years and draws a reasonable conclusion about strategic importance, it fails to reflect the brand’s progression from launch to integration into the core portfolio. Thus, the core evolution is misrepresented, warranting a moderate correctness score. Contextual relevance is high because the response stays on topic and discusses strategic positioning appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 435,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "The strategic importance of Embedded Processing products evolved from 2022 to 2023 as they maintained growth amid declining Analog revenue. In 2023, Embedded Processing revenue increased by 3% to $3,368 million compared to $3,261 million in 2022, driven by a favorable product mix. However, operating profit declined by 20% to $1,008 million due to higher manufacturing costs. Despite the profit margin contraction, the segment's resilience and growth contrasted with the 15% revenue decline in the Analog segment, highlighting its growing strategic relevance in stabilizing TI's overall performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific revenue figures for Embedded Processing were disclosed in 2022, but the LLM claims precise figures: $3,261 million in 2022 and $3,368 million in 2023 (a 3% increase). These numbers are not supported by the original answer and contradict it directly. Additionally, the LLM introduces operating profit of $1,008 million and a 20% decline due to manufacturing costs—information absent in the ground truth. The 15% decline in Analog revenue is also not mentioned in the original answer. (2) Quantitative accuracy is very low because all cited numbers (revenue, growth rate, profit, cost changes) are fabricated or incorrect. There is no evidence in the ground truth to support any of these figures. The total revenue of $17.52 billion in 2023 is mentioned in the original answer, but the LLM fails to reference this total or connect Embedded Processing’s role within it. (3) The reasoning is partially sound in identifying that Embedded Processing offset Analog’s decline, which aligns with the original answer’s claim of a compensatory role. However, the multi-hop synthesis is flawed because it invents data rather than acknowledging the lack of disclosed figures in 2022 and the qualitative strategic shift. The conclusion about 'growing strategic relevance' is plausible but based on false premises. (4) Contextual relevance is moderate—the answer addresses the evolution of strategic importance and contrasts Embedded Processing with Analog, which is relevant. However, the inclusion of fabricated metrics severely undermines correctness. The original answer emphasizes qualitative continuity and a new compensatory function, while the LLM over-quantifies with incorrect data, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 497,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "Chevron's involvement in Angola LNG has seen a notable shift in equity earnings, decreasing from $1,857 million in 2022 to $405 million in 2024. This decline suggests a strategic recalibration or operational challenges in the Angola LNG project during this period. Despite this, Chevron maintains a 36.4% stake in Angola LNG, which processes and liquefies natural gas for international markets, indicating its continued commitment to the LNG sector. The reduction in earnings may reflect broader market dynamics, project-specific issues, or adjustments in Chevron's portfolio to align with evolving energy strategies.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces financial figures—$1,857 million in equity earnings in 2022 and $405 million in 2024—that are not present in the original answer and cannot be verified against the ground truth. These numbers appear fabricated or misattributed, as the ground truth makes no mention of equity earnings or any financial performance metrics for Chevron's Angola LNG involvement. The only accurate quantitative detail is the 36.4% stake in 2024, which matches the original answer. (2) The calculation of a decline in earnings is unsupported by the provided ground truth, which focuses on the evolution from operational participation in 2022 to a defined equity stake in 2024, not financial performance. Thus, the core quantitative claim is incorrect. (3) The multi-hop reasoning is partially sound in that the model identifies a progression in Chevron’s involvement and links it to strategic positioning in the LNG market. However, it misrepresents the nature of the evolution: the original answer emphasizes increasing structural commitment (from operational role to formal equity stake), whereas the LLM interprets it as a decline due to falling earnings—an inference not supported by the evidence. (4) While the LLM correctly identifies the 36.4% stake and Chevron’s ongoing role in Angola LNG, the introduction of false financial data significantly undermines factual accuracy. The contextual framing about strategic commitment to LNG is reasonable but based on flawed premises. Correctness score is low due to major quantitative inaccuracies, though some qualitative elements and relevance to the question remain.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 448,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "The CH-53K program has seen a notable production ramp-up within Lockheed Martin's RMS division, contributing to higher product sales in 2024 compared to 2023. This increase indicates that the CH-53K is becoming a more significant contributor to RMS's revenue and is likely playing a more prominent role in the division's portfolio, particularly as it offsets declines in other programs like the VH-92A. The program's growth reflects its importance in supporting military heavy-lift helicopter needs and aligning with international and domestic demand.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in describing the CH-53K program's growing role and production ramp-up, but it fails to include any of the specific financial figures from the ground truth for 2021 and 2024. The original answer states that in 2021, the program contributed to a $540 million increase in RMS net sales and a $140 million increase in operating profit. By 2024, it contributed $1.1 billion to higher product sales. None of these figures are mentioned in the LLM response, making it factually incomplete. (2) Quantitatively, the LLM omits all dollar amounts and years (2021 vs 2024) that are central to the question. It references 2024 and implies growth from 2023, but the ground truth comparison is between 2021 and 2024. The LLM incorrectly frames the timeline around 2023–2024, missing the 2021 baseline entirely. (3) The reasoning is partially sound in that it identifies the CH-53K as a growing program within RMS and notes its increasing importance, possibly offsetting other program declines. However, it fails the multi-hop requirement of comparing financial contributions and production status across 2021 and 2024. The transition from risk retirement and early production (2021) to high-volume production (2024) is not captured. (4) The contextual relevance is moderate because the answer discusses the program’s role and growth in RMS, which is relevant, but lacks the core quantitative and temporal comparisons required. Due to the absence of key financial data and incorrect time framing, the correctness and quantitative accuracy scores are low. The qualitative accuracy is mid-range because the general direction of the conclusion (increasing importance) aligns with the truth, but without proper support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 476,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "Between 2022 and 2023, PayPal updated its expected credit loss models for revolving consumer receivables in the second quarter of 2023. The most notable evolution was the exclusion of unemployment rates as a macroeconomic factor for revolving credit products after the first quarter of 2023, while continuing to incorporate factors like household disposable income and retail e-commerce sales. Additionally, the reasonable and supportable forecast period for revolving consumer products remained consistent at approximately 5 years in 2023, compared to 2 years in 2022. These changes reflect a more refined approach to modeling macroeconomic impacts on credit losses for revolving consumer credit.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in PayPal's use of macroeconomic factors—specifically, the removal of unemployment rates after Q1 2023 and the inclusion of household disposable income and retail e-commerce sales. However, it incorrectly states that the forecast period was updated to 5 years in 2023 compared to 2 years in 2022, which is not supported by the original answer and introduces a significant quantitative inaccuracy. The original answer does not mention any change in forecast period length, so this detail is fabricated or misattributed. (2) The date of the model update is partially correct—the removal of unemployment rates after Q1 2023 aligns with the ground truth, but the claim of a Q2 2023 model update is not explicitly confirmed and may be inferred incorrectly. The core macroeconomic shift (removal of unemployment, addition of income and e-commerce) is accurate. (3) The multi-hop reasoning is generally sound—linking changes in model inputs to broader modeling strategy—but the addition of unsupported details about forecast period duration undermines quantitative reliability. (4) The answer is contextually relevant and captures the qualitative shift in macroeconomic indicators. Due to the incorrect forecast period claim, which is a major quantitative error, the correctness score is reduced to 7, though the core conceptual evolution is accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 395,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks' foreign currency debt-related gains or losses included in AOCI decreased from a net gain of $140.2 million in 2023 to $135.2 million in 2024, indicating a slight reduction in the positive impact of foreign currency fluctuations on its debt. This suggests that while the company still benefits from foreign currency movements, the magnitude of these benefits has slightly diminished, reflecting potential stabilization or reduced exposure in its foreign currency-denominated debt positions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the change. The ground truth states that Starbucks had a loss of $6.3 million in 2023 and a gain of $135.2 million in 2024, representing a shift from loss to large gain. However, the LLM claims a gain of $140.2 million in 2023 and $135.2 million in 2024, which is not only wrong but reverses the actual trend. The only correct number is the $135.2 million gain in 2024. (2) The quantitative error is severe: the 2023 figure is completely incorrect ($140.2M vs actual $6.3M loss), and the characterization of both years as gains is false. The calculation of a 'decrease' from 2023 to 2024 is based on false premises. (3) The multi-hop reasoning fails because the model did not correctly retrieve or synthesize the AOCI-related foreign currency debt gains/losses for the two years. Instead, it appears to have hallucinated a different dataset or confused the numbers with another company or context. The conclusion about 'slight reduction in positive impact' is invalid because 2023 was actually a loss year, not a gain year. (4) Correctness is very low due to major factual errors in core data. Quantitative accuracy is poor because one of two numbers is wrong and the direction of change is misrepresented. Qualitative accuracy is low due to flawed logic and misinterpretation of exposure trend. Contextual relevance is moderate because the answer addresses the right topic and metric (AOCI, foreign currency debt), but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 420,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "Between 2022 and 2023, the fair value of energy-related derivatives for Alabama Power increased from $15 million to $15 million (no change), while for Georgia Power, it increased from $13 million to $13 million (also no change). Despite no change in individual values, the combined liabilities related to energy-related derivatives for both companies increased from $210 million in 2022 to $234 million in 2023, indicating an overall upward trend in their combined liabilities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) It misrepresents the fair value changes for both Alabama Power and Georgia Power. The LLM claims Alabama Power's fair value increased from $15M to $15M and Georgia Power's from $13M to $13M, implying no change in assets, but the ground truth shows Alabama Power had a net liability of $144M in 2022 (not $15M in assets), and only in 2023 did it report $15M in assets and $110M in liabilities. Georgia Power had no 2022 asset value mentioned in the ground truth, only 2023 data ($13M assets, $124M liabilities). (2) The combined liabilities are grossly miscalculated: the LLM states combined liabilities increased from $210M in 2022 to $234M in 2023, but the correct 2022 combined net liability was $255M (Alabama Power's $144M + Georgia Power's implied $111M from prior year context), and in 2023 it decreased to $206M ($95M + $111M). (3) The multi-hop reasoning failed completely: the model did not correctly identify the net liabilities for each company, confused assets with total fair value, and invented 2022 data for Georgia Power that was not present. (4) The conclusion of an 'upward trend' is false; the correct trend is a reduction in net liabilities. The only partial relevance is that the answer addresses the right companies and topic (derivatives), but all key facts and calculations are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 375,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion, increasing its ownership to approximately 100%. However, the entity was subsequently sold and deconsolidated in fiscal 2025, indicating that Walmart disposed of its ownership in Alert Innovation by the end of fiscal 2024 or early fiscal 2025.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion acquisition of Alert Innovation in fiscal 2023 and Walmart's ~100% ownership, which matches the ground truth. However, it incorrectly states that the sale and deconsolidation occurred in fiscal 2025, while the original answer specifies fiscal 2024. This is a critical error in temporal accuracy, as the question specifically asks about the evolution between fiscal 2023 and fiscal 2024. The LLM implies the divestiture happened in fiscal 2025, suggesting Walmart still held the asset through fiscal 2024, which contradicts the ground truth that the exit occurred in fiscal 2024. (2) The dollar amount ($0.4 billion) is accurate and correctly formatted. The ownership percentage (~100%) is also correct. However, the fiscal year of disposition is wrong—this is a factual error, not just a wording issue. (3) The multi-hop reasoning is partially sound: the model correctly links acquisition and divestiture as two phases of Walmart's relationship with Alert Innovation. But it fails to correctly synthesize the timeline across the two fiscal years, breaking the chain of accurate inference. The conclusion that Walmart disposed of ownership 'by the end of fiscal 2024 or early fiscal 2025' introduces ambiguity and misaligns with the definitive fiscal 2024 deconsolidation in the ground truth. (4) Scores reflect that core financial facts are correct (hence partial credit), but the misstatement of the divestiture year undermines the correctness score. Quantitative accuracy is reduced due to the incorrect fiscal year (a key quantitative temporal metric). Qualitative accuracy is moderately high due to correct entities and logical flow, but penalized for incorrect synthesis. Contextual relevance is high as the answer directly addresses the question's focus on acquisition and disposition evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 504,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "Between 2022 and 2023, the regulatory approval status of Trodelvy expanded, with the FDA approving it for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting in 2022. In 2023, Trodelvy's sales increased by 56% to $1.1 billion, indicating strong demand in new and existing geographies. This growth and expansion of approvals reflect Gilead's oncology strategy of expanding its commercial portfolio and clinical pipeline to drive future growth, emphasizing innovation and the development of transformative therapies to address unmet medical needs in oncology.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding the timing of the FDA approval. According to the ground truth, Trodelvy received FDA and EC approvals for HR+/HER2- breast cancer in 2023, not in 2022 as stated in the LLM answer. This misplacement of the approval date undermines the accuracy of the regulatory timeline. However, the LLM correctly identifies the indication (unresectable locally advanced or metastatic HR+/HER2- breast cancer) and the patient criteria (prior endocrine therapy and at least two additional systemic therapies). The $1.1 billion sales figure and 56% growth in 2023 are plausible and contextually supportive, though not present in the original answer, so they cannot be verified from the ground truth; their inclusion adds detail but does not contradict known facts. (2) Quantitative accuracy is partially correct: the 56% growth and $1.1 billion sales figure are not in the original answer, so they cannot be confirmed or denied, but no internal inconsistencies are present. The critical error is the misattribution of the FDA approval to 2022 instead of 2023, which is a major factual and temporal inaccuracy. (3) The multi-hop reasoning is partially sound: the model correctly infers that expanded approvals reflect a strategic focus on oncology growth and portfolio expansion, which aligns with the original answer’s interpretation. However, the incorrect timeline weakens the synthesis between regulatory events and strategic implications. (4) Contextual relevance is high—the answer addresses both the evolution of regulatory status and Gilead’s oncology strategy, using appropriate terminology and logical connections. Despite the incorrect date, the overall direction of the reasoning is consistent with the ground truth. The correctness score is 6 due to the mix of accurate details and a significant factual error in timing that affects the core narrative of regulatory progression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 526,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's financial relationship with ABG evolved significantly through capital transactions. In 2023, Simon recognized multiple non-cash gains due to dilutions in its ownership stake in ABG, including a $157.1 million pre-tax gain from selling a portion of its interest and a $10.3 million gain from a deemed disposal due to ABG's capital transaction. By 2024, Simon fully exited its remaining interest in ABG, selling it for $1.2 billion and recognizing a substantial pre-tax gain of $414.8 million. These transactions reflect a strategic shift by Simon to divest its stake in ABG, optimizing its portfolio and capital allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group (SPG) recognized non-cash pre-tax gains of $36.4 million in Q2 2023 and $145.8 million in Q3 2023 due to dilution from ABG and SPARC Group equity issuance, totaling $182.2 million in 2023—not $157.1 million and $10.3 million as stated. The LLM incorrectly reports a $1.2 billion sale of SPG’s remaining ABG interest in 2024 with a $414.8 million gain, which is entirely absent from the ground truth. In reality, SPG did not report any new capital transactions with ABG in 2024; instead, the 2024 filings only referenced historical transactions (e.g., 2021 and 2022 events). (2) Quantitative accuracy is severely compromised: the LLM invents numbers not present in the original data (e.g., $414.8M gain, $1.2B sale) and misrepresents the actual gains and their timing. The sum of the actual 2023 gains is $182.2M, not $167.4M as implied by the LLM’s figures. (3) The multi-hop reasoning is flawed—the LLM incorrectly infers a full exit in 2024 based on no evidence from the ground truth, which states that SPG simply stopped reporting active transactions and only referenced past ones. The strategic shift is misrepresented: the truth indicates a move from active engagement in 2023 to a dormant, historically referenced relationship in 2024, not a full divestiture. (4) Contextual relevance is moderate because the answer addresses capital transactions and strategic positioning, but the conclusions are based on fabricated data. Correctness and quantitative accuracy are low due to major factual and numerical errors; qualitative accuracy is slightly higher because the general theme of changing financial engagement is partially aligned, but reasoning is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 486,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "Chevron's relationship with Chevron Phillips Chemical Company LLC (CPChem) evolved in terms of financial reporting and investment value between 2022 and 2024, as reflected in the provided data. In 2022, Chevron's investment in CPChem was reported at $7,765 million, with equity in earnings of $608 million. By 2024, the investment value increased to $8,571 million, and equity in earnings rose to $903 million, indicating a stronger financial performance and higher returns from the joint venture. Additionally, Chevron provided a loan of $669 million to CPChem to support the Golden Triangle Polymers Project, highlighting Chevron's ongoing commitment to and investment in CPChem's growth initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the nature of Chevron's relationship with Chevron Phillips Chemical Company LLC (CPChem) between 2022 and 2024. According to the ground truth, in 2022 CPChem was a consolidated subsidiary, reported in Note 8 of the 10-K, indicating full consolidation in financial statements. However, the LLM incorrectly states that in 2022 the investment was already being reported at $7,765 million as an equity method investee, which contradicts the ground truth—this value is actually the 2023 investment amount under the equity method, not 2022. The shift from consolidation to equity method is a key point missed entirely by the LLM. (2) Quantitatively, the 2024 investment value of $8,571 million is correct, and the increase from $7,765 million (2023) is accurate, but attributing $7,765 million to 2022 is wrong. The equity in earnings figures ($608M in 2022 and $903M in 2024) are plausible but not supported by the ground truth, which does not mention earnings—so their inclusion introduces unverified data. The $669 million loan is not mentioned in the original answer and lacks verification. (3) The multi-hop reasoning is flawed: the model fails to recognize the critical accounting change (consolidation to equity method), which is central to the evolution of the relationship. Instead, it assumes consistent equity method reporting, missing the structural shift. (4) While the answer discusses investment values and earnings growth—relevant to financial reporting and value—it omits the most important qualitative shift in the relationship. The contextual relevance is fair because it addresses financial reporting and investment trends, but the core factual transformation is misrepresented. Thus, the correctness score is low due to major factual and conceptual errors, despite some accurate numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 509,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "Between the end of 2023 and the end of 2024, Meta completed its 2022 Facilities Consolidation Strategy, which involved subleasing, early termination, or abandonment of office buildings. In 2023, the company had incurred $2,506 million in pre-tax charges related to facilities consolidation, and by 2024, the total restructuring charges under this strategy were $389 million, all related to facilities consolidation. This indicates that the financial impact of the strategy significantly decreased in 2024 as the initiatives were largely completed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies that Meta completed its facilities consolidation strategy by the end of 2024, it fabricates specific financial figures—$2,506 million in pre-tax charges in 2023 and $389 million in 2024—that are not supported by the ground truth. The original answer states that the 2024 filing included a retrospective summary of total pre-tax charges across 2022–2024, but does not specify annual breakdowns or these exact numbers. (2) The calculation of a decrease from $2,506M to $389M implies precise year-over-year financials that are not present in the ground truth, making the quantitative claims misleading. The ground truth does not provide annual charge amounts, so these numbers cannot be verified and appear to be hallucinated. (3) The multi-hop reasoning is partially sound: the model correctly infers progression from 'substantially completed' in 2023 to 'completed' in 2024, showing understanding of the timeline and strategic closure. However, it fails to accurately represent the nature of the financial disclosure—retrospective aggregation rather than annual comparison. (4) Contextual relevance is high because the answer addresses the evolution of the strategy and attempts to quantify financial impact. However, due to major quantitative errors and lack of support for key financial claims, the overall correctness is low. The answer gives a plausible narrative but is factually unreliable on critical financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 430,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs from 2022 to 2024 has shown a continued strategic focus on developing and delivering advanced hypersonic strike weapons for the U.S. military. In 2022, the company was already engaged in multiple hypersonics programs with the U.S. Air Force and Army. By 2024, this focus remained strong, with hypersonics programs explicitly listed under both the Missiles and Fire Control (MFC) and Space segments, indicating expanded collaboration with the U.S. Army and Navy. This evolution reflects the company's alignment with national defense priorities and its commitment to advancing next-generation capabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly identifies Lockheed Martin's continued strategic focus on hypersonics and involvement with U.S. military programs, it misrepresents the evolution between 2022 and 2024. The original answer states that in 2022, hypersonics was a 'key growth area dependent on U.S. Government authorization and funding,' indicating developmental status and uncertainty, whereas the LLM claims Lockheed was 'already engaged in multiple hypersonics programs' in 2022—this contradicts the ground truth by overstating the maturity of the programs at that time. By 2024, the ground truth confirms active production under multiple programs with the Air Force and Army, but the LLM adds unverified expansion to the Navy, which is not supported in the original. (2) There are no numeric values or calculations in either answer, so quantitative accuracy is not applicable—score reflects no factual numeric errors. (3) The multi-hop reasoning is partially sound: the model connects Lockheed Martin’s hypersonics work across time and services, but fails to accurately capture the shift from funding-dependent development (2022) to active production (2024), which is the core of the evolution. The addition of the Navy and MFC/Space segment details introduces unsupported specifics not present in the ground truth, suggesting hallucination or overinference. (4) Correctness is scored at 5 due to significant factual discrepancies in program status evolution despite relevant context and correct general direction of strategic focus. Qualitative accuracy is low due to incorrect entity relationships and unsupported program expansions. Contextual relevance is high because the response stays on topic and addresses strategic focus and program progression, albeit inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 502,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "From 2022 to 2023, Southern Company's treatment and disclosure of energy-related derivatives showed a shift in both designation and financial impact. In 2023, the company reported a pre-tax loss of $59 million from energy-related derivatives not designated as hedging instruments, primarily impacting natural gas revenues and costs, compared to a $76 million loss in 2022. Additionally, the cumulative fair value hedging adjustments for long-term debt increased slightly for Southern Company, from $282 million in 2022 to $235 million in 2023, indicating a reduction in the hedging impact on debt valuation. These changes reflect adjustments in market conditions and hedging strategies over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Southern Company evolved its disclosure practices—specifically, in 2023 it began reporting pre-tax effects of energy-related derivatives not designated as hedging instruments, with comparative data going back to 2021. However, the LLM answer fabricates specific financial figures such as a '$59 million loss in 2023' and '$76 million loss in 2022' from derivatives not designated as hedging instruments, which are not present in the original answer and cannot be verified from the provided truth. Additionally, the claim about 'cumulative fair value hedging adjustments for long-term debt' increasing from $282 million to $235 million is numerically inconsistent (235 < 282, so it decreased, not increased) and is entirely absent from the original answer. (2) The numbers cited in the LLM response do not appear in the ground truth, indicating hallucination rather than accurate retrieval or synthesis. There is no mention of specific dollar amounts related to undesignated derivatives in the original answer, nor any data on long-term debt hedging adjustments. (3) The multi-hop reasoning is flawed: the question asks about evolution in treatment and disclosure, particularly designation and financial impact. The correct answer focuses on a change in reporting scope—from only regulatory hedging instruments in 2022 to including non-hedging-designated derivatives in 2023. The LLM instead shifts focus to fabricated quantitative impacts and irrelevant debt valuation adjustments, missing the core conceptual shift in disclosure policy. (4) Due to significant factual inaccuracies, made-up numbers, and failure to capture the key evolution in disclosure practice, the correctness score is low at 3. Quantitative accuracy is 2 due to incorrect and inconsistent numbers. Qualitative accuracy is 3 because while the topic of derivative treatment is relevant, the reasoning and entity relationships are misrepresented. Contextual relevance is 6 because the answer addresses Southern Company and derivatives, showing some understanding of the domain, but fails on execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 587,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "Between 2022 and 2023, Gilead's intellectual property strategy regarding Truvada evolved as the company continued to navigate the loss of exclusivity for Truvada in the United States, which occurred in October 2020. In 2022, the focus shifted to managing the impact of generic competition and mitigating its effects on revenue. By 2023, Gilead's patent disclosures emphasized ongoing efforts to strengthen and diversify its portfolio, including expanding into new therapeutic areas and leveraging strategic collaborations. While Truvada's patent protections had expired, Gilead shifted its emphasis to other key products and innovations, such as lenacapavir and expanded indications for existing therapies, to drive future growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the October 2020 loss of exclusivity for Truvada in the U.S., which aligns with the ground truth and is a key factual anchor. However, it diverges significantly in describing Gilead's 2023 strategy. The original answer states that in 2023, Gilead shifted to structured disclosures of patent expiration dates for key products including Truvada, focusing on U.S. and EU timelines. The LLM instead claims Gilead emphasized portfolio diversification, new therapeutic areas, collaborations, and other products like lenacapavir—details not present in the ground truth. These represent a mischaracterization of the strategic evolution. (2) Quantitatively, the date (October 2020) is accurate and correctly referenced. There are no numerical calculations in this question, so accuracy is limited to correct date usage, which is satisfied. (3) The multi-hop reasoning is partially sound—linking the loss of exclusivity to strategic changes is logical—but the synthesis is flawed. The LLM infers broader strategic shifts not supported by the original answer, failing to capture the specific evolution from reactive acknowledgment (2022) to proactive, structured IP disclosure (2023). (4) The correctness score is 5 due to partial factual alignment but significant deviation in the core strategic shift. Quantitative accuracy is high (8) because the only number/date is correct. Qualitative accuracy is moderate (5) as key entities (Gilead, Truvada, patent loss) are right, but reasoning and synthesis are incorrect. Contextual relevance is 7 because the answer stays on topic but introduces unverified strategic directions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 454,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "Between 2022 and 2024, SPG's use of the Supplemental Facility showed a pattern of borrowing and repayment activities. In 2022, SPG repaid $750 million under the Supplemental Facility. In 2023, SPG borrowed €750 million under the Supplemental Facility and later repaid it in November 2023. In 2024, SPG issued $1.0 billion in senior unsecured notes and used the proceeds to repay $900 million in maturing notes. These activities indicate that SPG used the Supplemental Facility for both short-term liquidity needs and long-term refinancing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that in 2022, SPG repaid $750 million under the Supplemental Facility, whereas the ground truth indicates SPG borrowed $1.05 billion in January 2022 (not repaid $750 million). The $750 million figure actually corresponds to the 2023 euro-denominated borrowing (€750 million), which the model misattributes in part to 2022 repayment. The 2023 borrowing of €750 million ($815.4 million) and repayment in November 2023 is correctly noted, though the U.S. dollar equivalent is omitted. In 2024, the LLM claims SPG issued $1.0 billion in senior unsecured notes to repay $900 million in maturing notes, but the ground truth states the notes were used to redeem other outstanding notes at maturity—without specifying amounts—so the $1.0B and $900M figures are unsupported. (2) Quantitative accuracy is low: the key 2022 borrowing of $1.05B is entirely missing, replaced with an incorrect $750M repayment; the $815.4M USD equivalent of the euro borrowing is not mentioned; and fabricated figures for note issuance and repayment in 2024 reduce numerical reliability. (3) The reasoning partially captures the short-term use of the Supplemental Facility but fails to accurately synthesize the multi-hop timeline and purpose: the 2022 borrowing funded mortgage extinguishment (a key detail omitted), and the 2024 shift in financing strategy is oversimplified and inaccurately quantified. (4) Contextual relevance is high—the answer addresses the evolution of borrowing and repayment and attempts to infer strategic trends—but factual errors severely undermine correctness. Overall, the answer is partially aligned in structure and intent but fails on core factual accuracy, especially in the 2022 activity and numerical details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 492,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "From 2022 to 2024, MetLife has maintained a strong focus on liquidity and capital management, with cash buffer needs playing a central role in its strategy. In 2022, MetLife reported substantial short-term liquidity of $12.4 billion and liquid assets of $223.0 billion, emphasizing its ability to meet obligations and manage risks through diversified funding sources and stress testing. By 2024, the company continued to prioritize liquidity, maintaining robust short-term liquidity and liquid assets, while also highlighting the importance of cash buffers in supporting capital allocation decisions, regulatory compliance, and risk mitigation. The evolution reflects a strategic emphasis on preserving financial flexibility amid market uncertainties and regulatory demands.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2022 quantitative figures—$12.4 billion in short-term liquidity and $223.0 billion in liquid assets—matching the ground truth exactly, which supports a high quantitative accuracy score. The entities (MetLife, years 2022 and 2024, liquidity metrics) are accurate and correctly attributed. (2) All numbers are factually correct and properly contextualized within the 2022 data. However, the LLM does not provide updated quantitative figures for 2024 or explicitly state any change in liquidity levels, which is a minor omission but not a factual error. (3) The multi-hop reasoning is partially sound: the model correctly identifies the continued importance of liquidity in both years. However, it misses a key qualitative shift noted in the ground truth—the 2024 caution that increasing cash buffers could limit capital for innovation, acquisitions, and shareholder returns. This trade-off between cash buffers and capital deployment is a central evolution in strategy and is underemphasized in the LLM response, which instead generalizes about 'preserving financial flexibility' without acknowledging the constraining effect of larger buffers. (4) The answer remains contextually relevant and well-structured, addressing liquidity, capital allocation, and strategic priorities. Due to the accurate numbers and correct entity/year alignment, the quantitative accuracy is perfect. However, the qualitative accuracy is reduced because the nuanced strategic evolution—highlighting the cost of larger buffers—is not adequately conveyed, leading to a correctness score of 7, reflecting mostly correct information with a significant omission in strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 467,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Between 2022 and 2023, Starbucks' exposure to 'Foreign currency - other' derivatives showed notable changes in asset and liability classifications. In 2022, derivative assets related to 'Foreign currency - other' were split between $39.9 million in prepaid expenses and other current assets and $33.5 million in other long-term assets. By 2023, the asset classification shifted to $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets, indicating a significant reduction in overall exposure. On the liability side, in 2022, $0.3 million was classified in accrued liabilities and $- in other long-term liabilities, while in 2023, $4.7 million was in accrued liabilities and $4.1 million in other long-term liabilities, showing an increase in liabilities associated with these derivatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Starbucks had *no asset* value for 'Foreign currency - other' derivatives, only a $0.3 million liability. However, the LLM claims there were assets of $39.9 million and $33.5 million in different categories, which is completely incorrect. In 2023, the LLM correctly identifies the $1.9 million asset in prepaid expenses but adds a $1.7 million long-term asset not mentioned in the ground truth, which only reports the $1.9 million asset and $4.7 million liability. On liabilities, the LLM invents a $4.1 million long-term liability in 2023, which is not present in the original answer. (2) Number verification: 2022 asset values are entirely fabricated; 2022 liability ($0.3M) is correct; 2023 asset ($1.9M) partially correct but adds incorrect $1.7M; 2023 liability ($4.7M) correct but adds unsupported $4.1M. Calculations and comparisons based on these numbers are therefore invalid. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the actual data across years and misrepresents the evolution of exposure. It incorrectly suggests a 'reduction in overall exposure' on the asset side when the ground truth shows an emergence of an asset position from zero, and overstates the liability increase by including non-existent long-term components. (4) Scores justified as follows: correctness is low (2/10) due to major factual errors in core data; quantitative accuracy is poor (2/10) because most numbers are wrong; qualitative accuracy is slightly higher (3/10) as the model attempts the right type of analysis (comparing year-over-year changes in classification) but with incorrect data; contextual relevance is moderate (6/10) because the structure and intent align with the question, even if facts are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 501,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "The Coca-Cola Company's financial stake in Coca-Cola FEMSA decreased from 2023 to 2024, with the carrying value of the investment dropping from $1,786 million to $1,786 million in 2023 to $1,786 million to $1,786 million in 2024, as indicated by the difference between fair value and carrying value in Note 6. The strategic engagement remains strong, as Coca-Cola FEMSA is one of the Company's key bottling partners, operating across Latin America and contributing significantly to the Coca-Cola system's unit case volume.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The key claim that Coca-Cola's financial stake in Coca-Cola FEMSA decreased is false according to the ground truth, which states that by 2024, The Coca-Cola Company held a 28% ownership stake, indicating a strategic shift toward deeper financial integration, not a reduction. The repeated number '$1,786 million to $1,786 million' appears to be a formatting or hallucination error and does not reflect any actual change, but more critically, this figure is not mentioned in the ground truth at all, making it factually unsupported. (2) There are no valid calculations or numeric comparisons in the LLM answer that align with the ground truth. The ground truth does not provide any carrying value or fair value figures, so citing 'Note 6' and specific dollar amounts introduces fabricated data. The absence of the 28% ownership figure—a central fact—is a major quantitative and qualitative failure. (3) The multi-hop reasoning is flawed: the question requires synthesizing changes in both strategic engagement and financial stake over time. The LLM fails to identify the evolution from independent bottler to equity method investee, which is the core transformation. Instead, it incorrectly assumes a decline in investment based on unsupported financial figures. (4) While the answer correctly notes Coca-Cola FEMSA's operational role in Latin America and its importance to the system, this only partially satisfies contextual relevance. However, the incorrect financial narrative and missing ownership percentage severely undermine the answer's validity. Thus, the correctness score is low due to major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 469,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "Between 2022 and 2024, Intel has positioned FPGAs as a key component within its broader strategy for programmable and adaptable computing solutions. In 2022, FPGAs were highlighted as part of \"adjacent products,\" which included offerings such as modems, Ethernet, and silicon photonics, aimed at complementing platform products to deliver comprehensive solutions. By 2024, FPGAs were integrated into the broader xPU category, which encompasses CPUs, GPUs, AI accelerators, and FPGAs, reflecting their role in addressing diverse computing architectures. Intel's focus on FPGAs has evolved to emphasize their programmability and adaptability in applications such as data centers, AI, and network infrastructure, aligning with the company's strategic shift toward a more diversified and performance-driven product portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of Intel's FPGA positioning between 2022 and 2024, noting their initial role as 'adjacent products' and increased importance by 2024. However, it diverges from the ground truth by stating FPGAs were integrated into the 'xPU category' in 2024, which is not mentioned in the original answer. Instead, the ground truth specifies that FPGAs moved from being 'adjacent products' to being explicitly listed under direct product definitions, indicating a structural shift in production focus. This misrepresentation affects qualitative accuracy. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are incorrect. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes FPGA's changing role across time and business segments, but fails to accurately reflect the specific organizational shift (from 'adjacent' to 'direct product') as documented in the ground truth. Instead, it introduces the xPU framework, which may be contextually relevant but is not supported by the provided truth. (4) The answer is contextually relevant and captures the general strategic trend, but lacks precision in describing the nature of the shift. Thus, correctness is reduced to 7 due to the substitution of a plausible but unverified strategic narrative (xPU integration) for the actual structural repositioning documented in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 422,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips' financial activity in the Lower 48 region showed significant changes in asset acquisition and depreciation, depletion, and amortization (DD&A) expenses. Capital expenditures for the Lower 48 increased from $5,630 million in 2022 to $6,487 million in 2023, reflecting higher investment in asset acquisition and development. Additionally, DD&A expenses for the Lower 48 rose from $4,854 million in 2022 to $5,729 million in 2023, indicating increased asset utilization and depletion of reserves in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the DD&A expenses for the Lower 48 region as $4,854 million in 2022 and $5,729 million in 2023, matching the ground truth exactly. The increase of $875 million is accurate (5,729 - 4,854 = 875), though the LLM does not explicitly state the difference, it correctly implies a rise. The LLM introduces capital expenditures ($5,630M in 2022 and $6,487M in 2023), which are not mentioned in the original answer. However, these figures are contextually relevant to asset acquisition and investment activity and do not contradict the ground truth; they add supplementary detail. (2) All numeric values for DD&A are correct and match the ground truth. The capital expenditure figures, while not in the original answer, are plausible and consistent with the narrative of increased investment post-Concho acquisition. No calculation errors. (3) The multi-hop reasoning is sound: the LLM connects increased DD&A and capex to heightened asset utilization and investment in the Lower 48, aligning with the original answer’s conclusion about continued investment following the acquisition. The mention of the Concho acquisition is missing in the LLM answer, which is a minor omission affecting completeness. (4) The answer is highly factually accurate, contextually appropriate, and adds relevant financial context. The only reason for not scoring a 10 is the omission of the Concho acquisition as the driver in 2022, which was a key point in the original answer. Otherwise, all core facts, numbers, and reasoning are correct and semantically aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 435,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Between 2022 and 2024, Emerson's ownership in AspenTech increased significantly. In 2022, Emerson owned 55% of AspenTech on a fully diluted basis after acquiring Heritage AspenTech. By 2024, Emerson's ownership had increased to approximately 57%, and on November 5, 2024, Emerson announced a proposal to acquire the remaining shares of AspenTech for $240 per share, which would make AspenTech a wholly owned subsidiary. \n\nFinancially, the inclusion of AspenTech positively impacted gross margins. In 2023, the Heritage AspenTech acquisition contributed 0.6 percentage points to the gross margin increase. By 2024, while acquisition-related inventory step-up amortization negatively impacted margins by 1.3 percentage points, the Test & Measurement acquisition and higher pricing partially offset this, leading to an overall gross margin of 50.8%.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Emerson owned 55% of AspenTech in 2022 after the acquisition—this is false. According to the ground truth, the acquisition was completed in 2022, implying full control, and by 2024, Emerson owned 55% on a fully diluted basis, not in 2022. The claim that ownership increased to 57% by 2024 is unsupported by the original answer, which states 55% ownership in 2024. Additionally, the LLM introduces a November 5, 2024 announcement to acquire remaining shares for $240 per share, which is not mentioned in the ground truth and appears fabricated. (2) Quantitative inaccuracies include the $240 per share offer (ground truth mentions $87.69 paid in 2022), and the failure to mention the $6.0 billion cash payment and $168 million retained on AspenTech’s balance sheet. While the 0.6 percentage point margin boost in 2023 is correct, the 2024 gross margin explanation is partially flawed: the LLM attributes the offset to 'Test & Measurement acquisition and higher pricing,' but the ground truth attributes the net positive impact to AspenTech’s ongoing contribution despite the $231 million inventory step-up amortization (which reduced margins by 1.3 points). The final gross margin of 50.8% is correctly stated. (3) The multi-hop reasoning is partially sound—linking ownership evolution and financial impact on margins—but fails in synthesis due to incorrect temporal assignment of ownership stakes and introduction of unverified events. The model conflates timeline and ownership structure. (4) Despite these issues, the answer is contextually relevant, addressing both ownership and margin impact. However, major factual and quantitative errors—especially the incorrect ownership percentages, made-up acquisition proposal, and misattribution of margin drivers—severely undermine correctness. Minor credit is given for correctly citing the 0.6-point margin boost and 50.8% 2024 gross margin.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 537,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "Between 2022 and 2024, the treatment and availability of shares under the 2015 Director Stock Plan evolved in terms of share recovery and issuance mechanics as follows: The number of shares remaining available for future issuance under the 2015 Director Stock Plan decreased from 34,073,114 in 2022 to 30,660,961 in 2024. This reduction reflects the cumulative effect of shares covered by new awards and imputed reinvested dividends, which outpaced share recoveries. Shares recovered in 2024 continued to follow the same mechanics as prior years, becoming available for reissuance upon events such as award forfeitures, cash settlements, or tax withholding through share tenders. The issuance mechanics remained consistent, with each share issued under the 2015 Director Stock Plan reducing the available share pool by one.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of the 2015 Director Stock Plan between 2022 and 2024, noting consistent share recovery mechanics and the net reduction in available shares. It accurately states that 30,660,961 shares were available in 2024 and that recovered shares (from forfeitures, cash settlements, etc.) are reused, aligning with the ground truth. However, the LLM introduces a specific figure—34,073,114 shares available in 2022—that is not present in the original answer and cannot be verified from the provided ground truth. This number may be factually correct but lacks support in the reference, making it a potentially unsupported addition. (2) The ground truth does not provide a 2022 availability number, so the quantitative claim of a decrease from 34,073,114 to 30,660,961 cannot be confirmed and appears to be an inference or external data point. Other numbers—37,608,213 recovered shares and 42,343,146 covered by awards/dividends—are not mentioned in the LLM answer, resulting in partial omission of key quantitative context. (3) The reasoning is sound: the LLM correctly infers that new issuances and reinvested dividends outpaced recoveries, leading to a net reduction in availability, which is consistent with the ground truth’s conclusion. It also correctly identifies that the mechanical treatment of shares (1:1 reduction, reuse of forfeited shares) remained unchanged. (4) The answer is highly relevant and well-structured, addressing both treatment and availability. The main deduction is for introducing an unverified 2022 share count and omitting the full cumulative figures (authorized, recovered, issued) that ground the analysis in the original answer. While the direction and logic are correct, the unsupported number and missing data reduce quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 497,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "Starbucks' relationship with the Global Coffee Alliance (GCA) showed increased strategic emphasis and revenue contribution from fiscal year 2022 to 2023. In fiscal 2022, the GCA contributed to a $216 million increase in \"Other revenues,\" driven by higher product sales and royalty revenue. By fiscal 2023, the GCA was highlighted as a key component of Starbucks' growth strategy, with continued expansion in global ready-to-drink products and licensed store support, indicating a stronger strategic focus. While specific 2023 revenue figures for the GCA are not provided, the emphasis on innovation and partnership suggests a growing role in Starbucks' financial performance.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details. The ground truth states that the Global Coffee Alliance contributed to a $250 million increase in revenue in fiscal year 2022 within the Channel Development segment, but the LLM incorrectly reports a $216 million increase in 'Other revenues'—both the amount and the revenue category are wrong. This misrepresentation undermines the quantitative accuracy. Additionally, the LLM claims that specific 2023 revenue figures are 'not provided,' whereas the original answer does not give a 2023 revenue figure either but correctly avoids asserting one; however, the LLM's implication that such data exists but is merely omitted is misleading. (2) The entity accuracy is mostly correct—Starbucks, the Global Coffee Alliance, and the general timeline (fiscal 2022 to 2023) are accurate. However, the misattribution of revenue to 'Other revenues' instead of 'Channel Development' shows a failure in precise metric identification. The mention of Nestlé, while contextually relevant (as part of the GCA with Nestlé), is absent in the LLM response, weakening the completeness of the strategic explanation. (3) The reasoning partially captures the evolution in strategic emphasis—highlighting increased focus on global ready-to-drink products and licensed store support—but fails to articulate the key shift described in the ground truth: from viewing the alliance as a revenue driver to a strategic enabler of global product reach and brand extension. The LLM mentions 'growth strategy' and 'innovation,' which are relevant, but lacks the nuanced synthesis of how the alliance's role evolved conceptually. (4) Contextually, the answer is relevant and addresses both strategic emphasis and revenue contribution, fulfilling the multi-part structure of the question. However, due to incorrect financial figures and incomplete qualitative reasoning, the overall correctness is compromised. The answer is partially correct but contains critical factual errors that affect its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 555,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "Between 2022 and 2023, NEE's financial stake in the Mountain Valley Pipeline (MVP) significantly declined, as it completely wrote off its investment in 2022. In 2023, NEE's equity method investments totaled $6,156 million, and the difference between the investment carrying amount and underlying equity in net assets was $(1,205) million, with a large portion attributed to the MVP. This indicates a strategic shift away from high-risk, non-core infrastructure projects, focusing instead on more stable and regulated energy assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It claims NEE 'completely wrote off its investment' in the Mountain Valley Pipeline (MVP) in 2022, which contradicts the ground truth stating MVP remained an active equity method investee in both 2022 and 2023. (2) The LLM cites a $1,205 million difference between carrying amount and underlying equity in net assets in 2023 attributed to MVP, but this figure is not present in the original answer and lacks support from the provided truth. (3) The original answer notes a slight narrowing of ownership range in MVP from 32%–55% in 2022 to 32.8%–52.6% in 2023, indicating a minor adjustment, not a write-off or significant decline. The LLM misrepresents this as a 'significant decline' and infers a strategic exit, which is unsupported. (4) The mention of MVP in 'Nonrecurring Fair Value Measurements' in 2023 is omitted entirely, missing a key financial treatment change. (5) While the total equity method investment figures are correct ($6,159M in 2022 and $6,156M in 2023), the interpretation of these numbers is flawed. The LLM incorrectly uses the small decrease in total investments to imply a strategic divestment, whereas the ground truth suggests stability with minor stake adjustments. (6) The reasoning is unsound: the conclusion about shifting away from high-risk projects is speculative and contradicted by continued equity involvement. Multi-hop synthesis fails—no evidence supports a write-off or strategic exit. Overall, core facts are wrong, calculations are unsupported, and the narrative misaligns with the truth. Minor credit is given for correctly stating the total equity investment amounts and addressing the general topic of investment strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 476,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Medtronic's InterStim Therapy product line has evolved by expanding its neurostimulator offerings and therapeutic applications. In 2022, the recently launched InterStim Micro and InterStim X neurostimulators were highlighted, with the InterStim II being recharge-free. By 2024, the product line included the InterStim X and InterStim II recharge-free neurostimulators, as well as the InterStim Micro rechargeable neurostimulator, targeting overactive bladder, urinary retention, and chronic fecal incontinence. Additionally, the therapeutic indications remained focused on pelvic health, with continued growth and acceptance of these neurostimulation therapies.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the neurostimulator offerings in 2022 and 2024—InterStim II, InterStim Micro, and InterStim X—and notes the expansion of therapeutic indications to include chronic fecal incontinence by 2024. However, there is a factual inaccuracy regarding the rechargeability of the InterStim Micro: the ground truth does not specify it as rechargeable in 2024, nor does it contrast recharge vs. non-recharge models in 2022 as the LLM claims. The original answer emphasizes that by 2024, InterStim II and InterStim X were specifically labeled as 'recharge-free,' but the LLM incorrectly implies InterStim Micro is rechargeable without confirmation from the source. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is high by default—no errors in this dimension. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes changes in product lineup and indications over time, showing evolution from 2022 to 2024. However, it introduces a detail (rechargeability of InterStim Micro) not present in the ground truth, weakening the qualitative accuracy. (4) The answer is contextually fully relevant, addressing both neurostimulator offerings and therapeutic indications across the two years. Despite the minor factual overreach, the core evolution—product continuity and expanded indication to chronic fecal incontinence—is accurately conveyed, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 412,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolved significantly from 2022 to 2024. In 2022, SPG increased its ownership in ABG by contributing interests in the licensing ventures of Forever 21 and Brooks Brothers, and by acquiring additional interests in ABG through capital transactions. By 2023, SPG continued to adjust its stake, with ownership diluting slightly to approximately 11.7% due to ABG capital transactions, and recognized non-cash gains on deemed disposals. In 2024, SPG fully exited its investment by selling all remaining interests in ABG for $1.2 billion, resulting in a pretax gain of $414.8 million. This marked the end of SPG's strategic equity relationship with ABG.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the numbers are incorrect: the original answer states Simon Property Group (SPG) held a 1.37% interest in ABG in 2022, but the LLM claims SPG increased ownership and reached approximately 11.7% by 2023—this percentage and timeline are unsupported. The LLM claims SPG sold all remaining interests in 2024 for $1.2 billion, realizing a $414.8 million pretax gain, whereas the ground truth reports a partial sale with a $18.8 million gain and a separate $100 million cash investment in ABG—both figures are entirely misrepresented. (2) The answer is incomplete and misleading: it omits the key strategic move in 2022 involving the merger of Forever 21 into SPARC Group with ABG and falsely claims a full exit in 2024, contradicting the original answer’s indication of an ongoing dynamic relationship. (3) Entity accuracy is partially correct—SPG, ABG, and SPARC are correctly identified, and the general timeframe (2022–2024) is respected—but the financial events and their magnitudes are wrong. (4) Reasoning is flawed: the LLM fabricates a narrative of increasing stake and eventual full exit, failing to correctly synthesize the multi-hop information about partial divestment and reinvestment. The claim of a $1.2B sale and $414.8M gain has no basis in the provided truth. While the answer addresses the evolution of the relationship (contextually relevant), the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 421,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses for the Lower 48 region increased significantly from 2021 to 2023. In 2021, the DD&A expense was $4,067 million, rising to $4,854 million in 2022, and further to $5,729 million in 2023. This upward trend reflects increased investment activity and higher production volumes in the region during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the DD&A expenses for 2021 ($4,067 million) and 2023 ($5,729 million), matching the ground truth. It also includes the 2022 figure ($4,854 million), which is accurate and adds useful context not required but enhances completeness. All numeric values are correct and properly formatted. (2) Quantitative accuracy is perfect—no errors in numbers or implied calculations (e.g., the increasing trend is correctly presented). (3) The reasoning is sound: the upward trend is correctly interpreted as reflecting increased investment activity and production, aligning with the ground truth's implication of growing emphasis on the Lower 48. The multi-hop synthesis across years is accurate and well-articulated. (4) The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer emphasizes 'asset utilization or investment activity' and 'growing emphasis on the Lower 48 as a core operational area,' which the LLM touches on but slightly rephrases without fully echoing the strategic emphasis. However, the core facts, numbers, and interpretation are correct and semantically equivalent. Contextual relevance is perfect as it directly addresses the evolution of investment activity via DD&A expenses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 359,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "Verizon's treatment and valuation approach for international bonds in their pension plans remained consistent from 2023 to 2024, with both years categorizing international bonds as Level 2 assets based on matrix pricing and inputs from third-party valuation sources. In 2023, international bonds were valued at $341 million, and in 2024, they were valued at $113 million, indicating a reduction in holdings but no change in valuation methodology.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, Verizon used matrix pricing with third-party inputs for international bonds but did not disclose a specific value. However, the LLM claims a value of $341 million in 2023 and $113 million in 2024, which contradicts the ground truth. The correct 2024 value is $12 million total ($10M Level 1, $2M Level 2), not $113 million. (2) The quantitative inaccuracies are severe: the dollar amounts are completely incorrect, and the LLM falsely asserts that international bonds were categorized as Level 2 in both years, while the ground truth shows a shift with $10M classified as Level 1 in 2024. There is no mention of Level 1 classification in the LLM response, missing a key evolution. (3) The multi-hop reasoning is flawed. The question asks about the evolution in treatment and valuation approach, but the LLM incorrectly concludes the methodology remained consistent, when in fact the ground truth indicates a shift from general description in 2023 to specific itemization and segmentation in 2024. The LLM fails to recognize this increased transparency and structural change. (4) The contextual relevance is moderate because the answer addresses the topic of international bond valuation in Verizon’s 10-K and attempts to compare years, but the factual foundation is incorrect, undermining the analysis. Due to major errors in numbers, entity classification (Level 1 vs Level 2), and reasoning about methodological evolution, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 431,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Between 2022 and 2024, Emerson's relationship with AspenTech evolved significantly. In May 2022, Emerson acquired Heritage AspenTech, increasing its stake and integrating AspenTech's industrial software businesses. By 2024, Emerson owned approximately 57% of AspenTech's outstanding shares and proposed to acquire the remaining shares for $240 per share, signaling full operational and financial integration. This progression reflects a shift from a partial ownership and collaborative structure to a near-complete acquisition, aligning AspenTech more closely with Emerson's strategic goals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the claim that Emerson owned 'approximately 57%' of AspenTech by 2024 is incorrect; the ground truth states Emerson retained a 55% stake in 'New AspenTech' after contributing the Industrial Software Business and $6.0 billion in cash. The $240 per share acquisition offer for remaining shares is not supported by the original answer and introduces false information. Additionally, the 2022 financial stake was $8,326 million (not a share percentage), which the LLM omits entirely. (2) The LLM incorrectly frames the evolution as a near-complete acquisition, whereas the ground truth describes a strategic restructuring into a new entity with majority ownership, not a full buyout. (3) The event in May 2022 is misrepresented: Emerson did not acquire 'Heritage AspenTech' at that time—rather, the $8.326 billion stake reflects prior acquisitions and adjustments already reflected in the 2022 balance sheet. (4) The operational integration is inaccurately portrayed as a result of an impending full acquisition, while the actual integration stems from the formation of 'New AspenTech' with combined assets and formalized control. The LLM fails to mention the $6.0 billion cash contribution or the creation of a new entity, missing key multi-hop elements. While the general direction of increased integration is contextually relevant, the specific facts, figures, and structure are largely incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 421,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "Between 2022 and 2023, Starbucks' position in interest rate swaps shifted from being classified as derivative assets and liabilities to primarily liabilities. In 2022, interest rate swaps were listed as $34.0 million in other long-term liabilities and $- in other long-term assets. By 2023, the interest rate swaps were reported as $19.2 million in other long-term liabilities and $- in other long-term assets, indicating a decrease in the asset position and a continued liability classification. This suggests a reduction in the fair value of the swaps and a shift in their net position towards liabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains partially correct information but misses key details and introduces inaccuracies. It correctly identifies the $34.0 million long-term liability in 2022 and the $19.2 million long-term liability in 2023. However, it fails to mention the $0.4 million classified under accrued liabilities (current) in 2023, which is a critical part of the classification shift. Additionally, the LLM incorrectly suggests that interest rate swaps were ever classified as assets (mentioning 'derivative assets' and '$-' in long-term assets), which is not supported by the ground truth. The net liability in 2023 should be $19.6 million ($0.4M + $19.2M), but the LLM only reports $19.2 million, missing the current portion. (2) Quantitatively, the $34.0 million (2022) and $19.2 million (2023 long-term) values are correct, but the absence of the $0.4 million current liability leads to an incomplete and thus inaccurate total. The calculation of net decrease from $34.0M to $19.6M is not reflected, as the LLM implies a drop to only $19.2M without acknowledging the full $19.6M total. (3) The reasoning is flawed in suggesting a shift from 'assets and liabilities' to 'primarily liabilities'—the ground truth indicates swaps were always a liability, just reclassified into current and long-term portions. The multi-hop synthesis fails to capture the structural change in classification (from solely long-term to split current/long-term), which is central to the question. (4) Despite these issues, the answer is contextually relevant and correctly identifies the overall decrease in liability and the continued presence in long-term liabilities. Hence, partial credit is given for directional accuracy but penalized for factual incompleteness and incorrect asset classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 482,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolved significantly from 2022 to 2023. In 2022, legal and regulatory challenges led to an impairment charge of approximately $0.8 billion, fully writing off the equity method investment of $0.6 billion and recording a $0.2 billion liability for future ARO costs. By 2023, NEER's involvement included equity contributions for the pipeline's construction, with $1,060 million allocated in 2024 for the Mountain Valley Pipeline under capital expenditures. This indicates a shift from impairment and write-offs in 2022 to renewed financial commitments in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $0.8 billion impairment charge in 2022, it incorrectly breaks this down into a $0.6 billion equity write-off and $0.2 billion liability for ARO (asset retirement obligation) costs—this breakdown is not present in the ground truth and is unsupported. The ground truth states the entire $0.8 billion was an impairment due to low probability of completion, with no mention of ARO. Additionally, the LLM claims that in 2023, NEER made equity contributions and allocated $1,060 million for 2024 capital expenditures for the pipeline—this is false; the original answer mentions no such capital allocation or equity contributions. Instead, the actual 2023 commitment was a 20-year transportation agreement with ~$70 million annual obligation, contingent on completion. This key detail is entirely missing. (2) Quantitative accuracy is low: the $1,060 million figure is fabricated; the $0.6B + $0.2B = $0.8B math is internally consistent but based on incorrect data. The correct numbers are $0.8B impairment (2022), 32.8% equity stake maintained, and ~$70M/year obligation (2023). (3) Multi-hop reasoning is partially sound—the model recognizes a shift from impairment to renewed involvement—but incorrectly interprets the nature of the 2023 commitment, confusing capital investment with a contractual transportation obligation. It fails to synthesize the correct type of financial involvement in 2023. (4) Contextual relevance is high as the answer addresses the evolution over time and focuses on financial commitment. However, due to major factual and quantitative errors, especially the invention of capital expenditures and misrepresentation of the impairment, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 489,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company, which reinsures group annuity insurance contracts covering obligations of European and Canadian pension plans, decreased from $1,643 million as of December 31, 2023, to $1,883 million as of December 31, 2024. This indicates an increase of $240 million in the value of these investments over the one-year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the amounts ($1,643 million in 2023 and $1,883 million in 2024) and the $240 million increase, which matches the ground truth. However, it incorrectly states that the investment 'decreased' when it actually increased, which is a critical error in directional logic despite correct numbers. (2) Quantitatively, all numbers and dates are accurate: $1,643 million as of December 31, 2023, and $1,883 million as of December 31, 2024, with a correct difference of $240 million. The calculation is sound, but the interpretation (decrease vs increase) is factually wrong. (3) The multi-hop reasoning is otherwise strong: the LLM correctly links The Coca-Cola Company to its captive insurance company, identifies the purpose (reinsuring group annuity contracts for European and Canadian pension plans), and synthesizes the evolution across two years. This shows good entity and context understanding. (4) The correctness score is 8 because while all data points are accurate and the context is well-covered, the erroneous use of 'decreased' undermines the conclusion. Quantitative accuracy is 8 due to correct values but flawed interpretation. Qualitative accuracy is 9 due to strong reasoning and entity linkage despite the directional error. Contextual relevance is 10 as all parts of the question are addressed with appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 384,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "Intel's approach to the Intel 4 process node evolved significantly from 2022 to 2024. In 2022, Intel 4 was in development as its first EUV lithography node, with a focus on achieving significant density scaling and performance-per-watt improvements. By 2024, Intel 4 had transitioned to high-volume manufacturing, with the Intel Core Ultra processor as its first high-volume client product, beginning shipments in 2023 and ramping production in Ireland. Intel 4 became a key part of Intel's product roadmap, expected to represent an increasing share of processor production in 2025 as the company shifted focus to more advanced nodes like Intel 18A.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Intel 4 from development in 2022 to high-volume manufacturing by 2024, noting its use in the Intel Core Ultra processor. The mention of EUV lithography, density scaling, and performance-per-watt improvements adds context consistent with Intel's strategic goals. (2) All dates and timeframes are correct: Intel 4 ramped in 2023 and reached high-volume manufacturing by 2024, with production in Ireland—this matches the original answer. There are no numerical inaccuracies. (3) The multi-hop reasoning is sound: the answer synthesizes information about production status (from initial ramp-up to volume manufacturing) and strategic positioning (becoming a key node for Core Ultra and future production share). The only minor gap is that the original answer specifically notes higher period charges in 2022 due to ramp-up costs, which the LLM omits—this is a small but relevant financial detail indicating early-stage challenges. (4) Despite this omission, the LLM captures the core evolution and strategic significance. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing both production status and roadmap positioning across the 2022–2024 timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 366,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Between 2022 and 2024, Emerson's strategic relationship with AspenTech evolved significantly in terms of ownership and financial integration. In May 2022, Emerson contributed two of its industrial software businesses to AspenTech and received approximately $6.0 billion in cash, resulting in Emerson owning 55% of AspenTech's outstanding shares. By November 2024, Emerson proposed to acquire the remaining 43% of AspenTech not already owned by Emerson for $240 per share, increasing its ownership to 100% and fully integrating AspenTech into its portfolio. Financially, AspenTech's performance and transactions, such as the Micromine acquisition and foreign currency hedges, were reflected in Emerson's financial statements, and Emerson's 2024 financial results included the impact of its proposed full acquisition of AspenTech.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson merged its industrial software business with AspenTech in 2024 and retained a 55% stake in the new entity—there was no prior ownership of 55% in 2022. The LLM incorrectly states that in May 2022, Emerson contributed software businesses and received $6.0 billion in cash, gaining 55% ownership—this is false; in 2022, AspenTech was merely a strategic partner with no ownership stake by Emerson. Additionally, the claim that in November 2024 Emerson proposed to acquire the remaining 43% for $240 per share, increasing ownership to 100%, is not supported by the original answer, which only states Emerson retained 55% in the merged entity. (2) Quantitative inaccuracies include the $6.0 billion cash receipt, the 43% remaining stake (should be 45%), and the $240 per share price—all of which are fabricated. The original answer mentions a 0.6 percentage point improvement in gross margins in 2023 and SG&A impact in 2024, which the LLM omits entirely. (3) The multi-hop reasoning is flawed: the model incorrectly infers a timeline of increasing ownership starting in 2022, when the truth is that the shift occurred in 2024 from partnership to 55% ownership. It also invents a full acquisition not present in the ground truth. (4) While the LLM addresses the question's theme—evolution of ownership and financial integration—the core facts are incorrect. The contextual relevance is moderate because it discusses ownership and financials, but the qualitative and quantitative errors severely undermine correctness. Hence, low scores in correctness (3), quantitative accuracy (2), and qualitative accuracy (3).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 468,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "From 2022 to 2024, Intel's approach to the Intel 4 process node has evolved significantly in terms of manufacturing readiness and performance improvements. In 2022, Intel introduced the Intel 4 process node as part of its updated naming structure, marking it as its first EUV lithography node. By 2024, Intel 4 had moved to high-volume manufacturing in Ireland and was used for the Intel Core Ultra processor, which began shipping in 2023. The node offers approximately 20% performance-per-watt improvement over Intel 7 and is expected to represent an increasing portion of Intel's processor production in 2025. This evolution reflects Intel's progress in scaling and adopting advanced manufacturing technologies to enhance product performance and efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel 4 was introduced in 2022 as part of a naming update and as Intel's first EUV node; by 2024, it reached high-volume manufacturing in Ireland; it delivers a 20% performance-per-watt improvement over Intel 7; and it is used in the Intel Core Ultra processor, which began shipping in 2023. (2) Quantitative accuracy is perfect: the 20% improvement is correctly stated, and all dates (2022 introduction, 2023 shipping, 2024 manufacturing ramp) match the ground truth. The mention of 2025 production expectations is a minor forward-looking addition not in the original but does not contradict it. (3) Multi-hop reasoning is sound: the answer synthesizes information across time (2022 to 2024), technology (EUV adoption), manufacturing (Ireland ramp), and product integration (Core Ultra). (4) The only minor shortcoming is the addition of 'expected to represent an increasing portion... in 2025,' which is plausible but not present in the ground truth, slightly affecting qualitative accuracy. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 339,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "The role and positioning of InterStim Micro within MDT's Pelvic Health therapies remained consistent between 2022 and 2024, as it continued to be highlighted as a key product for treating overactive bladder, non-obstructive urinary retention, and chronic fecal incontinence. In both years, it was mentioned as part of the Pelvic Health portfolio under the Specialty Therapies division, with a focus on neurostimulation therapies. In 2024, it was specifically noted as a rechargeable neurostimulator contributing to the growth of Pelvic Health therapies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but misses a key evolution in the strategic positioning of InterStim Micro. (1) Correct elements: InterStim Micro remained part of MDT's Pelvic Health portfolio treating overactive bladder, urinary retention, and fecal incontinence; it was correctly identified as rechargeable in 2024; and it contributed to growth in Pelvic Health therapies. The entity names (InterStim Micro, MDT, Pelvic Health) and timeframes (2022, 2024) are accurate. (2) Quantitative accuracy is perfect—no numerical data is misstated, and no incorrect figures are introduced. (3) However, the reasoning is partially flawed: the LLM claims the role and positioning 'remained consistent,' which contradicts the ground truth showing a clear strategic shift—by 2024, InterStim Micro was explicitly differentiated as the rechargeable option versus the recharge-free InterStim X and II, indicating a more defined and distinct market positioning. This evolution is central to the question and was not adequately captured. (4) Contextual relevance is high as the answer stays focused on the product's role in Pelvic Health therapies. The correctness score is 7 because core facts are accurate but a key qualitative shift in product positioning is mischaracterized, reducing the depth of multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 362,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The disclosure around the dilutive effect of LTIP Units in Simon Property Group's 10-K filings shows consistent reporting across the periods reviewed. For 2022, 2023, and 2024 (as per the 2024 filing), the company explicitly states that no securities, including LTIP units, had a material dilutive effect. This indicates that the potential dilutive impact of LTIP units remained immaterial across these reporting periods, with no significant changes in the materiality of their effect on earnings per share or unit calculations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that no securities, including LTIP units, had a material dilutive effect in 2022, 2023, and 2024, which aligns with the ground truth regarding the conclusion on dilution impact. The dates and entities (LTIP units, reporting periods) are accurate, supporting a high quantitative accuracy score. However, the LLM fails to capture a key qualitative evolution in the disclosure: the reduction in detail about LTIP units' exchangeability into common stock. In 2022, the filing explicitly mentioned that LTIP units were exchangeable for common stock, but by 2024, this detail was omitted even though the conclusion on materiality remained unchanged. The LLM interprets the consistency in conclusion as 'no significant changes' in disclosure, but the ground truth emphasizes a simplification and reduction in explanatory detail about the conversion mechanism. This represents a failure in multi-hop reasoning and synthesis across years to detect changes in disclosure language, not just conclusions. While the answer is factually correct about the lack of material dilutive effect, it misses the core aspect of how the disclosure *around* that effect evolved—specifically, the decreased transparency about the conversion feature. Thus, the qualitative accuracy is significantly penalized. The answer remains contextually relevant as it addresses the question’s focus on dilutive impact over time, but lacks the nuanced comparison of disclosure content changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 408,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "From 2022 to 2024, MetLife's approach to managing cash buffer needs in relation to stock repurchases has emphasized maintaining sufficient liquidity to meet regulatory and operational requirements while balancing shareholder returns. In 2022, the company had a $3.0 billion repurchase authorization with $1.5 billion remaining as of December 31, 2021. By 2024, MetLife continued to highlight the importance of liquidity buffers, noting that cash buffer needs could limit the capital available for repurchases. The company also emphasized that regulatory restrictions, capital requirements, and market conditions could impact its ability to repurchase shares, reflecting a more cautious approach to ensure financial flexibility and compliance with evolving regulatory expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that MetLife had a $3.0 billion repurchase authorization with $1.5 billion remaining as of December 31, 2021, which aligns with the original answer's reference to 2022 context based on prior year data. This is factually accurate and properly contextualized. The evolution toward a more cautious approach in 2024 due to liquidity and regulatory considerations is also accurately reflected. (2) All numeric values—$3.0 billion and $1.5 billion—are correct and match the ground truth. The date (December 31, 2021) is correctly cited as the reference point for the remaining authorization, even though discussed in the context of 2022 activity, which is consistent with how the original answer presents it. (3) The multi-hop reasoning is sound: the model connects the 2022 repurchase capacity with the 2024 shift in tone regarding liquidity buffers, synthesizing information across time periods and strategic priorities. It correctly infers a shift toward conservatism, citing regulatory, capital, and market factors as constraints—consistent with the original answer’s emphasis on regulatory, market, and internal capital considerations. (4) The only minor shortcoming is that the LLM answer does not explicitly frame the 2024 stance as a 'shift' or 'evolution' from a more active posture in 2022, though this is implied. The original answer more clearly articulates the contrast in posture (active vs. conservative), making the evolution slightly more explicit. However, the LLM captures the essence and factual basis for the change, warranting a high score. All other aspects—context, entities, reasoning, and relevance—are fully aligned with the question and ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 469,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "From fiscal year 2022 to 2023, Starbucks' foreign currency - other derivative positions shifted significantly in balance sheet classifications. In 2022, foreign currency - other derivative assets were $39.9 million in \"prepaid expenses and other current assets\" and $33.5 million in \"other long-term assets,\" while derivative liabilities were $0.3 million in \"accrued liabilities\" and $- in \"other long-term liabilities.\" By 2023, derivative assets were $1.9 million in \"prepaid expenses and other current assets\" and $1.7 million in \"other long-term assets,\" with derivative liabilities increasing to $4.7 million in \"accrued liabilities\" and $4.1 million in \"other long-term liabilities.\" This indicates a reduction in asset positions and an increase in liability positions, reflecting a net shift in exposure and potential hedging adjustments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the 2022 figures. According to the ground truth, in fiscal year 2022, Starbucks did not report foreign currency - other derivative assets as $39.9 million in prepaid expenses and $33.5 million in long-term assets. Instead, the $103.9 million was recognized in OCI before reclassifications, with $22.0 million reclassified from AOCI to earnings — these are comprehensive income items, not balance sheet line items. The LLM incorrectly presents 2022 balance sheet classifications that are not supported by the original answer. The 2023 figures ($1.9M current assets, $1.7M long-term assets, $4.7M accrued liabilities, $4.1M long-term liabilities) are correctly reported. (2) Quantitative accuracy is low because the 2022 asset and liability numbers are entirely wrong, and the liabilities are misrepresented (e.g., '$0.3 million' in accrued liabilities in 2022 has no basis in the ground truth). The original answer does not provide balance sheet-level classifications for 2022, so the LLM fabricated these values. (3) The multi-hop reasoning is partially sound in that the model identifies a shift from 2022 to 2023 and attempts to compare asset reductions and liability increases. However, because the 2022 baseline is incorrect, the comparison is flawed. The model fails to recognize that the 2022 data is reported in terms of OCI and reclassifications, not balance sheet placements, indicating a misunderstanding of financial statement presentation. (4) Contextual relevance is high because the answer addresses the evolution of derivative positions and balance sheet classification changes as asked. However, due to major quantitative errors and misrepresentation of financial data, the correctness score is limited to 4 — partially correct on 2023 data and directional trend, but fundamentally incorrect on 2022 figures and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 517,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Procter & Gamble's global cash management strategy has evolved to prioritize liquidity and operational efficiency in response to its restructuring activities and financial performance from fiscal 2022 to 2024. In fiscal 2022, the company focused on managing cash flow amid rising commodity and transportation costs, with operating cash flow at $16.7 billion and adjusted free cash flow at $13.8 billion, despite a 13% decrease compared to the prior year. The company also implemented extended payment terms with suppliers and a Supply Chain Finance program to optimize working capital. \n\nBy fiscal 2024, the company's cash flow improved significantly, with operating cash flow increasing to $19.8 billion and adjusted free cash flow rising to $16.9 billion, a 21% increase from 2023. This improvement was driven by higher net sales, productivity savings, and cost efficiencies from restructuring efforts, including the liquidation of operations in certain Enterprise Markets. The company also incurred $659 million in restructuring costs in 2024, primarily due to foreign currency translation losses and operational optimization. These strategic actions reflect a more agile and cost-focused approach to global cash management, aligning with the company's broader goal of enhancing profitability and shareholder returns.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures not present in the ground truth. While it correctly notes $659 million in restructuring costs in fiscal 2024 (matching the original answer), it introduces operating cash flow and adjusted free cash flow figures ($16.7B, $13.8B, $19.8B, $16.9B) and percentage changes (13% decrease, 21% increase) that are not supported by the ground truth. These numbers and trends are entirely fabricated or misattributed, severely undermining quantitative accuracy. (2) The original answer emphasizes shifts in corporate net earnings—$872M improvement in 2022 and $1.0B decrease in 2024 due to a $1.4B impairment charge on Gillette intangibles—but the LLM omits these critical earnings movements and the impairment entirely. Instead, it focuses on cash flow improvements and supplier payment terms, which are not mentioned in the ground truth. (3) The LLM correctly identifies increased restructuring costs in 2024 and links them to Enterprise Markets (e.g., Nigeria), which aligns with the original answer’s mention of Enterprise Markets, showing partial multi-hop reasoning. However, it fails to connect restructuring to the deterioration in corporate net earnings or the non-cash $216M foreign currency translation loss component of the $659M charge. (4) The answer is contextually relevant—discussing cash management, restructuring, and financial performance—but substitutes unsupported data and omits key facts (especially the impairment and earnings impact), leading to a misleading narrative of improving financial health. The qualitative reasoning is plausible but not grounded in the provided truth. Thus, while the direction of strategy (liquidity focus, cost efficiency) is semantically aligned, the factual foundation is weak, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 505,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's positioning and application of Omniverse evolved significantly in terms of integration with enterprise solutions and simulation technologies. In 2022, Omniverse was highlighted as a real-time 3D design collaboration and virtual world simulation platform, primarily used by artists, designers, and creators for industrial applications such as digital twins and autonomous vehicle testing. By 2023, Omniverse had expanded its role as a core component of NVIDIA's enterprise solutions, serving as a development platform and operating system for building virtual world simulation applications. It was increasingly adopted for industrial digitalization, including real-time 3D product configurators and AI-driven autonomous systems, supported by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the evolution of Omniverse from a collaboration and simulation platform in 2022 to a development platform and operating system in 2023 is accurately described. Key applications such as digital twins, autonomous vehicle testing, and industrial digitalization are correctly identified. The integration with NVIDIA's accelerated computing infrastructure (on-premises and cloud) is properly noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift in positioning and application across years and connects it to enterprise integration and simulation technologies. The only minor omission is that the original answer specifies free availability for individuals in 2022 and use cases like surgical training and architectural walkthroughs, which the LLM answer does not mention. However, these are contextual details that do not undermine the core accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution in positioning and application with respect to enterprise solutions and simulation technologies. Overall, the LLM captures the essential evolution with high fidelity, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 405,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "AMT's financial commitments related to communications sites from 2023 to 2024 show a significant increase in anticipated spending and future obligations. In 2023, the company expected capital expenditures of $1.545 billion to $1.655 billion, including site construction and data center investments. By 2024, this range increased to $1.545 billion to $1.655 billion, with a specific mention of $450 million allocated for data-center assets. Additionally, operating lease obligations as of December 31, 2024, totaled $11.531 billion, with $7.088 billion of these obligations extending beyond 2029. These figures indicate a growing financial commitment to maintaining and expanding communications infrastructure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, AMT anticipated spending approximately $450 million specifically on data center assets as part of construction for 2,500 to 3,500 communications sites. However, the LLM incorrectly claims total capital expenditures of $1.545 billion to $1.655 billion for 2023 and repeats the same range for 2024, which is not supported by the original answer. Furthermore, the LLM introduces $11.531 billion in operating lease obligations and $7.088 billion extending beyond 2029—details absent from the ground truth. The key 2024 figure in the original answer is a $4.5 billion undiscounted future cash outlay for asset retirement obligations (ARO) on leased sites, which the LLM completely omits. Instead, it mentions $450 million for data centers in 2024, reversing the context: that amount was for 2023 in the original. (2) Quantitative accuracy is very low: the $4.5 billion ARO—a central figure—is missing, while fabricated numbers like $1.545B–$1.655B capex and $11.531B lease obligations are introduced without basis. The only correct number is $450 million, but it is misattributed in timing and context. (3) Multi-hop reasoning fails: the original answer traces an evolution from near-term capital planning (2023) to long-term liability recognition (2024), highlighting a shift in financial exposure. The LLM does not capture this shift, instead presenting static capex ranges and unrelated lease totals without showing how obligations evolved. It conflates capital expenditures with operating leases and omits the critical concept of asset retirement obligations. (4) Contextual relevance is moderate because the answer discusses financial commitments related to communications sites and attempts to compare 2023 and 2024. However, due to incorrect figures and missing core concepts, the response misrepresents the nature and evolution of AMT's obligations. The conclusion about 'growing financial commitment' is directionally plausible but unsupported by correct reasoning or data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 560,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil's characterization of asset divestitures in relation to strategic objectives remained consistent in stating that assets are divested when they no longer meet strategic objectives or are worth more to others. However, in 2024, there was a slight shift in the language used to describe the proceeds from these transactions. In 2023, the proceeds were described as being combined with operating cash flow to evaluate cash available for investment and shareholder distributions. In 2024, the language emphasized that proceeds from asset sales are part of the Corporation's disciplined review process to ensure alignment with strategic objectives, reinforcing their role in supporting capital allocation decisions.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the characterization of ExxonMobil's language evolution regarding asset divestiture proceeds. (1) Correct elements: The answer correctly identifies that ExxonMobil maintained a consistent strategic rationale—divesting assets that no longer align with strategic objectives or are more valuable to others—and ties proceeds to capital allocation and investment decisions. The years (2023 vs 2024) are correctly referenced. (2) Quantitative accuracy: There are no numeric values in the question or ground truth, so this dimension is neutral; no errors present. (3) Multi-hop reasoning: The LLM fails in accurately synthesizing the specific evolution in *language used to describe the proceeds*. The ground truth states that in 2023, proceeds were described as 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' and in 2024, this was streamlined to 'proceeds from asset sales and returns of investments.' The LLM incorrectly claims that in 2023, proceeds were discussed in the context of being combined with operating cash flow for investment and distributions, which is not supported by the ground truth. Similarly, the 2024 shift is misrepresented as emphasizing integration into the disciplined review process, whereas the actual change was a *streamlining of terminology*, not a change in conceptual framing. (4) The answer is contextually relevant and addresses the question’s focus on language evolution and strategic alignment, but the core factual claim about how proceeds were described in each year is incorrect. Thus, while the strategic continuity is accurately noted, the specific linguistic evolution—the central focus of the question—is misrepresented, leading to a moderate score of 5 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 500,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort increased from 2022 to 2023, as the consolidated assets rose from $9.7 billion to $7.8 billion, while consolidated liabilities increased from $8.1 billion to $7.2 billion during the same period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Comcast's financial exposure increased from 2022 to 2023, when in fact both assets and liabilities decreased. The original answer shows assets dropped from $9.7B to $7.8B and liabilities from $8.1B to $7.2B, indicating reduced exposure. The LLM misrepresents the direction of change, claiming increases when both figures declined. (2) While the numeric values themselves are mostly accurate—$9.7B and $8.1B for 2022 assets/liabilities, and $7.8B and $7.2B for 2023—the LLM incorrectly frames the changes as increases. This is a critical error in interpretation. The numbers are present but the directional comparison is reversed, leading to a false conclusion. (3) The multi-hop reasoning fails because the model does not correctly synthesize the change over time. It must compare 2022 vs 2023 figures and infer trend direction. The LLM incorrectly concludes 'increased' despite lower dollar amounts in 2023, showing flawed logic. (4) Scores are low because the core factual interpretation is wrong. Quantitative accuracy is partially preserved due to correct base numbers, but qualitative and overall correctness suffer from the reversed trend claim. Contextual relevance is moderate as the answer addresses the right entities and time frame but draws the opposite conclusion of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 376,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's risk factor related to Customer Demand Volatility has shown a heightened sensitivity to macroeconomic conditions and supply chain disruptions. In 2024, the company emphasized increased volatility due to economic uncertainties, including inflationary pressures, fluctuating commodity prices, and the lingering effects of global pandemics, which have amplified demand unpredictability. Additionally, Caterpillar highlighted that supply chain disruptions—such as material shortages, logistics constraints, and labor inefficiencies—have become more pronounced, further impacting its ability to meet customer demand and affecting financial performance. This evolution reflects a more complex and interconnected risk environment compared to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: the persistence of Customer Demand Volatility as a risk factor from 2023 to 2024 is properly acknowledged, and the evolution in emphasis—from pandemic-driven economic uncertainty in 2023 to broader commodity and material price changes and supply chain disruptions in 2024—is accurately reflected. The LLM correctly identifies inflationary pressures, labor inefficiencies, and supply chain issues as ongoing concerns, and appropriately expands on them in 2024 with material shortages and logistics constraints. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years 2023 and 2024 are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning—comparing Caterpillar’s risk factor disclosures across two years and synthesizing changes in both demand-side and supply-side dynamics—is sound and logically presented. The LLM captures the broadening of the risk profile even if it uses slightly different phrasing (e.g., 'heightened sensitivity' and 'more complex and interconnected risk environment' instead of 'broadening of the risk profile'). (4) The semantic meaning is equivalent to the ground truth: while the LLM answer emphasizes 'macroeconomic conditions' and 'amplified demand unpredictability' more than the original, it does not misrepresent the facts. The only minor shortcoming is that the original answer specifically notes a shift to include 'commodity price changes' and 'shortages of labor and material' as explicit additions in 2024, which the LLM mentions but integrates less distinctly as evolved elements versus ongoing issues. This slight lack of precision in delineating the evolution prevents a perfect 10, but the overall correctness remains very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 519,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "The fair value of Net derivative assets (liabilities) increased from $19 million in 2021 to $58 million in 2023 and further to $69 million in 2024. The valuation methodology consistently used discounted cash flows with swap rates as the primary unobservable input, with the weighted average swap rate increasing from 2% in 2021 to 4% in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states the fair value was $19 million as of December 31, 2021 (reported in 2022), and $58 million as of December 31, 2023 (reported in 2024). The LLM incorrectly states values for 2021, 2023, and adds a $69 million figure for 2024 not present in the original. There is no mention of a $69 million value in the ground truth. (2) The valuation methodology shift is misrepresented: the original answer indicates a move toward observable inputs (like swap rates of 3-5%, weighted average 4%) by 2024, whereas the LLM claims swap rates were 'unobservable inputs' and cites a 2% rate in 2021 not mentioned in the original. The characterization of inputs as 'unobservable' contradicts the ground truth's emphasis on increased use of observable inputs. (3) Multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution across years and misrepresents both the quantitative progression and methodological change. It invents data points (e.g., 2024 value, 2% rate) and misaligns timelines. (4) Despite these issues, the answer is contextually relevant—it addresses fair value changes and methodology evolution—but scores low on correctness due to major factual and conceptual errors in numbers, dates, and methodology description.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 371,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "From 2022 to 2023, NVIDIA's GeForce NOW cloud gaming offering evolved to become more integrated within the company's broader GPU and cloud platform ecosystem. In 2022, GeForce NOW was positioned as a cloud gaming service enabling access to PC games on underpowered devices. By 2023, it was highlighted as part of NVIDIA's unified accelerated computing platform, emphasizing its role in delivering interactive graphics applications across devices and reinforcing NVIDIA's leadership in AI-enhanced computer graphics. Additionally, GeForce NOW was linked to NVIDIA's broader cloud infrastructure, including vGPU and Omniverse, showcasing its alignment with enterprise and creative workflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: GeForce NOW's positioning in 2022 as a cloud gaming service enabling access to games on less powerful devices matches the original answer's emphasis on extending graphics leadership and ecosystem reach. In 2023, the integration into NVIDIA’s accelerated computing platform narrative is correctly described, including alignment with broader cloud infrastructure. (2) There are no numeric values to verify, so quantitative accuracy is 10 by default. (3) The multi-hop reasoning is sound—correctly synthesizing the evolution of GeForce NOW’s strategic positioning across two years and within the broader ecosystem, including links to vGPU and Omniverse (which are valid components of NVIDIA’s cloud offerings, though Omniverse is not explicitly mentioned in the ground truth). The only minor gap is that the original answer specifically references NVIDIA DGX Cloud and AI training platforms as part of the 2023 narrative, which the LLM omits, instead generalizing to 'AI-enhanced computer graphics.' This is semantically close but slightly less precise. (4) Contextual relevance is perfect—the response directly addresses the evolution of GeForce NOW’s positioning within NVIDIA’s GPU and cloud ecosystem. Overall, the answer conveys the same core evolution with high fidelity, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 397,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Between 2022 and 2023, Inlyta's revenue increased by 3% globally, with a 4% increase in the U.S. and a 3% increase internationally. The growth in the U.S. was driven by the adoption of combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced renal cell carcinoma (RCC). However, this growth was partially offset by lower volumes and lower net price in certain European markets. Internationally, the growth was primarily due to continued expansion in emerging markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3% global revenue growth for Inlyta from 2022 to 2023, which aligns with the ground truth (from $1,003M to $1,036M, a ~3.3% increase, reasonably rounded to 3%). However, the LLM introduces two sub-figures not present in the original answer: a 4% increase in the U.S. and a 3% increase internationally. These specific regional growth percentages are not supported by the ground truth and represent additional, unverified quantitative claims. The core global growth figure is correct, but the breakdown introduces inaccuracies. (2) The revenue figures themselves ($1,003M and $1,036M) are not explicitly stated in the LLM answer, which only reports the percentage change. While the 3% growth is accurate, the omission of absolute values reduces quantitative completeness. The calculation of 3% growth from the given numbers is correct (~3.29%), so the rounding is acceptable. (3) The reasoning and synthesis are strong: the LLM correctly identifies the key drivers—adoption of Inlyta with immune checkpoint inhibitors in first-line advanced RCC treatment in the U.S. and growth in emerging markets—as well as the offsetting factor of lower volumes and net prices in certain European markets. These elements are accurately pulled and synthesized from the multi-hop context. (4) Contextual relevance is excellent; the answer directly addresses both parts of the question—revenue performance evolution and influencing factors—with appropriate focus and structure. The main deduction is in quantitative accuracy due to unsupported regional growth percentages and omission of absolute revenue figures, hence the 8/10 correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 459,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "From 2023 to 2024, the amortization assumptions for network location intangibles evolved as the Company extended the estimated useful life of its tower assets from 20 to 30 years, effective January 1, 2024. This change resulted in a corresponding extension of the amortization period for related intangible assets, which are amortized similarly to towers. Additionally, the impairment review process remained consistent, with evaluations conducted on an individual site basis, primarily triggered by factors such as lack of tenant leases or expenses exceeding revenues. No new impairment charges for network location intangibles were reported in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the company extended the estimated useful life of tower assets from 20 to 30 years effective January 1, 2024, which is not supported by the ground truth. The original answer states a weighted average amortization period of 15 years as of December 31, 2023, with no mention of a change to 30 years or prior 20-year life. This misrepresents a core quantitative and qualitative aspect of the amortization assumption evolution. Additionally, the LLM states that the impairment review process 'remained consistent,' but the ground truth indicates a notable expansion in 2024 with more detailed disclosures and individual tower-level assessments, representing a change from 2023. The LLM also fails to mention the $470 million increase in asset retirement obligations, which the ground truth identifies as indirectly impacting valuation and useful life assumptions. (2) Quantitative inaccuracies include the invented figures of 20-year and 30-year useful lives and the absence of the correct 15-year weighted average amortization period. The $470 million liability increase is entirely omitted. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers continuity in impairment processes and invents a change in useful life without evidence. It fails to connect the asset retirement obligation update to intangible asset valuation, a key synthesis point in the ground truth. (4) While the answer addresses the general topic of amortization and impairment, the severe factual and numerical errors—especially the fabricated useful life extension—warrant a low correctness score. Contextual relevance is moderate as it discusses the right themes but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 477,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has significantly intensified between 2023 and 2024, with the region becoming a core component of its upstream growth portfolio. In 2023, Guyana's production from the Stabroek Block exceeded 390 thousand barrels of oil per day (kbd), with the third FPSO vessel, Prosperity, achieving nameplate capacity ahead of schedule. By 2024, the company anticipates the addition of two more FPSO vessels, Yellowtail and Uaru, each with initial production capacity of approximately 250 kbd, and aims to operate six FPSO vessels on the Block by year-end 2027. This reflects a strategic focus on scaling production in Guyana as a key growth driver, contributing to increased oil-equivalent production and enhancing the Corporation's global supply portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. According to the ground truth, in 2023, Guyana's production reached nearly 440 kbd in Q4 due to the startup of the Prosperity FPSO. However, the LLM states production 'exceeded 390 kbd'—a significant underreporting—and claims Prosperity achieved 'nameplate capacity ahead of schedule,' which is not mentioned in the original. The original does not state the number of FPSOs planned for 2024 or specify that Yellowtail and Uaru each have 250 kbd capacity; these details are either fabricated or misattributed. The 2027 target of six FPSOs is plausible but absent from the ground truth, making it unverifiable and potentially misleading. (2) The calculation and timing of production capacity are incorrect: the original emphasizes the 2023–2024 strategic reclassification of Guyana into 'Advantaged Assets' alongside Permian and LNG, which the LLM omits entirely. This is a key qualitative shift that the LLM fails to capture. Instead, it focuses on forward-looking FPSO additions not emphasized in the 2024 update. (3) The multi-hop reasoning is partially sound—linking Guyana to upstream growth and production scaling—but fails to synthesize the core strategic evolution: from discovery/early production (2023) to a financially mature, earnings-driven asset (2024). The LLM emphasizes physical expansion (FPSOs) over strategic repositioning in ExxonMobil’s portfolio, missing the central point. (4) While the answer is contextually relevant and addresses upstream growth and production capacity, the incorrect numbers and omission of the 'Advantaged Assets' reclassification—central to the 2024 strategic shift—severely undermine factual correctness. The answer introduces unverified details, reducing quantitative and qualitative accuracy despite maintaining relevance to the topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 511,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "Between 2022 and 2023, the X1 platform's integration with third-party streaming services expanded significantly, with the introduction of the Xumo Stream Box (formerly Flex) and enhanced access to services like Peacock, Disney+, and Netflix. This evolution reflects Comcast's strategy to reduce cord-cutting by offering a hybrid viewing experience that combines traditional cable with popular streaming content in a unified interface. Additionally, by integrating these services and earning commission revenue from their sales, Comcast aims to increase average revenue per user (ARPU) by encouraging customers to consume more premium content through bundled offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continuation and expansion of third-party streaming integrations on the X1 platform between 2022 and 2023, including key services like Disney+, Netflix, and Peacock, which aligns with the ground truth. It also accurately captures Comcast's strategic goals of reducing cord-cutting and increasing ARPU through commission revenue and bundled offerings. However, it introduces the 'Xumo Stream Box (formerly Flex)' and frames the evolution around this device, which is not mentioned in the ground truth. Instead, the actual 2023 development involved integration of Xumo Play, NBC, and Sky into the NOW TV service targeted at broadband customers—a specific strategic pivot not reflected in the LLM response. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is unaffected and scores highly. (3) The multi-hop reasoning is partially sound: the model correctly infers strategic intent from integration trends, but fails to synthesize the correct 2023 developments involving NOW TV and the shift toward broadband bundling. This represents a significant omission in entity and contextual accuracy. (4) While the overall strategy interpretation is reasonable and contextually relevant, the substitution of Xumo Stream Box/Flex for the actual NOW TV/Xumo Play/Sky integration reduces factual precision. Hence, correctness and qualitative accuracy are moderately impacted, but not severely due to preservation of core strategic logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 420,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's relationship with FG Wilson, in terms of distribution network coverage for electric power generation systems, expanded. In 2023, FG Wilson's network covered 109 countries through 110 distributors, and by 2024, this network had grown to cover 158 countries through 108 distributors. This indicates an increase in the geographic reach of FG Wilson's distribution network despite a slight reduction in the number of distributors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: in 2023, 110 distributors covered 109 countries; in 2024, 108 distributors covered 158 countries. These numbers exactly match the ground truth, and the interpretation—that geographic reach expanded despite a slight reduction in distributor count—is accurate. (2) Quantitative accuracy is perfect: all numbers (110, 109, 108, 158) are correct, and no calculations are required beyond comparison, which is handled appropriately. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes over time in both distributor count and country coverage, drawing a valid conclusion about strategic expansion in reach with optimized distributor footprint. (4) The only reason for not scoring a 10 in qualitative accuracy is the omission of the phrase 'strategic shift toward optimizing distributor efficiency while broadening market access'—a minor interpretive nuance present in the original answer. However, the core reasoning is preserved. Contextual relevance is full, as the response directly and completely addresses the evolution of Caterpillar's relationship with FG Wilson in distribution network coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 338,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Capital One's exposure to securitized debt obligations decreased between 2022 and 2024. As of December 31, 2024, the carrying value of securitized debt obligations was $14.26 billion, compared to $18.04 billion as of December 31, 2023. The fair value of these obligations also decreased to $14.335 billion in 2024 from $18.067 billion in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that in 2024, the carrying value of securitized debt obligations was $18,043 million ($18.043 billion) and fair value was $18,067 million ($18.067 billion), whereas the LLM claims these values were $14.26 billion and $14.335 billion respectively—significantly lower. Additionally, the LLM incorrectly states that the 2023 carrying value was $18.04 billion, but the original answer does not provide 2023 data; it only gives 2022 context and 2024 figures. There is no mention of a decrease in exposure in the ground truth—on the contrary, stable valuation and continued involvement are implied. (2) The numbers are quantitatively inaccurate: LLM reports $14.26B carrying and $14.335B fair value in 2024, which contradicts the ground truth of $18.043B and $18.067B. The LLM also fabricates a 2023 comparison not present in the original. (3) The reasoning is flawed: the multi-hop aspect requires comparing exposure across 2022 and 2024 using available data. The ground truth lacks 2023 numbers and only describes 2022 qualitatively and 2024 quantitatively. The LLM incorrectly infers a decline by introducing unsupported year-over-year data. It fails to recognize that the original answer implies continuity and stable valuation. (4) Scores are justified as follows: correctness is low (2/10) due to major factual and directional errors; quantitative accuracy is poor (2/10) due to wrong numbers and invented comparisons; qualitative accuracy is slightly higher (3/10) because the LLM attempts to discuss carrying and fair value correctly as concepts, though misapplies them; contextual relevance is moderate (6/10) because it addresses securitized debt obligations and the right company and time frame, but with incorrect data synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 500,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "Between 2023 and 2024, McDonald's use of line of credit agreements remained stable, with the company maintaining a $4.0 billion committed line of credit agreement as of December 31, 2024. Additionally, the company's subsidiaries had $7 million in borrowings under uncommitted foreign currency line of credit agreements in 2024, compared to no specific mention of such uncommitted lines in 2023. The evolution reflects continued access to credit facilities to support cash flow management and financing activities, including debt service, dividends, and share repurchases.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct elements but misses key aspects of the evolution in McDonald's use of line of credit agreements and overall financing dynamics between 2023 and 2024. While it correctly notes continued access to credit facilities, it fails to capture the significant shift in liquidity and financing strategy reflected in the ground truth. The $4.0 billion committed line of credit is mentioned, which aligns with typical disclosures, but this specific figure is not in the original answer and cannot be verified against the provided ground truth. The $7 million in uncommitted foreign borrowings in 2024 is a minor detail not present in the original and does not reflect the broader trend. (2) Quantitatively, the LLM omits critical figures from the ground truth: the $4.4 billion and $7.5 billion cash used in financing activities in 2023 and 2024, respectively, and the drop in cash and equivalents from $4.6 billion to $1.1 billion. These are central to understanding the shift in cash flow management. The LLM also does not mention the change in bond issuances as a driver, which is a key explanatory factor. (3) The multi-hop reasoning is weak: the original answer connects changes in financing cash outflows, bond issuance patterns, cash balances, and reliance on credit facilities over two years to infer a strategic shift. The LLM only states that credit lines were maintained, missing the inference that increased reliance on credit facilities in 2024 was due to a depleted cash balance from prior-year debt timing. This represents a failure to synthesize the full causal chain. (4) Contextual relevance is high because the answer addresses line of credit usage and ties it to cash flow management, but correctness and completeness are compromised by omission of core financial data and misrepresentation of the evolution as 'stable' when the ground truth describes a meaningful shift toward greater reliance due to reduced liquidity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 533,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "Between 2022 and 2024, the Worldwide Business Conduct Manual has remained a foundational element in reinforcing Procter & Gamble's internal controls, emphasizing the company's commitment to integrity and compliance. In both years, the manual is highlighted as a key tool in ensuring adherence to legal and ethical standards, supporting the reliability of financial reporting, and aligning with the company's governance structure. The consistent emphasis on the manual reflects P&G's ongoing dedication to robust corporate governance and ethical business practices.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Worldwide Business Conduct Manual plays a consistent role in reinforcing internal controls and ethical conduct at Procter & Gamble in both 2022 and 2024, which aligns with the ground truth. However, it fails to capture the key evolution highlighted in the original answer: the 2024 enhancement linking the manual more explicitly to structured governance mechanisms such as the Global Leadership Council and the Disclosure Committee. This shift toward a more integrated governance approach is entirely missing, representing a significant omission in qualitative accuracy. (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numeric errors exist. (3) The multi-hop reasoning is partially sound—the model synthesizes the role of the manual across two years but does not adequately compare the differences in governance integration between 2022 and 2024. The answer treats the manual’s role as static rather than evolving, missing the core analytical point of the question. (4) While the response is contextually relevant and accurately reflects the ongoing importance of the manual, it lacks the critical comparative insight about P&G's evolving governance strategy, which is central to the question. Thus, correctness and qualitative accuracy are reduced despite accurate general statements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 403,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "Exxon's strategic positioning in Guyana has significantly strengthened between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions. The long-lived assets in Guyana increased from $6.766 billion in 2023 to $9.689 billion in 2024, indicating substantial capital investment in the region. Additionally, Guyana is explicitly listed as an \"Advantaged Asset\" in the 2024 earnings driver definitions, highlighting its role as a key growth project contributing to Exxon's strategic focus on high-return assets. This evolution underscores Guyana's growing importance in Exxon's portfolio as a major source of earnings and capital deployment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative data: it states that Exxon's long-lived assets in Guyana were $6.766 billion in 2023 and increased to $9.689 billion in 2024. However, the ground truth states that the 2023 value was $9,689 million (i.e., $9.689 billion), with no mention of a 2024 figure. Thus, the LLM incorrectly reverses the timeline and fabricates a 2023 number not present in the original answer. This is a major quantitative inaccuracy. (2) The calculation of growth from $6.766B to $9.689B implies a ~43% increase, which is not supported by the source data and introduces a false narrative of recent capital surge. The original answer does not provide a 2024 asset figure, only a strategic reclassification. (3) On qualitative accuracy, the LLM correctly identifies the strategic shift—Guyana being named an 'Advantaged Asset' in 2024 under the 'Advantaged Volume Growth' earnings driver—which aligns with the ground truth. It accurately captures the evolving strategic emphasis, even if the numerical timeline is wrong. (4) Contextually, the response is well-structured and relevant, addressing both asset disclosures and earnings driver definitions as asked. However, the core numerical foundation is flawed, undermining the correctness score despite correct terminology and reasonable synthesis of strategic implications. The answer would score higher if not for the inversion of financial data between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 406,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "Capital One's reliance on securitized debt obligations as a funding source increased from 2022 to 2024. In 2022, $6.25 billion in securitized debt obligations were issued, while in 2024, the amount of securitized debt obligations on the balance sheet was $14.264 billion, indicating a significant increase in the use of this funding source over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific dollar value for securitized debt obligations was disclosed in 2022, but the LLM incorrectly claims that $6.25 billion was issued in that year—this figure is not present in the original answer and is therefore fabricated. In 2024, the correct carrying value is $14,264 million ($14.264 billion), which the LLM correctly reports in billion format, so this part is accurate. However, the inference of 'increased reliance' based on a comparison between an issued amount (2022) and a carrying value (2024) is flawed and unsupported by the source. (2) Quantitative accuracy is low because the 2022 figure is entirely incorrect and not disclosed in the original text. The 2024 value is correctly stated as $14.264 billion, matching the $14,264 million in the ground truth. However, the use of 'issued' in 2022 vs. 'on the balance sheet' in 2024 creates a false comparison. (3) The reasoning is unsound: the original answer emphasizes increased transparency and continued use, not necessarily increased reliance. The LLM assumes growth based on incomplete and mismatched data points, failing to reflect the nuanced evolution described in the ground truth. It misses the key point about disclosure practices changing from qualitative (2022) to quantitative (2024). (4) Contextual relevance is moderate because the answer addresses the general topic and time frame, but the incorrect data and flawed logic undermine the overall correctness. The conclusion about increased reliance is not supported by the evidence provided in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 451,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "Between fiscal years 2022 and 2023, NVIDIA's Omniverse platform evolved from being primarily a real-time 3D design collaboration and virtual world simulation tool to a more integrated and enterprise-focused platform. In 2022, Omniverse was described as a software subscription for enterprise use, emphasizing its role in enabling artists, designers, and creators to collaborate in leading design applications. By 2023, Omniverse was positioned more broadly as a development platform and operating system for building virtual world simulation applications, with industrial enterprises adopting it for digital twins, real-time 3D product configurators, and testing autonomous systems. This shift reflects increased enterprise adoption and a broader scope in supporting digitalization across industries.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of NVIDIA's Omniverse from a 3D collaboration tool in FY2022 to a broader enterprise simulation platform in FY2023, with accurate positioning shifts and examples of enterprise adoption such as digital twins and real-time 3D configurators. However, it incorrectly states that Omniverse was a 'software subscription for enterprise use' in 2022 — the ground truth specifies this subscription model was introduced in 2023, with free access for individuals also beginning then. This is a minor factual inaccuracy regarding timing of the business model rollout. (2) There are no numeric values, dollar amounts, or calculations in the question or answers, so quantitative accuracy is not applicable — all temporal references (fiscal years 2022 and 2023) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two fiscal years, identifying the shift in positioning and adoption. It accurately reflects increased enterprise focus and industrial use cases. The only gap is the misattribution of the subscription model to 2022 instead of 2023. (4) The answer is contextually highly relevant, directly addressing both positioning and enterprise adoption. The core facts about Omniverse’s expanded role and industrial applications are correct, warranting a high qualitative and overall correctness score despite the minor error in service model timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 401,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Between 2022 and 2023, the net amounts due between Pfizer and Viatris under their agreements decreased significantly. As of December 31, 2023, the net amounts due to Viatris were $33 million, compared to $94 million as of December 31, 2022. This reduction reflects the ongoing completion of services under transitional agreements and the maturation of their post-separation relationship.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net amounts due to Viatris as $94 million as of December 31, 2022, and $33 million as of December 31, 2023, matching the ground truth exactly. (2) All numeric values and dates are accurate, and the comparison (a decrease from $94M to $33M) is correctly presented. There are no calculation errors. (3) The reasoning is sound: the answer correctly infers that the reduction reflects the completion of transitional services and the maturation of the post-separation relationship, which aligns with the implication in the original answer about winding down or stabilization of financial arrangements. (4) The answer is semantically equivalent to the ground truth, with no omissions or inaccuracies. All evaluation dimensions—quantitative accuracy, completeness, entity accuracy, reasoning, and contextual relevance—are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 267,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024 by advancing development projects and increasing production capacity. In 2023, the Payara development commenced operations with the Prosperity FPSO, and the Yellowtail project progressed, with the Uaru project funded. By 2024, Guyana was explicitly classified as an \"Advantaged Asset\" under the updated earnings drivers, highlighting its role in ExxonMobil's growth strategy. This classification reflects the region's significance as a high-return project, signaling increased strategic focus and integration into the company's core growth initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of ExxonMobil's strategic emphasis on Guyana from 2023 to 2024. It accurately notes the operational progress in 2023 (Payara, Yellowtail, Uaru) and the key strategic shift in 2024 with Guyana's classification as an 'Advantaged Asset' under the updated earnings drivers. While the original answer specifies 12.6 net exploratory and development wells completed in 2023, this quantitative detail is omitted in the LLM response, but no incorrect numbers are presented. (2) There are no numerical inaccuracies; the LLM avoids making up figures and only reports qualitative developments that align with the ground truth. The absence of the 12.6 wells metric reduces completeness slightly but does not affect quantitative accuracy since no false numbers are given. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2023 to 2024), identifies the shift from operational activity to strategic classification, and links Guyana to ExxonMobil’s core growth strategy, paralleling the Permian and LNG. The reasoning mirrors the original answer’s logic. (4) The LLM answer is contextually fully relevant, directly addressing both parts of the question—evolution of strategy and specific changes in project activity or classification. The only minor gap is the omission of the exact well count, which slightly affects completeness but not overall correctness. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 411,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "From 2022 to 2023, the weighted-average interest rate for senior notes with maturities greater than 10 years remained unchanged at 3.8%. The face value of these notes increased slightly from $52.8 billion in 2022 to $53.4 billion in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, in 2022 the weighted-average interest rate was 3.67%, not 3.8%, and it remained at 3.8% in 2023—this implies a slight increase, not no change. The LLM incorrectly states the rate 'remained unchanged at 3.8%', which misrepresents the evolution. Additionally, the 2022 face value is incorrect: the ground truth reports $54.536 billion, but the LLM states $52.8 billion. The 2023 face value ($53.4 billion) is correct. (2) Quantitative accuracy is low: two out of three numbers are wrong (interest rate in 2022 and face value in 2022), and the claim of 'no change' in interest rate contradicts the data (3.67% → 3.8%). The face value trend is also misrepresented: the ground truth shows a decrease from $54.536B to $53.4B, but the LLM claims an increase from $52.8B to $53.4B, reversing the direction of change. (3) The reasoning is partially sound in structure—it attempts to compare two years across two metrics—but fails in multi-hop synthesis because it uses incorrect base data. The conclusion about stability in interest rates is misleading due to the incorrect starting rate. (4) Contextual relevance is high because the answer addresses the right metrics, time frame, and debt category. However, due to major numerical errors and mischaracterization of trends, the overall correctness score is low despite relevant structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 404,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "Between 2023 and 2024, the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shifted their domestic equity investment allocations and valuation methodologies as follows:\n\n- **Alabama Power**: In 2023, domestic equity investments were valued at $443 million under Level 2 inputs and $208 million under Level 3 inputs. By 2024, the entire domestic equity allocation of $651 million was classified under Level 2 inputs, indicating a shift away from Level 3 inputs. This suggests an increase in the use of observable market data for valuation.\n\n- **Georgia Power**: In 2023, domestic equity investments were valued at $321 million under Level 2 inputs and $1 million under Level 1 inputs. In 2024, the domestic equity allocation of $322 million remained primarily in Level 2 inputs, with no significant change in classification. \n\nOverall, the trusts moved toward greater reliance on Level 2 inputs in 2024, reflecting more transparency and the use of observable market data for valuation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both numbers and classifications. For Alabama Power, it incorrectly states that in 2023, $443 million was in Level 2 and $208 million in Level 3, when the ground truth shows $396 million in Level 1 and $169 million in Level 2 (total $565M), with no mention of Level 3. The 2024 figures for Alabama Power are partially correct in total ($651M) but misclassified: LLM claims entire amount is in Level 2, while truth is $443M Level 1 and $208M Level 2. For Georgia Power, LLM reverses the years: it claims $321M in Level 2 in 2023, but truth is $255M Level 1 and $1M Level 2 in 2023, rising to $321M Level 1 in 2024. LLM incorrectly states Georgia Power had $321M in Level 2 in 2023, which is wrong in both amount and level. (2) Calculations are flawed: LLM fails to report correct totals or proper breakdowns. For example, Alabama Power’s 2023 total is correct at $565M in truth, but LLM implies a total of $651M in 2023 (443+208), which is actually the 2024 total. (3) Multi-hop reasoning is unsound: the model fails to correctly synthesize data across years and companies, misassigning values and input levels, and draws incorrect conclusions about a shift toward Level 2 inputs when the truth shows a significant increase in Level 1 (more liquid) investments for both companies. (4) Contextual relevance is moderate—LLM addresses the right topic (valuation shifts in decommissioning trusts) and uses appropriate terminology (Level 1/2/3), but the factual foundation is so flawed that the analysis is misleading. The conclusion about increased reliance on Level 2 inputs is incorrect—both companies actually increased Level 1 allocations, indicating greater use of actively traded instruments, not Level 2. Due to severe quantitative and qualitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 505,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "From 2022 to 2023, NVIDIA's strategic positioning of CUDA evolved by reinforcing its role as the foundational programming model across its full-stack computing platform, enabling accelerated computing for diverse workloads such as AI, data analytics, and scientific computing. In 2023, CUDA's integration expanded further across end markets like automotive, healthcare, and professional visualization, supported by domain-specific software stacks and ecosystem partnerships, solidifying its importance in NVIDIA's unified architecture for multi-billion-dollar industries.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of CUDA's strategic positioning from 2022 to 2023. It correctly identifies CUDA as the foundational programming model within NVIDIA's full-stack computing platform and notes its expanded integration across end markets such as automotive, healthcare, and professional visualization—aligning with the ground truth. The mention of domain-specific software stacks and ecosystem partnerships reflects the broader vertical integration emphasized in 2023. However, the LLM answer omits a key detail from the original answer: the explicit emphasis on CUDA supporting 'hundreds of domain-specific software libraries, SDKs, and APIs' in 2023, which was not highlighted in 2022. This represents a minor but notable omission in completeness, particularly regarding the depth of software ecosystem expansion. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are present), and all entities (NVIDIA, CUDA, end markets) are correctly identified. The reasoning is sound and reflects multi-hop synthesis across time periods and market segments. The answer is fully contextually relevant, directly addressing the question about strategic evolution in positioning and integration. The wording differs but maintains semantic equivalence on most points, just missing the full extent of the software stack emphasis in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 389,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "From 2022 to 2023, the net amounts owed by Pfizer to Viatris decreased significantly, from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, services under the transitional service agreements (TSAs) with Viatris were largely completed by December 31, 2023, indicating a reduction in ongoing contractual obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the net amounts owed decreased from $94 million in 2022 to $33 million in 2023, and the completion of TSAs by December 31, 2023, is accurately stated. (2) The answer correctly identifies the entities (Pfizer, Viatris), the financial metric (net amounts owed), and the time frame (2022 to 2023). (3) The multi-hop reasoning is sound—linking the reduction in net amounts owed to the winding down of transitional services. (4) The only minor omission is that the original answer notes TSA services were 'largely completed by the end of 2022,' which the LLM answer does not mention, though it correctly states they were completed by end of 2023. This slight lack of detail does not undermine the core accuracy. The answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 263,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "From 2022 to 2023, Duke Energy faced increasing pressure from both retail deregulation and evolving environmental regulations, which collectively impacted its compliance costs and operational strategies. In 2022, the company highlighted the risks of retail deregulation, such as increased competition and potential unrecovered costs, alongside the ongoing challenges of complying with environmental laws, including those related to coal combustion residuals (CCR) and carbon emissions. By 2023, Duke Energy emphasized a heightened regulatory and legislative focus on climate change, with more aggressive state-level carbon reduction goals and stricter environmental compliance requirements. These developments increased Duke Energy's capital and operating expenditures, necessitating greater investments in clean energy and compliance measures, while also heightening the risk of delayed or incomplete cost recovery through regulatory mechanisms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Duke Energy's challenges related to retail deregulation and environmental compliance from 2022 to 2023. It accurately notes that in 2022, Duke highlighted risks from deregulation such as unrecovered costs and competition, alongside environmental compliance issues like coal combustion residuals (CCR) and carbon emissions. In 2023, it correctly identifies increased regulatory pressure, including more aggressive state-level carbon goals and heightened climate focus. While the original answer specifically mentions PURPA-related above-market purchased power commitments as a key mechanism linking deregulation to cost recovery risk, the LLM answer generalizes this to 'unrecovered costs' and 'delayed or incomplete cost recovery'—which is semantically close but omits the specific multi-hop link to QFs and PURPA. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is mostly sound: the LLM synthesizes information across years and regulatory domains (retail market structure and environmental regulation), correctly identifying that deregulation limits cost recovery while environmental requirements increase costs. However, it misses the specific causal mechanism in the ground truth—PURPA obligations creating above-market costs that become unrecoverable under deregulation—representing a minor gap in qualitative depth. (4) The answer is highly contextually relevant, directly addressing the relationship between deregulation and environmental compliance cost recovery. The correctness score is 8 due to accurate core facts and strong synthesis, with a minor deduction for not specifying the PURPA-QF cost recovery mechanism central to the 2022 risk.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 498,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline of 1.7 share points. This decline contrasts with the pricing strategy applied to Skoal during 2023, which included multiple price increases (e.g., $0.09 per can in January 2023 and $0.09–$0.10 per can in April and July 2023), indicating an attempt to offset volume declines and maintain profitability despite market share losses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in retail share from 9.3% in 2023 to 7.6% in 2024, which is accurate and matches the ground truth. However, the pricing details are incorrect. The ground truth states that the price increases referenced in 2023 were for a $0.11 per can increase effective January 23, 2024 (announced in 2023), and prior increases in 2022 (not 2023) of $0.09, $0.09, and $0.08. The LLM incorrectly places multiple $0.09–$0.10 increases in January, April, and July 2023, which contradicts the source. (2) The calculation of the 1.7 percentage point decline is correct (9.3% - 7.6% = 1.7%), but the dollar amounts and timing of price increases are factually wrong. The LLM invents price hikes in 2023 that are not in the original data, while omitting the correct $0.11 increase announced in 2023 but effective in 2024. (3) The multi-hop reasoning is partially sound—linking price increases to declining market share is a valid interpretation and aligns with the contrast implied in the question. However, the synthesis is based on incorrect pricing data, undermining the factual basis of the conclusion. (4) The contextual relevance is high as the answer addresses both parts of the question and attempts to contrast market share trends with pricing strategy. The qualitative reasoning is logical but built on inaccurate quantitative inputs, leading to a partially correct answer with significant factual flaws in the pricing timeline and amounts. Hence, correctness is reduced to 6 due to major quantitative inaccuracies despite correct market share numbers and reasonable interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 445,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen's investment in 'Other short-term interest-bearing securities' slightly decreased from $138 million in 2023 to $135 million in 2024. This minimal change, along with the company's focus on U.S. Treasury bills and money market mutual funds, indicates a conservative short-term investment strategy prioritizing safety of principal, liquidity, and low risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Amgen's investment decreased from $138 million in 2023 to $135 million in 2024, while the ground truth confirms it remained unchanged at $138 million in both years. This is a critical factual error affecting the core of the response. (2) The quantitative inaccuracy is significant—$135 million vs. $138 million is not a minor rounding difference but a misstatement of financial data. No calculation is required in this question, but the comparison across years is incorrect. (3) The reasoning about a conservative strategy is plausible and contextually reasonable given Amgen’s focus on low-risk instruments, but it is based on a false premise of a decrease. The multi-hop synthesis fails because the model did not correctly retrieve and compare the two-year data points. (4) The contextual relevance is fair because the answer addresses the right metric and attempts to interpret strategy, but the incorrect numbers undermine the conclusion. Correctness and quantitative accuracy are low due to the wrong figures; qualitative accuracy is partially acceptable due to correct entity and metric identification, but flawed logic reduces the score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 338,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "General Dynamics' involvement in Abrams Main Battle Tank Upgrades increased in contract value from 2022 to 2024. In 2022, the company received $360 million for Abrams tank upgrades, mission control units, and technical support. By 2024, this had grown to $350 million, specifically for Abrams upgrades, engineering, logistics support, and system sustainment. While the direct contract value slightly decreased, the 2024 award reflects a broader scope emphasizing sustainment and technical support, indicating a shift toward long-term support and modernization efforts.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $360 million 2022 contract and the $350 million 2024 contract for Abrams upgrades and support services, which aligns with the ground truth. However, it omits the separate $285 million contract awarded in 2024 for producing Abrams tanks in the SEPv3 configuration for Romania, a critical component of the evolution in contract scope and value. This omission significantly undermines completeness and quantitative accuracy. (2) While the individual figures of $360M and $350M are accurate, the conclusion that contract value 'slightly decreased' is misleading because it fails to account for the additional $285M contract. The total contract value in 2024 ($350M + $285M = $635M) represents a substantial increase over 2022's $360M. The LLM incorrectly implies a decline or stagnation in value when there is actually a significant increase. (3) The reasoning correctly identifies a shift toward broader scope including sustainment and technical support, which is valid based on the $350M contract. However, it fails the multi-hop synthesis by not connecting the new production contract for Romania as evidence of expanded scope into new configurations, which is central to the ground truth's conclusion. (4) Scores reflect that core facts are partially correct and reasoning is sound where applied, but major omissions in quantitative data and incomplete synthesis of contract evolution justify a mid-range correctness score. Contextual relevance is high as the answer stays focused on the topic and draws reasonable inferences from the data it does include.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 441,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "From 2023 to 2024, AIG's financial relationship with Corebridge underwent significant changes. In 2023, Corebridge was still consolidated under AIG, and AIG recognized income from discontinued operations of $902 million attributable to AIG. However, in 2024, AIG deconsolidated Corebridge on June 9, 2024, resulting in a loss of $4.8 billion, primarily due to the recognition of an accumulated comprehensive loss of $7.2 billion. Post-deconsolidation, AIG accounted for its retained interest in Corebridge using the fair value option, recognizing equity method income of $601 million in 2024, which included dividends and changes in Corebridge's stock price. Additionally, AIG sold a significant portion of its Corebridge shares, including a 21.6% stake to Nippon for $3.8 billion, resulting in a $282 million gain in the fourth quarter of 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several details not present in the ground truth and contains specific numerical figures (e.g., $902M income, $4.8B loss, $601M equity income, $282M gain, 21.6% stake sale to Nippon for $3.8B) that are not mentioned or verifiable from the original answer. These numbers, while plausible, cannot be confirmed as accurate based on the provided ground truth, which focuses on the structural shift in the financial relationship rather than specific P&L impacts or transaction gains. The only date confirmed in both answers is June 9, 2024, which marks a key transition point. However, the original answer does not mention deconsolidation, fair value accounting, or share sales, making the inclusion of such detailed financials unsupported. (2) The ground truth states that Corebridge had borrowing ability through February 25, 2025, as of 2023, and that AIG began recognizing equity method income tied to stock price and dividends starting June 9, 2024. The LLM correctly identifies the shift to equity-based income recognition but incorrectly labels it as 'equity method income' while also conflating it with fair value accounting—these are distinct methods. The original answer implies a move to equity method accounting, but the LLM adds unsupported specifics like $601M income. (3) The multi-hop reasoning is partially sound: the model infers a transformation in the relationship from borrowing to equity-based returns, which aligns with the ground truth. However, it fabricates transactional and financial details beyond what the knowledge graph supports, undermining factual accuracy. (4) The contextual relevance is high because the answer addresses the evolution of the financial relationship and focuses on borrowing and income recognition. Qualitative accuracy is moderate due to correct conceptual framing but flawed execution on method and unsupported numbers. Quantitative accuracy is low because most figures are unverifiable and likely incorrect or extrapolated. Correctness score is 6 due to correct directional narrative but significant overreach in unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 569,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Solar Roof product evolved from focusing on production challenges and installation capabilities to addressing strategic dependencies and scaling efforts. In 2022, the company highlighted challenges related to production ramps, supplier constraints, and the need to improve installation efficiency. By 2024, Tesla emphasized collaboration with real estate developers and builders to integrate Solar Roof into new homes, indicating a shift toward broader market adoption and infrastructure integration. Additionally, the 2024 filing reflects a stronger focus on localized procurement and scaling energy product installations globally, underscoring strategic dependencies on supply chain and workforce development.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the timeline and emphasis of Tesla's Solar Roof strategy. It incorrectly states that in 2022, Tesla was focused on 'production challenges and production ramps' and 'supplier constraints', which contradicts the ground truth: in 2022, Tesla was actively selling the product and improving installation efficiency through collaboration with builders, with an emphasis on engineering and aesthetics. The shift to production ramp challenges and supplier risks as a central dependency is correctly attributed to 2024 in the ground truth, but the LLM reverses the timeline by assigning these issues to 2022. Conversely, the LLM incorrectly assigns collaboration with real estate developers and builders to 2024, when this was a 2022 strategy according to the original answer. (2) There are no numeric values, dates, or calculations in the response to evaluate for quantitative accuracy; all time references (2022, 2024) are correct as years, but their associated facts are swapped, so the temporal alignment is flawed. (3) The multi-hop reasoning is unsound because the model fails to correctly synthesize the evolution over time—it swaps key strategic focuses between years, leading to an inverted narrative. The dependency on supply chain and workforce in 2024 is plausible, but the original answer does not mention 'localized procurement' or 'global scaling of installations' as highlighted in the LLM response, introducing unsupported details. (4) The contextual relevance is moderate because the answer addresses the general topic of Solar Roof evolution, production, and dependencies, but the reversal of key facts across years undermines the qualitative and overall correctness. The answer appears plausible but misrepresents the actual progression documented in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 501,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "The retail share of Skoal in the U.S. oral tobacco market decreased from 9.3% in 2023 to 7.6% in 2024. This decline indicates a weakening competitive position for Skoal, as it lost market share amid industry shifts toward oral nicotine pouches and challenges in the MST (moist smokeless tobacco) category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Skoal's retail share decreased from 9.3% in 2023 to 7.6% in 2024, matching the ground truth exactly. This addresses the first part of the question about how the share changed. The conclusion that this indicates a weakening competitive position is also consistent with the original answer. (2) Quantitatively, all numbers and years are accurate—9.3% and 7.6% for the correct years—with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two time points and draws a valid inference about competitive positioning. While the original answer includes a comparative point about on! gaining share, the LLM answer compensates by providing contextual insight about industry shifts toward nicotine pouches and challenges in the MST category, which is plausible and relevant, though not explicitly in the ground truth. (4) The answer is highly accurate and relevant, missing only the specific contrast with on!'s performance, which is a minor omission that doesn't detract from the core correctness. Hence, a score of 9 is justified—excellent but not fully complete in comparative context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 335,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "The risk associated with the concentration of device share among premium tier companies has increased between 2023 and 2024, particularly due to geopolitical tensions and vertical integration by key customers. In 2024, the revocation of Qualcomm’s export license to Huawei led to a loss of approximately $560 million in product revenues, and further risks exist if Huawei gains market share in China at the expense of other OEMs using Qualcomm products. Additionally, Chinese OEMs are increasingly developing their own integrated circuit products under government initiatives like \"Made in China 2025,\" which could reduce Qualcomm’s pricing power and revenue stability. These factors, combined with the premium tier market’s maturation and slowing growth, heighten the vulnerability of Qualcomm’s revenue to shifts in customer behavior and geopolitical policies.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, such as the $560 million revenue loss due to the revocation of Qualcomm’s export license to Huawei. This figure is not mentioned in the original answer and cannot be verified from the provided knowledge graph, making it factually unsupported. Additionally, there is no mention in the ground truth of a revoked export license in 2024 or Huawei’s direct impact on revenue in that year, which undermines the factual basis of the LLM's key argument. (2) The original answer does not include any numerical data, so the introduction of $560 million is an unsupported addition, failing the quantitative accuracy criterion. No other numbers are provided in either answer for comparison. (3) While the ground truth correctly identifies the ongoing risk of customer concentration and its implications for pricing power and revenue stability, the LLM shifts focus to geopolitical factors and vertical integration under 'Made in China 2025'—topics not explicitly mentioned in the original. Although these are plausible external risks, they represent a divergence from the documented evolution in Qualcomm’s own risk disclosures between 2023 and 2024. The multi-hop reasoning is partially sound in connecting customer concentration to pricing pressure, but the emphasis on Huawei and export licenses introduces speculative elements not grounded in the source material. (4) The contextual relevance remains high because the LLM addresses the core theme—evolving risk from device share concentration affecting Qualcomm’s pricing and revenue—and attempts to build a logical narrative. However, the correctness score is low due to the introduction of unverified facts and misalignment with the actual content of the original answer, which focused on shifting emphasis in risk disclosure rather than new geopolitical events or financial losses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 521,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen's allocation to money market mutual funds increased significantly between 2023 and 2024. As of December 31, 2023, the fair value of money market mutual funds was $10,266 million, while as of December 31, 2024, it rose to $10,354 million. This reflects a slight increase of $88 million in Amgen's allocation to money market mutual funds during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Amgen's allocation to money market mutual funds increased between 2023 and 2024. The ground truth confirms that the allocation remained unchanged at $10,266 million in both years. The LLM incorrectly reports a rise to $10,354 million in 2024, which is not supported by the data. (2) The quantitative values are wrong: the 2024 figure is falsely stated as $10,354 million, introducing an incorrect $88 million increase. This calculation is based on fabricated data. The 2023 value ($10,266 million) is correct, but the 2024 value and the difference are not. (3) The multi-hop reasoning failed—the question required comparing Amgen’s disclosed investments in money market mutual funds across two years. The model incorrectly inferred a change when the data shows no change, indicating a failure in accurate synthesis. (4) Despite the incorrect core facts, the answer is contextually relevant, addressing the right company, metric, and time frame. However, the severe factual and numerical inaccuracies—especially in the reported figures and the direction of change—result in a very low correctness and quantitative accuracy score. The qualitative accuracy is slightly higher only because the model attempted the correct type of comparison, albeit with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 371,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "General Dynamics' participation in the Capital Construction Fund (CCF) has seen an increase in the amount of U.S. government accounts receivable pledged to the fund. In 2022, the pledged amount was $295 million, which rose to $333 million by 2024, indicating a $38 million increase over the two-year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the pledged amounts for 2022 ($295 million) and 2024 ($333 million), which align with the ground truth. However, it omits the intermediate data point for December 31, 2023 ($315 million), which is part of the complete evolution between 2022 and 2024. While the overall trend and final comparison are accurate, this omission reduces completeness. (2) The calculation of a $38 million increase is correct ($333M - $295M = $38M), though the ground truth implies a two-step increase (to $315M then $333M), which the LLM does not reflect. (3) The reasoning is sound in identifying an increasing trend and linking it to CCF participation, but fails to fully synthesize the multi-hop nature of the data across three time points. (4) Scores reflect high factual accuracy and relevance, with a moderate deduction for missing the 2023 data point and incomplete temporal granularity in the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 273,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly following the IPO and subsequent deconsolidation. In 2023, AIG retained significant ownership in Corebridge, and its investment income from Corebridge was reflected in net investment income and realized gains. However, in 2024, after deconsolidation on June 9, 2024, AIG's retained interest in Corebridge was accounted for under the equity method, with changes in Corebridge's stock price and dividends impacting AIG's net investment income. Tax implications were also affected, as Corebridge was deconsolidated from AIG’s U.S. federal income tax group, limiting future tax attribute sharing. This deconsolidation resulted in a $4.8 billion loss for AIG, primarily due to the recognition of an accumulated comprehensive loss.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of AIG's relationship with Corebridge, including the shift from consolidation to equity method accounting and tax deconsolidation. However, there are key inaccuracies: the deconsolidation date is stated as June 9, 2024, while the ground truth indicates that ownership dropped below 80% after the September 19, 2022 IPO, triggering tax deconsolidation in 2023. The LLM incorrectly implies deconsolidation occurred in 2024, which misaligns the timeline. Additionally, the $4.8 billion loss is mentioned but not present in the original answer and lacks sourcing or alignment with the provided ground truth. The equity method income is referenced generally, but the original specifies it began June 10, 2024, and covers a partial year; the LLM omits the exact start and duration. (2) Quantitative accuracy is partially compromised: while $4.8 billion is a plausible figure, it is not in the original answer and thus introduces unverified data. The correct timing of events (2023 vs. 2024) affects the accuracy of period attribution. (3) Multi-hop reasoning is sound in concept—linking IPO, ownership drop, tax deconsolidation, and accounting change—but the sequencing and timing are off, weakening the synthesis. The LLM correctly identifies the equity method shift and tax implications like loss of tax attribute sharing. (4) Despite timing and number discrepancies, the answer remains contextually relevant and conveys the essential transformation in the financial relationship. The qualitative reasoning is strong, but factual precision on dates and figures reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 449,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "From 2022 to 2024, Tesla's approach to Solar Roof production has evolved with a focus on improving installation capabilities and reducing costs. In 2022, the company emphasized increasing production by onboarding and training new installers and collaborating with real estate developers to streamline installation processes. By 2024, Tesla expanded its educational and training programs, such as the Education Assistance Program and Tesla START, to develop skilled talent in manufacturing and service roles, which supports the Solar Roof initiative. Supply chain challenges, including component shortages and global trade disruptions, remained a concern in both periods, but Tesla's efforts to enhance localized procurement and optimize inventory management were key strategies to mitigate these issues.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's 2022 focus on installer training and collaboration with real estate developers to streamline Solar Roof installation, which aligns with the ground truth. It also acknowledges ongoing supply chain challenges like component shortages and global disruptions. However, the 2024 evolution is inaccurately framed: the ground truth states Tesla shifted focus to systemic supply chain risks—global component procurement, supplier failures, inflationary pressures, and production scalability—whereas the LLM emphasizes expanded educational programs (Tesla START, Education Assistance Program) as the primary 2024 strategy, which is not supported in the original answer. These programs may exist but are not cited as central to Solar Roof production evolution in the ground truth. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or figures. (3) The multi-hop reasoning is partially sound: the model connects 2022 and 2024 strategies, but fails to correctly synthesize the shift from localized labor development to systemic supply chain and manufacturing risk management. Instead, it introduces new programs not mentioned in the ground truth, indicating a misalignment in reasoning. (4) Scores reflect that core facts (2022 strategy, ongoing supply chain issues) are accurate, but the 2024 strategic evolution is misrepresented, leading to a moderate deduction in correctness and qualitative accuracy. Contextual relevance remains high as the answer stays focused on Solar Roof production and supply chain themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 447,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina increased from $7 billion to $8 billion between 2022 and 2023. As of 2023, approximately $4 billion had been spent, indicating significant progress under the Coal Ash Act. The company has completed the excavation of coal ash at several sites and is on track to meet closure requirements, with the majority of remaining costs expected to be incurred over the next 10 years. This suggests Duke Energy is actively managing its obligations under the regulatory framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the direction of cost change. The original answer states that the estimated total cost decreased from $8B–$9B in 2022 to $7B–$8B in 2023, but the LLM incorrectly claims it increased from $7B to $8B, which is the opposite trend. This is a major quantitative and directional error. The amount spent ($4 billion through 2023) is correctly reported, as is the prior spending of $3.1 billion through 2021 (implied in original), though the LLM does not explicitly reference the 2022 figure. (2) The numbers are partially correct but mischaracterized: the $7B–$8B range in 2023 is accurate, but presenting it as an increase from a $7B baseline in 2022 is wrong because the 2022 range was higher ($8B–$9B). The $4 billion spent is correct. No calculations are performed, but the comparison over time is flawed. (3) The multi-hop reasoning is partially sound—linking cost estimates, spending, and progress under the Coal Ash Act—but the incorrect cost trend undermines the conclusion. The LLM correctly infers progress from spending and excavation, but the cost refinement (downward) is misrepresented, which affects the interpretation of efficiency or improved planning. (4) Correctness is scored low (4) due to the critical error in cost direction. Quantitative accuracy is poor (3) because of the incorrect cost evolution. Qualitative accuracy is moderate (5) as the general narrative of progress is plausible but based on flawed data. Contextual relevance is high (8) because the answer addresses the question’s scope and includes relevant details about progress and timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 453,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024, indicating a modest improvement in its market position within the oral tobacco product segment during this period. However, this growth was not enough to offset declines in other products, as the total oral tobacco products segment's retail share decreased from 42.5% to 37.5% over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values: 'on!' retail share increased from 6.8% in 2023 to 8.3% in 2024, and total oral tobacco segment share declined from 42.5% to 37.5%. These match the ground truth exactly. (2) Quantitative accuracy is perfect—percentages and years are correct, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is mostly sound: the model correctly contrasts 'on!' growth with the overall segment decline. However, while the original answer concludes that 'on!' strengthened its position within the broader market, the LLM response says the growth 'was not enough to offset declines in other products', which slightly misframes the implication. The original insight emphasizes relative outperformance and market share gain in a shrinking segment, whereas the LLM answer could be interpreted as suggesting 'on!' failed to compensate for broader losses—shifting focus from relative performance to aggregate impact. This is a subtle but important distinction in interpretation. (4) Despite this minor qualitative nuance, the answer is factually complete, contextually relevant, and quantitatively precise, warranting a high score. The core conclusion—that 'on!' gained share while the segment declined—is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 365,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "Qualcomm's reliance on Chinese OEMs for revenue remained significant in 2024, with continued exposure to risks such as government policies (e.g., China's \"Made in China 2025\" initiative), U.S.-China trade tensions, and the potential for Chinese OEMs to develop their own integrated circuit products. In 2024, the revocation of Qualcomm's export license to Huawei by the U.S. Department of Commerce further highlighted the vulnerability of its business in China, with Huawei's prior product revenues amounting to $560 million in fiscal 2024 before the license was revoked. This evolving reliance and exposure to geopolitical and policy risks pose a threat to Qualcomm's business stability, as any further restrictions or shifts in customer behavior could significantly reduce revenues and cash flows.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific claims not present in the ground truth, most notably the revocation of Qualcomm's export license to Huawei and the $560 million revenue figure from Huawei in fiscal 2024. These details are factually unsupported by the original answer and represent significant fabrication or hallucination. The ground truth does not mention Huawei, any license revocation, or specific dollar amounts related to individual OEMs. (2) Quantitative accuracy is low because the $560 million figure is incorrect in this context—no such number appears in the original answer, and there is no verification that this amount is accurate or from a disclosed source. The mention of 'fiscal 2024' is potentially correct in timeframe but not substantiated by the original. (3) While the LLM correctly identifies the ongoing reliance on Chinese OEMs and links it to geopolitical risks like U.S.-China trade tensions, it fails to accurately reflect the continuity emphasized in the original answer between 2023 and 2024. Instead, it introduces a new, dramatic event (license revocation) that changes the narrative. The multi-hop reasoning is partially sound—connecting reliance on OEMs to business risk—but flawed due to the inclusion of false specifics. (4) The contextual relevance is moderate because the answer addresses the core theme of dependency and risk, but the introduction of unsupported events undermines factual correctness. The qualitative accuracy is mid-range because the conceptual understanding of risk factors is present, but entity accuracy (Huawei, license revocation) and quantitative claims are incorrect. Overall, the answer contains plausible themes but fails on key factual elements, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 479,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Between 2022 and 2023, Amgen's total available-for-sale investments remained composed primarily of money market mutual funds and other short-term interest-bearing securities. In 2022, the total available-for-sale investments were $4,335 million, with $1,676 million in U.S. Treasury bills, $2,659 million in money market mutual funds, and no amount in other short-term interest-bearing securities. By 2023, the total available-for-sale investments increased to $10,404 million, with $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities, while U.S. Treasury bills were no longer held. This indicates a shift from U.S. Treasury bills to money market mutual funds as the primary component of Amgen's available-for-sale investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the composition of Amgen's 2022 available-for-sale investments. According to the ground truth, in 2022, Amgen held $1,676 million in marketable securities (not U.S. Treasury bills) and $2,659 million in cash and cash equivalents (not money market mutual funds). The LLM incorrectly assigns $2,659 million to money market mutual funds in 2022, which is false; the shift to money market funds occurred in 2023. Additionally, the LLM claims there was 'no amount in other short-term interest-bearing securities' in 2022, but the ground truth does not specify this, so such a claim is unsupported. In 2023, the LLM correctly reports $10,404 million total, $10,266 million in money market mutual funds, and $138 million in other short-term interest-bearing securities, and correctly notes the elimination of U.S. Treasury bills, which aligns with the ground truth. (2) Quantitative accuracy is partially correct for 2023 totals and breakdowns, but 2022 composition is entirely misattributed. The total $4,335 million in 2022 is correct, but its components are wrong. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the 2022 security types, conflating cash and cash equivalents with money market funds and mislabeling marketable securities as U.S. Treasury bills. The conclusion about a shift from Treasury bills to money market funds is based on incorrect premises, even though the direction of a strategic shift is broadly consistent. (4) Contextual relevance is high as the answer addresses the evolution of investment composition over time and attempts to compare specific security types. However, due to major factual errors in the 2022 breakdown, the qualitative and quantitative accuracy scores are low. Correctness is scored at 4 due to partial correctness in totals and 2023 data, but major errors in 2022 composition that undermine the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 528,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "Shake Shack was present as a tenant at SPG's Woodbury Common Premium Outlets in 2023, as listed among its selected tenants, but there is no mention of Shake Shack in any of the 2022 premium outlet tenant lists provided. Therefore, Shake Shack entered SPG's premium outlet portfolio between 2022 and 2023, specifically at Woodbury Common Premium Outlets in New York.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error: it claims Shake Shack was not present at Woodbury Common Premium Outlets in 2022, while the ground truth confirms it was listed as a tenant in 2022. This reverses the timeline of Shake Shack's presence. Additionally, the LLM fails to mention the expansion to Las Vegas Outlets North Premium in Nevada in 2023, which is a key part of the evolution and indicates strategic growth. (2) Quantitatively, the years 2022 and 2023 are correctly referenced, and the location names (Woodbury Common Premium Outlets, New York) are accurate, but the absence of the Las Vegas expansion undermines completeness and accuracy. There are no numerical calculations in this question, so the focus is on correct dates and entities. (3) The multi-hop reasoning is flawed: the model incorrectly infers entry between 2022 and 2023 due to missing data in the 2022 list, failing to recognize that presence in 2022 was documented. It also does not synthesize the full evolution—retention in Woodbury and expansion to Las Vegas—which is central to answering how the presence evolved. (4) Contextual relevance is high because the answer addresses the right properties and timeframe, and attempts to interpret changes in tenancy. However, due to the critical error in timeline and omission of a major expansion, the correctness and qualitative accuracy scores are low. The answer is partially correct in identifying Woodbury Common as a location but fails on core facts and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 419,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "Between 2022 and 2024, retirement annuity contracts remained classified as Level 3 assets within the fair value hierarchy, indicating that their fair value is determined using significant unobservable inputs. In 2022, these contracts had a fair value of $35, increasing to $22 in 2024. This consistent classification suggests that GD's valuation methodology for these assets relies on internal models or assumptions due to the lack of observable market data, reflecting the illiquid or non-traded nature of these instruments.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that retirement annuity contracts remained in Level 3 of the fair value hierarchy between 2022 and 2024, which aligns with the ground truth. However, it introduces incorrect quantitative data—stating the fair value was $35 in 2022 and $22 in 2024—which is not present in the original answer and appears fabricated. No such dollar amounts are mentioned in the ground truth, making this a significant factual error. (2) There are no valid calculations to verify due to the absence of numerical data in the ground truth; thus, the inclusion of specific dollar figures undermines quantitative accuracy. These numbers are not only incorrect but also irrelevant to the actual evolution in classification or methodology. (3) The multi-hop reasoning is partially sound: the model correctly infers that remaining in Level 3 indicates reliance on unobservable inputs and internal models. However, it misses the key qualitative point about improved disclosure practices—specifically, the inclusion of NAV-valued investments in reconciliation tables in 2024, which was not explicitly done in 2022. This omission reflects a failure to fully synthesize the nuance in reporting evolution. (4) The contextual relevance is high because the answer addresses the classification stability and its implication on valuation methodology. Still, the incorrect numbers severely reduce overall correctness. The qualitative accuracy is moderate due to correct conceptual understanding but incomplete reasoning. Quantitative accuracy is very low due to invented figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 435,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly. In 2023, AIG owned 52.2% of Corebridge and recognized income from its equity stake, with changes in ownership affecting AIG's equity. By 2024, AIG deconsolidated Corebridge, reducing its ownership to 22.7% by the end of the year through secondary offerings and a major sale to Nippon Life. This deconsolidation resulted in a $4.8 billion loss, primarily due to the recognition of accumulated comprehensive losses. Post-deconsolidation, AIG accounted for its retained interest using the fair value option, recognizing dividends and stock price changes in net investment income.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it claims AIG owned 52.2% of Corebridge in 2023 and reduced ownership to 22.7% by end of 2024 via secondary offerings and a sale to Nippon Life — this is incorrect. The ground truth states that AIG's relationship shifted due to Corebridge's IPO on September 19, 2022, which terminated Blackstone’s exchange right, and by 2024, AIG began accounting for Corebridge under the equity method starting June 9, 2024. There is no mention of a sale to Nippon Life or specific ownership percentages like 52.2% or 22.7% in the ground truth. Additionally, the $4.8 billion loss from deconsolidation is not mentioned in the original answer and appears fabricated. (2) Quantitative inaccuracies include the 52.2%, 22.7%, and $4.8 billion figures, none of which appear in the ground truth. The ground truth references potential equity dilution of up to 24.1 million shares in 2022 and 4.4 million in 2023, but these are conditional and based on a hypothetical scenario that did not occur due to the 2022 IPO — this nuance is missing in the LLM answer. The LLM incorrectly implies these dilutive events were active in 2023, while the original answer clarifies the exchange right was terminated in 2022. (3) The multi-hop reasoning is flawed: the LLM fails to connect the termination of the exchange right due to the 2022 IPO, which is central to why there was no actual dilution. Instead, it invents a narrative around deconsolidation and a sale to Nippon Life not present in the ground truth. The shift to equity method accounting is partially correct but misdated and mischaracterized — the original specifies income recognition from dividends and stock price changes starting June 9, 2024, under an equity method investment, not fair value option. (4) Despite these major factual errors, the LLM does capture the general direction of change — from a controlling stake to a minority investment with income recognition — which supports moderate contextual relevance and some qualitative accuracy. However, the incorrect numbers, invented transactions, and flawed reasoning severely undermine factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 582,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort from 2022 to 2024 has remained consistent as a 30% equity interest, with the resort's debt not guaranteed by Comcast. As of December 31, 2024, Universal Beijing Resort had $3.4 billion of debt outstanding, compared to $3.5 billion in 2023, and Comcast consolidates the resort as a variable interest entity. The maximum risk of financial loss for Comcast remains limited to its 30% equity stake in the resort.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but has significant inaccuracies. It correctly states that Universal Beijing Resort had $3.4 billion in debt as of December 31, 2024, and $3.5 billion as of December 31, 2023, which aligns with the ground truth. However, it omits the earlier disclosed debt figures for 2020 ($2.5B) and 2021 ($3.6B), which are critical to showing the evolution of financial exposure. More importantly, the claim that Comcast holds only a 30% equity interest and that its risk is limited to that stake directly contradicts the ground truth: Comcast now consolidates Universal Beijing Resort as a VIE, meaning it includes 100% of the resort’s assets and liabilities ($7.3B assets, $7.0B liabilities) in its balance sheet—indicating full financial exposure, not limited to a minority stake. (2) Quantitatively, the 2023 and 2024 debt numbers are accurate, but the omission of 2020 and 2021 data reduces completeness and context. The consolidation figures ($7.3B assets, $7.0B liabilities) are entirely missing. (3) The multi-hop reasoning fails: the model does not synthesize the shift from non-consolidation (or partial disclosure) to full consolidation as a VIE, which is central to understanding the evolution of financial exposure. Instead, it incorrectly frames Comcast’s involvement as a passive equity investor with capped risk. (4) Contextual relevance is high because the answer addresses debt levels and consolidation, but correctness and qualitative reasoning are low due to fundamental misrepresentation of Comcast’s financial exposure and consolidation treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 444,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "Between 2022 and 2023, the structure of aircraft trade-in commitments remained largely consistent in terms of customer eligibility and risk exposure. In both years, Gulfstream customers with orders for new aircraft were granted options to trade in their existing aircraft as partial payment. These options typically set the fair market value of the trade-in aircraft 45 or fewer days before the delivery of the new aircraft, requiring the customer to either exercise or allow the option to expire. Some commitments guaranteed a predetermined trade-in value, which posed higher risk in the event of adverse market conditions. As of December 31, 2023, the estimated change in fair market values from the date of the commitments was not material, indicating no significant increase in risk exposure compared to 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding customer eligibility. The ground truth states that in 2022, trade-in options were available to 'some customers' broadly, but in 2023 they were narrowed to 'some Gulfstream customers,' indicating a restriction in eligibility. However, the LLM incorrectly claims that Gulfstream customers were eligible in both years, missing this key structural change. (2) Quantitatively, the LLM correctly notes that the estimated change in fair market values was 'not material' as of 2023, and correctly references timing mechanisms (e.g., 45 days before delivery) and risk from guaranteed values—these details align with typical disclosures and do not contradict the ground truth numerically. There are no explicit numbers to verify (e.g., dollar amounts, percentages), so the quantitative accuracy is high based on consistency with plausible financial reporting practices. (3) The multi-hop reasoning is flawed: the model fails to recognize the shift from general customer eligibility to a more specific subset (Gulfstream-only), which is central to the question about structural changes. It also overlooks the strategic emphasis on Gulfstream in 2023 as a sign of potential risk concentration. Instead, it asserts consistency across years, contradicting the ground truth. (4) Contextual relevance is moderate—the response addresses trade-in structures, risk exposure, and timing, so it stays on topic, but misses the core evolution in eligibility and strategic focus. The conclusion that the structure 'remained largely consistent' is incorrect per the ground truth, which highlights narrowing eligibility and increased specificity around risk. Thus, while some elements are accurate, the overall correctness is compromised by missing a key qualitative shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 496,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Tesla Semi has evolved from being in the development phase to entering pilot production, as noted in the 2024 filing. In 2022, the Semi was not yet in production, while by 2024, it was listed under pilot production in Nevada. Strategically, the Semi is positioned as part of Tesla's broader push into commercial electric vehicles, leveraging advancements in battery and powertrain technology to expand into new markets and support the company's mission of sustainable energy adoption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that in 2022, the Tesla Semi was in development and not yet in production, and by 2024, it had entered 'pilot production' in Nevada—matching the original answer's key facts. (2) There are no numeric values requiring calculation, but the years (2022 and 2024) and the term 'pilot production' are used correctly and consistently with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points (2022 vs 2024) and correctly infers a strategic evolution in Tesla's approach. It appropriately contextualizes the Semi within Tesla's broader commercial EV strategy and mission, which is a reasonable extension of the original answer’s mention of strategic positioning. (4) The only minor gap is that the original answer explicitly frames the shift as a 'strategic shift from merely planning...to actively preparing for market entry,' while the LLM adds interpretation about 'leveraging battery and powertrain technology'—which is plausible but not directly stated in the ground truth. This does not make it incorrect, but slightly extends beyond the provided information. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 366,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "The valuation allowance related to Altria's investment in Cronos decreased from $379 million in 2022 to $397 million in 2023, and further to $402 million in 2024. This minimal increase suggests that Altria's expectations regarding the realizability of the associated deferred tax assets have remained largely unchanged over this period, indicating continued uncertainty about the ability to realize these tax benefits.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the direction of change in the valuation allowance. The ground truth states the allowance increased from $379 million in 2022 to $402 million in 2024, but the LLM incorrectly claims it decreased from $379M in 2022 to $397M in 2023, then increased to $402M in 2024. This misrepresents the trend. The 2024 figure ($402M) is correct, but the 2023 figure ($397M) is unsupported by the ground truth, which does not mention 2023. (2) The quantitative accuracy is partially correct: the $379M (2022) and $402M (2024) figures are accurate, but the inclusion of an incorrect $397M for 2023 and the false claim of a decrease undermine precision. No calculation is required, but the directional comparison (increase vs. decrease) is wrong. (3) The multi-hop reasoning is flawed because the LLM fabricates an intermediate data point and mischaracterizes the trend, leading to an incorrect conclusion about 'minimal increase' and 'largely unchanged' expectations. The ground truth emphasizes a steady increase and continued significant uncertainty, which the LLM partially captures in tone but not in factual basis. (4) Contextual relevance is high—the answer addresses the right companies, metric, and time frame, and attempts to interpret the implication for deferred tax asset realizability. However, due to the quantitative and reasoning errors, the overall correctness is only partial.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 400,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value accounting, with changes in fair value recognized in earnings. This change resulted in gains being recognized in 2023 due to the fair value adjustment. In 2024, the financial treatment shifted again, with net unrealized losses on strategic equity investments, including BeiGene, impacting other income (expense), net. This indicates a decline in the investment's fair value compared to gains in the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen changed its accounting method from equity to fair value in 2023, recognized gains that year due to revaluation, and in 2024 reported net unrealized losses on the BeiGene investment within Other income (expense), net. There are no numeric discrepancies—though no specific dollar amounts are mentioned in either answer, the directional financial impact (gains in 2023, losses in 2024) is correctly captured. (2) Quantitative accuracy is perfect: the years (2023, 2024), accounting changes, and resulting financial impacts (gains then losses) match the original. Format variations are not applicable here as no specific figures are cited. (3) The multi-hop reasoning is sound—correctly linking the change in accounting method in 2023 to gains, and the subsequent valuation decline in 2024 to unrealized losses, showing evolution over time. The only minor shortcoming is that the LLM slightly implies a 'second change' in 2024 ('shifted again'), whereas the original indicates the fair value method continued but with negative movement; this is a nuance in phrasing but doesn't undermine factual correctness. (4) Contextual relevance is excellent—the response directly addresses the evolution of financial treatment and valuation impact across both years, fully satisfying the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 387,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar's positioning and market strategy evolved by integrating regional branding and streamlining its service structure in key markets. Notably, in Latin America, Disney+ and Star+ were merged into a single Disney+ product offering by June 2024, simplifying the service structure and consolidating general entertainment and family content under one brand. Additionally, in India and Southeast Asia, the service continues to operate under the Disney+ Hotstar brand, emphasizing localized content and sports programming to cater to regional preferences. This shift reflects a broader strategy to unify and optimize the Disney+ brand globally while maintaining tailored regional identities where necessary.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2024 merger of Disney+ and Star+ in Latin America by June 2024 is accurately stated, and the continued use of the Disney+ Hotstar brand in India and Southeast Asia is correctly noted. (2) Quantitative accuracy is perfect: the date 'June 2024' matches the ground truth's 'by the end of June 2024'—this is semantically equivalent. No financial figures are involved. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across regions (India/Southeast Asia vs. Latin America) and time (2023 to 2024), identifying both continuity (regional branding in Asia) and change (consolidation in Latin America). (4) The only minor shortcoming is that the LLM does not explicitly mention that Disney+ Hotstar was described as a DTC service in India in 2023, though this is implied in context. It also slightly generalizes the 'broader strategy' without directly citing Disney’s Direct-to-Consumer portfolio, but the core strategic shift toward brand unification is correctly inferred. Overall, the answer is factually correct, complete, and contextually appropriate with only negligible omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 342,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "Between 2023 and 2024, PayPal refined its approach to Protection Programs by enhancing risk exposure management and loss recovery mechanisms. The company emphasized improved fraud detection and prevention measures to address evolving fraud schemes and mitigate transaction losses. Additionally, PayPal focused on optimizing recovery processes, including seeking compensation from merchants involved in disputes, although challenges remained in fully recovering losses due to factors like merchant insolvency or fraudulent activity. These changes reflect a strategic effort to reduce financial impact and maintain consumer and merchant confidence in its payment services.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the general evolution of PayPal's Protection Programs from 2023 to 2024, noting enhanced risk management, challenges in loss recovery, and the impact of fraud and merchant insolvency. However, it omits key specifics from the ground truth: in 2023, PayPal did not treat protection programs as a separate service and recorded costs in 'transaction and credit losses' at the time of payment—this accounting treatment is absent in the LLM response. The 2024 disclosures about increased exposure due to regulatory changes and evolving fraud schemes are partially reflected but not explicitly tied to new transparency in reporting. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is unaffected—scored 10. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift in risk and recovery approach, but fails to synthesize the specific accounting and disclosure changes that mark the evolution between years. The absence of the 2023 accounting policy detail weakens the qualitative accuracy. (4) Despite missing some factual nuance, the LLM answer remains contextually relevant and conveys a plausible narrative of improvement in risk and recovery mechanisms, aligning with the broader trend in the ground truth. Thus, correctness is reduced to 7 due to missing key differentiating details between 2023 and 2024 disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 400,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "NextEra Energy's relationship with solar generation facilities from 2022 to 2024 has evolved through strategic sales and ownership restructuring. In 2022, NextEra Energy Resources sold noncontrolling interests in several solar facilities, retaining operational control while reducing direct ownership. By 2024, the company consolidated Variable Interest Entities (VIEs) with significant solar generation capacity, maintaining control over operations and maintenance. Financial exposure increased through consolidated VIEs with substantial assets and liabilities, reflecting a shift toward managing solar facilities through structured ownership and third-party financing arrangements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in NextEra Energy's relationship with solar generation facilities from 2022 to 2024, noting divestitures in 2022 and a shift toward VIE consolidation by 2024. However, it omits specific quantitative details present in the ground truth, such as the 100% sale of a 100 MW Arizona solar facility and the 90% sale in a portfolio of four solar facilities. The 765 MW of capacity from eight consolidated VIEs in 2024 is not mentioned, which is a significant omission in quantitative accuracy. (2) While the LLM correctly references VIE consolidation and increased financial exposure, it fails to include exact figures for ownership stakes (e.g., 10% direct ownership interest in additional solar facilities) and does not mention gains or cash proceeds from sales in 2022. These missing numbers reduce quantitative accuracy despite no incorrect numbers being stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes a strategic shift from ownership divestiture to structured financial involvement via VIEs, capturing the essence of the transformation. It accurately reflects increased financial exposure through consolidated VIEs and third-party financing, aligning with the ground truth’s conclusion. (4) The answer is contextually relevant and well-structured, addressing both ownership structure and financial exposure as required. Due to the absence of key metrics and specific transactions, the correctness score is reduced to 7—core facts are correct, but important details are missing, preventing a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 438,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "ACN's investment in Mutual Fund Debt Securities decreased from $484,182 in 2022 to $379,989 in 2023. The valuation methodology remained consistent, with these investments classified entirely within Level 2 of the fair value hierarchy, as they were valued using quoted prices for similar instruments or model-derived valuations with observable inputs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values. According to the ground truth, ACN's Mutual Fund Debt Securities were valued at $379,989 in 2022 and decreased to $253,025 in 2023. However, the LLM incorrectly states the 2022 value as $484,182 and the 2023 value as $379,989, which reverses the correct figures and misrepresents the trend. The only correct number is $379,989, but it is assigned to the wrong year. (2) The quantitative inaccuracies are severe: the decrease is reported between incorrect starting and ending values, leading to a false impression of the magnitude and direction of change. The actual decrease is $126,964 ($379,989 → $253,025), whereas the LLM implies a decrease of $104,193 based on its incorrect numbers. (3) The qualitative reasoning is partially sound—the LLM correctly notes that the valuation methodology remained entirely within Level 2 of the fair value hierarchy, which aligns with the ground truth. It also correctly interprets that Level 2 relies on observable inputs or similar instruments, showing accurate understanding of valuation methodology. However, it fails to mention that the methodology did not change, which was a key part of the question. (4) Contextual relevance is high because the answer addresses both the investment evolution and valuation methodology as asked. Despite correct framing and relevant concepts, the severe numerical errors undermine the factual integrity of the response, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 419,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron's financial stake in Tengizchevroil (TCO) increased slightly between 2022 and 2023, with the investment rising from $26,534 million in 2022 to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO decreased from $4,386 million in 2022 to $3,375 million in 2023. The company maintains a 50% equity ownership interest in TCO and has a loan of $4,500 million to fund the development of the FGP/WPMP project.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million in 2022, not $26,534 million as stated by the LLM. The 2023 carrying value is not explicitly provided in the ground truth, only that it was approximately $80 million higher than its underlying equity in net assets—there is no mention of $26,954 million. Additionally, the equity in earnings figures are incorrect: the ground truth reports $1,238 million in 2022, while the LLM claims $4,386 million in 2022 and $3,375 million in 2023, which are completely inconsistent with the source. (2) The only correct quantitative element is the $4,500 million loan to fund the FGP/WPMP project, which matches the ground truth. All other numbers are factually wrong. (3) The qualitative reasoning is partially sound in that the LLM recognizes an increase in financial involvement due to the loan and attempts to compare earnings and investment values. However, it fails to capture the key qualitative shift in 2023—the use of a more complex valuation approach and the disclosure of a discrepancy between carrying value and underlying equity—which reflects deeper strategic involvement. The model also omits the comparative analysis of carrying value vs. net assets, a critical point in the original answer. (4) Contextual relevance is moderate because the answer addresses Chevron’s stake and evolution in TCO with correct entities (Tengizchevroil, FGP/WPMP, loan amount) and correct ownership percentage (50%), but the severe numerical inaccuracies and missing core insights from the ground truth drastically reduce correctness. The answer fabricates financial figures rather than reflecting actual disclosures, leading to a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 493,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "Disney's relationship with the ABC Network has remained integral to its broader entertainment ecosystem between 2023 and 2024, particularly through ESPN's continued role in programming the sports daypart on ABC, known as \"ESPN on ABC.\" Additionally, ABC Network content, such as programming from ABC, Freeform, and FX Channels, continues to be available on Hulu's SVOD service one day after linear airing, reinforcing ABC's integration with Disney's streaming platforms. These strategic linkages highlight ABC's role in supporting cross-platform content distribution and viewer engagement within Disney's entertainment portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies ABC's integration with Hulu, noting that ABC content is available on Hulu's SVOD service one day after linear airing, which aligns with the ground truth. However, it introduces 'Freeform' and 'FX Channels' as part of the same content pipeline without grounding in the original answer, which only mentions ABC content specifically. Additionally, the emphasis on 'ESPN on ABC' and ESPN's role in programming is not mentioned in the ground truth and appears to be an unsupported addition. (2) There are no numeric values, dates, or calculations in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is partially sound: the LLM captures the shift toward streaming integration, but fails to contrast the 2023 vs. 2024 strategic positioning as required. The original answer highlights a shift from linear networks and affiliate fees in 2023 to digital integration and contribution to streaming in 2024; the LLM does not reflect this evolution or the reduced emphasis on linear revenue. Instead, it presents a static view of ABC's role. (4) The contextual relevance is high because the answer addresses ABC's strategic positioning within Disney's ecosystem and its relationship with streaming platforms. However, the lack of temporal evolution and introduction of extraneous entities (Freeform, FX) reduce qualitative accuracy. The core fact about Hulu integration is correct, but the absence of the strategic shift and misattribution of ESPN's role limit correctness to a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 441,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "Between 2022 and 2023, General Dynamics increased its Combat Systems segment's revenue contribution from 18% to 20% of consolidated revenue, with military vehicle revenue rising from $4,581 million in 2022 to $5,036 million in 2023. This growth indicates a heightened focus on land systems, including the ASCOD vehicle, as part of broader modernization and production initiatives. The ASCOD's inclusion in ELS's diverse portfolio of armored vehicles, alongside increased investment in production capacity and next-generation capabilities, suggests a strategic shift toward expanding General Dynamics' global land combat solutions and meeting rising international demand for versatile tracked combat systems.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the core of the question. The original question asks about the evolution of General Dynamics' positioning of the ASCOD vehicle in its Land Systems portfolio between 2022 and 2023, specifically focusing on changes in language and what that indicates about production focus or investment. Instead, the LLM response discusses revenue increases in the Combat Systems segment and overall military vehicle revenue, which are not mentioned in the ground truth and do not directly support conclusions about ASCOD's strategic positioning. (2) The quantitative claims—such as Combat Systems revenue rising from $4,581 million to $5,036 million and its share of consolidated revenue increasing from 18% to 20%—are not present in the ground truth and cannot be verified as accurate. These figures appear fabricated or misattributed, failing the quantitative accuracy check. There is no evidence in the original answer that such numbers were disclosed or relevant to the ASCOD discussion. (3) The multi-hop reasoning is flawed. The ground truth hinges on a linguistic shift in disclosures: from 'producing and upgrading' ASCOD in 2022 to merely 'offering' it in 2023, suggesting reduced investment. The LLM fails to identify or analyze this key shift. Instead, it infers increased focus on ASCOD based on unrelated segment-level revenue growth, which does not logically follow—especially since the ground truth suggests a potential de-emphasis on ASCOD in favor of Piranha 5 and AJAX. (4) While the LLM stays within the general domain of General Dynamics' land systems and mentions ELS (European Land Systems), it misinterprets the signal from the data and draws an opposite conclusion from the ground truth. The contextual relevance is moderate because it discusses related topics (land systems, international demand), but it fails the core task of tracking strategic positioning changes via disclosure language. Hence, correctness is very low due to factual inaccuracy, incorrect reasoning, and failure to engage with the actual evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 561,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities decreased from $3.0 billion in 2023 to $2.0 billion in 2024, representing a reduction from 39% to 26% of European customer balances available for corporate use. This decline suggests a more conservative approach to leveraging customer funds for credit activities, potentially reflecting a strategic shift to prioritize liquidity management, regulatory compliance, or risk mitigation in response to evolving economic conditions or internal financial priorities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the quantitative evolution of PayPal's utilization of European customer balances for credit activities: $3.0 billion in 2023 (39%) and $2.0 billion in 2024 (26%), which matches the ground truth exactly. All numbers, percentages, and years are accurate, satisfying quantitative accuracy. (2) The answer addresses the first part of the question—how utilization evolved—completely and correctly. However, it partially misses the second part regarding what the shift indicates about PayPal's broader credit funding strategy. While it correctly infers a strategic reduction in reliance on customer balances and suggests possible reasons (liquidity management, regulatory compliance, risk mitigation), it omits the key supporting evidence from the ground truth: PayPal's multi-year agreement to sell consumer installment receivables, with a significant increase in loans sold—from $5.5 billion in 2023 to $20.8 billion in 2024. This data point is critical to fully explaining the strategic pivot toward external financing. (3) The multi-hop reasoning is sound in interpreting the decline as a strategic shift, but the synthesis is incomplete because it fails to incorporate the receivables sale program, which is essential for a full qualitative understanding. (4) The correctness score is 8 due to full factual accuracy in numbers and reasonable interpretation, but with a meaningful omission in strategic context. Quantitative accuracy is 10 because all numbers are correct. Qualitative accuracy is 8 due to logical reasoning but missing key evidence. Contextual relevance is 10 as the answer stays focused and relevant throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 458,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "Between 2022 and 2024, the valuation and categorization of equity securities within NEE's Special Use Funds evolved significantly. In 2022, NEE's equity securities were valued at $5,511 million, with no Level 3 assets, while by 2024, the value increased to $6,164 million, with $229 million categorized under Level 3. This shift indicates a greater portion of investments with less observable market data, suggesting a potential diversification into more complex or illiquid assets. The increase in Level 2 investments (primarily in commingled funds) also highlights a strategic move toward diversified, professionally managed funds, enhancing transparency through structured investment vehicles.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, NEE's Special Use Funds held $906 million in equity securities (carrying amount), not $5,511 million as stated. FPL held $672 million. By 2024, NEE held $2,614 million in Level 1 securities and FPL held $1,028 million in Level 1, with additional disclosures for Level 2 and Level 3. The LLM incorrectly reports a total value of $6,164 million in 2024 and introduces $229 million in Level 3 assets, which is not supported by the ground truth. The ground truth emphasizes growth in Level 1 securities and improved disclosure granularity, not an increase in Level 3 assets. (2) The numbers are entirely incorrect: $5,511M and $6,164M do not appear in the original data; no mention of Level 3 assets in the ground truth for 2024; the actual increase is from $906M to $2,614M for NEE and $672M to $1,028M for FPL. The LLM answer misrepresents both scale and composition. (3) The multi-hop reasoning is flawed. The question requires comparing valuation methods and categorization across years and entities (NEE and FPL). The LLM fails to distinguish between NEE and FPL, conflates total values, and invents a narrative around Level 3 assets and commingled funds not present in the ground truth. It incorrectly infers a shift toward less transparent assets, while the truth indicates a move toward more transparent reporting with granular level disclosures. (4) The contextual relevance is moderate because the answer addresses valuation evolution and transparency, but the factual foundation is so inaccurate that the conclusions are invalid. Correctness and quantitative accuracy are very low due to fabricated numbers and mischaracterization of investment composition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 481,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Accenture's share purchase program saw a significant increase in total shares acquired under the public program, with $1,964,612 shares purchased in fiscal 2022 and $5,349,600 in additions/adjustments in fiscal 2023. Shares acquired through employee-related transactions remained relatively consistent, with $97,251 shares acquired in fiscal 2022 and no direct comparable figure provided for fiscal 2023, though employee-related transactions typically involve share withholding for payroll tax obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. In fiscal 2022, Accenture purchased 1,964,612 shares (correctly stated), but the LLM incorrectly claims 5,349,600 shares were added in fiscal 2023 under the public program — this number does not appear in the ground truth and contradicts it, as the original answer states there is no mention of public program purchases in fiscal 2023. The LLM also incorrectly formats share counts as dollar amounts (e.g., '$1,964,612 shares' and '$97,251 shares'), which is factually wrong and misleading. (2) Quantitative accuracy is severely compromised: the correct fiscal 2022 public purchase was 1,964,612 shares for $576 million (not $1,964,612), and employee-related transactions involved 97,251 shares (not $97,251). The $5,349,600 figure in fiscal 2023 has no basis in the provided truth. (3) The multi-hop reasoning is flawed: the question asks about the evolution of the program, and the ground truth indicates a reduction or pause in the public program in 2023, while the LLM claims a significant increase — the opposite of the correct conclusion. The LLM fails to recognize that the absence of public program activity in 2023 is a key shift. (4) Contextual relevance is moderate because the answer addresses share purchases and employee-related transactions, but the incorrect data and reversed conclusion undermine usefulness. The mention of consistent employee-related transactions is partially valid, though the lack of 2023 data is underemphasized. Overall, the answer is mostly incorrect due to fabricated numbers and reversed trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 439,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC (CPChem) remained consistent between 2022 and 2023. CPChem continued to be accounted for using the equity method, as Chevron holds a 50% equity ownership interest. In both years, CPChem was not consolidated into Chevron's financial statements, and its summarized financial data was disclosed separately in the notes to the consolidated financial statements.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) It claims Chevron's reporting relationship with Chevron Phillips Chemical Company LLC (CPChem) remained consistent between 2022 and 2023, stating CPChem was accounted for using the equity method and not consolidated in both years. However, the ground truth confirms that in 2022, CPChem *was* consolidated into Chevron’s financial statements, as evidenced by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among consolidated subsidiaries. The significant change occurred in 2023 when Chevron explicitly transitioned to the equity method and ceased consolidation. (2) There are no numeric values in the question or answer requiring calculation, but the temporal facts (2022 vs 2023 treatment) are critical and entirely misrepresented. (3) The multi-hop reasoning fails completely: the model should have identified the presence of CPChem in consolidated notes in 2022 versus the explicit disclosure of equity method accounting in 2023, indicating a structural change. Instead, it asserts consistency where there was a clear shift. (4) The answer contradicts the ground truth on the core issue—consolidation status change—making it highly inaccurate. Contextual relevance is low but not zero because the answer addresses the right entity and topic, albeit incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 385,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "In 2022, General Dynamics' Combat Systems segment received a $175 million contract from the U.S. Army for the production of Hydra-70 rockets. By 2023, the role of Hydra-70 rockets expanded significantly, as OTS (Ordnance and Tactical Systems) received awards to increase its production capacity for metal parts from 18,000 to 86,000 rounds per month by 2025 and expand propellant capacity from 4 million to 16 million pounds per year by 2028. This expansion supports the U.S. Army's effort to accelerate artillery production, highlighting an increased contract involvement and a strategic focus on scaling production capacity for Hydra-70 rockets.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $175 million 2022 contract for Hydra-70 rockets and the expansion of production capacity from 18,000 to 86,000 rounds per month by 2025, which aligns with the ground truth. However, it introduces additional information not present in the original answer—specifically, the expansion of propellant capacity from 4 million to 16 million pounds per year by 2028—which, while plausible, is not supported by the provided ground truth and represents an overreach. Additionally, the LLM refers to 'OTS (Ordnance and Tactical Systems)', whereas the ground truth specifies 'Orbital Technologies Corporation' as OTS, creating a minor entity inaccuracy. (2) Quantitatively, the $175 million contract value and the production capacity increase (18k to 86k rounds/month) are accurate and correctly formatted. The added propellant capacity figures, while internally consistent, are extraneous and not verifiable from the ground truth, slightly reducing quantitative accuracy. (3) The multi-hop reasoning is largely sound: the LLM connects the 2022 contract to increased production capacity in 2023 and infers strategic scaling, which is supported. However, it synthesizes beyond the provided data by adding propellant expansion, indicating a minor failure in strict evidence-based reasoning. (4) The answer is highly contextually relevant, addressing both contract involvement and production capacity evolution. The core facts are correct, but the addition of unverified details prevents a top score. Thus, correctness is rated 8 due to minor factual overreach and entity misidentification, despite strong alignment on key points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 456,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) is listed as incorporated by reference from the 10-12B/A form filed on May 14, 2015. In the 2024 filing, the same exhibit is also incorporated by reference, but the associated form is now listed as a 10-Q filed on April 30, 2024, indicating an amendment or restatement of the agreement. This suggests that PayPal updated the documentation for the Global Restricted Stock Unit Award Grant Notice in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the general topic. (1) It incorrectly states that in the 2024 filing, the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) is now incorporated by reference from a 10-Q filed on April 30, 2024. According to the ground truth, the 2024 filing still incorporates Exhibit 10.07+ from the same 10-12B/A filed on May 14, 2015 — there was no change in documentation source for this base RSU notice. (2) The LLM falsely implies that the base RSU grant notice was updated or amended in 2024, when the ground truth explicitly states it 'remained in place' and 'unchanged'. (3) The LLM fails to mention the key evolution: the update to the *performance-based* variant (Exhibit 10.08+), which was the actual document updated in 2024 and linked to the April 30, 2024 10-Q. This is a critical omission in both completeness and accuracy. (4) The multi-hop reasoning is flawed — the model conflates two distinct exhibits (10.07+ and 10.08+) and misattributes the update to the wrong document. While the dates (May 14, 2015 and April 30, 2024) are correctly mentioned, they are applied to the wrong exhibits, undermining quantitative and qualitative accuracy. The answer is contextually relevant as it discusses documentation status and changes, but the core factual claims are incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 385,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within Bristol-Myers Squibb's portfolio has expanded significantly, both in terms of revenue and regulatory approvals. In 2022, Opdivo generated $7.5 billion in revenue, maintaining its position as a key oncology product. By 2024, Opdivo secured multiple new approvals, including FDA and EC approvals for new indications such as unresectable urothelial carcinoma, combination therapies, and subcutaneous delivery via Opdivo Qvantig. These advancements reinforced Opdivo's leadership in immuno-oncology and expanded its therapeutic applications, enhancing its strategic importance in BMS's oncology portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Opdivo's 2022 revenue as $7.5 billion, which aligns with the ground truth of $7,523 million (rounded appropriately). However, the LLM implies a revenue increase or growth from 2022 to 2024 by stating the role expanded 'in terms of revenue,' which contradicts the ground truth that states there was 'not showing a significant revenue increase from earlier years.' This is a factual inaccuracy in interpretation. (2) The date of the FDA approval in March 2024 for urothelial carcinoma is correctly reflected in spirit, but the LLM overstates by claiming 'multiple new approvals' including EC approvals and subcutaneous delivery via Opdivo Qvantig, which are not mentioned or supported in the ground truth. Only the FDA approval for urothelial carcinoma in combination with cisplatin and gemcitabine is confirmed. (3) The multi-hop reasoning is partially sound—linking revenue performance and regulatory developments to assess portfolio evolution—but overreaches by adding unverified approvals, weakening the synthesis. (4) The contextual relevance is high as the answer addresses both revenue and regulatory aspects of Opdivo’s role. Quantitative accuracy is high due to correct revenue figure (with acceptable rounding), but qualitative accuracy is reduced due to unsupported claims about additional approvals and misleading implications about revenue growth. Correctness score is 7 because core facts (revenue, key approval) are correct, but significant embellishments reduce factual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 423,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC (CPChem) evolved between 2022 and 2023, with increased investment in key projects. In 2022, CPChem made a final investment decision on a new C3 splitter unit at its Cedar Bayou facility in Texas, and Chevron provided a loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Texas, in which CPChem owns 51 percent. By 2023, Chevron's equity earnings from CPChem rose to $608 million from $867 million in 2022, indicating continued financial support and project progress. These investments reflect Chevron's strategic focus on expanding CPChem's petrochemical capabilities and advancing growth in the downstream and chemicals sectors.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it incorrectly states that Chevron provided the $387 million loan in 2022, while the ground truth specifies this occurred in 2023. Additionally, the LLM claims equity earnings rose to $608 million in 2023 from $867 million in 2022, which is backwards—earnings actually decreased, not increased. These errors undermine the core financial narrative. (2) Quantitative accuracy is low: the $387 million loan amount is correct, but its timing is wrong. The equity earnings figures ($608M in 2023 vs $867M in 2022) are inverted, making the comparison false. The 51% ownership in the Golden Triangle Polymers Project is correctly stated. (3) The multi-hop reasoning is partially sound—linking Chevron’s support to CPChem projects and interpreting strategic intent—but flawed due to incorrect temporal attribution. The evolution from equity ownership in 2022 to direct financing in 2023 is a key point in the ground truth, but the LLM conflates the timeline, failing to show the shift over time. (4) Contextual relevance is high because the answer addresses project funding, investment structure, and strategic direction. However, due to major factual and numerical errors, especially in timing and financial performance, the correctness score is low. The answer gives a plausible but factually incorrect picture of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 390,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, PayPal's protection programs saw an increase in financial commitments, as reflected in the allowance for transaction losses and negative customer balances. The allowance for transaction losses rose from $64 million in 2023 to $86 million in 2024, while the allowance for negative customer balances increased from $218 million to $256 million. The changes in these reserves were driven by higher provisions in 2024 ($1,114 million) compared to 2023 ($1,192 million), partially offset by higher realized losses in 2024 ($1,218 million) compared to 2023 ($1,313 million).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increases in the allowance for transaction losses ($64M to $86M) and negative customer balances ($218M to $256M), which matches the ground truth and addresses the evolution in financial commitments. However, it introduces two incorrect quantitative figures—provisions in 2024 ($1,114M) vs. 2023 ($1,192M) and realized losses in 2024 ($1,218M) vs. 2023 ($1,313M)—that are not present in the original answer and contradict the ground truth, which does not mention these aggregate provision or loss amounts. These numbers appear fabricated or misattributed, severely undermining quantitative accuracy. (2) The core dollar amounts for the allowances are correct and properly attributed to 2023 and 2024, but the additional financial data about provisions and realized losses are unsupported by the ground truth and likely incorrect, suggesting a failure in data synthesis or hallucination. (3) The reasoning correctly infers increased financial commitments from reserve increases, showing sound qualitative logic and multi-hop understanding of the trend. However, the inclusion of unverified aggregate figures indicates flawed reasoning in extending beyond disclosed data. (4) The answer is contextually relevant and captures the main trend of increased reserves, but the incorrect addition of provision and loss totals significantly reduces factual reliability, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 402,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "Between 2022 and 2024, McDonald's has reinforced its strategic framing of franchising as a core business model, emphasizing collaboration and co-investment with franchisees. In 2024, the Company highlights that franchisees are critical to its success and that co-investments with franchisees are designed to modernize restaurants, improve performance, and enhance the brand. This reflects a continued and possibly stronger emphasis on franchisee partnerships compared to 2022, where similar themes were present but not as explicitly detailed in the provided pages.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of direction and overall trend, correctly identifying a strategic shift toward emphasizing franchising as a core model and highlighting franchisee co-investment as key to modernization and performance. There are no numeric inaccuracies, and the years (2022 vs 2024) are correctly referenced, earning full marks for quantitative accuracy. However, the LLM response lacks the specific qualitative depth of the original answer: it does not capture the shift from 'neutral, structural terms' in 2022 to a 'value-laden' and 'paramount' framing in 2024, nor does it explicitly note that franchising was tied to food quality, customer experience, and profitability in 2024. The phrase 'not as explicitly detailed in the provided pages' introduces uncertainty and underrepresents the documented evolution in tone and strategic emphasis. While the core idea of increased emphasis is correct, the answer misses the precise nature of the framing shift (from descriptive to strategic), which is central to the question. This limits its qualitative accuracy. Contextual relevance is high, as the response stays focused on the strategic framing of franchisee relationships and co-investment over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 350,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "Between 2022 and 2023, the FDA authorized three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, indicating progress in Altria's regulatory efforts for heated tobacco products. However, the FDA has not exempted Marlboro HeatSticks from graphic health warning requirements, and the product remains subject to the same regulations as cigarettes. This suggests that while Altria has achieved some authorization milestones for heated tobacco products, regulatory challenges and restrictions persist, reflecting the cautious and evolving nature of FDA oversight in this category.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the FDA authorized three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, which matches the ground truth. This is a key factual and quantitative point, and the date and number of varieties are accurate. However, the LLM adds that Marlboro HeatSticks remain subject to graphic health warnings and are regulated like cigarettes, which, while contextually plausible, is not explicitly confirmed in the ground truth. The original answer notes that in 2022 the FDA was considering them on a case-by-case basis for graphic health warnings, but does not confirm the final outcome on warning labels—so the LLM may be inferring or adding external knowledge. (2) Quantitatively, all numbers and dates are correct: January 2023 authorization and three varieties match the ground truth exactly. (3) The multi-hop reasoning is sound: the model connects the 2023 authorization to Altria’s regulatory progress, correctly inferring that this represents a milestone. It also acknowledges ongoing regulatory challenges, which adds nuance, though this specific point is not in the original answer. (4) The answer is highly relevant and mostly factually aligned, but the addition about graphic warning requirements goes beyond the provided ground truth, slightly reducing qualitative accuracy. Still, the core facts, timing, and implications about Altria’s progress are correctly conveyed, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 409,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The valuation of mutual fund equity securities held by ACN in non-U.S. pension plans decreased from $273,541 in 2021 to $239,293 in 2022, indicating a decline in the market value of these investments during this period. This shift suggests a potential reallocation or reduced emphasis on mutual fund equity securities in the company's investment strategy for non-U.S. pension plans, possibly to manage risk or adjust to changing market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of the time period and values referenced. The question asks about the evolution between 2022 and 2023, but the LLM discusses 2021 to 2022, which is irrelevant to the query. The ground truth states that ACN's mutual fund equity securities decreased from $239,293 million in 2022 to $196,226 million in 2023, a drop of $43,067 million. The LLM incorrectly reports a decrease from $273,541 (in 2021) to $239,293 (in 2022), which does not address the required 2022–2023 comparison. (2) The only correct number is $239,293 million, but it is misattributed to 2022 as a decline from 2021 rather than being correctly positioned as the starting point for 2022 in the 2022–2023 trend. The $273,541 figure is not part of the ground truth for this question and appears to be factually incorrect or miscontextualized. (3) The reasoning fails on multi-hop requirements: the model must identify the correct values for 2022 and 2023, compute the change, and interpret the strategic implication. The LLM instead provides data for earlier years and an irrelevant plan type (non-U.S. pension plans), which is not specified in the original answer. This suggests a failure to correctly retrieve and synthesize the relevant data points. (4) The interpretation about strategic reallocation is semantically similar to the ground truth, but because it is based on incorrect data and timeframes, the conclusion lacks validity. Scores are low due to major factual and temporal inaccuracies, partial use of one correct number, and failure to address the core time period of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 443,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "Chevron's involvement in Angola LNG Limited remained consistent from 2022 to 2023, with the company maintaining a 36.4 percent interest in the entity, which operates an onshore natural gas liquefaction plant in Soyo, Angola. In both years, the focus was on supplying feedstock to the plant, with efforts directed toward developing non-associated gas in offshore Angola to support the Angola LNG facility. There is no indication of significant changes in Chevron's operational focus or investment emphasis during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron maintained a 36.4% interest in Angola LNG Limited from 2022 to 2023, which matches the ground truth. However, it incorrectly claims that the operational focus remained unchanged, asserting that 'in both years, the focus was on supplying feedstock' and 'developing non-associated gas.' The ground truth indicates a shift in disclosure emphasis in 2023—from operational development (e.g., processing associated gas and developing non-associated gas) to a broader financial and portfolio-level presentation, where Angola LNG was grouped with other equity affiliates like Tengizchevroil. This shift in emphasis is a key part of the correct answer and is entirely missing from the LLM response. (2) Quantitatively, the 36.4% interest is accurately reported, and no other numbers are involved, so quantitative accuracy is perfect. (3) The multi-hop reasoning is flawed: the question asks about evolution in operational focus and investment emphasis, requiring synthesis across two years and two types of disclosures (operational vs. financial/portfolio). The LLM fails to detect the change in narrative focus in 2023, instead asserting continuity without evidence. (4) While the answer is factually correct on ownership and location, it misses the core qualitative shift in disclosure strategy, leading to a partial correctness score. Contextual relevance is high because the answer addresses the right company, project, and time frame, but the reasoning gap reduces overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 423,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "From 2022 to 2023, MMM's investment in Certificates of Deposit/Time Deposits increased significantly. In 2022, the amount was $21 million, and by 2023, it had risen to $49 million. This represents an increase of $28 million, or 133%.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MMM's investment in Certificates of Deposit/Time Deposits increased from 2022 to 2023 and correctly states the 2023 amount as $49 million. However, it incorrectly reports the 2022 amount as $21 million instead of the ground truth $14 million. This leads to an incorrect change of $28 million (vs. $35 million) and an incorrect percentage increase of 133% (vs. 250%). (2) The calculation of the difference ($49M - $21M = $28M) and percentage (28/21 ≈ 133%) is mathematically correct based on its inputs, but the inputs themselves are factually wrong. The ground truth shows a $35 million increase (49 - 14 = 35), which is a 250% increase (35/14 = 2.5). (3) The reasoning structure is sound—multi-hop synthesis between two years is attempted, and the conclusion about significant growth aligns with the ground truth—but the faulty 2022 value undermines the accuracy. (4) The contextual relevance is high because the answer addresses both parts of the question (evolution and magnitude) and uses appropriate financial terminology. However, the quantitative inaccuracies significantly reduce correctness. The qualitative score reflects correct logic but incorrect data sourcing. Final correctness score is 4 due to major factual error in baseline value, leading to cascading errors in derived metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 377,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "Between 2021 and 2024, McDonald's increased the percentage of franchised restaurants in its system. In 2021, 93% of the 40,031 total restaurants were franchised, while in 2024, 95% of the 43,477 total restaurants were franchised, indicating a slight but consistent shift toward a more franchised business model.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages (93% in 2021 and 95% in 2024) are accurate, and the total restaurant counts (40,031 in 2021 and 43,477 in 2024) align with external data from McDonald's filings, though these totals were not in the original answer but are factually correct and add useful context without introducing error. (2) The core metrics—franchise percentages—are correctly reported and reflect the intended trend. (3) The reasoning is sound: the answer identifies a slight but consistent shift toward franchising, which matches the original answer's interpretation of a 'deliberate shift' and 'strategic emphasis.' (4) The entities (McDonald's, franchised restaurants, years 2021–2024) are correct, and the multi-hop synthesis across years is accurate. The answer is semantically equivalent to the ground truth, with slightly more detail but no factual deviation. All scoring categories warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 285,
        "total_tokens": 1441
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective March 31, 2021, as noted in the 2022 10-K (page 117). Between 2022 and 2023, there is no indication of further amendments to the plan's effective date or structure in the provided pages from the 2023 10-K. Therefore, the plan's structure and effective date remained unchanged during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that there is 'no indication of further amendments' between 2022 and 2023. The ground truth confirms that the plan was further amended and restated with a new effective date of October 26, 2022, which falls within the 2022–2023 period. This directly contradicts the LLM's conclusion that the plan remained unchanged. (2) The date 'March 31, 2021' is correctly cited from the 2022 10-K, but the LLM fails to recognize or report the updated effective date of 'October 26, 2022' mentioned in the 2023 filing, which is a critical factual omission. No calculations are involved, but the handling of dates—central to the question—is inaccurate. (3) The multi-hop reasoning is flawed: the question asks for evolution between 2022 and 2023, requiring comparison of disclosures across both years’ filings. The LLM incorrectly infers no change based on absence of explicit discussion in the 2023 10-K excerpts, failing to acknowledge the updated effective date that should have been reflected. (4) The contextual relevance is moderate because the answer addresses the right plan and time frame, and cites a correct prior amendment, but the core conclusion is wrong. Due to major factual inaccuracy regarding the amendment status and effective date update, the correctness score is low despite some accurate contextual elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 384,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "Between fiscal years 2022 and 2023, Accenture's investment in Duck Creek Technologies showed an increase in valuation. As of August 31, 2022, the carrying amount of the investment was $138,902, with an estimated fair value of $223,166 for Accenture's approximately 16% ownership stake. By fiscal 2023, the investment generated a $253 million gain, which was reported as part of the results of operations. This indicates that the valuation of Accenture's stake in Duck Creek Technologies rose significantly during this period, positively impacting Accenture's financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the fiscal 2022 carrying amount ($138,902), fair value ($223,166), 16% ownership, and the $253 million gain in fiscal 2023. These match the ground truth exactly, with acceptable formatting (e.g., $253 million vs $253M). (2) All numbers are accurate and properly attributed to the correct fiscal years. The gain is correctly stated as being reported in results of operations, which aligns with the ground truth noting it was 'called out in the financial statements' and impacted adjusted EPS and tax rate. (3) The reasoning is sound: the LLM infers a significant valuation increase and positive financial impact, which is supported by the data. It correctly identifies the shift from a passive equity-method investment to a realized gain event. However, it omits the specific mention that the gain affected adjusted earnings per share and effective tax rate calculations—important qualitative details in the original answer. This minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, addressing both investment valuation and financial impact as asked. Overall, the response is factually correct, well-reasoned, and only slightly less detailed than the ground truth in explaining the financial statement implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 375,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "Between 2022 and 2024, Breyanzi's therapeutic application expanded significantly, particularly in the treatment of B-cell malignancies. In 2024, the FDA granted accelerated approval for Breyanzi for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have received at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor. Additionally, Breyanzi received FDA approval for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after at least two prior lines of systemic therapy. These approvals expanded Breyanzi's market potential by broadening its use across a wider range of lymphoid cancers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of Breyanzi's therapeutic applications between 2022 and 2024 and accurately reports the two new indications approved in 2024: for relapsed or refractory CLL/SLL and for FL, both after at least two prior lines of therapy. The dates (March and May 2024) are not explicitly mentioned in the LLM answer, but the approvals are correctly attributed to 2024, which aligns with the ground truth. The additional detail about required prior therapies (BTK and BCL-2 inhibitors) in the CLL/SLL indication is accurate and adds context not in the original answer but is consistent with FDA approval criteria, thus enhancing rather than contradicting the ground truth. (2) All quantitative elements—number of prior therapies, year of approvals (2024), and patient populations—are correct. No numerical calculations are required, and all dates are factually sound within the allowed level of specificity. (3) The multi-hop reasoning is sound: the model synthesizes information about prior indications (implied from 2022) with new 2024 approvals, correctly identifying the expansion in market potential due to broader eligibility. The logical flow from initial use to expanded use across B-cell malignancies is coherent and supported by the data. (4) The answer is contextually excellent, directly addressing both parts of the question: evolution over time and new indications in 2024. The only minor shortcoming is the lack of specific approval months (March and May), which were in the ground truth but not critical to the core facts. This justifies a high score of 9 rather than 10, as the omission slightly reduces precision, though not accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 464,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "Between 2022 and 2023, 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450, particularly for respirator mask/asbestos litigation, remained consistent in methodology but reflected updated liability estimates. In 2023, 3M increased its accruals for respirator mask/asbestos liabilities by $57 million, bringing the total accrual to $574 million as of December 31, 2023. The insurance receivables remained immaterial, with 3M noting that it had collected substantially all remaining insurance coverage for these claims. The evolution in 2023 primarily involved adjustments to probable liabilities based on updated claims data, legal developments, and higher average costs for resolving claims involving serious injuries.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that 3M's approach to estimating insurance receivables evolved from a general reference to ASC 450 in 2022 to a more detailed methodology in 2023 involving the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30, including analysis of policy terms, case law, and claim nature. The LLM answer incorrectly claims the methodology remained consistent, which directly contradicts the ground truth. (2) The quantitative inaccuracies are significant: the LLM introduces a $57 million increase in accruals and a total of $574 million in 2023, which are not present in the original answer and cannot be verified against the provided truth. The only numeric data in the ground truth is the increase in claimants from 4,028 (2022) to 4,042 (2023), which the LLM omits entirely. (3) The multi-hop reasoning is flawed: the question asks about the evolution in accounting approach for insurance receivables, not just changes in liabilities or accruals. The LLM focuses on liability accruals and cost trends, missing the core shift in accounting methodology and the role of insurance receivables estimation. It also fails to connect the increase in claimants to the more detailed approach in 2023, as stated in the original. (4) The contextual relevance is moderate because the answer discusses related topics (legal proceedings, respirator/asbestos litigation, ASC 450), but it misrepresents the nature of the evolution. The qualitative accuracy is low due to incorrect synthesis and entity relationships. Overall, the answer fabricates financial figures and misses the key conceptual shift, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 476,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "Between 2022 and 2023, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners in the first quarter of 2022. However, it retained a 39% noncontrolling interest in a newly formed joint venture called Tropicana Brands Group (TBG), which operates across North America and Europe. In the U.S., PepsiCo continued to act as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers with chilled direct-store-delivery. There is no indication of further changes to this arrangement in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 sale of Tropicana, Naked, and other juice brands to PAI Partners and PepsiCo's retention of a 39% noncontrolling interest in TBG, which aligns with the ground truth. The entity name 'Tropicana Brands Group (TBG)' is a reasonable inference, though the ground truth refers to 'The Beachbody Company (TBG)'—this is a notable discrepancy affecting entity accuracy. The LLM also correctly notes PepsiCo's exclusive distribution role in 2022 for small-format and foodservice channels via chilled DSD. However, it fails to mention the key 2023 change: PepsiCo ceased direct distribution of Naked products. Instead, the LLM states 'there is no indication of further changes,' which contradicts the ground truth that operational involvement ended. This omission significantly impacts completeness and reasoning. (2) Quantitatively, the 39% stake and 2022 timeframe are accurate. No calculations are involved, but all numeric and temporal references are correct. (3) The multi-hop reasoning is partially sound—information about the sale and retained stake is synthesized correctly, but the model does not capture the evolution in 2023, failing to connect the shift from operational to purely financial involvement. (4) Correctness is reduced due to the critical omission of the 2023 operational withdrawal, which is central to the question about evolution between 2022 and 2023. While contextually relevant and mostly factually accurate, the answer does not fully reflect the transition, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 428,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment and disclosure around the ExtraBucks Rewards program remained consistent in recognizing revenue as rewards are redeemed, with unredeemed rewards reflected as a contract liability. However, in 2024, there was a slight increase in the contract liabilities related to ExtraBucks Rewards, as evidenced by the growth in the ending balance of contract liabilities from $149 million in 2023 to a higher amount in 2024, indicating an increase in accumulated but unredeemed rewards. No significant changes in the determination of performance obligations were noted in the disclosures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and omits key aspects of the evolution in accounting treatment. While it correctly notes consistency in revenue recognition timing and contract liability treatment, it introduces a specific quantitative claim—'growth in the ending balance of contract liabilities from $149 million in 2023 to a higher amount in 2024'—that is not present in the original answer (ground truth). The ground truth does not mention any dollar amounts or changes in contract liability balances, so this figure ($149M) is fabricated or misattributed, severely undermining quantitative accuracy. (2) There is no verification for the $149 million figure or any comparison between 2023 and 2024 balances in the ground truth; thus, the calculation or observation is unsupported and incorrect. This represents a critical failure in quantitative accuracy. (3) Regarding multi-hop reasoning, the LLM fails to capture the qualitative evolution in the disclosure about performance obligations. The original answer emphasizes that in 2024, the language became more refined, specifically tying the performance obligation to customers who accumulate ExtraBucks based on historical spending levels, and notes more structured language around transaction price allocation and standalone selling price evaluation—indicating a more mature accounting approach. The LLM incorrectly states that 'no significant changes in the determination of performance obligations were noted,' which directly contradicts the ground truth. (4) Despite these issues, the LLM correctly identifies the consistent elements of revenue recognition timing and contract liability classification, showing partial understanding of the topic and maintaining some contextual relevance. However, the introduction of false quantitative data and the failure to report the nuanced refinement in performance obligation language result in a low correctness score. The answer is partially aligned in structure and intent but factually flawed in critical areas.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 552,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Netflix's reliance on integrated payment partners, as reflected in the cost of revenues section, decreased slightly between 2023 and 2024. In 2023, cost of revenues was 58% of total revenues, while in 2024, it decreased to 54% of total revenues. The 2024 cost of revenues increase was primarily driven by higher content amortization rather than changes in payment processing fees. This suggests that while integrated payment partner costs remained a component of operating expenses, their relative impact on overall costs decreased compared to the prior year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that Netflix continued using integrated payment partners in both 2023 and 2024, with only a reduction in disclosure detail in 2024. However, the LLM incorrectly infers a decrease in reliance based on overall cost of revenues as a percentage of total revenues (58% in 2023 vs 54% in 2024), which is not supported by the original answer and introduces fabricated metrics. There is no mention in the ground truth of these percentages or a comparative analysis of cost of revenues as a percentage of total revenue. (2) The quantitative inaccuracies are severe: the 58% and 54% figures are not present in the original answer and cannot be verified from the provided context. The claim that cost of revenues decreased as a percentage of revenue due to lower impact from payment processing fees is speculative and unsupported. The original answer does not provide any financial metrics about the magnitude of payment processing fees or their proportional impact. (3) The multi-hop reasoning is flawed. The question asks about the evolution of reliance on integrated payment partners based on the cost of revenues section disclosures. The correct answer hinges on qualitative disclosure changes (i.e., reduced granularity in 2024), not quantitative cost trends. The LLM instead substitutes this with a false quantitative analysis, missing the actual point about disclosure strategy. It fails to recognize that the relationship persisted and that the change was in reporting detail, not operational reliance. (4) The contextual relevance is moderate because the LLM addresses payment partners and cost of revenues, but it misinterprets the nature of the evolution (quantitative vs. qualitative/disclosure-based), leading to a fundamentally incorrect conclusion. Thus, while the topic is relevant, the substance is not aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 527,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "From 2022 to 2023, 3M's approach to managing PFAS contamination in Minnesota evolved in response to regulatory changes and new health-based standards. In 2022, the company was focused on addressing PFAS contamination at its Cottage Grove, Oakdale, and Woodbury sites under the 2007 SACO, including remediation and compliance with existing HBVs and HRLs. By 2023, 3M faced more stringent HBVs for PFOA and PFOS issued by the Minnesota Department of Health in January 2024, prompting the company to evaluate the impact on its SACO obligations. Additionally, in 2023, 3M received a draft Clean Water Act permit for the Cottage Grove facility with significantly revised PFAS limits, some below the limit of quantification, and was actively engaging with MPCA to address these changes. The company also responded to a Notice of Violation related to PFAS discharges at its Hutchinson facility and worked on a stormwater management plan for Cottage Grove.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: 3M's ongoing activities under the 2007 SACO at Cottage Grove, Oakdale, and Woodbury; the January 2024 issuance of more stringent HBVs by the Minnesota Department of Health for PFOA and PFOS; the evaluation of SACO obligations in response; the draft Clean Water Act permit for Cottage Grove with very low PFAS limits; engagement with MPCA; the March 2023 Notice of Violation at the Hutchinson facility; and stormwater management planning for Cottage Grove. (2) Quantitative accuracy is excellent: dates (January 2024 HBVs, 2023 NOV) and regulatory timelines are correctly cited. The LLM correctly notes the draft permit was issued in 2023 even though the ground truth mentions the final proposal in January 2024—this is a reasonable interpretation as the process began in 2023. (3) Multi-hop reasoning is sound: the answer synthesizes information across time (2022 to 2023), locations (multiple Minnesota sites), regulatory bodies (MDH, MPCA), and compliance instruments (SACO, Clean Water Act permits). (4) Minor omission: the December 2022 MPCA order on Cottage Grove stormwater is not mentioned, which slightly reduces completeness. Also, the reference to 'HRLs' (Health Risk Limits) is not in the original and may be an overextension, though related. Wording differences (e.g., 'draft permit' vs 'proposed permit') are semantically acceptable. Overall, the answer captures the evolution in 3M’s approach due to tightening standards and enforcement, making it factually robust and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 440,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "Between 2022 and 2023, PepsiCo increased its use of foreign currency derivatives, with the notional value rising from $3.0 billion as of December 31, 2022, to $3.8 billion as of December 30, 2023. This increase indicates a more active approach to managing foreign exchange risk, likely in response to heightened currency volatility or expanded international operations. The company continues to use these derivatives primarily as hedging instruments, with gains and losses offsetting changes in the underlying hedged items, reflecting a disciplined and strategic foreign exchange risk management approach.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the notional values of $3.0 billion in 2022 and $3.8 billion in 2023 are accurately reported, with correct dates (December 31, 2022, and December 30, 2023—minor date variation due to fiscal year-end alignment is acceptable and consistent with SEC filings). (2) The answer addresses both parts of the question: the evolution in use (increase from $3.0B to $3.8B) and the implication for risk management strategy (more active hedging due to volatility or expansion). (3) Entities—PepsiCo, foreign currency derivatives, and the relevant years—are correctly identified. (4) The reasoning is sound: the increase in notional value is correctly interpreted as a strategic move to manage FX risk, and the mention of offsetting gains and losses aligns with the ground truth's 'no material net impact on earnings.' The LLM conveys the same semantic meaning as the original answer, with equivalent qualitative insights and no factual or calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 297,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil's approach to capitalizing on improving living standards shifted toward expanding chemical production capacity in key growth markets, particularly in China. In 2022, the company focused on restarting U.S. Gulf Coast projects and made progress on a multi-billion-dollar chemical complex in China. By 2023, ExxonMobil advanced this geographic strategy by investing in a fully foreign-owned petrochemical complex in Dayawan, China, designed to meet rising domestic demand for high-performance polyethylene and polypropylene. Additionally, the company added new production units in the U.S., such as a performance polymers line and a linear alpha olefins unit in Baytown, Texas, to support demand for advanced materials. These moves reflect a stronger emphasis on strategic capacity additions in both North America and high-growth Asian markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic shift from 2022 to 2023 in ExxonMobil's approach, highlighting the focus on expanding chemical production in both the U.S. and China. It accurately identifies the Baytown, Texas expansions for performance polymers and linear alpha olefins and the advancement of a foreign-owned petrochemical complex in Dayawan, China. However, it omits specific quantitative details from the original answer: the 500,000 metric tons per year of advanced recycling capacity planned by 2026 and the over 2.5 million metric tons per year of polyethylene and polypropylene capacity in China. These are key metrics that quantify the scale of the projects and their strategic importance. (2) While the LLM mentions 'multi-billion-dollar chemical complex' and 'new production units,' it lacks the precise capacity figures, which reduces quantitative accuracy. The years (2022, 2023, 2026) are referenced appropriately in context, but the 2026 timeline for advanced recycling is missing in the LLM response. (3) The multi-hop reasoning is sound—the model correctly synthesizes information across years and geographies, identifying the evolution from U.S.-focused integrated projects to a dual focus on high-performance materials and foreign investment in China. The logic connecting improving living standards to demand for advanced materials and localized production is well-reasoned and consistent with the ground truth. (4) The answer is contextually excellent, directly addressing the question’s focus on evolution in strategy, geographic focus, and capacity additions. The omission of specific capacity numbers prevents a top score in correctness and quantitative accuracy, but the qualitative reasoning and entity identification (ExxonMobil, Baytown, Texas, Dayawan, China, performance polymers, etc.) are accurate and well-integrated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 509,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "3M's investment in Certificates of Deposit/Time Deposits increased significantly from 2022 to 2023, rising from $21 million to $49 million. This shift suggests a strategic move toward short-term, low-risk investments, likely to preserve liquidity and manage cash more conservatively in response to economic or market uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reported the increase in 3M's Certificates of Deposit/Time Deposits from $21 million in 2022 to $49 million in 2023, matching the ground truth exactly. The quantitative evolution — more than doubling — is accurately reflected, though the phrase 'more than doubling' was not explicitly stated, but the numbers themselves are correct. (2) All numeric values are accurate: $21 million (2022) and $49 million (2023) are correctly cited, and no calculations (e.g., percentage change) were required beyond basic interpretation, which the model handled correctly. Format consistency is acceptable. (3) The multi-hop reasoning is sound: the model correctly identified the two-year comparison, linked the correct financial instrument to 3M, and inferred a plausible strategic rationale — a shift toward low-risk, short-term investments to preserve liquidity — which aligns with the ground truth's interpretation of increased liquidity or reallocation to stable/higher-yielding instruments. The LLM slightly reframes the implication (emphasizing 'economic uncertainties' not explicitly in the original), but this is a reasonable qualitative extension, not a factual error. (4) The answer is contextually complete and relevant, addressing both the quantitative evolution and the strategic implication. The only minor gap is not explicitly noting the 'more than doubling' magnitude, but the raw numbers convey this. Thus, the answer is factually correct, well-reasoned, and fully relevant, warranting a high score with only slight deduction in qualitative accuracy for subtle interpretive expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 444,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "Mastercard's approach to proprietary insights in 2023 emphasized a stronger commitment to data responsibility and trust-building compared to 2022. In 2023, the company explicitly highlighted its \"principled and responsible use of secure consumer and merchant data,\" reflecting a more deliberate focus on ethical data practices. This evolution indicates a shift toward reinforcing trust with stakeholders by aligning data usage with broader commitments to security and transparency, which was less explicitly articulated in the 2022 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the shift in language from 'principled use' in 2022 to 'principled and responsible use of secure data' in 2023 is accurately captured. The emphasis on data responsibility, security, and trust-building is correctly identified. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022 and 2023), which are accurate. (3) The multi-hop reasoning—comparing Mastercard's disclosures across two years to infer a strategic shift in tone and focus—is sound and well-articulated. The LLM correctly synthesizes the evolution in language to conclude a stronger focus on security and stakeholder trust. (4) The answer is contextually excellent, directly addressing how Mastercard’s approach evolved in terms of data responsibility and trust-building language. The only minor shortcoming is that it does not explicitly quote the 2022 phrase 'principled use of consumer and merchant data' verbatim, though it captures the meaning. This slight omission prevents a perfect 10 on qualitative accuracy, but the semantic equivalence is strong. Overall, the response is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 367,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "Between 2022 and 2023, the factors influencing the accounting estimates for pension and retiree medical plans at PepsiCo evolved due to the ongoing conflicts in Ukraine and the Middle East, as well as the high interest rate and inflationary cost environment. These external factors increased the uncertainty and complexity in estimating future obligations and assumptions for these plans. This indicates a more challenging and volatile external environment, which has a direct impact on the financial estimates and assumptions used in accounting for pension and retiree medical liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the shift in external factors affecting pension and retiree medical plan estimates from 2022 to 2023, specifically citing the conflicts in Ukraine and the Middle East, high interest rates, and inflation. These align with the ground truth. However, the LLM omits the key detail that in 2022, the primary influence was uncertainty related to the ongoing impacts of the COVID-19 pandemic—a critical baseline for the evolution being asked about. While the answer accurately describes the 2023 environment and draws a reasonable conclusion about increased volatility and complexity, it fails to fully address the comparative evolution between the two years by not acknowledging the prior-year health-related disruptions. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the reasoning is sound where applied, though incomplete. The context of the question—how factors evolved—is partially missed due to the absence of the 2022 starting point. Thus, the answer is factually correct in what it includes but lacks completeness in the multi-hop comparison, warranting a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 337,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross thousand acres (11,977 net) in 2022 to 24,221 gross thousand acres (11,548 net) in 2023. This slight reduction suggests a modest decline in the company's land position in the region, potentially due to lease expirations or strategic relinquishments after evaluation. However, the company's continued significant acreage in the region, combined with its stated success in obtaining lease extensions, indicates ongoing exploration potential and a commitment to maintaining a strong presence in Other Americas.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative data: ExxonMobil's undeveloped acreage in the Other Americas region was 25,096 gross and 11,977 net thousand acres in 2022, decreasing to 24,221 gross and 11,548 net thousand acres in 2023. These figures exactly match the ground truth, with acceptable formatting (e.g., 'gross thousand acres' vs 'gross thousands of acres'). (2) All numbers are accurate and no calculations are required beyond correct reporting. (3) The reasoning is sound and adds context not explicitly in the original answer—such as 'lease expirations or strategic relinquishments' and 'success in obtaining lease extensions'—which are plausible interpretations consistent with the data and company behavior, though the latter detail about lease extensions is not present in the ground truth. This addition does not contradict but slightly extends the original inference. (4) The answer fully addresses both parts of the question: the evolution of acreage (quantitative change) and what it indicates about exploration potential. The interpretation aligns semantically with the original answer’s conclusion that the reduction may reflect relinquishments or transitions to development, while ongoing acreage suggests continued exploration interest. The only minor deviation is the introduction of 'lease extensions' as a supporting point, which is reasonable but not verifiable from the ground truth. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with a small deduction in qualitative accuracy due to the slight addition of unverified but plausible context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 451,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "From 2022 to 2023, the use of foreign currency contracts not designated in hedging relationships by 3M evolved in terms of both volume and financial impact. In 2023, the gross notional amount of these contracts decreased significantly to $1,023 million from $2,816 million in 2022. The fair value gains and losses recorded in earnings also declined, with a 2023 fair value amount of $5 million compared to $73 million in 2022. This reduction indicates a lower exposure and financial impact from these non-hedged derivative instruments in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, MMM used foreign exchange contracts not designated in hedging relationships with a gross notional amount of $3.7 billion. However, the LLM states $2,816 million in 2022 and $1,023 million in 2023—both figures are incorrect and not close to the true value. Additionally, the LLM introduces specific fair value gains ($73M in 2022, $5M in 2023) that are not present in the original answer and contradict the qualitative shift described in the ground truth. (2) The quantitative inaccuracies are severe: the notional amounts are off by hundreds of millions, and the fair value figures are fabricated or misattributed. There is no mention in the original answer of a decrease in notional amount or specific fair value gains/losses—instead, the focus is on a strategic shift in how derivatives are used. (3) The multi-hop reasoning is flawed. The original answer emphasizes a qualitative shift in strategy—from using contracts to offset intercompany balances to a broader use of non-designated derivatives impacting earnings directly. The LLM instead focuses on a numerical decline, which is unsupported, and misses the conceptual evolution entirely. It fails to identify the continuity in purpose (offsetting non-functional currency items) and the strategic shift in accounting treatment and financial statement impact. (4) While the LLM stays on topic and discusses foreign currency contracts not designated in hedging relationships, it misrepresents both the magnitude and the nature of the change. The contextual relevance is moderate because it addresses the right topic and timeframe, but the factual and conceptual inaccuracies severely undermine correctness. Thus, the correctness and quantitative accuracy scores are low; qualitative accuracy is slightly higher due to correct identification of the instrument type and general topic, but still penalized for flawed reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 536,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "Between 2022 and 2023, the role and emphasis of Cyber and Intelligence Solutions within Mastercard's value proposition have evolved to become a more integral and highlighted component of its value-added services. In 2023, Mastercard emphasized these solutions as a key part of its broader offerings, noting their role in enabling secure, confident, and efficient transactions across its global payments ecosystem. This reflects a growing focus on security and data protection as critical differentiators in Mastercard's competitive positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately captures the evolution of Cyber and Intelligence Solutions from a less emphasized component in 2022 to a more prominent, strategically highlighted offering in 2023. The answer correctly notes the shift in emphasis without misrepresenting the timeline or entities involved. Quantitatively, there are no numerical values to verify, so accuracy is scored as 10 by default. Qualitatively, the reasoning is sound and reflects the multi-hop synthesis between the two years and the changing positioning of the service line. The only minor shortcoming is that the LLM does not explicitly mention the 2022 context where Cyber and Intelligence Solutions were grouped among other value-added services (e.g., loyalty programs, gateway services), which slightly reduces completeness in qualitative terms. However, the core message about increased strategic emphasis in 2023 is correctly conveyed. Contextual relevance is perfect—the response directly addresses the question about the evolution of the service’s role within Mastercard’s value proposition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 319,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "The treatment and disclosure of Income Tax Expense and Accruals in the list of critical accounting policies remained consistent between 2022 and 2023, as both years include it explicitly as one of the four critical accounting policies and estimates. In 2022 (page 57) and 2023 (page 33), it is listed alongside revenue recognition, goodwill and other intangible assets, and pension and retiree medical plans. The 2023 disclosure (page 35) provides a more detailed explanation of the tax rate estimation process, tax reserves, and adjustments due to audits or new tax laws, but the overall treatment and inclusion in critical accounting policies did not change significantly from 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution highlighted in the ground truth. (1) Quantitatively, the answer is accurate: it correctly identifies that 'Income Tax Expense and Accruals' was listed as a critical accounting policy in both 2022 (page 57) and 2023 (page 33), and correctly references the consistent grouping with other policies. These details align with the source data. (2) However, the qualitative assessment reveals a significant gap: while the ground truth emphasizes a structural evolution—moving to a subsection under 'Critical Accounting Policies' with enhanced organization and deeper integration with Note 5—the LLM downplays this change by stating the treatment 'did not change significantly.' This contradicts the ground truth's emphasis on a shift toward more detailed and organized reporting. (3) The multi-hop reasoning is sound in identifying continuity but fails to fully synthesize the change in presentation and transparency, which is central to the question about 'evolution.' (4) The answer is contextually relevant and well-structured, but the underemphasis on structural and disclosural improvements reduces its factual completeness. Hence, a score of 6 is warranted: core facts are correct, but the synthesis of change over time is inadequate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 360,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "Between 2023 and 2024, Intel advanced the Universal Chiplet Interconnect Express (UCIe) standard as a core component of its systems of chips strategy. In 2023, Intel demonstrated UCIe in silicon, showcasing its capability to enable communication between chips in a system. By 2024, the company emphasized UCIe as part of its broader systems of chips capabilities, integrating it with advanced packaging technologies and driving industry standards to optimize performance and power efficiency. This evolution reflects Intel's focus on enabling optimized, interconnected chiplet-based systems, particularly for AI and high-growth applications, as part of its Open System Foundry model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Intel introduced and demonstrated UCIe in silicon in 2023 and advanced to production and integration into advanced packaging and broader systems of chips strategy in 2024. The answer correctly identifies UCIe as a core component of Intel's strategy. (2) There are no numeric values to verify, so quantitative accuracy is not applicable beyond correct use of years (2023, 2024), which are accurate. (3) The multi-hop reasoning is sound—linking UCIe’s evolution from demonstration to production within the context of Intel’s broader systems of chips and Open System Foundry strategy. The LLM adds contextual detail about AI and high-growth applications and the Open System Foundry model, which are consistent with Intel’s strategic direction and enhance relevance without introducing inaccuracies. (4) The only minor gap is that the original answer specifies Intel was 'actively producing based on this standard' in 2024, while the LLM says it was 'emphasizing' and integrating UCIe—slightly less strong but still semantically aligned. Overall, the answer is factually correct, complete, and contextually rich, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 345,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment of CVS's Accelerated Share Repurchase (ASR) transactions remained consistent, with the initial portion of shares being recorded as a treasury stock transaction and the remaining shares treated as a forward contract classified within capital surplus. However, the completion timelines evolved slightly: in 2023, the final shares were received within one month (e.g., February 2023 for the January 2023 ASR), while in 2024, the final shares were received in March 2024 for the January 2024 ASR, indicating a two-month interval for settlement.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in CVS's ASR transactions between 2023 and 2024. (1) Quantitatively, the answer correctly identifies the timing of final share deliveries: February 2023 (within one month) and March 2024 (two months after January 2024 initiation), aligning with the ground truth. However, it omits specific dollar amounts ($2.0 billion in 2023, $3.0 billion in 2024), initial and final share counts (17.4M + 5.4M in 2023; 31.4M + 8.3M in 2024), and the percentage of initial delivery (80% in 2023, 85% in 2024). These omissions prevent a perfect score but do not distort the overall accuracy. (2) The accounting treatment is correctly described: initial shares as treasury stock and the forward portion in capital surplus, later reclassified upon completion. The answer correctly notes consistency in treatment across years. (3) The multi-hop reasoning is sound—comparing timelines and accounting across two filings—and the conclusion about a slightly extended timeline (one month vs. two months) is valid based on the dates provided. (4) While some granular data is missing, the semantic meaning and key comparative insights (consistent accounting, longer settlement in 2024) are preserved. The answer is fully relevant and directly addresses the question’s focus on accounting treatment and timeline evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 376,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "From 2022 to 2023, UPS's financial exposure and reporting approach related to the Central States Pension Fund (CSPF) showed a significant shift in actuarial estimates. In 2022, UPS recorded a $2.3 billion pre-tax loss related to coordinating benefits attributable to the CSPF, reflecting an increase in potential coordinating benefits. By 2023, this estimate reversed with a $5.1 billion pre-tax gain, indicating a reduction in the estimated coordinating benefits required. Additionally, in 2023, UPS provided a sensitivity analysis showing the potential impact of changes in discount rates and other assumptions on pension obligations and expenses, highlighting increased transparency and a more refined approach to risk exposure reporting.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. While it correctly states that UPS disclosed a $2.3 billion pre-tax actuarial loss in 2022 related to the Central States Pension Fund, it falsely claims a $5.1 billion pre-tax gain in 2023, which is not supported by the ground truth. The original answer makes no mention of such a reversal or gain—instead, it describes a shift in reporting focus to sensitivity analysis. This $5.1 billion figure is entirely fabricated and represents a critical error in quantitative accuracy. (2) The sensitivity analysis described in the LLM answer references changes in discount rates and 'other assumptions,' but the ground truth specifies that UPS highlighted a 25 basis point change in expected and actual returns on assets as the key sensitivity factor, with a cross-reference to Note 5. The LLM answer misrepresents the nature of the sensitivity analysis. (3) The multi-hop reasoning is flawed: the model incorrectly infers a reversal in actuarial estimates (loss to gain) rather than recognizing a shift in disclosure strategy—from quantifying a specific obligation in 2022 to emphasizing sensitivity of returns in 2023. This reflects a failure to synthesize the evolution in reporting approach correctly. (4) Despite the significant factual errors, the answer is contextually relevant in that it addresses the timeframe, the entity (UPS and CSPF), and the general theme of evolving pension reporting. However, the core financial claims are incorrect, warranting a low correctness score. Minor credit is given for correctly identifying the 2022 $2.3 billion loss and the general direction of increased analytical disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 459,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "Between 2022 and 2023, Mastercard has emphasized the role of its Cyber and Intelligence Solutions in enabling secure, efficient, and confident transactions across its global payments ecosystem. In 2022, the value proposition highlighted these solutions as part of a broader suite of services that provide \"proprietary insights\" using consumer and merchant data. By 2023, the emphasis evolved to position Cyber and Intelligence Solutions as foundational to ensuring transactions are \"secure, easily and with confidence,\" reflecting a more proactive and integrated approach to security and trust in the digital payments landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Mastercard's messaging around Cyber and Intelligence Solutions from 2022 to 2023. It accurately captures the shift from positioning these services as part of a broader suite offering 'proprietary insights' in 2022 to a more central, foundational role in enabling secure and confident transactions in 2023. The phrasing 'secure, easily and with confidence' slightly misquotes the original 2022 language ('easily and with confidence'), but this is a minor wording issue. The LLM correctly identifies the enhanced integration of cyber solutions into Mastercard’s strategic narrative, though it omits the specific linkage to new networks like open banking and digital identity mentioned in the 2023 update, which is a notable but not critical omission. There are no numerical values in the question or answer, so quantitative accuracy is not applicable but assumed perfect. The reasoning is sound and reflects appropriate multi-hop synthesis across years and messaging shifts. The answer remains highly relevant and factually consistent with the original, warranting a high correctness score with a small deduction for missing strategic context in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 349,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In PepsiCo's 2022 SEC filing, the 4.450% Senior Note due 2046 was referenced as Exhibit 4.11, incorporated by reference to a Form 8-K filed on October 14, 2015. In the 2023 filing, this note was not listed directly, but a similarly named 4.450% Senior Note due 2028 (Exhibit 4.59) was referenced, incorporated by reference to a Form 8-K filed on February 15, 2023. Thus, the 2023 filing reflects an updated note with a different maturity date and a newer documentation date, indicating a replacement or reissuance of the original 2046 note.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12 in the 2022 filing (not 4.11) and reclassified as Exhibit 4.13 in the 2023 filing (not absent or replaced). The LLM incorrectly states that the note was 'not listed directly' in 2023 and falsely claims it was replaced by a '4.450% Senior Note due 2028' (Exhibit 4.59) referencing a February 15, 2023 Form 8-K. No such replacement is indicated in the ground truth; instead, the same 2046 note was reclassified with a reference to a February 24, 2016 Form 8-K, not 2023. (2) Quantitative accuracy is poor: the exhibit numbers (4.11 vs correct 4.12/4.13), maturity year (2028 vs 2046), and Form 8-K dates (February 15, 2023 vs correct February 24, 2016) are all incorrect. Only the October 14, 2015 date matches, though tied to the wrong exhibit number. (3) The multi-hop reasoning is flawed: instead of recognizing a reclassification of the same note across years, the model invents a new note and concludes a reissuance without evidence. It fails to identify that the same instrument was reorganized in disclosure structure. (4) Contextual relevance is moderate because the answer addresses exhibit referencing and documentation dates as asked, but the incorrect entities and narrative undermine usefulness. The conclusion about 'replacement or reissuance' is unsupported and misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 401,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Intel's relationship with Positive Technologies remained consistent between 2023 and 2024, as both filings indicate that Intel continued to communicate with Positive Technologies under an OFAC-issued license. These interactions, which began prior to Positive Technologies being designated under U.S. sanctions in April 2021, involve IT security research and coordinated disclosure of security vulnerabilities. No gross revenues or net profits are associated with these activities, and Intel plans to continue them in compliance with the OFAC license terms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative and entity-related aspects: it correctly identifies Intel and Positive Technologies, references the OFAC license, notes the continuation of communications post-sanctions (imposed in April 2021), and accurately states that no gross revenues or net profits are associated with the activities. The timeline (2023–2024) and context (IT security research and coordinated disclosure) are correctly represented. However, the LLM answer describes the relationship as 'remained consistent,' which understates the evolution highlighted in the ground truth. The original answer emphasizes a shift from disclosing past communication in 2023 to expressing a forward-looking intent to sustain the partnership in 2024—indicating a qualitative evolution in tone and strategic posture. The LLM response fails to capture this nuance, presenting the relationship as static rather than evolving toward a more sustained and intentional collaboration. This omission affects the depth of qualitative accuracy, though core facts remain correct. Multi-hop reasoning is sound but not fully refined in capturing subtle shifts in corporate disclosure strategy. Wording differences do not impair semantic meaning significantly, but the lack of emphasis on the forward-looking shift prevents a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 369,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million between 2023 and 2024, as noted in the long-term debt listings on pages 168 (2023) and 161 (2024). This stability suggests that the notes were not refinanced, redeemed, or significantly altered during this period, indicating a consistent component of the company's long-term debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million in both 2023 and 2024, which matches the ground truth exactly. The dollar amount, interest rate, maturity date, and years are all accurate. (2) All numeric values are correct: $5,000 million is consistently reported for both years, and no erroneous calculations are present. Format is consistent with ground truth (using 'million' rather than full numeric expansion, which is acceptable). (3) The LLM accurately infers that the stability indicates no refinancing, redemption, or alteration of this debt instrument, which aligns with the reasoning in the original answer. However, it omits the comparative context provided in the ground truth — specifically, the contrast with the 2.7% senior notes due August 2040, which decreased significantly from $1,250 million to $367 million. This missing comparison reduces completeness in multi-hop synthesis, as the original answer uses this contrast to highlight selective debt management. (4) Despite this omission, the LLM answer is factually correct, contextually relevant, and draws a reasonable conclusion from the data. The absence of the comparative example slightly weakens the qualitative depth but does not impair the core correctness. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy, and a high overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 407,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 were listed as securities registered pursuant to Section 12(b) of the Exchange Act in both the 2022 and 2024 SEC filings, indicating their continued public trading status. In both filings, the notes were traded under the symbol \"XOM32\" on the New York Stock Exchange, showing no change in their registration or exchange listing between 2022 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the 0.835% Notes due 2032 were listed in both the 2022 and 2024 filings with the trading symbol XOM32, which aligns with the ground truth. All quantitative elements—interest rate (0.835%), maturity year (2032), symbol (XOM32), and exchange (NYSE)—are accurate. (2) There are no calculations involved, but all cited facts (dates, percentages, symbols) match the original answer and are factually correct. (3) However, the LLM answer is incomplete in its reasoning and synthesis. While it correctly notes the continuity of the 2032 notes, it omits the key comparative insight from the ground truth: the disappearance of the 0.142% Notes due 2024 (XOM24B) in the 2024 filing, which provides context for changes in Exxon’s debt structure. This multi-hop element—comparing the presence/absence of other notes to infer evolution in the debt portfolio—is missing, weakening the qualitative reasoning. (4) The answer is contextually relevant and factually precise, but the lack of comparative analysis reduces its completeness and depth. Hence, correctness is scored 7 for missing a key analytical point, though all stated facts are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 335,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "Between 2022 and 2024, American Express significantly reduced its fair value allocation to U.S. Government treasury obligations, declining from $1,704 million in 2022 to $287 million in 2024. In terms of maturity distribution, the 2024 portfolio was entirely concentrated in obligations due within 1 year, whereas in 2022, the majority ($1,680 million) was held in treasury obligations with maturities beyond 1 year. This shift indicates a move toward shorter-term holdings in 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both quantitative and qualitative aspects. According to the ground truth, in 2022 American Express held $477 million in short-term U.S. Treasury obligations with no long-term exposure, but the LLM claims $1,704 million in 2022 and $1,680 million in maturities beyond 1 year—directly contradicting the truth that there was zero long-term exposure. In 2024, the actual holdings were $189 million short-term and $98 million intermediate-term (1–5 years), totaling $287 million, which the LLM incorrectly states as entirely within 1 year. While the total fair value of $287 million in 2024 is numerically correct, the maturity breakdown and 2022 figures are wrong. (2) The LLM’s calculation of a decline from $1,704M to $287M is factually baseless—the actual decline is from $477M to $287M. The claim that 2022 had $1,680M in long-term instruments is false; ground truth confirms zero long-term holdings. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the evolution from exclusively short-term in 2022 to including intermediate-term in 2024. Instead, it inverts the strategy, claiming a shift from long-term to short-term, which is the opposite of the truth. (4) Due to pervasive factual errors in numbers, entity allocations, and reasoning, the correctness and quantitative accuracy scores are very low. Contextual relevance is slightly higher because the answer addresses the right topic (fair value and maturity evolution), but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 423,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon introduced the 2.500% Note due 2050 in June 2020, as disclosed in the 2022 10-K filing (page 72). By 2024, this note remained part of Amazon's long-term debt structure, with no indication of repayment or modification, as noted in the 2024 10-K (page 75). The note was issued under an indenture and officers' certificate, and its terms remained unchanged between the two periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all dates and percentages are correct: the 2.500% Note due 2050 was indeed introduced in June 2020 (per Officers' Certificate dated June 3, 2020), and its presence in both the 2022 and 2024 10-K filings is accurately noted. The lack of modification or repayment by 2024 is correctly stated. (2) The answer correctly identifies that the note remained unchanged and was still part of Amazon's long-term debt structure, which matches the ground truth's assertion that Exhibit 4.6 in 2024 was an exact replication of Exhibit 4.5 from 2020. (3) The multi-hop reasoning is sound—information is synthesized across years (2022 and 2024 filings) and correctly traces the continuity of the note. (4) While the LLM does not explicitly mention the exhibit numbers (Exhibit 4.5 and 4.6), this is a minor omission; the core facts about the note’s introduction, continuation, and unmodified status are all correct. The answer conveys semantic equivalence to the original answer, with only slight differences in detail depth. Hence, a high score is warranted, with a small deduction in qualitative accuracy for missing the exhibit-level specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 343,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "The number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement increased from nine in 2022 to eleven in 2023, indicating two additional amendments were made during 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the most recent amendment in 2022 was the Eighth Amendment (filed March 10, 2022), not the Ninth. By 2023, the Twelfth Amendment was filed (October 11, 2023), meaning four additional amendments occurred (Ninth through Twelfth), not two. The LLM incorrectly states there were nine amendments in 2022 and eleven in 2023, which misrepresents both the starting and ending counts. (2) The quantitative inaccuracies are critical: the number of amendments and the progression between years are wrong. The difference between 9 and 11 is 2, but the correct increase is from 8 to 12, i.e., four amendments. Dates are omitted entirely in the LLM response, which reduces precision. (3) The reasoning is partially sound in that the model recognizes the need to compare amendment counts across years and infer evolution, but it fails at the multi-hop synthesis of correctly identifying the latest amendment in each year and calculating the difference. The model appears to have misidentified the amendment numbers, leading to flawed conclusions. (4) Contextual relevance is fair because the answer addresses the evolution of amendments over time and focuses on the correct document and institution. However, due to major factual and numerical errors, the correctness and accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 385,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "NVIDIA's approach to CUDA has evolved significantly between 2022 and 2024, particularly in terms of integration with new computing architectures and software ecosystems. In 2022, CUDA was primarily highlighted as a foundational programming model for NVIDIA GPUs, enabling accelerated computing across diverse markets like gaming, data center, and automotive. By 2024, CUDA's role expanded to support a broader full-stack computing platform, now including CPUs and DPUs, with the introduction of the Blackwell architecture. This evolution reflects CUDA's integration into data center-scale solutions, enabling advanced AI workloads and generative AI applications. Additionally, CUDA's ecosystem has grown, with over 5.9 million developers leveraging it to deploy NVIDIA's technology across industries, supported by tools like NVIDIA AI Enterprise and DGX Cloud.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of NVIDIA's CUDA strategy from 2022 to 2024. It accurately reflects the shift from CUDA as a GPU programming model to a broader full-stack platform integrated with heterogeneous architectures (CPUs, DPUs) and enterprise AI ecosystems. The mention of expanded integration with data center-scale solutions and generative AI aligns with the ground truth. However, the LLM introduces the 'Blackwell architecture' and '5.9 million developers'—specific details not present in the original ground truth and not verifiable from the provided knowledge graph. While these may be factually accurate in reality, they go beyond the supported evidence and introduce unverified specifics. Additionally, the ground truth emphasizes CUDA-X, APIs, SDKs, and domain-specific frameworks as part of the expanded platform, which the LLM omits. The quantitative accuracy is perfect—no incorrect numbers or dates are presented (the 5.9M developer figure is not contradicted, just unverified). The reasoning is sound and multi-hop, connecting CUDA’s role across time and architectural changes. Contextual relevance is excellent, directly addressing the question’s focus on integration with new architectures and software ecosystems. The answer would score higher if it included CUDA-X and avoided unsupported specifics like Blackwell and developer count.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 385,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial relationship with Paxlovid underwent significant changes in revenue recognition and contractual obligations. In 2023, Paxlovid revenue was heavily impacted by a $3.5 billion non-cash revenue reversal due to expected returns of EUA-labeled U.S. government inventory. By 2024, this was partially offset by a $771 million favorable adjustment following the return of 5.1 million treatment courses. Additionally, in 2024, Pfizer supplied a U.S. Strategic National Stockpile (SNS) of 1 million treatment courses at no cost, recognizing $442 million in revenue. Overall, Paxlovid revenue dropped from $1,279 million in 2023 to $5,716 million in 2024, reflecting the transition from government contracts to commercial markets and reduced demand post-pandemic surge.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several critical factual inaccuracies, particularly in the final revenue figures. It states that Paxlovid revenue increased from $1.279 billion in 2023 to $5.716 billion in 2024, which is factually incorrect and contradicts the ground truth. In reality, the $3.5 billion reversal in 2023 reduced revenue, and the $771 million favorable adjustment and $442 million SNS revenue in 2024 represent partial reversals of prior write-downs, not a surge in total revenue. The claim of $5.716 billion in 2024 revenue is unsupported and mathematically inconsistent with the provided data. (2) Quantitative accuracy is severely compromised: while the $3.5 billion reversal, $771 million adjustment, and $442 million SNS revenue are correctly cited, their interpretation and aggregation are wrong. The LLM incorrectly implies net revenue increased dramatically in 2024, when in fact the evolution reflects adjustments to prior write-downs and stabilized contractual obligations. Additionally, the LLM misrepresents the SNS supply as being 'at no cost' while recognizing $442 million in revenue, which is logically inconsistent. (3) The multi-hop reasoning is partially sound—identifying the reversal, adjustment, and SNS contribution shows synthesis across events—but the conclusion about transitioning to commercial markets due to reduced demand is not supported by the ground truth, which emphasizes remaining performance obligations of $1 billion, not a decline in commercial activity. (4) Contextual relevance is high as the answer addresses revenue recognition and contractual obligations directly, but the qualitative accuracy is undermined by flawed financial logic and incorrect bottom-line figures. The core dynamics of revenue reversal and adjustment are captured, but the overall narrative is misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 499,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "The availability of shares under the 2003 Incentive Program decreased from 65,754,069 shares available in 2022 to 47 million shares available by the end of 2024. This reflects a reduction in the number of shares remaining for future awards, likely due to grants made during this period. The structure of the program remained consistent, with awards including restricted stock and stock units subject to graded vesting periods, though the Pioneer acquisition in 2024 added converted awards under the Pioneer LTIP, which had shorter vesting terms.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the availability of shares decreased from 65.75 million in 2022 to 47 million in 2024, implying a reduction in the total program size, when in fact the total maximum number of shares was increased to 220 million by 2024. The 47 million refers to the remaining available shares, not a reduction in the program cap. This misrepresents the evolution of the program's structure. (2) Quantitative inaccuracies include the misinterpretation of the 220 million share authorization in 2024 as a reduction rather than a substantial increase. While the 65,754,069 figure for 2022 is correct and 47 million remaining in 2024 is accurate, the LLM fails to mention the critical fact that the total cap was raised to 220 million, leading to a fundamentally incorrect conclusion. The restricted stock units granted increasing from 9,392 thousand to 10,393 thousand is omitted entirely. (3) The reasoning is flawed in the multi-hop synthesis: the model correctly identifies usage (implied by remaining shares) but incorrectly infers a shrinking program, when the truth is an expanded program with moderate usage. The mention of the Pioneer acquisition and converted awards introduces new information not in the ground truth, which may be contextually plausible but is unsupported and distracts from the core evolution of the 2003 Incentive Program. (4) Scores reflect major quantitative and qualitative errors undermining correctness, though the answer is contextually relevant and attempts to address the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 439,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "AdSense's role within Google's advertising revenue streams has seen a shift between 2022 and 2024, with its growth being partially offset by declines in impressions. In 2021, AdSense contributed to the growth of Google Network revenues, which increased by $8.6 billion, driven by strength in AdMob, Google Ad Manager, and AdSense. However, by 2024, impressions related to AdSense declined, indicating a potential shift in focus or performance within the broader advertising technology portfolio. This evolution reflects Google's broader strategy to enhance its advertising technologies, including leveraging AI to improve ad formats, delivery, and user experiences across platforms like Google Search, YouTube, and Google Network properties.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that AdSense contributed to Google Network revenue growth alongside AdMob and Google Ad Manager, and references the $8.6 billion year-over-year increase. However, it incorrectly attributes this growth to 2021 instead of 2022, which is a significant factual error. The original answer specifies 2022 as the year when AdSense was cited as a key growth driver, but the LLM shifts the timeline incorrectly. Additionally, the claim that 'impressions related to AdSense declined' by 2024 is not supported in the ground truth and introduces unsupported speculation. (2) The $8.6 billion figure is accurate, but the misattribution of the year (2021 vs. 2022) undermines quantitative accuracy. There are no calculations in the answer, but the misuse of time periods affects the validity of the data presentation. (3) The multi-hop reasoning is partially sound—linking AdSense to the broader Google Network and acknowledging a strategic shift toward AI-powered tools—but it fails to accurately reflect the evolution described in the ground truth. The original answer emphasizes that AdSense was no longer specifically highlighted as a growth lever by 2024, with newer products like Demand Gen and Performance Max taking center stage. The LLM mentions AI improvements but does not identify these specific products or the strategic repositioning of AdSense as a mature, foundational offering. (4) The answer is contextually relevant and addresses the evolution of AdSense within Google's ad portfolio, but the factual inaccuracies—especially the wrong year and unsupported claim about declining impressions—reduce its correctness. The qualitative reasoning is plausible but lacks precision and misses key details from the ground truth, resulting in a partially correct response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 507,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "Between 2022 and 2023, the UPS Retirement Plan's benefit accrual structure for non-union participants was modified to cease future benefit accruals for additional service and compensation effective January 1, 2023. This change meant that non-union employees hired prior to July 1, 2016, could no longer earn new benefits under the UPS Retirement Plan after this date. Instead, future retirement contributions for non-union employees were shifted to the UPS 401(k) Savings Plan, where they began receiving retirement contributions of 5% to 8% of eligible compensation based on years of vesting service starting in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key change in the UPS Retirement Plan: the cessation of future benefit accruals for non-union participants effective January 1, 2023. It accurately notes that this applied to non-union employees hired before July 1, 2016, aligning with the original answer's eligibility criteria. The date (January 1, 2023) is correct, and the shift of retirement contributions to the UPS 401(k) Savings Plan is factually accurate. The percentages (5% to 8% of eligible compensation based on vesting service) are consistent with known UPS policy changes in 2023 and represent a reasonable inference or external knowledge that complements the ground truth. However, the original answer does not explicitly mention the 401(k) shift or contribution percentages, so while this information is contextually relevant and likely correct, it goes beyond the provided ground truth without citation from the source documents. This introduces a minor completeness issue in terms of fidelity to the knowledge graph content, though not a factual error. The core multi-hop reasoning—linking the 2022 plan structure to the 2023 accrual freeze for non-union participants—is sound and well-synthesized. The answer is semantically aligned with the ground truth and addresses both parts of the question: evolution between years and specific changes to future accruals. The only limitation is the addition of 401(k) details not present in the original answer, which slightly affects qualitative accuracy but not correctness. Quantitative accuracy is high—dates and percentages are correct and plausibly sourced. Contextual relevance is excellent, as all information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 461,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Between 2022 and 2024, Amazon's short-term credit facilities evolved in several key ways. In 2022, the company had a $7.0 billion unsecured revolving credit facility with an interest rate of 0.50% over the benchmark rate and a commitment fee of 0.04%. By 2024, Amazon replaced its prior 364-day revolving credit agreement with a new $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement), which matures in October 2025 and carries an interest rate of 0.45% over the Secured Overnight Financing Rate with a commitment fee of 0.03%. Additionally, outstanding borrowings under other short-term credit facilities increased slightly from $147 million in 2023 to $151 million in 2024. The credit capacity also expanded, with the Commercial Paper Programs increasing from $10.0 billion in 2022 to $20.0 billion in 2024. Overall, Amazon appears to have optimized its credit structure by securing more favorable interest rate terms and increasing its short-term borrowing capacity.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. Correct elements include: the 2022 $7.0 billion credit facility with 0.50% spread and 0.04% fee, the 2024 $5.0 billion 364-day facility with SOFR + 0.45% and 0.03% fee, and the $147M and $151M borrowings under other short-term facilities in 2023 and 2024. However, it incorrectly states that Amazon replaced its prior 364-day facility with the new one, while the ground truth indicates the new $5.0 billion facility was *added*, not a replacement. More critically, the LLM claims Amazon expanded its Commercial Paper Programs from $10.0B to $20.0B between 2022 and 2024 — this information is entirely absent from the ground truth and appears fabricated. Additionally, the LLM omits the key fact that Amazon established a new $15.0 billion unsecured revolving credit facility in 2024, which is a major expansion and central to the evolution of its credit structure. The increase in unused letters of credit from $7.2B (as of end-2021) to $8.3B (end-2024) is also missing. (2) Quantitative accuracy is partially correct: $7.0B, $5.0B, $147M, $151M, 0.50%, 0.45%, 0.04%, 0.03% are accurate. But the $10B to $20B commercial paper claim lacks support and is likely incorrect. The $15.0B facility is completely missing. (3) Multi-hop reasoning is flawed: the model fails to synthesize the full evolution — especially the addition of the $15.0B facility — and incorrectly frames the $5.0B facility as a replacement. It also introduces unsupported information (commercial paper expansion), indicating poor grounding in the source data. (4) Scores reflect partial correctness: some key facts are right, but major omissions and one significant fabrication (commercial paper) reduce correctness and quantitative accuracy to mid-range. Qualitative reasoning is similarly compromised. Contextual relevance is high as the answer addresses the right topic and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 523,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Between 2022 and 2023, Costco's use of variable-priced contracts for energy purchases remained consistent, as it continued to enter into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. This indicates that Costco employs a mixed commodity price risk management strategy, combining fixed-price contracts for certain facilities with variable-priced contracts to manage exposure to energy price fluctuations. The continued use of variable-priced contracts suggests a balanced approach to managing energy costs while maintaining flexibility in response to market conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that Costco continued using variable-priced contracts for electricity, natural gas, and fuel for gas stations on an index basis from 2022 to 2023, which matches the original answer. All entities (Costco, variable-priced contracts, energy types, time frame) are correctly identified. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound in noting consistency in strategy, but introduces a slight overinterpretation: the original answer does not mention 'fixed-price contracts for certain facilities' or characterize the strategy as 'mixed' or 'balanced.' While this may be a reasonable inference, it is not explicitly supported in the ground truth, which emphasizes continuity and lack of significant shift rather than a deliberate balance. This minor addition affects qualitative accuracy slightly. (4) The answer fully addresses both parts of the question—evolution (consistency) and strategic implication—and remains highly relevant. The core facts and synthesis across 2022 and 2023 are correct, warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 351,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "NVIDIA AI Enterprise has evolved significantly between 2022 and 2024 as a central component of NVIDIA's data center offerings. In 2022, it was positioned as a comprehensive suite of enterprise-grade AI software, emphasizing tools like NVIDIA NIM, NeMo, and AI Blueprints to simplify the development and deployment of generative AI applications. By 2024, its role expanded with the introduction of the NVIDIA Blackwell architecture, which integrates GPUs, CPUs, DPUs, and networking to deliver a full-stack, data center-scale infrastructure optimized for generative AI and accelerated computing workloads. This evolution reflects NVIDIA's strategic focus on providing end-to-end AI solutions with enhanced performance and efficiency to meet the growing demands of enterprise and cloud customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies regarding the timeline and positioning of NVIDIA AI Enterprise. While it correctly identifies the product as enterprise-grade AI software, it incorrectly states that in 2022 it was already positioned as a 'comprehensive suite'—the ground truth indicates it was introduced as part of the Compute & Networking segment, emphasizing its strategic foundational role, not its completeness. The LLM also introduces NVIDIA NIM, NeMo, and AI Blueprints as components in 2022, which are not mentioned in the original answer and lack verification in the context provided. Furthermore, the claim that the evolution by 2024 is tied to the 'NVIDIA Blackwell architecture' integrating GPUs, CPUs, DPUs, and networking is not supported by the original answer, which instead emphasizes the product's shift to a monetization vehicle within a full-stack platform including DGX Cloud. (2) There are no numeric values, dates, or calculations in either answer beyond the years 2022 and 2024, which are correctly used—thus quantitative accuracy is high. (3) The multi-hop reasoning is partially sound in that it attempts to trace the evolution of a product across time and link it to broader strategic moves; however, it fabricates architectural and product-level details (e.g., Blackwell integration) not present in the ground truth, undermining the synthesis. (4) The contextual relevance is strong because the answer addresses the evolution of NVIDIA AI Enterprise within data center offerings, but the qualitative accuracy suffers due to incorrect attribution of features and strategic shifts. The core idea of increased commercial importance is implied but not clearly articulated as a shift from strategic initiative to monetization vehicle, which is central to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 497,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "Pfizer's contractual obligations related to Paxlovid significantly evolved between 2023 and 2024, primarily due to the transition from government contracts to commercial market sales. In 2023, Paxlovid revenues were largely driven by government contracts, with a significant non-cash revenue reversal of $3.5 billion recorded in the fourth quarter due to expected returns of EUA-labeled inventory. By 2024, Paxlovid revenues increased to $5,716 million, reflecting a shift to commercial sales and a $771 million favorable adjustment from returned EUA-labeled treatment courses. This indicates a strategic pivot toward commercial markets and a more predictable revenue stream, suggesting a more stable and potentially growing future revenue outlook for Paxlovid.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly identifies the $3.5 billion non-cash revenue reversal in Q4 2023 related to expected returns of EUA-labeled Paxlovid, it incorrectly states that Paxlovid revenues in 2024 were $5,716 million and includes a 'favorable adjustment of $771 million from returned EUA-labeled treatment courses.' This specific figure and characterization are not supported by the ground truth, which does not mention a $771 million favorable adjustment or total 2024 revenue. Instead, the ground truth states that as of December 31, 2024, remaining performance obligations were approximately $1 billion—this is a forward-looking contractual obligation, not revenue recognized in 2024. The LLM conflates revenue recognition with performance obligations and introduces unsupported figures. (2) The $5,716 million revenue and $771 million adjustment are not present in the original answer and contradict the more cautious, stabilization narrative of $1 billion in remaining obligations. These numbers appear fabricated or misattributed. (3) The qualitative reasoning about a shift from government to commercial sales and improved outlook is partially aligned with the ground truth’s interpretation of stabilization and improved forecasting. The LLM correctly infers a strategic pivot and more stable outlook, which is consistent with the evolution from uncertainty (reversal) to defined obligations. However, it overstates the positive trend with unsupported revenue growth claims. (4) The contextual relevance is high because the answer addresses both years, the nature of contractual obligations, and the implication for future revenue. The qualitative logic is sound in direction but flawed in precision due to incorrect data. Quantitative accuracy is low due to invented figures; correctness score is moderate because core concepts (reversal, EUA returns, stabilization) are present but key financial claims are inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 546,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "Between 2022 and 2024, Google's exposure to new regulatory costs in international markets evolved in both scope and nature. In 2022, the focus was on general regulatory risks such as anti-corruption laws, data privacy concerns, and foreign exchange controls, with international revenues accounting for approximately 54% of total revenue. By 2024, the scope broadened to include more specific and intensified challenges, such as geopolitical tensions (e.g., conflicts in the Middle East and Ukraine), sanctions, and export controls, with international revenues rising to 51% of total revenue. Additionally, the nature of regulatory challenges became more complex, incorporating evolving foreign policy landscapes, increased litigation risks, and heightened scrutiny around data protection and compliance with local laws in diverse jurisdictions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly identifies an evolution in Google's regulatory exposure between 2022 and 2024, it introduces factual inaccuracies not present in the ground truth. Specifically, the claim that 'international revenues accounted for approximately 54% of total revenue' in 2022 and 'rising to 51%' in 2024 is factually incorrect—this contradicts itself (a rise to a lower percentage) and is not supported by the original answer, which does not mention revenue percentages at all. This significantly undermines quantitative accuracy. (2) There are no correct numbers in the LLM response that align with the ground truth, as the original answer does not provide any revenue percentages or financial figures. The inclusion of such unverified metrics harms credibility. (3) The qualitative reasoning partially captures the broadening scope of regulatory challenges—mentioning geopolitical tensions, sanctions, and export controls—but diverges from the specific evolution described in the ground truth. The original answer emphasizes a shift from data transfer issues (EU-UK) and customer requirements in 2022 to increased uncertainty, lack of due process, and unclear legal precedents in 2024. The LLM answer replaces these precise regulatory developments with more generic geopolitical and compliance issues, missing the core nuance of 'uncertainty regarding regulatory outcomes' and 'liabilities under local laws without due process.' (4) Contextual relevance is high because the answer addresses the evolution of regulatory challenges over time and attempts a comparative analysis. However, the failure to accurately represent the nature of the regulatory risks—especially the shift from data-specific to broader legal and procedural uncertainties—results in a partially correct but misleading synthesis. The multi-hop reasoning is present but based on incorrect or invented data, leading to a correctness score of 5—partially correct but with significant factual and inferential flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 555,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "Between 2022 and 2023, UPS's approach to funding postretirement medical benefits remained consistent, with expected benefit payments being sourced from both plan trusts and corporate assets. No significant changes were introduced in the mix of funding sources during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that UPS's funding approach for postretirement medical benefits remained unchanged between 2022 and 2023, with expected benefit payments sourced from both plan trusts and corporate assets—this matches the original answer exactly in substance. (2) There are no numerical figures requiring calculation in this question, but the years (2022 and 2023) are correctly referenced, and the funding sources are accurately described. (3) The multi-hop reasoning—comparing UPS's disclosures across two years to assess evolution—is correctly executed; the model correctly infers that no change occurred based on consistent language. (4) The answer is fully relevant, directly addressing the question about evolution in funding sources and correctly concluding no significant change. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 272,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "NVIDIA AI Enterprise, introduced in 2022 as a comprehensive suite of enterprise-grade AI software, has evolved by 2024 to become more broadly integrated into NVIDIA's data center and AI solutions. Initially offered as a standalone software suite, it is now part of a full-stack AI platform that includes hardware (GPUs, CPUs, DPUs), networking, and software tools such as NVIDIA NIM, NeMo, and AI Blueprints. This integration enables enterprises to develop, deploy, and manage generative AI applications more efficiently, with enhanced scalability and performance across on-premises and cloud environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: NVIDIA AI Enterprise was introduced in 2022 as an enterprise AI software suite and evolved by 2024 into a full-stack platform. The inclusion of NVIDIA NIM, NeMo, and AI Blueprints is accurately stated. (2) There are no numeric inaccuracies—while the ground truth mentions a specific 2.5x increase in token throughput, the LLM answer does not include this metric but also does not contradict it. The absence of this quantitative detail prevents a perfect score, but since no incorrect numbers are presented, quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution from a standalone software suite to an integrated hardware-software solution across time (2022 to 2024), capturing the expansion in scope and deployment options. (4) The answer is contextually fully relevant, addressing both the role and scope evolution and the broader supply and integration in 2024. The only minor omission is the lack of specific performance improvement metrics (2.5x throughput), which slightly affects completeness but not overall correctness. Hence, the qualitative accuracy is slightly reduced, but all other dimensions are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 358,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "From 2022 to 2024, ExxonMobil's proved reserves through equity companies increased from 467 million barrels of oil equivalent (BOE) in 2022 to 1,481 million BOE in 2024. This growth is primarily driven by significant additions in Asia, particularly in natural gas reserves, which rose to 4,242 billion cubic feet (equivalent to 1,276 million BOE). The strategic positioning reflects a focus on expanding natural gas resources in Asia, aligning with regional energy demand trends and long-term energy transition goals. This shift highlights ExxonMobil's emphasis on leveraging equity investments in high-growth, resource-rich regions to strengthen its global reserve portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, ExxonMobil's proved reserves from equity companies were 14 million barrels gross (1 million net), not 467 million BOE as claimed. The 2024 figures in the LLM answer (1,481 million BOE) do not match the ground truth either: the correct 2024 reserves are 467 million barrels of crude oil, 120 million barrels of NGLs, and 5,367 Bcf of natural gas. The LLM incorrectly converts 4,242 Bcf of gas to 1,276 million BOE, which is not supported by the data, and the total BOE calculation is flawed. (2) The ground truth does not provide a total BOE for 2024, but using standard conversion (6 Bcf = 1 million BOE), 5,367 Bcf ≈ 894.5 million BOE, plus 467 + 120 = ~1,481.5 million BOE total — coincidentally matching the LLM's total but derived from incorrect component values and timing. The LLM misattributes the 467 million barrels (which is crude oil only in 2024) as the total 2022 reserve, reversing the timeline. (3) The multi-hop reasoning is partially sound in identifying Asia as the growth region and linking it to strategic positioning, which aligns with the ground truth. However, the synthesis is based on incorrect data inputs, undermining the validity. (4) The contextual relevance is moderate because the answer addresses the evolution and strategic implications, and correctly identifies Asia as the focus. However, the quantitative inaccuracies are severe, especially the reversal of 2022 and 2024 figures, leading to a low correctness score. The qualitative reasoning is somewhat logical but built on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 448,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "The financial relationship with Google Network Partners between 2022 and 2024 shows that they remained a significant source of revenue generation, particularly through advertising on their properties. Revenues from Google Network properties are recognized on a gross basis, with amounts paid to partners recorded as cost of revenues. While specific figures for this relationship are not directly provided in the given pages, the 2024 document notes an increase in Google Services operating income driven by higher revenues, partially offset by increased content acquisition costs and TAC (traffic acquisition costs), which includes payments to Google Network partners. This suggests that while their role in revenue generation has grown, their impact on cost structure has also increased.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Google Network Partners remained important for revenue generation and that payments to them are recorded as cost of revenues, with revenues reported on a gross basis—this aligns with the 2022 ground truth. It also correctly notes that TAC (which includes payments to partners) increased in 2024, affecting cost structure. However, it misses the key evolution highlighted in the original answer: the shift in financial reporting emphasis from revenue generation (2022) to cost and cash flow impact (2024), where payments to partners are framed as a primary use of operating cash. This conceptual shift is central to the question and is not captured. (2) There are no specific numerical figures in either the ground truth or LLM answer, so quantitative accuracy is not compromised—no incorrect numbers or calculations are present, earning a full score. (3) The multi-hop reasoning is partially sound: the model connects TAC to Google Network Partners and infers cost impact from operating income trends. However, it fails to synthesize the change in narrative framing between 2022 and 2024, which requires cross-year contextual analysis of reporting language. (4) The answer is contextually relevant and factually consistent with available information, but lacks the deeper insight into how the financial relationship was *framed differently* over time, which is critical for full correctness. Hence, the correctness and qualitative accuracy scores are reduced, while contextual relevance remains high due to appropriate focus and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 438,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "UPS's foreign currency exchange risk management strategy showed a notable shift in the financial impact of undesignated foreign currency forward contracts on earnings volatility between 2022 and 2023. In 2023, the company recognized a loss of $7 million from these undesignated contracts, compared to a significantly larger loss of $69 million in 2022. This reduction in the loss suggests a more stable or improved management of foreign currency exposure through these instruments in 2023, leading to lower earnings volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative inaccuracy: The LLM claims specific losses of $7 million in 2023 and $69 million in 2022 from undesignated foreign currency forward contracts. However, the original answer (ground truth) does not provide any such numerical figures—there is no mention of $7M or $69M losses in either year. These numbers are fabricated or hallucinated, failing the core requirement of factual accuracy. (2) Completeness: The question asks about the evolution of UPS's risk management strategy and the financial impact of undesignated contracts on earnings volatility, particularly in terms of disclosure and presentation. The LLM completely misses the key evolution—namely, the enhanced disclosure in 2023, including side-by-side reporting of fair value changes and settlements, and the explicit linkage of undesignated derivatives to earnings volatility. Instead, it invents a narrative around reduced losses, which is unsupported by the ground truth. (3) Reasoning: The multi-hop synthesis is flawed. The LLM incorrectly infers that a reduction in losses indicates improved risk management, but the ground truth does not support any such performance-based conclusion—it focuses on transparency and disclosure improvements, not actual P&L outcomes. (4) Semantic equivalence: The LLM answer discusses earnings volatility, which is relevant, but misrepresents the nature of the evolution (performance vs. disclosure). While the topic of undesignated forwards and earnings impact is contextually relevant, the factual foundation is incorrect. Thus, despite addressing the general theme, the answer fails on correctness due to hallucinated data and omission of the actual strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 478,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Between 2022 and 2023, Costco's membership format continued to play a central role in its profitability strategy by reinforcing member loyalty and generating consistent fee revenue. In 2022, membership fee revenue increased by 9% to $4,224, driven by new member sign-ups, Executive membership upgrades, and higher renewal rates. By 2023, this trend continued, with membership fee revenue rising 5% to $4,828, primarily due to new member sign-ups and Executive upgrades, although this growth was partially offset by one less week of membership fee income in 2023. This evolution highlights Costco's ongoing emphasis on expanding and retaining its membership base to sustain profitability through recurring fee revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims membership fee revenue increased from $4,224 to $4,828 between 2022 and 2023, implying growth from $4.224 billion to $4.828 billion (a ~14% increase), but this contradicts the ground truth, which does not provide specific revenue figures or growth percentages. More critically, the actual reported membership fee revenues for Costco were approximately $4.12 billion in 2022 and $4.52 billion in 2023, so both the numbers and the 9% and 5% growth rates cited are incorrect. (2) The claim of 'one less week of membership fee income in 2023' is not supported by the original answer or typical SEC filings—Costco’s fiscal years are 52- or 53-week periods, but this specific explanation for revenue impact is not mentioned in the ground truth and appears fabricated. (3) Qualitatively, the LLM captures the general idea that membership drives loyalty and fee revenue and that Executive upgrades and new sign-ups contribute to profitability. However, it fails to capture the key evolution in language and strategic emphasis described in the ground truth—specifically, the shift in narrative from membership being 'integral to profitability' as a general statement in 2022 to a more consolidated role in 2023, and especially the new concern about lower renewal rates in newer markets affecting the worldwide renewal rate. This is a critical omission in the multi-hop reasoning required to assess strategic evolution. (4) The contextual relevance is moderate because the answer addresses membership’s role in profitability and fee revenue, which is relevant, but misses the core qualitative shift and introduces false quantitative data. Thus, while the direction of reasoning is appropriate, the factual foundation is flawed, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 514,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "NVIDIA's approach to CUDA has evolved significantly between 2022 and 2024, with a stronger emphasis on integration within the broader data center platform and software ecosystem. In 2022, CUDA was highlighted as a foundational parallel programming model that supports GPU-accelerated computing across diverse applications, including AI training and inference. By 2024, CUDA's role expanded as part of a full-stack computing infrastructure, with the introduction of the Blackwell architecture and the inclusion of CPUs and DPUs in the data center platform. This evolution reflects NVIDIA's strategy to unify hardware and software layers, enabling CUDA to support not only traditional GPU workloads but also large-scale AI and HPC applications across interconnected data center systems.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of CUDA between 2022 and 2024. It accurately captures the shift from CUDA as a foundational programming model in 2022 to a more integrated component of a full-stack data center platform by 2024. The mention of AI training, inference, and HPC applications reflects CUDA's expanding role. However, the LLM introduces the 'Blackwell architecture' and mentions CPUs and DPUs being newly included in the data center platform in 2024, which are not present in the original answer and cannot be verified from the provided ground truth. While these details may be factually accurate in a broader context, they represent external knowledge not supported by the knowledge graph source. The original answer emphasizes CUDA's integration into CUDA-X and its role in acceleration libraries, APIs, and domain-specific frameworks—details that the LLM omits. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and contextually relevant, with only minor omissions and the addition of unsupported specifics preventing a top score. The answer correctly synthesizes the strategic shift in CUDA’s positioning, fulfilling the multi-hop requirement of comparing 2022 and 2024 contexts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 372,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid evolved significantly from 2023 to 2024. In 2023, Paxlovid revenues were $1,279 million, with a major portion tied to government contracts, while in 2024, revenues surged to $5,716 million as the product transitioned to commercial markets. The deferred revenues for Paxlovid decreased from $5.1 billion in 2023 to $2.2 billion in 2024, driven by product deliveries and a $771 million favorable adjustment in Q1 2024. Remaining performance obligations for Paxlovid were approximately $1 billion as of December 31, 2024, with expected deliveries from 2025 through 2028.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Pfizer recorded a $3.5 billion non-cash revenue reversal in Q4 2023 due to expected returns of 6.5 million treatment courses from U.S. government inventory. However, the LLM claims Paxlovid revenues were $1,279 million in 2023 and $5,716 million in 2024, which contradicts the reversal narrative and introduces unsupported revenue figures. The deferred revenue figures ($5.1B in 2023, $2.2B in 2024) and a $771M favorable adjustment in Q1 2024 are not mentioned in the ground truth and appear fabricated. Only the remaining performance obligations of ~$1B as of end-2024 and delivery timelines (2025–2028) align with the original answer. (2) Quantitative accuracy is severely compromised: none of the revenue or deferred revenue numbers match the ground truth, and no calculations or figures from the original answer (e.g., $3.5B reversal, 6.5M courses) are correctly reported. The LLM invents precise numbers not present in the source. (3) The multi-hop reasoning is flawed: the model fails to connect the 2023 revenue reversal due to product returns with the shift to firm contracts by 2024. Instead, it fabricates a narrative of revenue growth and deferred revenue reductions without grounding in the provided facts. (4) Contextual relevance is moderate—the answer addresses financial commitments and timelines and attempts to compare 2023 and 2024, but the substance is factually incorrect. The only correct elements are the $1B remaining obligations and 2025–2028 delivery window, which are critical but insufficient given the extensive inaccuracies elsewhere.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 455,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "ExxonMobil has significantly increased its strategic emphasis on Guyana between 2022 and 2024, as evidenced by its disclosures on reserves development and advantaged asset reporting. In 2022, Guyana was highlighted as a key area for future production growth, with reserves additions from discoveries and development activities. By 2024, Guyana is explicitly categorized as an \"advantaged asset\" within ExxonMobil's earnings driver framework, underscoring its role in driving volume growth and high returns. This evolution reflects the successful development of Guyana's Stabroek Block and its growing contribution to ExxonMobil's global production and reserves portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Guyana's role in reserves growth in 2022 and its elevation to 'advantaged asset' status by 2024 are accurately described. The mention of 'reserves additions from discoveries and development activities' in 2022 corresponds to the ground truth's '1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves'—though the exact number (1.3 billion) is omitted, the qualitative description is consistent. (2) No incorrect numbers or dates are presented; the years 2022 and 2024 are correctly used, and no erroneous calculations are made. The absence of the specific 1.3 GOEB figure is a minor omission but does not detract significantly from the overall correctness. (3) The multi-hop reasoning is sound: the model correctly infers a strategic evolution from reserves growth to advantaged production and earnings visibility, linking disclosures across years and reporting categories. (4) The answer is contextually relevant, directly addressing the evolution of strategic emphasis through reserves and asset reporting. The only reason for not scoring a 10 is the lack of the specific 1.3 billion BOE reserves figure, which is a quantitatively minor but factually notable detail in the original answer. However, the semantic meaning and strategic interpretation remain fully aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 384,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "The planned utilization of the ATR 72-600F aircraft decreased significantly from 2022 to 2024. In 2022, FedEx planned to purchase 24 ATR 72-600F aircraft across 2023 to 2026, but by 2024, this number was reduced to just 10 aircraft, all scheduled for delivery in 2025. This reduction indicates a diminished role for the ATR 72-600F in the company's fleet strategy, suggesting a shift toward other aircraft types or a reassessment of the aircraft's strategic value in the company's operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, the company projected a decline from 11 ATR 72-600F units in 2023 to just 1 by 2026. By 2024, this projection shifted to 7 units in 2025 and 3 by 2026. In contrast, the LLM claims that in 2022, FedEx planned to purchase 24 ATR 72-600F aircraft from 2023–2026, and by 2024, this was reduced to 10 aircraft all in 2025—information not present in the ground truth and factually incorrect. There is no mention of FedEx or purchases in the original answer; the focus is on planned utilization (number of units), not acquisitions. (2) The numbers are entirely wrong: 24 vs. 11, 10 vs. 7/3, and the timeline of deliveries is misrepresented. The original does not mention 'purchases' or 'deliveries in 2025 only'—instead, it discusses planned fleet size over years. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution of fleet projections from 2022 to 2024. It misidentifies the nature of the data (purchase plans vs. utilization projections) and misrepresents the trend. While it correctly infers a reduced role, it misses the key nuance that the phaseout slowed, not accelerated—contradicting the original conclusion that the aircraft retained a more sustained role. (4) The contextual relevance is moderate because it addresses fleet strategy and evolution over time, but the factual foundation is incorrect, leading to a misleading interpretation. The qualitative reasoning is partially sound in drawing strategic implications, but based on false premises. Quantitative accuracy is very low due to invented figures and timelines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 458,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "NVIDIA's approach to offering Omniverse evolved significantly between 2022 and 2024, particularly in its integration with AI and simulation platforms. In 2022, Omniverse was described as a real-time 3D design collaboration and virtual world simulation software, primarily used for connecting design applications and enabling virtual simulations. By 2024, Omniverse had expanded to serve as a development platform and operating system for building and running virtual world simulation applications, with a stronger emphasis on integration with generative AI and NVIDIA's broader AI ecosystem. It was also highlighted as a key component in NVIDIA's autonomous vehicle development, providing synthetic data generation and simulation capabilities for AI model training and validation. This evolution reflects NVIDIA's broader strategy to unify AI, simulation, and real-time 3D workflows across industries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: the description of Omniverse in 2022 as a 3D collaboration and simulation platform, and its evolution by 2024 into a development platform and operating system for virtual world simulations, is consistent with the original answer. The emphasis on enterprise use, digital twins, and integration with AI and simulation workflows is correctly conveyed. (2) There are no numeric values, dates, or financial figures in dispute—both answers reference 2022 and 2024 appropriately, and no calculations are required. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the shift in Omniverse’s role over time and connects it to broader strategic integration with AI, particularly generative AI and autonomous systems. It accurately identifies the expansion into synthetic data generation for AI training, which is a valid inference from the 2024 capabilities described in the ground truth (e.g., testing autonomous robots and vehicles). (4) The only minor gap is that the LLM answer does not explicitly mention the shift from free individual use to enterprise focus or on-premises/cloud infrastructure, which are details present in the original. However, the core evolution—from a collaboration tool to a specialized simulation and AI-integrated platform—is clearly and correctly articulated. Wording differs slightly but maintains semantic equivalence. Thus, the answer is excellent with only minor omissions, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 433,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "Between 2022 and 2023, Google Play's role in generating non-advertising revenue continued to grow, driven by sales of apps, in-app purchases, and digital content. The 2023 filing highlights that non-advertising revenues, including Google Play, are increasingly contributing to overall revenue growth. Additionally, Google Play is mentioned as a key component of \"Google subscriptions, platforms, and devices\" revenue, which saw fluctuations influenced by customer demand and product launches. While specific revenue figures for Google Play are not provided, the overall increase in non-advertising revenue and the emphasis on platform growth suggest that Google Play remained a significant contributor to this segment in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth and addresses the evolution of Google Play's role in non-advertising revenue between 2022 and 2023. (1) There are no specific numeric values (e.g., revenue figures) in either the original or LLM answer, so quantitative accuracy is not compromised—no incorrect numbers are presented, and the absence of specific figures is accurately reflected. Thus, quantitative accuracy is 10. (2) The LLM correctly identifies that Google Play contributes to non-advertising revenue through app sales, in-app purchases, and digital content in both years, aligning with the original answer. It also correctly situates Google Play within the 'subscriptions, platforms, and devices' category in 2023, reflecting the strategic repositioning mentioned in the ground truth. (3) The multi-hop reasoning is sound: the model infers increased strategic importance from the broader revenue segment trends and categorization changes, even without explicit line-item data. However, the LLM answer slightly underemphasizes the structural shift in 2023—specifically, the transition to a more 'defined revenue stream under platforms' and the implication of a more structured, stable monetization role. This nuance about strategic categorization and revenue stability is present in the original but not fully captured in the LLM response, leading to a qualitative accuracy score of 8. (4) Contextual relevance is perfect—the response directly addresses the question’s focus on the evolution of Google Play’s role, maintains appropriate scope, and avoids irrelevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 438,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods in workers' compensation reserving for guaranteed cost and excess of deductible business evolved between 2022 and 2023 by extending the weight given to these methods for excess of deductible business to the most recent five accident years in 2023. In 2022, expected loss ratio methods for excess of deductible business were already given significant weight, but in 2023, this approach was reinforced to reflect updated assumptions about loss trends, rate changes, and market conditions. For guaranteed cost business, the methods remained primarily influential only in the most recent accident year, with continued emphasis on development methods due to the availability of historical claims data.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces a significant factual inaccuracy regarding the evolution of AIG's use of expected loss ratio methods between 2022 and 2023. According to the ground truth, the reserving methodology remained 'broadly consistent' between the two years, with no indication that the use of expected loss ratio methods for excess of deductible business was extended or newly reinforced in 2023 — the LLM incorrectly implies a change or extension in 2023. In reality, in 2022, AIG already gave significant weight to expected loss ratio methods for excess of deductible business in the most recent five accident years, and this did not change in 2023. The LLM falsely suggests an evolution that is not supported by the original answer. The part about guaranteed cost business being limited to the most recent accident year is accurate and consistent with the ground truth. However, the LLM omits key points from the original answer: (1) the shift to presenting incurred and paid losses net of reinsurance and undiscounted in 2023 as a reporting refinement, and (2) the continued impact of large deductible business on slowing claims reporting patterns. While the LLM correctly identifies the methods used (loss development, frequency/severity, expected loss ratio), it misrepresents the nature of change over time. Quantitative accuracy is moderate — no explicit numbers are wrong, but the temporal comparison (2022 vs 2023) is incorrect. Qualitative accuracy suffers due to flawed reasoning about methodological evolution. Contextual relevance is high as the response stays focused on the topic and uses appropriate terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 452,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Cisco restructured its product category segmentation. In fiscal 2022, the Collaboration category was part of a broader set of categories including Secure, Agile Networks, Internet for the Future, End-to-End Security, Optimized Application Experiences, and Other Products. By fiscal 2024, Cisco simplified its categories to Networking, Security, Collaboration, and Observability. The Collaboration category remained a distinct segment but saw a slight 2% revenue increase in fiscal 2024 compared to a 5% decline in fiscal 2022, reflecting some stabilization and growth in offerings like Collaboration Devices, Contact Center, and CPaaS, despite a dip in Meetings revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the evolution of Cisco's product category segmentation between fiscal 2022 and 2024, noting the initial six categories and the consolidation into four by 2024, including the retention of 'Collaboration' and the introduction of 'Observability'. This core structural change is accurately captured. However, the LLM introduces quantitative claims not present in the ground truth: specifically, a '2% revenue increase in fiscal 2024' and a '5% decline in fiscal 2022' for the Collaboration category. These figures are unsupported by the original answer and represent a significant factual overreach, as the ground truth does not mention any revenue changes. (2) The numbers cited (2% increase, 5% decline) cannot be verified and are likely hallucinated, failing the quantitative accuracy check. There are no calculations in the ground truth to validate or replicate. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the reorganization of product categories across years and identifies Collaboration as a persistent category. However, it adds extraneous performance metrics that were not asked for and not present in the source, indicating a deviation from the question's focus on segmentation evolution rather than financial performance. (4) Despite the hallucinated numbers, the structural and categorical changes are correctly described, earning moderate scores for qualitative accuracy and contextual relevance. The correctness score is reduced primarily due to the inclusion of false quantitative data, which undermines trust in the response, even though the categorical evolution is well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 457,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "Amgen's disclosure regarding the 3.125% 2025 Notes remained consistent in terms of the notional amount of $1,000 million from 2022 to 2023. In 2022, the effective interest rate was LIBOR + 1.8%, while in 2023, it transitioned to SOFR + 2.1%, reflecting the shift from LIBOR to SOFR as the benchmark interest rate. This change aligns with broader market practices and regulatory transitions away from LIBOR.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $1,000 million carrying value in 2022 (matching ground truth), it incorrectly states that the 2022 interest rate was LIBOR + 1.8%. The ground truth explicitly states that *no specific interest rate framework was disclosed* in 2022. Additionally, the LLM falsely claims a transition from LIBOR to SOFR occurred for this note, but the ground truth indicates the SOFR + 2.1% framework was only introduced in 2023, with no prior LIBOR-based disclosure. (2) The $1,000 million amount is correct and consistent across years, but the interest rate details are fabricated. There is no mention of LIBOR or any spread in 2022 in the original answer, so the claimed 'transition' is unsupported. (3) The multi-hop reasoning is flawed: the model assumes a benchmark transition narrative (LIBOR to SOFR) based on market trends but applies it incorrectly to Amgen’s specific disclosures. The actual evolution is from *no rate framework disclosed* to *SOFR + 2.1% disclosed*, not a shift from one benchmark to another. (4) Scores reflect major factual errors in both quantitative (interest rates) and qualitative (disclosure evolution) aspects. Contextual relevance is moderate because the answer addresses the right topic and timeframe, but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 377,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 764 BCF at the end of 2021 to 296 BCF at the end of 2024, according to the provided data. This growth is attributed to factors such as upward revisions due to improved regional LNG market dynamics and technical advancements, as well as extensions and discoveries in equity affiliates, particularly in the Middle East and Australia. The increase in reserves indicates a strategic focus on expanding COP's presence in this region, leveraging favorable market conditions and development opportunities in key areas like LNG.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that COP's natural gas reserves in the Asia Pacific/Middle East region decreased from 326 BCF in 2022 to 296 BCF in 2024. The LLM incorrectly claims an increase from 764 BCF in 2021 to 296 BCF in 2024, which is not only a wrong starting figure but also misrepresents a decrease as an increase. (2) The numbers are significantly off: 764 BCF in 2021 is not supported by the ground truth, and no data for 2021 was requested or provided in the original answer. The 2024 figure (296 BCF) is correct, but it is framed as growth when it is actually a decline from 326 BCF. The calculation and trend are therefore fundamentally wrong. (3) The multi-hop reasoning is flawed—the question asks for evolution from 2022 to 2024, requiring comparison across those years. The LLM introduces an irrelevant year (2021) and fabricates a narrative of growth and strategic expansion, which contradicts the ground truth indication of a potential strategic pullback. (4) The contextual relevance is low because the answer discusses upward revisions and discoveries, which are not in the original data, and draws the opposite strategic conclusion. Scores are low due to complete failure in quantitative accuracy and reasoning, with only minimal relevance to the geographic region and metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 383,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Alphabet's repurchase activity of Class C Capital Stock increased from $52.577 billion in 2022 to $52.868 billion in 2023, indicating a slight rise in the amount spent on repurchasing shares. This suggests that Alphabet continued to prioritize returning value to shareholders through share buybacks in 2023, reflecting a consistent and potentially more aggressive capital allocation strategy focused on optimizing equity and enhancing shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, Alphabet repurchased $59.3 billion in 2022 and $62.2 billion in 2023 across Class A and Class C shares. However, the LLM states $52.577 billion in 2022 and $52.868 billion in 2023, which are both incorrect and understate the actual amounts. Additionally, the LLM focuses only on Class C shares, while the original answer specifies that repurchases included both Class A and Class C shares. The LLM also omits the critical information about the April 2023 $70.0 billion authorization and the $36.3 billion remaining as of year-end 2023, which are key to understanding the strategic shift. (2) The numbers provided by the LLM do not match the ground truth, and the year-over-year change is misrepresented: the correct increase is $2.9 billion ($62.2B - $59.3B), whereas the LLM reports only a $0.291 billion increase, which is both numerically and contextually wrong. (3) The reasoning is partially sound in interpreting that increased buybacks indicate a focus on shareholder returns, but it fails the multi-hop synthesis by not incorporating the new authorization and remaining capacity, which are essential for assessing the evolution of capital allocation strategy. (4) While the general direction of the conclusion (continued focus on buybacks) is plausible, the incorrect figures and missing strategic developments severely undermine the answer's accuracy. The contextual relevance is moderate because the topic and intent align with the question, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 444,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "AIG's use of frequency/severity methods between 2022 and 2023 has evolved in terms of the lines of business where they are applied and the reasoning behind their usage. In 2022, frequency/severity methods were primarily used for short-tail classes such as U.S. Property, where the nature of losses is low frequency/high severity. These methods were not employed for aviation exposures due to the high severity nature of the claims and the varying mix of claims from year to year. By 2023, the application of frequency/severity methods remained consistent for short-tail lines like U.S. Property, but the reasoning emphasized the importance of adjusting IBNR factors based on emerging claim experience, rate changes, loss trends, and inflation. Additionally, the methods were not applied to aviation exposures for the same reasons as in 2022. The evolution reflects a continued focus on adapting these methods to align with the specific characteristics and emerging trends of each line of business.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual omission that undermines its overall accuracy. (1) What was correct: The answer correctly states that in 2022, AIG used frequency/severity methods for short-tail classes like U.S. Property and avoided them for aviation due to high severity and variable claim mix—this aligns with the ground truth. It also accurately notes continued use in 2023 for short-tail lines and provides valid reasoning around IBNR adjustments, inflation, and loss trends. (2) Quantitative accuracy: There are no numerical values in the question or answer, so this aspect is not applicable; however, all dates (2022, 2023) and entity names (AIG, U.S. Property, aviation) are correct. (3) Multi-hop reasoning assessment: The critical failure is in the evolution between 2022 and 2023. The ground truth states that AIG *expanded* the use of frequency/severity methods to include U.S. Workers' Compensation—a long-tail line—in 2023. The LLM answer completely omits this key development and instead claims the application 'remained consistent,' which contradicts the documented strategic shift. This missing synthesis across years and lines of business represents a major flaw in multi-hop reasoning. (4) Justification for scores: Correctness is scored 5 because while core facts about 2022 and ongoing usage are accurate, the failure to identify the expansion into Workers' Compensation—a central part of the evolution—makes the answer significantly incomplete. Qualitative accuracy is 5 due to flawed reasoning about the evolution. Quantitative accuracy is 10 because no numbers are incorrect (none present). Contextual relevance is 8 because the answer stays on topic and discusses relevant lines and reasoning, even if it misses a key change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 483,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "From 2022 to 2023, Amgen's financial relationship with BeiGene evolved as follows:\n\n1. **Cost Recovery**: Net costs recovered from BeiGene for oncology product candidates decreased from $199 million in 2022 to $109 million in 2023.\n2. **Product Sales**: Product sales from Amgen to BeiGene increased from $64 million in 2022 to $125 million in 2023.\n3. **Profit and Loss Sharing**: Profit and loss share expenses related to the initial product-specific commercialization period decreased from $53 million in 2022 to $40 million in 2023. \n\nThese changes reflect ongoing collaboration dynamics and shifts in cost and revenue sharing under their joint oncology development and commercialization agreement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $199M to $109M cost recovery, $64M to $125M product sales, and $53M to $40M profit and loss sharing expenses—each value exactly matches the original answer. (2) The answer is complete, addressing all three financial dimensions (cost recovery, product sales, profit and loss sharing) across both years as required by the question. (3) Entity accuracy is correct: Amgen and BeiGene are properly identified, and the financial metrics are accurately named and contextualized within their collaboration. (4) The reasoning is sound and reflects appropriate multi-hop synthesis across time periods and financial categories. While the LLM does not explicitly state the interpretive conclusion about maturation of the collaboration (as the original answer does), it provides all the necessary factual basis for that inference and uses appropriate phrasing like 'ongoing collaboration dynamics' to contextualize the changes. The omission of the interpretive summary does not detract from factual correctness or completeness of the core financial evolution. All information conveyed is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 348,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "From 2022 to 2024, COP's natural gas reserves in the Asia Pacific/Middle East region experienced notable changes. In 2022, reserves ended at 326 BCF, with upward revisions of 423 BCF due to higher prices and regional LNG market dynamics, partially offset by downward revisions from operating costs. In 2023, reserves declined to 296 BCF due to downward revisions of 81 BCF from lower prices, despite minor upward technical revisions. By 2024, reserves slightly increased to 296 BCF, with minor upward revisions of 9 BCF and no significant purchases or extensions in the region. No major purchases or sales occurred in the Asia Pacific/Middle East region during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. While it correctly states the 2022 starting reserves (326 BCF) and the 2024 ending reserves (296 BCF), it fabricates large revisions not present in the ground truth: claiming 423 BCF upward revisions in 2022 and 81 BCF downward revisions in 2023, which are not supported by the original answer. The only revision mentioned in the ground truth is a +9 BCF addition in 2023, which the LLM does mention but buries within incorrect context. The LLM also incorrectly states that reserves 'increased' to 296 BCF in 2024, when in fact they decreased from 326 BCF in 2022 to 296 BCF in 2024. (2) The ground truth specifies that production subtracted 25 BCF in 2024, but the LLM fails to mention production entirely as a factor in the decline. The LLM correctly notes no purchases in 2024, aligning with the original answer. (3) The multi-hop reasoning is flawed: the LLM invents price- and cost-driven revisions not present in the source, misrepresents the direction and magnitude of changes, and fails to accurately track the reserve trajectory over time. It incorrectly implies a drop to 296 BCF in 2023 and then a flat 'increase' to the same value in 2024, when the ground truth shows a gradual decline from 326 to 296 BCF over the period with specific 2024 production impact. (4) Despite these issues, the answer is contextually relevant and attempts to address all parts of the question—reserves evolution, revisions, production, and purchases. The mention of 9 BCF revisions and no purchases aligns with the truth, earning partial credit. However, the severe quantitative inaccuracies and flawed reasoning limit the correctness score to 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 470,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "From 2022 to 2024, FedEx's planned usage of the B767F aircraft decreased significantly. In 2022, FedEx had committed to purchase 38 B767F aircraft across 2023 and 2024. However, by 2024, the number of B767F aircraft planned for purchase dropped to just 14 for 2025, with no commitments beyond 2026. This reduction indicates a strategic shift in fleet planning, likely driven by a focus on more fuel-efficient aircraft like the B777F and a reassessment of long-term operational needs and cost efficiencies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a reduction to 10 by 2025. By 2024, this projection changed to 11 for 2025 and only 3 by 2026. In contrast, the LLM claims that in 2022, FedEx had committed to purchase 38 B767F aircraft across 2023 and 2024, which is not supported by the ground truth. There is no mention of a purchase commitment of 38 aircraft in the original answer, nor is there any mention of 'purchase' at all—only projected usage numbers. The LLM incorrectly frames the data as purchase commitments rather than projected usage, which is a critical misrepresentation. (2) The numbers are entirely incorrect: 38 aircraft (LLM) vs. 14 (ground truth) for 2023–2024; 14 for 2025 (LLM) vs. 10–11 (ground truth); and no mention of 2026 in the original 2022 plan, but the LLM says 'no commitments beyond 2026'—which is speculative and unsupported. (3) The multi-hop reasoning is flawed: the LLM fails to correctly track the evolution of projected usage over time as presented in the original answer. It misidentifies the nature of the data (usage vs. purchase), introduces non-existent figures, and draws conclusions based on false premises. (4) While the general direction of the conclusion—that FedEx is reducing reliance on B767F—aligns with the original, the factual foundation is so weak that the answer cannot be considered correct. The contextual relevance is moderate because it addresses fleet planning strategy, but the inaccuracies severely undermine correctness. Quantitative accuracy is very low due to wrong numbers and mischaracterized data. Qualitative accuracy is partially acceptable due to the correct identification of a strategic shift, but reasoning is based on false data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 499,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "AIG's use of Expected Loss Ratio Methods between 2022 and 2023 evolved in terms of lines of business and reasoning as follows:\n\n1. **Lines of Business**: In 2022, Expected Loss Ratio methods were primarily applied to newer or less mature accident years, particularly in short-tail lines like U.S. Property and certain casualty segments. By 2023, the application expanded to include more recent accident years across a broader range of lines, including U.S. Workers' Compensation and Excess Casualty, where loss emergence is slower and historical data is limited.\n\n2. **Reasoning**: In 2022, the methods were used to supplement loss development techniques, especially in lines with inconsistent or insufficient historical loss data. By 2023, the methods were weighted more heavily in response to evolving market conditions, inflationary pressures, and changes in underwriting terms. The expected loss ratios were adjusted to reflect updated rate changes and emerging trends, particularly in lines with high severity and long-tail characteristics.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of factual content and reasoning, with accurate qualitative descriptions of AIG's evolving use of Expected Loss Ratio (ELR) methods between 2022 and 2023. It correctly identifies the expansion from shorter-tail to longer-tail lines and references U.S. Workers' Compensation as a key area of application in 2023, aligning with the ground truth. The reasoning about limited historical data and inflationary pressures is plausible and contextually appropriate. However, there are minor but notable discrepancies: (1) The original answer specifies aviation exposures in 2022 as a key use case for ELR methods, which the LLM omits, instead citing U.S. Property and general casualty segments—this is a partial misalignment in entity accuracy. (2) The ground truth emphasizes that in 2022, ELR was used primarily for the latest accident year in high-severity contexts like aviation, while the LLM generalizes to 'newer accident years' and 'short-tail lines' without highlighting the high-severity rationale. (3) The shift described in the original—from short-term forecasting in high-severity lines to broader use in long-tail, structurally complex lines like Workers' Compensation with risk-sharing features—is captured in spirit but not fully articulated in the LLM response; the mention of 'complex risk-sharing features' is missing, which is a key qualitative nuance. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect numbers are presented), and the contextual relevance is high since the response directly addresses the evolution in lines of business and reasoning. The multi-hop synthesis is reasonable but lacks precision in mapping the exact business lines and motivations across years. Thus, while the core facts are correct, the answer misses some specific details and nuances present in the ground truth, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 524,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "Cisco's positioning around Enterprise Data Center Transformation from 2022 to 2024 has evolved to emphasize strategic alliances and a broader architectural approach to address the convergence of technologies in the data center. In 2022, the company highlighted the increasing competition from entities that were also strategic alliance partners, as the enterprise data center transformed through the integration of computing, networking, storage, and software. By 2024, Cisco expanded its strategic alliances with companies like Apple, Equinix, and Google, and emphasized a five-prong innovation strategy (build, buy, partner, invest, co-develop) to strengthen its competitive position. This evolution reflects a more proactive and diversified approach to maintaining leadership in the data center space amid a dynamic competitive landscape.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Cisco's evolving positioning around Enterprise Data Center Transformation between 2022 and 2024, noting the technological convergence and competitive dynamics involving strategic partners. It accurately reflects the shift in focus toward broader alliance strategies by 2024. However, it introduces specific alliance partners—Apple, Equinix, and Google—that are not mentioned or verified in the ground truth, which only states a general expansion of alliances without naming companies. Additionally, the 'five-prong innovation strategy' (build, buy, partner, invest, co-develop) is not present in the original answer and appears to be an embellishment or inference not supported by the source. (2) There are no numeric values, dates, or financial metrics in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes Cisco’s changing stance on alliances and competition across years, but fails to restrict its claims to the information in the ground truth, introducing unsupported specifics. This affects qualitative accuracy. (4) Despite the addition of unverified details, the core evolution—increased complexity in alliances and a shifting competitive landscape including new players like Nvidia (though Nvidia is not mentioned in the LLM answer)—is partially reflected. The omission of Nvidia as a key new entrant from the competitive landscape weakens the answer. However, the overall structure, relevance, and direction of the response remain strong, warranting a correctness score of 7 for being substantially accurate but with notable factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 465,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "The effective interest rate for the 3.125% 2025 Notes changed from LIBOR + 1.8% in 2022 to SOFR + 2.1% in 2023, reflecting a transition from LIBOR to SOFR-based rates. The notional amount associated with the 3.125% 2025 Notes remained unchanged at $1,000 million between 2022 and 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The notional amount did not remain unchanged at $1,000 million between 2022 and 2023; rather, it decreased from $5.2 billion in 2022 to $1.0 billion in 2023. The LLM incorrectly states the 2022 notional amount as $1,000 million, which contradicts the ground truth. Additionally, the ground truth does not mention LIBOR + 1.8% as the 2022 effective rate; instead, it notes that new swaps were entered due to low interest rates but does not specify the pre-existing rate. The shift to SOFR + 2.1% in 2023 is correctly identified. (2) Quantitative accuracy is low: the $5.2 billion figure in 2022 is entirely omitted and replaced with an incorrect $1,000 million, which is only accurate for 2023. The effective interest rate in 2022 is fabricated (LIBOR + 1.8%) and not supported by the original answer. (3) Multi-hop reasoning is flawed: the model fails to correctly track the evolution of the notional amount over time and invents a rate for 2022 not present in the source. It also misses the broader context of a dynamic hedging strategy and reduction in hedged exposure. (4) Contextual relevance is moderate because the answer addresses the right financial instrument and time frame and correctly identifies the 2023 effective rate and notional amount, but major errors in key facts severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 385,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "Cisco has significantly elevated AppDynamics' strategic positioning within its product portfolio from 2022 to 2024, particularly within its observability offerings. In 2022, AppDynamics was mentioned as a key element in delivering full-stack observability, alongside technologies like ThousandEyes. By 2024, AppDynamics, through the acquisition of Splunk, became a central component of the Observability product category, contributing to a 27% revenue increase in this category. This reflects a stronger emphasis on AppDynamics as a core offering for providing insights and analytics across hybrid and multicloud environments.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly notes AppDynamics' role in full-stack observability in 2022 alongside ThousandEyes, it incorrectly claims that AppDynamics became central to the Observability category 'through the acquisition of Splunk' by 2024. Cisco's acquisition of Splunk was announced in 2023 but closed in 2024, and Splunk enhances rather than subsumes AppDynamics; the original answer correctly identifies that AppDynamics was integrated into a newly created 'Observability' revenue category, not via Splunk's acquisition. (2) The 27% revenue increase in the Observability category is entirely fabricated and not present in the ground truth; no quantitative financial performance data was provided in the original answer, making this a serious quantitative error. (3) The multi-hop reasoning is partially sound—recognizing a shift in strategic emphasis from 2022 to 2024—but flawed in causality and entity relationships. The integration of AppDynamics into a formal Observability category is correctly inferred as a sign of increased strategic importance, but the reasoning is undermined by incorrect attribution to Splunk's acquisition. (4) Contextual relevance is high because the answer addresses the evolution of AppDynamics' positioning within observability; however, correctness is severely impacted by false entities (Splunk acquisition as a mechanism) and invented metrics (27% growth), warranting a low quantitative accuracy score and moderate qualitative accuracy due to partial factual alignment on structural changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 437,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The effective interest rate for the 4.663% 2051 Notes remained at 5.6% in both 2022 and 2023, while the notional amount stayed constant at $1.5 billion during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that in 2022, the 4.663% 2051 Notes were part of a $5.2 billion hedged portfolio with swaps terminated and replaced, but the LLM claims the notional amount was $1.5 billion with a 5.6% effective rate—both figures are factually wrong for 2022. In 2023, the notional amount was indeed $1.5 billion, which matches, but the effective rate was SOFR + 4.3%, not 5.6%. The LLM fails to mention the hedging strategy change or the SOFR-based rate, which are key qualitative points. (2) The only correct number is the 2023 notional amount ($1.5 billion); all other figures (5.6% rate in both years) are fabricated and do not appear in the ground truth. There is no mention of SOFR or swap restructuring, so calculations and rates are entirely inaccurate. (3) The multi-hop reasoning is flawed: the model fails to connect the 2022 hedging activity involving $5.2 billion to the later refinement in 2023 of $1.5 billion at SOFR + 4.3%. It incorrectly assumes static values across years without acknowledging structural changes in the debt or hedging strategy. (4) Correctness and quantitative accuracy are low due to major factual errors. Qualitative accuracy is poor due to missing reasoning about hedging evolution. Contextual relevance is moderate because the answer addresses the right instrument and time frame, but with wrong details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 401,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods has evolved in terms of segmentation criteria and lines of business. In 2023, AIG emphasized higher attachment points in the U.S. Excess Casualty portfolio by adjusting participations in various layers within an insured's program. Additionally, for U.S. Workers' Compensation, AIG continued to use a combination of loss development and expected loss ratio methods, with segmentation by state, industry subset, and deductible size. The proportion of large deductible business has increased, which has slowed the reporting pattern of claims. These changes reflect a more refined approach to risk segmentation and underwriting strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description of AIG's evolving use of expected loss ratio methods between 2022 and 2023, with accurate entity identification (AIG, U.S. Workers' Compensation, segmentation criteria). It correctly notes the increased granularity in segmentation by state, industry subset, and deductible size in 2023, aligning with the ground truth. However, the LLM introduces information not present in the original answer—specifically, the mention of 'U.S. Excess Casualty portfolio' and 'higher attachment points'—which were not part of the documented evolution in the ground truth. Additionally, while the ground truth emphasizes that in 2022 the expected loss ratio method was used only in a general sensitivity analysis without detailed segmentation, the LLM does not clearly contrast the 2022 baseline, instead focusing on 2023 developments. This results in a partial omission of the comparative evolution. There are no numerical inaccuracies (quantitative accuracy is high, scoring 10), and the contextual relevance is strong as the response directly addresses the question's focus on methodological evolution. The reasoning is sound but not fully complete in synthesizing the multi-hop contrast between years and lines of business, hence a qualitative accuracy score of 7. Overall, the answer captures the core correct information but lacks full completeness in contrasting 2022 vs 2023 and includes a minor extraneous detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 403,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "PepsiCo's engagement with the 2.850% Senior Notes due 2026 remained consistent between 2023 and 2024, as these notes were authorized and referenced in both years' filings. In 2024, PepsiCo expanded its debt issuance strategy by introducing new senior notes, such as the 4.500% Senior Notes due 2029, the 4.800% Senior Notes due 2034, and the 5.250% Senior Notes due 2054, as part of its broader approach to managing debt maturity profiles and optimizing capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo maintained engagement with the 2.850% Senior Notes due 2026 across both years and expanded its debt strategy in 2024, which aligns with the ground truth's overall narrative. However, the specific new notes cited in the LLM answer — the 4.500% due 2029, 4.800% due 2034, and 5.250% due 2054 — do not match the ground truth, which reports the introduction of a 7.00% Senior Note due 2029 and a 5.50% Senior Note due 2035. These discrepancies in interest rates and maturity dates are significant and factually incorrect. (2) Quantitative accuracy is low because all three new note rates and maturities are wrong. Even though the format of presenting percentages and dates is correct, the actual values do not reflect the ground truth data. There are no calculations in the response, so no arithmetic verification is needed, but the factual numbers are inaccurate. (3) The multi-hop reasoning is partially sound: the model correctly infers that PepsiCo broadened its debt strategy and situates the 2.850% notes within a larger capital structure context. However, it fails to accurately synthesize the specific instruments introduced in 2024, undermining the factual basis of the conclusion. (4) Contextual relevance is high because the answer addresses both parts of the question — continuity of the 2026 notes and evolution in debt strategy — and uses appropriate financial terminology. The reasoning structure mirrors the ground truth, but with incorrect supporting data. Thus, while the qualitative logic is reasonable, quantitative inaccuracy severely limits correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 447,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Between fiscal years 2022 and 2024, Cisco's exposure to channel partner financing guarantees increased, with the maximum potential future payments rising from $188 million in 2022 to $127 million in 2024 (before accounting for deferred revenue adjustments). This evolution suggests that Cisco has maintained a measured approach to its financial risk management strategy, limiting the scale of its guarantees and ensuring that these obligations remain immaterial to its overall financial position. The company's continued facilitation of such guarantees reflects a strategic effort to support channel partners' working capital needs while prudently managing its own risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in fiscal year 2022, Cisco's channel partner financing volume was $27.9 billion, with $1.4 billion subject to guarantees as of July 30, 2022. The LLM incorrectly states that 'maximum potential future payments' were $188 million in 2022 and $127 million in 2024, which contradicts the disclosed $1.4 billion guarantee balance in 2022 alone. These figures are not only wrong but also inconsistent with the scale of Cisco's actual exposure. Furthermore, the LLM claims exposure increased, while the ground truth indicates that no updated quantitative data was provided for 2024, making any comparison speculative. (2) The numbers cited in the LLM answer ($188M, $127M) do not appear in the original answer and are factually incorrect. There is no mention of 'maximum potential future payments' in the ground truth, nor any deferred revenue adjustments. The absence of 2024 figures in the original means the LLM fabricated data rather than acknowledging the lack of disclosure. (3) The multi-hop reasoning is flawed. The question requires synthesizing changes in disclosure practices and interpreting their implications. The ground truth emphasizes reduced transparency and inability to assess actual exposure change due to missing 2024 data. The LLM instead asserts a trend with false numbers, failing to recognize the shift in disclosure policy as a key signal. (4) The contextual relevance is moderate because the answer addresses channel partner financing and risk management, but the incorrect data and false trend undermine its validity. The qualitative reasoning about supporting partners while managing risk is plausible but unsupported by the actual facts. Due to major quantitative errors and incorrect synthesis, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 503,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "The 2.45% 2030 Notes were issued in 2020 with a coupon rate of 2.45%. In 2021, the company entered into interest rate swap contracts with a notional amount of $1.0 billion, effectively converting the fixed-rate coupon to a floating rate of LIBOR + 1.0%. By 2023, these swaps were updated to use SOFR as the reference rate, maintaining an effective interest rate of SOFR + 1.3% on a notional amount of $1,000 million. Thus, the interest rate structure evolved from LIBOR-based to SOFR-based swaps, reflecting the transition in benchmark rates.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the interest rate swaps were entered into in 2021, while the ground truth specifies 2022. Second, it claims the floating rate was LIBOR + 1.0%, but the original answer states the swap converted the fixed rate to a LIBOR-based coupon without specifying a spread in 2022; only in 2023 was the rate explicitly SOFR + 1.3%. The LLM invents a LIBOR + 1.0% spread not present in the ground truth. The notional amount ($1.0 billion or $1,000 million) and the transition from LIBOR to SOFR are correctly captured. (2) Quantitative accuracy is partially correct: the $1.0 billion notional is accurate and format variations are acceptable, but the fabricated spread (LIBOR + 1.0%) and wrong year (2021 vs 2022) reduce accuracy. (3) The multi-hop reasoning is generally sound—recognizing the evolution of the interest rate structure from fixed to floating and then benchmark transition—but relies on incorrect dates and terms. The core idea of benchmark transition is correct, but details are flawed. (4) Contextual relevance is high as the answer addresses the evolution of the note's interest rate structure over time and focuses on the right financial instrument. However, due to key factual errors in dates and rates, the correctness score is moderate at 5, reflecting partial accuracy with significant omissions and inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 395,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "Between 2022 and 2023, FedEx's relationship with Pass-Through Certificates remained consistent in terms of financial guarantees and obligations. In both years, FedEx Express issued $970 million of Pass-Through Certificates, Series 2020-1AA, with a fixed interest rate of 1.875% due in February 2034. These Certificates are secured by 19 Boeing aircraft, with a net book value of $1.8 billion in 2022 and $1.7 billion in 2023. Crucially, the payment obligations under the Certificates are fully and unconditionally guaranteed by FedEx in both years, indicating no material change in the company's financial commitment or structure related to these instruments.",
      "correctness_score": 2,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that $970 million of Pass-Through Certificates, Series 2020-1AA, were issued and secured by 19 Boeing aircraft with a net book value of $1.8 billion in 2022, it incorrectly claims that FedEx maintained full and unconditional guarantees in both 2022 and 2023. The ground truth explicitly states that in 2023, FedEx clarified that these certificates were *not* direct obligations nor guaranteed by FedEx or FedEx Express—indicating a reversal of position, not consistency. This is a critical error in the core claim of the response. Additionally, the $1.7 billion net book value in 2023 is not mentioned in the original answer and cannot be verified from the ground truth. (2) Quantitatively, the $970 million, 1.875% interest rate, 2034 maturity, and $1.8 billion 2022 net book value are plausible but only partially supported; the 2023 net book value of $1.7 billion and continued guarantee are incorrect. The interest rate and maturity date are not present in the ground truth, so their inclusion appears fabricated. (3) The multi-hop reasoning is flawed: the question asks about the *evolution* of the relationship, requiring comparison and synthesis across years. The LLM incorrectly concludes no change occurred, directly contradicting the ground truth’s key point of a shift from guaranteed to non-guaranteed status. (4) Scores reflect that while some numbers align and the topic is relevant, the central factual claim is false, undermining correctness and qualitative reasoning. Contextual relevance is moderate because the answer discusses the right instruments and timeframe but misrepresents the key development.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 468,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "From 2023 to 2024, Mastercard increased its use of risk mitigation arrangements to manage gross settlement exposure, as evidenced by the rise from $12,167 million in 2023 to $13,466 million in 2024. This increase indicates a more proactive approach to risk management, reflecting the company's efforts to enhance its safeguards against potential settlement failures and reduce net exposure. The evolution suggests a strategic focus on strengthening credit risk controls and adapting to changing risk environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in risk mitigation arrangements from $12,167 million in 2023 to $13,466 million in 2024, matching the ground truth exactly. It also correctly references the time frame (2023 to 2024) and the trend of increasing mitigation use. However, while the ground truth includes gross settlement exposure figures ($75,023M in 2023 and $78,385M in 2024), the LLM answer omits these specific exposure totals, which are part of the full evolution described in the original answer. This is a minor omission but does not distort the overall message. (2) All numeric values cited in the LLM response are accurate and match the ground truth; no calculation errors are present. Format variations are acceptable and correctly interpreted. (3) The reasoning is sound: the model correctly infers that increased use of mitigation arrangements indicates a more proactive or robust risk management strategy. It logically connects rising mitigation with enhanced risk controls, aligning with the multi-hop synthesis required (linking numerical trends to strategic implications). (4) The answer is contextually relevant and directly addresses both parts of the question—evolution over time and strategic implication—though slightly less complete due to missing the gross exposure figures. The qualitative assessment is strong, with appropriate interpretation of risk management intent. The omission prevents a perfect 10, but the core facts and logic are correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 420,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments decreased from $145 million as of May 31, 2023, to $146 million as of May 31, 2024, indicating a relatively stable exposure management strategy. This slight increase in liabilities suggests that Nike maintained a consistent approach to hedging foreign currency risks, particularly for key currency pairs like Euro/U.S. Dollar and Chinese Yuan/U.S. Dollar, despite fluctuations in exchange rates. The stability in liabilities reflects Nike's ongoing efforts to mitigate the impact of currency volatility on its financial results.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, Nike's total liabilities for foreign exchange forwards and options designated as hedging instruments increased from $48 million in 2022 to $115 million in 2024. However, the LLM claims liabilities were $145 million in 2023 and $146 million in 2024—numbers that do not appear in the original answer and are factually wrong. The LLM also references May 31, 2023, and May 31, 2024, but the ground truth compares 2022 and 2024, not 2023 to 2024, introducing incorrect time periods. (2) The quantitative inaccuracies are severe: the LLM reports $145M and $146M, which are not supported by the ground truth. The correct totals are $48M in 2022 and $115M in 2024—an increase of $67M. The LLM’s calculation of a 'slight increase' from $145M to $146M is both numerically and directionally incorrect (wrong base years and values). (3) The multi-hop reasoning is flawed: the question requires comparing liabilities across 2022 and 2024, synthesizing data from two different years and balance sheet categories (accrued liabilities and deferred income taxes). The LLM fails to perform this synthesis, instead inventing figures and citing non-matching years. It also introduces specific currency pairs (Euro/USD, CNY/USD) not mentioned in the ground truth, adding unsupported detail. (4) While the LLM attempts to interpret the strategic implication (stable hedging strategy), this contradicts the ground truth conclusion of a 'significant increase' indicating higher exposure or strategic shift. Thus, the reasoning and conclusion are invalid. The answer is contextually relevant in topic and structure but fails on factual and logical grounds.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 476,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "Between the 2022 and 2023 10-K filings, the representation of Bounty within P&G's Baby, Feminine & Family Care segment remained consistent, as it was listed under the Family Care sub-category in both years. In 2022, the segment description noted Bounty as part of the North American family care business, while in 2023, it was similarly positioned. This consistent mention suggests stable brand visibility within the segment, with no significant changes in its role or emphasis.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Bounty was listed in both the 2022 and 2023 10-K filings as a key brand. According to the ground truth, Bounty was not explicitly listed among the key brands in the 2022 10-K, but was explicitly included in 2023. This misrepresents the evolution of Bounty's representation. The LLM claims 'consistent mention' and 'stable brand visibility,' which directly contradicts the ground truth indicating an increase in visibility due to the new explicit listing in 2023. (2) There are no numeric values in this question, so quantitative accuracy is not applicable; however, the LLM did not fabricate any numbers, so no penalty on that dimension. (3) The multi-hop reasoning failed: the question required comparing two filings across years to detect a change in brand categorization and infer visibility implications. The LLM incorrectly concluded no change occurred, failing to synthesize the key difference in brand listing status. (4) Contextual relevance is moderate because the answer addresses the right segment and company, and attempts a year-over-year comparison, but the core conclusion is factually wrong. Correctness and qualitative accuracy are low due to the central factual error in entity representation and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 362,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "Oracle's approach to its hardware business, particularly Oracle Engineered Systems, between fiscal 2022 and fiscal 2023 remained relatively consistent in terms of revenue recognition, with hardware revenues generally recognized at the point in time when the hardware product and related software are delivered to the customer and ownership is transferred. However, strategically, Oracle emphasized the importance of enabling customer choice and flexibility by facilitating migration of applications and infrastructure software licenses to Oracle Cloud Services. This reflects a broader strategic shift toward cloud-based offerings, even as the hardware business maintained its role in providing essential infrastructure technologies.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in Oracle's approach between fiscal 2022 and 2023, particularly regarding changes in revenue recognition treatment and strategic emphasis on R&D and integration. (1) Correctly identifies that revenue is recognized at the point of delivery and ownership transfer, which aligns with the 2023 policy in the ground truth. However, it fails to note that in 2022, revenue recognition was discussed in the context of cloud and license contracts without explicit mention of hardware and software as a combined performance obligation—a key evolution highlighted in the original answer. (2) There are no numeric values to verify, so quantitative accuracy is not applicable; however, the absence of specific financials or calculations does not detract from accuracy since the question doesn't require them. (3) The multi-hop reasoning is weak: the LLM does not synthesize the shift from a contractual/timing focus in 2022 to a more integrated, innovation-driven strategy in 2023 involving combined performance obligations and R&D investments. Instead, it emphasizes cloud migration, which is contextually relevant but not the core strategic shift described in the ground truth. (4) While the answer is relevant and well-structured, it conflates Oracle’s broader cloud strategy with the specific evolution of the hardware business, thereby missing the nuanced change in both accounting treatment and strategic focus on hardware-software integration and innovation. This results in a moderate correctness score due to significant omissions in qualitative and comparative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 447,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "Between 2022 and 2023, sales of ERLEADA increased by 26.9%, from $1.881 billion to $2.387 billion. This significant growth indicates a strong market trajectory for ERLEADA, driven by continued share gains and market expansion in the treatment of Metastatic Castration-Resistant Prostate Cancer.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: ERLEADA sales were $1,881 million (=$1.881 billion) in 2022 and $2,387 million (=$2.387 billion) in 2023, with a 26.9% growth rate—correctly calculated and reported. (2) Quantitative accuracy is perfect: the dollar amounts and percentage increase align exactly with the original answer, allowing for format variation (e.g., billion vs. million). (3) The multi-hop reasoning is sound—sales figures across two years are correctly compared, and the conclusion about market trajectory is logically derived. (4) The LLM adds contextual insight ('continued share gains and market expansion in the treatment of Metastatic Castration-Resistant Prostate Cancer') that is plausible and enhances relevance without contradicting the ground truth. All parts of the question are addressed: sales evolution and market trajectory. Thus, all scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 276,
        "total_tokens": 1418
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "From 2023 to 2024, CMCSA's relationship with local broadcast television stations has shifted toward increased financial dependency and negotiation challenges. Programming expenses for video services, including retransmission consent payments to local broadcast stations, have risen on a per-subscriber basis, driven by demands for higher payments and industry consolidation. This trend has heightened operational costs and reduced CMCSA's negotiating flexibility. Additionally, as consumers shift toward DTC streaming services like Peacock, CMCSA faces declining linear television viewership and subscriber losses, reducing the leverage traditionally held by broadcast stations. This evolving dynamic has placed CMCSA in a more vulnerable position, requiring it to balance higher costs with the need to adapt to changing distribution models and consumer preferences.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a shift in CMCSA's relationship with local broadcast television stations from 2023 to 2024, noting increased financial dependency due to rising retransmission consent costs and reduced negotiating power. It accurately reflects trends like higher programming expenses per subscriber and the impact of consumer shift to DTC streaming. However, it misses the core evolution emphasized in the ground truth: the shift from direct competition in 2023 (for viewers and ad revenue) to operational dependency in 2024 (via retransmission consent for content distribution). This key strategic transformation—competition to dependency—is not clearly articulated. Instead, the LLM focuses on cost pressures and negotiation dynamics without framing the relationship change as a fundamental shift in competitive positioning. (2) There are no specific numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the original or LLM answer, so quantitative accuracy is not compromised; the LLM does not fabricate numbers. (3) The multi-hop reasoning is partially sound: it connects rising retransmission costs, subscriber declines, and DTC competition, but fails to synthesize the exact nature of the relationship shift—i.e., from competing entities to interdependent ones where CMCSA’s linear networks depend on local stations to deliver broadcast content. This weakens the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the timeframe, entities, and themes of dependency and distribution. However, the absence of the central 'competition to dependency' narrative from the ground truth limits correctness, warranting a score of 6—partially correct with significant conceptual omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 483,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "The value of Held-to-Maturity (HTM) securities held by Mastercard (MA) decreased significantly from $306 million in 2023 to $38 million in 2024. This decline indicates a strategic shift in the company's investment approach, likely reallocating funds from short-term, interest-bearing time deposits to other investment vehicles such as available-for-sale securities or equity investments. The reduction in HTM securities suggests a potential pursuit of higher returns or greater flexibility in managing its investment portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the quantitative change in HTM securities from $306 million in 2023 to $38 million in 2024, matching the ground truth exactly. These numbers are accurate and properly attributed to MA (Mastercard) and the correct years. (2) All numeric values are correct—$306 million in 2023 and $38 million in 2024—with no calculation errors. The format is consistent and acceptable. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift due to the sharp decline. However, it introduces a detail not present in the ground truth—reallocating funds from 'short-term, interest-bearing time deposits'—which is inaccurate because HTM securities are typically long-term, not short-term, and the original answer does not mention time deposits. Additionally, the suggestion of a move toward 'available-for-sale securities or equity investments' is speculative and not supported in the ground truth, which instead suggests a move toward more liquid or short-term positions. This mischaracterization affects the qualitative accuracy. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of HTM value and strategic implication—and remains focused on MA's investment strategy. The correctness score is 8 because while all key facts and numbers are correct, the interpretation contains plausible but unsupported details that slightly misrepresent the strategic rationale.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 408,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "Between 2022 and 2023, the Always brand remained within the Baby, Feminine & Family Care segment, specifically under the Feminine Care category. In 2022, Always was listed under the sub-category of \"Feminine Care (Adult Incontinence, Feminine Care)\" alongside Tampax. In 2023, the categorization was slightly refined, with Always explicitly positioned under the \"Feminine Care\" sub-category, which includes \"Adult Incontinence, Menstrual Care.\" This reflects a more specific product focus for Always, particularly on menstrual care, while continuing to include its role in adult incontinence under the Always Discreet sub-brand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Always remained within the Baby, Feminine & Family Care segment and was categorized under Feminine Care in both 2022 and 2023. The evolution in categorization—from a broader 'Feminine Care' grouping to a more specific alignment with 'Menstrual Care' under the updated structure—is accurately reflected. The mention of 'Adult Incontinence, Menstrual Care' as the 2023 sub-category structure matches the strategic shift described in the original answer. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023) and categorical labels are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in sub-category naming and positioning across years, noting the refinement in focus. (4) The only minor shortcoming is that the LLM introduces the Always Discreet sub-brand and its connection to adult incontinence, which is plausible but not mentioned in the ground truth. While this addition is reasonable and consistent with known branding, it slightly exceeds the provided information, preventing a perfect score. Otherwise, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 365,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Between 2022 and 2023, Oracle's positioning and financial contribution of Oracle Engineered Systems, as part of its hardware business, remained relatively stable in terms of revenue contribution, representing 6% of total revenues in both fiscal 2023 and 2024. Revenue recognition for Oracle Engineered Systems, as part of hardware products, is generally recognized at the point in time when the hardware product and its related software are delivered to the customer and ownership is transferred. The strategic emphasis on hardware, including Oracle Engineered Systems, has been consistent with Oracle's broader focus on providing enterprise IT solutions, though the hardware business has lower operating margins compared to Oracle's cloud and license business due to higher production and support costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Oracle's hardware business, including Engineered Systems, represented 6% of total revenues in fiscal 2023 and 2024, which aligns with the ground truth. It also accurately describes revenue recognition as occurring at the point in time when the product and related software are delivered. However, it omits a key detail from the original answer: in 2022, no specific percentage of total revenue was disclosed for Engineered Systems or hardware, whereas the LLM implies the 6% figure applied in 2022 by stating the contribution 'remained relatively stable' and representing 6% in both 2023 and 2024, which could be misinterpreted as also being 6% in 2022. This is a minor inaccuracy in trend interpretation. (2) All numeric values (6%, fiscal 2023 and 2024) are correct and match the ground truth. The revenue recognition timing is accurately described. (3) The reasoning is mostly sound—correctly identifying Engineered Systems as part of hardware and tracking its revenue contribution. However, the synthesis across years is slightly flawed: the model fails to highlight the evolution from no explicit percentage in 2022 to a clear 6% disclosure in 2023, which is a central point in the original answer about increased transparency and strategic emphasis. (4) The answer is contextually relevant and addresses both revenue recognition and strategic emphasis, though it downplays the shift in disclosure clarity and new strategic factors like R&D investments and manufacturing partner impacts mentioned in 2023. Overall, the answer is factually strong but misses nuanced evolution in reporting and strategy, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 463,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Comcast's relationship with representation firms in advertising sales has shifted slightly between 2023 and 2024. In 2023, the company noted that it works with representation firms as an extension of its sales force to sell a portion of advertising units allocated to it, recording revenue net of agency commissions. By 2024, the description of this relationship remained largely consistent, but the emphasis on representation firms was reduced, with a greater focus on internal sales efforts and direct advertising sales. This suggests a potential slight reduction in reliance on representation firms in favor of internal sales strategies.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of Comcast's relationship with representation firms. While it correctly states the 2023 arrangement—working with representation firms as an extension of the sales force and recording revenue net of commissions—it falsely claims that in 2024 there was a reduced emphasis on these firms and a shift toward internal sales. The ground truth states the opposite: in 2024, Comcast evolved the relationship into formal representation agreements, expanding the role of these firms to sell advertising on behalf of third parties, indicating deeper strategic alignment. This represents a significant strategic expansion, not a reduction. The LLM answer thus misrepresents the direction of change and fails to identify the key shift from a co-selling model to a formalized representation structure. There are no numeric values to evaluate, so quantitative accuracy is scored as 10 by default. Qualitative accuracy is low due to incorrect reasoning and entity relationship synthesis. Contextual relevance is moderate because the answer addresses the general topic and timeframe but draws the wrong conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 329,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle's approach to its industry-specific hardware offerings between fiscal 2022 and fiscal 2023 remained relatively consistent in terms of revenue recognition, with revenues for hardware products and related software generally recognized at the point in time when the hardware is delivered to the customer and ownership is transferred. However, strategically, Oracle emphasized a continued focus on cloud services over hardware, as evidenced by the decline in hardware's contribution to total revenues (6% in both fiscal 2024 and 2023, but with a marginal decrease in hardware revenues from $3,359 million in fiscal 2022 to $3,183 million in fiscal 2023). The company also highlighted the challenges of hardware's lower operating margins and the competitive pressure from cloud infrastructure offerings, signaling a strategic shift toward cloud-based solutions.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and misrepresents Oracle's strategic emphasis. The original answer states that Oracle increased its strategic focus on hardware innovation in fiscal 2023 through R&D investments, signaling a more deliberate push in this area. In contrast, the LLM claims Oracle emphasized a shift toward cloud services and away from hardware, which contradicts the ground truth. This fundamental error undermines the core of the response. (2) Quantitatively, the LLM introduces numbers not present in the original answer: hardware revenues of $3,359 million in fiscal 2022 and $3,183 million in fiscal 2023, and a 6% contribution to total revenue in fiscal 2023 and 2024. These figures are not supported by the ground truth and introduce unverified data. While revenue decline might be plausible, it is not mentioned in the original answer and thus cannot be assumed. (3) The multi-hop reasoning is flawed. The question asks about evolution in revenue recognition and strategic emphasis. The LLM correctly notes that revenue recognition remained point-in-time upon delivery, which aligns with the original answer’s description for both years. However, it fails to capture the key evolution: in fiscal 2023, Oracle provided a more detailed explanation of combined performance obligations (hardware plus software), which the LLM omits entirely. This is a critical missing nuance in revenue recognition changes. (4) Contextual relevance is moderate—the answer addresses revenue recognition and strategy in the right domain, but the incorrect strategic narrative and unsupported numbers reduce usefulness. The answer appears plausible but diverges significantly from the ground truth in both qualitative and quantitative aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 483,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "Sales of IMBRUVICA (ibrutinib) declined by 13.7% in 2023 compared to 2022, driven by operational growth of -13.2% and a negative currency impact of 0.5%. This decrease was primarily attributed to global competitive pressures facing the drug.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 13.7% year-over-year decline in IMBRUVICA sales from $3.784 billion in 2022 to $3.264 billion in 2023, which matches the ground truth calculation (difference is ~$520 million, or 13.7%). This demonstrates strong quantitative accuracy. The breakdown into operational growth (-13.2%) and currency impact (-0.5%) adds granularity not in the original answer but does not contradict it, assuming these sum to the total -13.7% decline. (2) However, the LLM omits key contextual factors mentioned in the ground truth, such as pandemic-related delays in new patient starts in 2022 and the increasing market saturation or treatment shifts in oncology in 2023. Instead, it attributes the decline solely to 'global competitive pressures,' which, while correct, is incomplete. (3) The multi-hop reasoning is partially sound—it correctly synthesizes the sales trend across years and identifies competition as a driver—but fails to incorporate the evolution of contributing factors over time (i.e., how 2022 dynamics led into 2023 trends). (4) Scores reflect high factual accuracy in numbers (quantitative accuracy: 9), moderate shortfall in depth and completeness of reasoning (qualitative accuracy: 6), high relevance to the question (contextual relevance: 9), and an overall correctness score of 7 due to missing key explanatory elements despite correct core metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 389,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "From 2023 to 2024, Comcast's involvement with Universal Beijing Resort remained consistent in terms of ownership structure, as Comcast retained a 30% interest. The debt levels slightly decreased, with Universal Beijing Resort's outstanding debt dropping from $3.5 billion in 2023 to $3.4 billion in 2024. Financial risk exposure remained unchanged, as Comcast's maximum risk of loss is limited to its 30% equity stake, with no additional guarantees or liquidity arrangements in place.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Comcast maintained a 30% ownership stake in Universal Beijing Resort from 2023 to 2024; total debt decreased from $3.5 billion to $3.4 billion, consistent with the ground truth. The term loan reduction from $3.1B to $3.0B is implied by the overall debt decrease and consistent, though not explicitly mentioned. (2) Quantitative accuracy is perfect: all dollar amounts and percentages match the original answer, with acceptable format usage. (3) The reasoning is sound—correctly identifying that Comcast consolidates the resort as a VIE and that financial risk remains limited to its equity interest, indicating proper multi-hop synthesis across ownership, debt, and risk exposure. (4) The only minor omission is not explicitly stating that Comcast consolidates Universal Beijing Resort as a VIE, though the implication of consolidation is present through the discussion of risk and ownership. This does not detract significantly from the answer’s correctness. All parts of the question (debt levels, ownership, financial risk) are addressed with high fidelity. Semantic equivalence is achieved, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 348,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "From 2022 to 2023, the financial commitment related to future lease payments for build-to-suit facilities and equipment increased significantly. In 2022, the undiscounted future payments for these leases were approximately $3.4 billion, expected to commence between 2023 and 2024. By 2023, this amount had decreased to approximately $0.9 billion, with commencement dates expected from 2025 to 2027. This shift indicates that FedEx is likely adopting a more measured and long-term leasing strategy, delaying the commencement of new build-to-suit leases and spreading out capital commitments over a longer timeframe.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the opening sentence, stating that the financial commitment 'increased significantly' when in fact it decreased from $3.4 billion to $0.9 billion—a major factual misstatement that contradicts the ground truth. However, the specific dollar amounts ($3.4 billion in 2022 and $0.9 billion in 2023) and the commencement date ranges (2023–2024 for 2022, 2025–2027 for 2023) are correctly reported, supporting partial credit. (2) Quantitatively, the numbers are accurate and match the ground truth, with correct formatting and magnitude. The reduction from $3.4B to $0.9B is a ~73.5% decrease, which the model fails to interpret correctly due to the erroneous 'increased' claim. (3) The multi-hop reasoning is partially sound—synthesizing data across two years and identifying a shift in timing of lease commencements—but the conclusion mischaracterizes the trend. While the interpretation about a 'more measured and long-term leasing strategy' and 'spreading out capital commitments' aligns thematically with the ground truth's 'strategic shift toward fewer long-term commitments,' the flawed premise (increase vs. decrease) undermines the reasoning. (4) Contextual relevance is high, as the answer addresses both parts of the question—evolution of lease payments and implications for leasing strategy—and uses appropriate financial terminology. However, the incorrect directional characterization of the change severely impacts overall correctness, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 422,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Mastercard's relationship with Dynamic Yield LTD evolved from an acquisition in 2022 to being integrated into the company's strategic focus on enhancing its value-added services and solutions. The acquisition of Dynamic Yield for $325 million in 2022, which added capabilities in data personalization and customer engagement, indicates Mastercard's emphasis on expanding its offerings in digital solutions and improving customer experience. This aligns with the growth in Mastercard's value-added services and solutions revenue, which increased from $9,274 million in 2023 to $10,832 million in 2024, reflecting the company's strategic focus on diversifying its revenue streams and investing in technologies that support digital transformation and customer-centric innovation.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct facts but misses key elements from the ground truth and introduces inaccuracies. It correctly states the $325 million acquisition amount and references the strategic intent behind acquiring Dynamic Yield (data personalization, customer engagement). However, it fails to mention that the acquisition occurred in April 2022, not 2023, and omits the critical detail about $200 million of goodwill attributed to synergies. More importantly, the LLM answer fabricates a revenue increase in value-added services from $9,274 million in 2023 to $10,832 million in 2024—this data is not in the original answer and cannot be verified from the provided context. (2) Quantitative accuracy is partially correct: the $325M acquisition figure is accurate, but the revenue figures for 2023 and 2024 are not present in the ground truth and appear to be hallucinated. There is no mention of revenue growth in the original answer, so this undermines the quantitative reliability. (3) The multi-hop reasoning is flawed. The original answer emphasizes that by 2024, there were no new developments with Dynamic Yield, indicating integration completion and a strategic pivot to cybersecurity via the Recorded Future acquisition. The LLM answer instead implies ongoing strategic focus on Dynamic Yield through revenue growth, which contradicts the ground truth. It fails to mention the shift to Recorded Future or the stabilization of the Dynamic Yield relationship. (4) The contextual relevance is high because the answer addresses Mastercard’s strategic focus and ties Dynamic Yield to broader digital transformation goals. However, due to significant omissions (goodwill, integration status, pivot to cybersecurity) and the inclusion of unsupported financial data, the qualitative and correctness scores are reduced. The answer captures part of the strategic narrative but misrepresents the evolution and current state of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 531,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Lowe's Companies, Inc. Severance Plan for Senior Officers was amended and restated on May 26, 2022, as indicated in the 2024 filing (page 79). The most recent amendment is referenced in Exhibit 10.28, which was filed on November 27, 2024, showing an update to the plan since the 2022 version.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the most recent amendment date of the Severance Plan for Senior Officers as May 26, 2022, and accurately states that it was filed on November 27, 2024, under Exhibit 10.28—both of which match the ground truth. It also correctly references the 2024 filing (page 79), which aligns with the source context. However, the LLM omits the prior state of the plan in 2022 (i.e., that it was previously amended and restated on May 29, 2020, and filed on August 26, 2020, as Exhibit 10.29), which is part of the question's requirement to describe the evolution between 2022 and 2024. (2) All numeric values—dates (May 26, 2022; November 27, 2024), exhibit number (10.28)—are factually correct and match the ground truth. No calculations are required. (3) The reasoning is sound in identifying the update to the plan and linking it to the correct filing, but it fails to fully synthesize the multi-hop aspect of how the plan evolved *from* 2022 *to* 2024 by not acknowledging the earlier version. (4) Despite the omission, the answer is highly accurate, contextually relevant, and conveys the key update. The missing detail prevents a perfect score, but core facts and dates are correct, warranting a 9/10 on correctness and qualitative accuracy. Quantitative accuracy and contextual relevance are flawless.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 375,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $830 million as of December 31, 2021, to $872 million as of December 31, 2023. This increase indicates that market perceptions of the company's debt improved over this period, as higher fair value relative to par suggests stronger investor confidence and lower perceived credit risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative values. The original answer states that the fair value decreased from $999 million on December 31, 2021, to $872 million on December 31, 2023. However, the LLM incorrectly reports the 2021 value as $830 million and claims an increase, which is factually wrong. This misrepresents both the starting value and the direction of change. (2) The calculation of change is therefore also incorrect: the true change is a decrease of $127 million, while the LLM implies a $42 million increase. These numbers are critical and must be accurate. (3) The multi-hop reasoning is flawed because the LLM misidentifies the trend in fair value and draws the opposite conclusion. A decrease in fair value typically suggests worsening market confidence or higher required yields, but the LLM incorrectly infers improved market perception due to a supposed increase. This reverses the correct financial logic. (4) While the LLM correctly identifies the metric (fair value of 6.375% Senior Notes), the time periods, and attempts to interpret market implications, the core factual inaccuracies in numbers and resulting flawed reasoning severely undermine the answer. The contextual relevance is high because it addresses the right instrument and time frame and attempts interpretation, but correctness is low due to major quantitative and qualitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 394,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "Between 2022 and 2023, IMBRUVICA's sales declined by 13.7%, from $3.784 billion to $3.264 billion. This decline was attributed to global competitive pressures, indicating that IMBRUVICA is facing increasing competition in the oncology segment, which is affecting its market position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. While it correctly states the 2023 sales figure of $3,264 million, it incorrectly reports 2022 sales as $3.784 billion instead of the correct $4,369 million. This leads to an incorrect decline percentage of 13.7% versus the actual 25.2%. These numbers are critical to the question and directly impact the interpretation of market performance. (2) Calculation verification: The correct decline is (4,369 - 3,264) / 4,369 = 1,105 / 4,369 ≈ 25.2%, not 13.7%. The LLM's calculation based on $3.784B would be (3,784 - 3,264) / 3,784 ≈ 13.7%, which is mathematically correct only if the starting value were accurate, but it is not. (3) The qualitative reasoning about competitive pressures and weakening market position is directionally correct and aligns with the ground truth's implication of a weakening position due to competition, especially as other oncology drugs grow. The answer correctly identifies the oncology segment and attributes the decline to competition, which shows sound multi-hop reasoning in interpretation, though not in data retrieval. (4) Contextually, the answer addresses both parts of the question—sales evolution and market position—and provides relevant context about competitive dynamics. However, the severe quantitative inaccuracies undermine the factual foundation of the conclusion, warranting a low correctness score despite reasonable structure and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 410,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million (as of January 28, 2022) to $427 million (as of January 31, 2025), while the LCNRV reserve decreased from $168 million (as of January 28, 2022) to $222 million (as of January 31, 2025). A 10% change in the shrink reserve would have impacted net earnings by approximately $31 million in 2022 and $32 million in 2024, indicating a growing sensitivity to shrinkage. In contrast, the LCNRV reserve had a smaller and more stable impact on net earnings during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the LCNRV reserve 'decreased from $168 million to $222 million', which is incorrect—the reserve actually increased from $168M to $222M, so describing it as a decrease is a major inaccuracy. All other numerical values are correct: the shrink reserve increased from $414M to $427M, and the sensitivity impacts on net earnings are accurate ($32M for shrink, ~$17M for LCNRV). However, the LLM incorrectly states that a 10% change in shrink reserve would impact net earnings by $31M in 2022—this figure is not in the original answer and is unsupported. The original only provides the 2024 sensitivity figures. (2) Date formatting is acceptable (fiscal year-ends like January 28, 2022, and January 31, 2025, align with typical 10-K reporting cycles), but the LCNRV directional change is wrong. The $32M impact on net earnings for shrink is correctly reported for 2024, but the $17M LCNRV impact is omitted in the LLM answer. (3) The multi-hop reasoning is partially sound—LLM correctly links reserve changes to earnings sensitivity and infers growing exposure to shrinkage. However, it misrepresents the LCNRV trend and invents a 2022 shrink sensitivity not in the source, weakening the synthesis. (4) Correctness score is 5 due to the significant error in the LCNRV direction and the addition of unsupported data, though core facts like reserve levels and 2024 shrink impact are correct. Quantitative accuracy is 5 due to the mix of correct numbers and one major directional error. Qualitative accuracy is 6 because reasoning is logical but based on flawed data. Contextual relevance is 9—answer stays focused and addresses all question parts, despite inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 474,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "From 2022 to 2023, Qulipta transitioned from an indefinite-lived intangible asset to a commercialized product. In 2022, it was part of AbbVie’s IPR&D assets, but by 2023, it received regulatory approvals in the U.S. and the EU for the preventive treatment of chronic migraine. This led to a significant financial contribution, with Qulipta’s net revenues increasing by over 100% in 2023 due to strong market share uptake and commercialization success.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qulipta's transition from an R&D asset to a commercialized product between 2022 and 2023, which aligns with the ground truth. However, it introduces inaccuracies: it claims Qulipta received regulatory approvals in both the U.S. and EU in 2023, but the original answer does not specify EU approval, only U.S. commercialization. More critically, the LLM states that net revenues increased by 'over 100%' in 2023 due to market uptake, but the ground truth provides exact revenue figures ($405M U.S., $3M international) without mentioning growth percentage or prior-year revenue. There is no support for a '100% increase' claim, making this a significant quantitative error. (2) The original answer includes precise financial contributions ($405M domestic, $3M international), which the LLM omits entirely, instead substituting an unsupported percentage increase. The $1.0 billion reclassification event in 2022 is mentioned in the original answer as part of the accounting impact of approval, but the LLM only vaguely references IPR&D assets without tying it to the $1.0 billion reclassification, missing a key financial detail. (3) The multi-hop reasoning is partially sound—linking regulatory approval to commercialization and revenue generation is logical and consistent with the knowledge graph. However, the model fails to connect Qulipta’s 2022 status to the specific $1.0 billion asset reclassification, weakening the financial evolution narrative. (4) The contextual relevance is high because the answer addresses the evolution in status and financial role. Qualitative accuracy is moderate due to correct conceptual framing but incorrect or unsupported specifics. Quantitative accuracy is low due to missing actual revenue numbers and fabrication of a '100% increase' not present in the source. Correctness score reflects partial accuracy with significant factual gaps and one major unsupported numerical claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 530,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with reimbursements collected from Resideo amounting to $140 million in both years. This indicates that the risk exposure related to environmental liabilities has been effectively mitigated through the indemnification and reimbursement agreement with Resideo, as the company continues to receive predictable and capped compensation for costs incurred at designated sites.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Honeywell's financial dependency on Resideo for environmental liabilities remained consistent between 2022 and 2023 and that the arrangement involves capped payments related to environmental costs. However, it inaccurately states that reimbursements were exactly $140 million in both years, while the ground truth specifies that Resideo is obligated to pay up to $140 million per year, covering 90% of Honeywell’s annual net spending—this implies the actual amount could be less than $140M if spending doesn’t reach the cap. The LLM treats the cap as the actual payment amount, which is a factual overstatement. (2) Quantitative accuracy is compromised because the answer asserts a precise dollar figure ($140M in both years) without acknowledging the conditional nature of the payment (up to $140M). While $140M is correctly cited as the maximum, presenting it as the actual reimbursement amount both years lacks support in the ground truth and introduces potential misinterpretation. (3) The reasoning is otherwise sound: the LLM correctly infers that the consistent reimbursement structure indicates stable risk mitigation and unchanged risk exposure, aligning with the multi-hop logic of connecting financial dependency with risk strategy over time. (4) Scores reflect that core facts and context are preserved (hence high qualitative and contextual scores), but quantitative inaccuracy reduces overall correctness. The answer is semantically close but not fully factually precise on the key financial figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 431,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target's definition of \"original maturity\" for cash equivalents has remained consistent between 2022 and 2024, with both years defining cash equivalents as highly liquid investments with an original maturity of three months or less from the time of purchase. However, the composition of cash and cash equivalents has shifted, with a notable decrease in short-term investments from $4,985 million in 2022 to $3,893 million in 2024. This suggests a potential shift in cash management strategy toward maintaining more liquidity in cash and receivables rather than investing in short-term instruments, possibly to enhance operational flexibility or respond to changing market conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Target's definition of 'original maturity' for cash equivalents remained at three months or less from purchase in both 2022 and 2024, which aligns with the ground truth. However, the ground truth does not mention any shift in the composition of cash equivalents or specific dollar amounts for short-term investments in 2022 ($4,985 million) and 2024 ($3,893 million). These figures are not present in the original answer and appear to be fabricated or incorrectly sourced, undermining quantitative accuracy. (2) The numbers cited—$4,985 million and $3,893 million—are not supported by the ground truth and introduce false precision. There is no mention of short-term investment balances in the original answer, so these values cannot be verified and likely reflect hallucination. (3) The multi-hop reasoning is partially sound in that it identifies consistency in the definition of original maturity, but it incorrectly infers a strategic shift based on unsupported numerical changes. The original answer notes a broader discussion of fair value measurements in 2024, indicating improved disclosure or framework refinement, not necessarily a change in investment levels. The LLM misses this nuance and instead invents a narrative around liquidity strategy based on phantom data. (4) While the core definition is correct and the question’s main theme (evolution in treatment and strategic implication) is addressed, the inclusion of false quantitative data and incorrect reasoning about strategic shifts significantly reduces factual reliability. The contextual relevance remains high because the response stays on topic and attempts to interpret strategic implications, albeit based on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 476,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "The valuation and classification of NVDA's 3.50% Notes Due 2040 remained consistent between 2023 and 2024, with a carrying value of $1,000 million in both years. This stability indicates that the company has not repaid or restructured these long-term debt instruments, suggesting a strategy of maintaining long-term fixed-rate debt to manage its capital structure and interest costs over an extended period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key aspects. It claims the carrying value of NVDA's 3.50% Notes Due 2040 was $1,000 million in both 2023 and 2024, but according to the ground truth, the value was $851 million as of January 28, 2024 (reported in the 2023 filing), and increased to $1,000 million as of January 26, 2025 (reported in the 2024 filing). The LLM incorrectly states the value was stable, when in fact it increased significantly. (2) The quantitative inaccuracies are severe: the $851 million figure from 2023 is entirely omitted and replaced with the 2024 value, misrepresenting the trend. The effective interest rate (3.54%) and remaining term (15.2 years) mentioned in the 2024 data are also missing. (3) The reasoning is flawed: the LLM concludes that 'stability' indicates a strategy of maintaining fixed-rate debt, but the actual evolution shows a meaningful increase in valuation, which the model fails to acknowledge. The multi-hop synthesis across years is incorrect—instead of showing change, it asserts consistency. (4) While the general topic of long-term debt strategy is relevant, the factual errors in numbers and trends severely undermine the answer's correctness. The contextual relevance is moderate because the answer addresses the right instrument and general strategic implication, but with incorrect data. Thus, the scores reflect major factual and quantitative deficiencies, with only partial relevance to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 407,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Between 2022 and 2023, Venclexta's total global revenue increased by 15%. In the United States, revenue grew by 8%, driven by market growth, share uptake, and favorable pricing, while international revenue rose by 22%, attributed to market share gains and growth across all indications.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Venclexta's total global revenue was $2,009 million in 2022 and $2,288 million in 2023, which represents a year-over-year growth rate of 13.9% in 2023 (not 15% as stated by the LLM). The LLM incorrectly reports an overall growth rate of 15%, which does not match the actual increase of ($2,288 - $2,009) / $2,009 = 13.9%. Additionally, the LLM introduces breakdowns by region (U.S. and international) that are not present in the original answer and were not asked for in the question, potentially introducing unsupported details. (2) The quantitative inaccuracies are critical: the 15% growth figure is wrong, and no actual revenue figures are provided, omitting key data points ($2,009M and $2,288M). The regional growth percentages (8% U.S., 22% international) are not verifiable from the ground truth and appear to be fabricated or misattributed. (3) While the LLM attempts multi-hop reasoning by discussing performance trends, it fails to correctly synthesize the core financial metrics across years. It misses the explicit request to report total global revenue and growth rate for both years, instead offering a single aggregated growth estimate and irrelevant regional splits. (4) The contextual relevance is moderate because the answer addresses revenue evolution, but the lack of correct figures and inclusion of extraneous, unverified regional data reduces its accuracy. The qualitative reasoning is partially sound in discussing drivers like market share and pricing, but these are not part of the original answer and do not compensate for missing or incorrect core facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 460,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "Between 2022 and 2023, Netflix amended its Executive Severance and Retention Incentive Plan, with the Amended and Restated version effective as of January 1, 2024, as disclosed in the 2023 filing. This update reflects a formal revision to the plan, indicating a continued focus on structured executive compensation and retention strategies. No such amendment was explicitly noted in the 2022 filing, suggesting that the 2023 change represents a recent evolution in the company's approach to executive incentives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key evolution: the 2023 filing introduced the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. The effective date (January 1, 2024) and the context of a forward-looking amendment are accurately conveyed. (2) Quantitatively, all dates are correct—no numbers or dates are misstated. The absence of an explicit amendment in the 2022 filing is correctly noted, consistent with the ground truth that the prior version was amended as of September 10, 2021. (3) The reasoning is sound: the LLM correctly infers that the 2023 disclosure represents a recent evolution, even though the prior plan was last amended in 2021. The multi-hop synthesis—comparing the 2022 and 2023 filings to detect changes—is logically executed. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2021 amendment date or the full title 'Amended and Restated Executive Severance and Retention Incentive Plan' from the 2022 filing, which slightly reduces completeness in qualitative accuracy. However, the core factual progression and intent of the question—how the plan evolved between 2022 and 2023—are clearly and correctly addressed. Wording differences do not affect semantic equivalence. Contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 390,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "From 2022 to 2024, Lowe's documentation of its Benefit Restoration Plan evolved by being formally referenced in the 2024 10-K filing (Exhibit 10.3) as \"Lowe's Companies Benefit Restoration Plan, as amended and restated as of January 1, 2025.\" This indicates a formalized and updated structure for the plan, aligning it with broader retirement benefits strategies. The continued existence and documentation of the plan suggest that Lowe's remains committed to supplementing retirement benefits for employees whose compensation is limited by IRS regulations, reflecting a strategic approach to maintaining competitive and comprehensive retirement offerings for eligible employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the plan was referenced in the 2024 10-K as 'amended and restated as of January 1, 2025' (Exhibit 10.3), which matches the original answer's citation of the updated filing. The explanation that the plan supplements benefits for employees affected by IRS limits is consistent with both years. (2) Quantitative accuracy is perfect: the date (January 1, 2025) and exhibit number (10.3) are correctly cited, and no numerical errors exist. Format and phrasing match expected variations. (3) Reasoning is sound: the LLM correctly infers that formal documentation in 2024 indicates a strategic, forward-looking approach to retirement benefits, particularly for high-earners. It synthesizes the evolution from implicit continuation in 2022 to explicit restatement in 2024. (4) The only minor gap is that the LLM does not explicitly mention the inclusion of both employee deferrals and employer match contributions as part of the plan structure, which was noted in the original answer. However, this omission does not undermine the core correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong multi-hop understanding across years and filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 361,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA's financial obligations related to the 0.584% Notes Due 2024 were $1,250 million as of January 28, 2024 (fiscal year 2024). By January 26, 2025 (fiscal year 2025), these obligations were fully repaid, as indicated by the $0 balance for the 0.584% Notes Due 2024. This reflects the repayment of the notes in fiscal year 2025, as noted in the document.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the liability was $1,185 million in fiscal year 2023 and was fully repaid by fiscal year 2024. However, the LLM claims the obligation was $1,250 million as of January 28, 2024 (fiscal 2024), which contradicts the ground truth where the obligation should have already been repaid by then. Additionally, the LLM states repayment occurred in fiscal year 2025, but the original answer confirms repayment was completed by fiscal year 2024. (2) The numbers are incorrect: $1,250M vs. $1,185M, and the timing of repayment is off by a fiscal year. The $0 balance should appear in fiscal 2024, not 2025. (3) The multi-hop reasoning is flawed—the LLM fails to correctly track the evolution between fiscal years 2023 and 2024 as required by the question, instead shifting focus to fiscal 2025, which is outside the scope. (4) While the general structure and intent of the response are relevant—discussing the repayment of the notes—the core facts, timing, and amounts are incorrect, leading to a low correctness score. Contextual relevance is moderate because the topic and metric are correct, but accuracy is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 344,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Between 2022 and 2023, Mavyret's global revenue slightly decreased by 7.2% (from $1,541 million in 2022 to $1,430 million in 2023). In the United States, revenue declined by 12.7% (from $755 million in 2022 to $659 million in 2023), while international markets saw a minor decline of 1.9% (from $786 million in 2022 to $771 million in 2023).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: 2022 global revenue ($1,541 million), 2023 global revenue ($1,430 million), U.S. revenue in 2022 ($755 million) and 2023 ($659 million), international revenue in 2022 ($786 million) and 2023 ($771 million). (2) Percentages are correctly calculated: the 12.7% U.S. decline ((755-659)/755 ≈ 12.7%) and 1.9% international decline ((786-771)/786 ≈ 1.9%) match the ground truth. The overall global decline is correctly characterized as 7.2% ((1541-1430)/1541 ≈ 7.2%). (3) The multi-hop reasoning is sound—information is synthesized across U.S. and international markets and across two years to describe trends. (4) The answer addresses all parts of the question: global performance, U.S. trend, and international trend. Wording differs slightly from the original answer but maintains full semantic equivalence. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 281,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "Between 2022 and 2024, Netflix remained in compliance with the covenant limitations related to its Senior Notes, with no material changes in the scope of restrictions. The covenants continued to limit the Company's ability to create liens, consolidate or merge, engage in sale and lease-back transactions, and incur additional indebtedness for certain subsidiaries. As of both December 31, 2024 and December 31, 2023, Netflix was in compliance with all related covenants, indicating consistent adherence to the repayment obligations and restrictions outlined in the debt agreements.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Netflix remained in compliance with covenant limitations in both 2022 and 2024 and accurately identifies core restrictions such as liens, mergers, sale and lease-back transactions, and subsidiary indebtedness. It also correctly notes ongoing compliance as of December 31, 2023 and 2024. However, it fails to mention a key evolution highlighted in the ground truth: by 2024, certain Senior Notes no longer included restrictions on sale and lease-back transactions, indicating a narrowing of covenant scope. This omission misrepresents the 'evolution' aspect of the question. Additionally, the LLM omits the $400 million repayment of the 5.750% Senior Notes in 2024, a critical fact showing active debt management and a shift in debt composition. (2) Quantitatively, the LLM does not include any incorrect numbers but misses the $400 million repayment and the €5,170 million euro-denominated tranches mentioned in the original. Since it doesn’t report these figures at all, there are no numerical inaccuracies, but the absence affects completeness and correctness. (3) The multi-hop reasoning is partially sound—compliance is correctly affirmed across years, and covenants are generally well-described. However, the model fails to synthesize the nuanced evolution in covenant scope and the significance of the debt repayment, which are essential for fully answering how compliance and obligations 'evolved.' (4) The contextual relevance is high because the response addresses covenant compliance and restrictions directly, but the lack of key developments reduces its overall accuracy. The qualitative accuracy is moderate due to correct identification of entities and general facts but significant omission of evolving details. Correctness score is 5 due to partial accuracy with major omissions affecting the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 509,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "Between 2022 and 2023, Honeywell restructured its Safety and Retail product line by merging the Safety and Retail business unit with the Advanced Sensing Technologies business unit to form the Sensing and Safety Technologies business unit. This structural change, announced in July 2022, reflects a strategic evolution to consolidate and streamline safety-related offerings under a unified business unit focused on sensing and safety technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key structural change—merging Safety and Retail with Advanced Sensing Technologies to form Sensing and Safety Technologies—and notes the July 2022 announcement, which aligns with the ground truth. The strategic rationale of consolidation and streamlining is accurately conveyed. However, the LLM omits the 2022 revenue figure ($2,387 million) for the Safety and Retail unit, which was included in the original answer and directly addresses the 'evolve' aspect of the question by quantifying the unit's scale before the change. (2) All mentioned dates (July 2022) and entity names are correct; no numerical inaccuracies are present. The absence of the revenue number affects completeness but not the accuracy of what is stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about organizational changes across time (2022 to 2023) and links the structural change to strategic intent. The only gap is the missing revenue data point that would strengthen the evolution narrative. (4) The answer is highly accurate, contextually relevant, and well-reasoned, meriting a 9 in correctness and qualitative accuracy. Quantitative accuracy is 10 because all stated numbers and dates are correct (and no incorrect numbers are introduced), and contextual relevance is 10 as the response directly addresses the question's focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 390,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "Between 2023 and 2024, the status and role of Class B-2 Common Stock evolved primarily through its convertibility into Class A Common Stock. As of September 30, 2024, 49 shares of Class B-2 Common Stock were outstanding, compared to none in 2023, indicating the emergence of this class following a Class B-1 Common Stock exchange offer. Class B-2 Common Stock, like Class B-1, is convertible into Class A Common Stock, and its conversion would increase the number of Class A shares outstanding, diluting the voting power of existing Class A stockholders. This conversion dynamic impacts corporate governance by potentially altering voting control and aligning the interests of Class B-2 holders with Class A stockholders.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The original answer states that by 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 exchange offer, indicating it was no longer active. However, the LLM claims that as of September 30, 2024, 49 shares were outstanding and that the class emerged after the exchange offer—directly contradicting the ground truth. This reversal of facts undermines the entire response. (2) The quantitative claim of '49 shares outstanding as of September 30, 2024' is incorrect and unsupported by the original answer, which explicitly states no Class B-2 shares were outstanding in 2024 before the exchange. There is no mention of 49 shares or any specific number in the ground truth. This is a critical error in numerical and temporal accuracy. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers that Class B-2 emerged after the Class B-1 exchange, while the truth indicates a strategic elimination or transition away from Class B-2. The model fails to capture the evolution from active (2023) to non-outstanding (2024), which is the core of the question. Instead, it reverses the timeline and status. (4) While the LLM correctly notes convertibility into Class A stock and potential dilution effects—elements present in the original answer—its overall narrative contradicts the key transformation: the phase-out of Class B-2. Contextual relevance is moderate because it discusses the right topics (convertibility, dilution, governance), but the factual foundation is inverted, leading to a misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 441,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "Between 2023 and 2024, The Home Depot enhanced the ease of the shopping experience by expanding both digital and in-store capabilities. In 2023, the company focused on improving store navigation, self-checkout options, and mobile app features such as store-specific maps to help customers locate items. Investments in store technology, including self-service lockers and curbside pickup, were also highlighted. In 2024, the company continued these efforts with further investments in store design, including wayfinding signage, electronic shelf labels, and enhanced front-end areas. Additionally, the company expanded its digital capabilities by improving the interconnected shopping experience, focusing on personalized marketing, and enhancing the functionality of its website and mobile apps. These efforts were aimed at creating a seamless, frictionless experience across all customer touchpoints.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies The Home Depot's evolution in shopping experience enhancements from 2023 to 2024, with accurate focus areas for both years. In 2023, it correctly notes investments in store navigation, self-checkout, mobile app features, self-service lockers, and curbside pickup—consistent with the ground truth emphasis on mobile app navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout. While 'self-service lockers' and 'curbside pickup' are not explicitly mentioned in the ground truth, they are plausible extensions of in-store convenience efforts and do not contradict the original. In 2024, the LLM highlights continued investment in store design (wayfinding, electronic shelf labels) and expanded digital capabilities like personalized marketing and app functionality, aligning well with the ground truth's focus on personalized digital experiences, customer review summaries, enhanced product content, and data-driven insights. The shift toward personalization and seamless cross-channel experience is accurately reflected, though the LLM does not specifically mention 'customer product review summaries' or 'shopability,' which are key nuances in the original. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes changes across two years and distinguishes between digital and in-store developments appropriately. It captures the progression from operational improvements (2023) to more personalized, data-integrated experiences (2024), demonstrating correct qualitative synthesis. (4) The correctness score is 8 due to minor omissions of specific 2024 initiatives (e.g., review summaries, shopability) but overall accurate portrayal of strategic evolution. Contextual relevance is perfect—directly addresses the question with appropriate scope and focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 538,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "From 2022 to 2024, the Target Corporation Long-Term Incentive Plan evolved by introducing new forms of equity awards. In 2022, the plan included awards such as Restricted Stock Units (RSUs), Performance-Based RSUs, and Performance Share Units. By 2024, the plan expanded to include additional award structures, such as Cliff-Vested RSUs and Performance Award Performance Share Units, as outlined in the 2024 10-K filings. These changes reflect a broader approach to long-term incentives, incorporating both time-based and performance-based vesting mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Target Corporation's Long-Term Incentive Plan from 2022 to 2024. (1) It correctly identifies the core equity award types present in 2022—Restricted Stock Units (RSUs), Performance-Based RSUs, and Performance Share Units—though it omits some specific forms listed in the ground truth such as Non-Qualified Stock Options, Price-Vested Stock Options, and Non-Employee Director awards. However, these omissions do not distort the overall structure or misrepresent the plan. (2) The introduction of Cliff-Vested RSUs and Performance Award Performance Share Units in 2024 is accurately reported, matching the ground truth. There are no numerical values requiring calculation, but dates (2022 and 2024) are correct. (3) The multi-hop reasoning—comparing the plan structure across years using 10-K filings—is sound and logically synthesized. The conclusion about a broader approach with time-based and performance-based mechanisms is a valid qualitative inference. (4) While the LLM simplifies the list of 2022 awards, it captures the key evolution: expansion of award types in 2024. The answer is semantically equivalent in intent and fact, with only minor completeness gaps. Hence, a high score is warranted, with a small deduction in qualitative accuracy for incomplete enumeration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 374,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Qulipta's commercial performance showed significant growth from its FDA approval in 2021 through 2023. In 2021, Qulipta had no prior-year revenue, and by 2022, its net revenues increased by more than 100%. In 2023, Qulipta's net revenues again increased by more than 100%, driven by strong market share uptake and market growth, as well as the regulatory approval for the preventive treatment of chronic migraine in adults in April 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall growth trajectory of Qulipta correctly and notes strong year-over-year revenue increases, but lacks specific revenue figures provided in the ground truth. It states that revenues increased by 'more than 100%' in both 2022 and 2023, which is partially accurate—Qulipta went from $0 in 2021 to $158M in 2022 (a 100%+ increase), and from $158M to $408M in 2023 (a ~158% increase). However, the absence of actual dollar amounts ($405M U.S., $3M international, $408M total) significantly reduces quantitative accuracy. (2) The mention of the April 2023 FDA approval for chronic migraine is accurate and adds context not in the original answer, but this expansion does not compensate for missing core financial data. The claim of 'more than 100% growth' in both years is directionally correct but imprecise and masks the actual scale and evolution of performance. (3) The multi-hop reasoning is sound—linking FDA approval in 2021 to subsequent revenue growth and regulatory expansion in 2023 shows synthesis across time and events. However, the answer fails to integrate specific financial disclosures from AbbVie’s reports that quantify performance, which is central to the question. (4) Correctness is scored 6 because the core trend is right but key data points are missing; quantitative accuracy is 5 due to lack of numbers and reliance on vague percentage growth; qualitative accuracy is 7 due to correct entity identification (Qulipta, AbbVie, FDA, indications) and logical reasoning; contextual relevance is 9 as the response directly addresses the commercial evolution and includes relevant regulatory developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 455,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "Between the 2022 and 2024 SEC filings, Netflix's treatment and disclosure of the 2020 Stock Plan show a structural shift and reduced activity. In 2022, the plan included both stock options and restricted stock units (RSUs), with significant stock-based compensation expenses of $575.5 million. By 2024, no new stock options or RSUs were granted in 2023 and 2022, and the focus shifted to vesting and compensation expenses from prior grants, with total stock-based compensation expense decreasing to $272.6 million. The 2024 filing also highlights a decline in the number of unvested RSUs and PSUs, indicating a reduction in active equity compensation activities under the 2020 Stock Plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that Netflix's disclosure evolved from minimal (2022: only an exhibit reference) to detailed (2024: explicit description of equity instruments and activities). In contrast, the LLM claims specific financial figures ($575.5M and $272.6M stock-based compensation), grant activity halts, and declines in unvested RSUs/PSUs—none of which are supported by the original answer. These numbers and trends are entirely absent from the ground truth and thus factually wrong. (2) Quantitative accuracy is very low: the dollar amounts, claims about grant cessation in 2022–2023, and assertions about declining unvested awards have no basis in the provided truth. There is no mention of any financial figures or activity levels in the original answer, so these invented numbers severely undermine accuracy. (3) The multi-hop reasoning is flawed. The question asks about evolution in disclosure and treatment of the 2020 Stock Plan. The correct inference is a shift from passive documentation to active, descriptive disclosure. The LLM instead fabricates a narrative about declining equity activity and financials, missing the core theme of transparency and reporting depth. It fails to identify that the key evolution is in disclosure quality, not compensation volume. (4) Contextual relevance is moderate because the LLM addresses Netflix, the 2020 Stock Plan, and compares 2022 vs 2024 filings—but it misinterprets the nature of the evolution (focusing on activity levels instead of disclosure practices). Thus, while the topic is relevant, the substance is factually and logically unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 462,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "Between 2022 and 2023, Boeing classified its aluminum purchase agreements as derivative instruments for accounting purposes, as these agreements were priced at prevailing market rates and did not qualify for hedge accounting treatment. In 2022, the company noted that these agreements were part of its long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the strategic use of these derivatives remained consistent, with Boeing continuing to hold aluminum contracts and foreign currency forward contracts, though the notional amounts for aluminum contracts decreased from $412 million in 2022 to $115 million in 2023. The fair value of these contracts was determined using an income approach based on market prices.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces information not present in the ground truth. Most critically, it names 'Boeing' as the company, which is not mentioned in the original answer and cannot be inferred from the context—this is a major entity error. Additionally, the LLM introduces specific dollar amounts ($412 million in 2022 and $115 million in 2023) and discusses a decrease in notional amounts, which are not present or verifiable in the ground truth. These numbers may be plausible but are unsupported by the provided data, making them hallucinated. (2) The quantitative accuracy is low because the figures cited (e.g., $412M to $115M) have no basis in the original answer, which contains no numerical data. Any calculation or comparison based on these is therefore invalid. (3) The qualitative reasoning partially aligns with the ground truth: the LLM correctly identifies that aluminum purchase agreements are classified as derivative instruments and used for strategic sourcing and non-U.S. business needs in 2022, and that they are priced at market rates. It also notes continued use in 2023, which matches the evolution described. However, it fails to mention the key 2023 clarification that contract quantities 'offset each other,' which is central to the strategic evolution. Instead, it shifts focus to notional value changes and foreign currency contracts, which are not part of the original answer. (4) Contextual relevance is moderate—the response addresses the topic of aluminum purchase agreements and derivatives over the two years, and the general strategic framing is appropriate. However, due to the incorrect company identification, fabricated numbers, and omission of the offsetting positions insight, the correctness score is significantly reduced. The answer reflects partial understanding but fails on core factual and multi-hop synthesis requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 520,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "Between 2023 and 2024, the disclosure of the Directors' Code of Conduct remained consistent in terms of accessibility, as it continued to be posted on BNY Mellon's website at the same URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. There was no indication of changes to the scope or content of the Directors' Code of Conduct during this period, and the company maintained its commitment to disclosing amendments or waivers on its website.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in multiple key aspects. It claims the URL remained the same between 2023 and 2024, but the ground truth states the URL changed in 2024 to a new domain (bny.com) and path (investor-relations). This is a critical error in both accessibility and entity accuracy. Additionally, the LLM states there was no change in scope, but the ground truth explicitly notes the addition of a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES' in 2024, which represents a significant expansion in scope. (2) There are no numeric values to verify, but the URLs—acting as key identifiers—are incorrect. The LLM repeats the 2023 URL without acknowledging the 2024 change, which is a direct factual inaccuracy. (3) The multi-hop reasoning failed completely: the model did not synthesize changes in document location (URL shift) or content (new insider trading section), both of which are required to answer the question about evolution in accessibility and scope. (4) The contextual relevance is moderate because the answer addresses the general topic (disclosure of the Directors' Code of Conduct), but it contradicts the ground truth on both accessibility and scope changes, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 353,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "Between 2023 and 2024, the structure and value of HD's 4.95% Senior Notes evolved significantly. In 2023, the company issued $750 million of 4.95% Senior Notes due September 2026, while in 2024, HD issued $1.75 billion of 4.95% Senior Notes due June 2034 and $750 million of 4.95% Senior Notes due September 2026. This shift indicates a strategic move to extend the maturity of its long-term debt, potentially to lock in favorable interest rates and manage refinancing risk over a longer horizon.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, HD issued $750 million of 4.95% senior notes due September 30, 2026 in 2023, and by 2024, the carrying amount was $747 million (reflecting amortization of the $1.6 million discount). Additionally, HD reported $980 million in 4.95% senior notes due September 2052. However, the LLM incorrectly states that in 2024, HD issued $1.75 billion of 4.95% notes due June 2034 and another $750 million due September 2026 — none of which appears in the ground truth. The 2034 maturity and $1.75 billion figure are entirely fabricated. (2) Quantitative accuracy is severely lacking: the LLM invents a $1.75 billion issuance and repeats the $750 million figure without reflecting the actual carrying value of $747 million. The ground truth does not mention any June 2034 notes. (3) The multi-hop reasoning is flawed: while the LLM correctly infers a strategy of extending debt maturities, it does so based on incorrect data. The actual reasoning should be based on the introduction of a long-dated 2052 note, not a 2034 note. The model fails to mention the 2052 $980 million issuance, which is central to the company's long-term debt strategy. (4) Contextual relevance is moderate because the answer addresses the general theme of debt maturity extension and interest rate strategy, but the factual foundation is incorrect, undermining the conclusion. The qualitative reasoning is plausible but unsupported by accurate data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 417,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Between 2021 and 2023, Intel recognized $471 million in observable price adjustments for its investment in Beijing Unisoc Technology Ltd. in 2021, and the net book value of the investment remained stable at $1.1 billion as of both December 30, 2023, and December 31, 2022. This indicates that while there was a valuation adjustment in 2021, the net book value of the investment did not change significantly over the subsequent two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $471 million observable price adjustment in 2021 and the $1.1 billion net book value as of December 30, 2023, and December 31, 2022, matching the ground truth exactly. These numbers are accurate and properly attributed to the correct years and entities. (2) All quantitative values are correct—$471 million and $1.1 billion—with appropriate dates (December 30, 2023, and December 31, 2022). The format matches closely, and no calculation errors are present. (3) The reasoning is sound: the LLM correctly infers that despite the 2021 valuation adjustment, the net book value remained stable in the following two years. It captures the evolution of Intel’s accounting treatment by noting the stability post-adjustment, though it does not explicitly state that the investment was classified as a non-marketable equity security by 2023—a detail present in the original answer. This is a minor omission affecting completeness but not the core factual accuracy. (4) The answer is contextually fully relevant, directly addressing the evolution of financial treatment and valuation. The correctness score is 9 because while all key facts and numbers are correct, the answer omits the specific accounting classification (non-marketable equity security), which is part of the financial treatment evolution. Quantitative accuracy is perfect. Qualitative accuracy is high but docked slightly for the missing classification detail. Contextual relevance is full.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 415,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "AbbVie's engagement with Qulipta evolved significantly from 2022 to 2023 in terms of regulatory and commercial development. In 2022, Qulipta was newly launched in the U.S. for chronic migraine, as indicated by its minimal net revenues ($158 million). By 2023, Qulipta achieved substantial commercial growth, with U.S. net revenues reaching $405 million and international revenues of $408 million, reflecting strong market adoption. Regulatory progress included FDA approval in April 2023 for chronic migraine and EC approval in August 2023 for migraine prevention in the EU, marking key milestones in its global expansion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Qulipta did not receive FDA approval until April 2023, meaning it could not have been 'newly launched in the U.S.' in 2022 as claimed. The reported 2022 net revenues of $158 million for Qulipta are not supported by the original answer and contradict the timeline, since commercial launch would follow, not precede, FDA approval. The 2023 revenue figures ($405M U.S., $408M international) are entirely fabricated and not present in the ground truth. (2) The only correct quantitative elements are the FDA approval in April 2023 and EC approval in August 2023, which match the original answer. However, all financial figures (revenues) are incorrect and unsupported. (3) The multi-hop reasoning is flawed: the model incorrectly infers a 2022 U.S. launch based on revenue data not present in the ground truth and fails to mention the key 2022 event—reclassification of $1.0 billion in R&D intangible assets due to regulatory approvals. This critical financial and strategic development is entirely omitted, breaking the chain of reasoning about AbbVie's engagement evolution. (4) While the answer is relevant to the question and attempts to discuss regulatory and commercial evolution, the factual foundation is unsound. The correctness score is low due to major errors in financial data and timeline, despite partial accuracy on approval dates. Contextual relevance is high because the structure and intent align with the question, but qualitative accuracy is limited by incorrect synthesis and missing key information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 444,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "Between 2022 and 2023, Boeing's framing of 'upgrades and conversions' within the Global Services segment remained consistent in its core description but showed a subtle shift in strategic emphasis. In 2022, the focus was on sustaining aerospace platforms through a full spectrum of services, including upgrades and conversions, as part of a broader lifecycle support strategy. By 2023, the language highlighted leveraging an extensive services network to span the lifecycle of defense and commercial aircraft programs, with upgrades and conversions explicitly positioned as part of efforts to grow market share through customer satisfaction and productivity. This suggests a more proactive and growth-oriented approach in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Boeing's strategic framing of 'upgrades and conversions' in the Global Services segment between 2022 and 2023. (1) The answer correctly identifies that in 2022, 'upgrades and conversions' were part of a broader lifecycle support strategy, grouped among other services, and described in general terms. In 2023, it notes a shift toward a more strategic, growth-oriented positioning—framed around market share growth, customer satisfaction, and productivity—which is consistent with the ground truth's observation of a more integrated and deliberate role. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable; however, the years (2022 and 2023) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the model synthesizes changes in language across two years and infers a strategic shift, which is the core of the question. The LLM introduces the idea of 'growing market share through customer satisfaction'—a nuance not explicitly in the ground truth—but this is a reasonable interpretation and does not contradict it. (4) The main difference from the ground truth is that the LLM emphasizes 'growth-oriented' strategy more than the original answer, which focuses on integration into a 'full spectrum of sustaining platforms.' While this adds a slightly different spin, the core insight about increased strategic emphasis is preserved. Thus, the answer is semantically equivalent with minor interpretive expansion. Minor deduction in qualitative accuracy due to added emphasis not fully grounded in the source, but overall highly accurate and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 474,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Intel's investment in Beijing Unisoc Technology Ltd. had a net book value of $1.1 billion as of both December 30, 2023, and December 31, 2022. In 2021, Intel recognized $471 million in observable price adjustments for this investment, indicating a valuation increase during that year. No significant changes in valuation or impairment charges were noted for 2022 and 2023, suggesting the investment remained stable in value during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor date discrepancy. The ground truth states that the $1.1 billion net book value was as of December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, the LLM incorrectly cites December 31, 2022, instead of December 25, 2021, for the earlier valuation. This misrepresents the fiscal year-end date from the actual filing. Despite this, the core financial figures are accurate: the $1.1 billion net book value in both years and the $471 million observable price adjustment in 2021 are correctly reported. (2) Quantitatively, all dollar amounts are correct and properly attributed. The $471 million adjustment is correctly tied to 2021, and the stability in 2022 and 2023 is consistent with the absence of similar adjustments in later filings. The error lies only in the specific date reference, not in the financial data itself. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and filings to compare valuation treatment over time, noting the presence of a revaluation event in 2021 and its absence in subsequent years. It appropriately infers stability in the investment’s valuation post-2021. (4) The answer is contextually relevant and addresses the evolution of Intel’s financial relationship with Unisoc, focusing on valuation and recognition. The minor date inaccuracy prevents a perfect score, but the overall factual content and reasoning are strong, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 424,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "Between 2023 and 2024, the role of Self-Service Lockers within Home Depot's interconnected shopping experience has expanded as part of the company's efforts to enhance convenience and fulfillment options for customers. In fiscal 2023, Home Depot introduced self-service lockers at the front entrance of many stores to enable convenient online order pickup. By fiscal 2024, these lockers were integrated into the broader suite of customer fulfillment options, complementing services like curbside pickup and forming part of the company's strategy to provide a seamless, multi-channel shopping experience. This evolution reflects Home Depot's continued investment in optimizing store-based fulfillment to meet customer demand for speed and flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the evolution of Self-Service Lockers at Home Depot between 2023 and 2024, and no incorrect numbers or dates are presented (quantitative accuracy is perfect). The answer correctly identifies that in 2023, lockers were introduced for convenient online order pickup, and by 2024, they were more integrated into the fulfillment network. However, it omits a key quantitative detail from the original answer: that approximately 50% of U.S. online orders were fulfilled through stores in 2024, which underscores the operational significance of lockers. This omission reduces completeness and weakens the support for the claim of strategic integration. Additionally, while the LLM mentions 'curbside pickup' and 'multi-channel shopping experience,' it does not explicitly reference the interconnected retail programs (BOSS, BOPIS, BODFS, BORIS) that contextualize the lockers' role in 2024, which is a key multi-hop element in the original answer. The reasoning is sound but less precise in connecting lockers to specific omnichannel fulfillment strategies. The answer remains contextually relevant and conveys a semantically similar narrative, but lacks specific evidence that would demonstrate full synthesis across the required data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 363,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities in 2024 shows increased specificity compared to 2023. In 2023, the disclosure briefly mentions that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. In 2024, the disclosure expands to clarify that these estimates are not discounted and are based on historical claims experience, demographic factors, severity factors, and other actuarial assumptions, while also noting the unpredictability of claim costs due to factors like inflation and regulatory changes. This evolution reflects a more detailed explanation of the methodology and associated risks.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual inaccuracy that undermines the overall correctness. According to the ground truth, in 2023 Costco did *not* specify the factors used in estimating insurance/self-insurance liabilities (e.g., historical claims, demographic factors, etc.), providing only a general description of its risk management mechanisms. However, the LLM incorrectly states that in 2023, the company 'briefly mentions' these specific factors, which contradicts the original answer. This misrepresents the evolution of disclosure, making it appear that the 2024 filing only added clarification (e.g., non-discounting and unpredictability) rather than introducing the detailed methodology for the first time. The 2024 description in the LLM answer is accurate—mentioning lack of discounting, inflation, and regulatory changes as sources of unpredictability—which aligns with increased transparency. However, because the core comparison between 2023 and 2024 is flawed (the key improvement was the introduction of actuarial factors in 2024, not their presence in 2023), the qualitative accuracy and overall correctness are significantly reduced. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. Contextual relevance is high as the response addresses the question's focus on evolution and specificity. The reasoning would have been sound if based on correct data, but the multi-hop synthesis fails due to incorrect attribution of 2023 disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 418,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "The financial impact of the Aldevron acquisition on inventory-related costs evolved from 2022 to 2023 as follows: In 2021, the acquisition of Aldevron resulted in $76 million in inventory fair value adjustment charges included in the cost of sales. By 2022, these acquisition-related inventory charges had decreased, as noted in the $59 million reduction in cost of sales from fair value adjustments to inventory related to Aldevron. In 2023, the impact of these charges was further reduced and no longer a significant factor, as the year-over-year decrease in cost of sales was primarily driven by lower sales volumes and an $87 million inventory charge in the Biotechnology segment unrelated to Aldevron. Thus, the financial impact of the Aldevron acquisition on inventory-related costs diminished from 2022 to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that the Aldevron acquisition occurred in 2021 with a $76 million charge, while the ground truth specifies a $59 million charge in 2022. There is no mention of a 2021 acquisition or $76 million in the original answer. The $59 million figure is correctly cited but mischaracterized as a 'reduction' in cost of sales, when it was actually an increase due to fair value adjustments. The 2023 portion incorrectly suggests that Aldevron-related charges were 'further reduced,' when in fact they were no longer present. While the $87 million Biotechnology segment charge in 2023 is correctly identified as unrelated to Aldevron, the reasoning misrepresents the nature of the shift. (2) Quantitative errors include the false $76 million charge in 2021 and mislabeling the $59 million 2022 impact as a reduction rather than an increase. The 2023 $87 million charge is accurate. (3) The multi-hop reasoning is flawed: the model fails to correctly trace the timeline and nature of the inventory costs, incorrectly inferring a diminishing trend from 2021 to 2023 when the data only supports a one-year acquisition impact in 2022 followed by a different type of charge in 2023. It introduces data not in the original (2021 acquisition, $76M) and misinterprets the direction of the financial impact. (4) Scores reflect major factual and directional errors in numbers and reasoning, though the answer is contextually relevant in discussing inventory cost evolution and identifying the 2023 charge as separate from Aldevron.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 439,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "Between 2023 and 2024, Costco's treatment and recognition of shop card liabilities remained consistent, with the company accounting for outstanding shop card balances as a shop card liability, net of estimated breakage, included in other current liabilities in the consolidated balance sheets. There is no indication of a material change in the methodology or estimation of these liabilities during the period. This consistency suggests that Costco maintains a stable and predictable approach to managing unclaimed balances on shop cards, relying on historical redemption data to estimate breakage and recognizing revenue upon redemption.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Costco consistently accounted for shop card liabilities as a liability net of estimated breakage in both 2023 and 2024, with revenue recognized upon redemption. All entities (Costco, shop card liabilities, breakage, redemption) and years (2023, 2024) are correct, and there are no numerical inaccuracies—this supports a high quantitative accuracy score. Contextual relevance is strong as the response directly addresses the question about treatment and recognition of shop card liabilities and infers Costco’s approach to unclaimed balances. However, the LLM misses a key qualitative distinction present in the ground truth: while the methodology may not have changed materially, the 2024 filing placed greater emphasis on 'estimated breakage' and its linkage to redemption data, indicating a more refined or formalized approach. The LLM incorrectly states there is 'no indication of a material change in the methodology,' which downplays the evolution in disclosure and analytical emphasis. This omission affects the reasoning and completeness of the multi-hop synthesis—though the core facts are right, the conclusion about Costco’s approach is less nuanced than the ground truth. Hence, qualitative accuracy and overall correctness are partially impacted, warranting a 7 rather than a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 374,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "From 2022 to 2023, Intel's Foundry Services (IFS) evolved significantly in strategic partnerships and customer engagement. In 2023, IFS secured four design wins on Intel 18A, including a major high-performance computing customer with a large prepayment, and five new design wins in advanced packaging, particularly for AI-related designs. The IFS Accelerator Ecosystem Alliance program doubled in size to over 40 strategic agreements, including multigenerational partnerships with ARM and Synopsys to support chip design on Intel’s process nodes. Additionally, IFS expanded its RAMP-C program partnerships with the U.S. Department of Defense, enabling customers like Nvidia and Microsoft to develop and fabricate chips on Intel 18A. In 2022, the foundation was laid with the launch of the IFS Accelerator program and initial strategic partnerships, but 2023 marked a significant acceleration in ecosystem development and customer commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: four design wins on Intel 18A in 2023, five new advanced packaging design wins (AI-related), expansion of the IFS Accelerator Ecosystem to over 40 agreements, and multigenerational agreements with ARM and Synopsys. These match the original answer exactly. (2) Quantitative accuracy is perfect: numbers (4, 5, 40+) and timeframes (2022–2023) are correct, with no calculation errors. (3) Reasoning is sound—correctly frames 2022 as foundational (launch of IFS Accelerator) and 2023 as execution with concrete customer engagements. The mention of RAMP-C expansion with the U.S. Department of Defense and customers like Nvidia and Microsoft adds detail not in the ground truth, but does not contradict it and is plausible context; however, these specific names (Nvidia, Microsoft) and RAMP-C are not mentioned in the original answer, introducing minor unverified detail. This does not constitute a factual error but slightly exceeds the provided truth. (4) The answer is contextually excellent, directly addressing evolution in partnerships and customer engagement across the two years. The core evolution from strategic intent to execution is correctly captured. Minor deduction in qualitative accuracy due to the addition of specific third-party names not in the ground truth, though the overall synthesis and multi-hop reasoning remain strong. Correctness score is 9 due to this slight over-specification, but all critical facts and numbers are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 426,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "Between 2022 and 2023, DHR's relationship with Aldevron remained significant in terms of goodwill and net cash consideration. In 2021, the Aldevron acquisition resulted in $6.1 billion in goodwill and a net cash consideration of $9.561 billion. By 2023, the goodwill related to Aldevron remained unchanged at $6.1 billion, as no adjustments were mentioned for that specific acquisition. However, in 2023, DHR's overall goodwill increased due to the Abcam Acquisition, but Aldevron's contribution remained consistent. The net cash consideration for Aldevron also remained stable, with no new transactions or adjustments reported in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It incorrectly states that the Aldevron acquisition occurred in 2021, while the ground truth confirms the goodwill was recorded in 2022. It also falsely claims that the net cash consideration of $9.561 billion was part of the 2021 transaction, but the original answer states this figure emerged in 2023 as an updated or revised net cash consideration. The LLM incorrectly asserts that both goodwill and net cash consideration 'remained unchanged' and 'stable' between 2022 and 2023, directly contradicting the ground truth, which indicates a significant evolution in financial commitment, particularly with the increase in net cash consideration to $9.561 billion in 2023. (2) Quantitatively, while the $6.1 billion goodwill and $9.561 billion net cash consideration numbers are accurate, their attribution to the wrong years (2021 instead of 2022 and 2023) invalidates their correctness in context. The timeline misplacement leads to incorrect conclusions about stability versus evolution. (3) The multi-hop reasoning is flawed: the model fails to recognize that the question asks for a comparison of financial impact *between 2022 and 2023*, and instead misattributes data to 2021 and assumes no change, missing the core evolution—increased cash outlay beyond initial goodwill. It also conflates Aldevron with the Abcam acquisition, which is irrelevant to the question. (4) Scores are low due to critical errors in dates and interpretation of financial evolution. The answer is contextually relevant in discussing goodwill and cash consideration but fails on factual accuracy and reasoning, warranting a correctness score of 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 461,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The maturity date of the AT&T Inc. 1.800% Global Notes has extended from September 14, 2039, as listed in the 2022 SEC filing, to September 5, 2026, as listed in the 2024 SEC filing. This indicates a shift in the company's debt structure toward shorter-term maturities, potentially reflecting a strategy to refinance long-term debt, manage interest rate risk, or align with evolving capital needs and market conditions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect in terms of factual content. It states that the maturity date changed from September 14, 2039 (2022 filing) to September 5, 2026 (2024 filing), which is the reverse of the ground truth. In reality, the maturity date changed from September 5, 2026 (2022) to September 14, 2039 (2024), representing a significant extension. (2) The dates are quantitatively wrong and inverted, making the calculation of the change (over 13-year extension) incorrect. Instead, the LLM implies a shortening of maturity by about 13 years, which is factually false. (3) The reasoning is flawed because it draws conclusions based on an incorrect direction of change. The LLM suggests a shift toward shorter-term maturities and possible refinancing strategy, but the actual extension indicates a move toward longer-term debt, likely to lock in rates or reduce near-term refinancing risk. The multi-hop synthesis failed—correct identification of the same note across two filings was not achieved. (4) The correctness and quantitative accuracy scores are very low due to the inversion of dates and resulting false conclusion. Qualitative accuracy is poor due to incorrect logic and entity-time mapping. Contextual relevance is slightly higher because the answer attempts to interpret the implication on debt structure, albeit based on wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 382,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target remained in compliance with its debt leverage covenant in both 2023 and 2024, as noted in both years' filings, with no practical effect on its ability to pay dividends. In 2024, the company modified its credit facility structure by obtaining a new $1.0 billion 364-day unsecured revolving credit facility in October 2024, replacing the prior 364-day facility and extending the maturity of its existing $3.0 billion facility to October 2028. These changes likely contributed to maintaining covenant compliance by enhancing liquidity and providing flexibility in managing debt obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Target remained in compliance with its debt leverage covenant in both 2023 and 2024, which aligns with the ground truth. It accurately notes the renewal of the $1.0 billion 364-day credit facility in October 2024, extending its maturity to October 2025 (implied by '364-day' facility obtained in October 2024). The $3.0 billion five-year facility’s extension to October 2028 is correctly mentioned. However, the LLM incorrectly states that the $3.0 billion facility was 'extended' in 2024, while the ground truth indicates it was already in place with a 2028 maturity and simply remained unchanged. This is a minor factual inaccuracy in phrasing, suggesting an active extension when none occurred. (2) Quantitatively, all dollar amounts ($1.0 billion, $3.0 billion), timeframes (364-day, October 2025/2028), and years (2023, 2024) are correct. The description of the credit facilities matches the original in amount and structure. (3) The multi-hop reasoning is sound: the model connects covenant compliance across two years and links it to changes in credit facility structure. It correctly infers that the renewal enhanced liquidity and supported compliance. The only flaw is the mischaracterization of the $3.0 billion facility as 'extended' rather than 'maintained.' (4) Despite this minor error, the answer is contextually relevant, complete in addressing both parts of the question, and semantically close to the ground truth. The core facts—compliance, facility amounts, renewal of 364-day facility, and rationale—are accurate, warranting a high score but not perfect due to the facility extension inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 456,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023 by integrating its RISE strategy with expanded external collaboration initiatives. In 2022, Intel emphasized digital readiness through programs like AI for Youth and AI for Workforce, in partnership with governments and institutions. By 2023, these efforts were further expanded under the RISE Technology Initiative, which aimed to deepen relationships with customers and partners to create shared value. The 2023 strategy also focused on making technology more inclusive while addressing broader societal challenges such as health, safety, and climate change, reflecting a more comprehensive and collaborative approach to digital readiness.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It mentions programs like 'AI for Youth' and 'AI for Workforce' and claims they were part of Intel's 2022 efforts, which are not supported by the ground truth. The evolution described—focusing on health, safety, and climate change under RISE in 2023—is not aligned with the actual progression detailed in the original answer. The core factual development from 2022 to 2023 involving the Alliance for Global Inclusion and the Inclusion Index is entirely missing. (2) There are no correct quantitative elements: the ground truth includes specific numbers such as 18 recognized organizations out of 27 respondents and the 50% scoring threshold, none of which appear or are referenced in the LLM answer. The absence of these critical metrics severely undermines quantitative accuracy. (3) The multi-hop reasoning is flawed. The question requires synthesis across years (2022 to 2023), strategy (RISE), and collaboration (Alliance for Global Inclusion → Inclusion Index → recognition system). The LLM fails to connect these dots, instead fabricating partnerships and programmatic expansions not present in the source. It does not demonstrate understanding of the shift from framework-building to performance measurement. (4) While the answer is contextually relevant—discussing digital readiness, RISE, and collaboration—it misses the specific trajectory described in the ground truth. The general theme of 'increased collaboration' is directionally plausible but lacks the precise, fact-based evolution required. Hence, correctness and qualitative accuracy are low due to factual inaccuracies and missing key developments, though the topic area is appropriately addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 475,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson's relationship with Micromine began in 2022 when AspenTech, a subsidiary of Emerson, entered into an agreement to acquire Micromine for approximately $623 million. However, the acquisition did not proceed, and on August 1, 2023, AspenTech announced the termination of the agreement due to regulatory uncertainties in Russia. No termination fee was paid. Financially, the failed acquisition led to expenses related to foreign currency forward contracts, which resulted in a mark-to-market gain of $56 in 2023, but no direct acquisition costs were incurred in 2024. Thus, the relationship ended without a financial commitment to finalize the acquisition.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it incorrectly states that the agreement began in 2022, while the ground truth specifies 2023. Second, the mark-to-market gain is reported as $56 in the LLM answer, but the correct amount is $24, which is a significant quantitative error. The acquisition price is correctly stated as approximately $623 million (AU$900), though the LLM omits the AU$900 figure. (2) The date of termination is inaccurately stated as August 1, 2023, with no such specific date confirmed in the ground truth; only the year 2023 is specified. The claim that 'no termination fee was paid' is not mentioned in the ground truth and thus introduces unverified information. (3) The multi-hop reasoning is partially sound—linking Emerson to AspenTech to Micromine and recognizing the termination due to Russian regulatory issues is correct. However, the LLM fails to mention that by 2024, AspenTech terminated the foreign currency forward contracts, which is a key financial development. Instead, it vaguely states 'no direct acquisition costs were incurred in 2024,' missing the full financial de-risking action. (4) The contextual relevance is high as the answer addresses the evolution and financial implications, but the correctness score is reduced due to key factual and numerical errors. The qualitative accuracy is moderate because entity relationships are mostly correct, but reasoning lacks completeness in describing the 2024 financial cleanup. Quantitative accuracy is low due to the incorrect gain amount and wrong year for the deal initiation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 438,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) decreased from 17 million shares in 2022 to 15 million shares in 2023. The average purchase price of shares during the fiscal year also decreased from $305.14 in 2022 to $277.19 in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers for shares available (17 million in 2022, 15 million in 2023), shares purchased (~1 million each year), and average purchase prices ($305.14 in 2022, $277.19 in 2023) are accurately reported. The LLM correctly captures the decrease in both share availability and average price. (2) The answer addresses both parts of the question: changes in share availability and changes in average purchase price from 2022 to 2023. (3) Entities—The Home Depot, U.S. ESPP, and fiscal years 2022 and 2023—are correctly identified. (4) The reasoning is sound: the LLM correctly synthesizes multi-hop information (two different years, two different metrics) and draws the appropriate comparison. Although the LLM omits the detail about associates purchasing approximately one million shares each year, this information is not directly asked in the question, which focuses on availability and average price. Thus, the omission does not affect correctness. The answer is semantically equivalent to the ground truth and fully accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 317,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "Between 2022 and 2023, the pattern of impairment triggers and associated charges across DHR's business segments shows a shift in risk exposure within its intangible asset portfolio. In 2022, there were no impairment charges recorded for intangible assets. However, in 2023, impairment triggers were identified in the Biotechnology segment during Q2 and in both the Diagnostics and Biotechnology segments during Q4, leading to impairment charges of $77 million. This indicates a growing risk exposure in the Biotechnology segment, likely due to market or operational challenges, while the Diagnostics segment also faced renewed pressures after a period of stability in 2022. The shift suggests a reallocation of risk from the Diagnostics segment to the Biotechnology segment, potentially driven by evolving market dynamics or performance issues in newer acquisitions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the 2022 filing. It claims 'no impairment charges recorded for intangible assets' in 2022, which contradicts the ground truth stating a $10 million impairment charge in the Diagnostics segment in Q1 2021 (disclosed in the 2022 filing). This is a critical error in quantitative and entity accuracy. The 2023 charges of $77 million are correctly reported, as are the segments (Biotechnology in Q2, Diagnostics and Biotechnology in Q4) and timing. (2) The quantitative accuracy is compromised because the model omits the $10 million 2021 charge and falsely asserts no impairments in 2022, undermining the comparative analysis. The $77 million figure is correct. (3) The reasoning is partially sound: the model correctly infers increased risk in the Biotechnology segment and identifies a shift in risk profile. However, it fails to acknowledge that the Diagnostics segment had prior impairments (2021), incorrectly portraying it as having 'a period of stability in 2022'. The multi-hop synthesis is incomplete—while it connects 2023 events correctly, it misrepresents the 2022/2021 baseline. (4) Contextual relevance is high—the answer addresses the evolution of impairment patterns and interprets shifting risks appropriately. The conclusion about growing Biotechnology segment risk aligns with the ground truth, though based on flawed premises. Correctness score is 6 due to major factual error in baseline data but correct identification of 2023 events and reasonable interpretation of risk shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 433,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 (as of January 30, 2022) to $598 million in 2023 (as of January 28, 2024). This increase suggests a higher level of business activity or commitments tied to trade contracts, potentially reflecting expanded operations or more extensive supplier agreements in 2023 compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the increase in outstanding letters of credit from $362 million in 2022 to $598 million in 2023, matching the ground truth exactly in value. The mention of specific dates (January 30, 2022, and January 28, 2024) adds detail not in the original answer but does not contradict it—these likely reflect the actual filing/reporting dates for the fiscal years, which is acceptable context. (2) All numeric values are accurate: $362M and $598M are correctly stated, and the direction of change (increase) is correct. No calculation is required beyond recognition of an increase, which is properly noted. (3) The reasoning is sound: the LLM infers increased business activity or commitments tied to trade contracts, which aligns with the ground truth's interpretation of 'growing involvement or expansion.' The phrasing 'potentially reflecting expanded operations or more extensive supplier agreements' is a slightly more cautious formulation but remains semantically consistent with the original. (4) The answer is fully relevant, addresses both parts of the question (change in value and its implication), and synthesizes the correct entities (letters of credit, trade contracts, correct years). The only minor deviation is the slightly more tentative language in the interpretation ('suggests', 'potentially'), which reduces qualitative strength by a small margin but does not impair correctness. Overall, this is a highly accurate, factually correct, and contextually appropriate response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 420,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "The 0.300% Notes due 2028 were first disclosed in IBM's 2023 SEC filing (page 20 of IBM_10k_2023.pdf) as part of the list of instruments defining the rights of security holders, filed under Form 8-K on February 10, 2020. In the 2024 SEC filing (page 1 of IBM_10k_204.pdf), the Notes are again listed under the company's registered securities, confirming their continued existence and trading status on the New York Stock Exchange under the symbol IBM28B. This consistency in disclosure indicates that IBM maintains transparent and up-to-date reporting of its financial instruments, adhering to SEC requirements and providing investors with ongoing visibility into its debt structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 0.300% Notes due 2028 in both the 2023 and 2024 filings, with accurate dates (February 10, 2020) and correct trading symbol IBM28B on the NYSE. Page references are provided, though minor document name typo ('IBM_10k_204.pdf' instead of 'IBM_10k_2024.pdf') does not affect factual accuracy. All numeric and date information is correct, satisfying quantitative accuracy. (2) Quantitatively, the percentages, years, and filing dates match the ground truth exactly. No calculations are required, but the references to Form 8-K and exhibit details are consistent. (3) The multi-hop reasoning is partially sound: the LLM confirms the presence of the notes in both years and notes their trading status. However, it misses the key evolution highlighted in the ground truth — the shift from passive disclosure (as an exhibit defining rights) in 2023 to active recognition as a traded instrument in 2024. Instead, the LLM interprets the consistency as evidence of stable transparency, which downplays the significance of the change in disclosure nature. This reflects a weaker qualitative synthesis of the evolution and its implications. (4) Contextually, the answer is highly relevant, addressing both filings and IBM's financial disclosures. The conclusion about transparency is reasonable but less insightful than the ground truth’s emphasis on increased market engagement or liquidity. Thus, while factually accurate on key entities and dates, the LLM underperforms in interpreting the nuanced shift in disclosure status, warranting a 7 for correctness and qualitative accuracy despite perfect quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 453,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "In 2023, IBM's 1.750% Notes due 2031 were disclosed as being registered on the New York Stock Exchange under the trading symbol \"IBM31\" in the 10-K filing. In 2024, the same notes were again listed under the same trading symbol and exchange in the updated 10-K, indicating no change in registration status. However, the 2024 filing includes updated references to the instruments defining the rights of the holders, reflecting ongoing compliance and disclosure practices.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the 1.750% Notes due 2031 were already registered on the NYSE under 'IBM31' in 2023, which contradicts the ground truth. According to the original answer, in 2023 the notes were only disclosed and incorporated by reference from a 2019 filing, with no mention of stock exchange registration. The registration under trading symbol IBM31 occurred in 2024, representing a key evolution. This misrepresentation of the timeline and status is a major factual error. (2) Quantitatively, the percentage (1.750%), maturity year (2031), and trading symbol (IBM31) are correctly stated, and the years 2023 and 2024 are properly referenced. However, the critical fact about when registration occurred is wrong, undermining the accuracy. (3) The multi-hop reasoning fails because the model did not correctly synthesize the change over time: the shift from mere disclosure (2023) to formal listing (2024) is the core of the question, but the LLM claims the notes were already listed in 2023, missing the evolution entirely. (4) Contextual relevance is high because the answer addresses disclosure, registration, and updates in filings, but the qualitative and factual inaccuracies—especially the incorrect assertion about 2023 registration—severely reduce correctness. The answer conveys the opposite of the truth regarding the evolution of the notes' status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 388,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "Eli Lilly's financial relationship with Zyprexa evolved significantly between 2023 and 2024, primarily through the sale of the rights for the olanzapine portfolio, which includes Zyprexa. In 2023, Zyprexa revenue was $1,694.8 million, with $1,615.4 million generated outside the U.S. This was driven by the sale of the rights for the olanzapine portfolio. By 2024, Zyprexa revenue is not explicitly listed, but the sale of these rights would have shifted revenue recognition to the point of sale, impacting the business model by transitioning from ongoing product sales to a one-time transaction. This change reflects a strategic shift in how revenue from Zyprexa is recognized, moving from recurring sales to a lump-sum recognition upon the sale of rights.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that Eli Lilly generated $1.45 billion from the sale of the olanzapine portfolio rights outside the U.S. in 2023, but the LLM claims Zyprexa revenue was $1,694.8 million overall with $1,615.4 million outside the U.S., which contradicts the verified data. These numbers are not supported by the knowledge graph and appear fabricated or misattributed. (2) The LLM incorrectly frames the 2023 revenue as ongoing product sales rather than a one-time sale of rights, misrepresenting the nature of the $1.45 billion. The ground truth clarifies that this was a direct result of selling rights, not recurring sales. Additionally, the LLM fails to mention that in 2024, revenue from Zyprexa was no longer reported under product sales but was instead included in 'collaboration and other arrangements revenue,' a key shift in revenue classification. (3) While the LLM correctly identifies a strategic shift from ongoing sales to a transactional model, it mischaracterizes the timing and mechanism—portraying the shift as occurring at the point of sale in 2023, but not accurately reflecting the 2024 reporting change in revenue categorization. The multi-hop reasoning is partially sound in identifying a business model evolution, but flawed in execution due to incorrect data and incomplete synthesis of how revenue recognition changed across years. (4) The contextual relevance is high because the answer addresses the evolution of the financial relationship and attempts to explain revenue recognition and business model changes. However, due to major quantitative errors and incomplete qualitative accuracy, the correctness score is low. The answer conveys a plausible narrative but with incorrect figures and insufficient precision regarding the actual accounting treatment shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 517,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "The Mobility Preferred Interests were fully repurchased by AT&T by April 2023, eliminating any outstanding obligations by December 31, 2023. In 2023, these interests were reclassified from equity to a liability at fair value, impacting earnings per share calculations by contributing 72 shares to diluted EPS. By 2024, with no remaining interests outstanding, they no longer affected diluted EPS, as reflected in the absence of related shares in the 2024 EPS reconciliation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core timeline—reclassification in 2023 and full repurchase by April 2023—but introduces a specific number (72 shares) not present in the ground truth and potentially incorrect. The ground truth mentions no share impact on diluted EPS, but rather explains that under ASU 2020-06, the ability to settle in stock was reflected in diluted EPS for periods prior to repurchase. The LLM incorrectly implies that 72 shares were added to diluted EPS in 2023 and that this impact ceased in 2024, which misrepresents the accounting treatment. Additionally, the ground truth states that the total repurchase amount was $5,414 (likely million), but the LLM omits this key financial figure entirely. The liability split ($2,670 current and $2,670 noncurrent) is also missing, which is a significant omission in the financial impact description. (2) The date of repurchase (April 2023) is correctly stated. However, the $5,414 repurchase amount is missing, and the 72-share impact on diluted EPS is unsupported by the ground truth and likely fabricated or misremembered. No calculation is shown, but the introduction of an unverified number reduces quantitative accuracy. (3) The reasoning correctly identifies the shift from liability to retirement and the cessation of EPS impact by 2024, but mischaracterizes the nature of the EPS effect. The ground truth emphasizes retrospective accounting treatment under ASU 2020-06 for prior periods, not a forward-looking 72-share dilution in 2023. The LLM fails to mention the standard (ASU 2020-06) and misapplies the concept of diluted EPS impact. (4) The answer is contextually relevant and addresses both years and both aspects of the question (redemption obligations and EPS impact), but the factual inaccuracies in numbers and accounting logic reduce correctness. While the high-level narrative of 'reclassified, repurchased, no longer affects EPS' is directionally correct, the missing liabilities breakdown, incorrect EPS explanation, and invented share number prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 554,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "Between 2023 and 2024, IBM's 0.875% Notes due 2030 remained listed on the New York Stock Exchange under trading symbol IBM30A, as disclosed in both the 2023 and 2024 10-K filings. However, in the 2024 filing, there is no new registration or supplemental indenture specifically mentioned for these notes, suggesting their terms and registration status remained unchanged from prior years. The 2024 filing reflects continued incorporation by reference of prior indentures, including those related to similar debt instruments, but no material evolution in the listing or registration status of the 0.875% Notes due 2030 is indicated.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim about the status of the 0.875% Notes due 2030. According to the ground truth, in 2023 the notes were only incorporated by reference from a prior filing (Exhibit 4.1 to Form 8-K filed February 8, 2022), meaning they were not explicitly listed or registered at that time. However, by 2024, there was a material change: the notes were explicitly listed in the table of registered securities with trading symbol IBM30A and registered on the NYSE—indicating a clear evolution from referenced to fully registered status. The LLM incorrectly asserts that the notes 'remained listed' in both years and that there was 'no material evolution,' which directly contradicts the ground truth. This represents a failure in multi-hop reasoning: the model did not correctly interpret the shift from incorporation by reference to explicit registration. While the mention of IBM30A and the NYSE aligns with the truth, placing this status in 2023 is factually wrong. The answer also correctly notes the absence of a new registration or supplemental indenture in 2024, but this minor accuracy does not offset the fundamental misrepresentation of the timeline and status change. Quantitative accuracy is partially preserved (correct symbol, correct interest rate and maturity), but the critical qualitative and contextual shift is missed, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 387,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "From 2023 to 2024, the structure and distribution terms of the Telco Preferred Interests evolved with the addition of new classes and adjustments to reset schedules. In 2023, the Telco preferred interests included Telco Class A-1 (4.25% annual distribution, reset every seven years) and Telco Class A-2 and A-3 (6.85% annual distribution, reset every seven years starting November 1, 2027). In 2024, AT&T announced plans to issue an additional $2,250 of Telco Class A-4 preferred interests with an initial distribution rate of 5.94% annually, subject to reset every four years starting November 1, 2028. This evolution indicates AT&T's strategic use of preferred equity instruments to diversify its financing structure, manage cost of capital through adjustable rates, and align with long-term liquidity needs while maintaining flexibility in cash flow and dividend policies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2024, the total Telco Preferred Interests were $7,250, composed of the original $2,000 Class A-1 and $5,250 Class A-2/A-3 issued in 2023—no new issuance of $2,250 in Class A-4 is mentioned. The LLM incorrectly invents a new class (A-4) with a 5.94% rate and a four-year reset, which is not supported by the original answer. The original answer confirms that both classes remain at their original rates (4.25% and 6.85%) and are subject to seven-year resets, not four. (2) Quantitative accuracy is severely compromised: the $2,250 new issuance, 5.94% rate, and November 1, 2028 reset date are all fabricated. The correct total in 2024 is $7,250, which matches the sum of $2,000 + $5,250, but the LLM misattributes growth to a new instrument rather than correctly noting the continuation and clarification of existing terms. (3) The multi-hop reasoning is flawed—the LLM fails to correctly synthesize the evolution as a continuation and expansion of existing instruments with clarified covenants, instead inventing new structures. The correct qualitative insight is that AT&T maintained consistent structure but expanded reliance on preferred equity; the LLM’s claim about diversifying with adjustable reset periods is unsupported. (4) Contextual relevance is moderate because the answer addresses the general theme of financing strategy and preferred equity use, but the incorrect details undermine the conclusion. Correctness is low due to major factual and numerical errors, despite attempting the right analytical frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 445,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One's risk exposure under loss sharing agreements with government-sponsored enterprises (GSEs) related to multifamily commercial real estate loans increased between 2022 and 2023. As of December 31, 2023, the liability recognized on the consolidated balance sheets for these agreements was $137 million, compared to $82 million as of December 31, 2022. This increase indicates a higher level of risk exposure associated with these loans during 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in Capital One's liability under loss sharing agreements from $82 million in 2022 to $137 million in 2023, accurately reflecting the evolution in risk exposure. All key facts from the ground truth are present and factually correct. (2) Quantitative accuracy is perfect: both dollar amounts ($82M and $137M) and years (2022 and 2023) match the original answer exactly. The comparison between the two years is correctly stated. (3) The multi-hop reasoning is sound—linking loan origination practices to risk exposure via loss sharing agreements and interpreting the liability increase as higher risk. The only minor omission is that the LLM does not explicitly mention Capital One's 'intent to sell' the loans to GSEs, which provides context for why the loss sharing agreements exist. While this doesn't affect the core correctness, it slightly reduces completeness in explaining the mechanism behind the liability. (4) Despite this small omission, the answer is semantically equivalent in conveying the main point: increased risk exposure due to higher liabilities. The response is fully relevant, focused, and factually accurate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 343,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "From 2022 to 2023, Amazon's co-branded credit card programs remained a notable part of its payment-related risks, with no explicit mention of a strategic shift in their significance. However, the 2023 filing highlights increased regulatory scrutiny and compliance obligations tied to evolving data security, consumer protection, and payment processing rules. These new obligations could lead to higher operational costs, potential penalties, or disruptions if Amazon fails to comply with changing payment card association rules or regulatory interpretations. The potential impact on operating results includes higher fees, fines, or loss of payment processing capabilities if compliance challenges arise.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the strategic shift and specific new compliance obligations highlighted in the ground truth. (1) Correctly identifies that co-branded credit card programs remained a risk and that regulatory scrutiny increased from 2022 to 2023, and correctly notes potential impacts on operating results such as higher costs or penalties. However, it fails to mention the strategic expansion of the programs in 2023 or the introduction of data localization rules, which were explicitly absent in 2022 and are central to the shift in regulatory risk. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: it connects increased compliance obligations to potential operational impact, but fails to synthesize the specific evolution from traditional payment rules (e.g., data security) in 2022 to new data governance requirements like data localization and cross-border data transfer risks in 2023. This omission weakens the qualitative accuracy. (4) Contextual relevance is high because the answer addresses regulatory risks and operating impacts, but it lacks specificity on the new international regulatory dimensions that marked the 2023 shift. Overall, the answer captures the general trend but misses critical details that define the strategic and regulatory evolution, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 411,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "Between 2022 and 2024, PM's financial relationship with RBH evolved significantly, particularly regarding consolidation and valuation. In 2022, RBH had been deconsolidated from PM's financial statements since March 2019 due to its CCAA proceedings, and PM accounted for its remaining investment in RBH as an equity security without readily determinable fair value. By 2024, PM evaluated its investment in RBH for impairment and concluded that its estimated fair value was lower than its carrying value. As a result, PM recorded a $2,316 million non-cash impairment charge, reducing the carrying value of its investment in RBH to $714 million, based on a discounted cash flow analysis and assumptions about the allocation of the global settlement amount and tax deductibility in Canada.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the deconsolidation of RBH in 2019 (not 2022, but correctly notes it was deconsolidated by 2022) and the shift to an equity investment subject to impairment in 2024. However, it introduces specific financial figures—$2,316 million impairment charge and $714 million carrying value—that are not present in the ground truth and cannot be verified. The ground truth mentions a CAD 3.1 billion allocation of damages related to RBH but does not state that PM recorded an impairment charge of $2,316 million or a revised carrying value of $714 million. These numbers appear fabricated or hallucinated. (2) Quantitative accuracy is low because the key numbers in the LLM answer (impairment amount, carrying value) are unsupported by the original answer. There is no mention of a specific impairment charge or final carrying value in the ground truth. While the use of a discounted cash flow analysis and assumptions around global settlement and tax treatment are consistent, the precise figures undermine factual correctness. (3) The multi-hop reasoning is partially sound: the model correctly infers a shift from deconsolidation to equity accounting and recognizes the need for impairment analysis based on fair value estimation. It also appropriately references key valuation assumptions (discount rates, settlement allocation, tax deductibility), aligning with the audit judgment mentioned in the ground truth. However, it overreaches by asserting a specific outcome (impairment recorded) and exact dollar amounts without basis. (4) Contextual relevance is high—the answer addresses consolidation status evolution and valuation considerations directly. Qualitative accuracy is moderate because core concepts (deconsolidation, equity investment, impairment analysis, valuation uncertainty) are correct, but the addition of unverified specifics reduces reliability. Correctness score is 6 due to correct conceptual framework but significant factual inaccuracies in numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 543,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "Baqsimi's financial performance and strategic positioning evolved significantly between 2023 and 2024. In 2023, Baqsimi contributed $677.6 million in total revenue, a substantial increase from $139.3 million in 2022, indicating a notable rise in its revenue contribution. This growth was primarily driven by increased demand and higher realized prices in the U.S. Additionally, in 2023, Baqsimi was part of a $579.0 million sale of rights in the U.S., which further enhanced its strategic value within LLY's product portfolio. By 2024, while specific revenue figures for Baqsimi were not provided, its role as a high-growth product and its inclusion in significant business development activities underscored its importance in LLY's strategic focus on expanding its diabetes and endocrinology offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states Baqsimi's 2023 total revenue as $677.6 million, it incorrectly claims a $579.0 million sale of rights in the U.S. in 2023, which contradicts the ground truth stating the sale of rights led to Baqsimi being removed from direct revenue reporting in 2024. The $579.0 million figure does not appear in the ground truth and is likely confused with another transaction. Additionally, the LLM implies Baqsimi remained strategically central in 2024, whereas the ground truth confirms it was divested and no longer reported as a direct revenue contributor. (2) The quantitative accuracy is partially correct on the 2023 revenue but introduces a false $579.0 million sale figure and omits the correct U.S. and international revenue breakdowns ($645.7M and $31.9M). It also fabricates a 2022 revenue of $139.3 million not present in the original answer, making comparisons invalid. (3) The multi-hop reasoning is flawed: instead of recognizing that the sale of rights resulted in Baqsimi's removal from product revenue in 2024, the model incorrectly infers continued strategic importance. It fails to synthesize the cause-effect relationship between the divestiture and the absence of 2024 revenue reporting. (4) Contextual relevance is moderate because the answer addresses revenue trends and strategic role, but the incorrect facts and reasoning undermine the overall validity. The model captures the question's intent but delivers a factually incorrect narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 427,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "From 2022 to 2024, the composition of Union Pacific's Total Highway Revenue Equipment shifted significantly in favor of owned equipment. In 2022, the company owned 48,962 containers and 29,875 chassis, while leasing 1,856 containers and 14,148 chassis. By 2024, the number of owned containers increased to 46,375 (a decrease of 2,587) and owned chassis rose to 4,356 (an increase of 1,363), while leased containers dropped to 288 (a decrease of 1,568) and leased chassis fell to 1,197 (a decrease of 12,951). This indicates a substantial reduction in leased chassis and a shift toward a more owned-heavy composition in highway revenue equipment.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, in 2022, Union Pacific owned 78,837 total units (not broken down by container/chassis in the original), but the LLM incorrectly states 48,962 owned containers and 29,875 owned chassis (summing to 78,837, which matches total owned units). However, the LLM misattributes the composition, implying containers and chassis are the only components and assigning incorrect values. More critically, the LLM claims owned containers increased to 46,375 in 2024, but the ground truth states total owned units dropped to 50,731 (not just containers), making the LLM's breakdown invalid. The leased chassis number in 2024 is reported as 1,197 by the LLM, but ground truth states total leased units (all types) dropped to 1,485 — so even if all were chassis, 1,197 is inconsistent without further breakdown. (2) The LLM incorrectly states that owned chassis increased from 29,875 to 4,356 — this is a decrease, not an increase, and the direction of change is wrong. It also claims owned containers decreased slightly, but the ground truth does not provide container-specific owned numbers, only total owned equipment. The LLM fabricates granular data not present in the original. (3) The multi-hop reasoning is flawed: the model invents a container/chassis split for owned equipment in 2022 that isn't in the ground truth and extrapolates incorrectly to 2024. It also misinterprets trends — the ground truth describes a broad reduction in both owned and leased assets, especially leased containers and chassis, but the LLM frames it as a shift toward more owned equipment, which contradicts the overall decline. (4) Contextual relevance is fair because the answer addresses the question’s focus on owned vs. leased changes and mentions containers and chassis. However, due to major quantitative and qualitative errors — including incorrect numbers, misstated trends, and fabricated breakdowns — the correctness score is low. Minor credit is given for correctly noting the drop in leased containers (1,856 to 288) and leased chassis decline, though exact leased chassis numbers are not fully verifiable from the original. Overall, the answer misrepresents the data and draws incorrect conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 614,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations increased slightly as part of its overall funding structure. As of December 31, 2022, securitized debt obligations totaled $16.97 billion, and by December 31, 2023, they rose to $18.04 billion. These obligations represented a smaller portion of the company's total funding sources compared to deposits and other debt but remained a consistent component of its liquidity and capital management strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the carrying values of securitized debt obligations for 2022 ($16.97 billion) and 2023 ($18.04 billion), which aligns with the ground truth value of $18.043 billion in 2023 (rounding difference is acceptable). These figures are quantitatively accurate and reflect a slight increase, as stated. (2) However, the LLM misses a key qualitative shift described in the original answer: the reclassification of securitized debt obligations under Level 2 of the fair value hierarchy in 2023, indicating a move toward standardized valuation methods. This evolution in risk and accounting treatment is a central part of how the role of these obligations changed, but it is entirely omitted. (3) While the LLM correctly identifies securitized debt as a consistent component of funding, it fails to synthesize the multi-hop insight that their role became more structured and possibly less volatile due to the valuation hierarchy change. The reasoning is factually sound regarding amounts but incomplete in capturing strategic and methodological evolution. (4) The contextual relevance is high because the answer addresses funding structure and trends over time, and the numbers are accurate. However, the absence of the fair value hierarchy shift significantly limits qualitative accuracy, preventing a higher score. Thus, correctness is partially impacted despite strong quantitative performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 397,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, LLY's revenue from Zyprexa shifted significantly in both source and recognition method. In 2023, Zyprexa revenue was primarily derived from product sales, with $79.4 million in U.S. revenue and $1,615.4 million from international sales. However, in 2024, the source of Zyprexa revenue transitioned to collaboration and other revenue, specifically from the sale of rights for the olanzapine portfolio, which was recognized as collaboration and other revenue when control of the asset transferred to the other party. This change reflects a shift from ongoing product sales to a one-time transaction involving intellectual property rights.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in revenue source and recognition method for Zyprexa between 2023 and 2024, aligning with the ground truth that revenue moved from product sales to collaboration and other arrangements following the sale of rights to the olanzapine portfolio. The qualitative reasoning about the change in recognition—due to a one-time transaction involving IP rights and transfer of control—is sound and reflects accurate multi-hop synthesis. (2) However, the quantitative accuracy is severely flawed: the LLM provides specific revenue figures ($79.4M U.S., $1,615.4M international) for Zyprexa in 2023 that are not present in the original answer and cannot be verified from the ground truth. These numbers appear fabricated or misattributed, as the original answer makes no mention of any dollar amounts. This constitutes a major error in factual reporting. (3) The multi-hop reasoning is otherwise strong—the model correctly infers that the 2023 sale led to 2024 collaboration revenue recognition, showing understanding of revenue classification changes post-transaction. (4) The contextual relevance is high because the answer directly addresses the evolution in source and recognition method. Due to the inclusion of unsupported numerical data, the correctness score is reduced to 6—partially correct but with significant factual inaccuracies in the quantitative details, despite sound conceptual understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 403,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "The valuation methodology for Federal Government Securities in the pension plan has remained consistent from 2022 to 2024, as they are classified as Level 2 investments and valued using a bid evaluation process with bid data from independent pricing sources. However, the classification of these securities within the overall asset allocation has shifted due to a strategic de-risking approach, with a reduction in equity allocation and an increase in debt securities, including Federal Government Securities, to align with updated target ranges of 70–80% debt and 20–30% equity in 2025 compared to 45–55% equity and debt in 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Federal Government Securities are classified as Level 2 investments in both 2022 and 2024, which aligns with the ground truth. However, it introduces information not present in the original answer, such as a 'strategic de-risking approach', changes in equity/debt allocation (45–55% in 2022 vs 70–80% debt in 2025), and shifts in asset allocation strategy, none of which are mentioned or supported by the ground truth. The original answer focuses solely on valuation methodology and classification, not on portfolio allocation changes. (2) The dollar amount ($742 million in 2022) from the ground truth is omitted entirely in the LLM response, which is a significant quantitative omission. No actual numbers are provided for 2024. The percentages cited (e.g., 70–80% debt) are not in the original and cannot be verified from the provided truth. (3) The multi-hop reasoning is partially sound in recognizing continuity in Level 2 classification, but it incorrectly infers broader portfolio strategy changes that were not asked about or supported by the source. The question asks specifically about valuation methodology and classification evolution, not asset allocation strategy. The LLM conflates valuation classification with investment allocation, which are distinct concepts. (4) The correctness score is 5 due to partial factual accuracy on classification but major omissions (missing $742M) and introduction of unsupported strategic rationale. Quantitative accuracy is low (4) due to missing key figures and inclusion of unverified percentages. Qualitative accuracy is moderate (5) as core classification is correct but reasoning drifts into unsupported claims. Contextual relevance is 7 because the response stays on topic regarding pension plan securities but veers into tangential strategic discussions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 505,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "From 2022 to 2023, Capital One maintained a consistent utilization of credit scores for product segmentation decisions, as both years show similar credit score distributions for domestic credit card and auto loan portfolios. In 2022, 69% of domestic credit card borrowers had scores above 660, and in 2023, this slightly decreased to 68%. For auto loans, the percentage of borrowers with scores above 660 remained stable at 53%. This consistency suggests that Capital One's credit risk modeling strategy prioritizes maintaining a balanced risk profile across its consumer loan portfolios, leveraging credit scores to segment products and manage risk effectively without significant shifts in underwriting criteria.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both its core claim and supporting data. The original answer states that Capital One updated the *time period of credit score data used* in product segmentation—from relying on 2020–2021 data in 2022, to using 2022–2023 data in 2023. The LLM instead claims that Capital One maintained consistency in credit score distributions (e.g., 69% to 68% above 660 for credit cards), which is not supported by the ground truth and introduces specific percentages not mentioned in the original. These numbers (69%, 68%, 53%) are fabricated or misattributed, as the original does not provide any such statistics. (2) There are no valid calculations or accurate numbers in the LLM response that align with the ground truth. The shift described is about data recency in modeling, not stability of borrower scores. (3) The multi-hop reasoning is flawed: the question asks about the *evolution in data utilization* for segmentation, not the stability of borrower credit profiles. The LLM misinterprets the evolution as static strategy due to 'stable' percentages, missing the key point about updating data sources for risk modeling. It fails to recognize that the change in underlying data periods (2020–2021 → 2022–2023) reflects a strategic shift toward more timely risk assessment. (4) The contextual relevance is moderate because it discusses credit scores, product segmentation, and risk modeling, but the factual foundation is incorrect, leading to a misleading conclusion about 'consistency' when the truth emphasizes *change in data timeliness*. This indicates a failure in both retrieval and reasoning across time-based data usage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 458,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "From 2022 to 2023, AWS has maintained its position as a core strategic pillar for Amazon, with continued emphasis on its role in driving technological innovation and supporting broader business growth. In 2023, AWS remains a distinct business segment, reflecting its importance in generating revenue through on-demand technology services such as compute, storage, and machine learning. The 2023 filing highlights AWS's role in underpinning Amazon's technology infrastructure and its ongoing investment in expanding capabilities, consistent with 2022 disclosures. Notably, AWS's leadership structure and operational focus remain unchanged, with Adam N. Selipsky as CEO and continued prioritization of innovation and enterprise services.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in AWS's strategic positioning from 2022 to 2023 as described in the ground truth. (1) What was correct: The answer correctly identifies AWS as a core business segment in 2023 and accurately describes its services (compute, storage, machine learning), which aligns with the 2023 filing. It also correctly notes AWS's role in innovation and infrastructure, and there are no incorrect numbers or dates—hence a quantitative accuracy of 10. (2) However, the answer fails to capture the significant shift in AWS's role: in 2022, it was framed as part of broader technology and content spending and an investment area, not yet elevated to a core business segment on par with North America and International. The LLM implies continuity (e.g., 'maintained its position as a core strategic pillar'), but the ground truth shows a structural and strategic evolution—from investment area to one of three central business segments. (3) Multi-hop reasoning is weak: the model does not synthesize the change in segment classification and strategic framing across the two years, which is the core of the question. It also introduces irrelevant details (e.g., Adam Selipsky as CEO) not present in the ground truth and not requested. (4) Contextual relevance is high because the answer discusses AWS’s role and evolution, but the qualitative accuracy is low due to the failure to identify the key transformation. Thus, correctness is scored 6—some facts are right, but the central analytical point is missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 424,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved significantly in terms of accounting treatment and financial exposure. In 2022, RBH was deconsolidated from PMI's financial statements due to its entry into CCAA proceedings to address Canadian tobacco litigation. PMI no longer consolidated RBH's results after March 22, 2019. By 2024, a proposed settlement plan in the CCAA proceedings outlined a CAD 32.5 billion global settlement, with unresolved allocation among RBH and its co-defendants. This uncertainty led PMI to record a $2,316 million non-cash impairment charge in 2024 for its investment in RBH, as the estimated fair value fell below its carrying value. Thus, PMI's exposure shifted from litigation-related charges to a significant impairment due to the potential settlement of Canadian tobacco claims.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the deconsolidation of RBH in 2022 due to CCAA restructuring and the $2,316 million non-cash impairment charge in 2024, which aligns with the ground truth. The proposed CAD 32.5 billion settlement is accurately mentioned. However, there is a factual error regarding the deconsolidation date: the LLM states RBH was no longer consolidated after March 22, 2019, which contradicts the ground truth that deconsolidation occurred in 2022 due to CCAA proceedings. This is a significant misstatement of timing and undermines the accuracy of the accounting timeline. (2) Quantitatively, the $2,316 million impairment and CAD 32.5 billion settlement figures are correct and match the ground truth. The error lies not in the numbers themselves but in the incorrect dating of the deconsolidation event. (3) The multi-hop reasoning is largely sound—linking CCAA proceedings to deconsolidation, then to the proposed settlement, and finally to the impairment charge shows appropriate synthesis. However, the incorrect deconsolidation date disrupts the logical flow between 2019 and 2022 events, suggesting a failure to correctly sequence the financial relationship evolution. (4) Despite this key error, the answer captures the core evolution from deconsolidation to equity investment with impairment, and the financial exposure shift is well articulated. Hence, correctness is reduced to 8 due to the material misstatement of the deconsolidation date, though other elements remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 420,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, Biktarvy has maintained a significant commercial role for Gilead, contributing substantial revenue. In 2022, Biktarvy generated $8,624 million in product sales, and while specific 2024 revenue figures are not provided, its continued prominence in Gilead's HIV portfolio suggests sustained commercial importance. However, associated product risks include increasing competition, potential pricing pressures from government programs like the Inflation Reduction Act, and the need for ongoing innovation to maintain market share. These factors could impact Biktarvy's future revenue growth and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states the 2022 revenue for Biktarvy as $8,624 million, matching the ground truth exactly. It appropriately notes the absence of specific 2024 revenue figures, which aligns with the original answer. The commercial significance is accurately portrayed as sustained, with continued importance in GILD's HIV portfolio.\n\n2) Quantitatively, the only numeric data point in the ground truth is the 2022 revenue, which is reported correctly. No calculations are required, and the format ($8,624 million) matches precisely.\n\n3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers from available data that Biktarvy remains commercially significant despite rising risks. While the original answer emphasizes 'reliance on TAF-based therapies' and 'shifts in treatment paradigms' as key risks, the LLM substitutes these with broader but related risks—competition, pricing pressures (e.g., Inflation Reduction Act), and need for innovation. These are contextually valid and reflect accurate qualitative understanding, though slightly less specific than the ground truth.\n\n4) The answer is semantically equivalent in intent and factual content. It captures both revenue contribution and evolving risk landscape. The minor deduction in qualitative accuracy (9 instead of 10) is due to the substitution of the precise risk factors (TAF reliance, treatment paradigm shifts) with more general competitive and pricing risks, which, while plausible, are not the exact risks highlighted in the source. However, this does not undermine the overall correctness. Contextual relevance is perfect—the response directly addresses the evolution of commercial significance across both revenue and risk dimensions from 2022 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 478,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.8 billion in 2023 to $1.9 billion in 2024, reflecting a rise in the value of its 37.03% economic interest. Car hire expenses also increased from $399 million in 2023 to $432 million in 2024, indicating higher operational usage of TTX rail cars.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces inaccuracies in key quantitative data. The ground truth states that Union Pacific's financial stake in TTX increased from $1.6 billion (referenced in the 2022 filing, reflecting 2021 value) to $1.9 billion in 2024. However, the LLM claims the increase was from $1.8 billion in 2023 to $1.9 billion in 2024, which misrepresents the baseline and timeline. Similarly, car hire expenses rose from $375 million in 2021 to $432 million in 2024 according to the original answer, but the LLM cites $399 million in 2023 as the starting point, skipping earlier data and narrowing the time frame. These changes alter the narrative of a multi-year trend. (2) The final 2024 values ($1.9 billion stake and $432 million car hire) are correct, which supports partial credit. However, the intermediate figures for 2023 and implied growth trajectory are unsupported by the ground truth and introduce factual errors. The 37.03% economic interest is plausible but not mentioned in the original answer, making it an unverified addition. (3) The reasoning shows an understanding of the relationship between financial stake and operational usage, and the conclusion about growing involvement aligns semantically with the original. However, the multi-hop synthesis is flawed because it fails to accurately trace the evolution from 2021–2022 (as referenced in the 2022 filing) through 2024, instead focusing only on 2023–2024. This omits the full scope of the question, which asks about evolution from 2022 to 2024. (4) Correctness and quantitative accuracy are scored at 5 due to major factual discrepancies in input numbers despite correct endpoints. Qualitative accuracy is slightly higher because the logic and interpretation of increasing involvement are sound, even if based on incorrect inputs. Contextual relevance is high as the answer addresses both investment value and car hire expenses as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 531,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "Tesla shifted its approach to scaling Solar Roof production from 2022 to 2023 by expanding installer training initiatives and enhancing supply chain risk management. In 2022, Tesla focused on onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. By 2023, the company emphasized structured training programs, such as the Engineering Development Program launched in January 2024, targeting specialized engineering talent and enhancing skills in high-demand manufacturing technologies. Additionally, Tesla improved supply chain risk management by diversifying localized procurement, addressing component shortages, and increasing resilience against global disruptions like the semiconductor shortage and geopolitical uncertainties.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general shift in Tesla's approach from installer-focused initiatives in 2022 to supply chain resilience in 2023, which aligns with the ground truth. However, it introduces a factual inaccuracy by referencing the 'Engineering Development Program launched in January 2024,' which is not mentioned in the original answer and falls outside the 2022–2023 timeframe of the question. This undermines the quantitative and qualitative accuracy. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy hinges on dates and program specifics. The mention of a January 2024 program is incorrect for a question about 2022–2023 changes, and no such program is referenced in the ground truth. This is a significant error. (3) The multi-hop reasoning is partially sound—correctly identifying the shift from installer training to supply chain focus—but fails in synthesis by inventing a specific training program not present in the source. The original answer notes a *reduction* in emphasis on installer training and a pivot toward supplier reliability and component constraints, not an enhancement or continuation of training programs. (4) The contextual relevance is high because the answer addresses both installer training and supply chain risk management as required. However, the correctness score is limited to 6 due to the fabricated program detail and misrepresentation of the 2023 strategy as continuing to enhance training, when the ground truth indicates a strategic pivot away from that focus. The core idea of increased supply chain focus is correct, but the added detail distorts the factual shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 462,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "Between 2022 and 2023, The Coca-Cola Company continued to manufacture and sell fountain syrups directly to authorized fountain wholesalers and fountain retailers in the United States, as bottlers in the U.S. are generally not authorized to manufacture fountain syrups. This arrangement remained consistent, with the Company handling the production and distribution of fountain syrups, which are then sold or delivered to restaurants and other retailers either directly or through authorized wholesalers. There is no indication of a significant change in this structure during the specified period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating that The Coca-Cola Company manufactures fountain syrups in the U.S. and that U.S. bottlers are generally not authorized to manufacture them. It correctly notes that the Company sells to authorized fountain wholesalers and retailers, and that there was no significant change in structure. However, it misses a key qualitative evolution highlighted in the ground truth: in 2023, the Company explicitly expanded its description to include selling to bottling partners (authorized fountain wholesalers or bottling partners) who then distribute to fountain retailers, indicating a more formalized or clarified tiered distribution model. The LLM incorrectly concludes there was 'no indication of a significant change,' when the shift in language from 2022 to 2023 reflects a clearer acknowledgment of bottling partners' distribution roles, which constitutes an evolution in the relationship with fountain retailers via distribution channels. While no numbers or dates are incorrect (hence high quantitative accuracy), the reasoning fails to capture the nuance of multi-hop synthesis across years and documents regarding structural clarification. This omission reduces completeness and qualitative accuracy, though the response remains contextually relevant and factually sound on surface-level details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 372,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "IBM's 0.950% Notes due 2025 are disclosed as registered securities on the New York Stock Exchange under the trading symbol \"IBM25B\" in both the 2022 and 2024 10-K filings. In 2024, the Notes are explicitly listed in the \"Securities registered pursuant to Section 12(b) of the Act\" section, confirming their classification as a registered debt instrument. In 2022, while the Notes were not explicitly detailed in the provided pages, the general treatment of similar instruments (e.g., 7.00% Debentures) suggests consistent classification and registration practices. Thus, the Notes have remained classified as registered debt instruments with no material evolution in their disclosure or classification between 2022 and 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but significantly misrepresents the evolution of IBM's treatment and disclosure of the 0.950% Notes due 2025 from 2022 to 2024. (1) Quantitatively, the trading symbol 'IBM25B' and the interest rate (0.950%) are correctly identified, and the reference to NYSE listing in 2024 aligns with the ground truth. However, the claim that the Notes were 'disclosed as registered securities on the New York Stock Exchange' in the 2022 10-K is incorrect. The ground truth states that in 2022, the Notes were only referenced in Form 8-K filings (specifically Exhibit 4.1 filed May 22, 2017), not actively listed or registered for trading at that time. (2) The LLM incorrectly asserts that the Notes were registered and disclosed in the same manner in both 2022 and 2024, directly contradicting the ground truth, which highlights an evolution from mere disclosure in 2022 to formal registration and listing by 2024. (3) The reasoning is flawed: the model assumes consistency based on 'similar instruments' in 2022 due to lack of direct evidence, which is speculative and unsupported by the provided data. This fails the multi-hop requirement to contrast disclosure practices across years using specific filing evidence. (4) While the answer addresses the question's topic and uses correct entities (IBM, 0.950% Notes due 2025, NYSE), it misses the core evolution—shift from disclosure via 8-K to active listing under Section 12(b)—which is central to the question. Thus, despite some accurate details, the conclusion is factually wrong, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 437,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "From 2022 to 2024, Gilead's strategic positioning of Biktarvy in the HIV treatment market has evolved to emphasize competitive differentiation through its efficacy and tolerability profile, which has helped maintain its market leadership. However, the company faces increasing financial risk exposure due to pricing pressures from government programs like the Inflation Reduction Act of 2022 and growing competition from generic and branded alternatives. These factors have heightened the need for Gilead to balance innovation and cost management while defending Biktarvy's value proposition in a rapidly evolving regulatory and competitive landscape.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges from the ground truth in key aspects of strategic evolution. (1) Correct elements: The answer correctly identifies increasing financial risk exposure for GILD's Biktarvy from 2022 to 2024 and acknowledges competitive pressures, which aligns with the original answer’s theme of rising risk. It also appropriately notes Biktarvy’s competitive differentiation through efficacy and tolerability, consistent with its market leadership. (2) Quantitative accuracy: There are no specific numbers (e.g., revenue figures, percentages) in either the original or LLM answer, so no numeric inaccuracies exist—this aspect is neutral but does not detract. (3) Multi-hop reasoning assessment: The LLM introduces the Inflation Reduction Act of 2022 as a source of pricing pressure, which is contextually plausible but not present in the ground truth. More critically, it omits the core insight from the original answer: that the financial risk stems specifically from reliance on nucleoside-based therapies like TAF and a potential paradigm shift away from such regimens. This is a significant omission in the strategic rationale. Additionally, the original emphasizes the threat of generic competition and changing therapeutic preferences as undermining long-term differentiation—while the LLM mentions competition, it does not tie it to a shift in treatment paradigms or TAF-based regimen obsolescence. (4) The answer is contextually relevant and well-structured, addressing both financial risk and competitive positioning. However, it substitutes the actual multi-hop insight (evolving scientific and portfolio-level risk around TAF dependence) with a more general regulatory and pricing narrative. Thus, while semantically plausible, it fails to capture the specific strategic evolution documented in the knowledge graph, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 510,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued to reduce its defined benefit pension obligations by transferring additional pension liabilities to insurance companies. In 2022, the company transferred $4.3 billion of gross defined benefit pension obligations to an insurance company for approximately 13,600 retirees and beneficiaries, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, Lockheed Martin made a voluntary offering to certain former employees, resulting in $414 million in lump-sum settlement payments for approximately 6,500 participants, which reduced the benefit obligation without recognizing a settlement charge. These actions reflect the company's ongoing strategy to mitigate the financial impact of its defined benefit pension plans by reducing volatility and the size of its net pension obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: in 2022, Lockheed Martin transferred $4.3 billion in pension obligations via annuity contracts and recognized a $1.5 billion noncash settlement charge; in 2023, the company made $414 million in lump-sum payments to about 6,500 former employees. These numbers match the original answer exactly, and formatting is consistent. (2) Quantitative accuracy is perfect—dollar amounts ($4.3 billion, $1.5 billion, $414 million), participant counts (13,600 retirees in 2022, ~6,500 in 2023), and years (2022 vs. 2023) are all accurate. (3) The reasoning is sound and captures the strategic evolution: shifting from large-scale annuity transfers (2022) to direct individual settlements (2023). The LLM correctly notes that the 2023 payments were lump-sum settlements to former employees who had not yet started benefits, and accurately states that no settlement charge was recognized in 2023—this is a subtle but important distinction that aligns with accounting rules (settlement charges are triggered only when the payment exceeds a threshold of the total service and interest cost; voluntary lump sums can avoid charges). (4) The only minor shortcoming is that the LLM says the 2022 transfer was 'to an insurance company' (singular), while the original answer refers to 'group annuity contracts' (plural), which is slightly more precise but not factually incorrect. Also, the LLM describes the 2023 action as reducing obligation 'without recognizing a settlement charge,' which is correct but adds value beyond the original answer. Overall, the response is factually accurate, contextually relevant, and demonstrates correct multi-hop synthesis across years and financial impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 479,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "Between 2022 and 2024, the composition of IBM's debt instruments maturing in 2025 remained consistent regarding the 2.875% Notes due 2025. In both years, these notes were listed as securities registered under Section 12(b) of the Securities Exchange Act of 1934, traded under the symbol \"IBM25A\" on the New York Stock Exchange. There is no indication of changes in the terms or structure of these notes during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that the composition of IBM's debt instruments maturing in 2025 remained consistent between 2022 and 2024. The ground truth states that while the 2.875% Notes due 2025 (IBM 25A) were present in both years, the 0.875% Notes due 2025 (IBM 25C) were listed in 2022 but no longer appeared in 2024, indicating a change in composition. The LLM fails to mention this key shift entirely. (2) Quantitatively, the LLM correctly identifies the 2.875% Notes due 2025 and their ticker 'IBM25A' (with minor formatting difference from 'IBM 25A'), which aligns with the ground truth. However, it omits the other notes (0.950% and 0.875%) that were part of the 2022 composition, leading to an incomplete and misleading picture. (3) The multi-hop reasoning required to compare IBM’s debt composition across years is entirely missing. The model does not synthesize information from 2022 and 2024 filings to detect changes, instead asserting consistency without evidence. It focuses narrowly on the continued registration of IBM25A without addressing the broader evolution of the debt portfolio. (4) While the answer is contextually relevant—focusing on the correct company, instrument, and time frame—it fails on correctness and qualitative reasoning due to omission of critical comparative data and incorrect conclusion about stability in composition. Hence, low scores on correctness and qualitative accuracy despite acceptable quantitative and relevance scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 417,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "From 2022 to 2024, Biktarvy has emerged as a pivotal product within Gilead's HIV portfolio, driven by its continued growth and resilience amid competitive pressures and market challenges. In 2022, Biktarvy's sales increased due to higher demand and a favorable pricing environment, partially offsetting declines from Truvada and Atripla following their loss of exclusivity. By 2024, Biktarvy's strategic importance has further solidified as it remains a key driver of Gilead's HIV business, with ongoing efforts to expand its indications, such as the approval of a pediatric formulation in 2021. However, the risk profile has also evolved, as Biktarvy faces potential competition from new therapies and the broader shift in treatment paradigms, including the emergence of long-acting HIV treatments like lenacapavir. Additionally, pricing pressures from government and third-party payers continue to pose a risk to its profitability and market share.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but diverges significantly from the ground truth in terms of strategic evolution and risk assessment of Biktarvy. (1) Correctly identifies Biktarvy as a key product in Gilead's HIV portfolio and acknowledges competitive pressures, including long-acting therapies like lenacapavir and pricing pressures. These are contextually relevant and align with broader industry trends. (2) Quantitatively, no specific financial figures (e.g., 11% revenue increase in 2022) are mentioned, but none are fabricated either—this results in partial credit. The mention of pediatric approval in 2021 is factually accurate but not directly tied to the 2022–2024 evolution asked in the question. (3) The multi-hop reasoning is partially sound: it connects Biktarvy’s growth to portfolio dynamics and recognizes emerging risks. However, it incorrectly frames Biktarvy’s strategic importance as 'further solidified' by 2024, which contradicts the ground truth that its position became 'more precarious' and exposed to material risk due to overreliance on TAF-based therapies. The original answer emphasizes a shift from growth driver to vulnerable asset; the LLM misses this critical nuance. (4) While the answer is well-structured and contextually relevant, it fails to capture the core insight from the 2024 10-K about the systemic risk to Gilead’s HIV franchise due to its dependence on nucleoside analogs like TAF, which undermines the qualitative accuracy. Thus, the answer is plausible but factually misaligned on the key point of strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 432,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "Between the end of fiscal year 2022 and the end of fiscal year 2023, the balance of the U.S. litigation escrow account increased from $1,449 million to $1,764 million. During fiscal year 2023, there were deposits of $1,000 million into the account, while payments amounted to $685 million. In contrast, during fiscal year 2022, the balance increased from $983 million to $1,449 million, with $850 million deposited and $418 million in payments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the final account balances and deposit amounts. According to the ground truth, the balance increased from $1,449 million at the end of FY2022 to $3,089 million at the end of FY2023, but the LLM incorrectly states it rose only to $1,764 million. The LLM also fabricates payments ($685M in FY2023, $418M in FY2022) that are not mentioned in the original answer and are not supported by the ground truth. Deposit contributions are wrong: LLM reports $1,000M in FY2023 deposits (correct for FY2022 per truth), but truth states $1,500M in FY2023. It also incorrectly states $850M deposited in FY2022, while truth says $1,000M. (2) Numerically, the only correct figure is the ending balance for FY2022 ($1,449M), which the LLM repeats correctly. All other numbers—especially the FY2023 ending balance and deposit amounts—are incorrect. Calculations based on payments and net changes are unsupported and contradict the original. (3) The reasoning is flawed: the LLM introduces a level of detail (payments, net flows) not present in the source and misattributes values across years. It fails the multi-hop requirement by not correctly tracking the evolution of the account balance and deposits across the two fiscal years as stated in the truth. (4) Scores reflect major quantitative inaccuracies (2/10), poor reasoning due to fabricated data (3/10), partial relevance since it addresses the right topic and time frame (6/10), and very low overall correctness (2/10) due to core factual errors in key metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 432,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "Between 2022 and 2023, the role of fountain syrups in Coca-Cola's North America operating segment remained consistent in terms of manufacturing and distribution responsibilities. The company continued to manufacture fountain syrups in the United States and sell them to fountain retailers or authorized fountain wholesalers and bottling partners, who then distribute them to fountain retailers for use in producing beverages for immediate consumption. These activities remained part of the North America operating segment, with no significant changes in the described responsibilities during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Coca-Cola continued to manufacture fountain syrups in the U.S. and sell them to retailers, wholesalers, and bottling partners in both 2022 and 2023, which aligns with the ground truth. However, it omits a key nuance present in the original answer: the 2023 shift in language regarding bottling partners being authorized to manufacture fountain syrups outside the U.S. using company concentrates. This evolution in description—suggesting a more decentralized, authorization-based model internationally—is absent from the LLM response, leading to a partial omission of the 'evolution' aspect of the question. (2) There are no numerical values in this question, so quantitative accuracy is not applicable; however, the years 2022 and 2023 are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies continuity in North America but fails to synthesize the subtle but important shift in the company's disclosure about manufacturing authorization outside the U.S., which represents a qualitative evolution in operational model description. This limits the depth of the reasoning. (4) The answer is contextually relevant and factually accurate regarding U.S. operations, but the lack of mention of the expanded role of bottling partners outside the U.S. in 2023 reduces completeness and qualitative accuracy, warranting a score of 7 for correctness and qualitative accuracy. Quantitative accuracy receives a 10 by default (no numbers involved, but no errors in temporal or entity references), and contextual relevance is high as the response directly addresses the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 465,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "Between 2022 and 2024, IBM's debt instruments maturing in 2025 remained consistent in terms of the 0.950% Notes due 2025, as both the 2022 and 2024 10-K filings list these notes as registered securities. No changes in the composition or structure of the 0.950% Notes due 2025 are indicated in the provided pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 0.950% Notes due 2025 were present in both 2022 and 2024, which is factually accurate per the ground truth. However, it fails to mention the broader composition changes in IBM's 2025-maturing debt—specifically, the presence of three notes in 2022 (including the 0.875% and 2.875% Notes) and the disappearance of the 0.875% Notes by 2024. This omission significantly undermines completeness and correctness. (2) There are no numerical inaccuracies per se, as the LLM avoids citing specific dollar amounts or making incorrect percentages. However, it does not quantify or reference the other notes, missing key data points from the ground truth. (3) The multi-hop reasoning is incomplete: the question asks about the evolution of the composition of debt instruments, which requires comparing the full set of 2025-maturing notes across years. The LLM only confirms continuity of one instrument rather than analyzing changes in the overall structure. (4) While the response is relevant and factually consistent regarding the 0.950% Notes, it lacks the comparative analysis necessary to fully answer the question, resulting in a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 339,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "Between 2022 and 2024, Disney's strategic approach to cruise ships evolved from focusing on operational recovery and cost realignment to pursuing expansion and new investment opportunities. In 2022, Disney emphasized cost realignment and introduced an ad-supported Disney+ service, while in 2024, the company announced plans for additional expansion of its cruise ship fleet, highlighting a shift toward growth and capital investment in the cruise segment as part of broader Experiences and Products initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Disney's strategic approach to cruise ships between 2022 and 2024. It correctly identifies the shift from a focus on cost realignment and recovery in 2022 to active expansion and investment in cruise ships by 2024. The mention of 'additional expansion of its cruise ship fleet' in 2024 matches the original answer's key point. However, the LLM introduces information not present in the ground truth—specifically, the reference to 'operational recovery,' 'cost realignment,' and the 'ad-supported Disney+' service—as part of the 2022 strategy. While Disney did discuss cost realignment and Disney+ in its 2022 10-K, these were not tied to cruise ship strategy in the disclosed context; the original answer emphasizes that cruise ships were mentioned only as part of broader travel and resort experiences dependent on consumer demand. This misattribution slightly distorts the multi-hop reasoning by implying a strategic pivot from cost-cutting in cruising to expansion, which isn't fully supported. Despite this, the core evolution in cruise strategy is accurately captured, with correct entities (Disney, Experiences segment), correct years (2022 vs 2024), and no numerical inaccuracies (no specific numbers involved). The answer is contextually relevant and semantically close to the original, earning high marks, but loses minor points for introducing tangential strategic elements not linked to cruise operations in the source filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 421,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "From 2022 to 2023, Lockheed Martin's approach to pension risk transfer transactions evolved by continuing to execute these transactions to mitigate the volatility of pension obligations, as outlined in both the 2022 and 2023 filings. In 2022, the company had already completed a significant pension risk transfer transaction in August 2021, transferring $4.9 billion in pension obligations to an insurance company, which reduced plan volatility for 18,000 retirees. By 2023, the company reiterated its intent to explore additional risk transfer opportunities, though no new large-scale transactions were disclosed. Strategically, the company aimed to reduce its exposure to pension liabilities and stabilize future cash flows, while acknowledging that future transactions could result in noncash settlement charges. Financially, these actions helped reduce the need for future pension contributions and the impact of actuarial assumptions on earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic intent and financial rationale behind Lockheed Martin's pension risk transfer transactions but contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The $4.9 billion pension obligation transfer is correctly cited, but the number of retirees affected is wrong—LLM states '18,000 retirees' while the ground truth reports '95,000 retirees' since December 2018 (not just from the 2021 transaction). This is a major error. Additionally, the LLM omits the exact noncash settlement charge of $1.7 billion in 2022, instead vaguely referencing 'noncash settlement charges' without specifying the amount. (2) Completeness: The answer fails to mention the cumulative $11.6 billion in obligations transferred since 2018, a key detail in the original answer showing the scale of the program. It also omits the new risk introduced in 2023: potential residual liability if insurers default on GACs, which is a critical evolution in strategic framing. (3) Entity Accuracy: The companies, years, and transaction types (GACs) are correctly identified. The timeline (August 3, 2021 transaction discussed in 2022 filing) is slightly misaligned in emphasis but not entirely incorrect. (4) Reasoning: The LLM correctly infers that the strategic intent remains focused on reducing volatility and stabilizing cash flows, and that future transactions may incur noncash charges. However, it misses the shift from active execution (2022) to cautious evaluation with awareness of residual risk (2023), which is central to the evolution. (5) Semantic Equivalence: While the overall narrative of continued risk transfer is plausible, the omission of key figures and risks reduces factual fidelity. The financial impact is oversimplified without referencing the $1.7B charge or contribution implications in detail. The answer is contextually relevant and addresses both financial impact and strategic intent, but with incomplete and partially inaccurate data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 541,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "Between 2022 and 2023, Tesla's relationship with its financing partners has evolved in terms of accounts receivable management and leasing program risks. In 2023, Tesla highlighted increased exposure to credit risk due to potential defaults in its vehicle and solar energy system financing programs, especially in the event of economic downturns. Additionally, Tesla noted the challenges of managing accounts receivable due to fluctuations in customer payments and government rebate timelines. Regarding leasing program risks, Tesla emphasized the importance of accurately projecting residual values for leased vehicles, as any significant deviation could reduce profitability. The company also acknowledged the need to secure adequate financing and business partners to support the growth of its leasing programs, indicating a more cautious approach to managing residual risk and credit exposure in 2023 compared to 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Tesla's relationship with financing partners from 2022 to 2023, particularly regarding accounts receivable management and leasing program risks. (1) It correctly identifies the increased credit risk in 2023 due to potential defaults in financing programs and notes the importance of residual value projections for leased vehicles—both of which align with the ground truth. It also accurately mentions the need to secure adequate financing and partners to support leasing growth. However, it omits the specific 2022 detail that accounts receivable settlement could take up to approximately two weeks, which was a concrete operational timing issue impacting liquidity. This omission slightly weakens the comparative analysis between years. (2) There are no numeric inaccuracies; the answer avoids making up figures and sticks to qualitative descriptions, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes information across years and domains (accounts receivable, credit risk, residual value, partner dependency), though it could have more explicitly contrasted the 2022 focus on cash flow timing with the 2023 shift toward broader risk management. (4) Contextual relevance is high—the response directly addresses both sub-questions about accounts receivable and leasing risks, and the overall cautious shift in approach is well conveyed. Minor deduction in correctness and qualitative accuracy due to the missing two-week settlement detail, but core facts and synthesis remain accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 436,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola shifted its fountain syrup distribution strategy by increasing the role of authorized fountain wholesalers and bottling partners in distributing fountain syrups to retailers. Previously, in the United States, the Company primarily manufactured and sold fountain syrups directly to authorized fountain wholesalers and some fountain retailers. In 2023, the strategy evolved to involve bottling partners more actively in the distribution process, allowing them to sell and distribute fountain syrups to fountain retailers. This change aimed to enhance distribution efficiency and align with the broader goal of optimizing the Coca-Cola system's production, marketing, and distribution capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a strategic shift in Coca-Cola's fountain syrup distribution between 2022 and 2023 involving increased bottler participation, which aligns with the ground truth. However, it omits the critical geographic distinction: the ground truth specifies that by 2023, bottlers outside the U.S. were authorized to manufacture fountain syrups using Coca-Cola concentrates—a key multi-hop detail. The LLM incorrectly generalizes the change to all bottling partners without specifying the international scope, and inaccurately implies that the prior U.S.-centric model was the global model. It also fails to mention that U.S. bottlers were generally not authorized to manufacture fountain syrups, a key contrast. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or financials. (3) The reasoning is partially sound but incomplete: the model recognizes a shift toward greater bottler involvement, but fails to synthesize the geographic differentiation (U.S. vs. international) and the change from direct manufacturing by Coca-Cola to authorized manufacturing by bottlers abroad. This missing synthesis undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the core topic of distribution strategy evolution and bottler roles. Correctness is scored at 6 due to significant omissions in key factual distinctions, despite capturing the general direction of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 417,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved with an increase in receivables from $9 million to $12 million and a new investment activity of a $17 million equity contribution in proportion to AMD's 15% ownership. Additionally, AMD provided a $100 million term loan to one of the ATMP JVs in October 2024, secured by the JV's receivable balance due from AMD.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly identifies the increase in receivables from $9 million in 2023 to $12 million in 2024, it incorrectly states a '$17 million equity contribution' by AMD, which is not mentioned in the ground truth—there was no direct investment or equity contribution noted in either year. Additionally, the LLM claims this contribution was in line with a '15% ownership,' which is not present in the original answer and introduces unverified information. The $100 million term loan is correctly mentioned, but the LLM adds that it was 'secured by the JV's receivable balance due from AMD,' which contradicts the ground truth: the loan was to support the JV's corporate purposes and there is no indication it was secured by AMD's own receivables. (2) Quantitative accuracy is partially correct: $9M to $12M receivables is accurate, and $100M loan amount is correct. However, the $17M equity contribution and 15% ownership are fabricated numbers with no basis in the ground truth, significantly reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model recognizes the evolution in financial relationship and attempts to synthesize changes across years and financial activities—but it fails by introducing unsupported investment details and misrepresenting the nature of the loan. The conclusion about increased financial integration is plausible but based on incorrect premises. (4) Contextual relevance is high as the answer addresses the evolution of the financial relationship, receivables, and new financial activities. However, due to significant factual and quantitative errors, especially the false equity contribution and loan security detail, the overall correctness score is low despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 493,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued to manage its nonqualified defined benefit pension plans by reducing the size and volatility of its net pension obligations. In 2023, the company made a voluntary settlement offering to approximately 6,500 former employees who had not yet started receiving their vested benefits, resulting in $414 million in lump-sum payments from the pension trust and a corresponding reduction in the pension obligation. This followed a similar approach in 2022, where the company transferred $4.3 billion in pension obligations to an insurance company through group annuity contracts, recognizing a $1.5 billion noncash pension settlement charge. These actions reflect a strategic shift to mitigate financial risks and reduce the burden of pension liabilities on the company's financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: in 2022, Lockheed Martin transferred $4.3 billion in pension obligations via group annuity contracts and recognized a $1.5 billion noncash settlement charge; in 2023, it made $414 million in voluntary lump-sum payments to approximately 6,500 former employees. All numbers, years, and entities are accurate. (2) Quantitative accuracy is perfect: $4.3 billion, $1.5 billion, $414 million, and 6,500 employees are all correctly reported with no calculation errors. Format variations (e.g., 'lump-sum payments' vs 'settlement payments') are semantically equivalent. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across two years and two different methods of pension liability reduction (annuity transfer vs. lump-sum settlements). It accurately infers a strategic shift toward reducing pension risk, though it slightly softens the contrast by saying 'continued a similar approach' rather than highlighting the shift from large-scale to targeted settlements as emphasized in the original. This minor nuance in interpretation does not undermine the overall correctness. (4) Scores reflect near-perfect factual alignment, with only a slight deduction in qualitative accuracy due to the less precise characterization of the strategic evolution. Contextual relevance is full—answer directly addresses both years, the nature of actions, and financial impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 405,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "Between 2023 and 2024, AMD's investment in the ATMP JV increased from $99 million to $149 million, reflecting an additional $17 million contribution in 2024. Additionally, AMD's equity income from the ATMP JV rose from $16 million in 2023 to $33 million in 2024, indicating an improvement in the venture's performance during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 2023 carrying value ($99M), 2024 carrying value ($149M), additional contribution ($17M), 2023 equity income ($16M), and 2024 equity income ($33M) are all correctly reported. The implied calculation (99M + 17M = 116M, with the remainder of the increase likely due to retained earnings or valuation adjustments) is consistent with the data, and the equity income increase is correctly stated. (2) The answer is complete, addressing both AMD's investment evolution (carrying value and contribution) and equity income changes—both key parts of the question. (3) Entities (AMD, ATMP JV), years (2023, 2024), and financial metrics (investment carrying value, equity income) are correctly identified and used. (4) The reasoning is sound: the LLM correctly infers increased investment and improved performance based on rising equity income, which aligns with the multi-hop synthesis required (tracking changes across two years and two financial dimensions). (5) The semantic meaning is equivalent to the original answer, with no omissions or distortions. Minor wording differences (e.g., 'improvement in the venture’s performance' vs. 'significant increase') do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 364,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson significantly reduced its ownership stake in Kenvue. In May 2023, Kenvue completed its IPO, after which Johnson & Johnson retained approximately 89.6% ownership. On August 23, 2023, Johnson & Johnson further divested 80.1% of its Kenvue shares through an exchange offer, reducing its ownership to 9.5%. This exchange resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By May 2024, Johnson & Johnson completed a Debt-for-Equity Exchange of its remaining Kenvue shares for commercial paper, resulting in a loss of approximately $0.4 billion and effectively ending its ownership in Kenvue.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the early ownership percentages and timeline. It incorrectly states that after Kenvue's IPO in May 2023, Johnson & Johnson retained 89.6% ownership, and that on August 23, 2023, it divested 80.1% of its shares. The ground truth does not mention an 89.6% initial post-IPO stake or a specific 80.1% divestment on that date. Instead, the original answer states that J&J retained a 9.5% stake after the exchange offer in 2023, resulting in a $21.0B gain — this part is correctly reported. However, the LLM fabricates intermediate steps not present in the ground truth. (2) The $21.0 billion non-cash gain (including $2.8B on retained shares) and the $0.4 billion loss in 2024 are correctly reported and match the ground truth. The final outcome — full exit by end of 2024 via Debt-for-Equity Exchange — is also accurate. (3) The multi-hop reasoning is partially sound: the model correctly connects the 2023 retained stake, associated gains, and the 2024 full exit with a loss. However, the inclusion of unsupported details (89.6%, 80.1%, May 2024 timing) undermines the quantitative and qualitative accuracy. (4) The contextual relevance is high as the answer addresses the evolution of ownership, retained equity, and gains/losses. Correctness score is 6 due to correct core financial outcomes but significant errors in intermediate ownership figures and timeline details. Quantitative accuracy is low (5) due to incorrect percentages and dates. Qualitative accuracy is 7 because the overall narrative structure and logic are reasonable despite factual flaws. Contextual relevance is 9 as the answer stays focused on the question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 470,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "Based on the provided document pages, AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. is referenced in the 2022 filing (page 134) under \"4-c Guaranty of certain obligations,\" which includes Southwestern Bell Telephone Co. as one of the entities whose obligations are guaranteed. However, in the 2023 filing (pages 101-105), there is no explicit mention of Southwestern Bell Telephone Co. in the context of guarantee agreements. This suggests that Southwestern Bell Telephone Co. was included in AT&T's guarantee agreements in 2022 but was not specifically listed in 2023, indicating a potential evolution or restructuring of the guarantee relationships between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its conclusion, directly contradicting the ground truth. The original answer states that AT&T's guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the entity explicitly included in Exhibit 4-c in both years. However, the LLM claims that Southwestern Bell Telephone Co. was not specifically listed in the 2023 filing, suggesting a change in the guarantee relationship. This is factually wrong according to the ground truth, which confirms the guarantee was maintained and referenced in the same exhibit (4-c) in both years. The LLM may have misread or failed to locate the 2023 reference, leading to an erroneous inference of change or restructuring. While the 2022 information is correctly cited (entity listed in Exhibit 4-c), the 2023 analysis is flawed, undermining the multi-hop comparison. There are no numerical calculations, so quantitative accuracy is not heavily penalized, but the qualitative reasoning fails on entity tracking and synthesis across years. Contextual relevance is moderate because the answer addresses the right documents and topic, but the conclusion is misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 333,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs from 2022 to 2023 has seen a strategic shift toward early production phases, with the company performing on multiple hypersonics programs and anticipating that several will enter early production by 2026. In 2022, the company emphasized its role in advanced development programs, including hypersonics, under its Skunk Works division. By 2023, the focus had evolved to include specific hypersonics programs with the U.S. Army and Navy, highlighting progress in design, development, and production. This evolution reflects a stronger strategic positioning in the hypersonics domain, aligning with the broader 21st Century Security vision and growth initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of Lockheed Martin's evolving role in hypersonics programs from 2022 to 2023, with accurate entity identification (Lockheed Martin, U.S. Army, Navy, Skunk Works) and correct timeframes. It correctly identifies a strategic shift toward more active involvement in hypersonics, including design, development, and anticipated early production by 2026. However, the original answer emphasizes a structural change in reporting—hypersonics moving from a 'growth area' in 2022 to being explicitly listed among major programs in the Space segment in 2023—which the LLM answer omits. This is a key factual nuance indicating formal program elevation within the company's portfolio. While the LLM mentions progress toward production, it introduces the forward-looking date '2026' not present in the ground truth, which may be accurate but is not supported by the provided knowledge graph. The reasoning is sound and contextually relevant, but the absence of the segment-level reporting change and the introduction of unverified forward-looking timelines reduce qualitative accuracy. Quantitatively, there are no numbers to verify, so accuracy is 10. Contextual relevance is high as the answer directly addresses strategic positioning and program development evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 366,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The balance of the U.S. litigation escrow account increased from $1.4 billion as of September 30, 2022, to $1.764 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while $1.000 billion was deposited during fiscal year 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the starting balance ($1.4 billion as of September 30, 2022) and the deposits for fiscal years 2022 ($850 million) and 2023 ($1.0 billion), which matches the ground truth. However, it reports an incorrect ending balance of $1.764 billion as of September 30, 2023, whereas the ground truth states $3.089 billion. This is a major quantitative error. (2) The calculation implied by the LLM answer—starting balance of $1.4B + $0.85B (FY22 deposit) + $1.0B (FY23 deposit) = $3.25B total inflow—does not align with the reported $1.764B ending balance, indicating internal inconsistency. The correct evolution should reflect a balance increase to $3.089B, not $1.764B. (3) The multi-hop reasoning is partially sound: the model correctly retrieves deposit amounts and the initial balance, but fails to accurately report or compute the final balance, suggesting a failure in synthesizing the full account evolution. (4) Scores reflect that core data points (deposits, initial balance) are correct (supporting qualitative and contextual accuracy), but the critical final balance is wrong, severely undermining quantitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 335,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "From 2022 to 2024, Outdoor Garden's role within HD's product strategy has slightly declined in terms of sales contribution. In 2022, Outdoor Garden accounted for 6.8% of net sales, while in 2024, it represented 6.5%. Despite this slight decrease in percentage, Outdoor Garden remains a key component of the Hardlines major product line, indicating its continued strategic importance in the company's merchandising structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2024, Outdoor Garden was grouped under the broader 'Hardlines' department, but there is no mention of its 2024 sales percentage in the original answer. The LLM incorrectly claims that Outdoor Garden represented 6.5% of net sales in 2024, which is not supported by the provided ground truth. Additionally, the ground truth does not provide any 2024 performance metric, so asserting a decline from 6.8% to 6.5% is a fabrication. (2) The only correct quantitative figure is the 2022 net sales percentage (6.8%), which matches the ground truth. However, the $10,317 million in net sales for 2022 is omitted entirely, and the 2024 percentage is invented. This results in very low quantitative accuracy. (3) The reasoning is flawed because the LLM assumes a strategic 'slight decline' based on a non-existent metric, whereas the ground truth emphasizes a structural reclassification — from a standalone product line to a component of Hardlines — which reflects a change in reporting and positioning, not necessarily performance. The LLM fails to mention the key qualitative shift in classification, which is the central point of the original answer. (4) Contextual relevance is moderate because the answer discusses the general topic and mentions Hardlines, but it misses the core evolution — organizational reclassification — and instead invents a narrative around declining sales share. The multi-hop synthesis is incorrect: it should have connected 'distinct product line in 2022' to 'subsumed under Hardlines in 2024' as a strategic repositioning, not a performance-based decline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 459,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD has maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024 by sustaining a culture of inclusivity, innovation, and respect, as reflected in high employee engagement scores. The company conducts annual surveys to measure culture and engagement, with 2024 results showing continued top 10% performance among high-tech peers. AMD also prioritizes diversity, belonging, and inclusion through initiatives like Employee Resource Groups (ERGs) and programs such as \"Advancing Women in Technology.\" Additionally, AMD offers competitive total rewards, flexible work arrangements, and robust development opportunities, including mentoring and leadership programs. This strategy suggests that AMD is proactively investing in talent retention by fostering a supportive and innovative workplace, which is critical in the competitive semiconductor industry for attracting and retaining top talent.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies not supported by the ground truth. While the original answer confirms that AMD maintained identical cultural messaging between 2023 and 2024 as its workforce grew from ~26,000 to ~28,000 (a 7.7% increase), the LLM introduces unverified details such as 'high employee engagement scores,' 'annual surveys showing top 10% performance among high-tech peers,' 'Employee Resource Groups (ERGs),' 'Advancing Women in Technology,' and specific programs like mentoring and leadership initiatives. These details are not present in the original answer and cannot be verified from the provided knowledge graph. (2) Quantitatively, the LLM fails to mention the actual workforce numbers (26,000 in 2023, 28,000 in 2024) or the 7.7% growth, which are central to the original answer. No calculations are attempted or needed, but the omission of key figures reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that cultural emphasis supports talent retention in a competitive industry—but it builds this conclusion on fabricated evidence rather than the actual continuity of AMD's stated cultural values across years. The original answer hinges on the repetition of identical language in both years despite growth, which the LLM overlooks entirely. (4) Contextual relevance is high because the response addresses workforce expansion, culture, and talent retention in the semiconductor industry. However, correctness and qualitative accuracy are low due to hallucinated details and failure to report the core evidence (repeated verbatim cultural statement across years). The answer sounds plausible but diverges significantly from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 476,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "Based on the provided document pages, there is no specific information indicating any changes or evolution in AT&T's relationship with The Ohio Bell Telephone Company between 2022 and 2023 in terms of guarantee obligations. The pages reference historical guarantees for subsidiaries, including The Ohio Bell Telephone Company, but do not provide details about modifications or updates to these obligations during the specified period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is incorrect in asserting that there is no information about changes in AT&T's relationship with The Ohio Bell Telephone Company between 2022 and 2023. The ground truth states that while the guarantee structure remained similar, the exhibit reference was updated from Exhibit 4-c (originally filed in 2011) to reflect current documentation practices in 2023, indicating continuity with updated reporting. This evolution in documentation is a factual detail that the LLM failed to identify or report. There are no numeric values to assess, so quantitative accuracy is not applicable but assumed correct by default. The qualitative accuracy is low because the model missed the key multi-hop insight: the guarantee persisted and was formally maintained through updated exhibit referencing, which reflects an evolution in documentation even if not in substance. The answer is contextually relevant in that it addresses the right entities and topic (guarantee obligations), but it incorrectly concludes no information is available when the ground truth does provide a specific answer. Thus, while the response is not off-topic, it fails to extract and synthesize the correct inference from the available data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 341,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "Between 2023 and 2024, the financial impact of GE's relationship with AerCap showed a significant decline in gains on retained and sold ownership interests. In 2023, gains on retained and sold ownership interests increased by $5.7 billion, primarily driven by investments in GE HealthCare and AerCap. However, in 2024, these gains decreased by $5.2 billion, largely due to a decline in gains related to the same AerCap and GE HealthCare investments. This shift reflects a notable reduction in the positive financial contributions from these investments in the subsequent year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $5.7 billion increase in gains in 2023 and the $5.2 billion decrease in 2024 are accurately reported, with proper attribution to AerCap and GE HealthCare. Number formats match and are consistent. (2) Quantitative accuracy is perfect—both dollar amounts and directional changes (increase/decrease) are correct, and the comparison across years is properly framed. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and two entities (AerCap and GE HealthCare), noting the shift in financial impact. The only minor limitation is that the original answer emphasizes the $5.7B was an increase in corporate operating profit due to gains, while the LLM slightly simplifies this to 'gains increased by $5.7B'—a nuance that doesn't distort meaning but slightly reduces precision in financial causality. (4) The answer is fully relevant, directly addressing the evolution of financial impact between 2023 and 2024. Overall, the semantic meaning matches the ground truth, with only negligible differences in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 327,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "Home Depot's strategic use of HD Supply between 2022 and 2024 has evolved to further support its focus on professional customers and MRO (Maintenance, Repair, and Operations) services. HD Supply, primarily through its MRO business, has been instrumental in serving the needs of multifamily, hospitality, healthcare, and government facilities. In 2024, Home Depot continued to leverage HD Supply to provide a broader range of MRO products and value-added services, enhancing its offerings to professional customers. Additionally, the acquisition of SRS in 2024 complemented HD Supply's role by expanding Home Depot's reach into the professional market, particularly in roofing, landscaping, and pool services, thereby strengthening its ecosystem for Pros.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in conveying Home Depot's strategic evolution with HD Supply from 2022 to 2024, particularly in relation to professional customers and MRO services. It accurately identifies HD Supply's role in serving multifamily, hospitality, healthcare, and government facilities through MRO offerings, which aligns with the 2024 strategic focus in the ground truth. The mention of value-added services and expanded product offerings for Pros is contextually appropriate and consistent with Home Depot's trajectory. However, the LLM omits the key 2022 context highlighted in the original answer: that Home Depot was still grappling with integration risks and uncertainties post-acquisition in 2022. This contrast—between early integration challenges and later strategic maturity—is a critical multi-hop element of the question and is missing from the LLM response. Additionally, the LLM introduces the acquisition of SRS in 2024 as a complementary move, which may be factually accurate but is not present in the provided ground truth and introduces external information not supported by the knowledge graph. This affects qualitative accuracy, as it shifts focus slightly and adds unverified context. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The answer remains contextually relevant and well-structured around the professional customer and MRO focus. Overall, the core facts about HD Supply’s strategic role in 2024 are correct, but the lack of 2022 contrast and introduction of unsupported details prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 438,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "Between 2023 and 2024, AMD's patent portfolio grew from approximately 18,500 patent matters worldwide (12,800 issued patents and 5,600 pending applications) in 2023 to approximately 18,800 patent matters in 2024 (13,200 issued patents and 5,600 pending applications). This indicates a slight increase in the size of AMD's patent portfolio, with a rise in issued patents. The company continues to rely on cross-licensing and technology exchange agreements, which are typical in the semiconductor industry, to both transfer and receive technology and intellectual property rights. This growth in the patent portfolio enhances AMD's ability to engage in such agreements and supports its ongoing innovation and product development.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative data from the ground truth: AMD's patent portfolio was 18,500 patent matters in 2023 (12,800 issued, 5,600 pending) and grew to 18,800 in 2024 (13,200 issued, 5,600 pending). These numbers are factually accurate and match the original answer exactly. (2) The calculation of the increase (300 additional patent matters, all in issued patents) is implied correctly, and the consistency in pending applications is accurately reflected. (3) The reasoning is sound: the LLM correctly infers that the growing patent portfolio strengthens AMD's position in cross-licensing agreements and supports technology exchange, aligning with the original answer's implication of enhanced strategic leverage. It also correctly notes the continued reliance on such agreements. (4) The only minor shortcoming is that the LLM does not explicitly state that the strengthened IP position 'likely enhances its leverage in cross-licensing agreements' as directly as the original answer, slightly weakening the qualitative emphasis on strategic advantage. However, the implication is present through the discussion of enhanced engagement ability. Overall, the answer is factually complete, contextually relevant, and semantically equivalent, warranting a high correctness score with only a slight deduction in qualitative accuracy for less explicit emphasis on strategic leverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 394,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "From 2023 to 2024, Johnson & Johnson's financial stake in Kenvue evolved significantly. In August 2023, following an exchange offer, Johnson & Johnson retained a 9.5% ownership stake in Kenvue, valued at $4.3 billion. By May 2024, the company completed a Debt-for-Equity Exchange, using its remaining Kenvue shares to satisfy $3.6 billion in commercial paper, resulting in Johnson & Johnson no longer owning any shares of Kenvue. This disposal led to a $0.4 billion loss recorded in Other (income) expense. The strategic relationship transitioned from post-separation services under transition agreements to full divestiture by mid-2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Johnson & Johnson's stake in Kenvue from 2023 to 2024. All key facts are accurate: the 9.5% stake valued at $4.3 billion in August 2023, the May 2024 debt-for-equity exchange using remaining shares to satisfy $3.6 billion in commercial paper, the resulting $0.4 billion loss, and the complete exit from Kenvue. The mention of the loss being recorded in 'Other (income) expense' aligns with the ground truth's reference to 'other assets' and associated expense. (2) Quantitative accuracy is perfect: percentages (9.5%), dollar amounts ($4.3B, $3.6B, $0.4B), and timing (August 2023, May 2024) match the ground truth exactly. The number of shares (182,329,550) is omitted in the LLM answer but is not critical to the overall correctness as the dollar value and disposal mechanism are accurately conveyed. (3) The multi-hop reasoning is sound—correctly linking the initial retention of shares post-spin-off, the subsequent financial treatment, and the final disposal to settle debt. The strategic shift from retained stake to full divestiture is logically and accurately presented. (4) The only minor shortcoming is the omission of the specific share count and the explicit mention that the $0.4 billion expense in 2023 was due to 'subsequent changes' in the stake's value. However, this does not detract significantly from the overall accuracy. The answer is contextually complete, directly addressing the evolution of the financial stake and strategic relationship. Thus, a score of 9 is justified—excellent accuracy with only minor detail omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 443,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "Based on the provided information, AT&T's relationship with Indiana Bell Telephone Co. Inc. in terms of inclusion in guarantee disclosures remained consistent between 2022 and 2023. In both years, Indiana Bell Telephone Co. Inc. was listed among the subsidiaries whose obligations were guaranteed by AT&T, as noted in the 2023 and 2022 10-K filings under the relevant guarantee disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that AT&T's guarantee relationship with Indiana Bell Telephone Co. Inc. remained unchanged between 2022 and 2023, with the entity included in guarantee disclosures in both years under the relevant filings. All entities (AT&T, Indiana Bell Telephone Co. Inc.), time periods (2022, 2023), and the nature of the disclosure (guarantee of subsidiary obligations) are accurately identified. The answer correctly synthesizes information across the two years, confirming continuity—this reflects sound multi-hop reasoning. The only minor shortcoming is that the LLM does not explicitly reference 'Exhibit 4-d' as the specific document where the guarantee is disclosed, which is included in the ground truth and adds precision. However, mentioning 'relevant guarantee disclosures' in the 10-K filings is contextually appropriate and semantically close. There are no numerical inaccuracies, and the conclusion aligns fully with the ground truth. Thus, the answer is factually correct and contextually relevant, with only a slight lack of specificity in documentation reference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 311,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "From 2023 to 2024, GE's financial relationship with AerCap evolved as follows: \n\nIn 2023, GE reported gains on retained and sold ownership interests of $5.7 billion, which included activities related to its AerCap investment. By 2024, these gains had decreased by $5.2 billion, indicating a reduction in investment gains from AerCap. Additionally, GE paid net cash of $203 million to AerCap in 2023 for ongoing sales, leases, and transition services. As of December 31, 2023, GE's equity and note investment in AerCap had an estimated fair value of $944 million, down from $7,403 million in 2022, reflecting a decline in the valuation of its stake.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly identifies the $203 million net cash payment to AerCap in 2023 and the $5.2 billion decrease in gains on retained and sold ownership interests from 2023 to 2024. However, it incorrectly states that GE reported $5.7 billion in gains in 2023 'related to its AerCap investment,' which is not supported by the ground truth—the $5.7 billion figure is not mentioned in the original answer, nor is it attributed solely or specifically to AerCap. Additionally, the LLM introduces a fair value of $944 million for GE's stake in AerCap as of December 31, 2023, down from $7,403 million in 2022, which is absent from the original answer and cannot be verified against the provided ground truth. (2) The $203M cash payment and $5.2B decrease in gains are quantitatively accurate and correctly framed as year-over-year changes. However, the introduction of the $5.7B gain figure and the $944M/$7,403M valuation comparison are unsupported by the ground truth and represent factual overreach. These numbers may be contextually plausible but are not part of the verified knowledge graph output. (3) The multi-hop reasoning is partially sound—LLM correctly infers a shift from operational involvement to investment-based returns based on reduced gains and cash flows. However, it misattributes the source of gains and introduces unverified valuation data, weakening the logical chain. The original answer emphasizes a structural shift in relationship (from operational collaboration to investment stake), which the LLM captures in spirit but not fully in factual support. (4) The contextual relevance is high—the answer addresses cash involvement and investment gains as asked, and the overall narrative aligns with the transition described. However, due to the inclusion of unverified quantitative claims, the correctness and quantitative accuracy scores are reduced significantly. A score of 6 reflects partial correctness with key factual errors that impact interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 556,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "From 2022 to 2024, The Home Depot has evolved its approach to store appearance and competition by enhancing the interconnected shopping experience through digital integration and store improvements. Investments in store navigation tools, self-checkout options, and mobile app features have improved customer convenience and satisfaction. Additionally, the company has focused on integrating digital and in-store experiences, such as curbside pickup and self-service lockers, to meet evolving customer expectations. These efforts reinforce Home Depot's competitive edge by combining a modern, efficient store appearance with seamless digital capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of The Home Depot's strategy from 2022 to 2024, noting the shift from focusing on store appearance as a standalone competitive factor to integrating it within a broader 'interconnected shopping experience' that combines physical and digital elements. The mention of investments in store navigation, self-checkout, mobile app features, curbside pickup, and self-service lockers reflects accurate qualitative synthesis of digital integration efforts, consistent with the 2024 emphasis on digital platforms enhancing navigation and presentation. While the original answer explicitly references 2022's focus on appearance, location, and ease of shopping (both online and in-store), and the 2024 pivot toward digital as a core component, the LLM conveys this progression effectively through implication and concrete examples. There are no numerical figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default due to absence of numeric errors. The reasoning is sound, demonstrating multi-hop understanding across years and strategic domains (physical appearance → digital integration). The only minor shortcoming is that the LLM does not explicitly contrast the 2022 vs. 2024 emphasis as clearly as the original (e.g., 'from physical aesthetics alone to a holistic, digitally-enhanced experience'), slightly reducing qualitative precision. However, the core facts, entities (The Home Depot), time frame (2022–2024), and strategic evolution are correctly identified and synthesized. The answer is fully contextually relevant, directly addressing store appearance, competition, customer experience, and digital integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 478,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved with increased resales and a new financial arrangement. In 2024, AMD's resales to the ATMP JV rose to $121 million from $14 million in 2023. Additionally, in October 2024, AMD provided a $100 million one-year term loan to one of the ATMP JVs, secured by the JV's receivable balance due from AMD, indicating a new financial support arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in resales from $14 million in 2023 to $121 million in 2024, and accurately reports the October 2024 $100 million one-year term loan to one of the ATMP JVs. All financial figures and dates match the ground truth. (2) Quantitative accuracy is perfect: $14M, $121M, $100M, and October 2024 are all correctly stated. The comparison between years is accurate. (3) The reasoning is sound and captures the evolution of the financial relationship—increased resales and new direct financial support via a loan. However, the LLM adds a detail not present in the ground truth: that the loan was 'secured by the JV's receivable balance due from AMD.' This detail is not mentioned in the original answer and introduces unverified information, slightly reducing qualitative accuracy. (4) Despite this minor addition, the core multi-hop synthesis—linking resale growth and new loan arrangement to show deepening financial ties—is correct and well-articulated. The answer is fully relevant and addresses both parts of the question: resales and new financial arrangements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 319,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson has enhanced its privacy compliance programs to address evolving privacy laws and international data flow regulations. In 2023, the Company acknowledged the growing risks of new privacy laws, data localization requirements, and international data transfers, emphasizing the need for established privacy compliance programs and controls. By 2024, the Company expanded on these efforts, highlighting increased enforcement of privacy laws globally and the risks posed by unauthorized access and cross-border data flow restrictions. It reinforced its commitment to maintaining privacy compliance through mandatory employee training, structured third-party risk management, and ongoing assessments to adapt to legislative changes and regulatory expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Johnson & Johnson's privacy compliance programs between 2023 and 2024. It correctly identifies the focus in 2023 on new privacy laws, data localization, and international data flows, and the expansion in 2024 to include global legislative expectations and cross-border data flow restrictions. The answer accurately reflects the increased enforcement and broader geographic scope (from 'other territories' in 2023 to 'globally' in 2024), though it does not explicitly mention the shift in emphasis from 'other territories' to 'globally' as highlighted in the original answer. It adds specific details about employee training, third-party risk management, and ongoing assessments, which are reasonable inferences or elaborations consistent with the type of controls one would expect, though not explicitly stated in the ground truth. There are no numerical values to verify, so quantitative accuracy is scored as 10. The reasoning is sound, with correct multi-hop synthesis across years and regulatory themes. The answer is contextually fully relevant and semantically equivalent in intent and substance, with only minor omission of the nuanced shift in geographic framing. Hence, a correctness score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 358,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "Between 2023 and 2024, GE's financial exposure to Bank BPH saw a decrease in estimated total borrower litigation losses, from $2,669 million as of December 31, 2023, to $2,461 million as of December 31, 2024. Additionally, the related valuation allowances also decreased, with $1,517 million and $1,712 million of the allowances attributed to estimated borrower litigation losses in 2024 and 2023, respectively. This reduction reflects the impact of the settlement program initiated in 2023, which fully offset the financing receivables balance as of December 31, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: total estimated borrower litigation losses decreased from $2,669 million in 2023 to $2,461 million in 2024; valuation allowances were $1,712 million in 2023 and $1,517 million in 2024. These numbers match exactly, with correct years and amounts. (2) All calculations implied (e.g., the decrease in total losses and valuation allowances) are accurate. The LLM correctly notes the reduction in both total losses and valuation allowances. (3) The reasoning is sound: it correctly identifies the settlement program initiated in 2023 as a driver of the reduction and notes that by the end of 2024, the valuation allowance fully offset the financing receivables balance—this key qualitative point from the original answer is captured, though slightly less explicitly. (4) The only minor shortcoming is that the LLM does not explicitly mention the $957 million and $944 million in other liabilities for 2023 and 2024 respectively, which are part of the total loss breakdown in the ground truth. While the total losses are correctly stated, the absence of this component reduces completeness slightly. However, since the focus of the question is on 'valuation allowances' and overall exposure, and those are accurately addressed, the answer remains highly accurate. Wording is semantically equivalent and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 394,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024 by maintaining consistent net sales performance while being reclassified into the \"Hardlines\" major product line in 2024. In 2022, Indoor Garden accounted for 6.4% of net sales ($10,105 million), and by 2024, it represented 6.6% ($10,519 million), showing stable financial performance. In 2024, the merchandising department structure was reorganized, placing Indoor Garden under the Hardlines category, which also includes Hardware, Outdoor Garden, and Power. This repositioning reflects a strategic realignment to better categorize and manage product lines for internal reporting and decision-making.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in financial data. According to the ground truth, in 2022, the Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue. However, the LLM incorrectly reports $10,105 million and 6.4%, which are not only wrong but suggest a misinterpretation of the data. Similarly, the 2024 figures are fabricated: the LLM claims $10,519 million and 6.6%, but no such data exists in the ground truth, which does not provide 2024 financials for Indoor Garden. (2) The only correct element is the 2024 reclassification of Indoor Garden under the 'Hardlines' merchandising department, which aligns with the ground truth. However, the LLM adds unsupported details such as grouping with 'Hardware, Outdoor Garden, and Power', which are not mentioned in the original answer. (3) The reasoning is partially sound in connecting financial performance to strategic positioning, but the multi-hop synthesis fails because it builds on incorrect financial data. The conclusion about 'stable financial performance' is invalid due to the use of false numbers. (4) The contextual relevance is moderate because the structure of the response addresses the evolution of treatment and positioning, and correctly identifies the reclassification. However, the core quantitative foundation is wrong, severely undermining the answer's correctness. The qualitative score reflects partial entity and reasoning accuracy, while the low quantitative score reflects major factual errors in key metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 432,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive has maintained a sourcing strategy to manage cost volatility and commodity price fluctuations by combining cost containment measures, sourcing strategies, productivity initiatives, and selective commodity hedging contracts. In 2022, the company used futures contracts, primarily in the Hill's Pet Nutrition segment, to hedge against raw material volatility, while in 2024, it emphasized ongoing efforts to manage disruptions in the global supply chain and mitigate inflationary pressures through price increases, cost efficiencies, and limited use of hedging. The evolution reflects a continued focus on proactive risk management amid ongoing market uncertainties.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and contextually relevant to the question about Colgate-Palmolive's evolving sourcing strategies from 2022 to 2024. It correctly identifies the continued use of sourcing strategies, cost containment, productivity initiatives, and selective hedging. The mention of futures contracts in the Hill's Pet Nutrition segment in 2022 aligns with plausible segment-specific risk management, though this specific detail is not present in the ground truth. The 2024 emphasis on supply chain disruptions, inflationary pressures, and price increases is consistent with the original answer’s theme of increased external pressures. However, the LLM answer omits key elements from the ground truth: (1) the explicit shift toward managing specific commodities like resins, essential oils, and soybeans; (2) the broader risk management framework in 2022 that included derivative instruments and local currency borrowings (not just futures in Hill’s); and (3) the heightened focus on geopolitical and climatic disruptions as drivers of more defensive tactics in 2024. While the LLM captures the general evolution toward more proactive and diversified cost management, it does not fully reflect the multi-hop synthesis of expanded commodity exposure and strategic adaptation detailed in the original. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and the reasoning is sound but incomplete. Thus, the answer earns a 7 for correctness and qualitative accuracy due to missing specifics, despite being well-structured and contextually accurate overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 448,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "TREMFYA's sales performance improved between 2023 and 2024, with sales increasing by 16.6% in 2024 compared to a 17.9% increase in 2023. This growth was driven by market expansion, share gains in psoriasis and psoriatic arthritis (PsO/PsA), and continued product strength. In 2024, operational growth contributed 18.1%, partially offset by a 1.5% negative currency impact.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 16.6% sales growth in 2024 and the $3.67 billion sales figure (implied by context), as well as the 18.1% operational growth and 1.5% negative currency impact, which aligns with the ground truth. However, it incorrectly states that TREMFYA had a 17.9% increase in 2023, which is not supported by the original answer—no growth rate for 2023 is provided in the ground truth, only the 2023 sales figure ($3,147 million). This is a factual error in quantitative comparison. (2) The calculation of 2024 growth from $3,147M to $3,670M is indeed approximately 16.6%, so that is accurate. The breakdown of 18.1% from operations and -1.5% currency impact matches the original. However, the claim about 2023 growth (17.9%) cannot be verified and appears fabricated or misattributed. (3) The multi-hop reasoning is mostly sound—the model correctly synthesizes sales performance and contributing factors across years and attributes growth to correct drivers like market expansion, PsO/PsA share gains, and operational strength. It correctly separates operational growth from currency effects. (4) The answer is contextually relevant and captures the essence of TREMFYA’s performance evolution. Due to the incorrect 2023 growth figure, quantitative accuracy is reduced, but qualitative reasoning and overall correctness remain high because core facts (2024 growth, drivers, currency impact) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 400,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "The structural change in Disney's relationship with A&E from 2022 to 2023 involved Disney no longer consolidating A+E Television Networks (A+E) in its financial statements, as it transitioned from a 50% equity investment to a joint venture accounted for under the equity method. This change affected Disney's reporting by reducing the direct inclusion of A+E's subscriber numbers and financial results within Disney's consolidated figures. Instead, Disney now reports its share of A+E's income or loss as \"Equity in the income (loss) of investees, net\" in its Consolidated Statements of Operations. Subscriber data for A+E channels is also disclosed separately, rather than being fully integrated into Disney's consolidated subscriber metrics.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Disney transitioned from a 50% equity investment to a joint venture in 2023, when the ground truth indicates the opposite: in 2022, Disney had an arms-length partnership (not a 50% stake), and in 2023, it took a 50% equity stake. This reverses the timeline and nature of the structural change. (2) Quantitative accuracy is low: while the LLM does not contradict the 58 million 2023 subscriber number directly, it fails to mention the key 69 million 2022 subscriber figure from the original answer, omitting a critical data point. More importantly, it misrepresents the direction of the change in ownership structure, which is a core quantitative and qualitative element. (3) The reasoning is partially sound in describing how equity method accounting affects reporting (e.g., income reported under 'Equity in the income of investees'), which aligns with the ground truth. However, the multi-hop synthesis is flawed because it misidentifies the starting and ending states of the relationship—this undermines the logical foundation of the answer. (4) Contextual relevance is high because the LLM addresses the right topic—changes in reporting due to structural shifts—and references appropriate financial reporting terms and concepts. However, due to the reversal of the ownership timeline and omission of key subscriber numbers, the correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 409,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "In 2023, GE reported a realized and unrealized gain of $129 million related to its investment in and note with AerCap. By 2024, GE had fully monetized its AerCap shares, leaving only an AerCap senior note as its remaining position, indicating the financial impact of the relationship had diminished significantly, with no further gains or losses reported for 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual inaccuracies. It correctly identifies the $129 million gain in 2023, aligning with the ground truth, though it mischaracterizes it as both 'realized and unrealized' when the original answer specifies it was an 'unrealized gain' only. This is a key distinction in financial reporting and affects accuracy. (2) The major error lies in the 2024 information: the LLM claims GE 'fully monetized its AerCap shares' and 'no further gains or losses were reported,' which directly contradicts the ground truth stating a $5.2 billion drop in gains on retained and sold ownership interests in 2024, with AerCap being a primary contributor. This $5.2 billion decline is a critical financial event that the LLM omits entirely. Instead of 'no further gains or losses,' the reality is a substantial negative shift. (3) The multi-hop reasoning is flawed: the question asks about the evolution of financial impact between 2023 and 2024, requiring comparison of gains/losses across years. The LLM fails to perform this comparison and incorrectly implies the relationship's impact ended, rather than deteriorated. It also does not mention the $5.2 billion decrease, which is central to the 2024 financial impact. (4) While the LLM correctly identifies the entities (GE, AerCap) and the time frame (2023–2024), and the initial $129M figure is accurate, the omission of the $5.2B decline and misrepresentation of the nature and outcome of the 2024 position severely undermines factual correctness. The answer is contextually relevant and addresses the general topic, but lacks the key quantitative and qualitative details needed for accuracy. Hence, scores are moderate on quantitative and qualitative accuracy, higher on relevance, and low overall correctness due to missing a major financial event.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 505,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Between 2022 and 2024, Mastercard has enhanced its multi-layered security approach by expanding collaboration with third-party service providers and integrating advanced security measures to address emerging threats. In 2024, the company explicitly mentions working with third-party providers to monitor and respond to cyber and physical threats, indicating a more proactive stance in securing the ecosystem. This evolution reflects Mastercard's strategic response to increasingly complex cybersecurity risks by embedding stronger protections and leveraging partnerships to ensure the integrity of its global payments network.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Mastercard's security approach between 2022 and 2024. It correctly identifies that in 2024, Mastercard explicitly included third-party service providers in its security monitoring and response efforts, reflecting a more proactive and ecosystem-wide strategy. The answer captures the strategic shift toward stronger partnerships and enhanced resilience, which matches the original answer's conclusion. However, it omits a key detail from the ground truth: in 2022, while Mastercard had a robust multi-layered security program, there was no explicit mention of third-party provider risk management—a critical contrast that underscores the evolution. The LLM implies an expansion of collaboration with third parties but does not clearly state that third-party risk was not explicitly addressed in 2022, thus slightly weakening the comparative analysis. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and all entities (Mastercard, third-party providers, cybersecurity threats) are correctly identified. The reasoning is sound and contextually relevant, with only a minor gap in completeness regarding the 2022 baseline. Hence, the correctness and qualitative accuracy scores are high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 374,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Between 2022 and 2023, Target Corporation remained in compliance with its debt leverage covenant under its credit facilities. In 2023, Target obtained a new $1.0 billion 364-day unsecured revolving credit facility and extended its existing $3.0 billion unsecured facility to October 2028, enhancing its liquidity and covenant flexibility. The company confirmed its ongoing compliance with these covenants as of February 3, 2024, and expects to remain in compliance, despite changes in credit facilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Target remained in compliance with its debt leverage covenant in both 2022 and 2023; it obtained a new $1.0 billion 364-day unsecured revolving credit facility in 2023 (expiring October 2024); and extended its $3.0 billion facility to October 2028. These details match the original answer exactly. (2) Quantitative elements—dollar amounts ($1.0 billion, $3.0 billion), facility durations (364-day, five-year), and expiration dates (2028, 2024)—are all accurate. The LLM correctly notes compliance as of February 3, 2024, which is consistent with the 2023 filing context. (3) The multi-hop reasoning is sound: the model synthesizes information about covenant compliance across two years and links it to structural changes in credit facilities. The only minor omission is that the original answer specifies the prior $3.0 billion facility was set to expire in October 2026 before extension, which the LLM does not mention—this contextual detail about the change is missing but does not undermine the core accuracy. (4) The answer is semantically equivalent to the ground truth, with slightly more concise phrasing and a focus on 'covenant flexibility' and 'liquidity,' which are reasonable interpretations. Overall, the response is factually correct, complete in substance, and contextually appropriate, warranting a high score with a small deduction for the omitted pre-extension expiration date.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 412,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "From 2023 to 2024, the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, has evolved to include increased regulatory scrutiny, ethical concerns, and operational complexities. In 2023, the risks primarily focused on the ethical implications of AI, such as potential impacts on human rights, privacy, and employment, as well as the challenges of ensuring accurate and unbiased AI outputs. By 2024, the risks expanded to include the introduction of new laws and regulations, such as the EU's AI Act and the Digital Services Act (DSA), which impose additional compliance burdens. Additionally, the development of generative AI products like Agentforce introduced new risks related to data provenance, content accuracy, and the potential for generating copyrighted or harmful content, requiring increased investment in compliance, governance, and model development.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the evolution of Salesforce's AI-related risks from 2023 to 2024 with strong factual alignment to the ground truth. It correctly identifies the expansion of risk categories in 2024 to include regulatory scrutiny (e.g., EU AI Act, DSA), ethical concerns, content accuracy, and copyright risks tied to generative AI like Agentforce. It also notes increased compliance and governance costs, matching the original answer's emphasis on rising investment in AI governance. However, the LLM slightly mischaracterizes the 2023 risk focus: the ground truth specifies that 2023 risks were primarily about third-party integration liabilities and warranty expectations, not broad AI ethics like human rights or employment impacts. While the LLM correctly notes some 2023 AI ethics concerns, it overemphasizes them as primary risks, which were more prominent in 2024. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are involved), and the reasoning is logically structured and contextually relevant. The answer synthesizes multi-hop elements (evolution over time, new regulations, product-specific risks) well, but the misattribution of 2023 risk focus prevents a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 347,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "Between fiscal years 2023 and 2024, Lowe's significantly enhanced its delivery capabilities for parcel-eligible items. In 2023, most such items could be delivered within two business days at standard shipping rates. By 2024, the company expanded its fulfillment capacity, maintaining the two-day delivery standard while also enabling same-day delivery for certain products through its gig provider network. Additionally, Lowe's achieved next-day delivery for major appliances in nearly every U.S. zip code by 2024, reflecting improvements in its supply chain and distribution infrastructure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding 'same-day delivery' that is not supported by the original answer. Quantitatively, all timeframes (two-day delivery in 2023, next-day delivery for major appliances in nearly every U.S. zip code by 2024) are accurately reported. The fiscal years are correctly referenced, and the expansion of delivery capabilities is properly contextualized. However, the original answer states that by 2024, most parcel-eligible items could be delivered within 'two business days or less,' which may include faster delivery options, but does not explicitly mention 'same-day delivery' or a 'gig provider network'—details introduced in the LLM answer that go beyond the provided ground truth. This represents a slight overstatement or inference not present in the source. The core improvements—faster delivery times and expanded geographic coverage for major appliances—are correctly identified and synthesized across the two fiscal years, demonstrating sound multi-hop reasoning. The answer is highly relevant to the question and captures the evolution and specific improvements, albeit with minor embellishment. Thus, while the key facts and numbers are correct, the addition of unsupported specifics slightly reduces qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 374,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The financial impact of the Dermstore LLC sale on Target's consolidated revenues and operating income was minimal in both 2022 and 2023. According to the 2021 10-K, Dermstore represented less than 1% of consolidated revenues, operating income, and net assets at the time of its sale in February 2021. The 2023 10-K reaffirms this negligible impact, with no further material changes or contributions to revenues or operating income in subsequent years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the financial impact of the Dermstore LLC sale was minimal in both 2022 and 2023, with Dermstore representing less than 1% of Target's consolidated revenues, operating income, and net assets. This matches the ground truth. The sale date (February 2021) is correctly referenced, and the answer accurately notes no material changes post-sale. However, the LLM omits the $335 million pretax gain mentioned in the ground truth, which is a notable quantitative detail even if not directly tied to 2022–2023 impact. (2) All numbers and dates provided (e.g., <1%, February 2021) are factually correct and consistent with the original answer. The absence of the $335 million figure is a minor completeness gap but does not affect the core conclusion about 2022–2023 impact. (3) The reasoning is sound: the LLM correctly infers that because Dermstore was immaterial at sale and no subsequent changes were reported, its impact remained negligible through 2023. It appropriately cites the 2021 and 2023 10-Ks to support multi-hop reasoning across time. (4) The answer is contextually fully relevant, directly addressing the evolution of financial impact on revenues and operating income. The omission of the pretax gain slightly reduces completeness but does not undermine the correctness of the response regarding 2022–2023. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 411,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "Between 2023 and 2024, Data Cloud has evolved to become a more integral component of Salesforce's broader service offerings, emphasizing its role in unifying and connecting customer data across systems, apps, and devices to create a comprehensive view of customers. In 2023, Data Cloud was positioned as a hyperscale, trusted data engine native to Salesforce, enabling organizations to deliver personalized customer experiences. By 2024, it was highlighted as a core part of the Einstein 1 Platform, which allows customers to connect data and build AI-powered apps with low-code capabilities, thereby delivering entirely new CRM experiences. This evolution reflects Salesforce's strategic focus on leveraging Data Cloud to enhance AI integration, drive automation, and support digital transformation across industries.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Data Cloud between 2023 and 2024 and accurately reflects its growing integration within Salesforce's platform, particularly with the Einstein 1 Platform and AI capabilities. It correctly notes the 2023 positioning as a 'hyperscale, trusted data engine native to Salesforce' and its role in unifying customer data. However, the LLM answer omits key elements from the ground truth, particularly the strategic risks highlighted in 2024. The original answer emphasizes that by 2024, Salesforce acknowledged the 'relatively new and uncertain' market for Data Cloud, increasing competitive pressures, and limited experience in pricing consumption-based models—critical aspects of strategic positioning that the LLM answer fails to mention. Instead, the LLM focuses on positive integration and AI enhancement, which, while contextually relevant, does not fully capture the shift toward risk-aware messaging in 2024. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (Data Cloud, Salesforce, Einstein 1 Platform) and years are correct. The reasoning is logically sound but incomplete, as it synthesizes forward progress without addressing the competitive and monetization challenges that define the 2024 strategic shift. Thus, while contextually relevant and factually consistent in what it reports, it lacks completeness in conveying the full strategic evolution, particularly the risk dimension, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 416,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, LOW's treatment and accounting of forward interest rate swap contracts remained consistent in terms of hedge designation and financial impact. In both years, forward interest rate swap agreements were designated as cash flow hedges, with no notional amounts outstanding as of the reporting periods (February 2, 2024, and January 31, 2025). The financial impact from these contracts was primarily realized through settlements upon issuance of debt, with $247 million received in 2024 and $143 million and $136 million received in 2023 for prior-year contracts. Gains and losses from these hedges were recorded in other comprehensive income, with minimal net earnings impact.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that LOW shifted from cash flow hedges in 2023 to fair value hedges in 2024, using the shortcut method with no earnings impact. The LLM incorrectly claims the treatment remained consistent and that swaps were still designated as cash flow hedges in 2024, which contradicts the ground truth. (2) Quantitatively, the LLM misstates the timing and amounts: it claims $247 million was received in 2024 and $143M/$136M in 2023, but the original answer specifies only a $247 million receipt in 2023 upon settlement of the $2.0 billion notional swaps related to the March 2023 Notes. There is no mention of multiple settlements in 2023 or a 2024 receipt. The LLM also incorrectly states there were no notional amounts outstanding as of 2024 and 2025, failing to acknowledge the existence of fixed-to-floating swaps in 2024 under a different hedge designation. (3) The multi-hop reasoning is flawed: the question asks about evolution in accounting treatment, requiring synthesis across years and accounting methods. The LLM fails to detect the shift from cash flow to fair value hedging, misrepresents the hedge designation, and invents settlement figures. It also conflates forward interest rate swaps (used in 2023) with fixed-to-floating swaps (used in 2024), not recognizing they are distinct instruments with different accounting. (4) Correctness is scored low (2) due to major factual and conceptual errors. Quantitative accuracy is 3 due to one correct number ($247M) but incorrect attribution and invented figures. Qualitative accuracy is 2 due to failure in reasoning and entity/metric confusion. Contextual relevance is 6 because the answer addresses the general topic of hedge accounting and cites financial impacts, but with wrong details and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 506,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "From 2022 to 2023, Target's strategy around its owned brands has evolved to place a stronger emphasis on differentiation and curated assortments. In 2022, the focus was on \"strengthening our owned brands portfolio\" and expanding \"signature partnerships.\" By 2023, the strategy explicitly highlights \"differentiating from our competition with our owned brands and a curated assortment of leading national brands,\" reflecting a more deliberate effort to use owned brands as a key competitive advantage. The strategic objective shifted toward leveraging owned brands not just for value but as a central pillar for market differentiation and guest engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values in the question or answers that require verification—both focus on qualitative strategic evolution, so quantitative accuracy is not applicable but assumed correct by absence of errors. (2) The LLM correctly identifies the shift in strategy from 2022 to 2023: in 2022, Target was strengthening its owned brands and expanding partnerships (descriptive presence), and by 2023, it elevated them as a competitive differentiator (strategic emphasis). This matches the ground truth’s characterization of a move from showcasing to actively leveraging owned brands. (3) The multi-hop reasoning is sound—synthesizing a strategic shift across two years and identifying the evolution in objectives (from portfolio strengthening to market differentiation and guest engagement). The LLM captures the core strategic pivot even if it uses slightly different phrasing (e.g., 'curated assortment' and 'guest engagement' are not in the original but are contextually reasonable inferences). (4) The only minor gap is that the LLM omits the specific 2023 strategic objective of aiming to 'delight with newness, style, and value' and the explicit link to driving traffic, sales, and market share growth—details present in the original. However, the essence of leveraging owned brands for differentiation and growth is preserved. Thus, the answer is semantically equivalent with minor contextual omissions, warranting a high score but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 418,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "From 2022 to 2023, GM's approach to software-enabled services has expanded significantly, with a focus on enhancing its end-to-end software platform and scaling digital solutions. In 2023, the company emphasized its OnStar services, Super Cruise driver assistance technology, and a broader suite of software-defined features, apps, and services available over-the-air. This includes active safety, infotainment, connectivity, and driver assistance features, with plans to roll out additional features like security, climate, and comfort options. The deployment of these services is expanding across GM's product lineup, with select vehicles already utilizing the platform. This evolution indicates a strong investment in scalable digital solutions to enhance customer experience and support GM's transition to an all-electric and software-driven future.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of GM's software-enabled services from 2022 to 2023. It accurately captures the shift from a general description in 2022 to a more concrete, platform-driven approach in 2023, highlighting over-the-air updates and specific features like Super Cruise, active safety, infotainment, and connectivity. The mention of OnStar and driver assistance technologies is consistent with GM's ecosystem. The answer correctly infers increased investment in scalable digital solutions and ties it to GM's electric and software-defined vehicle strategy, which reflects the correct interpretation of strategic intent. However, the LLM omits specific vehicle models cited in the original answer—namely, the Cadillac LYRIQ and Chevrolet Silverado EV—as early adopters of the 2023 platform, which is a notable detail in demonstrating platform deployment. While it mentions 'select vehicles,' it lacks the specificity that would fully validate the multi-hop synthesis from platform description to real-world implementation. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect numbers or dates are presented), and all entities (GM, Super Cruise, OnStar) are correctly identified. The reasoning is sound and contextually relevant, showing a clear understanding of the strategic shift. The omission of specific model deployments prevents a top score in qualitative accuracy, but overall, the answer is factually correct, relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 425,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category increased from fiscal 2022 to fiscal 2023. In fiscal 2022, revenue from this category was $729 million, and it grew to $837 million in fiscal 2023, representing an increase of $108 million or approximately 15%.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the revenue growth in the category was $75 million (11%) in FY2022 and $80 million (14%) in FY2023 — not $108 million (15%) as stated. The LLM provides absolute revenue figures ($729M in 2022, $837M in 2023), which are not present in the original answer and are unsupported by the ground truth. These numbers appear fabricated or misattributed. (2) The calculation of $108 million increase and ~15% growth is incorrect based on the ground truth data. The actual incremental growth increased from $75M to $80M, not $108M. The percentage growth also increased from 11% to 14%, not 15%. The LLM’s calculation does not align with the provided truth. (3) While the LLM correctly infers that ThousandEyes' contribution grew from FY2022 to FY2023, it fails to accurately represent the multi-hop synthesis: the original answer emphasizes that growth was driven by ThousandEyes within a broader category, with specific attribution in both years. The LLM incorrectly implies that the entire category's revenue is attributable to ThousandEyes and misrepresents the magnitude and rate of growth. (4) The contextual relevance is moderate because the answer addresses the evolution of revenue contribution and the direction of change (upward) is correct. However, due to major quantitative errors and lack of fidelity to the actual data, the correctness score is low. The qualitative accuracy is partially preserved due to correct entity (ThousandEyes, product category) and time period identification, but reasoning is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 443,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "Amendment No. 4 to the Lockheed Martin Executive Severance Plan was disclosed in the 2023 10-K as Exhibit 10.34, incorporated by reference from a 2022 quarterly report. In the 2024 10-K, it was renumbered to Exhibit 10.36, indicating a reorganization of exhibits. This evolution suggests a systematic updating and reclassification of executive compensation-related disclosures, reflecting a more structured and transparent inclusion in the company's regulatory filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Amendment No. 4 was disclosed in the 2023 10-K as Exhibit 10.34 and incorporated from a 2022 quarterly filing, which aligns with the ground truth. However, it incorrectly states that in the 2024 10-K the amendment was 'renumbered to Exhibit 10.36', which is factually wrong according to the ground truth. The ground truth specifies that Amendment No. 4 was no longer listed as a standalone exhibit but was instead included as part of a sequence of amendments (Nos. 2, 3, 4, and 5), not renumbered to 10.36. This misrepresents the nature of the change in disclosure treatment. (2) The dates and exhibit numbers are partially accurate—Exhibit 10.34 in 2023 is correct, but Exhibit 10.36 in 2024 is not supported by the ground truth and appears to be fabricated or misremembered. There is no mention of Exhibit 10.36 in the original answer, making this a significant factual error. (3) The multi-hop reasoning is partially sound—the model recognizes a shift in disclosure strategy between two filings and attempts to interpret its significance. However, it fails to capture the key nuance that Amendment No. 4 was integrated into a broader historical sequence rather than renumbered, leading to an incorrect conclusion about 'reorganization' versus 'consolidation'. The inference about 'structured and transparent' disclosure is plausible but based on flawed premises. (4) The contextual relevance is high because the answer addresses both the evolution of treatment and its implications for disclosure strategy. However, due to the critical error in exhibit numbering and mischaracterization of the integration as a renumbering, the qualitative and quantitative accuracy scores are reduced. The correctness score is 5 because while some core facts are right, the central claim about renumbering is false, undermining the validity of the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 514,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "From 2023 to 2024, JPMorgan's Tier 1 leverage ratio remained stable at 7.2%, meeting the regulatory requirement of 4.0%. The Standardized CET1 capital ratio increased slightly from 15.0% in 2023 to 15.7% in 2024, both well above the minimum regulatory requirement of 11.4%. This indicates strong compliance with capital ratio requirements during the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies JPMorgan and the relevant capital ratios (Tier 1 leverage ratio and Standardized CET1 capital ratio) and addresses the 2023–2024 timeframe. However, it introduces a 2024 Standardized CET1 ratio of 15.7%, which is not present in the ground truth. The ground truth only provides the 2023 CET1 ratio (15.0%) and does not mention the 2024 value. Similarly, the LLM claims the Tier 1 leverage ratio was 7.2% in 2024, which matches the ground truth, but incorrectly implies it was also 7.2% in 2023—this value is not provided in the original answer for 2023, so asserting stability is unsupported. (2) Quantitative inaccuracies: the 15.7% CET1 for 2024 and the claim of stability in the Tier 1 leverage ratio are not substantiated by the ground truth. Only the 2023 CET1 (15.0%) and 2024 Tier 1 leverage ratio (7.2%) are confirmed. Regulatory requirements (11.4% and 4.0%) are correctly cited. (3) The reasoning is partially sound—compliance is correctly inferred, and the direction of strength is accurate—but the synthesis goes beyond the available data by imputing missing values and trends. The model adds plausible but unverified information, failing strict multi-hop fidelity. (4) Scores reflect that core entities and requirements are correct (high contextual relevance), key numbers are partially accurate (moderate quantitative score), reasoning is logical but overreaching (solid qualitative score), and overall correctness is compromised by unsupported additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 418,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "Between 2022 and 2023, GM Financial remained a distinct reportable segment within General Motors' consolidated financial statements, with its performance evaluated through EBT-adjusted due to the significance of interest income and expense in its operations. The 2023 filings show continued integration with the parent company, as GM Financial's financial results are consolidated into the overall financial statements, with adjustments made for deferred tax positions and intercompany transactions. There is no indication of a material change in its role or presentation during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that GM Financial remained a reportable segment and that its financials were consolidated with adjustments for intercompany transactions and deferred tax positions. It correctly notes the continued integration into GM's consolidated financial statements and the use of EBT-adjusted as a performance metric. However, it misses a key qualitative evolution highlighted in the original answer: the increased emphasis in 2023 on how GM Financial's tax-related figures (deferred tax positions and income tax provision) are explicitly adjusted due to inclusion in the consolidated tax return, and that these amounts differ from stand-alone reporting. This reflects a more nuanced integration and financial alignment that the LLM answer does not fully capture. While there are no incorrect facts, the response underrepresents the depth of change in financial presentation between 2022 and 2023, instead stating 'no indication of a material change,' which contradicts the ground truth's implication of an evolving disclosure focus. Quantitatively, no numbers are involved, so accuracy is not penalized. The reasoning is sound but incomplete in synthesizing the multi-hop nuance of changing disclosure emphasis across years. The answer remains contextually relevant and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 367,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "Between 2022 and 2024, Costco's treatment and disclosure of step-rent provisions in lease accounting remained consistent. Step-rent provisions, including periodic rent increases based on price indices or sales volume, are recognized as variable lease payments. These increases are not subject to straight-line recognition but are accounted for as they occur, reflecting the actual variable payments stipulated in the lease agreements. This approach was disclosed in both the 2022 and 2024 10-K filings, with no material changes in methodology or additional disclosures noted in the provided pages.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim that Costco's treatment of step-rent provisions remained consistent between 2022 and 2024. The ground truth states there was a clear shift in accounting treatment: in 2022, periodic rent increases based on price indices or sales volume were accounted for on a straight-line basis, but by 2024, these were recognized as variable lease payments, no longer straight-lined. The LLM incorrectly asserts no change occurred, directly contradicting the documented evolution. This is a major factual error in both reasoning and content. While the LLM correctly identifies the types of lease escalations (price indices, sales volume), it misrepresents the accounting methodology in both years. The claim that variable payments were 'accounted for as they occur' in both years contradicts the 2022 straight-line method described in the original answer. There are no numerical values to verify, so quantitative accuracy is minimally penalized, but qualitative accuracy is severely impacted due to incorrect synthesis across years. Contextual relevance is moderate because the answer addresses the right topic and entities (lease accounting, step-rent, variable payments), but the conclusion is factually wrong. The multi-hop reasoning failed—instead of detecting a change over time, it erroneously reported consistency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 377,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "From 2023 to 2024, the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans show a slight decrease in the amount expected to be paid out in 2025, from $1,860 million in 2023 to $1,800 million in 2024. Additionally, the long-term obligations from 2029 to 2033 decreased from $10,020 million in 2023 to $9,990 million in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers and time periods. It incorrectly states that the projected 2025 payment decreased from $1,860 million in 2023 to $1,800 million in 2024, while the ground truth shows it remained unchanged at $1,860 million. This is a critical quantitative error. Additionally, the LLM claims the long-term period is from 2029 to 2033 in both years, but the 2024 projection actually covers 2030–2034, not 2029–2033. While the $9,990 million figure for the later period is correct, it applies to a different timeframe than stated. (2) Number verification: 2023 2025 projection = $1,860M (correct in original, incorrect in LLM as $1,800M); 2024 2025 projection = $1,860M (LLM says $1,800M — wrong); 2023 long-term = $10,020M (correctly stated by LLM); 2024 long-term = $9,990M (correct amount but misattributed to 2029–2033 instead of 2030–2034). (3) Multi-hop reasoning is partially sound — the model attempts to compare two years’ projections across short- and long-term horizons — but fails in execution due to incorrect data retrieval and period misalignment. (4) Correctness and quantitative accuracy are low due to core number and time period errors. Qualitative accuracy is slightly higher because the model understands the structure of the question and direction of change (decrease in long-term obligations), though not fully accurate. Contextual relevance is high as the response addresses the right topic and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 411,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "Between 2023 and 2024, JPMorgan Chase's disclosures on resolution plan obligations highlighted a more detailed emphasis on liquidity risk management strategies and funding cost considerations. In 2023, the disclosures outlined general factors impacting liquidity, such as market stress, funding source limitations, and regulatory requirements like the liquidity coverage ratio and net stable funding ratio. By 2024, the disclosures expanded to include more specific strategies for addressing liquidity constraints, such as managing deposit outflows, pre-positioning liquidity in subsidiaries, and the potential need to raise funding from alternative, potentially more expensive sources. Additionally, 2024 emphasized the impact of external regulatory developments, such as proposed Basel III reforms and changes to the GSIB surcharge, on funding costs and liquidity planning.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key disclosures by JPMorgan Chase in 2023 and 2024 regarding resolution plan obligations, liquidity risk management, and funding costs. (1) The 2023 disclosures correctly identify regulatory requirements such as the liquidity coverage ratio (LCR) and net stable funding ratio (NSFR), as well as constraints related to funding sources and liquidity pre-positioning. The 2024 expansion accurately reflects increased focus on alternative funding sources and external regulatory developments. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the model correctly synthesizes how disclosures evolved over time, identifying both continuity and progression in risk factors. However, the LLM slightly misses the emphasis in the original answer on how 2024 disclosures explicitly tied resolution plan obligations to 'dynamic regulatory expectations' and 'systemic events'—particularly how changes in laws in response to macroeconomic shocks could affect liquidity and capital. While the LLM mentions regulatory changes like Basel III and GSIB surcharge, it does not fully capture the forward-looking, event-responsive framing present in the ground truth. (4) Despite this nuance, the answer remains factually accurate, contextually relevant, and captures the core evolution in disclosures. The omission is minor and does not undermine the overall correctness, warranting a score of 8 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy due to absence of numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 470,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Between 2022 and 2023, the financial structure of Optum Rx's pharmacy care services showed notable changes in revenue recognition and accounts receivable. Revenue recognition remained consistent with prescriptions being recognized when dispensed, based on negotiated fees and net of rebates. However, accounts receivable increased from $7.1 billion in 2022 to $8.6 billion in 2023, indicating a rise in amounts due from customers for pharmacy products and services. This increase may reflect higher transaction volumes or timing differences in receivables collection. Additionally, pharmaceutical manufacturer rebates receivable also increased from $8.2 billion in 2022 to $11.0 billion in 2023, suggesting greater rebate accruals due to expanded drug usage or contractual terms.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in accounts receivable from $7.1 billion in 2022 to $8.6 billion in 2023, which matches the ground truth and addresses part of the financial structure evolution. It also correctly notes that revenue recognition remained based on prescription dispensing. However, it introduces a new figure—pharmaceutical manufacturer rebates receivable increasing from $8.2 billion to $11.0 billion—which is not present in the original answer and cannot be verified from the provided ground truth. This addition introduces factual inaccuracies and potentially hallucinated data. (2) While the $7.1B to $8.6B increase is accurate, the inclusion of the $8.2B to $11.0B rebate receivable figure is unsupported by the original answer and contradicts the focus on 'accounts receivable related to products and services.' There is no mention of rebates receivable in the ground truth, so this represents a significant quantitative error. (3) The reasoning for the increase in accounts receivable (higher transaction volumes or timing differences) is reasonable and aligns with the original answer’s interpretation. However, the model fails to mention the key qualitative point about the gross revenue reporting model being due to Optum Rx's primary obligation to pay providers regardless of collection—a critical aspect of revenue recognition structure. This omission weakens the multi-hop synthesis. (4) The contextual relevance is high because the answer addresses revenue recognition and accounts receivable trends. Qualitative accuracy is moderate due to correct logic but missing key structural details. Quantitative accuracy is compromised by the unverified rebate receivable numbers. Correctness score is 6 due to partial factual correctness but significant addition of unsupported data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 497,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "Between 2022 and 2024, UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps remained consistent in purpose but showed some changes in execution. In 2022, UPS used interest rate swaps to convert fixed-rate debt into floating-rate obligations as fair value hedges and to convert floating-rate obligations into fixed-rate payments as cash flow hedges. By 2024, the company continued this strategy but with a notable reduction in the gains or losses reclassified from AOCI, with interest rate contracts showing a $5 million reclassification in 2024 compared to a $10 million reclassification in 2023. Additionally, in 2024, the pre-tax gains deferred in AOCI related to cash flow hedges were $146 million, expected to be reclassified over the next 12 months, indicating a continued but slightly adjusted exposure management approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, UPS had a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use. However, the LLM answer does not mention this key quantitative figure at all. Instead, it introduces unrelated data about gains/losses reclassified from AOCI ($5M in 2024 vs $10M in 2023) and $146M in pre-tax gains deferred in AOCI—information not present in the original answer and irrelevant to the question about notional exposure evolution. (2) The quantitative accuracy is low because the LLM fails to report the $28M 2022 notional amount and fabricates or misaligns other figures (e.g., AOCI reclassifications) that do not address the actual quantitative exposure (i.e., notional amount of swaps). There is no mention of the 2024 notional amount either, nor any indication of how the quantitative exposure evolved. (3) The multi-hop reasoning is flawed. The question asks for evolution in both quantitative exposure and strategic approach. While the LLM correctly notes UPS uses swaps for converting floating to fixed (cash flow hedges), it misses the core evolution: from a minor $28M hedge in 2022 to a broader strategic focus on managing the debt mix in 2024. The LLM incorrectly implies consistency rather than a strategic shift. (4) Contextual relevance is moderate because the answer discusses interest rate swaps and risk management, but it focuses on AOCI reclassifications and hedge accounting effects rather than the notional exposure and strategic intent emphasized in the original answer. The core evolution—increased strategic importance and expanded use—is entirely missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 466,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "Between 2022 and 2023, GM's financial relationship with LG Energy Solution (LGES) evolved significantly, particularly in the context of the Chevrolet Bolt EV recall. In 2023, GM expanded the recall to include all 2017-2022 model year Chevrolet Bolt EVs and EUVs due to battery defects. LGES agreed to reimburse GM for certain costs and expenses associated with the recall, and commercial negotiations also resolved other matters related to their Ultium Cells Holdings LLC joint venture. By December 31, 2023, GM had accrued a total of $2.6 billion for recall-related costs and recognized $1.6 billion in receivables from LGES. The remaining accrual for these matters was $0.6 billion at year-end.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GM accrued $2.6 billion in recall-related costs and recognized $1.6 billion in receivables from LG Energy Solution (LGES) by the end of 2023. The remaining $1.0 billion liability (not $0.6 billion as stated) would be the difference, but the LLM incorrectly states the remaining accrual as $0.6 billion, which is a minor calculation error ($2.6B - $1.6B = $1.0B, not $0.6B). This affects quantitative precision slightly. (2) The evolution from joint venture collaboration (Ultium Cells LLC) to a cost-recovery relationship due to the Bolt EV recall is accurately portrayed, including the expansion of the recall in 2023 and LGES’s reimbursement agreement. (3) Multi-hop reasoning is sound: the answer synthesizes GM’s joint venture activities and recall-related financial impacts across 2022 and 2023, correctly identifying the shift in relationship dynamics. (4) Entity names (GM, LG Energy Solution, Ultium Cells Holdings LLC), years (2022–2023), and financial terms (accruals, receivables) are accurate. The only issue is the incorrect remaining accrual amount, which slightly undermines quantitative accuracy but does not distort the overall narrative. The answer is contextually complete and relevant, addressing both joint venture and recall cost dimensions of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 383,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Observability product category increased from fiscal 2022 to fiscal 2023. Specifically, revenue in the Observability category grew by 14% ($80 million) in fiscal 2023 compared to fiscal 2022, driven by growth in ThousandEyes and monitoring and analytics offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that Observability revenue grew by 14% ($80 million) in fiscal 2023, but according to the ground truth, the $80 million increase occurred in fiscal 2022, not 2023. In fiscal 2023, the actual increase was $176 million (27% growth), not $80 million. The LLM incorrectly attributes the $80 million figure to 2023 and mislabels the percentage growth. (2) Quantitative accuracy is severely compromised: the dollar amount and percentage growth are both wrong for the time period cited. The correct fiscal 2023 growth is 27% ($176 million), not 14% ($80 million). Additionally, the LLM fails to mention Splunk's inclusion in 2023 or the 15% organic growth excluding Splunk, which is a key part of the evolution of ThousandEyes' contribution. (3) The reasoning is flawed: the model fails to correctly synthesize the multi-hop information across fiscal years. It conflates data from 2022 with 2023, reversing the timeline and misrepresenting the evolution. It also omits the critical context that Splunk's inclusion affected 2023 growth, making it impossible to assess ThousandEyes' standalone performance without adjustment. (4) While the general direction (growth in ThousandEyes contribution) is correct, the incorrect numbers, misattributed years, and missing context about Splunk and organic growth severely undermine factual correctness. The answer is contextually relevant to the question but fundamentally inaccurate in execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 416,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS's 7.620% Debentures, with a principal amount of $276 million and a maturity date of April 1, 2030, have maintained consistent redemption terms and interest payment structures between 2022 and 2024. The debentures are redeemable at UPS's option at any time, with the redemption price being the greater of the principal amount plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Interest is paid semi-annually in April and October. The interest rate on these debentures was reduced from 8.375% to 7.620% on April 1, 2020, and no further changes to the terms or structure have been disclosed in the provided documents for 2022 through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct factual elements, including the principal amount ($276 million), maturity date (April 1, 2030), semi-annual interest payments in April and October, and the redemption formula based on the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. These quantitative details match the ground truth and are accurately represented, warranting a high quantitative accuracy score. However, the LLM incorrectly states that the redemption terms were already in place and 'consistent' between 2022 and 2024, which contradicts the ground truth. The original answer emphasizes that in 2022, only basic details (principal, maturity, carrying value) were reported, while the detailed redemption terms were clarified in 2024 — indicating an evolution in disclosure, not consistency. The LLM fails to capture this key change in disclosure depth and misrepresents the evolution as static. Additionally, the mention of the interest rate reduction from 8.375% to 7.620% on April 1, 2020, while possibly true, is extraneous and not supported or required by the ground truth, introducing unverified information. (2) All provided numbers (dollar amounts, dates, percentages) are consistent with the original answer, though the $280 million carrying value mentioned in 2022 is omitted in the LLM response, representing a minor completeness gap. (3) The multi-hop reasoning is flawed: the question asks how the relationship evolved, requiring a comparison across years and synthesis of changes in disclosure. The LLM instead asserts no changes occurred, missing the nuance that while the debentures’ terms may have been fixed, UPS’s reporting and clarification of those terms evolved significantly — a key point in the ground truth. (4) Despite accurate numbers and relevant context, the incorrect characterization of 'no evolution' undermines the core of the answer, leading to a correctness score of 4. Contextual relevance is high because the answer addresses the right instruments and time frame, and qualitative accuracy is moderate due to sound entity identification but flawed reasoning about change over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 599,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "From 2022 to 2023, the total fair value of Fixed Maturity Securities AFS held by MET remained relatively stable, with a slight decrease from $6,802 million in 2022 to $6,714 million in 2023. The composition showed a decline in U.S. government bonds, which decreased from $1,507 million in 2022 to $1,575 million in 2023, while corporate securities increased from $3,001 million in 2022 to $3,083 million in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the total fair value of Fixed Maturity Securities AFS in 2022 was not $6,802 million; instead, the 2022 filing reported the carrying amount as of December 31, 2021, at $2,164 million. The correct total fair value of $6,714 million is for 2023, not a decrease from 2022. Thus, the claim of 'slight decrease' is incorrect—the value actually increased substantially from the prior reported amount. Additionally, the LLM states U.S. government bonds 'decreased from $1,507 million in 2022 to $1,575 million in 2023', which is factually wrong—the value increased, not decreased, and no data for 2022 U.S. government bonds or corporate securities was provided in the original answer to support the LLM's figures. (2) The only correct number in the LLM answer is the 2023 corporate securities value ($3,083 million) and 2023 U.S. government bonds ($1,575 million), which match the ground truth. However, the 2022 figures for both categories are fabricated or misattributed. The total fair value in 2022 is incorrectly stated as $6,802 million with no support in the original answer. (3) The multi-hop reasoning is flawed. The original answer draws from two different reporting years (2022 filing with 2021 data and 2023 filing with 2023 data), but the LLM incorrectly assumes comparable 2022 and 2023 fair values are available and directly comparable. It fails to recognize that the $2,164 million was a prior-year figure reported in 2022, not the 2022 fair value. This leads to a completely incorrect narrative of stability or slight decline, when the truth is a major increase. (4) Despite incorrect numbers and reasoning, the LLM does address the right entities (MET, Fixed Maturity Securities AFS, U.S. government bonds, corporate securities) and the correct time frame (2022 to 2023), showing contextual understanding. Hence, contextual relevance is high, but quantitative and overall correctness scores are low due to major factual and logical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 552,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "From 2022 to 2023, General Motors' financial involvement with Ultium Cells LLC remained consistent, with a $0.5 billion investment noted in 2021 and no additional investments disclosed in 2022 or 2023. However, in late 2022, GM self-disclosed potential regulatory violations related to the import of new chemical substances at Ultium Cells LLC under the Toxic Substances Control Act (TSCA). This led to a settlement with the EPA in November 2023, involving civil penalties estimated at approximately $5.1 million, which could increase depending on future import activity. The penalties were assessed jointly and severally to GM and Ultium Cells LLC, highlighting regulatory implications stemming from compliance issues at the joint venture.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $0.5 billion investment in Ultium Cells LLC and the November 2023 EPA settlement with $5.1 million in civil penalties. However, it incorrectly states that the investment was made in 2021, while the ground truth specifies the $0.5 billion was reported in 2022 as part of investing activities. This misattribution of the investment year is a factual error affecting quantitative and qualitative accuracy. Additionally, the LLM claims no additional investments were disclosed in 2022 or 2023, which may be accurate but slightly misrepresents the evolution — the key point in the original answer is the shift from financial investment to operational integration, which the LLM captures qualitatively but with less clarity. (2) The $5.1 million penalty and November 2023 settlement date are correct. The mention of potential increase in penalties is an addition not in the ground truth but is plausible and not factually incorrect. The error lies in the investment timing: ground truth says $0.5B in 2022, LLM says in 2021. (3) The multi-hop reasoning is partially sound — the LLM connects GM’s self-disclosure of TSCA violations to the joint EPA penalty, showing regulatory entanglement. However, it misstates the timeline of the self-disclosure as 'late 2022' while the ground truth specifies February 2023, which is a minor date discrepancy. More importantly, the LLM does not clearly articulate the evolution from financial to operational involvement as emphasized in the original answer. (4) Scores reflect high contextual relevance and mostly accurate numbers, but deductions are made for incorrect investment year and weaker synthesis of the relationship evolution, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 478,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "The company has used variable-priced contracts for natural gas and fuel purchases, including those for gas stations, based on index pricing. These contracts meet the criteria for derivative instruments but generally qualify for the \"normal purchases and normal sales\" exception, which means they do not require mark-to-market adjustments. There is no explicit information indicating a significant change in the company's use of such contracts between 2022 and 2024; the descriptions of these practices remain consistent across the two periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in describing the company's use of variable-priced contracts and their accounting treatment, correctly noting that these contracts qualify for the 'normal purchases and normal sales' exception and do not require mark-to-market adjustments. All entities (contract types, accounting terms, fuel types) are accurate, and there are no numerical inaccuracies (quantitative accuracy is high, hence score of 10). However, the key shortcoming lies in the reasoning and completeness: the original answer identifies an evolution in the company's approach—specifically, a shift toward more formalized or strategic use of variable-priced contracts by 2024, with explicit alignment to derivative accounting frameworks. The LLM answer incorrectly states there is 'no explicit information indicating a significant change' between 2022 and 2024, which contradicts the ground truth that shows a progression in how these contracts are managed and accounted for. This reflects a failure in multi-hop reasoning—synthesizing the change in tone, disclosure, and accounting treatment over time. While the individual facts are correct, the conclusion drawn is not aligned with the evolution described in the original answer. Thus, qualitative accuracy is moderate (5), as the model misses the nuanced shift in strategy and disclosure. Contextual relevance is high because the answer addresses the core topic, but it lacks the comparative analysis the question demands.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 406,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco's financial reporting approach for the APJC segment remained consistent between fiscal 2022 and fiscal 2023 in terms of the expense categories excluded from segment performance measurement. In both years, the company did not allocate research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, charges related to asset impairments and restructurings, and certain other charges to the APJC segment's performance measurement. This exclusion reflects the continued use of a centralized management approach where these expenses are considered unallocated corporate items.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Cisco's financial reporting approach for the APJC segment remained consistent between fiscal 2022 and 2023, with no change in the expense categories excluded from segment performance measurement. (2) All expense categories listed—research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—are correctly identified and match the original answer. There are no numeric values to verify, but the qualitative financial reporting details are precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the same exclusions applied in both years, indicating consistency in internal performance measurement, and adds contextual insight about centralized management and corporate unallocated items, which is a reasonable interpretation. (4) The answer is complete, factually accurate, and directly addresses the evolution (or lack thereof) in reporting approach. All entities (Cisco, APJC segment, fiscal years 2022 and 2023) are correct. Minor wording differences do not affect meaning—'certain other charges' in the LLM answer is a slight generalization but does not introduce inaccuracy. Scores are maximized across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 408,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "UNH's approach to managing medical cost trends in 2023 evolved to focus more on addressing rising outpatient procedure costs for seniors by engaging physicians and consumers with information to help them make clinically sound choices, aiming to achieve high-quality, affordable care. Additionally, the company emphasized accelerating the transition from fee-for-service care delivery models to fully accountable value-based care models to improve health outcomes and reduce overall system costs over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in UNH's approach from 2022 to 2023, particularly the shift toward targeted strategies for managing rising outpatient procedure costs for seniors. It correctly identifies the 2023 focus on engaging physicians and consumers with data-driven insights to support clinical decisions and promote affordable, high-quality care—aligning with the ground truth. It also appropriately highlights the strategic move toward value-based care models, which is consistent with UNH's broader direction as reflected in the knowledge graph. While the original answer emphasizes a contrast between 2022's general concern about deferred care and 2023's targeted response, the LLM answer omits explicit mention of the 2022 context (e.g., pandemic-related deferred care and risk-based arrangements). However, since the question focuses on the evolution *into* 2023 and the LLM clearly articulates the 2023 strategy and its intent, this omission is minor. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and all entities (UNH, outpatient costs, seniors, physicians, value-based care) are correct. The reasoning is sound and reflects appropriate multi-hop synthesis across time and strategy. The answer is semantically equivalent in key aspects and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 382,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "Between 2022 and 2024, UPS expanded its time-definite delivery services by enhancing service scope and network integration. In 2024, the company insourced the UPS SurePost residential delivery service, which had previously relied on the U.S. Postal Service, to gain greater control over service quality and reliability. Additionally, UPS continued to invest in its Global Smart Logistics Network, leveraging advanced technologies like RFID-enabled Smart Package Smart Facilities to optimize efficiency and end-to-end visibility. These improvements enabled UPS to offer more consistent and faster time-definite delivery options, particularly in international markets and high-growth sectors like healthcare logistics.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in UPS's time-definite delivery services between 2022 and 2024, particularly the insourcing of UPS SurePost from USPS in 2024 to improve service control and quality, which aligns with the ground truth. It also accurately references network integration improvements through technology like RFID-enabled Smart Package Smart Facilities and the Global Smart Logistics Network. However, the LLM omits specific details mentioned in the original answer about same-day pickup seven days a week and expanded returns services in approximately 150 countries—key elements of the expanded service scope in 2024. These omissions reduce completeness but do not invalidate the core factual accuracy. (2) There are no numerical values, dates, or financial figures in either answer that conflict; all references to years (2022, 2024) are correct. The absence of incorrect numbers supports a full score for quantitative accuracy. (3) The multi-hop reasoning is sound: the model connects network integration (2022 foundation) with later enhancements (2024 insourcing and tech investments), showing logical progression. However, it fails to fully synthesize the breadth of service expansion (returns, pickup frequency) present in the ground truth, slightly weakening qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing service scope and network integration as asked. The inclusion of healthcare logistics and international markets adds reasonable inference without straying from the topic. Overall, the answer is factually correct but partially incomplete on scope expansion details, justifying a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 465,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were included as part of the Thirteenth Supplemental Indenture dated April 20, 2016, under Exhibit 4.14. In the 2023 filing, there was no new supplemental indenture or amendment specifically referencing these 2026 notes, indicating that their terms and recognition remained unchanged from the 2022 disclosure.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the 2.50% interest rate, April 2026 maturity, and reference to the Thirteenth Supplemental Indenture dated April 20, 2016, are all correctly stated, and the exhibit number (4.14) is a plausible detail that does not contradict the ground truth. Thus, quantitative accuracy is high. However, the qualitative accuracy is low because the LLM misinterprets the evolution in disclosure treatment. The ground truth indicates a meaningful shift in recognition—from being referenced as part of historical documentation in 2022 to being explicitly recognized as issued instruments in 2023. In contrast, the LLM concludes that 'their terms and recognition remained unchanged,' which directly contradicts the ground truth. This reflects a failure in multi-hop reasoning: the model does not synthesize the change in narrative context between filings, instead inferring stability due to the absence of a new amendment. While the entities and years are correct, and the response is relevant to the question, it misses the core analytical point about evolving disclosure treatment. Hence, the correctness score is moderate due to accurate facts but incorrect interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 343,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "The impact of sovereign debt crises on Costco's merchandise sourcing and cost structure from 2022 to 2024 has primarily manifested through increased exposure to global economic uncertainties and trade-related actions. In 2022, the 10-K notes that sovereign debt crises, along with changes in tax policies, duties, tariffs, and trade actions (particularly between China and the U.S.), affected merchandise costs and sourcing. By 2024, the company's exposure had grown as international operations expanded, with 28% of net sales coming from international markets. The 2024 10-K highlights that fluctuations in foreign exchange rates and trade policies continued to influence the cost of inventory, especially for goods sourced internationally, and could impact gross margins if not effectively managed through merchandising and pricing strategies.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct context about macroeconomic risks affecting Costco's sourcing and cost structure, but diverges significantly from the ground truth in key qualitative aspects. (1) Correct elements: The mention of tariffs, trade actions, and foreign exchange impacts aligns with general risk factors in the filings, and the 28% international sales figure in 2024 is accurate and relevant. However, this specific percentage is not directly tied to sovereign debt crises in the original answer, so its inclusion here misattributes causality. (2) Quantitative accuracy: The 28% international sales figure is factually correct and matches the ground truth data, earning partial credit. No other numbers are presented, so no calculation errors exist, but the answer introduces a statistic not emphasized in the original response regarding sovereign debt. (3) Multi-hop reasoning is partially sound—linking sovereign debt to trade policies and sourcing costs is reasonable—but fails to reflect the evolution in tone and severity described in the ground truth. Crucially, the original answer notes a shift from 'could adversely affect' (2022) to 'negatively impact' (2024), indicating heightened concern, which the LLM omits entirely. Instead, it emphasizes international sales growth and FX risk, which, while related, are not the focus of the sovereign debt crisis impact as framed in the original. (4) The answer is contextually relevant and well-structured, but misses the core evolution: increased directness and severity of language around sovereign debt crises and their cascading effects on supply chains, supplier standards, and cost predictability. It substitutes broader macro risks for the specific trajectory described in the ground truth, resulting in a partially correct but incomplete and somewhat misaligned response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 497,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "The number of shares available for future grants under the 2020 Stock Incentive Plan decreased from 64 million in 2021 to 53 million in 2023. This reduction indicates that UnitedHealth Group has issued a significant number of share-based awards over this period, which may suggest active use of equity compensation for employees and executives. However, with 53 million shares still available in 2023, the company retains substantial capacity to issue new share-based awards under the plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the number of shares available for future grants in 2021 (64 million) and 2023 (53 million), matching the ground truth exactly. The change of -11 million shares is accurately implied. (2) All numeric values and years are correct, with no calculation or formatting errors. (3) The multi-hop reasoning is sound—comparing availability across years to infer trends in share-based award issuance. The LLM correctly identifies the reduction and its implication on award capacity. It adds a reasonable interpretation that the company has actively used equity compensation, which is logically consistent with the data. While the original answer only states the reduction in capacity, the LLM appropriately extends the reasoning to suggest continued substantial capacity in 2023, which is supported by the 53 million shares remaining. This addition is insightful and does not contradict the ground truth. (4) The answer is fully contextually relevant, addressing both parts of the question: the change in shares and what it indicates about future award capacity. The slight expansion beyond the original answer is justified and accurate, warranting a high score. Only a 9 is given for qualitative accuracy because the original answer did not comment on 'substantial capacity,' so while reasonable, it introduces mild interpretation beyond the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 387,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "Between 2022 and 2024, the expiration date of the IAM National Pension Fund / National Pension Plan collective bargaining agreement was extended from July 31, 2024 to July 31, 2029. Additionally, UPS's contribution significance remained notable, with contributions increasing from $48 million in 2022 to $53 million in 2024. In 2024, UPS also reached an agreement to withdraw from the IAM Fund, transferring impacted employees to the UPS Pension Plan and recording a $19 million withdrawal liability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) The expiration date is partially correct: it correctly states the extension from July 31, 2024 to July 31, 2029, which aligns with the original answer. However, (2) the financial figures are incorrect: the ground truth states that UPS contributed more than 5% of total plan contributions for 2019–2021 and continued to do so through 2022–2024, but does not provide specific dollar amounts like $48M or $53M. These numbers are fabricated or hallucinated. (3) Most critically, the claim that 'UPS reached an agreement to withdraw from the IAM Fund' in 2024 directly contradicts the original answer, which emphasizes the extension of the agreement and sustained contribution significance—indicating deeper engagement, not withdrawal. This is a major factual error. (4) The $19 million withdrawal liability is not mentioned in the ground truth and contradicts the narrative of continued participation. (5) While the model attempts multi-hop reasoning by connecting dates and contributions over time, it fails in synthesis—incorrectly inferring withdrawal instead of sustained involvement. The qualitative reasoning is therefore flawed. (6) Contextually, the answer addresses the evolution of the relationship but misrepresents its nature. Minor credit is given for correctly identifying the expiration date extension. Overall, the answer is mostly incorrect due to hallucinated numbers and a contradictory key event.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 419,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "Between fiscal years 2022 and 2023, the terms and availability under LOW's 2020 Credit Agreement evolved as follows: In 2022, the 2020 Credit Agreement had an availability of $2.0 billion and matured in March 2025. By 2023, the agreement was amended and restated as the 2023 Credit Agreement, extending its maturity to September 2028. The combined availability under the Credit Agreements remained at $4.0 billion, supported by the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: in 2022, the 2020 Credit Agreement had $2.0 billion availability and matured in March 2025; in 2023, it was amended into the 2023 Credit Agreement with maturity extended to September 2028, maintaining $2.0 billion availability. The combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained $4.0 billion, consistent with 2022. (2) Quantitative accuracy is perfect: all dollar amounts ($2.0 billion, $4.0 billion) and dates (March 2025, September 2028) match the ground truth exactly. (3) The multi-hop reasoning is sound—correctly linking the evolution of the 2020 agreement into the 2023 version and noting the continuity in total credit availability. (4) The only minor omission is that the LLM does not explicitly state that the $4.0 billion combined availability in 2022 was also due to two agreements (implied but not specified), and it doesn't name the 'Third Amended and Restated Credit Agreement' as being part of the 2022 structure. However, this does not distort the meaning. The answer is semantically equivalent and contextually fully relevant. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 378,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "MDLZ's notional amounts for Net Investment Hedge Derivative Contracts increased significantly between 2022 and 2024. As of December 31, 2022, the notional value was $3.9 billion, which grew to $7.5 billion by December 31, 2023, and further increased to $8.6 billion by December 31, 2024. This reflects a strategic expansion in hedging activities related to MDLZ's non-U.S. operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend of increasing notional amounts correctly and identifies the right financial instrument and company. However, there are significant quantitative inaccuracies. The original answer states that the $3,915 million figure was as of December 31, 2021 (reported in 2022), not December 31, 2022. Similarly, the $4,551 million was as of December 31, 2020. The LLM incorrectly assigns $3.9 billion to December 31, 2022, when no such value is provided in the ground truth for that date. The 2023 and 2024 figures are close but rounded: $7,456 million (actual) vs $7.5 billion (LLM), and $8,647 million vs $8.6 billion — these are acceptable with rounding. (2) The key error is temporal misalignment: the LLM treats data reported in a given year as data from the end of that year, but the original answer specifies that 2022 filing reports 2021 and 2020 figures. This leads to a misrepresentation of the timeline. (3) The multi-hop reasoning is partially sound — the model correctly infers a growing trend and connects it to hedging strategy — but fails to accurately map the time series due to incorrect dating. (4) Correctness is scored 7 because the core trend and direction are right, but key dates and values are wrong. Quantitative accuracy is 6 due to incorrect time anchoring and approximate figures. Qualitative accuracy is 8 because reasoning and entity identification (MDLZ, derivative contracts) are correct. Contextual relevance is 10 — the answer directly addresses the question's focus on evolution and notional amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 433,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "Between 2022 and 2024, Microsoft 365's integration with AI technologies evolved significantly, with 2024 introducing new capabilities such as Copilot for Microsoft 365, which combines AI with business data to enhance productivity and collaboration. Role-based AI extensions like Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes, while Copilot Pro offered enhanced AI assistance in Microsoft 365 apps and on the web. Additionally, Copilot Studio enabled customization of AI tools, further embedding AI into workflows for improved efficiency and insights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of Microsoft 365's AI integration from 2022 to 2024, noting the shift to an 'AI-first platform' with the introduction of Copilot for Microsoft 365 in 2024. The specific new capabilities—Copilot for Sales, Service, and Finance—are accurately mentioned, matching the original answer. The LLM adds slightly more detail with 'Copilot Pro' and 'Copilot Studio,' which are consistent with Microsoft's 2024 AI enhancements and represent valid extensions of the platform, even if not explicitly in the ground truth; these do not contradict it but rather provide additional context. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is 9 because while all core facts are correct, the original answer emphasizes the integration with Microsoft Graph and the framing of 'AI-first platform,' which the LLM mentions implicitly but not explicitly. However, this does not detract from factual correctness. The reasoning is sound, demonstrating multi-hop synthesis across time and capabilities. Contextual relevance is perfect—the answer directly addresses both parts of the question: evolution between 2022–2024 and new 2024 capabilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 358,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "Between 2022 and 2024, 3M's approach to PFAS discharge characterization in its wastewater permits at the Decatur, Alabama facility evolved from identifying and disclosing incomplete PFAS discharge characterization in its NPDES permit to implementing corrective measures and engaging in regulatory negotiations. In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit and had submitted an application to add additional PFAS to the permit. By 2024, the company had installed wastewater treatment controls to address PFAS and was working on optimizing these systems, while ADEM had not yet acted on the permit modification request. Additionally, 3M was cooperating with EPA and ADEM investigations and had entered into an interim Consent Order in 2020 to address PFAS-related discharges and emissions, which included commitments for future site operations and remediation activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, 3M disclosed incomplete PFAS discharge characterization and submitted a permit modification application to ADEM; by 2024, it had installed and was optimizing PFAS-specific wastewater treatment controls, while ADEM had not yet acted on the modification. These points match the original answer exactly. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but all dates (2022, 2024) and entity names (3M, Decatur facility, ADEM, EPA) are accurate. The mention of the 2020 interim Consent Order is factually correct and adds context not in the original answer but consistent with known disclosures—this does not detract from accuracy but slightly extends beyond the scope of the question. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 to 2024), entities (3M, ADEM), and actions (disclosure → application → implementation → optimization). The evolution in approach is logically presented. (4) The only reason for not scoring a perfect 10 is that the original answer emphasizes the shift from 'identifying the issue and initiating corrective actions' to 'implementing and refining treatment solutions while awaiting regulatory approval'—a nuance slightly better captured in the original. The LLM includes extra detail (Consent Order) that, while accurate, is not directly asked for in the question about 'evolution in wastewater permit characterization.' However, this does not introduce error. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 456,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Lowe's Companies, Inc. issued the 4.550% Notes as part of its Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049. There is no indication in the provided pages that the terms or structure of these specific 4.550% Notes were modified between 2022 and 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. (1) Quantitative accuracy: The dates (April 5, 2019, and April 5, 2049) and the interest rate (4.550%) are correctly stated. (2) Completeness: The answer addresses the evolution (or lack thereof) of the 4.550% Notes between 2022 and 2023 by correctly stating there was no modification. While it does not explicitly mention the 2022 reference to the notes (as in the original answer), it correctly infers no changes occurred, which is the core of the question. (3) Entity accuracy: Lowe's Companies, Inc., the Fifteenth Supplemental Indenture, and the note terms are correctly identified. (4) Reasoning: The logic is sound—since no changes were indicated, the notes remained unchanged. The only minor shortcoming is the lack of explicit mention that the notes were still referenced in both years, but the conclusion is semantically equivalent. Thus, the answer is highly accurate with only a slight omission in contextual detail, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 305,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ's financial relationship with KDP evolved significantly due to a change in accounting treatment for the investment. In 2023, MDLZ's ownership in KDP fell below 5%, leading to a shift from equity method accounting to treating the investment as a marketable security. During 2023, MDLZ sold approximately 76 million shares of KDP, receiving $2.4 billion in proceeds and recognizing a pre-tax gain of $493 million on the change in accounting. By the end of 2023, MDLZ had fully exited its investment in KDP. No further gains or losses related to KDP were recorded in 2024, as the investment had been completely sold off.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, MDLZ recognized a pre-tax gain of $71 million from the sale of KDP shares. However, the LLM incorrectly places the $493 million pre-tax gain in 2023, while the original answer clearly states this gain occurred in 2024. Additionally, the LLM claims MDLZ fully exited its investment by the end of 2023 and recorded no activity in 2024, which contradicts the ground truth that explicitly states the $493 million gain was recorded in 2024. (2) Quantitative accuracy is low: while the $493 million pre-tax gain and $71 million 2022 gain are mentioned in the correct magnitudes, their timing is wrong. The LLM also introduces new figures not in the original (e.g., '76 million shares', '$2.4 billion in proceeds') which are unsupported by the provided ground truth. (3) The reasoning about the accounting change (from equity method to marketable security due to ownership falling below 5%) is plausible and aligns with typical accounting rules, but this detail is not present in the original answer and cannot be verified from the given truth. The multi-hop synthesis is flawed because the model misaligns the timeline and invents intermediate steps. (4) Contextual relevance is high—the response addresses the evolution of MDLZ's financial relationship with KDP and focuses on gains from accounting changes—but the factual misalignment, especially on timing and unsupported details, severely undermines correctness. The core error is shifting the major 2024 gain to 2023 and asserting full exit by 2023, which contradicts the ground truth that the significant gain occurred in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 460,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "Between 2022 and 2024, the scale and positioning of Xbox Game Pass have significantly evolved. In 2022, Xbox Game Pass was described as offering access to a curated library of over 100 first- and third-party titles. By 2024, the library had expanded to over 400 titles, reflecting Microsoft's strategic emphasis on growing its gaming ecosystem and enhancing user engagement through a broader and more diverse content offering. This expansion aligns with Microsoft's focus on cloud gaming and creating a unified, accessible gaming experience across multiple devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Xbox Game Pass offered over 100 titles in 2022 and expanded to over 400 by 2024, matching the ground truth exactly in both scale and direction of growth. All numeric values and years are accurate. (2) Quantitative accuracy is perfect—no calculations were required, but the reported numbers (100+ in 2022, 400+ in 2024) are factually correct and match the ground truth. (3) The reasoning is sound and captures the multi-hop aspect by linking the expansion in title count to Microsoft's strategic emphasis on ecosystem growth, cloud gaming, and cross-device accessibility. While the ground truth explicitly calls Xbox Game Pass the 'cornerstone' of Microsoft's gaming platform, the LLM conveys a similar strategic elevation through phrases like 'growing its gaming ecosystem' and 'unified, accessible gaming experience,' which are semantically close. However, the omission of the exact term 'cornerstone' and slightly less precise framing of the strategic shift (e.g., not explicitly mentioning 'subscriptions' as a pillar) results in a minor deduction in qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing both the scale (number of titles) and strategic positioning over time. Overall, the response is factually complete and well-reasoned, warranting a high correctness score with only a slight gap in precise strategic terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 394,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "The structure and disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan remained consistent from 2022 to 2024. In both years, the form of the Deferred Stock Unit Award Agreement for non-employee directors was incorporated by reference from the 2018 Form 10-K, indicating no material changes to the agreement structure during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that the structure and disclosure of the Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan remained consistent from 2022 to 2024, which aligns with the ground truth. However, there is a critical factual error in the incorporation by reference: the LLM states it was from the 2018 Form 10-K, while the ground truth specifies that the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, with amendments as of May 8, 2023. This misrepresentation of the source filing and year undermines the quantitative and qualitative accuracy. Additionally, the ground truth notes that the agreement was first referenced in the 2022 10-K (not earlier), applicable to grants on or after January 1, 2019—information missing in the LLM response. While the conclusion about no material changes is partially supported, the LLM fails to acknowledge the updated referencing path in 2024, indicating ongoing maintenance through amendments, which is a key evolution in disclosure practice. Thus, while the answer is contextually relevant and captures the high-level stability of the agreement, it lacks precision in dates and sources and omits important details about the evolution in disclosure referencing, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 374,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Between 2023 and 2024, the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio showed a slight increase in total loans, from $26,153 million to $27,389 million for First Mortgages and from $479 million to $424 million for HELOCs. The origination costs for these portfolios increased from $100 million in 2023 to $112 million in 2024. In terms of geographic concentration, both years showed 42-43% of the First Mortgages and HELOCs portfolios concentrated in California, with consistent performance relative to the overall portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. The origination costs are accurately reported: $100 million in 2023 and $112 million in 2024, matching the ground truth. The California concentration is also mostly correct, stating '42-43%' which aligns with the 43% in 2023 and 42% in 2024. However, the LLM introduces loan balance figures not present in the original answer or implied by the question: $26,153 million and $27,389 million for First Mortgages and $479 million to $424 million for HELOCs. These numbers are not in the ground truth and cannot be verified from the provided context, making them potentially hallucinated or misattributed. (2) The quantitative accuracy is compromised by these unverified totals. While the origination costs and geographic percentages are correct, the inclusion of unsupported loan balances reduces confidence in the numerical fidelity. The HELOC decrease from $479M to $424M is particularly problematic as it contradicts the focus on origination costs and geographic concentration, and no such data was in the ground truth. (3) The reasoning partially addresses the evolution in composition, correctly noting increased origination costs and stable California concentration. However, it fails to interpret the implications—such as increased origination activity or slight reduction in geographic risk—as noted in the original answer. The multi-hop synthesis is weak because it adds irrelevant balance data instead of focusing on cost and concentration trends. (4) Scores reflect that core facts (costs, CA concentration) are correct (supporting a moderate correctness score), but the addition of unsupported figures harms quantitative accuracy. The answer remains contextually relevant and shows reasonable qualitative understanding, though with missed interpretive depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 500,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Nike's strategic emphasis on Dri-FIT technology appears to have remained consistent, with continued focus on integrating the technology into innovative product designs. Both years highlight the use of Dri-FIT as part of Nike's broader commitment to leveraging technologies like Nike Air, Zoom, Flyknit, and React to enhance performance and meet consumer preferences. However, there is no explicit mention of increased investment or new initiatives specific to Dri-FIT in fiscal 2024 compared to fiscal 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that Nike's strategic emphasis on Dri-FIT technology remained consistent between fiscal 2023 and 2024, which aligns with the ground truth. It accurately notes the continued integration of Dri-FIT alongside other key technologies like Nike Air, Zoom, Flyknit, and React, reflecting the same set of technologies listed in the original answer. The LLM correctly observes no new or increased emphasis on Dri-FIT in fiscal 2024, which is consistent with the ground truth statement that the exact same language was used in both years’ 10-K filings. While the LLM does not explicitly state that the 'exact same language' was used (a minor omission), it captures the semantic meaning and conclusion—that there was no change in emphasis. There are no numerical values in this question, so quantitative accuracy is scored based on absence of errors (N/A handled correctly). The reasoning is sound, entities (Nike, Dri-FIT, fiscal years) are correct, and the synthesis across years is appropriate. The answer is fully contextually relevant and addresses the evolution (or lack thereof) in strategic emphasis as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 322,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "Mondelez International has significantly enhanced its investment in backup and disaster recovery from 2022 to 2024 in response to increasing cybersecurity threats. In 2022, the company acknowledged the rising complexity of cyber threats and outlined efforts to strengthen network security, backup, and disaster recovery, alongside workforce training and threat monitoring. By 2024, Mondelez had expanded these efforts, emphasizing advanced identity and access management, multi-factor authentication, privileged access management, and 24/7 security operations to detect and respond to threats in real time. These measures reflect a more proactive and comprehensive approach to cybersecurity resilience in response to evolving threats.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of timeline (2022 to 2024) and the evolution of Mondelez's investment in backup and disaster recovery in response to increasing cybersecurity threats. It correctly identifies that in 2022, Mondelez was actively strengthening its cybersecurity posture, including backup and disaster recovery, due to rising threats. By 2024, it accurately reflects an expanded, more sophisticated effort. The mention of specific technical enhancements like multi-factor authentication, privileged access management, and 24/7 security operations is plausible and contextually relevant, though these details are not explicitly present in the original ground truth. The ground truth emphasizes 'state-sponsored actors' and 'artificial intelligence' as emerging threat drivers, which the LLM omits. While the LLM captures the overall trajectory and intent of Mondelez's cybersecurity evolution, it substitutes some specifics (e.g., identity management) not highlighted in the original answer, slightly reducing qualitative accuracy. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is fully contextually relevant, addressing the question's focus on investment evolution and threat response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 356,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "Microsoft's financial commitment and engagement with Black and African American-owned suppliers significantly evolved from fiscal year 2022 to 2024. In fiscal year 2022, the company was 90% of the way toward its goal to double spending with Black and African American-owned suppliers, reaching more than 90% of its $500 million target. By fiscal year 2024, Microsoft achieved its goal, spending $500 million with double the number of Black- and African American-owned suppliers. Additionally, the company increased deposits with Black- and African American-owned minority depository institutions and expanded initiatives like the Black Partner Growth Initiative and the Black Channel Partner Alliance to further support these suppliers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the key financial figures and timeline: in FY2022, Microsoft was over 90% toward its $500 million goal, and by FY2024, it had achieved the $500 million spending target. These quantitative details match the ground truth exactly, including the $500 million goal and the 90% progress in FY2022. (2) The LLM accurately reports that Microsoft doubled the number of Black and African American-owned suppliers by FY2024, aligning with the original answer. However, it omits the specific $150 million allocation to Minority Depository Institutions (MDIs) and funds supporting Black-owned small businesses, which is a notable addition in the ground truth for FY2024. While the LLM mentions increased deposits with MDIs, it does not quantify the $150 million commitment, representing a minor but meaningful omission. (3) The multi-hop reasoning is sound—comparing FY2022 progress to FY2024 achievement shows evolution in commitment. The inclusion of initiatives like the Black Partner Growth Initiative and the Black Channel Partner Alliance adds relevant context not in the original but does not contradict it. (4) The answer is highly factually accurate, with perfect quantitative alignment and strong qualitative reasoning. The omission of the $150 million figure prevents a perfect 10, but the core financial evolution is correctly conveyed, warranting a 9 for correctness and qualitative accuracy. Contextual relevance is full, as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 419,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "The availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees decreased from 10,638,639 shares as of December 31, 2021, to 8,565,087 shares as of December 31, 2023. This reduction suggests that Abbott has been actively issuing shares under the plan, reflecting ongoing participation by non-U.S. employees and a continued use of stock-based incentives to align employee interests with those of shareholders.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the number of shares available for future issuance in both years—10,638,639 as of December 31, 2021 (referenced in the 2022 filing) and 8,565,087 as of December 31, 2023 (from the 2023 filing). These figures match the ground truth exactly, satisfying quantitative accuracy. (2) The dates are correctly interpreted in context: the 2022 report refers to data as of December 31, 2021, and the 2023 report provides data as of December 31, 2023. This is standard in annual reporting and correctly handled. (3) The reasoning correctly identifies a reduction in available shares, but the interpretation diverges slightly from the ground truth. While the LLM attributes the decrease to active issuance and continued use of incentives, the original answer interprets it as a potential tightening or adjustment in strategy. Both are plausible, but the LLM's inference leans more positively without acknowledging possible strategic restraint. This is a difference in qualitative interpretation, not fact. (4) The answer is contextually relevant, fully addressing both parts of the question—evolution of share availability and strategic implication. The minor deduction in qualitative accuracy is due to the one-sided interpretation of the reduction as ongoing commitment rather than a possible strategic tightening, which the ground truth allows for. Overall, the answer is factually sound and well-reasoned, warranting a high correctness score with a small gap in interpretive balance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 420,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike has continued to emphasize innovation in product development, with Nike Air technology remaining a core component of its strategy. The 2024 10-K filing highlights the proliferation of Nike Air, along with other technologies like Zoom, Air Max, and React, as part of Nike's commitment to designing innovative products that meet consumer preferences. There is no indication of a shift away from Nike Air; rather, it is presented as a key innovation that typifies Nike's dedication to enhancing performance and comfort across its product categories.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key strategic shift described in the ground truth. (1) It correctly identifies that Nike Air remained a core component of Nike's innovation strategy in both fiscal years and is mentioned in the context of product development, which aligns with the original answer. However, it fails to capture the nuanced evolution in treatment between 2023 and 2024. In 2023, Nike Air was highlighted as emblematic of innovative dedication, suggesting it was still being actively promoted as a distinct innovation. By 2024, the ground truth indicates a shift: Nike Air is grouped with mature technologies like Zoom, Free, and React, signaling its transition to a foundational, integrated technology rather than a standalone growth driver. The LLM answer incorrectly states there is 'no indication of a shift,' which contradicts the original answer's central claim. (2) There are no numerical values to verify, so quantitative accuracy is not applicable—score reflects no factual numeric errors. (3) The multi-hop reasoning is weak: the model should have compared the framing of Nike Air across the two years and inferred a strategic maturation, but instead concludes continuity without recognizing the evolution in positioning. (4) Contextual relevance is high because the response stays on topic and references appropriate technologies and strategic themes, but the failure to identify the strategic repositioning significantly undermines factual correctness. Hence, correctness and qualitative accuracy are moderate due to missing a critical analytical point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 435,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "Between 2022 and 2023, Abbott maintained Osmolite as a key product within its Nutritional Products segment, specifically in its enteral feeding portfolio. Osmolite is highlighted as one of the nutritional products used in enteral feeding in healthcare institutions, alongside other products like Jevity, Glucerna, and Oxepa. There is no explicit mention of a strategic shift in positioning for Osmolite during this period, suggesting that Abbott continued to market and sell Osmolite as part of its broader enteral feeding solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that Osmolite remained part of Abbott's enteral feeding portfolio in both 2022 and 2023, used in healthcare institutions alongside products like Jevity, Glucerna, and Oxepa. The answer correctly notes the absence of any explicit strategic shift, which matches the original answer's conclusion of stable positioning without repositioning, discontinuation, or new introduction. All entities (Osmolite, Jevity, Glucerna, Oxepa) and timeframes (2022–2023) are accurate. There are no numerical figures in this question, so quantitative accuracy is scored based on correct handling of years and product names, which are precise. The only minor limitation is that the LLM does not explicitly list all the products mentioned in the 2022 portfolio (e.g., Nepro, Vital, Freego), but this omission does not affect the core conclusion about Osmolite’s stable strategic role. The reasoning is sound, demonstrating appropriate multi-hop synthesis across the two years and correct interpretation of continuity as an indicator of stable positioning. The answer is semantically equivalent to the ground truth and fully addresses the question about evolution (or lack thereof) in Osmolite’s positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 356,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "Between 2022 and 2024, 3M's regulatory engagement and remediation obligations related to PFAS discharge in Minnesota and Alabama have intensified. In Minnesota, the Company faced increasingly stringent regulatory actions, including a revised draft Clean Water Act permit for the Cottage Grove facility with significantly lower PFAS effluent limits, and a Notice of Violation in March 2023 for stormwater discharges at the Hutchinson facility. In Alabama, 3M entered into an interim Consent Order in July 2020 for the Decatur facility, committing to ongoing operations and remediation activities, and resolved an RCRA-related issue in September 2024 with an immaterial penalty. Both states have required substantial compliance efforts, including capital improvements, expanded monitoring, and ongoing negotiations with regulatory agencies.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of 3M's PFAS-related regulatory engagement and remediation obligations in Minnesota and Alabama between 2022 and 2024, with generally accurate qualitative trends. It correctly notes intensified regulatory scrutiny, the 2020 Interim Consent Order in Alabama, and the draft Clean Water Act permit in Minnesota with stricter PFAS limits. However, there are notable inaccuracies and omissions. The 'Notice of Violation in March 2023 for stormwater discharges at the Hutchinson facility' is not present in the ground truth and appears to be an addition not supported by the provided data. Similarly, the claim that 3M 'resolved an RCRA-related issue in September 2024 with an immaterial penalty' is absent from the original answer and introduces new, unverified events. The ground truth emphasizes the December 2024 revised draft permit from MPCA and updated HBVs from MDH in January 2024 and proposed HRLs in October 2024—key regulatory developments that the LLM omits. While the LLM correctly identifies the 2020 Interim Consent Order, it fails to mention that it was with ADEM or that the multilayer cap at Decatur was already completed by 2022. The answer also omits the fact that remediation was substantially completed at Cottage Grove by 2022, instead focusing only on future permit challenges. Quantitatively, no numerical values are incorrect because none are provided, but the dates mentioned (March 2023, September 2024) are either not in the ground truth or not verifiable. The reasoning is partially sound—correctly inferring increased regulatory pressure—but fails to fully synthesize the multi-hop timeline and evolving standards (e.g., MDH HBVs, HRLs). The answer remains contextually relevant and addresses both states and the time frame, but lacks completeness and precision in key details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 497,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "Between 2022 and 2024, The Coca-Cola Company's financial relationship with Coca-Cola HBC AG has remained classified as an equity method investment. As of December 31, 2024, The Coca-Cola Company owned a 22% stake in Coca-Cola HBC AG, consistent with the equity method of accounting. The carrying value of the investment in Coca-Cola HBC AG was $1,147 million in 2024, while the fair value based on quoted market prices was $2,675 million, indicating a significant difference of $1,528 million. This suggests that the investment's fair value has increased over time, though the carrying value has not fully caught up to market value.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Coca-Cola HBC AG remained an equity method investee from 2022 to 2024 and accurately states the 22% ownership stake as of December 31, 2024, which aligns with the ground truth. However, the LLM introduces specific financial figures—$1,147 million carrying value and $2,675 million fair value in 2024—that are not present in the original answer or supported by the provided evidence. These numbers, while possibly accurate in reality, are not part of the ground truth derived from the knowledge graph and thus represent unverified additions. (2) The calculation of a $1,528 million difference is mathematically correct ($2,675M - $1,147M = $1,528M), but since the inputs are not in the original answer, this quantitative analysis is extraneous and unsupported. (3) The multi-hop reasoning is partially sound: the model correctly infers continuity in investment classification and notes the new specificity of the 22% stake in 2024. However, it fails to mention that the 2022 stake percentage was not disclosed, which is a key qualitative point in the original answer about the evolution of transparency in the relationship. Instead, the LLM shifts focus to valuation metrics not requested in the question. (4) The contextual relevance is high because the response addresses the core topic—investment classification and stake evolution—but the emphasis on carrying and fair values deviates from the question’s focus on classification and ownership percentage. The correctness score is 6 due to accurate stake and classification information but significant addition of unsupported quantitative data and omission of the key point about disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 464,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024 by increasing investment in product development to enhance interoperability and integration across deployment models. In fiscal 2022, Oracle highlighted its commitment to hybrid deployments, including Oracle Cloud@Customer, and invested $7.2 billion in research and development to improve integration, performance, and flexibility. By fiscal 2024, Oracle further emphasized hybrid deployment models as a core part of its strategy, with continued innovation in Oracle Cloud Services (SaaS and OCI) to enable seamless transitions between on-premise and cloud environments. This evolution reflects Oracle's focus on customer choice and the integration of deployment models to meet diverse business needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's strategic evolution in hybrid deployments from fiscal 2022 to 2024, accurately stating the $7.2 billion R&D investment in fiscal 2022 and the continued focus on hybrid integration by fiscal 2024. The key product Oracle Cloud@Customer is correctly mentioned, and the emphasis on interoperability, customer choice, and seamless transitions across deployment models aligns with the ground truth. (2) Quantitatively, the $7.2 billion R&D figure is accurate and matches the original answer; no other numerical data is present, so no calculations are required. Format is consistent and correct. (3) The multi-hop reasoning is sound: the model synthesizes information across fiscal years, correctly identifying the shift from development-focused efforts in 2022 to integrated deployment models in 2024. While the original answer explicitly states that hybrid deployments became a 'standard deployment choice' by 2024, the LLM conveys a semantically equivalent idea by describing hybrid models as a 'core part of its strategy' and enabling 'seamless transitions.' (4) The answer is fully contextually relevant, directly addressing both product development investment and deployment model integration. The only minor shortcoming is a slightly less explicit articulation of the strategic evolution compared to the ground truth (e.g., not stating hybrid became a 'standard' option), but the core meaning is preserved. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 415,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "The filing status of the Mandatory Clawback Policy for Wells Fargo & Company remained consistent between the 2023 and 2024 SEC 10-K disclosures. In both years, the policy was filed directly with the respective 10-K reports. In 2023, it was listed as Exhibit 97 and filed herewith, and in 2024, it retained the same exhibit number and filing status.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the Mandatory Clawback Policy was filed directly in both 2023 and 2024. According to the ground truth, in 2024 the policy was not filed directly but was instead incorporated by reference from the prior year’s 10-K, which represents a key procedural change. This error fundamentally misrepresents the evolution of the filing status. (2) There are no numeric values to verify, so quantitative accuracy is not heavily penalized, but the absence of correct procedural details (e.g., 'incorporated by reference' vs. 'filed herewith') affects factual precision. (3) The multi-hop reasoning failed: the question required comparing the filing mechanisms across two years, and the model incorrectly concluded consistency when there was a clear shift in disclosure method. The LLM did identify the correct entity (Wells Fargo & Company) and the correct exhibit number (97), showing some entity accuracy. (4) Contextual relevance is moderate because the answer addresses the right topic and structure (filing status, exhibit number, years), but the core conclusion is wrong. The answer contradicts the ground truth by asserting consistency instead of identifying the procedural change, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 358,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher acquired CorEvitas, LLC in August 2023 as part of its strategy to expand its Laboratory Products and Biopharma Services segment. The acquisition added real-world evidence solutions to enhance drug development processes. The purchase price for CorEvitas was $910 million, with $730 million paid in cash and $184 million in debt settled. Financial implications included increased net interest expense due to debt financing and the addition of $627 million in goodwill, which is non-tax deductible. The acquisition also contributed to the company's 2023 investing activities, which used $2.70 billion and $0.91 billion in cash for The Binding Site Group and CorEvitas, respectively.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 acquisition of CorEvitas, LLC by Thermo Fisher for $910 million (matching the ground truth $0.91 billion), and notes its integration into the Laboratory Products and Biopharma Services segment, aligning with the evolution from investment to full acquisition. The breakdown of payment ($730M cash, $184M debt) is additional detail not in the ground truth but does not contradict it. The mention of $627 million in goodwill and non-tax deductibility is accurate and adds value. However, the ground truth emphasizes that in 2024, amortization of definite-lived intangibles began over 18 years—a key financial implication in the post-acquisition phase—which the LLM answer omits. (2) Quantitatively, all numbers are accurate: $910M = $0.91B, and the investing activities correctly list $0.91B used for CorEvitas. The $2.70B for The Binding Site Group is contextually relevant but not part of the core question. No calculation errors. (3) The multi-hop reasoning is sound: the answer connects the acquisition to strategic expansion, identifies financial outflows, and links to segment integration. However, it fails to fully address the 2024 evolution (amortization policy), which is a required part of the 'evolve between 2023 and 2024' aspect. (4) Scores reflect high accuracy in facts and numbers, minor omission in 2024 financial implications, and excellent contextual relevance to the question's focus on financial and relational evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 414,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce, contingent on each hour flown by V2500-powered aircraft through June 2027, are treated as \"Other commercial aerospace commitments.\" In 2022, these obligations were expected to total $10,015 million, with $836 million anticipated in 2023. By 2023, the total commitment had slightly decreased to $10,015 million, with $836 million expected in 2023. These payments are capitalized as collaboration intangible assets as they are made, reflecting their treatment as long-term economic commitments. The timing of these payments aligns with the ongoing service and flight activity of the V2500-powered aircraft fleet.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts—$10,015 million total commitment and $836 million expected in 2023—that are not present in the original ground truth answer. The ground truth makes no mention of any numerical values for the payment obligations, only describing the structure, timing, and accounting treatment. These fabricated figures severely undermine factual accuracy. Additionally, the claim that the total commitment 'slightly decreased to $10,015 million' is logically inconsistent (it was already $10,015 million in 2022), suggesting a failure in reasoning or data synthesis. (2) There is no verification possible for the numbers because they do not appear in the ground truth; their inclusion constitutes a significant quantitative error. The years 2022 and 2023 are correctly referenced, and June 2027 as the end date for flight hour contingencies matches the original, which is accurate. (3) The multi-hop reasoning is partially sound in that the model correctly identifies the ongoing nature of the agreement, the contingent structure based on flight hours through June 2027, and the capitalization of payments as collaboration intangible assets. It also correctly categorizes the obligations under 'Other commercial aerospace commitments.' However, the addition of unverified financial figures indicates a failure to distinguish between disclosed commitments and actual or estimated values, reflecting a flaw in information synthesis. (4) The contextual relevance is moderate because the answer addresses the key aspects of timing and capitalization treatment, but the inclusion of false quantitative data distorts the overall correctness. The qualitative accuracy is low due to the invented numbers and internal inconsistency, though the conceptual framework aligns with the original. Correctness score is low because the core issue—evolution of obligations—was misrepresented by implying a quantified change that the ground truth explicitly states did not occur ('no indication of a change in magnitude or timing').",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 554,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "The Coca-Cola Company's financial relationship with fairlife from 2022 to 2024 includes contingent payments tied to performance milestones. In 2020, the Company acquired the remaining ownership interest in fairlife, with a contingent milestone payment based on fairlife's operating results. As of December 31, 2023, the fair value of the remaining milestone payment was $3,017 million, contingent on fairlife achieving certain financial targets through 2024 and payable in 2025. By December 31, 2024, this liability increased to $6,126 million, reflecting updated fair value measurements based on agreed-upon formulas tied to fairlife's performance. The Company made a milestone payment of $275 million in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, there was no mention of ongoing contingent payments, and by 2024, a remaining milestone payment was disclosed—contingent on performance through 2024 and payable in 2025. However, the LLM claims specific dollar amounts ($3,017 million in 2023 and $6,126 million in 2024), which are not present in the original answer and are therefore fabricated. Additionally, the LLM states that a $275 million payment was made in 2023, which is not supported by the ground truth. (2) The quantitative inaccuracies are severe: the numbers cited (e.g., $3,017M, $6,126M, $275M) do not appear in the original answer and contradict it by implying detailed financial disclosures that were not made. There is no mention of fair value measurements or actual payments in the ground truth. (3) The multi-hop reasoning is partially sound in that the model identifies the 2020 acquisition and the existence of a contingent payment tied to 2024 performance, payable in 2025—this aligns with the evolution described in the original answer. However, the addition of specific dollar figures and payment events introduces false precision and undermines the reasoning. (4) The contextual relevance is moderate because the answer addresses the financial relationship and contingent payments, but the inclusion of invented data severely reduces factual correctness. The qualitative accuracy is low due to incorrect entities (specific dollar amounts, implied disclosures) and unsupported claims about payments and valuations. The correctness score is low because the core numerical claims are false, even if the general direction of the relationship (ongoing contingent payment from 2020 acquisition) is correctly inferred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 488,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "Between 2022 and 2024, Oracle's strategic positioning of Oracle Cloud Services has evolved to emphasize deeper integration with enterprise applications and infrastructure technologies. Oracle has enhanced its SaaS offerings, such as Oracle Fusion Cloud ERP, HCM, and EPM, to provide a unified, modular platform with a common data model, enabling seamless interoperability across core business functions. Additionally, Oracle has reinforced the role of Oracle Cloud Infrastructure (OCI) in powering these SaaS applications, leveraging technologies like machine learning and automation to deliver scalable, secure, and high-performance solutions. This evolution reflects Oracle's focus on providing a cohesive, flexible cloud ecosystem that supports hybrid and on-premise deployment models while driving customer migration to the Oracle Cloud.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly capturing Oracle's strategic evolution in positioning Oracle Cloud Services between 2022 and 2024. (1) It accurately reflects the increased emphasis on integration between enterprise applications (e.g., Fusion Cloud ERP, HCM, EPM) and infrastructure (OCI), aligning with the ground truth's focus on a more integrated, holistic platform. While the original answer highlights the Autonomous Database as a key 2022 innovation and the shift to a comprehensive suite by 2024, the LLM response focuses more on SaaS modularity and common data models—details not explicitly contradicted but not directly supported in the ground truth. (2) There are no numeric values, dates, or financial metrics in either answer, so quantitative accuracy is not applicable; however, the years 2022 and 2024 are correctly referenced, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes Oracle's cloud strategy across time and domains (applications and infrastructure), correctly inferring a shift toward integration and cohesion. However, it omits the specific 2022 emphasis on 'flexibility, interoperability, and customer choice' and the 2024 framing of 'choose the best option that meets their specific business needs,' which are key differentiators in the original answer. (4) Despite these omissions, the core evolution—from promoting standalone innovations to an integrated platform—is correctly conveyed in substance, warranting a high correctness score. The answer is slightly less precise in reflecting the exact language and emphasis of the filings but remains semantically aligned in strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 458,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "The Key/Specified Employee Policy was incorporated by reference in the 2023 SEC filing (WFC_10k_2023.pdf) as Exhibit 10(r), dated back to the Company's Annual Report on Form 10-K for the year ended December 31, 2018. In the 2024 SEC filing (WFC_10k_2024.pdf), there is no direct mention or update to the Key/Specified Employee Policy, indicating that it remained unchanged and continued to be incorporated by reference from the same prior filing. Thus, there is no new documentation or revision to the policy between the 2023 and 2024 filings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor discrepancy in the exhibit number. The original answer states that the Key/Specified Employee Policy was incorporated by reference to Exhibit 10(v) from the 2018 10-K, while the LLM answer cites Exhibit 10(r). This is a factual error in entity detail (exhibit designation), though the rest of the information aligns: the policy was introduced in 2023 as incorporated from the 2018 filing and remained unchanged in 2024 with no new documentation. The dates (2018, 2023, 2024) and the core reasoning about incorporation by reference and lack of updates are accurate. The LLM correctly infers that absence of mention in 2024 implies continuation without change, which reflects sound qualitative reasoning. However, the incorrect exhibit number reduces quantitative and qualitative accuracy. The answer fully addresses the question’s focus on evolution, documentation, and incorporation by reference, making it contextually relevant and semantically close to the ground truth despite the exhibit error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 299,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The aggregate principal balance of the 6.700% notes due 2028 remained unchanged at $285 million between 2022 and 2023. This stability suggests that RTX did not refinance or retire these notes during the period, indicating a strategy of maintaining existing long-term debt obligations without immediate restructuring. This approach may reflect a focus on preserving liquidity or optimizing debt maturity profiles for long-term financial stability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the aggregate principal balance remained unchanged at $285 million. According to the ground truth, the balance was $115 million in 2022 and increased to $285 million in 2023 — a significant change, not stability. This misstatement undermines the entire response. (2) Quantitatively, the LLM correctly reports the 2023 balance ($285 million) but completely misses the 2022 figure ($115 million), leading to an incorrect comparison. The claim of 'unchanged' is false; the actual increase of $170 million indicates active debt issuance or expansion. Calculations or comparisons based on stable value are invalid. (3) The reasoning is flawed due to incorrect data. The conclusion that RTX maintained or preserved liquidity by not restructuring contradicts the ground truth, which shows a clear strategic increase in debt. The multi-hop synthesis failed: the model did not correctly identify and compare the two time points across the same financial instrument. (4) Contextual relevance is moderate — the answer addresses the right metric and company and attempts to infer strategy, but the incorrect data leads to a misleading interpretation. While the focus on debt management strategy is appropriate, the conclusion is unsupported. Thus, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher due to proper framing of debt strategy discussion, but based on wrong facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 407,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "The carrying value of TMO's 1.95% 12-Year Senior Notes increased from $773 million in 2023 to $725 million in 2024, while the effective interest rate remained stable at 2.07%.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the carrying value 'increased' from $773 million in 2023 to $725 million in 2024, when in fact it decreased. The direction of change is wrong, which is a critical error. The 2023 carrying value ($773M) is correct, and the 2024 value ($725M) is numerically correct but mischaracterized as an increase. The effective interest rate is reported as 'stable at 2.07%', but in reality, it was 2.08% in 2023 and declined slightly to 2.07% in 2024. The final rate is correct, but the claim of stability ignores the change in 2023. (2) Quantitative accuracy is partially preserved: the dollar amounts and final rate are numerically accurate, but the comparison (increase vs. decrease) and the 2023 rate are missing/incorrect. The calculation of change direction is wrong. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution across years, misrepresenting the trend in both carrying value and effective interest rate. It does not acknowledge the 2023 rate of 2.08%, breaking the comparative logic. (4) Contextual relevance is high—the answer addresses the right company (TMO), instrument (1.95% 12-Year Senior Notes), and time frame (2023–2024)—but the factual inaccuracies severely undermine correctness. Due to major errors in quantitative trends and reasoning, the correctness score is low despite some accurate raw numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 400,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "The corporate governance implication of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings is that the 2024 filing directly includes the Directors' Code of Conduct on its website within the \"Available Information\" section, making it more transparent and accessible to stakeholders. In contrast, the 2022 filing only referenced the Code of Conduct in the \"Code of Ethics\" section without explicitly highlighting its availability. This shift reflects a stronger commitment to corporate transparency and accountability, aligning with best practices in governance by proactively disclosing ethical standards for directors.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its description of how BNY Mellon presented its Directors' Code of Conduct in 2022 and 2024, reversing the actual trend. According to the ground truth, in 2022 the company explicitly provided a direct URL link to the Code and discussed it in the context of ethics and governance, whereas in 2024 it was listed among other governance documents without a direct link or specific mention of updates—indicating reduced visibility. The LLM incorrectly claims that the 2024 filing 'directly includes' the Code with greater transparency and that the 2022 filing only referenced it without highlighting availability, which is the opposite of the truth. This misrepresentation invalidates the conclusion about improved transparency and accountability. There are no numerical values in the question, so quantitative accuracy is not applicable in a meaningful way, but since no numbers were misstated, it scores high by default. The qualitative accuracy is very low due to incorrect entity-state attribution (i.e., what was disclosed when) and flawed reasoning. The contextual relevance is partially met because the answer addresses corporate governance implications, but the analysis is based on a false premise. Thus, the overall correctness score is low due to a complete inversion of facts despite correct formatting and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 378,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon's Short-Term Credit Agreement evolved between 2023 and 2024 in the following ways:\n\n1. **Facility Size**: The facility size remained at $5.0 billion in both years.\n2. **Maturity Date**: In 2023, the Short-Term Credit Agreement matured in October 2024. In 2024, it was extended to October 2025, with the possibility of a 364-day extension if approved by the lenders.\n3. **Timing of Establishment**: The agreement was established in November 2023 and replaced in October 2024 with a new agreement that extended the maturity date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: facility size remained $5.0 billion in both years; maturity date moved from October 2024 (2023 agreement) to October 2025 (2024 agreement); establishment timing shifted from November 2023 to October 2024. (2) Quantitative accuracy is perfect: dollar amounts ($5.0 billion), dates (October 2024, October 2025), and timing (November to October) are all factually correct. (3) The multi-hop reasoning is sound—correctly identifying the renewal pattern across two years, synthesizing facility size, maturity, and establishment timing across agreements. (4) The only minor shortcoming is that the LLM mentions 'the possibility of a 364-day extension if approved by the lenders'—a detail not present in the ground truth and not confirmed by the provided data. While this may be a plausible feature of such credit agreements, it introduces unverified information, slightly reducing qualitative accuracy. Otherwise, the answer is complete, relevant, and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 311,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "From 2022 to 2024, AMD's APU strategy has evolved significantly, particularly in terms of product integration and target markets. In 2022, AMD focused on integrating CPUs and GPUs on a single chip for value and mainstream PCs, with an emphasis on performance and efficiency for notebooks and desktops. By 2024, AMD had advanced its APU strategy by introducing dedicated neural processing units (NPUs) on the same SoC as x86 CPUs, specifically targeting the AI PC segment. The launch of the AMD Ryzen AI 300 Series processors in 2024, featuring the 'Zen 5' architecture and an NPU, marks a strategic shift toward AI integration at the hardware level. This evolution positions AMD to capture growing demand in the AI PC market, enhancing its revenue potential by offering differentiated, high-performance solutions tailored for AI-driven workloads and immersive computing experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AMD's strategic shift from integrated CPU-GPU APUs in 2022 to including dedicated NPUs in 2024, particularly with the Ryzen AI 300 Series and 'Zen 5' architecture, which matches the core evolution described in the original answer. (2) There are no numeric values (e.g., revenue figures, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the answer synthesizes AMD's product integration shift (from general APUs to AI-optimized SoCs) and connects it to a change in target market (from mainstream PCs to AI PCs), correctly inferring the revenue implications. (4) The only minor gap is that the LLM answer does not explicitly mention AMD being 'the first' to integrate an NPU on the same SoC as an x86 CPU, a key differentiator highlighted in the ground truth. However, the implication of differentiation is still conveyed. Wording differs but semantic meaning and factual content are equivalent. All parts of the question—evolution in integration, target markets, and revenue implications—are fully addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 337,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic remained consistent. Dividends are generally subject to a 25% Irish dividend withholding tax unless exemptions apply, such as providing a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. U.S. residents who meet these exemptions and do not hold shares through an Irish branch or agency generally have no Irish income tax liability. Additionally, if withholding tax applies, it typically discharges any Irish income tax liability, provided the shareholder reports the withholding to Irish Revenue authorities. No material changes to this framework were noted in the 2024 filing compared to 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 25% Irish dividend withholding tax rate is accurately stated, and the conditions for exemption (Form 6166, Form V2) are correctly identified. The treatment of U.S. shareholders—no Irish income tax liability if exemptions are met and no Irish branch involvement—is consistent with the original answer. It also correctly notes that the 25% withholding tax discharges any Irish income tax liability if the shareholder reports it to Irish Revenue. (2) Quantitative accuracy is perfect: the 25% rate is correct, and there are no calculations required beyond accurate reporting of percentages and conditions. (3) The multi-hop reasoning is sound—information is synthesized across years (2023 to 2024) and jurisdictions (Ireland and U.S.), and the conclusion of no material change between years reflects accurate comparison. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in tax treatment, and covers all aspects of the question: withholding tax, exemptions, tax liability outcomes, and procedural requirements. Minor wording differences (e.g., 'reports the withholding' vs 'submitted the required statement') do not affect factual equivalence. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 370,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "The risk disclosure around new products and services evolved between 2022 and 2024 to explicitly include the company's transition to a platforms operating model. In 2024, the 10-K specifically notes the risk that \"we may not realize some or all of the expected benefits of our transition to a platforms operating model,\" highlighting the potential operational and strategic uncertainties associated with this initiative. This level of specificity was not present in the 2022 filing, indicating a more detailed acknowledgment of transformational risks tied to new business models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies the evolution in risk disclosure between 2022 and 2024, noting the increased specificity in 2024 regarding the 'transition to a platforms operating model' as a new source of risk. The quote 'we may not realize some or all of the expected benefits of our transition to a platforms operating model' is accurately reflected (minor wording difference: 'we' vs 'the company' is semantically equivalent). All entities—BNY Mellon (implied), the platforms operating model, and the years 2022 and 2024—are correctly identified. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is sound: the LLM correctly infers a shift from general strategic risk language in 2022 to more specific platform-related risk disclosure in 2024. The only minor shortcoming is that the LLM does not explicitly mention that in 2022, the risk applied broadly to 'new lines of business, new products and services, or transformational initiatives'—this context is slightly underdeveloped but not missing entirely. Overall, the answer is semantically equivalent, highly relevant, and demonstrates correct multi-hop reasoning across time periods and strategic initiatives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 360,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "Between 2023 and 2024, Amazon's 3.600% Note due 2032 remained disclosed as part of its long-term debt instruments in both years. In 2023, the note was referenced in the Supplemental Indenture dated April 13, 2022, under the 2023 10-K filing. In 2024, the note was similarly disclosed in the 2024 10-K under the same Supplemental Indenture, indicating no material changes to the terms or structure of the instrument during this period. Amazon continues to follow its policy of not filing full debt instruments when the total amount does not exceed 10% of consolidated assets, offering to furnish copies upon request.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 3.600% Note due 2032 was disclosed in both 2023 and 2024 under the same Supplemental Indenture dated April 13, 2022, and correctly notes no material changes to the terms of the note. This aligns with the ground truth. However, it omits a key factual evolution highlighted in the original answer: the trustee transition from Wells Fargo Bank, National Association (as prior trustee) to only Computershare Trust Company, National Association as successor trustee in 2024. This procedural change in the trustee relationship is a central part of the 'evolution' asked in the question and is entirely missing from the LLM response. (2) Quantitatively, all dates and percentages (3.600%, April 13, 2022) are accurate, and there are no calculation errors. The LLM correctly references the 2023 and 2024 10-K filings. (3) The reasoning is partially sound—while the model correctly infers continuity in the note’s terms and disclosure policy, it fails to perform the necessary multi-hop synthesis to detect the change in trustee structure between the two years, which is a critical procedural evolution. (4) The answer is contextually relevant and well-structured, but the omission of the trustee transition significantly reduces completeness and qualitative accuracy, as this is the primary evolution in the relationship. Thus, while factually accurate in what it reports, it misses a key detail required for full correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 406,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "From 2023 to 2024, MDLZ's treatment and disclosure of net investment hedge (NIH) derivative contracts showed notable changes in financial impact and presentation. In 2024, the fair value of NIH derivative contracts increased significantly, with asset derivatives rising to $305 million (from $163 million in 2023) and liability derivatives decreasing to $50 million (from $382 million in 2023). This shift indicates a more favorable financial position for MDLZ in 2024. Additionally, the presentation in the financial statements became more detailed, with expanded disclosures on the fair value of NIH contracts categorized under Level 2 inputs, reflecting observable market data. The 2024 disclosures also emphasized the impact of NIH contracts on other comprehensive earnings and net earnings, highlighting a more transparent view of their financial effects.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, MDLZ disclosed $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively, for derivative assets and liabilities. However, the LLM claims asset derivatives rose to $305 million in 2024 from $163 million in 2023 and liabilities dropped to $50 million from $382 million—none of which aligns with the original data. These numbers are entirely fabricated or misattributed. (2) There is no mention in the ground truth of Level 2 inputs, expanded fair value disclosures, or changes in presentation detail in 2024 related to categorization. The only stated change is a shift in emphasis from balance sheet valuation (2023) to income statement impact (2024), specifically in 'Other income, net' including amounts excluded from hedge effectiveness. The LLM invents a narrative about transparency and comprehensive earnings impact not present in the source. (3) The multi-hop reasoning is flawed: the model fails to recognize that the evolution is not in the balance sheet amounts per se but in the focus of disclosure—from balance sheet fair values in 2023 to income statement effects in 2024. It incorrectly assumes a quantitative trend between 2023 and 2024 without supporting data. (4) While the LLM attempts to address the question’s theme—evolution in treatment and disclosure—it does so with incorrect data and misdirected analysis, leading to a low correctness score. Contextual relevance is moderate because it discusses disclosure changes and financial impact, but the substance is factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 464,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "From 2023 to 2024, the Abrams Main Battle Tank's modernization strategy has advanced with the development of the M1E3 Abrams, a significant engineering upgrade aimed at enhancing lethality, survivability, and mobility to counter future threats. Technologically, the M1E3 incorporates updated systems architecture for easier and faster technology integration, while reducing sustainment requirements. International demand remains strong, with continued upgrades for non-U.S. partners and a growing installed base across Europe, the Middle East, and Indo-Pacific regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of the Abrams modernization strategy from 2023 to 2024. It correctly identifies the development of the M1E3 Abrams as a major engineering upgrade with improved systems architecture, reduced sustainment, and enhanced capabilities—consistent with the ground truth. It also accurately reflects strong international demand and the growing installed base in Europe, the Middle East, and the Indo-Pacific. However, it omits specific mention of the SEPv3 upgrades (communications, power generation, fuel efficiency, optics, armor) that were a key focus in 2023 according to the original answer. While the M1E3 is correctly highlighted, the transition from SEPv3 in 2023 to broader strategic emphasis in 2024 is slightly under-articulated. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and all entities (M1E3, General Dynamics implied, international regions) are correct. The reasoning is sound and contextually relevant, with only minor completeness gaps in detailing the full 2023 technical roadmap. Semantic equivalence is largely preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 328,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "Between 2022 and 2024, AMD has increasingly emphasized APUs in both mainstream and high-performance computing markets, reflecting a strategic shift toward integrated solutions. In 2022, APUs were primarily highlighted in consumer and commercial notebook and desktop platforms, focusing on performance and efficiency. By 2024, APUs were positioned more prominently in the Data Center and Embedded segments, with tailored solutions for AI, cloud, and semi-custom applications, such as the Steam Deck APU. This evolution underscores AMD's broader strategy to leverage APUs for cross-market versatility and to strengthen its presence in high-growth areas like AI and cloud computing.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a strategic evolution in AMD's positioning of APUs between 2022 and 2024 and notes increased emphasis in high-growth areas like AI and cloud. However, it contains significant inaccuracies in entity and segment mapping. The original answer states that in 2024, APUs were explicitly included in two of AMD's four reportable segments: Data Center and Client. The LLM incorrectly claims APUs were positioned in 'Data Center and Embedded segments', conflating Embedded with Client. The Client segment (not Embedded) is where APUs are tied to desktop and notebook CPUs. Additionally, while the LLM mentions the Steam Deck APU as a semi-custom application, this detail is not present in the ground truth and may misattribute strategic emphasis. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model infers a strategic shift over time and connects APUs to broader market trends. However, it fails to accurately reflect the structural reporting changes in AMD’s segments as defined in the ground truth, which is a key multi-hop element. (4) The contextual relevance is high because the answer addresses the evolution of APUs in market segmentation and strategy. But due to incorrect segment identification and unsupported claims (e.g., APUs in Embedded), the qualitative and overall correctness scores are reduced. Semantic equivalence is partially achieved but not fully due to factual misalignment in segment classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 439,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries remained consistent from 2023 to 2024. In both years, the company noted that the Irish Minister for Finance has the authority to restrict financial transfers between Ireland and third countries under the Act, and that such restrictions are subject to ongoing change. Additionally, transfers involving countries under United Nations or EU sanctions may also be subject to restrictions under Irish law. No substantive changes in the nature or scope of these disclosures were observed between the two periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in describing Medtronic's general disclosure about the Financial Transfers Act 1992, including the Irish Minister for Finance's authority and reference to third-country transfer restrictions. However, it incorrectly states that the disclosures remained 'consistent' and that restrictions were described as 'subject to ongoing change' in both years. According to the ground truth, while the core regulatory framework was still disclosed in 2024, the emphasis on the dynamic nature of the list of restricted countries was removed — a key evolution in disclosure. The LLM fails to identify this shift and instead asserts no substantive changes, which contradicts the ground truth's indication of a potential change in focus or stabilization. This represents a significant qualitative error in reasoning and interpretation, particularly in the multi-hop assessment of how disclosures evolved over time. There are no numerical inaccuracies (hence high quantitative score), and the response is contextually relevant, but the failure to detect and report the nuanced change in disclosure language results in a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 333,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "The G700 aircraft was expected to enter service in early 2024 following FAA certification, as disclosed in the 2023 filing. By 2024, GD confirmed that production had ramped up, and the G700 began deliveries in the second quarter of 2024, indicating successful progress from development to active production and customer delivery.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the G700 was expected to enter service in early 2024 following FAA certification (per 2023 disclosures), and deliveries began in Q2 2024, indicating successful certification and transition to production. (2) No numeric or date discrepancies exist—'second quarter of 2024' matches 'Q2 2024' in the original answer, and no calculations were required. (3) The multi-hop reasoning is sound: the model correctly synthesized information from 2023 (expectation and certification timeline) and 2024 (delivery commencement) disclosures to show progression from development to delivery. (4) The answer fully addresses the evolution of the G700's status and production outlook with precise, relevant details, making it contextually complete and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 252,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "The nature of PMI's relationship with KT&G evolved from 2023 to 2024 through a renewed and extended long-term collaboration agreement announced on January 30, 2023. This agreement grants PMI exclusive, worldwide rights (excluding South Korea) to commercialize KT&G's innovative smoke-free devices and consumables for 15 years, through January 29, 2038. The collaboration includes performance-review cycles every three years, ensuring flexibility for market changes, and provides PMI with access to KT&G's product-innovation pipeline, including offerings for low- and middle-income markets. This arrangement strengthens PMI's strategic dependency on KT&G for expanding its smoke-free product portfolio and enhancing its global commercialization efforts.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts from the ground truth, including the January 30, 2023 announcement date (minor discrepancy: ground truth says 'announced in 2023', LLM specifies 'January 30, 2023'—this is acceptable and potentially more precise), the 15-year term ending January 29, 2038, exclusivity worldwide except South Korea, and access to KT&G's product pipeline including for low- and middle-income markets. All entities (PMI, KT&G), timeframes, and strategic terms are accurate. (2) Quantitatively, all dates and durations are correct: 15-year agreement through January 29, 2038, aligns with a 2023 start. No financial figures are involved, so no calculation errors. (3) However, the LLM answer fails to fully capture the evolution of the relationship from 2023 to 2024 as required by the question. The ground truth emphasizes that by 2024, KT&G's products were integrated into PMI's own heat-not-burn portfolio, indicating a shift from exclusive distribution to strategic product integration. The LLM answer only describes the 2023 agreement and its features, with no mention of how the relationship evolved in 2024—this is a significant omission in the multi-hop reasoning. It treats the relationship as static post-2023, missing the deeper operational integration highlighted in the original answer. (4) Therefore, while the factual content is accurate (hence high quantitative and contextual scores), the qualitative reasoning is incomplete due to missing the 2024 evolution, which is central to the question. Correctness is reduced to 7 because the answer does not fully address the 'evolved from 2023 to 2024' aspect, particularly the shift in strategic dependency and product commercialization integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 477,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "From 2022 to 2024, AMD's approach to semi-custom SoC products has evolved by integrating these solutions more deeply into broader product ecosystems and emphasizing their role in AI and high-performance computing. In 2022, AMD highlighted the importance of semi-custom SoC products being incorporated into customers' products, with revenue tied to the success of those products in the market. By 2024, AMD positioned semi-custom SoC products as part of a broader strategy to deliver adaptive computing solutions across data centers, client computing, and gaming. This includes leveraging semi-custom SoCs as part of a comprehensive portfolio that integrates with AI accelerators, CPUs, GPUs, and software stacks to enable end-to-end solutions for AI, cloud, and edge computing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AMD's semi-custom SoC strategy from 2022 to 2024. It correctly identifies the shift from a model dependent on third-party product success (with revenue tied to customer adoption) to a more integrated, ecosystem-driven approach. The answer reflects key qualitative changes: in 2022, AMD emphasized market-dependent revenue and risks; by 2024, semi-custom SoCs are positioned as part of adaptive computing solutions across data centers, client computing, and gaming, integrated with AI accelerators, CPUs, GPUs, and software stacks. While the LLM answer does not explicitly mention the 'dedicated neural processing unit (NPU)' or 'x86 CPU integration for AI PCs' as in the ground truth, it does correctly highlight the strategic integration with AI and end-to-end solutions, which captures the essence of the evolution. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and synthesizes multi-hop information across years and strategic contexts. The answer is contextually complete and relevant, only slightly less detailed than the ground truth on specific architectural integration (e.g., NPU). Thus, a 9 is justified for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 381,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax on dividends paid to U.S. residents remained largely consistent, with a 25% Irish dividend withholding tax rate applying unless exemptions were met. In both years, U.S. residents holding shares through the Depository Trust Company (DTC) with U.S. addresses were exempt from withholding tax. Additionally, record owners who submitted valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2 were also exempt. No significant changes were noted in the exemption criteria or withholding tax obligations between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 25% Irish withholding tax rate and notes that exemptions exist for U.S. residents, which aligns with the ground truth. However, it introduces specific procedural details not present in the original answer—such as the use of the Depository Trust Company (DTC), Form 6166, and Irish Form V2—which are not mentioned in the ground truth and cannot be verified from the provided information. These additions introduce factual inaccuracies by implying granular consistency in exemption mechanisms between 2023 and 2024, whereas the original answer emphasizes that Medtronic’s 2024 disclosure provided *more structured conditions* and *clarified post-withholding procedures*, indicating evolution in guidance. (2) Quantitatively, the 25% withholding tax rate is correctly stated in both answers, satisfying numerical accuracy. There are no calculations, so numerical precision is not an issue. (3) The multi-hop reasoning is flawed: the question asks how the treatment *evolved* between 2023 and 2024, but the LLM incorrectly concludes there were 'no significant changes,' directly contradicting the ground truth, which highlights increased clarity and procedural refinement in 2024. The LLM fails to capture the progression in Medtronic’s disclosures regarding tax liability discharge via statement submission to Irish Revenue—a key qualitative development. (4) The contextual relevance is moderate because the answer addresses Irish withholding tax and U.S. residents, but it misses the core of the evolution by asserting stability instead of refinement. Correctness is scored low due to the critical omission of the evolving nature of the tax treatment and the introduction of unverified administrative details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 479,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "General Dynamics' Marine Systems segment experienced cost pressures in 2023 from supply chain impacts on the Virginia-class submarine schedule and cost growth on the DDG-51 program, leading to a 110 basis point decline in operating margin to 7.0%. In 2024, the company expects the Marine Systems segment's revenue to increase to approximately $12.8–12.9 billion, with an operating margin of around 7.6%, indicating some margin improvement. The Columbia-class submarine initiative contributed to higher ship construction revenue in 2023, and the company's 2024 outlook suggests continued focus on this program, though specific revenue projections for the Columbia-class were not provided.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the 110 basis point margin decline in 2023 due to supply chain issues on the Virginia-class and cost overruns on DDG-51, the 7.0% operating margin (implied from 110 bps decline leading to 7.0%), the 2024 revenue projection of $12.8–12.9 billion, and the expected margin improvement to 7.6%. It also correctly notes the Columbia-class program's role in driving 2023 revenue and continued strategic focus in 2024. (2) All numeric values match the ground truth: 110 basis points, $12.8–12.9 billion revenue range, and 7.6% margin are all accurate. The implied 7.0% margin in 2023 (from a 110 bps decline to reach ~7.0%) aligns with the original answer’s context. (3) The multi-hop reasoning is sound—linking 2023 cost pressures to margin decline, identifying Columbia-class as a revenue driver, and projecting improvement in 2024 based on revenue and margin outlook. The only minor gap is that the original answer explicitly states the margin decline was from a prior year’s higher level, while the LLM assumes or infers the 7.0% level, which is reasonable but slightly less precise in context. (4) The answer is highly relevant, complete, and factually accurate, with only a slight omission in not explicitly stating that the margin improvement reflects a recovery trend. No incorrect entities or time periods are used. The lack of specific Columbia-class revenue projections is correctly noted as absent in both answers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 410,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Based on the information provided, BKNG's financial dependency on Booking.com, as measured by the proportion of revenue derived from accommodation reservations, remained relatively stable between 2022 and 2023. Specifically, accommodation reservations accounted for approximately 89% of the Company's revenues in both 2023 and 2022, indicating no significant change in reliance on this core service during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. (1) Quantitative accuracy: The percentage (89%) and years (2022 and 2023) are correctly reported, with no calculation or numerical errors. (2) Completeness: The answer addresses the evolution of BKNG's dependency on Booking.com via accommodation revenue proportion, noting stability across both years, which matches the original answer's conclusion. (3) Entity accuracy: 'BKNG', 'Booking.com', '2022', '2023', and 'accommodation reservations' are correctly identified and contextualized. (4) Reasoning: The logic is sound—since the percentage remained unchanged, dependency did not significantly shift, which is consistent with the ground truth. The only minor difference is that the original answer explicitly states dependency 'slightly increased' but then clarifies the percentage 'remained unchanged', which creates a slight contradiction in the ground truth itself. The LLM avoids this by correctly interpreting 89% in both years as 'stable' or 'no significant change', which is more logically consistent. Thus, the LLM answer is actually more precise in reasoning. (5) Semantic equivalence: The meaning conveyed—continued heavy reliance with no material change—is identical. Minor wording differences (e.g., 'remained relatively stable' vs 'remained unchanged') do not affect factual accuracy. Scored 9/10 for correctness due to slight omission of the 'high dependency' qualitative emphasis in the original, though the implication is clear.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 420,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "Between 2023 and 2024, the company's Swiss Franc note, which had a face value of approximately $299 million at the end of 2023, was fully repaid by the end of 2024, with no remaining balance reported. This indicates that the company successfully managed and reduced its foreign currency obligations in Swiss Francs during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $299 million Swiss Franc note obligation at the end of 2023 and its complete removal by the end of 2024, which matches the ground truth. The statement that there was 'no remaining balance reported' accurately reflects the obligation being fully repaid or restructured. (2) Quantitatively, the $299 million figure is correct and properly attributed to 2023, with full repayment confirmed in 2024—no calculation errors or incorrect numbers. Format is consistent and acceptable. (3) The reasoning is sound: the LLM correctly infers that the elimination of the note indicates active management of foreign currency obligations. While the original answer mentions 'repaid or restructured' and the LLM specifies 'fully repaid,' this is a minor interpretive difference; 'repaid' is a plausible subset of 'repaid or restructured' and does not constitute a factual error. (4) The answer is contextually relevant, addressing both the evolution of the obligation and its implication for foreign currency risk management. The only minor shortcoming is slightly less nuance in acknowledging restructuring as a possibility, but the core facts, synthesis, and implications are correctly conveyed. Hence, high scores across all categories with a 9 on correctness due to slight narrowing of interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 375,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "Goldman Sachs introduced new Non-Employee Director RSU Award Agreements in the 2024 10-K filing, including variations such as \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled)\" and specific agreements for \"One-Time/Year-End RSU Award Agreements,\" which were not explicitly detailed in the 2023 filing. These modifications suggest a more nuanced approach to structuring and settling RSU awards for non-employee directors in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in identifying a change in Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements between the 2023 and 2024 10-K filings, but it introduces significant inaccuracies. The ground truth states that in 2023, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, and in 2024, retained that exhibit while adding a new one—Exhibit 10.18 titled 'Amendments to Certain Non-Employee Director Equity Award Agreements'. This indicates an expansion in disclosure to include amendments. However, the LLM incorrectly claims that new forms such as 'Cash-Settled' RSU agreements and 'One-Time/Year-End RSU Award Agreements' were introduced in the 2024 filing, which is not supported by the ground truth. These specific agreement types are not mentioned in the original answer, suggesting fabrication or misattribution. While the LLM captures the general direction of change—increased detail or evolution in RSU treatment in 2024—it fails on the specific nature of the change. The reasoning is flawed because it does not reflect the actual exhibits added or modified, and instead invents new agreement types. The dates (2023 vs 2024) and entity (Goldman Sachs) are correct, and the overall context of evolving RSU agreements is relevant, hence moderate scores in contextual relevance and quantitative accuracy (no numeric errors, but no numbers to verify either). However, due to the invention of unverified agreement types and failure to report the actual amendment disclosure, the qualitative and overall correctness scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 446,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "Between 2023 and 2024, PMI's financial relationship with Swedish Match AB, particularly in terms of long-term debt obligations tied to the acquisition, showed a significant reduction. In 2023, the Euro credit facility borrowings related to the Swedish Match AB acquisition amounted to $6,121 million, but by 2024, this had decreased to $2,610 million. This reduction was primarily due to PMI prepaying approximately €3 billion ($3.2 billion) under the 3-year tranche of the senior unsecured term loan facility on November 21, 2024. As of December 31, 2024, only the €2.5 billion ($2.6 billion) 5-year tranche of the term loan facility remained outstanding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the long-term debt obligations for both 2023 ($6,121 million) and 2024 ($2,610 million), matching the ground truth exactly. The reduction from $6,121M to $2,610M is accurately represented. (2) The additional detail about PMI prepaying approximately €3 billion ($3.2 billion) on November 21, 2024, and the remaining €2.5 billion ($2.6 billion) 5-year tranche is consistent with the debt reduction and adds context not in the original answer but does not contradict it. The dollar amounts and dates are factually aligned with known disclosures. (3) The multi-hop reasoning is sound: the model connects the acquisition-related debt in 2023 to the 2024 reduction, attributes it to a specific prepayment event, and explains the remaining obligation—demonstrating strong synthesis across time and financial instruments. (4) The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer did not include the prepayment date or tranche details, so while the added information is accurate and enhances the response, it slightly exceeds the scope of the ground truth without verification from the provided knowledge graph. However, since no facts are incorrect and all quantitative data match, the answer remains highly accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 370,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "From 2023 to 2024, BMY significantly advanced its strategic positioning around KRAS inhibition through the acquisition of Mirati in January 2024. This acquisition added Krazati, a best-in-class KRAS G12C inhibitor approved for second-line NSCLC and in development for first-line NSCLC in combination with a PD-1 inhibitor, as well as colorectal cancer. Additionally, BMY gained access to Mirati’s pipeline, including MRTX1719, a potential first-in-class PRMT5 inhibitor in Phase I. This move expanded BMY’s oncology portfolio and reinforced its focus on precision therapies targeting key oncogenic drivers like KRAS.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in BMY's strategic positioning around KRAS inhibition from 2023 to 2024. It correctly identifies the acquisition of Mirati in January 2024 (timing aligns with public announcement and closing), which brought Krazati into BMY's portfolio. The answer accurately notes Krazati's FDA approval for second-line NSCLC and its development in first-line NSCLC in combination with a PD-1 inhibitor, as well as its expansion into colorectal cancer—though it omits the specific detail that the colorectal cancer approval was in combination with cetuximab, a minor but relevant omission. The mention of MRTX1719 adds value and reflects accurate knowledge of Mirati’s pipeline, reinforcing BMY’s broader strategic intent. The $4.8 billion acquisition price is not mentioned, which is a quantitative omission, but no incorrect numbers are stated—thus, the absence lowers quantitative accuracy slightly but does not invalidate correctness. The reasoning is sound, synthesizing multi-hop information across time (2023 vs 2024), company status (pre- and post-acquisition), and drug development trajectory. The answer is contextually excellent, directly addressing how BMY’s KRAS strategy evolved. Minor completeness gaps prevent a perfect 10, but overall, the answer is factually strong and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 381,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan between 2023 and 2024 remained largely consistent, with the plan being referenced in both years' 10-K filings as an incorporated exhibit. However, in 2024, the firm introduced a new Clawback Policy effective December 1, 2023, which was disclosed in its 10-K. This policy, while not directly tied to the Restricted Partner Compensation Plan, reflects a broader governance enhancement that could impact compensation structures, including those of restricted partners, by enabling the firm to recover compensation under certain conditions. No specific amendments or new policies directly tied to the Restricted Partner Compensation Plan were disclosed in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continuity of the Restricted Partner Compensation Plan as an exhibit in both years and accurately notes the introduction of the Clawback Policy effective December 1, 2023, in the 2024 filing. This aligns with the ground truth. However, it omits a key detail from the original answer: the change in the exhibit numbering and positioning (from Exhibit 10.3 in 2023 to Exhibit 10.4 in 2024, and its later placement in the exhibit list), which is central to the question about 'positioning' evolution. (2) Quantitatively, the date (December 1, 2023) is accurate and consistent with the knowledge graph. There are no numerical inaccuracies. (3) The reasoning is sound in linking the Clawback Policy to broader governance trends, but it fails to synthesize the multi-hop insight that the reordering of exhibits reflects a strategic repositioning of disclosure priorities—placing clawback and accountability mechanisms ahead of partner compensation. This weakens the qualitative accuracy. (4) Despite the omission, the answer remains contextually relevant and factually grounded, correctly interpreting the significance of the Clawback Policy. The score reflects minor but notable incompleteness in addressing the full scope of 'disclosure and positioning' changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 367,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) significantly advanced its integration and categorization of heat-not-burn (HTU) products. In 2023, HTU shipment volumes increased by 14.7% compared to 2022, reflecting strong growth across all regions. PMI now categorizes HTUs as part of its broader smoke-free product portfolio, which also includes vapor and oral nicotine products. Additionally, the acquisition of Swedish Match in 2022 expanded PMI's smoke-free offerings, with HTUs contributing to a 14.8% increase in adjusted in-market sales in 2023. This evolution highlights PMI's strategic shift toward smoke-free products as a core component of its business.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces information not present in the ground truth. While it correctly identifies the re-categorization of heat-not-burn products under 'smoke-free products' in 2023, it fabricates key quantitative data: the 14.7% HTU shipment volume growth and 14.8% adjusted in-market sales increase are not mentioned in the original answer and cannot be verified from the provided ground truth. These specific percentages are therefore incorrect or unsupported. Additionally, the mention of the Swedish Match acquisition as a driver of integration in 2023 is contextually relevant but not part of the original answer’s focus on product categorization and integration of heat-not-burn products specifically. (2) The ground truth does not include any numerical data about shipment volumes or sales growth, so the inclusion of precise percentages (14.7%, 14.8%) constitutes a factual overreach. No calculations are performed in the original, so these numbers appear to be hallucinated. (3) The reasoning partially captures the multi-hop element by noting the shift in categorization from 2022 to 2023, which is accurate. However, it misses the key detail that in 2023, PMI explicitly included *licensed KT&G heat-not-burn products* in its portfolio—a critical point about business integration and expansion beyond internal products. This omission weakens the qualitative accuracy. (4) The contextual relevance is high because the answer addresses the evolution of product categorization and business integration over time, aligning with the question's intent. However, due to the inclusion of unsupported quantitative claims and the absence of a key factual detail (KT&G licensing), the correctness score is reduced to 5—partially correct but with significant factual gaps and errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 497,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb reinforced its compliance with the SEC Consent Order by enhancing the role of its business risk and disclosure group. This group was formally established as part of the Consent Order measures to ensure transparency and governance. In 2024, the company emphasized a more structured governance process, including escalation protocols for compliance concerns and regular monitoring of adherence to the policy. These steps reflect a continued commitment to aligning internal practices with the Consent Order requirements, particularly in managing sales to direct customers and ensuring timely and accurate disclosures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description of Bristol-Myers Squibb's compliance efforts with the SEC Consent Order and the role of the business risk and disclosure group, but it omits key details present in the ground truth. (1) What was correct: The LLM correctly identifies that the business risk and disclosure group was established in response to the SEC Consent Order and that its role was reinforced in 2024 with structured governance, escalation protocols, and monitoring. The timeline (2023 establishment, continued emphasis in 2024) aligns with the original answer. (2) Quantitative accuracy: There are no numerical values in this question, so this dimension is not applicable; however, the years 2023 and 2024 are used correctly, satisfying temporal accuracy. (3) Multi-hop reasoning assessment: The LLM synthesizes the evolution across two years and links the group’s function to SEC compliance, which is appropriate. However, it misses specific actions mentioned in the ground truth—namely, the implementation of a formal review and certification process for SEC filings, the retention of an outside consultant to re-engineer accounting processes, and the integration of the group into the ongoing compliance framework as a permanent component. These omissions reduce completeness and weaken the qualitative accuracy. (4) The answer remains contextually relevant and conveys a plausible narrative, but the lack of specificity about the group’s structural integration and supporting mechanisms results in a score of 7 for correctness and qualitative accuracy. The answer does not contain errors per se, but it is less comprehensive than required for full factual equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 463,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "Between 2023 and 2024, UNP maintained a consistent expected long-term rate of return of 5.25% for its pension plan, despite changes in the asset allocation mix. In both years, the target allocation remained at 20% to 30% for equity securities and 70% to 80% for debt securities. However, the actual asset allocation percentages for 2024 (24% equity and 75% debt) aligned with the 2023 percentages, indicating no significant shift in the mix. The expected return remained tied to the diversified portfolio strategy and historical returns, with no adjustment to the rate despite a notable increase in the discount rate from 5.00% in 2023 to 5.61% in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer focuses on a qualitative shift in UNP's disclosure language regarding how the expected return on pension assets is determined—specifically, a move from citing multiple factors (asset allocation, historical returns, market conditions) in 2023 to only mentioning dependence on asset allocation in 2024, along with the disclosure of a 6% actual return in 2023 and no such disclosure in 2024. The LLM answer instead introduces a consistent expected return of 5.25%, which is not mentioned in the ground truth, and discusses target and actual asset allocations (e.g., 24% equity, 75% debt), which are not present in the original answer. These numbers are unsupported by the provided truth. (2) The quantitative inaccuracies include the fabricated expected return rate (5.25%), specific allocation percentages, and the claim about discount rate increasing from 5.00% to 5.61%, none of which appear in the ground truth. There are no verifiable calculations in the LLM response that align with the original. (3) The multi-hop reasoning is flawed: the question asks about the evolution in *treatment* or *disclosure rationale* of the expected return in relation to asset allocation, not about numerical stability of returns or allocations. The LLM misinterprets the nature of the evolution, focusing on quantitative consistency rather than qualitative disclosure changes. It fails to recognize the shift in narrative emphasis from a multifactor explanation to a narrower one. (4) The contextual relevance is moderate because the answer stays within the domain of pension plan disclosures and asset allocation, but it misses the core point about disclosure language evolution. Due to major factual errors and misalignment with the ground truth, the correctness score is low at 2, with similarly low scores for quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 525,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon enhanced the accessibility and integration of its Directors' Code of Conduct by explicitly posting it on its website at https://www.bnymellon.com, as noted in the 2023 filing. In the 2022 filing, while the existence of the Directors' Code of Conduct was mentioned, the direct web link for public access was not provided, indicating an improvement in transparency and ease of access in 2023. Additionally, the 2023 filing emphasized the integration of the Directors' Code of Conduct within broader corporate governance reporting by listing it among other governance materials available on the website, such as committee charters and corporate governance guidelines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies the evolution in BNY Mellon's disclosure approach between 2022 and 2023: in 2022, the Directors' Code of Conduct was mentioned but not directly linked, while in 2023 it was explicitly listed among governance materials available online, improving accessibility and integration. The answer correctly captures the enhanced transparency and structured presentation in 2023, including the co-location of the Code with other key governance documents like committee charters and Corporate Governance Guidelines. The mention of the website URL (https://www.bnymellon.com) is a minor addition not in the original but is plausible and does not detract from accuracy. There is no quantitative data in the question or answer requiring numerical verification, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis across the two years’ disclosures. The only reason for not scoring a perfect 10 in qualitative accuracy is that the LLM slightly overemphasizes the 'explicit posting' and URL inclusion, which was not explicitly stated in the ground truth—though the direction of the claim (improved accessibility) is correct. Contextual relevance is excellent, addressing both accessibility and integration within governance reporting as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 389,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with engineered systems, reflecting a stronger focus on cloud migration and hybrid IT environments. The Database is now offered across Oracle Cloud Infrastructure (OCI), on-premise through Oracle Exadata Cloud@Customer, and hybrid models like OCI Dedicated Region, enabling customers to deploy workloads seamlessly across environments. This evolution underscores Oracle's commitment to supporting hybrid and multicloud strategies, allowing customers to leverage the benefits of cloud scalability and automation while maintaining control over sensitive or regulated data.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of deployment models and correctly identifies Oracle's strategic focus on hybrid and multicloud environments, including offerings like Oracle Exadata Cloud@Customer and OCI Dedicated Region. There are no numeric inaccuracies (quantitative accuracy is perfect), and the context of cloud migration and hybrid IT is well addressed. However, the LLM omits a key evolution highlighted in the ground truth: the shift toward deeper integration with Oracle Engineered Systems—specifically Oracle Exadata Database Machine—as a unified, optimized platform across deployment models in 2024. While the LLM mentions deployment flexibility, it does not capture the strategic pivot from flexible standalone deployment (2023) to tightly integrated, performance-optimized engineered systems (2024). This missing synthesis weakens the qualitative accuracy, as the answer fails to fully convey the maturation of Oracle’s strategy toward holistic infrastructure solutions. The reasoning is sound but incomplete, missing a critical multi-hop connection between deployment flexibility and engineered system integration. Contextual relevance remains high as the answer aligns well with the question’s intent, albeit with a partial explanation of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 359,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb (BMY) enhanced its formal review and certification process for annual and quarterly SEC reports by reinforcing governance procedures and compliance monitoring. Key developments include the establishment of a business risk and disclosure group, continued use of external consultants to evaluate and improve financial reporting processes, and a stronger emphasis on bottom-up input in the budgeting process with thorough documentation. These measures reflect a commitment to transparency and adherence to the terms of the SEC Consent Order, ensuring that sales practices and financial disclosures align with regulatory expectations.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low because the LLM introduces entities and details not present in the ground truth: it names 'Bristol-Myers Squibb (BMY)' and mentions a 'business risk and disclosure group', 'external consultants', and 'bottom-up input in the budgeting process', none of which are mentioned or implied in the original answer. The original answer refers to a generic company under a Consent agreement without naming it, and focuses on the evolution from initial implementation in 2023 (establishing governance and compliance monitoring) to integration into sales policies and sustained enforcement in 2024. The LLM answer incorrectly shifts focus to budgeting and external consultants rather than the integration of the certification process into company-wide sales policies and inventory controls. While the general theme of enhanced governance and compliance monitoring aligns with the question, the specific evolution described in the LLM response does not match the ground truth. The reasoning is partially sound in recognizing a progression in process maturity, but fails to accurately synthesize the correct multi-hop details (from establishment to integration into operational frameworks). Contextual relevance is moderate because the topic is related, but key factual misalignments reduce usefulness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 405,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) has increasingly positioned heat-not-burn (HTU) products as a core component of its smoke-free product strategy. In 2023, HTU shipment volumes grew by 14.7%, reflecting strong market adoption, particularly in Europe and Japan. PMI categorizes HTUs as \"reduced-risk products\" (RRPs), emphasizing their potential to present less risk to smokers compared to combustible tobacco. The company also expanded its HTU portfolio, including licensed KT&G products and zero-tobacco heat-not-burn options like LEVIA, to diversify its offerings and strengthen its market positioning in key regions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces unsupported quantitative data. The 14.7% HTU shipment volume growth in 2023 is not present in the original answer and cannot be verified from the provided ground truth, making it factually incorrect. Additionally, the mention of 'LEVIA' as a zero-tobacco heat-not-burn product and specific regional adoption in Europe and Japan are not mentioned in the original, introducing unverified details. (2) The quantitative accuracy is low because the 14.7% figure is fabricated or at least unsupported by the ground truth; no numerical data was provided in the original answer regarding shipment volumes or growth rates. This is a critical error in a financial/metrics context. (3) Qualitatively, the LLM captures part of the evolution: positioning heat-not-burn products within reduced-risk or smoke-free categories aligns with the original. The mention of licensed KT&G products matches the original and reflects an accurate multi-hop insight about expanded partnerships. However, the original emphasizes a shift in categorization—from RRPs as a broad category in 2022 to inclusion in the 'smoke-free product segment' alongside e-vapor and oral nicotine in 2023—which the LLM only partially reflects by mentioning RRPs without clarifying the structural reclassification. (4) Contextual relevance is high because the response directly addresses the evolution in market positioning and product categorization over the two years, uses correct entities (Philip Morris International, KT&G, heat-not-burn), and maintains focus on strategic shifts. Despite incorrect numbers, the overall direction of the answer is aligned with the question. However, the inclusion of unverified metrics significantly undermines factual correctness, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 495,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with other Oracle technologies. The company has expanded deployment options, enabling Oracle Database to be used across Oracle Cloud, on-premise environments, Oracle Exadata Cloud@Customer, OCI Dedicated Region, and other public cloud platforms. Additionally, Oracle has strengthened integration with its Oracle Cloud Infrastructure (OCI), Oracle Autonomous Database, and other Oracle Cloud services like Java Cloud and APEX, creating a cohesive ecosystem for developers and enterprises to build and deploy cloud-native applications efficiently.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of deployment options and integration with Oracle technologies, and correctly identifies Oracle's strategic emphasis on flexibility and ecosystem integration. It accurately references Oracle Cloud (OCI), Exadata Cloud@Customer, Dedicated Region, and integration with Autonomous Database, Java Cloud, and APEX—technologies consistent with Oracle's 2024 positioning. There are no numeric inaccuracies (quantitative accuracy is perfect), and the context is highly relevant to the question about deployment flexibility and integration evolution.\n\nHowever, the LLM answer misses a key nuance present in the ground truth: the strategic shift from emphasizing *customer choice via deployment flexibility and perpetual licensing* in 2023 to positioning Oracle Database as a *foundational component of engineered systems like Oracle Exadata* in 2024. While Exadata is implied through 'Exadata Cloud@Customer', the deeper integration into engineered systems—combining database, storage, OS, and hardware—is not explicitly highlighted as an evolution in strategic positioning. Instead, the LLM focuses on cloud service integration (e.g., Java Cloud, APEX), which, while valid, shifts emphasis away from the core strategic pivot toward engineered systems.\n\nThus, while the answer is factually sound and contextually relevant, it lacks completeness in capturing the full strategic evolution—particularly the move from standalone deployment flexibility to being a core element of integrated hardware-software systems. This omission affects qualitative accuracy and lowers the correctness score to 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 445,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "BMY's strategic relationship with Krazati evolved significantly in 2024 through the acquisition of Mirati, a commercial-stage targeted oncology company, which provided BMY with the rights to commercialize Krazati, a KRAS inhibitor approved for second-line NSCLC and in development for first-line NSCLC in combination with a PD-1 inhibitor. The financial commitment in 2024 included a total consideration of $4.8 billion for the acquisition, with $4.1 billion net of cash acquired, and an additional contingent value right (CVR) potentially worth up to $1.0 billion, subject to future regulatory milestones.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY acquired Mirati in 2024 for $4.8 billion, gaining rights to Krazati, which is a KRAS inhibitor approved for second-line NSCLC and in development for first-line; the $1.0 billion contingent value right (CVR) tied to regulatory milestones is accurately reported. (2) Quantitative accuracy is perfect: $4.8 billion total consideration and $1.0 billion CVR match the original answer exactly; the additional detail of $4.1 billion net of cash acquired is a precise elaboration not contradicting the ground truth. (3) Multi-hop reasoning is sound—correctly linking BMY’s 2023 strategic interest in Krazati as part of its oncology portfolio to the 2024 acquisition of Mirati as the mechanism of deepening that relationship. (4) The only minor omission is that the original answer notes FDA and EMA approvals specifically, while the LLM mentions approval without specifying both agencies—this is a small contextual gap but does not affect core accuracy. Also, the PRMT5 inhibitor is mentioned in the original as the target of the CVR, while the LLM generalizes it to 'future regulatory milestones'—slightly less specific but still factually consistent. Overall, the answer is semantically equivalent with excellent completeness and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 372,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "The 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV, listed under trading symbol BK/P, remained registered and fully and unconditionally guaranteed by The Bank of New York Mellon Corporation in both the 2022 and 2023 SEC filings. There is no indication of a change in the status or treatment of these securities between the two years, as they are consistently referenced in the list of securities registered under Section 12(b) of the Exchange Act.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: the securities' name, 6.244% rate, trading symbol BK/P, listing on NYSE, registration under Section 12(b) of the Exchange Act, and the full and unconditional guarantee by The Bank of New York Mellon Corporation are correctly stated for both 2022 and 2023. (2) There are no numeric or date inaccuracies—percentages and years match the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of SEC filings to conclude that there was no change in status or treatment, which is the core of the question. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of the securities’ status. Minor wording differences (e.g., 'Exchange Act' vs 'the Act') do not affect factual accuracy. All aspects of completeness, entity accuracy, and reasoning are satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 281,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "From 2022 to 2023, PMI's short-term credit arrangements increased from approximately $2.3 billion to $2.7 billion, while borrowings under these arrangements slightly increased from $225 million to $283 million. This suggests that PMI expanded its liquidity buffer in 2023, likely to support working capital needs and maintain flexibility, indicating a proactive near-term liquidity posture.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, PMI's short-term credit capacity was $1.9 billion in 2022, but the LLM states $2.3 billion—a material overstatement of $400 million. Additionally, the ground truth shows utilization decreased from $295 million to $283 million, whereas the LLM incorrectly claims utilization increased from $225 million to $283 million. These errors affect both the starting utilization figure and the direction of change (decrease vs. increase). (2) Number verification: Capacity in 2022—incorrect ($2.3B vs. $1.9B); Capacity in 2023—correct ($2.7B); Utilization in 2022—incorrect ($225M vs. $295M); Utilization in 2023—correct ($283M). Calculations of change in capacity and utilization are therefore flawed. (3) Multi-hop reasoning: The model correctly identifies the need to compare capacity and utilization across years and draws a conclusion about liquidity posture, which shows sound qualitative intent. However, due to incorrect data inputs, the reasoning is based on flawed premises. The conclusion about a 'proactive' liquidity posture contrasts with the ground truth's 'more conservative approach,' which is supported by increased capacity and *decreased* utilization. The LLM’s conclusion is partially justified by the capacity increase but undermined by the incorrect utilization trend. (4) Scores justified: Correctness scored 5 due to partial accuracy (2023 figures correct, 2022 figures wrong), leading to mixed validity. Quantitative accuracy is low (4) due to major errors in key financial figures. Qualitative accuracy is moderate (6) because the framework of analysis is reasonable, but entity and data precision fail. Contextual relevance is high (8) as the answer addresses all aspects of the question and provides a logical interpretation, despite factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 508,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "Between 2023 and 2024, Oracle has enhanced the positioning of its Autonomous Database by expanding its integration with other Oracle Cloud services and strengthening its automation capabilities. In 2024, Oracle emphasized deeper integration with services like Java Cloud and Oracle APEX, enabling developers to build modern, cloud-native applications. Additionally, the Autonomous Database now supports generative AI and machine learning for advanced analytics and real-time transaction processing, further automating database operations and improving scalability and security. These enhancements reflect Oracle's focus on delivering a more cohesive, intelligent, and developer-friendly cloud ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Oracle's Autonomous Database positioning from 2023 to 2024. It accurately captures the enhanced integration with Oracle Cloud services such as Java Cloud and Oracle APEX, and correctly emphasizes modern cloud-native application development, which is consistent with the 2024 focus. The mention of machine learning for automation, analytics, and real-time processing reflects the ground truth's emphasis on ML-powered diagnostics, fault prediction, and automatic threat detection. However, the LLM answer introduces 'generative AI'—a detail not present in the original 2024 filing—potentially overstating the capabilities described in the source material. While machine learning is correctly highlighted, generative AI is a more specific and advanced subset not explicitly mentioned in the ground truth, constituting a minor factual overreach. All dates (2023–2024) and entities (Oracle, Autonomous Database, Java Cloud, APEX) are accurate. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is sound and synthesizes the multi-hop elements (evolution over time, integration, automation), though slightly less precise due to the generative AI addition. The response is highly relevant and addresses both integration and automation aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 389,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "Between 2023 and 2024, GM's financial relationship with Ultium Cells Holdings LLC remained consistent in terms of capital involvement, with GM committing $0.8 billion in 2024 and $1.4 billion in 2023 to the entity. However, the strategic positioning of GM with Ultium Cells Holdings LLC remained unchanged, as GM did not have the power to direct the activities of the entity that most significantly affect its economic performance in both years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, in 2023 GM had a contingent commitment of $0.8 billion to Ultium Cells Holdings LLC, and in 2024 made a direct investment of $0.7 billion. The LLM incorrectly states that GM committed $1.4 billion in 2023 and $0.8 billion in 2024—both numbers are factually wrong and contradict the ground truth. (2) The quantitative inaccuracies are severe: the 2023 figure is double the correct amount ($1.4B vs $0.8B), and the 2024 figure is misrepresented as a new commitment rather than a realized investment, with the wrong amount ($0.8B vs $0.7B). Additionally, the LLM fails to note the shift from contingent commitment to actual investment, which is central to the evolution of the relationship. (3) The reasoning is flawed: the ground truth describes a strategic shift—from a variable interest entity (VIE) with no voting control to a more direct investment implying greater influence. The LLM incorrectly claims that strategic positioning 'remained unchanged' and that GM lacked control in both years, missing the key evolution in GM's influence. This shows a failure in multi-hop reasoning: the model did not synthesize the change in capital structure with the change in control and strategic positioning. (4) The contextual relevance is moderate because the answer addresses the right entities (GM, Ultium Cells Holdings LLC) and the time frame (2023–2024), and touches on capital involvement and strategic positioning, but the factual and logical errors severely undermine correctness. Hence, low scores for correctness, quantitative, and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 460,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "Between 2022 and 2024, the financial impact of the Litigation Management Deed evolved as follows: \n\n- In 2022, during the sixth anniversary release, $3.5 billion of as-converted value was released from the series B and C preferred stock, and 176,655 shares of series A preferred stock were issued. \n- In 2024, during the eighth anniversary release, $2.7 billion of as-converted value was released, and 99,264 shares of series A preferred stock were issued. \n\nThis indicates a decrease in the as-converted value released and a reduction in the number of series A preferred shares issued in 2024 compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: $3.5 billion and 176,655 shares in 2022, and $2.7 billion and 99,264 shares in 2024. These match the ground truth exactly in value, share count, and year. The conclusion about decreasing financial impact is also consistent. (2) Quantitative accuracy is perfect—dollar amounts and share counts are correct, and the comparison (decrease from 2022 to 2024) is accurate. (3) The only minor issue is that the LLM mentions 'series B and C preferred stock' in the context of as-converted value release, which is not mentioned in the ground truth. While this detail may be contextually plausible, it introduces an entity not present in the original answer and is not supported by the provided knowledge graph, slightly weakening the qualitative accuracy. However, it does not contradict the core facts. (4) The answer is highly relevant, directly addressing the evolution of financial impact, amounts released, and shares issued. The reasoning is sound and synthesizes multi-hop information correctly across two time points. The minor addition about series B and C does not detract significantly from overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 333,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "Between 2023 and 2024, the financial and strategic relationship between 3M and the Aearo Entities evolved significantly due to litigation impacts and business segment adjustments. In 2022, 3M deconsolidated the Aearo Entities due to their voluntary Chapter 11 bankruptcy, which was intended to address litigation related to respirator mask/asbestos and Combat Arms Earplugs matters. However, the bankruptcy was dismissed in June 2023, leading to the reconsolidation of Aearo Entities in Q2 2023. This reconsolidation shifted litigation costs related to the Aearo Entities from Corporate and Unallocated to the Safety and Industrial business segment. In 2023, 3M recorded a $4.2 billion pre-tax charge for the Combat Arms Earplugs Settlement (CAE Settlement), which was structured to resolve claims through $6.0 billion in payments through 2029. By 2024, the litigation impact had decreased, with corporate special item net costs declining year-over-year, reflecting reduced litigation burdens and the ongoing implementation of the CAE Settlement.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. (1) The original answer states that the reconsolidation of Aearo Entities had an immaterial income statement impact, but the LLM claims a $4.2 billion pre-tax charge was recorded in 2023—this figure is not supported by the ground truth and introduces a major quantitative error. The CAE Settlement amount of $6.0 billion through 2029 also does not appear in the original answer, making it an unsupported addition. (2) The LLM incorrectly states that litigation costs were shifted from Corporate and Unallocated to the Safety and Industrial segment; this detail is absent from the ground truth and contradicts the stated immaterial impact. (3) The original answer emphasizes that in 2024, the Aearo Entities were referenced in the context of divestiture/acquisition effects in the Transportation and Electronics segment due to prior deconsolidation and reconsolidation—a key strategic financial treatment point missing from the LLM response. Instead, the LLM focuses on declining litigation costs in 2024 without citing the actual segment-level reporting context. (4) The LLM correctly identifies the timeline: deconsolidation in 2022 due to bankruptcy and reconsolidation in 2023 after dismissal, which aligns with the multi-hop reasoning requirement. However, it fabricates specific financial figures and misattributes segment impacts, undermining both quantitative and qualitative accuracy. While the general evolution from litigation to strategic treatment is partially captured, the lack of correct details and introduction of unsupported numbers reduces correctness. Contextual relevance is high as the response addresses litigation and business segment adjustments as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 479,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "Between 2022 and 2024, the financial treatment of Class C Common Stock evolved with a significant increase in its earnings per share (EPS) performance. In 2022, Class C Common Stock had a basic EPS of $28.03, which rose to $38.97 in 2024. This increase reflects a stronger financial performance relative to other stock classes, such as Class A and Class B-1 Common Stock, which had lower EPS figures in the same period. Additionally, the structure of Class C Common Stock remained tied to the conversion and voting rights tied to developments in litigation, but its earnings performance outpaced other classes due to fewer shares outstanding and higher income allocation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the numerical values for earnings per share (EPS). According to the ground truth, in 2024, Class C Common Stock had a basic EPS of $33.17 and diluted EPS of $33.13, not $38.97 as stated by the LLM. Additionally, the LLM claims a 2022 basic EPS of $28.03 for Class C, but the original answer does not provide a specific EPS figure for Class C in 2022—only a qualitative description of its governance role. Thus, both the 2022 and 2024 EPS figures provided by the LLM are incorrect. The comparison to Class A is accurate in direction (Class C outperforming Class A in EPS), but the LLM does not cite the correct Class A EPS figures ($8.29 basic, $8.28 diluted in 2024). (2) The LLM introduces Class B-1 Common Stock, which is not mentioned in the original answer, introducing an unsupported entity. There is also no mention in the ground truth of litigation-related conversion or voting rights developments affecting Class C’s structure between 2022 and 2024—this appears to be fabricated or misattributed. (3) While the LLM correctly identifies the trend of improved financial performance for Class C relative to other classes, it fails to accurately represent the multi-hop synthesis from the knowledge graph: the evolution is not in governance structure (which remained unchanged) but in financial performance metrics becoming more prominent. The reasoning about 'fewer shares outstanding and higher income allocation' is speculative and not supported in the original answer. (4) The contextual relevance is moderate because the response addresses the core theme—evolution in financial treatment and EPS performance—but the quantitative inaccuracies and introduction of unsupported details severely undermine correctness. The qualitative reasoning is partially sound but based on incorrect data, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 521,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "Qualcomm's involvement in ADAS/AD technology has grown significantly from fiscal 2022 to fiscal 2024, as reflected in both strategic activities and revenue categorization. In fiscal 2022, ADAS/AD was part of the broader automotive revenue category under QCT, which totaled $1,509 million. By fiscal 2024, automotive revenue had increased to $2,910 million, explicitly including ADAS/AD, indicating stronger market adoption and product integration. Additionally, Qualcomm's acquisition of Veoneer's Arriver business in fiscal 2022 marked a strategic shift toward direct development of AD capabilities, which has likely contributed to this growth. The revenue increase and strategic investments demonstrate Qualcomm's expanded role in the ADAS/AD ecosystem.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that in fiscal 2022, ADAS/AD was part of strategic investment and development efforts, not explicitly broken out as a revenue line, and certainly not reported as $1,509 million under QCT automotive. The LLM incorrectly asserts specific revenue figures for fiscal 2022 and 2024 ($1,509M and $2,910M) that are not present in the ground truth and cannot be verified from the provided context. These numbers appear fabricated or misattributed. (2) The claim about the acquisition of Veoneer's Arriver business in fiscal 2022 is factually correct and aligns with Qualcomm's strategic moves, which supports qualitative accuracy to some extent. However, the answer incorrectly implies that this acquisition and revenue growth are explicitly tied to QCT and reported automotive revenues in 2022, whereas the ground truth emphasizes a shift from development (2022) to commercialization (2024) without citing exact revenue splits. (3) The multi-hop reasoning is partially sound—connecting acquisition activity to later commercialization and revenue growth is logical—but it fails to accurately reflect the evolution described in the ground truth, which hinges on categorization changes (from R&D to revenue-generating product line), not quantitative growth. The LLM invents precise revenue figures that are not in the original answer, undermining correctness. (4) While the LLM captures the general direction of evolution (increased involvement, strategic acquisition, growing importance), it misrepresents the evidence used to support this evolution. The ground truth relies on changes in revenue categorization as proof of commercialization, whereas the LLM substitutes this with unsupported numerical claims. Thus, despite relevant context and some correct strategic insights, the answer is significantly compromised by incorrect data, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 545,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's U.S. Retrospective Responsibility Plan evolved by expanding the mechanisms for addressing liability in covered litigation, particularly through amendments to the loss sharing agreement and omnibus agreement. These amendments extended the scope of U.S. covered litigation to include actions by opt-outs from the Rule 23(b)(3) Settlement Class in MDL 1720 and ensured that settlements or judgments are allocated according to the 66.6667% Visa portion under the omnibus agreement. This evolution suggests a more structured and comprehensive approach to managing litigation risk, as Visa is proactively refining its contractual and financial safeguards to distribute potential liabilities among stakeholders and mitigate the impact of litigation on its financial results.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct and captures the core evolution of Visa's U.S. Retrospective Responsibility Plan with accurate qualitative details about the expansion of mechanisms and the intent to manage litigation risk more comprehensively. The quantitative accuracy is high: the 66.6667% Visa portion is correctly cited, and the reference to MDL 1720 opt-outs aligns with the ground truth. However, the LLM answer omits key components of the 2024 plan mentioned in the original answer, such as the U.S. litigation escrow agreement, conversion feature for Class B common stock, makewhole agreements, indemnification obligations from Visa U.S.A. members, interchange judgment sharing agreement, and the omnibus agreement (beyond just amendments). While it mentions amendments to the loss sharing and omnibus agreements, it fails to convey the full suite of new, interrelated mechanisms that signify the plan’s structural transformation. This omission reduces completeness and weakens the qualitative accuracy, as the multi-hop synthesis across all components is incomplete. The reasoning is sound but not comprehensive—correctly inferring a more structured and proactive approach, but based on a subset of the full evidence. The answer remains contextually relevant and correctly interprets the strategic implication of risk distribution. Minor wording differences are acceptable under semantic equivalence, but the missing elements prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 401,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck's financial stake in Lynparza, as part of its collaboration with AstraZeneca, showed growth between 2023 and 2024, with alliance revenue increasing by 9% in 2024. This growth was driven by higher demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for a new indication, further enhancing its strategic importance and market reach. These developments indicate a positive evolution in both the product's performance and its strategic value to Merck.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% growth in alliance revenue in 2024 and the January 2025 China approval for Lynparza, both of which are factually accurate per the ground truth. It accurately reflects the performance improvement and strategic enhancement. However, it omits the specific $1.5 billion net intangible asset reported by Merck in 2023, which is a key part of the financial stake evolution. While the growth is correctly noted, the absence of the initial asset value reduces completeness. (2) All numbers and dates are correct: 9% revenue growth in 2024 and January 2025 China approval are accurately reported. No calculations were required, but the use of percentage and date is precise. (3) The multi-hop reasoning is sound—linking revenue growth to international demand and the China approval to strategic importance shows proper synthesis across time and entities (Merck, AstraZeneca, Lynparza, regulatory and financial data). The only gap is the missing 2023 asset value, which weakens the full financial evolution narrative. (4) The answer is highly relevant, directly addressing both financial stake evolution and performance/strategic indicators. The omission of the $1.5 billion figure prevents a perfect score, but all other elements are accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 366,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "Between 2022 and 2024, Skoal's market position within Altria's oral tobacco products segment declined, as its shipment volume decreased from 163.1 million units in 2023 to 147 million units in 2024, and its retail share dropped from 9.3% to 7.6%. This decline was partially offset by growth in the on! brand, which saw increased shipment volume and a rise in retail share from 6.8% to 8.3%. Overall, the oral tobacco products segment's total retail share decreased from 42.5% in 2023 to 37.5% in 2024, reflecting broader industry challenges and competition within the segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Skoal's retail share decline from 9.3% in 2022 to 7.6% in 2024, aligning with the ground truth. It also accurately states the overall segment retail share drop from 42.5% in 2023 to 37.5% in 2024 and on!'s increase from 6.8% to 8.3%. The shipment volume figures (163.1 million in 2023 to 147 million in 2024) are factually consistent with external data, though not included in the original answer; they do not contradict it and add relevant context. (2) All numeric values cited in the LLM answer that overlap with the ground truth are accurate. The timeline is correctly represented across 2022–2024, with appropriate year-to-year comparisons. No calculation errors are present. (3) The reasoning is sound: the LLM correctly infers that Skoal’s market position weakened and contextualizes this within broader segment trends. It appropriately highlights on!’s growth as a partial offset, which aligns with the ground truth’s emphasis on shifting dynamics within Altria’s portfolio. However, it omits explicit comparison to Copenhagen’s performance (from 23.5% to 19.1%), which was a key part of the original answer and relevant to assessing Skoal’s relative competitive performance. This is a minor omission in multi-hop synthesis but does not invalidate the overall conclusion. (4) The answer is highly relevant, directly addressing Skoal’s evolving market position and competitive dynamics. The inclusion of shipment data enhances the response, even if not in the original. The omission of Copenhagen’s trajectory slightly reduces completeness but does not impair the core factual accuracy. Hence, a score of 9 is justified—excellent accuracy with minor qualitative gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 469,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "The revenue contribution from Dynamics 365 within Microsoft Cloud increased from fiscal year 2022 to 2023. In fiscal year 2022, Dynamics products and cloud services revenue grew by 25%, driven by Dynamics 365 growth of 39%. In fiscal year 2023, Dynamics products and cloud services revenue reached $5,437 million, showing continued growth compared to $4,687 million in fiscal year 2022. This indicates a positive evolution in the revenue contribution from Dynamics 365 over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Dynamics 365 grew 39% in fiscal year 2022 and contributed to the 25% growth in Dynamics products and cloud services, it fabricates specific revenue figures for Dynamics 365: $5,437 million in FY2023 and $4,687 million in FY2022. These exact numbers are not present in the ground truth and cannot be derived from the provided information. The original answer only states that Dynamics 365 is part of the broader Microsoft Cloud revenue ($91.2B in FY2022 and $111.6B in FY2023), with no breakdown of Dynamics 365's standalone revenue. (2) The calculation of growth from $4,687M to $5,437M implies a ~16% increase, which is not supported by the source material. There is no explicit growth rate given for Dynamics 365 in FY2023 in the ground truth, so asserting continued growth with specific dollar amounts is incorrect. (3) The reasoning is partially sound in recognizing the need to compare across fiscal years and link Dynamics 365 to Microsoft Cloud, but it fails the multi-hop synthesis by inventing precise revenue figures not present in the source. The model incorrectly assumes that Dynamics product revenue can be isolated to Dynamics 365 with exact dollar values. (4) The contextual relevance is fair because the answer addresses the evolution of revenue contribution and references correct growth percentages for FY2022, but the inclusion of fabricated numbers severely undermines factual correctness. Hence, low scores for quantitative and overall correctness, moderate for qualitative reasoning, and acceptable relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 447,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program from 2023 to 2024 shows increased use of hedging instruments and expanded scope. In 2024, the fair value of foreign exchange contracts designated as hedging instruments rose to $406 million (asset) and $2 million (liability), compared to $189 million (asset) and $77 million (liability) in 2023. Additionally, the notional amounts of these contracts increased to $12,465 million in 2024 from $12,754 million in 2023, indicating a broader scope of hedging activities. The cumulative fair value hedging adjustments also decreased from $56 million in 2023 to $17 million in 2024, suggesting a shift in the timing or effectiveness of hedging strategies.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to accurately reflect the evolution of Merck's foreign exchange risk management approach from 2023 to 2024 as described in the ground truth. (1) The provided numbers—such as the fair value of contracts ($406M asset and $2M liability in 2024 vs $189M and $77M in 2023), notional amounts ($12,465M vs $12,754M), and cumulative hedging adjustments ($56M to $17M)—are not present in the original answer and appear to be fabricated or misattributed. There is no mention of designated hedging instruments or quantitative metrics in the ground truth, which undermines all numerical claims. (2) The original answer emphasizes a qualitative shift in strategy: from using only forward contracts in 2023 (undesignated, marked to market through income) to introducing put options and collar options in 2024, along with a more structured, layered hedging approach based on timing and cost-benefit analysis. The LLM completely misses this key evolution and instead invents a narrative around quantitative changes that are unsupported. (3) The multi-hop reasoning is flawed because the model fails to synthesize the correct qualitative changes in instruments and scope over time. Instead, it focuses on non-existent financial metrics, suggesting a misunderstanding of the source material. (4) While the answer is relevant to the general topic of foreign exchange hedging at Merck, it substitutes fabricated data for actual descriptive content, leading to a low correctness score. The contextual relevance is moderate because it addresses the right company and general theme, but the substance is factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 446,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "PayPal's involvement with merchant receivables from 2022 to 2024 shows a decline in credit loss provisions and an increase in direct investment in merchant financing products. The allowance for credit losses on merchant receivables decreased from $160 million in 2023 to $113 million in 2024, reflecting improved credit quality in the PayPal Business Loan (PPBL) portfolio. Additionally, PayPal increased its investment in merchant financing, purchasing $1.8 billion in merchant receivables in 2024 compared to $1.7 billion in 2023, demonstrating a growing commitment to expanding its merchant finance offerings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The ground truth states that PayPal purchased approximately $1.8 billion in merchant receivables in 2024, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. However, the LLM incorrectly claims that PayPal purchased $1.7 billion in 2023, which is not supported by the original answer. Additionally, the original answer does not mention any allowance amounts for 2023 ($160 million) or 2024 ($113 million), nor does it reference a decline in credit loss provisions—these figures are entirely fabricated. The principal and interest coverage ratio of 9% as of December 31, 2021 (down from 23% in 2020) is omitted entirely, which is a key part of the evolution in credit loss provisioning methodology. (2) The only correct quantitative point is the $1.8 billion in receivables purchased in 2024, which matches the ground truth. All other numbers (allowance amounts, 2023 purchase volume) are incorrect or unsupported. (3) The reasoning partially captures the shift toward greater direct investment in merchant financing, correctly identifying products like PPBL and the increase in receivables purchases. However, it fails to reflect the multi-hop synthesis from risk disclosure in 2022 to active investment by 2024, and invents data about credit loss allowances that misrepresents the trend. The conclusion about 'improved credit quality' is speculative and not grounded in the provided truth. (4) The contextual relevance is high because the answer addresses the core theme—evolution in PayPal's merchant receivables involvement—but the correctness score is low due to significant factual and quantitative errors. The qualitative accuracy is moderate because the direction of change (increased investment) is correct, but the reasoning is based on false data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 507,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "From 2022 to 2024, the financial significance of smokeable products to MO (Altria) has shown mixed trends. Operating income from smokeable products slightly increased from $10,670 million in 2023 to $10,821 million in 2024, indicating stable performance. However, goodwill allocated to smokeable products remained unchanged at $99 million during this period, suggesting no material revaluation or impairment adjustments directly tied to this segment. The segment's net revenues declined from $21,756 million in 2023 to $21,204 million in 2024, reflecting a modest reduction in sales. Overall, smokeable products remain a core contributor to Altria’s operating income but face revenue pressures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces data not present in the ground truth. While it correctly reports the 2023 operating income ($10,670 million) and 2024 operating income ($10,821 million), it incorrectly states that goodwill remained 'unchanged at $99 million during this period'—the ground truth explicitly notes that no updated goodwill figure is disclosed for 2024, so asserting it remained unchanged is an unsupported assumption. Additionally, the LLM introduces net revenue figures for 2023 ($21,756 million) and 2024 ($21,204 million), which are not mentioned in the original answer and cannot be verified from the provided ground truth, making this a significant factual overreach. (2) The operating income numbers are accurate and correctly reflect the increase from 2023 to 2024. However, the inclusion of unverified revenue data and the incorrect assertion about goodwill stability reduce quantitative accuracy. The goodwill amount for 2022 ($99 million) is correct, but extending it to 2024 as 'unchanged' is not justified. (3) The reasoning partially aligns with the multi-hop requirement—linking goodwill and operating income across years—but fails in synthesis because it assumes continuity in goodwill allocation without evidence. The ground truth emphasizes the lack of updated goodwill disclosure as a potential shift in reporting focus, which the LLM overlooks. Instead, it draws a firm conclusion about no revaluation, which is not supported by the available data. (4) Despite these issues, the answer remains contextually relevant, addressing both goodwill and operating income trends, and correctly identifying the sustained profitability of smokeable products. The core idea—that operational performance remains strong while asset valuation focus may be shifting—is partially aligned, but the introduction of unsupported revenue data and incorrect assumptions about goodwill limit correctness. Hence, a score of 6 is justified: partially correct but with significant factual and inferential errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 553,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "The revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud increased from $13,631 million in fiscal year 2022 to $14,989 million in fiscal year 2023, representing a growth of $1,358 million or approximately 9.96%.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claims. The original answer states that Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was $91.2 billion in FY2022 and $111.6 billion in FY2023. However, the LLM claims that the 'revenue contribution from the commercial portion of LinkedIn' specifically was $13,631 million ($13.631B) in 2022 and $14,989 million ($14.989B) in 2023. This is a misrepresentation: the provided figures in the LLM answer do not match any known public standalone revenue for LinkedIn’s commercial segment, and more critically, the original answer does not provide such granular data about LinkedIn’s individual contribution—only the total Microsoft Cloud revenue that includes LinkedIn. Therefore, the LLM has fabricated specific numbers for LinkedIn's commercial revenue that are not supported by the ground truth. The calculation of $1,358 million growth and 9.96% increase is internally consistent but based on false inputs. The reasoning is flawed because it assumes a level of disaggregated data (LinkedIn’s specific commercial cloud revenue) that was not present in the original answer. While the direction of growth (increase) aligns qualitatively, the LLM fails to correctly identify that the original answer does not isolate LinkedIn’s revenue but refers to the broader Microsoft Cloud segment. Thus, the model fails on multi-hop synthesis and instead invents precise figures, leading to a very low correctness score. Contextual relevance is moderate because it addresses the right topic and timeframe, but factual grounding is poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 439,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "Between 2023 and 2024, Lynparza's commercialization and market expansion showed growth, particularly in international markets. In 2023, Lynparza received approvals in the U.S., Japan, and other regions for the treatment of various cancers, including metastatic castration-resistant prostate cancer. By 2024, alliance revenue for Lynparza increased by 9%, driven by higher demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, further expanding its geographic reach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% revenue growth in 2024, the 2023 approvals in the U.S. and Japan for mCRPC, and the January 2025 China NMPA approval for early breast cancer. All key facts from the ground truth are present and factually accurate. (2) Quantitative elements—specifically the 9% revenue increase and the January 2025 date—are correct and match the original answer exactly. No calculation errors or date inaccuracies. (3) The multi-hop reasoning is sound: the answer synthesizes information across years (2023 to 2024 to 2025), geographies (U.S., Japan, China, international markets), and therapeutic areas (prostate cancer, breast cancer). It correctly links revenue growth to international demand and regulatory approvals to geographic expansion. (4) The only minor shortcoming is that the LLM generalizes the 2023 approvals as being in 'the U.S., Japan, and other regions' and does not explicitly name the FDA and MHLW or specify that the approval was for BRCA-mutated mCRPC in combination with abiraterone and prednisone/prednisolone based on the PROpel trial. While the therapeutic context is implied, the omission of the specific indication and trial name slightly reduces qualitative completeness. However, the core commercialization trajectory and revenue growth are accurately conveyed, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 383,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "The financial treatment of the Powder Metal Matter impacted RTX's future income tax benefits, as reflected in the deferred tax assets related to this matter. In 2023, the Powder Metal Matter contributed a deferred tax benefit of $644 million, while in 2024, this amount decreased to $455 million. This reduction suggests a decline in the anticipated future tax benefits associated with the Powder Metal Matter between the two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial figures for the Powder Metal Matter's impact on future income tax benefits: $644 million in 2023 and $455 million in 2024, which matches the ground truth. The reduction is accurately implied, though the exact difference ($189 million) and percentage decrease (29.3%) are not mentioned. (2) All numeric values are correct and match the ground truth; however, the answer omits the calculation of the absolute and percentage decline, which was part of the original answer’s analytical content. (3) The reasoning is sound in noting the shift in treatment toward deferred tax assets and the decline in anticipated benefits, but it misses the critical multi-hop element that in 2023 the matter was treated as a reduction in sales—this represents a qualitative shift in accounting treatment that the LLM fails to mention. This omission affects completeness and depth of synthesis across years. (4) Despite missing the initial sales reduction aspect and the quantitative change metrics, the answer remains factually accurate on the tax benefit figures and their downward trend, earning high marks for quantitative accuracy and contextual relevance. The qualitative accuracy is slightly reduced due to incomplete entity and treatment evolution description.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 368,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "The borrowing capacity under the Paidy Credit Agreement increased from ¥50.0 billion (approximately $355 million) in 2023 to ¥90.0 billion (approximately $574 million) in 2024. In 2022, the initial borrowing capacity was ¥60.0 billion, which was later increased by ¥30.0 billion in September 2022. As of December 31, 2024, no borrowing capacity was available under the Paidy Credit Agreement, as the full amount had been drawn down. The terms of the agreement remained largely consistent, with borrowings used for working capital, capital expenditures, and other permitted purposes, and interest rates based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60%.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. The original answer states that in 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. However, the LLM claims an initial borrowing capacity of ¥60.0 billion in 2022 and a subsequent increase by ¥30.0 billion in September 2022, which is not supported by the ground truth. The LLM also introduces a 2023 capacity of ¥50.0 billion (~$355 million), which contradicts both the 2022 and 2024 figures in the original answer and is factually incorrect. The ground truth does not mention any borrowing capacity drawdown to zero in 2024; instead, it states the capacity was increased to ¥90.0 billion (~$574 million) with no indication that it was fully drawn. This misrepresents the borrowing availability. (2) The only correct quantitative element is the 2024 borrowing capacity of ¥90.0 billion (~$574 million) and the interest rate structure (TIBOR + 0.40%–0.60%). However, the LLM incorrectly maps this rate to unchanged terms, while the ground truth explicitly states that the rate was unspecified in 2022 and only introduced in 2024. The maturity date (February 2027) and the addition of a consolidated leverage ratio covenant are entirely omitted. (3) The multi-hop reasoning is flawed: the LLM fabricates intermediate values (e.g., ¥60B in 2022, ¥50B in 2023) not present in the source, fails to note the critical shift from secured to unsecured status, and omits structural changes like covenants. It incorrectly implies continuity in terms when the agreement was actually restructured. (4) Due to major factual errors in numbers, dates, and structural terms, and failure to capture key evolution points (security status, covenant introduction, rate change), the correctness and accuracy scores are low. Contextual relevance is moderate because the answer addresses the general topic and timeframe, but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 548,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Altria's reliance on long-term senior unsecured notes as part of its capital resources decreased slightly between 2022 and 2024. At the end of 2022, Altria's total long-term debt was $26.2 billion, while by December 31, 2024, it had reduced to $24.9 billion. This reduction was driven by repayments of maturing notes, such as the $776 million and $345 million senior unsecured notes in early 2024, as well as the issuance of new notes in February 2025 to refinance some near-term maturities. The weighted-average coupon interest rate on total long-term debt remained stable at approximately 4.3% in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Altria continued to rely on long-term senior unsecured notes as a key source of capital in 2024, with a decrease in cash reserves from $4.5B to $3.1B, suggesting potentially increased reliance on external financing. In contrast, the LLM claims reliance decreased, citing a drop in total long-term debt from $26.2B to $24.9B, which is not supported by the ground truth. The ground truth does not mention total debt figures or repayments of $776M and $345M in 2024, nor does it reference a February 2025 note issuance—information absent from the original context. (2) The quantitative inaccuracies are severe: the LLM introduces specific debt totals and repayment amounts not present in the original answer, and the claim about debt reduction contradicts the implication of increased reliance on external financing. The 4.3% interest rate is also not mentioned in the ground truth. (3) The multi-hop reasoning is flawed. The original answer infers potential increased reliance on unsecured notes due to declining cash reserves, while maintaining the same credit facilities. The LLM incorrectly concludes decreased reliance based on fabricated debt figures and repayment events, failing to synthesize the correct logic from cash levels and financing strategy. (4) Scores are low due to major factual and reasoning errors. The answer is partially relevant (contextual relevance 5) as it discusses the correct company and financial instrument, but the core conclusion is factually incorrect and based on non-existent data, warranting a correctness score of only 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 454,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "RTX's financial treatment of the Powder Metal Matter shifted from a $2.9 billion pretax charge in 2023 to being included in the \"Other\" category of net sales in 2024, indicating its resolution or reduction in impact. This change suggests a positive shift in the matter's financial implications, contributing to a lower effective tax rate in 2023 and potentially leading to improved future income tax benefits as the related charges diminish.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that the Powder Metal Matter contributed $644 million to RTX's future income tax benefits in 2023 and $455 million in 2024, showing a decrease. However, the LLM claims a $2.9 billion pretax charge in 2023 and a reclassification into 'Other' net sales in 2024—information not present in the ground truth and factually inconsistent. There is no mention of a pretax charge or reclassification in the original answer, nor is $2.9 billion referenced anywhere. (2) The numbers are completely inaccurate: $2.9 billion vs. the correct $644 million in 2023, and no figure is provided for 2024 in the LLM answer that matches the correct $455 million. The direction of change is also misrepresented—LLM implies improvement due to diminishing charges, while the truth indicates a reduction in future tax benefits, which is a negative trend. (3) The multi-hop reasoning fails: instead of tracking the evolution of tax benefits over time, the LLM fabricates a narrative around pretax charges and net sales categorization, showing no synthesis from the correct data points. It misidentifies both the nature of the financial treatment (tax benefit vs. pretax charge) and its trajectory. (4) The contextual relevance is moderate because the answer addresses RTX and the Powder Metal Matter over 2023–2024 and attempts to discuss financial impact and tax implications, but the factual foundation is entirely flawed, leading to an incorrect conclusion about future benefits improving when the truth indicates a diminishing benefit.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 447,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "PayPal's utilization of the Paidy Credit Agreement evolved significantly between 2022 and 2024. In 2022, the Paidy Credit Agreement had a borrowing capacity of ¥60.0 billion, which was increased to ¥90.0 billion (approximately $574 million) by September 2022. In 2024, the full ¥90.0 billion was drawn down, leaving no available borrowing capacity under the agreement as of December 31, 2024. This indicates that PayPal fully utilized the increased borrowing capacity in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in borrowing capacity from ¥60.0 billion to ¥90.0 billion (approximately $574 million) and notes full drawdown by 2024, which aligns with the ground truth. However, it omits the 2022 borrowing capacity in dollar terms (~$198 million) and does not mention the $98 million outstanding as of December 31, 2021, which provides context for the available capacity at the start of 2022. This missing detail affects completeness but does not invalidate the core facts. (2) The numeric values for 2024 are accurate: ¥90.0 billion = ~$574 million and full drawdown is correctly stated. The LLM correctly converts yen amounts and timelines, though it does not reconcile the $198 million figure from 2022, which may reflect a different conversion rate or reporting point. (3) The reasoning is sound—LLM correctly infers increased reliance due to full utilization of an expanded facility, demonstrating proper multi-hop synthesis between capacity changes and drawdown behavior. (4) The answer is contextually excellent, directly addressing evolution in borrowing capacity and utilization. Scores reflect high accuracy with minor omissions in initial 2022 capacity details, warranting a strong but not perfect correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 358,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "From 2023 to 2024, Accenture Canada Holdings Inc.'s ownership structure and equity relationship with Accenture plc remained largely consistent, with noncontrolling interests held by current and former Accenture Leadership members remaining below 1% as of August 31, 2024. Exchangeable shares issued to pre-incorporation partners in Canada and New Zealand continue to be redeemable or exchangeable for Accenture plc Class A ordinary shares on a one-for-one basis. Additionally, Accenture Canada Holdings Inc. exchangeable shares entitle holders to distributions equivalent to those of Class A shares, and Accenture plc has maintained agreements to ensure alignment between Class X ordinary shares and exchangeable shares. No significant structural changes were reported in this relationship during the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that noncontrolling interests were less than 1% as of August 31, 2024, which aligns with the ground truth. It also accurately describes the exchangeable shares' one-for-one exchange feature with Accenture plc Class A ordinary shares and mentions the alignment with Class X shares. However, it incorrectly frames the evolution as 'largely consistent' and states 'no significant structural changes were reported,' which contradicts the ground truth that emphasizes a formalization and evolution in the equity structure in 2024, including specific restrictions ensuring Class X shares do not fall below exchangeable shares. This misrepresents the nature of the change. (2) Quantitatively, all numbers and dates are correct: 'less than 1%' and 'August 31, 2024' match the original. No calculations are involved, so numerical accuracy is high. (3) The multi-hop reasoning is partially flawed: while the LLM identifies the correct entities (Accenture plc, Accenture Canada Holdings Inc., exchangeable shares, Class A and Class X shares), it fails to correctly synthesize the evolution from a simpler noncontrolling interest disclosure in 2023 to a more structured, provision-based relationship in 2024. The answer downplays the significance of the structural developments. (4) Contextual relevance is strong—the response addresses ownership structure, noncontrolling interests, exchangeable shares, and equity relationships. However, the qualitative inaccuracy in characterizing the evolution reduces the correctness score. The answer is factually sound on components but incorrect in overall synthesis and conclusion, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 461,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "Between 2022 and 2024, Merck's approach to managing balance sheet risk through forward exchange contracts has evolved in terms of both currencies and cost-benefit considerations. In 2022, the company primarily focused on developed country currencies such as the euro, Japanese yen, British pound, Canadian dollar, and Swiss franc, using forward contracts to mitigate the effects of foreign exchange volatility on monetary assets and liabilities. By 2024, the scope expanded to include a broader range of currencies, with a continued emphasis on the euro, Swiss franc, Japanese yen, and Chinese renminbi. The cost-benefit analysis became more refined, with Merck evaluating the magnitude of exposure, exchange rate volatility, and hedging costs more rigorously to determine when it was economical to hedge, particularly for developing country currencies. This evolution reflects a more strategic and dynamic approach to managing balance sheet risk in response to changing market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) In 2022, Merck did not focus primarily on developed country currencies only; it explicitly included developing country currencies like the Chinese renminbi in its hedging program, which the LLM incorrectly frames as a 2024 expansion. The original answer states that the renminbi was specifically mentioned in 2022, not introduced later. (2) The LLM claims that by 2024, the scope 'expanded' and included a 'broader range' of currencies with continued emphasis on renminbi, but the ground truth indicates that the detailed discussion of cost-benefit analysis and specific mention of renminbi was *omitted* in 2024, suggesting a simplification or reduced emphasis, not refinement or expansion. (3) The assertion that cost-benefit analysis became 'more refined' and 'more rigorous' in 2024 is directly contradicted by the original answer, which notes the omission of such details in 2024 filings, implying less disclosure or a shift away from that framework. (4) There are no numeric values to verify, so quantitative accuracy is not the main issue, but the qualitative and reasoning errors are severe. The multi-hop synthesis is flawed: the model misinterprets the evolution, reversing the direction of change (increased detail vs. decreased). While the answer is relevant to balance sheet risk and forward contracts, the core factual claims about evolution are incorrect, leading to a low correctness score. Contextual relevance is moderate because the topic and concepts are appropriate, but accuracy is poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 437,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggests a reduction in its financial impact on future income tax benefits. In 2023, the Powder Metal Matter contributed $644 million to future income tax benefits, while in 2024, this amount decreased to $455 million. This decline indicates that the anticipated tax benefits related to this matter are diminishing, likely due to the resolution or reduced uncertainty surrounding the issue over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in future income tax benefits from $644 million in 2023 to $455 million in 2024, which matches the ground truth. However, it omits a critical part of the original answer: the 2023 context that the Powder Metal Matter had a $5.3 billion net sales charge that negatively impacted operational performance at Pratt & Whitney. This omission significantly weakens the multi-hop synthesis required to fully explain the shift in disclosure. (2) Quantitatively, the numbers are accurate—$644 million and $455 million are correctly cited for the future income tax benefits in 2023 and 2024, respectively—and the direction of change (decrease) is correctly interpreted. (3) The reasoning is partially sound but incomplete. The LLM correctly infers that diminishing tax benefits suggest resolution or reduced uncertainty, but it fails to recognize the key conceptual shift from an operational loss (in 2023) to a tax asset (in 2024), which is central to the original answer’s conclusion about evolving financial impact and deferral of benefits. This represents a failure in full multi-hop reasoning across both operational and tax-related disclosures. (4) The answer is contextually relevant and well-structured, but the missing operational impact in 2023 undermines completeness and qualitative accuracy, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 389,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "PayPal's involvement in the merchant receivables space grew between 2022 and 2024, with increased scale in its merchant finance offerings. In 2024, PayPal purchased approximately $1.8 billion in merchant receivables, up from $1.7 billion in 2023. The total outstanding balance in its merchant loans, advances, and interest and fees receivable rose to $1.5 billion in 2024 from $1.2 billion in 2023, net of participation interests sold to partner institutions. PayPal continues to partner with WebBank in the U.S. for its PPWC and PPBL products, where WebBank extends credit to merchants, and PayPal purchases and services the related receivables. The allowance for credit losses on merchant receivables decreased to $113 million in 2024 from $160 million in 2023, reflecting improved credit quality in the PPBL portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, all reported figures are accurate: $1.8 billion in merchant receivables purchased in 2024 (up from $1.7 billion in 2023), total outstanding balance rising from $1.2 billion to $1.5 billion, and the continued partnership with WebBank are all factually correct. The mention of the allowance for credit losses decreasing from $160M to $113M is additional information not present in the original answer but does not contradict it and may reflect real data; however, since it was not part of the ground truth, it doesn't enhance accuracy. (2) The key omission is the lack of specific mention that the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023—a specific metric highlighted in the original answer that reflects growing collaboration. This missing detail prevents a perfect score. (3) The qualitative reasoning is sound: the LLM correctly identifies the structure of the WebBank partnership (originating PPWC and PPBL products under a program agreement), PayPal’s role in purchasing and servicing receivables, and the accounting treatment implied by selling back participation interests. It also captures the evolution in scale and ongoing institutional collaboration. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: evolution of relationships with partner institutions and scale of offerings. Overall, the answer demonstrates strong multi-hop synthesis across years and entities, with only a minor gap in completeness regarding the participation interest figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 466,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck's alliance revenue from Lynparza increased by 9% in 2024 compared to 2023, primarily driven by higher demand in most international markets. The growth was supported by the approval of Lynparza in new indications and expanded market access, including the approval in China in January 2025 for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer. However, specific data on Lynparza's alliance revenue in 2022 is not provided in the given pages, so the exact evolution from 2022 to 2024 cannot be determined.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 9% growth in Lynparza alliance revenue by 2024 and attributes it to increased international demand and new approvals, including in China in January 2025 for adjuvant treatment of early breast cancer. However, it incorrectly states that 2022 revenue data is not available, when the ground truth explicitly provides the 2022 figure of $989 million. This omission significantly undermines completeness. Additionally, the LLM claims the 9% growth is 'compared to 2023', while the original answer states the growth is from 2022 to 2024—this misrepresents the time frame and could imply incorrect year-over-year data. (2) The percentage (9%) and the China approval date (January 2025) are accurate, and the indication aligns with the OlympiA trial. However, the absence of the $989 million figure from 2022 breaks quantitative completeness, and the shift to a 2023 baseline introduces a factual inaccuracy in the comparison period. (3) The reasoning captures the contributing factors correctly—international demand and new approvals—but fails the multi-hop synthesis by not connecting the 2022 baseline to the 2024 result to describe the full evolution. The answer retreats into a partial admission of missing data rather than reporting the known 2022–2024 trajectory. (4) Despite the reasoning and contextual relevance being strong in explaining drivers of growth, the failure to report the 2022 revenue and the mischaracterization of the growth period reduce factual correctness. The answer is partially correct but contains significant omissions and a misleading temporal comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 445,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "PayPal's involvement in merchant receivables between 2022 and 2024 has shown improvements in credit quality and a reduction in financial exposure. As of December 31, 2024, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.5 billion, up from $1.2 billion in 2023, indicating growth in the portfolio. However, the allowance for credit losses decreased to $113 million in 2024 from $160 million in 2023, reflecting improved credit quality, particularly in the PPBL portfolio. Additionally, delinquency rates have declined, with a higher percentage of merchant receivables being current and a lower percentage being over 90 days outstanding, showing enhanced risk management and operational performance.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct information but misses key aspects of PayPal's evolving role in merchant receivables. It correctly states the $1.5 billion outstanding balance in 2024 (up from $1.2 billion), aligning with the ground truth. However, it introduces new figures—allowance for credit losses decreasing from $160M to $113M and delinquency rates—without any mention of these in the original answer, making them unsupported. More critically, the LLM fails to mention PayPal's active *purchases* of merchant receivables ($1.8B in 2024 vs $1.7B in 2023), which is a central point in the ground truth showing expanded operational involvement. Instead, it frames the evolution around reduced financial exposure and improved credit quality, which contradicts the original narrative of increased engagement. (2) The $1.5B and $1.2B figures are accurate and correctly dated. However, the allowance and delinquency numbers are not present in the ground truth and cannot be verified; they appear to be hallucinated or drawn from external data. The absence of purchase volume data ($1.8B in 2024) is a significant quantitative omission. (3) The multi-hop reasoning is flawed: while the LLM identifies a trend in receivables growth, it misinterprets the nature of PayPal’s evolving role. The original answer emphasizes a shift from passive risk accounting (CECL, charge-offs) to active purchasing and servicing—indicating greater exposure and operational depth. The LLM instead suggests reduced exposure due to lower allowances and better delinquency, which is inconsistent with the ground truth. This reflects a failure to synthesize the correct operational and financial trajectory. (4) The contextual relevance is high because the answer addresses merchant receivables, mentions PPBL, and discusses trends over time. However, the qualitative accuracy is low due to incorrect emphasis and unsupported metrics. Quantitative accuracy is moderate due to partial correct figures but missing key data points and introduction of unverified ones. Correctness score is 5 due to partial factual alignment but significant omissions and misrepresentation of the evolution’s direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 586,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "Merck's involvement in the development and commercialization of Lynparza from 2022 to 2024 has shown regulatory progress and revenue growth. In 2022, Lynparza was under regulatory review in the EU for metastatic castration-resistant prostate cancer based on the PROpel trial. By 2024, Lynparza achieved regulatory approval in China for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer based on the OlympiA trial. Additionally, alliance revenue for Lynparza grew 9% in 2024, driven by higher demand in most international markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% alliance revenue growth in 2024 and the January 2025 China approval for Lynparza for adjuvant treatment of BRCA-mutated, HER2-negative high-risk early breast cancer based on the OlympiA trial. However, it incorrectly states that in 2022, Lynparza was under regulatory review in the EU for metastatic castration-resistant prostate cancer based on the PROpel trial, whereas the ground truth specifies that in 2022, Merck was awaiting an FDA decision for the adjuvant breast cancer indication with a PDUFA date in Q1 2022. This misrepresents the key regulatory focus for Merck in 2022. (2) Quantitatively, the 9% revenue growth is accurate, and the timing of the China approval (January 2025) is consistent with the 'by 2024' timeframe in the original answer, which notes continued momentum leading into 2025. No calculation errors. (3) The multi-hop reasoning is partially sound—linking regulatory progress and revenue growth across years—but fails to correctly align the 2022 regulatory status with the correct indication and agency (FDA vs. EU, breast cancer vs. prostate cancer). This reflects a failure in entity and context mapping despite correct identification of trials (OlympiA). (4) The answer is contextually relevant and well-structured, addressing both regulatory and commercial dimensions. The core commercial fact (9% growth) is correct, and the China approval is accurately described, supporting a score of 7 for overall correctness despite the significant 2022 error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 423,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Between 2022 and 2024, Boeing extended the risk management horizon for its commodity purchase contracts, with hedges now covering forecasted transactions through 2028, up from previous periods. Additionally, the financial exposure related to commodity contracts appears to have slightly increased, as the potential unrealized losses from a 10% market price change rose from $46 million in 2022 to an implied higher exposure based on the notional amounts and fair value changes detailed in 2024. Boeing continues to use commodity swaps and purchase contracts to hedge against price fluctuations, maintaining its strategy to offset gains and losses with underlying transactions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Boeing's use of commodity swaps and purchase contracts for hedging and references the $46 million exposure in 2022 from a 10% price change, which matches the ground truth. However, it incorrectly states that hedges cover transactions through 2028, while the ground truth specifies a horizon extending to 2031. This is a significant factual discrepancy in the risk management horizon. (2) The claim of 'implied higher exposure' in 2024 based on notional amounts and fair value changes is not supported by the original answer, which does not mention an increase in financial exposure or updated unrealized loss figures. In fact, the original emphasizes improved risk mitigation through longer-term hedging, not increased exposure. Thus, the quantitative assertion about rising financial exposure is speculative and incorrect. (3) The reasoning captures the strategic intent of extending hedging periods and links it to forecasted transactions, showing sound multi-hop understanding of Boeing’s evolving risk management. However, it fails to fully capture the strategic shift to multi-decade planning (through 2031) as a key evolution, instead citing a shorter 2028 horizon. (4) The contextual relevance is high as the answer addresses both risk management horizon and financial exposure. While the core strategy and 2022 data are accurate, the incorrect end date for hedging and the erroneous implication of increased financial exposure reduce factual correctness. Hence, a score of 6 is justified—partially correct but with significant errors in key quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 443,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Between 2021 and 2024, Schwab's exposure to PALs (Pledged Asset Lines) remained fully collateralized, with securities' fair values consistently exceeding the borrowings. As of December 31, 2021, and December 31, 2024, no allowance for credit losses was required for PALs due to full collateralization. Additionally, the allowance for credit losses on bank loans decreased from $18 million at December 31, 2021, to $18 million at December 31, 2024, indicating stable credit risk management in the loan portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly states that PALs were fully collateralized in 2021 and no allowance was required, it incorrectly claims that no allowance was required in 2024 due to full collateralization. The ground truth states that by 2024, there was a decrease in the allowance for credit losses (implying an allowance existed), driven by lower projected loss rates and improved credit quality—not solely by collateralization. This misrepresents the evolution of Schwab's risk management approach. (2) The quantitative claim that the allowance for credit losses on bank loans was $18 million in both 2021 and 2024 is not supported by the original answer, which does not mention bank loans or specific dollar amounts for allowances—this is extraneous and potentially misleading information. The original answer only notes a decrease in the allowance, not a stable value. (3) The multi-hop reasoning is flawed: the question asks for an evolution between 2021 and 2024 in terms of collateralization and allowance, but the LLM fails to recognize the shift from collateral-based risk mitigation to a broader credit assessment framework in 2024. Instead, it incorrectly implies that the rationale for no allowance remained unchanged. (4) Contextual relevance is high because the answer addresses PALs, collateralization, and credit losses over the correct time frame. However, correctness and qualitative accuracy are low due to core factual and conceptual errors in representing the allowance for credit losses and the reasoning behind risk mitigation changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 450,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "Between 2022 and 2024, Boeing's financial treatment and strategic positioning of the 777X program evolved as cost impacts and research & development (R&D) investments increased. In 2022, R&D expenses for the 777X program were part of a total R&D expense of $2,852 million, but by 2024, these expenses had risen significantly to $3,812 million, driven by higher investments in the 777X program and enterprise product development. Additionally, cost of sales in 2024 reflected a $1,562 million decrease compared to 2023, partly due to the reach-forward losses on the 777X program, indicating ongoing financial pressures and strategic focus on completing and mitigating risks associated with the 777X.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Boeing increased R&D spending by $525 million in 2023 over 2022 and by $435 million in 2024 over 2023, but the LLM incorrectly reports total R&D expenses of $2,852 million in 2022 and $3,812 million in 2024 without citing year-over-year increases. These totals are not in the original answer and appear fabricated. Additionally, the LLM claims a $1,562 million *decrease* in cost of sales in 2024 compared to 2023 'due to reach-forward losses,' which contradicts the ground truth: reach-forward losses *increase* cost of sales, and the original answer indicates the 777X was a cost burden in 2022, not that it reduced costs by 2024. (2) Quantitative accuracy is very low: the dollar figures for R&D are not supported by the ground truth, and the $1,562 million decrease in cost of sales is both unsupported and illogical in context. The correct pattern is increasing R&D investment (cumulative +$960M over two years), not a drop in cost of sales. (3) Multi-hop reasoning is flawed: the LLM misinterprets the financial impact of the 777X, reversing the direction of cost impact. It fails to identify the shift from 'cost burden' in 2022 to 'strategic investment' in 2024 based on R&D increases, instead implying ongoing losses without recognizing the strategic repositioning. (4) Contextual relevance is moderate—the answer addresses Boeing, the 777X, R&D, and cost impacts—but the incorrect data and reversed logic undermine the analysis. Due to major factual and logical errors, especially in numbers and financial causality, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 453,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Between 2022 and 2024, Schwab's exposure to and risk management of Portfolio Against Loans (PALs) remained relatively stable in terms of methodology, but the PALs portfolio grew significantly. The credit loss allowance for PALs continued to rely on the practical expedient based on collateral maintenance provisions, as the portfolio is collateralized by marketable securities with liquid markets, and over-collateralization limits inherent credit risk. However, the total PALs portfolio increased from $17,024 million in 2024 to a larger portion of total bank loans, reflecting growth in Schwab's lending activities. The allowance methodology for PALs did not change materially, but the overall credit risk exposure increased due to the portfolio's expansion.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions. While it correctly identifies that Schwab used the practical expedient for PALs due to collateralization and over-collateralization in 2022, it fails to mention the evolution in risk profile despite growth, which is central to the original answer. The claim that the PALs portfolio increased from $17,024 million in 2024 is factually incorrect — this number is presented as a future value when it should be a past or current value, and the directionality is wrong. Moreover, the original answer notes a slight decrease in 2023 before growth, which the LLM omits. The LLM incorrectly states that overall credit risk exposure increased due to portfolio expansion, while the ground truth indicates a reduced risk profile due to improved credit quality and lower projected loss rates — a key contradiction. (2) The number $17,024 million is likely a misstatement of actual reported figures; more critically, it is used incorrectly in temporal context (saying 'increased from $17,024 million in 2024' implies that 2024 is the starting point, which is illogical). No such figure appears in the ground truth, making this a fabricated or misplaced data point. There are no verifiable calculations in the LLM response. (3) The multi-hop reasoning is partially sound — the model connects collateralization to the use of the practical expedient and links portfolio growth to lending activity — but fails to synthesize the critical insight that despite growth, risk decreased due to improved metrics. This undermines the core analytical point of the original answer. (4) The contextual relevance is high because the LLM addresses both exposure and risk management across the time period and discusses allowance methodology and portfolio growth. However, due to significant factual errors in quantitative claims and a reversal of the correct risk conclusion, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because some conceptual elements are correct, but the reasoning leads to an incorrect overall assessment of risk evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 573,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ's value of British pound sterling notes changed from $3 million in 2021 to $45 million in 2022 and then dropped to $0 in 2023. This shift suggests that the company is actively managing its foreign exchange risk through net investment hedges, adjusting its exposure based on market conditions and strategic financial planning.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, MDLZ's value of British pound sterling notes was $3 million in 2022 and increased to $45 million in 2023. However, the LLM incorrectly states the $3 million was in 2021, $45 million in 2022, and $0 in 2023—none of which align with the original data. This misrepresentation of years and values severely undermines factual correctness. (2) Quantitative accuracy is very low: the correct progression is $3M (2022) → $45M (2023), but the LLM reports $3M (2021), $45M (2022), $0 (2023), introducing two incorrect data points and an erroneous drop to zero. Calculations and trends are therefore completely inaccurate. (3) The reasoning is flawed due to incorrect data inputs. While the LLM attempts to interpret the change as part of foreign exchange risk management via net investment hedges, it bases this on a non-existent drop to zero in 2023, leading to an invalid conclusion. The ground truth indicates a significant increase, suggesting increased exposure or hedging in GBP, not a reduction to zero. The multi-hop synthesis fails because the temporal and numerical foundations are wrong. (4) Contextual relevance is moderate—the answer addresses foreign exchange risk management strategy, which is relevant—but the incorrect data renders the interpretation misleading. The qualitative accuracy is low due to wrong entity-year alignments and faulty logic. Overall, the answer is mostly incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 421,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In both the 2022 and 2024 filings, Amgen's 3.125% 2025 Notes are associated with interest rate swap contracts that convert the fixed-rate coupon to a floating-rate SOFR-based coupon. In 2022, the effective interest rate was LIBOR + 1.8%, while in 2024, it was SOFR + 2.1%. This shift from LIBOR to SOFR reflects Amgen's adaptation to the transition away from LIBOR as the benchmark interest rate. The consistent use of interest rate swaps for these notes indicates Amgen's strategy to manage interest rate risk by balancing fixed and floating rate debt exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, the 3.125% 2025 Notes had a fixed interest rate with no variable rate terms, but the LLM claims the rate was converted via swaps to LIBOR + 1.8%, which is incorrect. The original answer does not mention LIBOR or interest rate swaps at all for 2022. In 2024, the ground truth states the rate was tied to SOFR + 2.1%, but this was a structural change to the note itself, not the result of a swap as the LLM implies. The LLM incorrectly introduces interest rate swaps both years, which are not mentioned in the ground truth. (2) Quantitatively, the SOFR + 2.1% figure in 2024 matches, but the 2022 LIBOR + 1.8% is fabricated. The 3.125% fixed rate is correctly referenced, but the derived 'effective' rates are not supported by the original data. (3) The multi-hop reasoning is flawed: the LLM assumes the presence of interest rate swaps and effective rate calculations that are not in the ground truth, leading to an incorrect conclusion about Amgen's strategy involving swaps. The actual shift is from fixed to floating rate structure in the note's terms, not a hedging strategy. (4) While the answer addresses the question's context and attempts to explain a strategic shift (LIBOR to SOFR transition), the core facts are wrong, severely undermining correctness. The contextual relevance is moderate because it discusses relevant concepts (rate benchmarks, risk management), but the factual foundation is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 420,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "Schwab's reliance on its Commercial Paper Issuance Program between 2022 and 2024 increased in response to market disruptions and rising interest rates. In 2022 and 2023, rapid interest rate hikes led to significant client reallocation of cash from sweep features to higher-yielding alternatives, creating liquidity demands. As a result, Schwab increasingly turned to higher-cost supplemental funding sources, including its commercial paper issuance program, to meet liquidity needs when internal cash was insufficient. This reliance became more pronounced during periods of reduced client cash balances and heightened market volatility, underscoring the program's role in maintaining Schwab's liquidity position amid challenging financial conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Schwab's reliance on its Commercial Paper Issuance Program from 2022 to 2024. (1) It correctly identifies that Schwab increased its reliance on the program in response to rising interest rates and market disruptions, aligning with the ground truth. The key drivers—rising short-term rates in 2022 and 2023, client cash outflows due to reallocation to higher-yielding alternatives, and insufficient internal cash—are all accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly links rising rates → client behavior → liquidity pressure → increased use of commercial paper. While the original mentions complementary funding sources like FHLB advances and repurchase agreements, and the 2022 introduction context, the LLM focuses on the trend of increasing reliance, which is the central theme. The omission of the shelf registration and credit line details in 2022 is a minor gap but does not undermine the overall correctness. (4) The answer is contextually relevant, directly addressing how reliance evolved due to market and rate conditions. Wording differs but semantic meaning matches. One point deducted from qualitative accuracy for not fully acknowledging the program's initial 2022 introduction as one of several tools, but the trajectory of increased use is correctly emphasized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 429,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "The 3.625% Notes due 2024 were outstanding in 2022 with a carrying value of $1,400 million and were hedged using interest rate swap contracts at SOFR + 3.4%. By 2024, these notes had matured and were repaid, as indicated by their $0 notional amount in the 2024 report. This evolution reflects the company's proactive debt management strategy, which includes refinancing and hedging to align with its long-term financial goals and optimize interest costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 3.625% Notes had a carrying value of $1,400 million in 2022 and were fully repaid by 2024 with a $0 notional amount, which matches the ground truth. However, the LLM introduces new information not present in the original answer — that the notes were 'hedged using interest rate swap contracts at SOFR + 3.4%' — which is not mentioned in the ground truth and cannot be verified from the provided data. This addition may be factually incorrect or speculative. (2) Quantitatively, the key numbers (3.625%, $1,400 million, $0 notional in 2024) are accurate and correctly formatted. The interest rate and dollar amounts match exactly. The SOFR + 3.4% figure is unverified and not in the original, but since it doesn't contradict directly, it doesn't fully invalidate the answer. (3) The multi-hop reasoning is partially sound: the model correctly infers repayment upon maturity and links it to debt management strategy. However, the ground truth emphasizes a strategic shift from fixed to floating rate debt as a replacement, which the LLM omits. Instead, it references hedging, which is a different mechanism and not equivalent to issuing floating rate debt. This misrepresents the nature of the strategic shift. (4) The answer is contextually relevant and addresses both the evolution of the notes and the implication for debt strategy. However, it substitutes the core strategic insight (refinancing into floating rate debt) with a less relevant one (hedging), reducing qualitative accuracy. The correctness score is 7 because the core facts are right but a key strategic point is misrepresented with unverified details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 456,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "Between 2022 and 2024, Schwab's approach to providing financial or other support to variable interest entities (VIEs) has remained consistent in terms of intent, as the company has not provided or intended to provide support beyond what is contractually required. However, the conditions for funding commitments have evolved, with CSB expecting to fulfill its remaining commitments to VIEs primarily between 2022 and 2025, subject to the occurrence of specific conditions. The nature of these investments, primarily through CRA-related initiatives like LIHTC investments, has not changed significantly in terms of Schwab's intent to avoid providing non-contractual support.",
      "correctness_score": 2,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim about Schwab's evolving approach to VIE support. According to the ground truth, there was a clear shift between 2022 and 2024: in 2022, Schwab explicitly stated it did not provide and did not intend to provide non-contractual support to VIEs; by 2024, it acknowledged it may choose to provide credit, liquidity, or other support to its proprietary funds under stress conditions like valuation declines or redemptions, indicating a more proactive stance. The LLM incorrectly states that Schwab's intent has 'remained consistent,' which directly contradicts the documented evolution. This is a critical factual error in both reasoning and substance. The mention of 'CSB expecting to fulfill its remaining commitments to VIEs primarily between 2022 and 2025' introduces entities and timelines not present in the original answer and appears to conflate VIE funding with CRA-related initiatives like LIHTC, which are not referenced in the ground truth. While the years 2022 and 2024 are correctly referenced (supporting a quantitative accuracy score of 6), the qualitative analysis fails on multi-hop reasoning—instead of contrasting the change in intent and conditions, it asserts consistency. The answer is contextually relevant in discussing VIEs and timeframes but fundamentally misrepresents the nature of Schwab’s evolving policy, leading to a low correctness score of 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 392,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "Between 2022 and 2023, MDLZ's financial relationship with JDE Peet's remained a strategic component of its liquidity and capital structure. In 2023, the investment in JDE Peet's provided additional flexibility, as noted in the liquidity and capital resources section, contributing to MDLZ's ability to manage its capital structure and fund operations. The 2023 cash flow activities also included proceeds from the sale of JDEP shares, which improved net cash from investing activities compared to the prior year. This indicates that the JDE Peet's investment continued to serve as a source of liquidity, supporting MDLZ's financial flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but misses key qualitative shifts in the relationship between MDLZ and JDE Peet's. (1) Correctly notes that the JDE Peet's investment contributed to liquidity and capital flexibility in 2023, aligning with the ground truth. It also correctly references proceeds from the sale of JDEP shares improving cash flow from investing activities, which is factually consistent and adds relevant detail not in the original answer. (2) Quantitative accuracy is high—no specific numbers are misstated, and references to cash flow impacts are plausible and contextually accurate. (3) However, the critical multi-hop element—the reclassification of the relationship from 'Has_Stake_In' in 2022 to 'Invests_In' in 2023—is entirely omitted. This evolution reflects a strategic shift in how MDLZ accounts for and views the investment, which is central to the question. The LLM instead implies continuity ('remained a strategic component'), contradicting the ground truth's emphasis on reclassification and evolving posture. (4) Contextual relevance is strong as the answer addresses liquidity, capital structure, and financial flexibility. But due to the failure to identify the change in relationship classification and its implications, the qualitative accuracy is significantly reduced. The answer provides partially correct information with accurate financial effects but flawed reasoning on the nature of the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 402,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "The interest rate hedging strategy for the 3.125% 2025 Notes evolved between 2022 and 2024 by transitioning from a fixed LIBOR-based rate to a SOFR-based rate. In 2022, the effective interest rate under the swap agreements was LIBOR + 1.8%. By 2024, this had changed to SOFR + 2.1%, reflecting the shift from LIBOR to SOFR as the reference rate. This change aligns with broader market transitions away from LIBOR to alternative reference rates like SOFR.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2022, the company terminated and reentered into new swap agreements, but the exact rate for the 3.125% 2025 Notes was not disclosed. However, the LLM incorrectly asserts that the 2022 effective rate was 'LIBOR + 1.8%', which is not supported by the original answer and introduces a specific figure that was not provided. Additionally, the shift from LIBOR to SOFR is plausible contextually, but the original answer does not mention LIBOR or any prior reference rate—only that the 2024 rate is SOFR+2.1%. Thus, the claimed transition is an unsupported inference. (2) The only correct numeric detail is the 2024 rate of SOFR+2.1% and the notional amount of $1,000 million, which aligns with the ground truth as of December 31, 2024. However, the LLM fabricates the 2022 rate (LIBOR+1.8%) and omits the key point that the rate was not disclosed. (3) The multi-hop reasoning is partially sound in that it attempts to describe an evolution between 2022 and 2024, but it fails to accurately represent the lack of disclosed rate in 2022 and invents a specific benchmark transition not confirmed in the source. The synthesis is therefore flawed. (4) Despite the incorrect specifics, the answer is contextually relevant and addresses the evolution of the hedging strategy and the 2024 rate correctly. It also provides reasonable market context about the LIBOR-to-SOFR transition, which may be accurate generally but is not substantiated in the provided ground truth. Hence, the correctness score is low due to factual overreach, especially in quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 464,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "From fiscal year 2022 to fiscal year 2023, the fair value of Walmart's equity investments measured using Level 2 inputs decreased from $5,819 million to $5,570 million. The magnitude of this change was a decrease of $249 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the fair value of Walmart's equity investments using Level 2 inputs was $5,819 million in fiscal year 2022 and decreased to $5,570 million in fiscal year 2023. (2) The magnitude of change is correctly calculated: $5,819M - $5,570M = $249M decrease, which is accurate. (3) The multi-hop reasoning—comparing values across two fiscal years and computing the difference—is sound and properly synthesized. (4) The entities (Walmart, equity investments, Level 2 inputs, fiscal years 2022 and 2023) are correctly identified and contextualized. (5) The answer is semantically equivalent to the original, conveying the same core information with slightly more concise wording. No errors in numbers, logic, or completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 244,
        "total_tokens": 1365
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "Apple's characterization of its reliance on marketing abilities remained consistent between its 2023 and 2024 10-K filings. In both years, the company emphasized that while intellectual property is important, it primarily relies on the innovative skills, technical competence, and marketing abilities of its personnel to drive success and maintain a competitive edge in the marketplace.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Apple's characterization of its reliance on marketing abilities 'remained consistent' between 2023 and 2024. The ground truth shows a clear evolution in language—from 'relies primarily' in 2023 to 'depends heavily' in 2024, with added strategic context about ensuring a 'continual and timely flow' of competitive offerings. This shift indicates a stronger, more strategic emphasis on marketing abilities, particularly in response to competitive pressures. The LLM fails to capture this evolution entirely, instead asserting consistency where there is meaningful change. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the question asks for a comparison across two years of 10-K filings, requiring identification of changes in language and tone. The LLM incorrectly concludes no change occurred, failing to synthesize the nuanced shift in wording and strategic framing. (4) While the LLM correctly identifies the three factors (innovative skills, technical competence, marketing abilities) and correctly references the role of personnel, it misses the core of the question—how the characterization evolved. This results in a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer discusses the right topic and documents but draws the wrong conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 417,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "The notional amount for the 3.625% 2024 Notes decreased from $1,400 million in 2022 to $0 in 2024, as the notes were fully repaid by their maturity date. The interest rate structure for these notes shifted from being hedged with interest rate swaps at LIBOR + 3.4% in 2022 to being fully unwound by 2024. This indicates that Amgen's hedging strategy involved using interest rate swaps to manage fixed-to-floating rate exposure on these notes, and as the notes matured, the associated hedging contracts were terminated, reflecting the completion of the hedging objective.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it claims the notional amount was $1,400 million in 2022, but according to the ground truth, the $1,400 million figure was for December 2023, not 2022. In 2022, Amgen terminated $5.2 billion in swaps covering multiple notes including the 3.625% 2024 Notes, not just $1.4 billion. The drop to $0 by 2024 is correct, but the timing and context are misrepresented. Additionally, the LLM incorrectly states the 2022 hedge was at LIBOR + 3.4%, while the ground truth specifies SOFR + 3.4% in 2023, with no mention of LIBOR or the rate in 2022. (2) The quantitative inaccuracies are significant: wrong notional amounts per year, incorrect interest rate benchmark (LIBOR vs SOFR), and omission of the $5.2 billion swap termination in 2022. The $1,400 million amount is correctly cited but misattributed to 2022 instead of 2023. (3) The multi-hop reasoning is partially sound—LLM correctly infers that unwinding hedges near maturity reflects completion of hedging strategy—but misses key nuances: the 2022 re-hedging at current rates on the same principal and the full wind-down by end-2024 after starting at $1,400M in 2023. It also fails to mention the reentering of swaps in 2022, a critical part of the strategy. (4) Despite factual errors, the answer is contextually relevant and captures the general direction of the hedging strategy. Scores reflect partial correctness: moderate on qualitative accuracy due to logical reasoning, low on quantitative accuracy due to incorrect numbers and rates, and a mid-range correctness score due to core misunderstanding of the timeline and amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 453,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "Schwab integrated TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, into its offerings for independent advisor clients, both in 2022 and 2023. This integration indicates Schwab's commitment to enhancing its competitive positioning in the RIA market by leveraging advanced tools and technologies to provide more comprehensive and tailored services to RIAs and their clients.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but lacks key details from the original answer. It correctly states that Schwab integrated iRebal for independent advisor clients in both 2022 and 2023 and links this to competitive positioning in the RIA market. However, it fails to capture the evolution between the two years — in 2022, Schwab was merely retaining iRebal without full integration, whereas by 2023 it had become a core offering, indicating deeper integration. This progression is central to the question and missing in the LLM response. (2) There are no numeric values in the LLM answer, but it does not contradict any quantitative facts (e.g., $1.6 trillion in assets, 15 million accounts) — it simply omits them. Since it doesn't include or misstate numbers, quantitative accuracy is not penalized. (3) The multi-hop reasoning is partially sound: the model connects Schwab’s integration of iRebal with its RIA market strategy, which is valid. However, it fails to synthesize the change over time — a critical aspect of the multi-hop requirement — and misses the significance of the broader TD Ameritrade integration context ($1.6T assets, 15M accounts) that supports the strategic narrative. (4) Contextual relevance is high because the answer addresses the integration and its strategic implication, but qualitative accuracy is reduced due to omission of key developmental details and supporting evidence from the ground truth. Correctness score reflects that core facts are present but essential nuances and evidence are missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 427,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "Apple's approach to the iMac product line evolved between 2023 and 2024, as evidenced by the company's 10-K filings. In 2024, Apple introduced a new iMac during the first quarter, indicating a focus on updating its desktop offerings. Additionally, the 2024 10-K notes that Mac net sales increased compared to 2023, primarily driven by higher laptop sales, which suggests a strategic emphasis on laptops over desktops like the iMac during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but introduces information not present in the ground truth and misses the core insight. While it correctly identifies that Apple discussed the iMac in the context of its product lineup, it incorrectly implies that the 2024 10-K explicitly mentions a 'new iMac' introduced in the first quarter — this detail is not supported by the provided ground truth. The ground truth emphasizes a shift in narrative treatment (from standard product to highlighted innovation), not timing of release. (2) There are no explicit numbers (e.g., sales figures, percentages) in either answer, so quantitative accuracy is not heavily penalized, but the LLM invents a causal link between Mac sales growth and laptops 'driving' it, which is speculative and not in the original. This undermines factual precision. (3) The multi-hop reasoning is flawed: the ground truth hinges on a qualitative shift in disclosure tone and categorization (iMac being listed among key launches), which reflects strategic repositioning. The LLM instead focuses on sales trends and an unverified product launch timeline, failing to capture the synthesis of narrative emphasis across years. (4) Contextual relevance is moderate — the answer addresses Apple’s iMac strategy and cites the 10-K, but misdirects on execution by emphasizing sales drivers and new product timing over disclosure-based strategic signaling. Thus, while relevant, it misses the key analytical point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 412,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "Between 2022 and 2024, RTX issued the 2.820% Notes Due 2051 for $1.0 billion in August 2021 to refinance maturing debt (specifically the 2.800% and 2.500% notes due 2022). These notes remained outstanding and unchanged in 2023 and 2024, indicating a stable long-term debt structure. The continued presence of these low-interest, long-maturity notes suggests RTX is managing its debt portfolio to extend maturities and reduce refinancing risk, aligning with its strategy of maintaining a balanced capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies but captures some correct elements. It correctly identifies the 2.820% Notes Due 2051 and the $1 billion ($1,000 million) principal amount, which aligns with the ground truth. However, it incorrectly states the notes were issued in August 2021, while the ground truth indicates they were introduced in 2022. This is a critical date error. Additionally, the LLM claims the issuance was to refinance maturing 2.800% and 2.500% notes due 2022, but this specific refinancing detail is not present in the ground truth and represents an unsupported inference. (2) Quantitative accuracy is partially correct: the $1.0 billion figure matches the $1,000 million in the original answer (allowing for format variation), but the issuance date (2021 vs 2022) is factually wrong. The ground truth does not mention any refinancing purpose, so that claim lacks support. (3) The multi-hop reasoning is partially sound—the model correctly infers stability in the 2051 notes and links this to long-term debt management strategy. However, it fails to incorporate the key insight from the ground truth that total long-term debt increased from $40,078 million to $41,146 million between 2022 and 2024, indicating broader debt growth despite no change in the 2051 notes. This omission significantly weakens the completeness and depth of the analysis. (4) The contextual relevance is high because the answer addresses RTX’s relationship with the 2051 notes and draws reasonable (though unsupported) conclusions about debt strategy. However, the correctness score is reduced due to factual errors in timing and unsupported claims about refinancing, along with missing the key comparative data on overall debt growth. Thus, while the answer is plausible and thematically relevant, it lacks full factual and quantitative fidelity to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 509,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "Between 2022 and 2023, the terms of Schwab's IDA agreement were amended to adjust the service fee on client cash deposits held at the TD Depository Institutions, reducing it from 25 basis points to 15 basis points. This change reflects a cost optimization measure, aligning with the Company's broader efforts to manage interest rate risk and liquidity. Additionally, the reference rate for the agreement was transitioned from LIBOR to alternative benchmark indices, as part of Schwab's comprehensive phase-out of LIBOR.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the service fee reduction from 25 to 15 basis points in 2022 and the 2023 LIBOR transition are accurately reported. No calculation errors. (2) The answer addresses both parts of the question—service fee changes and reference rate adjustments—and correctly identifies the entities (Schwab, IDA agreement, TD Depository Institutions) and timeframes (2022–2023). (3) The multi-hop reasoning is sound: it synthesizes fee structure changes in one year with benchmark rate evolution the next, reflecting the agreement’s evolution. (4) The only minor shortcoming is that the LLM attributes the fee reduction to 'cost optimization' and 'interest rate risk management,' which, while plausible, is not explicitly stated in the ground truth; the original answer emphasizes structural evolution rather than strategic rationale. This slight interpretive addition does not detract from factual correctness but introduces a minor qualitative divergence. Otherwise, semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 324,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "The change in Filorga's financial treatment from being a standalone reporting unit with $221 million in goodwill in 2023 to being listed among other trademarks within broader segments in 2024 suggests a shift in its strategic importance and valuation approach by the company. Filorga's integration into broader segments may indicate a reevaluation of its standalone value, potentially reflecting a reduced emphasis on its individual performance or a strategic decision to consolidate reporting for operational efficiency. This could also imply that Filorga's future cash flows and brand strength are now viewed as more aligned with the broader portfolio, leading to a simplified valuation approach as part of larger trademark groups.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in Filorga's financial treatment from 2023 to 2024, accurately stating that it was a standalone reporting unit with $221 million in goodwill in 2023 and was integrated into broader segments in 2024 without separate disclosure. All factual elements—goodwill amount, years, and nature of change—are correct. (2) Quantitative accuracy is perfect: the $221 million goodwill figure and the years 2023 and 2024 are correctly cited with no calculation errors. Format is consistent and matches the ground truth. (3) The reasoning is sound and captures the multi-hop synthesis: the shift from standalone to consolidated reporting implies a strategic reevaluation, reduced individual emphasis, and alignment with portfolio-level valuation. The LLM infers plausible implications—integration for operational efficiency, alignment of cash flows with broader portfolio, simplified valuation—consistent with the ground truth. However, it omits a specific mention of how this affects impairment analysis or potential strategic decisions like divestiture or brand prioritization, which are present in the original answer. This minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing the question about strategic importance and valuation approach. Overall, the LLM conveys semantically equivalent information with only slight reduction in depth, warranting a correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 415,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "The 2024 10-K filing reflects a more detailed and forward-looking disclosure about the iPhone 16 Pro compared to the 2023 filing, which primarily listed existing models. In the 2024 filing, Apple explicitly mentions the launch of the iPhone 16 Pro in the fourth quarter, aligning with broader product announcements and emphasizing innovation such as Apple Intelligence™ and updated operating systems. This shift indicates a strategic evolution toward highlighting product differentiation, technological advancements, and future offerings, reinforcing Apple’s focus on innovation and competitive positioning in its reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims the 2024 10-K includes a 'forward-looking disclosure' about the iPhone 16 Pro and mentions its 'launch in the fourth quarter,' which contradicts the ground truth: the 2024 10-K should reflect retrospective reporting of the iPhone 16 Pro as an existing product, not a future launch. The original answer states that in the 2023 10-K, the iPhone 16 Pro was announced as part of the Fourth Quarter 2024 lineup (i.e., forward-looking), while in the 2024 10-K it is treated as an established product—indicating the product has already launched and is now part of the current portfolio. The LLM reverses this progression. (2) There are no numeric values to verify, but the temporal logic (2023 vs 2024 reporting posture) is fundamentally wrong. (3) The multi-hop reasoning fails: the model does not recognize the shift from forward-looking (2023) to retrospective (2024) disclosure as a reflection of product lifecycle maturity. Instead, it incorrectly frames the 2024 filing as more forward-looking, which is the opposite of the truth. (4) The mention of 'Apple Intelligence™' and updated operating systems is speculative and not supported by the ground truth. While the answer is relevant to Apple's reporting strategy, its core factual premise is inverted, leading to a mostly incorrect response. Hence, low scores for correctness, quantitative, and qualitative accuracy; moderate score for contextual relevance due to addressing product strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 419,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "Between 2022 and 2023, the company enhanced its Economic Value of Equity (EVE) simulations by incorporating updated modeling assumptions and a more refined understanding of balance sheet dynamics. In 2023, EVE sensitivity generally increased due to a significant shortening of liability duration as interest rates rose, while asset duration remained largely stable. Key assumptions in the EVE calculations included improved projections of interest rate scenarios with rate floors, prepayment speeds for mortgage-related investments, and the behavior of non-maturity client cash. Additionally, the company updated deposit beta assumptions in a declining market interest rate environment, which improved the accuracy of simulations in capturing client cash allocation changes. These enhancements reflect a more dynamic and responsive approach to assessing long-term interest rate risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key modeling assumptions used in EVE simulations such as prepayment speeds, non-maturity deposit behavior, and deposit beta updates in a declining rate environment, which aligns with the ground truth. It also accurately notes the evolution toward a more dynamic modeling approach. However, it introduces a claim not present in the original answer — that 'EVE sensitivity increased due to a significant shortening of liability duration as interest rates rose' — which is not mentioned in the 2022–2023 comparison in the ground truth. Additionally, the original answer emphasizes that in 2023 the company began capturing 'client cash allocation changes' on the balance sheet in EVE simulations, a specific enhancement not clearly attributed to EVE in the LLM response, where it is instead linked to improved simulation accuracy generally. (2) There are no explicit numerical values (e.g., percentages, dollar amounts) in either the question or ground truth, so quantitative accuracy is high by default; the LLM does not fabricate numbers and correctly references years (2022, 2023). (3) The multi-hop reasoning is partially sound — the model connects evolving assumptions (e.g., deposit betas, client cash behavior) across years, but misattributes the cause and timing of balance sheet dynamics. The original answer specifies that client cash allocation impact was newly included in 2023, whereas the LLM implies it was always modeled but improved. (4) The contextual relevance is strong as the response stays focused on EVE evolution, assumptions, and balance sheet dynamics. The correctness score is 7 because core facts and modeling enhancements are present and accurate, but there is a notable omission of the explicit expansion of EVE’s role in 2023 to include client cash allocation effects and an addition of unsupported detail about liability duration shortening.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 518,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 enhanced its competitive positioning by expanding its product portfolio into edge networking, including mobile broadband and wireless access points. This move allowed Qualcomm to leverage its foundational technologies in Wi-Fi and 5G to offer end-to-end solutions, strengthening its presence in the broader networking market and differentiating itself from competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately captures Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 (correct years and entity actions). The answer correctly identifies the impact on competitive positioning and product portfolio breadth, noting the expansion into end-to-end solutions in edge networking. It mentions relevant technologies (Wi-Fi, 5G) and correctly frames the move as enhancing presence in the broader networking market. The only minor omission is the lack of explicit mention of specific competitors like Broadcom and Intel, and the absence of detailed product suite components such as network processors, which were included in the original answer. However, the core reasoning and synthesis across the two years and strategic phases are sound. All dates and technological references are accurate. There are no numerical inaccuracies (no calculations or dollar amounts involved), so quantitative accuracy is perfect. The answer is semantically equivalent in intent and meaning, with strong contextual relevance and high qualitative accuracy in reasoning and entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 339,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "From 2022 to 2023, the percentage of Schwab's adjustable-rate mortgages with interest-only terms slightly decreased from 27% to 28%, while the portion of interest-only loans not scheduled to reset for three or more years increased from 86% to 89%. This indicates a marginal shift toward longer reset periods for interest-only mortgages in Schwab's portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported percentages. According to the ground truth, in 2022, 28% of adjustable-rate mortgages were interest-only, decreasing to 27% in 2023. The LLM incorrectly states the opposite trend, claiming a rise from 27% to 28%. Similarly, the portion not scheduled to reset for three or more years was 89% in 2022 and decreased to 86% in 2023, but the LLM incorrectly reports an increase from 86% to 89%. These inversions of direction and values are major quantitative inaccuracies. (2) All numerical values are incorrect in direction and assignment to years, failing basic quantitative accuracy. The model swaps the years for both metrics, leading to a completely reversed interpretation. (3) The multi-hop reasoning is structurally sound—comparing two metrics across two years—but the logic is applied to incorrect data, leading to a false conclusion about a 'shift toward longer reset periods,' when in fact both metrics declined, indicating a tightening. (4) Contextual relevance is high because the answer addresses the right entities (Schwab, HELOC, interest-only terms, reset periods) and attempts the correct comparison, but factual correctness is severely compromised. Due to the inversion of key data points, the correctness score is very low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 375,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "Qualcomm's involvement in the XR (Extended Reality) market has shown a strategic shift from 2022 to 2023, as evidenced by their disclosures. In 2022, Qualcomm emphasized its investments in XR as part of its broader R&D efforts, including developing foundational technologies for devices like XR headsets. By 2023, the company expanded its focus, with specific mentions of XR as a key application area in QCT's IoT revenue stream, indicating increased product development and market engagement. Additionally, Qualcomm's strategic investments through Qualcomm Ventures in early-stage companies, particularly in the XR space, highlight a more targeted approach to fostering innovation and expanding opportunities in this sector.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates (2022 to 2023) and correctly identifies Qualcomm's strategic investments via Qualcomm Ventures in XR during 2022. It also acknowledges the increased focus on XR in 2023, particularly within QCT's IoT segment, which aligns with the commercialization shift. However, the LLM answer falls short in explicitly stating the key evolution: the transition from purely investment-driven involvement in 2022 to direct revenue generation in 2023. While it mentions XR as a 'key application area' in 2023, it does not clearly state that XR was explicitly listed among revenue-generating product areas, which is the critical multi-hop insight from the ground truth. The reasoning is sound but incomplete in synthesizing the shift from investment to monetization. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (Qualcomm, XR, Qualcomm Ventures, QCT, IoT) are correctly identified. The answer is contextually relevant and well-structured, but misses the core conclusion about revenue disclosure, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 320,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained unchanged at $1,100 million between 2022 and 2024. This stability indicates that RTX has not issued additional notes or repaid a portion of this specific long-term debt during this period, reflecting a consistent component of its long-term debt structure with a focus on extended maturities to manage refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the aggregate principal balance of the 3.030% Notes Due 2052 remained unchanged at $1,100 million between 2022 and 2024, which matches the ground truth exactly. All numeric values (principal amount, interest rate, maturity year, time period) are accurate. (2) Quantitative accuracy is perfect: $1,100 million is correctly reported for both years, with no erroneous calculations or misstatements. Format is consistent and acceptable. (3) The reasoning is sound and captures the core implication — that RTX maintained this debt without repayment or issuance, indicating stability in its long-term debt structure. It appropriately infers strategic consistency, particularly around extended maturities and refinancing risk management, which aligns semantically with the ground truth’s emphasis on 'strategic consistency' and 'long-term commitment.' (4) The only minor shortcoming is that the LLM answer does not explicitly mention that other components of long-term debt may have changed, which adds contextual nuance to the stability of this specific note. However, this omission does not detract significantly from the overall correctness. All other aspects — entity (RTX), metric (aggregate principal balance), years (2022–2024), and financial instrument — are accurately identified and synthesized. The answer is contextually highly relevant and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 393,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "AXP's focus on Corporate Card solutions evolved between 2023 and 2024 by emphasizing innovation and differentiation in its commercial payments offerings. In 2023, the company highlighted evolving card value propositions and differentiating corporate card and accounts payable expense management solutions. By 2024, AXP expanded on this strategy by integrating financing, banking, and payment solutions for business customers, indicating a broader push to enhance its commercial offerings. This shift suggests that AXP is prioritizing tailored, comprehensive solutions to strengthen its position in the commercial payments market and better meet the needs of its business clients.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: AXP's 2023 focus on evolving card value propositions and differentiating corporate card and accounts payable solutions is accurately reported. The 2024 shift toward integrating financing, banking, and payment solutions is also correctly stated. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2023 and 2024), which are accurate. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the evolution across two years and infers strategic intent. The only minor gap is that the LLM answer does not explicitly state that the Corporate Card is being embedded into a 'wider suite' or 'holistic commercial needs' as in the original, but it does convey the idea of 'comprehensive solutions' and 'broader push,' which are semantically close. (4) Contextual relevance is perfect—the response directly addresses both parts of the question: the evolution between 2023 and 2024 and what the shift suggests about commercial payments strategy. The conclusion about prioritizing tailored, comprehensive solutions accurately reflects the strategic implication. Overall, the answer is factually correct, well-reasoned, and only slightly less precise in framing the strategic embedding of the card into broader services, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 413,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "Between 2023 and 2024, PCA SKIN's strategic positioning within Colgate-Palmolive's Oral, Personal and Home Care segment remained consistent in terms of distribution channels. The brand continued to be sold primarily through traditional and e-commerce retailers, wholesalers, distributors, and in some geographies, directly to skin health professionals. There is no indication of a significant shift in distribution strategy during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in PCA SKIN's strategic positioning between 2023 and 2024. (1) The original answer states that in 2023, PCA SKIN was distributed through traditional and eCommerce retailers, wholesalers, distributors, and dentists, with no mention of skin health professionals. By 2024, the distribution channels were explicitly expanded to include skin health professionals in some geographies—a notable refinement in positioning. The LLM incorrectly frames this as a continuation, stating the brand was 'already' sold to skin health professionals in 2023, which is not supported by the 2023 data. (2) There are no numeric values or calculations in this question, so quantitative accuracy is not applicable; however, the years (2023, 2024) and entities (PCA SKIN, Colgate-Palmolive, Oral, Personal and Home Care segment) are correctly identified. (3) The multi-hop reasoning is flawed: the model fails to detect the change in distribution channel strategy from 2023 to 2024, which is the core of the question. Instead, it asserts consistency where there is a documented expansion. (4) While the answer is contextually relevant and uses appropriate terminology, it lacks the critical insight about strategic refinement in distribution, leading to a moderate correctness score. The answer would be more accurate if it acknowledged the addition of skin health professionals as a new distribution channel in 2024, rather than implying continuity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 408,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "Between 2022 and 2023, Opdivo's strategic focus and commercial positioning evolved through the expansion of new tumor indications and combination therapies. In 2023, Opdivo received FDA and EC approvals for adjuvant treatment of melanoma and neoadjuvant treatment of resectable NSCLC, broadening its use into earlier lines of therapy. Additionally, Opdivo continued to be developed in combination with Yervoy and other anti-cancer agents across multiple tumor types. These advancements supported Opdivo as a key growth driver, partially offsetting revenue declines from other products like Revlimid and contributing to higher sales of the New Product Portfolio, as noted in 2023 results. This strategic expansion positions Opdivo to sustain revenue growth by capturing new patient populations and enhancing its role in combination regimens.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Opdivo's strategic evolution between 2022 and 2023, with correct emphasis on new indications (adjuvant melanoma, neoadjuvant resectable NSCLC), earlier lines of therapy, and continued development of combination regimens with Yervoy and other agents. It correctly identifies the strategic intent to sustain revenue growth by expanding into new patient populations and combination use. There are no numeric inaccuracies—while no specific dollar figures or percentages are mentioned, the qualitative financial implications (Opdivo as a growth driver, offsetting declines in Revlimid, contributing to New Product Portfolio sales) align with the ground truth's implication of revenue trajectory support. The answer is contextually highly relevant and addresses all parts of the question: evolution in strategic focus, new indications, combination therapies, and revenue implications. The only minor gap is that the LLM answer does not mention the subcutaneous formulation—a key 2023 development noted in the ground truth that supports long-term adoption. While the core facts and reasoning are sound (multi-hop synthesis across approvals, combinations, and commercial impact), this omission slightly reduces completeness and qualitative accuracy. However, the answer still captures the essential trajectory and strategic intent, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 391,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "American Express's investment in foreign government bonds and obligations remained stable in fair value between 2023 and 2024, with $770 million in 2023 and $765 million in 2024. In terms of maturity distribution, in 2023, these obligations were primarily due after 10 years, while in 2024, all were due within one year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, American Express held $549 million in foreign government bonds in 2023, not $770 million as stated. The 2024 value is correctly reported as $765 million. The LLM incorrectly claims the investment remained stable, when in fact there was a substantial increase from $549M to $765M. (2) Maturity distribution is also wrong: in 2023, all $549 million matured in 12 months or more (i.e., over one year), not after 10 years. In 2024, $764 million matured within one year and $1 million after one year but within five years — the LLM correctly identifies that all matured within one year in 2024, but this contradicts the ground truth which shows $1 million maturing beyond one year. (3) The multi-hop reasoning is flawed: the model fails to recognize the significant increase in fair value and misrepresents the maturity shift. It incorrectly implies stability and a dramatic shift from long-term (>10 years) to short-term, while the actual data shows a shift from long-term (>1 year) to predominantly short-term, but with a large increase in total holdings. (4) The contextual relevance is moderate because the answer addresses the right topic and structure (fair value and maturity over time), but the factual inaccuracies severely undermine correctness. Quantitative accuracy is very low due to wrong numbers and mischaracterization of trends. Qualitative accuracy is low due to incorrect synthesis and reasoning. Correctness score is 2 due to mostly incorrect data and flawed interpretation, despite touching on the right concepts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 447,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "Between 2022 and 2024, Walmart's use of intercompany financing arrangements has remained consistent in its purpose to ensure cash is available in the country where it is needed at the minimum cost. In 2022, approximately $4.3 billion of cash held outside the U.S. was not freely transferable due to local laws or restrictions, with $2.2 billion requiring approval from Flipkart minority shareholders. By 2024, this amount decreased to $3.5 billion, with no specific breakdown of Flipkart-related restrictions mentioned. The conditions for transferring cash to the U.S. continue to involve approval from noncontrolling interest shareholders in certain subsidiaries and compliance with local legal constraints.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it states that the 2024 amount of cash not freely transferable is $3.5 billion, while the ground truth reports $3.3 billion. This $0.2 billion discrepancy affects the precision of the response. All other numbers (2022's $4.3 billion and $2.2 billion tied to Flipkart) are accurate. (2) The qualitative aspects are strong: the answer correctly identifies the shift in language from Flipkart-specific restrictions to broader noncontrolling interest shareholder approvals, reflecting a structural evolution in intercompany financing arrangements. It also correctly notes ongoing compliance with local laws. (3) The multi-hop reasoning is sound—synthesizing changes over time in both amount and conditions for transfer across subsidiaries and shareholder structures. The answer captures the essence of the evolution, even if the exact 2024 figure is slightly off. (4) Contextual relevance is perfect—the response directly addresses both parts of the question: the change in restricted cash amounts and the evolving conditions for transfer. The slight numerical error prevents a higher score, but core facts and reasoning remain intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 345,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "Between 2023 and 2024, the composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained largely consistent in terms of fixed income securities and equity securities allocation. In both years, the allocation was approximately 80% fixed income securities and cash equivalents and 20% equity securities. Specifically, in 2023, the plan had $210 million in fixed income and $54 million in equity securities, while in 2024, it had $198 million in fixed income and $50 million in equity securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported dollar amounts for 2024. According to the ground truth, the asset values were identical in 2023 and 2024: $210 million in fixed income and $54 million in equity securities. However, the LLM incorrectly states that in 2024, the plan had $198 million in fixed income and $50 million in equity securities, which contradicts the source data. While the percentages (approximately 80% and 20%) are reasonably close to the true values of 79.5% and 20.5%, the incorrect underlying figures undermine the accuracy. (2) Quantitative accuracy is severely compromised: the dollar amounts for 2024 are wrong, and no such change occurred according to the filings. The total plan assets should be $264 million in both years, but the LLM implies a drop to $248 million in 2024. Calculations based on incorrect inputs are not acceptable even if rounded. (3) The reasoning is partially sound in that it attempts to compare two years and assess stability in allocation, and it correctly identifies the plan and company. However, it fails the multi-hop requirement to accurately extract and compare exact figures across filings, leading to a false conclusion about minor changes when there were none. (4) Contextual relevance is high because the answer addresses the right plan, company, time frame, and asset classes, and interprets the intent of assessing allocation trends. However, due to major quantitative errors and incorrect synthesis, the overall correctness score is low despite relevant structure and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 433,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "Between 2022 and 2024, Honeywell's 2006 Stock Plan for Non-Employee Directors evolved by introducing and amending specific award agreements, such as the \"Form of Stock Option Agreement\" and \"Form of Restricted Stock Unit Agreement.\" These changes indicate a shift toward more structured and performance-based compensation mechanisms for non-employee directors, reflecting a broader trend of aligning director incentives with long-term company performance and shareholder interests.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. While it correctly references Honeywell and the 2006 Stock Plan for Non-Employee Directors, it incorrectly states that there were 'amendments' or 'introductions' of agreements between 2022 and 2024. The ground truth shows no new forms were introduced; rather, the 'Form of Restricted Unit Agreement' (Exhibit 10.32 in 2022) disappeared from the exhibit list by 2024 (Exhibit 10.29 for options only), suggesting a phase-out of restricted units. The LLM incorrectly implies both forms were actively used or updated, when in fact the restricted unit form was no longer listed. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not heavily applicable; however, the years 2022 and 2024 are correctly referenced, earning partial credit. (3) The multi-hop reasoning is flawed: the model fails to recognize that the evolution is defined by the removal of a specific exhibit (restricted units) rather than the introduction or amendment of agreements. It also incorrectly infers a shift toward 'performance-based' compensation, which is not supported by the evidence—stock options are not inherently more performance-based than restricted units. The ground truth suggests a shift toward stock options *over* restricted units, not necessarily toward performance-based structures. (4) The answer is contextually relevant and addresses the general topic of director compensation evolution, but misses the key factual shift (discontinuation of restricted unit agreements) and draws an unsupported conclusion about performance-based incentives. Thus, while the direction of change (evolving award types) is acknowledged, the specifics and implications are incorrect, warranting a moderate correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 493,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "Between 2022 and 2024, Walmart's ownership stake in Flipkart decreased from approximately 83% to 75% following a new equity funding in 2022. Financially, this dilution reduced Walmart's direct exposure to Flipkart's performance but maintained a significant controlling interest. Regulatory risks emerged, particularly in India, where Flipkart faced investigations by the Directorate of Enforcement regarding potential violations of Foreign Direct Investment rules and the Competition Commission of India (CCI) probing alleged antitrust violations. These matters could result in monetary penalties, share ownership restrictions, or other non-monetary relief, though outcomes remain uncertain and could materially affect Walmart's financial position.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in Walmart's ownership stake in Flipkart from 83% to 75% in 2022 and the associated equity funding event, which aligns with the ground truth. The financial implication of reduced direct exposure while maintaining control is accurately conveyed. However, the LLM omits the specific $3.2 billion equity funding amount, which is a key quantitative detail from the original answer. (2) All mentioned percentages and the timeline (2022 ownership change) are correct. The absence of the $3.2 billion figure is a minor but notable omission in quantitative completeness, though no incorrect numbers are presented. (3) The LLM correctly synthesizes the evolution of Walmart’s strategic position by linking reduced ownership to ongoing regulatory risks. It accurately references regulatory scrutiny in India, including FDI rule investigations and antitrust probes by the CCI. However, it does not specify that the show cause notice was issued in July 2021 (pre-2022) and relates to conduct between 2009–2015—before Walmart’s acquisition—nor does it clarify that Walmart cannot estimate potential losses or indemnification, a key financial disclosure. This weakens the depth of multi-hop reasoning regarding legacy risk exposure. (4) Despite these omissions, the answer remains contextually strong, addressing both financial implications and regulatory risks as required. The reasoning is sound and semantically close to the original, warranting high scores in qualitative accuracy and contextual relevance. The correctness score is 8 due to missing key financial figures and some regulatory timeline specifics, but core facts and synthesis are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 466,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "Between 2022 and 2024, HON's U.S. cash balances increased significantly, from $3.4 billion in 2022 to $8.0 billion in 2024, while total cash holdings rose from $10.9 billion to $11.0 billion. The geographic distribution of funds shifted, with a growing proportion held in the U.S., reflecting strategic emphasis on liquidity and capital access for acquisitions and operations. In 2024, $8.0 billion of cash was held in non-U.S. subsidiaries, compared to $8.1 billion in 2023 and $3.4 billion in 2022, indicating a more balanced global allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, HON had $11.5 billion in cash and equivalents as of December 31, 2021 (reported in 2022), not $10.9 billion in 2022. The 2024 total is correctly stated as $11.0 billion, but the claim that U.S. cash increased from $3.4 billion in 2022 to $8.0 billion in 2024 is incorrect — the ground truth states that $8.0 billion was held in *non-U.S.* subsidiaries in 2024, implying only $3.0 billion was in the U.S. Thus, the geographic distribution is completely reversed in the LLM answer. Additionally, the claim that non-U.S. cash was $3.4 billion in 2022 contradicts the ground truth, which does not specify a 2022 non-U.S. amount but implies a shift *toward* non-U.S. holdings by 2024. (2) Key numbers are wrong: total cash in 2022 is misstated ($10.9B vs $11.5B), U.S. cash balances are fabricated, and non-U.S. cash trends are misrepresented. The calculation that total cash rose from $10.9B to $11.0B is close but based on incorrect inputs. (3) The multi-hop reasoning fails: the model incorrectly infers a growing U.S. concentration when the truth indicates a shift *away* from the U.S. It also invents year-over-year data (e.g., $8.1B in 2023) not present in the ground truth. (4) Despite incorrect facts, the answer is contextually relevant — it addresses cash composition, geographic distribution, and strategic emphasis — but the qualitative reasoning is flawed due to incorrect data synthesis. The strategic emphasis on safety and diversification is omitted and replaced with unmentioned goals like 'acquisitions and operations.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 447,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "From 2023 to 2024, the financial treatment and liability estimation methodology for the Membership Rewards program evolved in terms of assumptions used for deferred fees and liability modeling. In 2023, the Membership Rewards liability was estimated using the Ultimate Redemption Rate (URR) and the Weighted Average Cost (WAC) per point, based on redemption trends, card product type, enrollment tenure, and other factors. By 2024, the methodology remained similar but included more explicit sensitivity analyses: a 25 basis point increase in URR would increase the liability by approximately $197 million, and a 1 basis point increase in WAC per point would increase it by approximately $220 million. These changes highlight a more refined and transparent approach to modeling assumptions and their potential impact on the liability.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timeline: it claims that in 2023, the liability was already estimated using Ultimate Redemption Rate (URR) and Weighted Average Cost (WAC) per point. However, the ground truth states that in 2023, the company only mentioned 'deferred fees' without detailing the URR/WAC methodology. The detailed modeling with URR and WAC was introduced in 2024, representing a key evolution. This misattribution of the methodology to 2023 undermines the core of the answer. (2) Quantitatively, the numbers are accurate: the $197 million impact from a 25 bps increase in URR and $220 million from a 1 bps increase in WAC are correctly reported, matching the ground truth. These values are critical and correctly conveyed. (3) The multi-hop reasoning is partially sound— the LLM correctly identifies the increased transparency and sensitivity analysis in 2024. However, it fails to correctly contrast 2023 (simpler deferred fee recognition) with 2024 (advanced model-driven approach), instead suggesting the same model was used in both years with only added sensitivity analysis. This misrepresents the evolution. (4) Contextual relevance is high—the answer addresses the right program, time frame, and type of change (from assumptions to sensitivity). But due to the fundamental misrepresentation of when the URR/WAC model was adopted, the qualitative and overall correctness scores are significantly reduced. The answer gives the impression of refinement rather than a substantive methodological shift, which is incorrect per the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 438,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "Adobe acquired Frame.io in October 2021 for approximately $1.18 billion and began integrating it into its Digital Media segment. By 2024, Frame.io is positioned as a core component of Adobe's creative ecosystem, directly integrated with key products like Adobe Premiere Pro, After Effects, Photoshop, and Lightroom, enabling seamless video collaboration and production workflows. Additionally, Frame.io is part of Adobe GenStudio, enhancing content production at scale and aligning with Adobe's broader strategy to unify creative tools and workflows across its Digital Media offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.18 billion acquisition amount and accurately reflects the strategic evolution of Frame.io from integration into the Digital Media segment to becoming a core part of Adobe's creative ecosystem by 2024. The key products integrated—Premiere Pro, After Effects, Photoshop, and Lightroom—are correctly listed. However, the original answer specifies Workfront as one of the integrated tools, while the LLM mentions Lightroom instead. This is a minor discrepancy, as both are part of Adobe’s ecosystem, but Workfront was explicitly named in the ground truth in the context of collaboration suite integration. (2) Quantitatively, all numbers and dates are accurate: acquisition in October 2021 (which aligns with the 2022 reporting cycle), $1.18 billion price tag—both match ground truth. The LLM correctly avoids misstating financials or timelines. (3) The multi-hop reasoning is sound: the answer traces Frame.io’s journey from acquisition to deeper integration, connects it to Adobe GenStudio, and links it to Adobe’s broader strategy of unifying creative workflows. The synthesis across time (2022 to 2024) and products is logically structured and factually supported. (4) The answer is contextually highly relevant, directly addressing how Frame.io’s strategic positioning evolved and its alignment with Adobe’s ecosystem. The substitution of Lightroom for Workfront prevents a perfect score, but otherwise, the response is factually robust, well-reasoned, and semantically equivalent to the original answer in intent and substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 436,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "The fair value measurements of equity-like funds using significant unobservable inputs (Level 3) for defined benefit pension plans increased from $25.4 million in 2022 to $25.1 million in 2023, showing a slight decrease. For retiree health benefit plans, the Level 3 fair value measurements for equity-like funds remained relatively stable, decreasing marginally from $2.4 million in 2022 to $2.4 million in 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The ground truth states that equity-like funds under private alternative investments had a Level 3 fair value of $5.5 million in 2022 and increased to $25.4 million in 2023. The LLM incorrectly reports $25.4 million in 2022 and $25.1 million in 2023, reversing the trend and misstating both values. Additionally, the LLM introduces 'defined benefit pension plans' and 'retiree health benefit plans', which are not mentioned in the original question or answer, indicating a complete mismatch in context. (2) Quantitatively, the numbers are wrong: 2022 value should be $5.5M, not $25.4M; 2023 value should be $25.4M, not $25.1M. The claimed 'slight decrease' is factually incorrect—the actual change is a fivefold increase. The retiree health plan figures ($2.4M) are entirely fabricated. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the investment category (private alternative investments, not pension or health plans), misattributes the data to incorrect entities, and draws an incorrect conclusion about the trend. There is no evidence of proper synthesis from the correct sources. (4) The contextual relevance is low because the answer discusses unrelated benefit plans instead of the composition of private alternative investments. The qualitative accuracy is extremely low due to incorrect entities, numbers, and logic. Only minimal credit is given for mentioning Level 3 inputs and equity-like funds, which are part of the correct conceptual framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 425,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "Adobe acquired Frame.io in October 2021 for approximately $1.18 billion and began integrating it into its Digital Media segment. By 2024, Frame.io is positioned as a cloud-native creative collaboration platform, directly integrated with key Adobe Apps like Adobe Premiere Pro, After Effects, Photoshop, and Lightroom. It supports real-time upload, review, and approval workflows and is part of Adobe GenStudio, enabling scalable content production. Frame.io's integration has expanded Adobe's Digital Media offerings by enhancing collaboration capabilities across the creative workflow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe acquired Frame.io in October 2021 (not 2022, but the answer correctly references the 2021 acquisition), and integration into the Digital Media segment began shortly after. By 2024, Frame.io was deeply integrated with Premiere Pro, After Effects, Photoshop, Lightroom, and included in Adobe GenStudio—details accurately reflected. (2) Quantitative accuracy is perfect: the $1.18 billion acquisition figure, while not in the original answer, is factually correct and adds valid context without contradicting the ground truth. Dates (2021 acquisition, evolution through 2024) are accurate. (3) Multi-hop reasoning is sound: the answer synthesizes Frame.io’s acquisition, initial integration, and expanded role by 2024 across Adobe’s creative suite, capturing the evolution in positioning. (4) The only minor omission is that Workfront is mentioned in the original answer as a key integration point, which the LLM answer leaves out. However, this does not undermine the core correctness. The answer effectively conveys the strategic evolution from initial integration to ecosystem embedding. Wording differs but semantic meaning matches. Contextual relevance is excellent, directly addressing the evolution between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 371,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "Between 2022 and 2024, CVS expanded its Medication Management approach by enhancing clinical programs and digital tools to improve medication adherence and cost efficiency. In 2022, CVS emphasized medication management programs like Pharmacy Advisor, which offered counseling and adherence support for chronic conditions, and introduced tools to address opioid misuse. By 2024, CVS had further integrated digital connectivity and AI-driven technologies, such as the Health Engagement Engine and the NovoLogix preauthorization tool, to optimize medication use and identify cost-saving opportunities. Additionally, the acquisition of Oak Street Health and expansion of in-home health evaluations (IHEs) enabled more personalized care and proactive medication management, reinforcing CVS's commitment to value-based care and patient outcomes.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of CVS's Medication Management approach from 2022 to 2024, highlighting key digital tools like NovoLogix and the integration of value-based care through Oak Street Health. It accurately notes the shift toward digital tools and personalized care. However, it introduces 'Pharmacy Advisor' and 'Health Engagement Engine' which are not mentioned in the ground truth and cannot be verified as part of CVS's 2022 programs. The ground truth emphasizes formulary management, real-time benefit tools, and the seven-day opioid supply policy in 2022—details omitted in the LLM response. In 2024, the LLM correctly identifies NovoLogix and Oak Street Health expansion but misses the CVS Weight Management program and GLP-1 integration, which are key clinical expansions. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—score reflects no factual numeric errors. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward digital and value-based care, and links Oak Street Health to enhanced medication management. However, it substitutes unverified programs (e.g., Pharmacy Advisor, Health Engagement Engine) instead of citing the specific clinical programs in the ground truth, indicating a gap in entity accuracy and synthesis. (4) The answer is contextually relevant and captures the overall direction of CVS's evolution, but lacks completeness and precision in key clinical program details, leading to a moderate deduction in correctness and qualitative accuracy. Minor hallucinations prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 459,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved significantly from 2022 to 2024 by enhancing collaboration features and deepening integration with key Creative Cloud applications. In 2022, Adobe acquired Frame.io and began integrating it into Creative Cloud, focusing on enhancing review and approval capabilities in Premiere Pro and After Effects. By 2024, Frame.io was further embedded into the ecosystem, supporting real-time upload, frame-accurate commenting, and integrations with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. Specific enhancements included Camera to Cloud functionality for automatic footage upload from cameras directly into Frame.io and expanded support for video workflows beyond post-production, such as casting and marketing campaign management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Adobe acquired Frame.io in 2022 and integrated it into Creative Cloud, with initial focus on Premiere Pro and After Effects. By 2024, integration expanded to Photoshop, Lightroom, and Workfront, and Camera to Cloud functionality was introduced. These points match the original answer. (2) There are no numeric values requiring calculation, but all dates (2022, 2024) and product names are accurate. (3) The multi-hop reasoning is sound—correctly tracing the evolution from acquisition to broader ecosystem integration and functional expansion. (4) The only minor omission is that the original answer specifies Frame.io evolved to support not just video but still images, design files, and PDFs; while the LLM mentions expanded support, it doesn't explicitly list these file types. Also, the strategic shift toward a broader creative asset platform is implied but not stated as clearly. Despite this, the core information, timeline, enhancements, and integrations are correctly conveyed with high fidelity. Wording differs slightly but maintains semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 329,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "The use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024 by playing a more significant role in determining fair value, particularly for Level 3 assets. In 2024, the fair value of loans and lending commitments increasingly relied on recently executed transactions, market price quotations, and benchmarking to comparable instruments. This is evident from the valuation techniques described, which emphasize the use of observable inputs and executed transactions to estimate fair value, especially when external price data are not available. The shift reflects a greater emphasis on market-based inputs to enhance the reliability of fair value measurements for non-recurring and Level 3 assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and entity synthesis compared to the ground truth. (1) Quantitatively, there are no numeric values to verify, so quantitative accuracy is not compromised. (2) However, the qualitative analysis is flawed: the LLM claims that recently executed transactions played a 'more significant role' in 2024, which contradicts the original answer stating that their role remained 'significant but more targeted'—indicating a refinement, not an increase, in importance. (3) The original answer specifies a shift in application—toward held-for-sale loans and other investments, using transaction data with DCF models and comparable multiples—while the LLM generalizes an increased reliance without evidence of this targeted evolution. Additionally, the LLM introduces 'Level 3 assets' and 'non-recurring' assets, which are not mentioned in the ground truth, adding unsupported detail. (4) The contextual relevance is high because the response addresses fair value determination and valuation inputs, but the reasoning misrepresents the nature of the evolution from 2023 to 2024. Thus, while some correct elements (e.g., use of market quotations, comparable instruments) are present, the core claim about increased significance is incorrect, warranting a mid-range score of 5 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 383,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "Between 2022 and 2024, Adobe's Substance 3D Stager has evolved from being a standalone 3D scene-building tool within the Substance 3D Collection to being more tightly integrated into the broader Substance 3D ecosystem and Adobe's Creative Cloud offerings. In 2022, Stager was described as part of a suite of tools for building and assembling 3D scenes. By 2024, the positioning emphasized its role in a more cohesive 3D workflow, working alongside tools like Substance 3D Painter and Sampler, and benefiting from Adobe's generative AI capabilities such as Firefly. This integration reflects Adobe's strategy to enhance cross-product collaboration and streamline creative workflows for 3D content creation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the evolution of Substance 3D Stager from 2022 to 2024 is accurately portrayed, with correct positioning as a tool for building and assembling 3D scenes. The integration into the broader Substance 3D ecosystem, including Painter, Sampler, Designer, and Modeler, is correctly noted, though the LLM omits explicit mention of Designer and Modeler, slightly reducing completeness. (2) There are no numeric values, dates, or calculations in the response beyond '2022' and '2024', both of which are correct and match the original answer. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across time (2022 vs 2024) and across product strategy (from standalone tool to integrated ecosystem), capturing Adobe's strategic shift. The mention of generative AI and Firefly adds context consistent with Adobe's 2024 direction, even if not in the original answer—this is a reasonable inference and does not detract from accuracy. (4) The answer is semantically equivalent to the ground truth, with only minor omissions (e.g., not naming all four tools explicitly) preventing a perfect score. Overall, the response is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 364,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "From 2022 to 2023, GE's strategic positioning regarding grid-scale batteries evolved as part of its broader energy transition strategy. In 2022, GE emphasized the importance of investing in emerging technologies like grid-scale batteries to support decarbonization goals and modernize power grids. By 2023, grid-scale batteries were highlighted as a critical enabler for renewable energy integration and achieving deep decarbonization in the power sector. GE acknowledged the growing role of such technologies in enabling reliable power systems with high renewable penetration, and the company positioned itself to invest in and develop these solutions as part of its long-term strategy. This shift reflects an increased strategic reliance on grid-scale battery technologies to support its energy transition objectives and maintain competitiveness in evolving markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in GE's strategic positioning toward grid-scale batteries from 2022 to 2023, with accurate dates and no numerical inaccuracies (quantitative accuracy is perfect, as no specific numbers are involved and all time references are correct). The answer reflects that in 2022, GE viewed grid-scale batteries as part of emerging technologies supporting decarbonization, and by 2023, they were elevated to a more critical role in enabling renewable integration and deep decarbonization. However, the original answer specifies a precise shift in language—from 'may become more important over time' to being a dependency 'in part' for achieving decarbonization goals—which the LLM paraphrases as 'critical enabler' and 'increased strategic reliance.' While semantically close, the LLM does not fully reproduce the nuance of GE's shift from speculative interest to partial strategic dependency as explicitly stated in the ground truth. The reasoning is sound and multi-hop (comparing GE's strategic language across two years), and the context is fully relevant. The omission of the exact phrasing from the filings slightly reduces qualitative accuracy, but the overall meaning and strategic trajectory are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 351,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "CVS's disclosure regarding the use of broker-quoted debt securities in its fair value measurements indicates that the company did not have any broker-quoted debt securities in either 2022 or 2024. In both years, Level 3 debt securities were valued using either outside brokers or internal analyses for private placements. The absence of broker-quoted debt securities remained consistent, with no material changes in their presence or impact on financial reporting between 2022 and 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that CVS did not have any broker-quoted debt securities in both 2022 and 2024, which aligns with the ground truth. However, it incorrectly claims that Level 3 debt securities were valued using 'outside brokers or internal analyses' in both years, which contradicts the original answer stating that CVS only used internal pricing for private placements and had no broker quoted securities. The LLM also fails to mention the key evolution in disclosure tone — that the 2024 filing dropped references to impact or review processes related to broker quoted securities, indicating reduced emphasis. This omission significantly affects the qualitative accuracy. (2) Quantitatively, the years (2020–2024) and the absence of broker quoted securities are correctly cited; no numerical errors are present, hence a high quantitative score. (3) The multi-hop reasoning is partially sound — the model identifies consistency in the absence of such securities but fails to synthesize the change in disclosure language and emphasis over time, which is central to the question about 'evolution' in disclosure. (4) Contextual relevance is strong as the answer addresses the core topic of broker-quoted securities in fair value measurements, but the lack of insight into the changing nature of disclosure reduces correctness. The answer is factually mixed and misses a key qualitative shift, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 399,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "Between 2023 and 2024, the composition of BlackRock's Equity Securities at FVTNI changed as follows: \n\n1. **Equity securities/mutual funds** increased from $1,585 million in 2023 to $1,950 million in 2024, reflecting a $365 million growth. \n\n2. **Equity method investments**, particularly in **private equity funds**, rose from $1,264 million in 2023 to $1,060 million in 2024, while **real assets funds** increased from $417 million to $520 million. **Hedge funds/funds of hedge funds/other** remained relatively stable at $588 million in 2023 and $552 million in 2024. \n\nThese changes indicate a strategic shift toward higher allocations in mutual funds and private equity and real assets investments in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, in 2023, equity securities/mutual funds were $1,211 million, but the LLM incorrectly states $1,585 million. Similarly, equity method investments in 2023 were $1,895 million, but the LLM reports $1,264 million (plus additional subcategories not present in the original). The 2024 values for equity securities/mutual funds ($1,950 million) are correct in the LLM answer, but the breakdown of equity method investments into private equity, real assets, and hedge funds is not supported by the original answer, which only provides a single aggregated figure of $2,783 million. The LLM invents subcategories and values (e.g., $1,060 million in 2024 for private equity funds) that contradict the ground truth. (2) Calculations are therefore also incorrect: the claimed $365 million growth in mutual funds is based on a false 2023 baseline. The original shows an actual increase from $1,211M to $1,950M, or $739M, not $365M. The LLM’s claim that equity method investments decreased from $1,264M to $1,060M conflicts with the ground truth showing an increase from $1,895M to $2,783M. (3) The multi-hop reasoning is flawed: while the LLM attempts to synthesize changes over time and categorize investments, it fabricates granular data not present in the source and fails to report the correct aggregated figures. It introduces a level of detail (subcategories) that was not in the original and uses it to draw conclusions not supported by the ground truth. (4) Despite these major errors, the answer is contextually relevant—addressing the right company, time frame, and general topic—and correctly identifies a strategic shift toward growth in these areas, which aligns with the trend in the original. However, due to severe quantitative inaccuracies and incorrect entity values, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 521,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "From 2022 to 2024, UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities remained consistent in methodology, with no material allowance for credit losses reported in any of the years. The Company evaluates impairments by assessing the present value of expected cash flows relative to amortized cost, issuer financial condition, and other relevant factors. While unrealized losses increased over the period due to interest rate fluctuations, the Company maintained that these losses were temporary and not credit-related, as no significant credit deterioration was observed. As a result, the allowance for credit losses remained immaterial in 2022, 2023, and 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that unrealized losses were due to interest rate changes and not credit deterioration, and that no significant credit deterioration was observed, which aligns with the 2022 portion of the ground truth. It also correctly notes the immateriality of the allowance for credit losses in 2022. However, it incorrectly claims the allowance remained immaterial in 2023 and 2024 and that the methodology remained unchanged, which contradicts the ground truth. The original answer specifies that by 2024, UnitedHealth Group had evolved its framework to include a more structured recognition of credit risk, with the allowance explicitly recorded through a separate allowance account and credit impairments affecting investment income—indicating a formalized shift in accounting treatment. The LLM answer misses this key evolution entirely. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—format and references to years (2022–2024) are correct. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the cause of unrealized losses and the qualitative assessment of credit risk in 2022, but fails to recognize the evolution in accounting policy by 2024, which requires synthesis across years and an understanding of changes in disclosure language around impairment recognition. This is a significant omission in the multi-hop analysis. (4) The correctness score is 5 due to major qualitative inaccuracies in representing the evolution of the impairment framework, despite correct context on interest rates and lack of credit deterioration. Quantitative accuracy is high (8) because no numbers are wrong—there just aren’t any. Qualitative accuracy is 5 due to partial correctness but failure to capture a key shift in accounting treatment. Contextual relevance is 8 because the answer addresses the right topic and timeframe, but lacks depth on the evolution aspect central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 549,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "Between 2022 and 2023, AMD's investment in the ATMP JV increased from $83 million to $99 million, reflecting a rise in the carrying value of its 15% equity interest. Additionally, AMD's equity income from the ATMP JV grew from $14 million in 2022 to $16 million in 2023, indicating improved performance of the joint venture during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the carrying value of AMD's investment in the ATMP JV increased from $83 million in 2022 to $99 million in 2023, and equity income rose from $14 million to $16 million—both figures are accurately reported. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and no calculations are required beyond the reported values. (3) The multi-hop reasoning is sound—information about two different years and two financial metrics (investment value and equity income) is correctly synthesized to show a trend of growth in AMD's financial relationship with the JV. (4) The LLM adds a minor but accurate detail (15% equity interest) that is consistent with typical JV disclosures and does not contradict the ground truth. The answer is complete, contextually relevant, and conveys the same conclusion: AMD’s stake and returns from the ATMP JV grew from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 286,
        "total_tokens": 1459
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth Group's exposure to tort claims, particularly those related to the delivery of health care services such as medical malpractice, has remained a consistent risk between 2022 and 2024. The nature of the claims includes allegations against affiliated physicians, health care practitioners, and staff for failure to adhere to clinical, quality, or patient safety standards. The potential financial impact of these claims has also remained significant, as the company is largely self-insured for litigation risks, and actual losses could exceed recorded liabilities. In 2024, the company emphasized the increasing complexity of legal actions, including claims under new theories of liability that may not be subject to damage caps, further heightening the financial and reputational risks associated with tort claims.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of UnitedHealth Group's tort claim exposure between 2022 and 2024. It accurately identifies the continuity of medical malpractice and professional liability claims, the self-insured nature of the risk, and the potential for losses to exceed recorded liabilities—key points from the 2022 filing. It also correctly notes the increasing complexity of legal actions and the emergence of new theories of liability not subject to damage caps, which aligns with the original answer. However, the LLM answer does not fully reflect the shift in emphasis observed in the 2024 filing: while it mentions clinical quality and patient safety (correctly), it does not explicitly highlight the expanded focus on reputational harm and adverse effects on business relationships, which the ground truth identifies as a key evolution in risk profile. Additionally, the LLM implies that 'new theories of liability' were a 2024 development, whereas the original answer attributes this concern to 2022. This misplacement slightly distorts the timeline. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific figures are involved), and the entities (UnitedHealth Group, tort claims, affiliated physicians, self-insurance) are correctly identified. The reasoning is sound but misses a nuanced shift in risk framing from financial exposure in 2022 to broader systemic and reputational risks in 2024. Contextual relevance is excellent—the response directly addresses the question's focus on nature and financial impact of tort claims over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 439,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Between 2023 and 2024, Boeing's three-year revolving credit agreement remained at $3.0 billion in capacity but saw a change in its maturity date, extending from August 2025 to August 2028. This extension, along with maintaining substantial unused borrowing capacity, indicates a strategic effort to enhance liquidity flexibility and ensure backup funding for corporate needs, reflecting confidence in financial stability and operational improvements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that Boeing extended the maturity of its three-year revolving credit agreement from August 2025 to August 2028, which is incorrect. According to the ground truth, the $3.0 billion three-year agreement remained in effect through August 2025 and was not extended. Instead, Boeing entered into a new, separate $4.0 billion five-year credit facility expiring in May 2029, while terminating two other facilities. The LLM incorrectly implies a modification of the existing agreement rather than the addition of a new facility. (2) Quantitative inaccuracies include the false extension of the maturity date and omission of the new $4.0 billion facility. The $3.0 billion amount is correct, but the evolution is misrepresented. The answer fails to mention the termination of two other credit facilities, a key part of the strategic shift. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct sequence of events—retention of the existing $3.0 billion facility, addition of a new $4.0 billion facility, and termination of others—leading to an incorrect conclusion about structural evolution. (4) While the general theme of enhancing liquidity is mentioned, the reasoning is based on false premises. The contextual relevance is moderate because the answer addresses Boeing's liquidity strategy, but the factual foundation is unsound, severely undermining correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 405,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "The financial impact of the 2017 Performance-based Options evolved between 2023 and 2024 as follows: the total fair value of options vested in 2024 was $52 million, compared to $56 million in 2023. Additionally, the aggregate intrinsic value of options exercised in 2024 was $373 million, a significant increase from $44 million in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the fair value of options vested decreased from $56 million in 2023 to $52 million in 2024, and the intrinsic value of options exercised increased from $44 million to $373 million. (2) Quantitative accuracy is perfect—each dollar amount and year is correctly stated, with no calculation or transcription errors. Format variations (e.g., 'aggregate intrinsic value' vs 'intrinsic value') are acceptable and do not alter meaning. (3) The multi-hop reasoning is sound: the model correctly synthesized data across two years and two financial metrics (fair value vested, intrinsic value exercised) related to the 2017 Performance-based Options. (4) The answer is contextually relevant, directly addressing the evolution of financial impact between 2023 and 2024 as requested. No critical information is missing, and the conclusion implied by the data (a shift from vesting value to exercise value) is logically supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 297,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "Between 2022 and 2023, AMD refined its methodology for estimating adjustments related to product return rights by incorporating more detailed historical return rate data and adjusting for known events or market conditions. Specifically, the company continued to use trended actual historical product return rate information but enhanced its approach by including more granular data on contractual return percentages and factoring in additional approvals for returns beyond contractual arrangements based on specific circumstances. This evolution allowed for more accurate and consistent revenue recognition adjustments, aligning estimates more closely with actual outcomes.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the actual evolution in AMD's methodology between 2022 and 2023. (1) What was correct: The answer correctly notes that AMD used trended historical return rate data and adjusted for known events, and that the approach evolved to include more granular or enhanced data. The entity (AMD), time frame (2022–2023), and general topic (product return rights adjustments) are accurate. (2) Quantitative accuracy: There are no specific numerical values (e.g., percentages, dollar amounts) in either the ground truth or the LLM answer, so no numeric inaccuracies exist—this aspect is neutral but does not detract. (3) Multi-hop reasoning assessment: The LLM fails to capture the core accounting standard-driven change described in the ground truth. Specifically, it omits the shift toward explicitly applying ASC 606-10-32-8 through 14 and the use of the 'most likely amount' method for variable consideration, which is central to the 2023 methodology. Instead, it invents details not present in the original—such as 'contractual return percentages' and 'additional approvals for returns beyond contractual arrangements'—which are not supported by the ground truth. (4) Justification for scores: The correctness score is 5 due to partial factual alignment but significant omission of the codified accounting standard integration and incorrect addition of speculative elements. Qualitative accuracy is low because the reasoning and synthesis are flawed—while the general idea of refinement is correct, the specific evolution in methodology is misrepresented. Quantitative accuracy is 10 by default (no numbers involved). Contextual relevance is high because the answer stays on topic and addresses the question’s intent, albeit with inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 485,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "From 2023 to 2024, the number of shares under option for the 2017 Performance-based Options decreased significantly, from 1,549,080 shares to 625,825 shares. This decline was primarily due to a large number of exercises (905,219 shares) in 2024, as the first tranche of these options fully vested at the end of 2022, the second at the end of 2023, and the final tranche at the end of 2024. The substantial exercise activity indicates strong employee participation and the value of the options, given the intrinsic value of exercised options in 2024 was $373 million. Additionally, a smaller number of shares were forfeited (18,036 shares), suggesting relatively low turnover among employees holding these awards during the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, all numbers are accurate: the starting number of shares (1,549,080 in 2023), ending number (625,825 in 2024), exercises (905,219), and forfeitures (18,036) are exactly correct. The difference between 1,549,080 and 625,825 is 923,255, which aligns with the sum of 905,219 (exercised) + 18,036 (forfeited) = 923,255, confirming internal consistency. (2) The answer is complete, addressing both the evolution of shares and the implications regarding exercise and forfeiture trends. (3) Entity accuracy is correct: the options are tied to the 2017 grant, and the vesting timeline (2022, 2023, 2024) is accurately described, explaining the multi-year vesting structure. (4) The reasoning is sound and adds contextual insight beyond the ground truth—such as referencing the $373 million intrinsic value and interpreting low forfeitures as low employee turnover—which is consistent with the data and enhances the explanation without introducing inaccuracies. The multi-hop synthesis (tracking share changes over time, linking to vesting schedule and employee behavior) is logically and factually sound. (5) Semantic equivalence is strong: the LLM conveys the same core facts and implications as the original answer, with added but accurate contextual interpretation. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 388,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024, Optum Rx's Pharmacy Care Services has expanded its role and strategic positioning within UnitedHealth Group's ecosystem by broadening its service offerings and enhancing integration with medical and behavioral care. In 2024, Optum Rx managed $178 billion in pharmaceutical spending, up from $112 billion in 2022, with a significant increase in specialty pharmaceutical spending to $74 billion from $45 billion. The division has also expanded its clinical programs, digital tools, and direct-to-consumer solutions, emphasizing a more holistic approach by embedding pharmacists into patient care teams and accelerating the integration of pharmacy care with medical and behavioral health services.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative data. According to the ground truth, Optum Rx managed $112 billion in pharmaceutical spending in 2022, including $45 billion in specialty pharmaceuticals. The 2024 figures were not provided in the original answer; however, the LLM incorrectly states that Optum Rx managed $178 billion in 2024 (up from $112B) and $74 billion in specialty spending (up from $45B). These numbers are fabricated and not supported by the source, making the quantitative claims entirely incorrect. (2) There are no calculations in the original answer to verify, but the LLM implies growth trends without any basis in the provided data. The ground truth explicitly states that 'specific spending figures were not provided in 2024,' which directly contradicts the LLM's precise dollar amounts. (3) The qualitative aspects partially align: the LLM correctly identifies an evolution toward greater integration with medical and behavioral care, a holistic approach, and use of clinical programs and digital tools. It also correctly frames Optum Rx as more strategically integrated within UnitedHealth Group’s ecosystem. However, it fails to mention the key strategic repositioning language from 2024 about being part of a 'value-oriented and more connected approach to health care' and leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services'—a core multi-hop insight. (4) Contextually, the answer addresses the question’s focus on evolution in service offerings and strategic positioning, so relevance is high. However, due to major factual errors in numbers and unsupported claims about spending growth, the correctness score is low. The qualitative accuracy is moderate because some directional trends are plausible, but unsupported by the actual data provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 516,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "The composition and valuation of BlackRock's Equity Securities at FVTNI related to investments held for deferred cash compensation plans increased from $241 million as of December 31, 2023, to $173 million as of December 31, 2024. This indicates a decrease of $68 million in the valuation of these specific investments between the two periods.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, BlackRock reported $9 million in Equity Securities at FVTNI related to deferred cash compensation plans in 2023, not $241 million. In 2024, this amount was reclassified and reported as $173 million under a different section (Equity Method), not under FVTNI. The LLM incorrectly states that the value decreased from $241M to $173M, which misrepresents both the correct figures and the direction of change. (2) The numbers are significantly wrong: the 2023 value is off by over $230 million, and the interpretation of the change as a decrease is misleading because the increase from $9M to $173M occurred alongside a reclassification. The calculation of a $68M decrease is based on false inputs and is therefore invalid. (3) The multi-hop reasoning failed completely — instead of recognizing a reclassification or realignment in reporting categories (from FVTNI to Equity Method), the model falsely assumes continuity within the same category and reports incorrect values. It missed the key qualitative shift in financial statement presentation entirely. (4) The contextual relevance is moderate because the answer addresses the general topic (deferred compensation investments and their valuation over time), but the severe factual and quantitative errors undermine any useful insight. Hence, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher only because the topic framing is somewhat relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 427,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "The aggregate available authorization for Accenture's open-market share purchase program increased from $3,129,296 as of August 31, 2022, to $6,694,281 as of August 31, 2024. This significant increase indicates a strategic commitment to returning value to shareholders through share repurchases, reflecting confidence in the company's financial position and a focus on optimizing capital allocation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that the aggregate available authorization decreased from $3,129,296 in 2022 to $2,694,281 in 2024, but the LLM claims it increased to $6,694,281 in 2024 — a significant overstatement. The correct change is a decrease of $435,015, whereas the LLM reports a large increase, which is the opposite of the truth. (2) The dollar amounts for 2022 ($3,129,296) are correctly cited, but the 2024 figure is wrong: $2,694,281 (correct) vs. $6,694,281 (claimed), a $4 million error. This invalidates any calculation or conclusion based on the number. (3) The multi-hop reasoning fails because the model misidentifies the trend (increase vs. actual decrease), leading to an incorrect interpretation of capital allocation strategy. Instead of recognizing a more conservative stance, it infers aggressive shareholder return, which contradicts the evidence. (4) The contextual relevance is moderate because the answer addresses the right question structure (change in authorization and strategic implication) and discusses capital allocation appropriately, but the factual foundation is entirely flawed. Due to major quantitative and qualitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 362,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved in terms of share repurchase activity and shareholder rights. In 2022, the company discussed its intention to use cash for share repurchases, including those of exchangeable shares, though specific repurchase figures for these shares were not detailed. By 2024, the company provided more granular data, reporting the repurchase of 47,752 exchangeable shares for $15,254 during fiscal 2024, indicating a more transparent and structured approach to repurchase activity. Additionally, shareholder rights related to exchangeable shares remained consistent, allowing holders to exchange their shares for Accenture plc Class A ordinary shares on a one-for-one basis, with the company retaining the option to satisfy exchanges with cash.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that in 2024, Accenture disclosed a remaining share repurchase authorization of $2,694,281, but the LLM incorrectly claims that 47,752 exchangeable shares were repurchased for $15,254 in fiscal 2024—this specific transaction data is not present in the original answer and contradicts the known truth. There is no mention in the ground truth of actual repurchase volume or dollar amount spent on exchangeable shares in 2024, only the remaining authorization. (2) The LLM invents precise figures ($15,254 for 47,752 shares) that do not appear in the original answer and cannot be verified from the provided truth; this severely undermines quantitative accuracy. Additionally, the original answer does not state that shareholder rights 'remained consistent'—rather, it emphasizes an evolution in disclosure with more detailed descriptions in 2024, including alignment of Class X shares with outstanding exchangeable shares, which the LLM omits. (3) The multi-hop reasoning is partially sound—the model correctly identifies the shift from general intent in 2022 to more detailed disclosure in 2024—but fails to accurately represent the nature of that evolution. It incorrectly focuses on fabricated transactional data rather than the structural and disclosure changes (e.g., commitment to align Class X shares) emphasized in the ground truth. (4) Contextual relevance is high because the answer addresses both share repurchases and shareholder rights over time, and correctly notes the one-for-one exchange right. However, due to major factual and quantitative errors, the correctness score is low despite reasonable structure and focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 480,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The global revenue from Electrophysiology Devices increased from $2,195 million in 2023 to $2,467 million in 2024. Excluding the impact of foreign exchange fluctuations, the percentage change in this revenue was 14.4%.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the global revenue from Electrophysiology Devices was $2,195 million in 2023 and $2,467 million in 2024, and the percentage change excluding foreign exchange fluctuations was correctly stated as 14.4%. (2) Quantitative accuracy is perfect: the dollar amounts are correct, and although the LLM did not explicitly state the 12.3% total change (which includes FX impact), the question specifically asks for the change excluding FX impact, which is the 14.4% figure provided. Thus, the omission of 12.3% does not reduce correctness since it was not required in the final answer. (3) The reasoning is sound—revenue figures for both years are correctly cited, and the appropriate percentage change (excluding FX) is reported. (4) The answer is contextually relevant, directly addressing both parts of the question: revenue evolution (via dollar figures) and the FX-excluded percentage change. Semantic equivalence is maintained with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 299,
        "total_tokens": 1427
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Accenture's investment in Duck Creek Technologies has seen a notable increase in valuation. As of August 31, 2022, the carrying amount of the investment was $138,902, with an estimated fair value of $223,166 for Accenture's approximately 16% ownership stake. By fiscal 2024, the investment gain related to Duck Creek Technologies positively impacted financial performance, contributing to an adjusted operating margin of 15.5% and adjusted earnings per share of $11.95, reflecting improved financial outcomes from the investment.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but includes significant inaccuracies. The ground truth states that Accenture's investment in Duck Creek Technologies was valued at $223,166 in fiscal 2022 with approximately 16% ownership under the equity method. The LLM introduces a new figure — a 'carrying amount' of $138,902 — which is not present in the original answer and contradicts the stated fair value of $223,166. This discrepancy undermines quantitative accuracy. Additionally, the LLM claims that by fiscal 2024, the investment contributed to an adjusted operating margin of 15.5% and adjusted EPS of $11.95; however, these metrics are not mentioned in the ground truth and cannot be verified as directly tied to the Duck Creek investment. The only correct quantitative point is the $223,166 valuation and ~16% ownership in 2022, and the general idea of a positive financial impact in 2024. (2) The $253 million gain in fiscal 2024 from the original answer is completely missing in the LLM response, which instead redirects to margin and EPS impacts without citing the actual gain amount. This is a major omission in both quantitative and qualitative terms. The LLM also fails to note the shift in how the investment affected financial performance — specifically the realization of a large gain — which is a key qualitative point in the original. (3) The multi-hop reasoning is partially sound: the model connects Accenture’s investment to financial performance over time, but it fabricates specific performance metrics (operating margin, EPS) as impacts rather than reporting the actual $253 million gain. This suggests a failure to accurately synthesize or retrieve the correct downstream financial effect. (4) Scores reflect partial correctness: contextual relevance is high because the answer addresses the evolution of the investment and its financial impact; qualitative accuracy is moderate due to correct entity and time identification but flawed reasoning; quantitative accuracy is low due to incorrect figures and missing the critical $253M gain; overall correctness is mid-range because core facts are partially right but key data points are wrong or invented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 590,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Between 2022 and 2023, Union Pacific's retention share and unit awards show a shift in focus from stock options to performance-based retention awards, indicating a strategic emphasis on aligning executive compensation with long-term performance and shareholder value. In 2022, the 2021 Plan included 389,207 retention shares and 361,935 stock options, while by 2023, the emphasis on stock options had diminished, with a larger portion of awards tied to retention units (1,218,397) under the 2013 Plan. This suggests a move toward performance-based compensation to incentivize executives to meet long-term financial goals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Union Pacific reported 389,207 retention shares outstanding (correctly cited), but there is no mention of 361,935 stock options in the original answer, nor is there evidence that these were part of the retention awards or the 2021 Plan. The LLM incorrectly introduces stock options as a comparative element, which is not supported by the ground truth. Furthermore, the LLM claims that in 2023, there were 1,218,397 retention units under the 2013 Plan, which is entirely incorrect. The ground truth states that 954,405 retention shares and 366,046 retention units were outstanding in 2023, totaling about 1,320,451 retention instruments—not 1,218,397, and not under the 2013 Plan, but rather the 2021 Stock Incentive Plan. The LLM also misattributes the plan (2013 vs. 2021), which is a critical entity error. (2) Quantitative accuracy is poor: the LLM invents numbers (e.g., 361,935 stock options, 1,218,397 retention units) not present in the ground truth and misrepresents the actual figures. The correct 2023 figures are 954,405 retention shares and 366,046 retention units—neither of which matches the LLM’s claim. (3) The multi-hop reasoning is flawed. While the LLM attempts to infer a strategic shift toward performance-based compensation, it bases this on fabricated data and incorrect comparisons. The ground truth does note a significant increase in retention instruments and the introduction of retention units, suggesting a refinement in strategy, but the LLM overreaches by framing it as a shift from stock options to retention awards without evidence. (4) Contextual relevance is moderate—the answer addresses executive compensation strategy and attempts to interpret trends, which is relevant. However, due to severe factual and quantitative errors, the conclusion is not well-supported. The qualitative reasoning would score higher if based on accurate data, but as is, it reflects a plausible but incorrect interpretation built on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 557,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "Between 2023 and 2024, MetLife's application of GAAP guidance for adjusted earnings remained consistent in excluding market volatility and asymmetrical accounting adjustments. Adjusted earnings continue to exclude net investment gains/losses, net derivative gains/losses, and MRB remeasurement gains/losses to smooth out the impact of market volatility. Additionally, asymmetrical accounting adjustments—such as those related to in-force reinsurance and non-economic losses at contract inception—are still excluded in 2024, aligning with the Company’s approach in 2023. The adoption of LDTI in 2024 further refined adjusted earnings by removing certain DAC, VOBA, and related intangible adjustments, but the core principles of excluding market volatility and asymmetrical accounting remained unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in the evolution of MetLife's adjusted earnings exclusions between 2023 and 2024. (1) Correctly identifies the ongoing exclusion of market volatility items such as MRB remeasurement gains/losses and net investment/derivative gains, which aligns with 2023 practices. Also correctly references LDTI adoption and the exclusion of DAC, VOBA, and related intangible adjustments. However, it incorrectly states that LDTI was adopted in 2024, while the ground truth specifies the update occurred in 2023. This is a critical factual error affecting the timeline of evolution. (2) The LLM fails to mention key developments in 2024: the expansion of exclusions to include policyholder liability remeasurement gains/losses related to asymmetrical accounting from in-force reinsurance and the new exclusion of equity method joint venture adjustments in net investment income—both of which represent meaningful refinements not present in 2023. (3) The reasoning is partially sound in recognizing continuity in excluding market volatility and asymmetrical accounting, but it misses the multi-hop synthesis that the evolution lies in the broadening and structuring of exclusions over time, not just consistency. (4) While terminology and context are generally relevant and entities (MetLife, LDTI, DAC, VOBA, MRBs) are correctly identified, the misattribution of LDTI adoption to 2024 undermines the qualitative accuracy. The answer suggests stability rather than the documented refinement and expansion, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 439,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "From 2022 to 2024, Accenture's approach to achieving compressed transformations has evolved by integrating more advanced technologies and expanding the scope of transformation services. In 2022, the focus was on leveraging emerging technologies like blockchain, robotics, 5G, edge computing, and quantum computing, while in 2024, the emphasis expanded to include generative AI, AI-driven operations, and the metaverse continuum. Additionally, the scope of services has broadened to include AI Navigator for Enterprise and more deeply integrated solutions across Strategy & Consulting, Technology, Operations, Industry X, and Song, enabling clients to reimagine products, optimize operations, and accelerate revenue growth through hyper-personalized experiences and intelligent products.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in the technologies attributed to Accenture's 2022 and 2024 strategies. The ground truth states that in 2022, Accenture leveraged digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse — but the LLM incorrectly lists blockchain, quantum computing, and AI-driven operations, which are not mentioned in the original. While generative AI and the metaverse continuum are correctly noted for 2024, the LLM omits key technologies such as artificial reality / virtual reality and enhanced development of automation equipment and commercial hardware. Additionally, the expansion into digitally transforming capital projects (e.g., plant construction, power grids, data centers) is entirely missing from the LLM response. Instead, it introduces 'AI Navigator for Enterprise' and organizational units like Industry X and Song, which, while possibly real, are not part of the documented evolution in the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable — score reflects no factual errors in this dimension. (3) The multi-hop reasoning is partially sound — the model recognizes a progression in technology and scope over time — but fails to correctly synthesize the specific technological additions and service expansions documented in the knowledge graph. The reasoning is plausible but factually misaligned. (4) The contextual relevance is high because the answer addresses the evolution of Accenture’s transformation approach, uses appropriate terminology, and maintains focus on technology and scope changes. However, the correctness score is moderate due to significant factual discrepancies in the technologies and service offerings described.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 490,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Between 2023 and 2024, Abbott maintained interest rate hedge contracts with notional values of approximately $2.2 billion in both years to manage exposure to changes in the fair value of fixed-rate debt. These contracts are designated as fair value hedges, converting fixed-rate interest obligations to variable rates for the hedged portion of the debt. The fair value of these contracts was reported as $95 million in 2024 and $95 million in 2023, with no material change in their use or purpose during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Abbott maintained $2.2 billion in notional value of interest rate hedge contracts in both 2023 and 2024, and accurately describes their purpose as fair value hedges converting fixed-rate debt to variable-rate debt. This aligns with the ground truth and addresses the core of the question about the evolution of hedge usage. However, the LLM introduces a new quantitative claim not present in the ground truth: that the fair value of the contracts was $95 million in both years. This specific fair value figure is not mentioned in the original answer and cannot be verified from the provided truth, making it an unsupported addition. Additionally, the LLM fails to mention the increase in the average interest rate on long-term debt from 3.6% in 2023 to 3.8% in 2024, which is a key point in the original answer indicating a shift in debt or market conditions despite stable hedge notional amounts. (2) While the $2.2 billion notional amount is correctly repeated, the inclusion of the $95 million fair value figure—absent from the ground truth—reduces quantitative accuracy. There is no indication this number is incorrect per se, but its presence in the absence of verification introduces factual risk. The omission of the 3.6% to 3.8% interest rate increase, a factual and comparative data point, further weakens quantitative completeness. (3) The reasoning is logically sound in concluding that Abbott’s use of hedges remained consistent, which is supported by the stable notional amount. However, the model misses the opportunity to synthesize the implication of stable hedges amid rising interest rates—a subtle but important multi-hop insight present in the original answer. This limits the depth of qualitative analysis. (4) The answer remains highly relevant to the question, focusing precisely on Abbott’s hedge contract usage over the two years and their role in managing interest rate exposure. Despite missing a key comparative metric and adding an unverified figure, the response stays on-topic and provides a coherent summary of the hedging strategy’s continuity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 569,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "MetLife's treatment and definition of Adjusted Earnings remained largely consistent between 2023 and 2024, with both years defining it as adjusted revenues less adjusted expenses, net of income tax. However, in 2024, there was a clarification that Adjusted Earnings is the Company's GAAP measure of segment performance and is used by the CODM for evaluating performance and allocating resources. Additionally, the adoption of ASU 2023-07 in 2024 enhanced segment expense disclosures, which indirectly impacted the transparency and presentation of Adjusted Earnings by providing more detailed segment expense information.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is partially correct in stating that Adjusted Earnings remained a key measure for segment performance and that ASU 2023-07 (related to LDTI) impacted disclosures in 2024. However, it fundamentally misrepresents the evolution of MetLife's Adjusted Earnings definition between 2023 and 2024. The ground truth indicates a significant change in 2023 due to LDTI adoption—specifically, the removal of adjustments for DAC, VOBA, and related intangibles, and the introduction of adjustments for changes in guarantees and MRB fair value. The 2024 definition further refined exclusions to include market volatility, asymmetrical accounting, divested businesses, and specific items like inflation-indexed benefits and non-economic losses from single premium annuities. The LLM answer incorrectly claims the treatment was 'largely consistent' and fails to mention any of these critical exclusions or the shift in adjustment methodology. It also incorrectly frames ASU 2023-07 as merely enhancing expense disclosures, when in fact it drove a material change in how Adjusted Earnings is calculated. The answer misses the multi-hop synthesis of how LDTI adoption altered both GAAP alignment and segment performance measurement. While it correctly identifies Adjusted Earnings as a GAAP measure used by the CODM, this is minor contextual accuracy overshadowed by major omissions and mischaracterizations of the definitional evolution. No numeric values are present, so quantitative accuracy is neutral. Overall, the answer lacks the necessary depth and factual precision to accurately reflect the changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 437,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "From 2022 to 2024, Accenture's available authorization for its share purchase program increased significantly, from $3,129,296 as of August 31, 2022, to $6,694,281 as of August 31, 2024, following additional repurchase authority approvals. In terms of share acquisition methods, the company conducted open-market share purchases, acquiring 9,635,751 shares in 2022 and 11,753,807 shares in 2024. Additionally, shares were acquired through employee equity plans, primarily via share withholding for payroll tax obligations. The 2024 program also included redemptions of Accenture Canada Holdings Inc. exchangeable shares.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Accenture had an aggregate available authorization of $3,129,296, but the LLM claims it increased to $6,694,281 by 2024 — this number is not present in the original answer and is therefore incorrect. There is no mention in the ground truth of any increase in authorization, nor of specific share purchase volumes (9.6M in 2022, 11.7M in 2024), which are fabricated. Additionally, the LLM incorrectly states that redemptions of Accenture Canada Holdings Inc. exchangeable shares were part of the 2024 program, while the original answer clarifies that by 2024, the program applied specifically to Accenture plc Class A ordinary shares and that prior acquisitions involving exchangeable shares were historical (in 2022 context), not ongoing in 2024. (2) Quantitative accuracy is very low: the only correct number is the 2022 authorization amount ($3,129,296). All other figures — including the 2024 authorization, number of shares purchased in 2022 and 2024, and implied growth — are unsupported and incorrect. Calculations or comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed. The original answer emphasizes a shift in acquisition methods — from broader share purchases including exchangeable shares in 2022 to primarily share withholding for tax obligations in 2024 — without affecting the public program's authorization. The LLM misrepresents this evolution by suggesting continued open-market purchases and inclusion of exchangeable shares in 2024, contradicting the shift described in the ground truth. It also invents metrics to suggest program expansion, which is not supported. (4) Contextual relevance is moderate because the LLM addresses the general topic of share purchase evolution, funding, and methods, and correctly notes share withholding for payroll taxes. However, due to major factual and quantitative errors, the answer misleads on the core developments. Correctness score is low due to fabrication of key financial data and misrepresentation of program scope over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 575,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "From 2023 to 2024, MetLife's treatment and valuation methodology for Unit-linked Securities showed a shift in fair value sensitivity and cost basis adjustments. In 2023, the fair value of Unit-linked Securities increased by $138 million, primarily driven by market gains included in net income, while in 2024, the fair value increased by $131 million, with a smaller net income impact. The cost basis adjustments reflected changes in purchases and sales, with a net increase in 2023 and a more significant net decrease in 2024. Additionally, transfers into and out of Level 3 remained minimal, indicating stable unobservable inputs for valuation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth describes a methodological shift in valuation approach—from a cost-based system in 2023 to a Level 3 fair value model with sensitivity analysis in 2024—driven by unobservable inputs like mortality and lapse rates. However, the LLM answer fabricates specific dollar amounts ($138M and $131M increases in fair value) that are not present in the original answer and misrepresents the nature of the change. There is no mention in the ground truth of net income impacts or cost basis adjustments due to purchases and sales, nor any claim about transfers into/out of Level 3 being minimal. (2) The quantitative figures provided in the LLM answer (e.g., $138M, $131M) have no basis in the original answer and cannot be verified; they appear to be hallucinated. The original answer contains no such numbers. (3) The multi-hop reasoning is flawed: instead of identifying the shift from amortized/original cost to Level 3 classification with sensitivity disclosures, the model focuses on nonexistent financial flows and net income effects, missing the conceptual evolution entirely. (4) While the LLM answer stays within the topic of Unit-linked Securities and mentions Level 3, which shows some contextual awareness, it fails on correctness due to fabricated data and mischaracterization of the methodology change. Hence, low scores for correctness, quantitative, and qualitative accuracy; moderate score for staying on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 419,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "Between fiscal years 2022 and 2023, the structure and vesting timeline of market-based RSUs evolved as follows: In fiscal year 2022, market-based RSUs generally vested over four years, subject to satisfaction of market conditions tied to total stockholder return (TSR) on an absolute basis and relative to an index group of companies. In fiscal year 2023, the company also introduced market-based RSUs with a five-year vesting timeline, contingent on achieving stock price performance milestones. This indicates a diversification in vesting timelines and performance metrics for market-based RSUs in 2023 compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the four-year vesting in 2022, the introduction of five-year vesting in 2023, and the performance conditions based on TSR and stock price milestones are accurately reflected. There are no numerical or date inaccuracies. (2) The answer correctly captures the evolution in structure and vesting timeline across the two fiscal years, addressing both the continuation of existing RSUs and the addition of new types. (3) The reasoning is sound: it identifies the expansion in vesting structures and performance metrics as a form of diversification, which is a valid interpretation of the multi-hop information across 2022 and 2023. (4) The only minor difference from the original answer is that the LLM mentions TSR being measured on an 'absolute basis' in addition to relative performance, which was not specified in the ground truth. However, this does not contradict the original and may reflect additional context; it doesn't detract from correctness. Also, the LLM omits the specific 0%–300% payout range tied to TSR in 2022, which is a small but notable omission affecting completeness. Despite this, the core evolution in structure and timeline is accurately conveyed, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 365,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "Between 2023 and 2024, the phase-in treatment of the CECL standard's ongoing impact on regulatory capital for Capital One progressed as follows: In 2023, 50% of the cumulative \"day 2\" CECL impact was phased in, while in 2024, 75% was phased in. During the phase-in period, the CECL Transition Rule allowed the company to add back the after-tax \"day 1\" CECL adoption impact and the cumulative \"day 2\" ongoing impact to regulatory capital at 25% per year from 2022 through 2024. As of December 31, 2024, 75% of the $2.4 billion CECL impact had been phased in, with the remaining 25% to be phased in by January 1, 2025.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its quantitative claims. While the ground truth states that the CECL phase-in was 25% per year from 2022 to 2024 (i.e., 25% in 2022, 50% cumulative by 2023, 75% by 2024), the LLM incorrectly states that '50% was phased in in 2023' and '75% in 2024', which misrepresents the annual increment as cumulative totals applied per year. This suggests a misunderstanding of the phase-in structure. Additionally, the mention of 'Capital One' and a '$2.4 billion CECL impact' introduces specific entity and dollar figures not present in the original answer, which does not reference any particular company or monetary amount—making these details fabricated or unsupported by the ground truth. (2) The calculation of the phase-in is partially correct in cumulative effect (75% by end of 2024) but wrong in framing: the annual phase-in is consistently 25%, not increasing amounts each year. The LLM implies an escalating phase-in (50% in 2023, then another 75% in 2024), which is illogical and factually incorrect. The date range (through 2024) and final phase-in completion (by 2025) are close but slightly misaligned—the rule ends December 31, 2024, so no phase-in occurs on January 1, 2025. (3) The multi-hop reasoning is partially sound in recognizing the ongoing 'day 2' impact and the use of the CECL Transition Rule, and it correctly identifies the 25% annual phase-in mechanism. However, it fails to accurately synthesize the consistent annual rate over the period, instead misrepresenting the progression. The introduction of Capital One and a specific dollar figure indicates either hallucination or improper inference beyond the provided context. (4) The contextual relevance is high because the answer addresses the regulatory treatment and phase-in timeline, using correct terminology like 'CECL Transition Rule', 'day 1' and 'day 2' impacts, and regulatory capital add-backs. However, due to key numerical and entity inaccuracies, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the conceptual framework is mostly intact despite errors in execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 584,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "Between 2022 and 2023, Broadcom continued its relationship with Wilmington Trust, National Association as trustee for its senior notes, with new indentures and supplemental agreements being executed. In 2022, an indenture dated April 14, 2022, introduced 4.00% Senior Notes due 2029. By 2023, additional indentures and amendments were made, including a July 12, 2024, indenture introducing 5.050% Senior Notes due 2027, 2029, and 2031, and a later October 2, 2024, indenture introducing 4.150%, 4.350%, 4.550%, and 4.800% Senior Notes due in 2028, 2030, 2032, and 2034, respectively. This indicates an expansion in the types of senior notes issued under their indentures during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dates, interest rates, and note maturities compared to the ground truth. For example, it claims an April 14, 2022 indenture introduced 4.00% notes due 2029, but the ground truth states the new indentures were dated April 18, 2022, and July 12, 2024, with no mention of a 4.00% note due 2029. The LLM also incorrectly states that a July 12, 2024 indenture introduced 5.050% notes due 2027, 2029, and 2031—this rate and structure do not appear in the original answer. Additionally, the October 2, 2024 indenture is fabricated; the ground truth mentions an October 2024 issuance but does not specify a date or include 4.350% or 4.550% notes. (2) The ground truth reports a 4.926% note due 2037 and later notes ranging from 4.150% (due 2028) to 4.800% (due 2034), which partially overlaps with the LLM’s 4.150% to 4.800% range but adds incorrect intermediate rates. The LLM invents multiple tranches not present in the original. (3) The multi-hop reasoning is partially sound—the model correctly identifies that the relationship evolved with new indentures and higher-yielding notes over time, and it maintains the correct trustee (Wilmington Trust). However, it fails to accurately reflect the actual terms and timeline of issuance, especially misrepresenting the 2022–2023 evolution by citing agreements dated in 2024 as if they were part of the 2023 developments. (4) The contextual relevance is high because the answer addresses the evolution of the relationship and types of notes issued. However, due to major quantitative errors and incorrect synthesis of financial terms, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the direction of evolution (more indentures, higher yields) aligns with the truth, but details are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 503,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One's regulatory capital add-back under the CECL Transition Rule evolved from 2023 to 2024 as part of a five-year phase-in process. In 2023, 50% of the cumulative \"day 2\" ongoing impact of the CECL standard was phased in, while in 2024, 75% was phased in. As of January 1, 2024, 75% of the $2.4 billion add-back was applied, with the remaining 25% expected to be phased in by January 1, 2025. This progression reflects the 25% annual phase-in requirement under the CECL Transition Rule from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the phase-in progression from 50% in 2023 to 75% in 2024 and accurately states the $2.4 billion add-back amount, consistent with the ground truth. The 25 percentage point increase and the five-year phase-in structure are correctly described. (2) All numeric values—$2.4 billion, 50%, 75%, and the annual 25% phase-in—are factually accurate and match the original answer. The statement that 75% of the $2.4 billion was applied as of January 1, 2024, is quantitatively sound. (3) The multi-hop reasoning is strong: the model correctly synthesizes the phase-in schedule with the dollar amount and time progression. However, there is a minor inaccuracy in stating the phase-in requirement runs 'from 2022 through 2024'—the rule began in 2021 and runs through 2025, so the annual 25% phase-in started in 2022 but continues beyond 2024. This slightly misrepresents the timeline but does not affect the core correctness for 2023–2024. (4) The answer is highly relevant, complete, and semantically equivalent to the ground truth, with only a small imprecision in the overall phase-in period. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 356,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "Following the Broadcom acquisition, the treatment of VMware stock options for non-employee directors evolved as follows: in 2022 (prior to the acquisition), all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors were scheduled to be accelerated and converted into the right to receive cash and shares of Broadcom common stock in equal parts upon the completion of the VMware Merger. By 2023, after the acquisition was completed, this conversion had been executed, with these awards having been settled in accordance with the terms outlined in the VMware Merger Agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that in 2022, VMware stock options and RSUs for non-employee directors were scheduled to be accelerated and converted into equal parts cash and Broadcom shares upon completion of the acquisition. By 2023, this conversion was executed. All key facts—acceleration, conversion into cash and Broadcom stock, timing relative to the acquisition—are correct. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal markers '2022' and '2023' are used accurately, reflecting the transition from plan to execution. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points (pre- and post-acquisition) and correctly infers the evolution from a planned event to a realized one. (4) The only minor shortcoming is a slight lack of explicit mention that the 2023 confirmation came from the 10-K filing (implied but not stated), and 'VMware Merger Agreement' is used without prior context. However, this does not detract from factual correctness. Wording differs slightly (e.g., 'settled in accordance with the terms' vs 'realized'), but semantic equivalence is maintained. No factual errors; high contextual relevance and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 372,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "Based on AbbVie's disclosures, the therapeutic positioning of Vraylar (cariprazine) has expanded from 2022 to 2024. In 2022, Vraylar was primarily indicated for schizophrenia and bipolar disorder, with ongoing trials for adjunctive treatment in major depressive disorder (MDD). By 2024, while the primary indications remained, the therapeutic scope had broadened to include its use as an adjunctive treatment for MDD, as evidenced by the continued discussion of its positioning in neuroscience and its integration into AbbVie's broader portfolio of mental health treatments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Vraylar's therapeutic positioning from 2022 to 2024. It correctly identifies that in 2022, Vraylar was indicated for schizophrenia and bipolar disorder, with ongoing trials for adjunctive treatment in MDD—a fact consistent with the original answer noting Phase 3 trials with mixed results. By 2024, the LLM accurately states that the therapeutic scope broadened to include adjunctive treatment for MDD. However, the LLM answer lacks the full specificity of the 2024 indications detailed in the ground truth, such as acute and maintenance treatment of schizophrenia, acute treatment of manic/mixed and depressive episodes in bipolar I disorder. While it captures the expansion into MDD as a key development, it omits the breadth of approved indications that demonstrate the full extent of therapeutic solidification. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Vraylar, AbbVie, MDD, bipolar disorder, schizophrenia) are correctly identified with appropriate timeframes (2022 to 2024). The reasoning is sound and contextually relevant, synthesizing the progression across years, but the completeness of the multi-hop synthesis is slightly lacking in detail. Hence, a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 371,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "GE's accounting policy for long-term services agreements has remained consistent from 2022 to 2024 in terms of revenue recognition method, as it continues to use the percentage-of-completion method based on costs incurred to date relative to total expected costs. However, there is an evolution in the detail provided regarding contract billing estimates. In 2024, GE explicitly highlights that billing terms are generally based on asset utilization (e.g., per hour of usage) or maintenance events, and it emphasizes the impact of customer utilization trends, market conditions, and asset retirements on revenue estimates. Additionally, in 2024, GE provides specific metrics, such as the long-term service agreements net liability balance and the sensitivity of revisions to estimated profitability, which were not as explicitly detailed in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in stating that GE's revenue recognition method has remained consistent using the percentage-of-completion method from 2022 to 2024. According to the ground truth, in 2022 GE used the straight-line basis for revenue recognition in long-term services agreements, particularly in Healthcare and Renewable Energy, and only shifted to the percentage-of-completion method by 2024, primarily in the CES segment. This misrepresentation of the core evolution in accounting policy severely undermines the factual accuracy. (2) While the LLM correctly mentions the $6.6 billion net liability and the $162 billion total estimated life of contract billings (implying ~4.1%), these numbers are not explicitly stated in the LLM answer, nor is the 4.1% calculation included, which is a key quantitative benchmark in the original answer. The absence of these specific figures reduces quantitative accuracy. (3) The multi-hop reasoning is flawed because the model fails to recognize the shift in revenue recognition method over time, which is the central point of the question. Instead, it incorrectly asserts consistency, indicating a failure to synthesize changes across years and segments. (4) The LLM does capture some contextual elements, such as increased disclosure in 2024 regarding asset utilization and customer trends, which aligns with the ground truth’s mention of more detailed forward-looking estimation. However, this does not compensate for the major error in the revenue recognition method timeline. The contextual relevance is moderate because the answer addresses related themes but misrepresents the key policy change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 458,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "IBM's disclosure of the 1.250% Notes due 2027 appears in both the 2022 and 2023 10-K filings, but with a key difference. In the 2023 filing, the 1.250% Notes due 2027 are explicitly listed under the section detailing securities registered pursuant to Section 12(b) of the Exchange Act with the trading symbol \"IBM 27B\" and listed on the New York Stock Exchange. In contrast, the 2022 filing does not specifically mention the 1.250% Notes due 2027 in the provided pages, suggesting a new or more prominent disclosure in 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key evolution in disclosure between the 2022 and 2023 10-K filings—namely, that in 2023, the 1.250% Notes due 2027 are explicitly listed under Section 12(b) with trading symbol 'IBM 27B' on the NYSE. This matches the ground truth. However, the LLM incorrectly states that the 2022 filing 'does not specifically mention' the notes, which contradicts the ground truth stating that in 2022, the notes were disclosed via reference to Exhibit 4.3 to Form 8-K filed January 30, 2019, as part of the instruments defining holders' rights. Thus, the notes *were* mentioned in 2022, just in a different context. (2) All quantitative elements—interest rate (1.250%), maturity year (2027), trading symbol (IBM 27B), exchange (NYSE), and reference to Section 12(b)—are accurate. No calculations are required. (3) The multi-hop reasoning is partially sound: the model correctly identifies the shift in disclosure format but fails to acknowledge the 2022 reference, leading to an incomplete comparison. It misses the nuance of evolution from referencing rights documentation to registering as a listed security. (4) The contextual relevance is high because the answer addresses the core of the disclosure change, but the factual error about absence in 2022 reduces qualitative and overall correctness. Hence, correctness and qualitative accuracy are marked down slightly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 390,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "Between 2022 and 2024, the structure and performance criteria of AbbVie's performance-vested RSUs remained consistent in terms of vesting increments, with awards generally vesting in one-third increments over a three-year performance period. The performance metrics have also remained aligned with AbbVie's ROIC performance relative to a defined peer group of pharmaceutical, biotech, and life sciences companies. There is no indication of material changes to the vesting structure or performance metrics during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: it correctly identifies that AbbVie's performance-vested RSUs vest in one-third increments over a three-year period and that the performance metric is based on ROIC relative to a peer group of pharmaceutical, biotech, and life sciences companies. All entities (AbbVie, RSUs, ROIC, peer group) and timeframes (2022–2024) are correctly referenced, and there are no numerical or date inaccuracies. The quantitative accuracy is perfect—no calculations are required, and all descriptive metrics align with the ground truth. Contextual relevance is strong, as the response directly addresses the evolution of vesting structure and performance metrics. However, the LLM answer falls slightly short in completeness and qualitative accuracy by failing to note the key nuance highlighted in the original answer: the *streamlining or simplification* of the performance criteria description by 2024, particularly the removal of references to specific years tied to tranches (e.g., awards granted in 2020 and 2021 mentioned in 2022 disclosures). While the LLM correctly states there were no 'material changes,' it misses the subtle but important evolution in disclosure clarity and standardization, which is central to the question about how the criteria *evolved*. This omission prevents a full 9–10 on correctness and qualitative accuracy, but the answer remains substantially correct and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 398,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "From 2022 to 2024, GE's financial relationship with AerCap, as reflected in realized and unrealized gains or losses, evolved from a significant unrealized loss to a smaller unrealized gain. In 2022, GE reported a realized and unrealized loss of $(865) million related to its investment in and note with AerCap. By 2023, this loss had decreased to $129 million, and by 2024, it had turned into a gain of $38 million, indicating an improvement in the valuation of its investment in AerCap over this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. The original answer states that in 2022, GE reported an *unrealized loss* of $865 million, but the LLM incorrectly describes this as a 'realized and unrealized loss of $(865) million', which misrepresents the nature of the loss. Additionally, the LLM introduces a figure for 2023 ($129 million loss), which is not present in the ground truth and cannot be verified from the provided information, making it an unsupported addition. The 2024 gain of $38 million is correctly reported as a 'realized and unrealized gain', aligning with the original answer. (2) The calculation and progression from -865M to +38M are plausible as a turnaround narrative, but the inclusion of the unverified 2023 figure undermines quantitative accuracy. The core 2022 and 2024 numbers are directionally correct in magnitude but mischaracterized in terms of realization status. (3) The multi-hop reasoning is partially sound—the model infers improvement over time and connects the financial performance across years—but it fabricates an intermediate data point (2023), indicating a failure in strict evidence-based synthesis. The original answer makes no mention of 2023, so introducing it distorts the timeline. (4) Despite the incorrect characterization of the 2022 loss and the invented 2023 figure, the overall direction of improvement is consistent with the ground truth, and the final 2024 gain is accurate. This partial correctness justifies a mid-range score. Contextual relevance is high as the response directly addresses the evolution of GE's financial relationship with AerCap through gains/losses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 460,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "In the 2023 SEC filing, IBM's 0.300% Notes due 2026 (trading symbol IBM 26B) are explicitly listed among the securities registered pursuant to Section 12(b) of the Exchange Act on page 1, indicating clear visibility and disclosure as part of IBM's publicly traded financial instruments. In contrast, the 2022 filing does not specifically mention the 0.300% Notes due 2026 in the provided pages, suggesting that the note may have been issued or became more prominent between 2022 and 2023, with increased disclosure in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) Quantitatively, all details are accurate: the 0.300% interest rate, the 2026 maturity, and the trading symbol IBM 26B are correctly stated. There are no numerical or date inaccuracies. (2) The answer correctly identifies that in 2023, the notes were explicitly listed as registered under Section 12(b) of the Exchange Act, which corresponds to being listed on the New York Stock Exchange, as noted in the ground truth. (3) Regarding multi-hop reasoning, the LLM infers from the absence of mention in the 2022 filing that the note was not prominently disclosed then, which is consistent with the ground truth stating it was only referenced in an exhibit from 2016. However, the LLM slightly underrepresents the 2022 status by saying it 'does not specifically mention' the note, whereas the ground truth clarifies it *was* disclosed via Exhibit 4 to Form 8-K in 2016, incorporated by reference. This is a minor omission in completeness but does not invalidate the conclusion. (4) The answer captures the evolution toward increased visibility and formal recognition, conveying the core insight. Wording differs but semantic meaning is equivalent. Minor deduction in qualitative accuracy for not acknowledging the 2016 exhibit reference in the 2022 context, but overall reasoning and contextual relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 395,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "Between 2022 and 2024, GE's approach to the RISE Program has evolved from an initial focus on concept development and testing to a more advanced stage of technological maturation and integration. In 2022, the RISE Program was highlighted as a suite of pioneering technologies aimed at enabling a more sustainable future of flight, with a focus on Open Fan, compact core, and hybrid electric systems. By 2024, GE had completed over 250 tests on the full-scale Open Fan engine and continued to invest in RISE as part of its broader commitment to sustainability, reflecting a strategic emphasis on advancing these technologies toward practical application and commercial viability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of GE's RISE Program from conceptual development in 2022 to advanced testing and investment by 2024. It accurately reflects the strategic shift toward technological maturation and sustainability. However, it omits the key detail from the ground truth that the RISE Program was a collaborative initiative with Safran, which is a significant entity-level omission. Additionally, while the ground truth emphasizes a 'more than 20% reduction in fuel consumption and CO2 emissions' as a core objective announced in 2022, this specific performance target is missing in the LLM response, representing a minor but notable factual gap. (2) The LLM mentions 'over 250 tests on the full-scale Open Fan engine' by 2024—a specific quantitative claim not present in the ground truth. Since this number cannot be verified against the provided truth data, it introduces unconfirmed information, though it does not contradict the truth. All other dates (2022, 2024) and technological focus areas (Open Fan, compact core, hybrid electric) align semantically with the original answer. (3) The multi-hop reasoning is sound: the model correctly infers a progression from concept to active development and links it to strategic emphasis on sustainability and commercialization. The synthesis across time periods is logical and coherent. (4) The correctness score is 8 because the core facts about GE’s evolving focus and investment are accurate, but the missing collaboration with Safran and the omitted emissions reduction target prevent a higher score. Quantitative accuracy is 9 due to correct use of years and plausible test numbers, though one figure is unverified. Qualitative accuracy is 8 due to strong reasoning but partial entity and objective omissions. Contextual relevance is 10 as the answer directly addresses the question’s focus on strategic and investment evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 520,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "From 2022 to 2023, American Express maintained asset securitizations as a cost-effective funding source within its diversified funding strategy, with no significant shift in emphasis. In 2022, the company highlighted the role of securitizations in funding its U.S. card business by transferring Card Member loans and receivables to trusts, which issue asset-backed securities. In 2023, the company reiterated the importance of securitizations, noting their continued use to fund Card Member loans and receivables when market conditions support cost efficiency. However, there was no indication of increased reliance or strategic expansion in securitization activities in 2023 compared to 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. The ground truth states that American Express shifted from merely defining asset securitizations in a glossary in 2022 to explicitly positioning them as a core component of its funding strategy in 2023, alongside deposits and unsecured debt, emphasizing diversification and risk mitigation. In contrast, the LLM claims there was 'no significant shift in emphasis' and 'no indication of increased reliance or strategic expansion,' which directly contradicts the documented evolution in strategic emphasis. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the absence of numbers does not excuse the factual misrepresentation of the strategic shift. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the qualitative shift from a definitional, glossary-based mention in 2022 to a strategic, integrated role in the 2023 funding strategy. This requires synthesizing the context and placement of disclosures across years, which the model did not do correctly. (4) While the LLM correctly identifies that securitizations were used in both years to fund card loans, it misses the key evolution in narrative and strategic framing. Thus, despite correct entity identification (American Express, asset securitizations, 2022–2023), the qualitative and overall correctness scores are low due to the central factual inaccuracy in interpreting the evolution of strategic emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 416,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "Emerson's financial and strategic relationship with AspenTech evolved significantly from 2022 to 2023. In 2022, Emerson acquired Heritage AspenTech, owning 55% of the shares, which contributed to increased sales and margin benefits in the Software and Control segment. By 2023, Emerson's investment in AspenTech continued to show positive returns, with the Heritage AspenTech acquisition adding 3% to sales growth and contributing favorably to gross margins. Operationally, AspenTech was integrated under Emerson's broader industrial software strategy, with its asset optimization software enhancing Emerson's digital ecosystem. Additionally, Emerson's ownership and strategic alignment with AspenTech supported Emerson's growth in high-margin software solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson did not acquire Heritage AspenTech in 2022; rather, in 2022, Emerson had a minority investment in AspenTech, which contributed $656 in sales and $12 in earnings with $14,484 in total assets. The acquisition of Heritage AspenTech and attainment of a 55% ownership stake occurred in 2023, not 2022 as the LLM incorrectly states. The LLM reverses the timeline, claiming the 55% ownership was established in 2022 and continued into 2023, which is factually wrong. (2) Quantitatively, the LLM introduces numbers not present in the ground truth: '3% to sales growth' and unspecified 'margin benefits' are not supported. The ground truth specifies a 0.6 percentage point improvement in gross margins in 2023 due to the acquisition, which the LLM omits and replaces with vague or incorrect figures. The correct 2022 financial contributions ($656 sales, $12 earnings, $14,484 assets) are entirely missing from the LLM response. (3) The multi-hop reasoning is flawed because the model fails to correctly sequence the evolution of the relationship: it should be a shift from minority investment (2022) to controlling interest (2023), but the LLM asserts the controlling interest began in 2022. This undermines the core strategic narrative. While the LLM correctly identifies operational integration into Emerson's software strategy and the role of asset optimization software, these qualitative points do not compensate for the timeline and quantitative errors. (4) Contextual relevance is high because the answer addresses investment returns and operational integration as asked. However, due to major factual and chronological inaccuracies, especially in key financial data and event sequencing, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because some strategic themes are plausible but built on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 531,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly through the acquisition of Heritage AspenTech in May 2022. Emerson contributed two industrial software businesses and $6.0 billion in cash to create \"New AspenTech,\" in which Emerson initially owned 55% of the outstanding shares. The transaction was accounted for using the acquisition method, with Emerson as the accounting acquirer, resulting in a noncontrolling interest of $5.9 billion for the 45% ownership retained by former Heritage AspenTech stockholders. In 2023, Emerson further solidified its control by proposing to acquire the remaining 43% of AspenTech not already owned, signaling a move toward full ownership. This acquisition added significant intangible assets and goodwill, impacting Emerson’s equity and expenses through amortization and acquisition-related charges.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 transaction structure: Emerson contributed industrial software businesses and $6.0 billion in cash to form New AspenTech, retaining a 55% stake, with a noncontrolling interest of $5.9 billion recorded—this aligns with the ground truth. The decrease to additional paid-in capital of $550 million in 2022 is omitted, which is a factual gap affecting quantitative completeness. The claim that Emerson proposed to acquire the remaining 43% in 2023 is factually incorrect—the ground truth does not mention this, and in reality, Emerson did not make such a move in 2023; the 43% figure also mismatches the 45% noncontrolling interest implied earlier. (2) The $6.0 billion cash contribution and $5.9 billion noncontrolling interest are accurate. However, the 2023 SG&A increase of $572 million and the 0.6 percentage point gross margin improvement—key operational impacts in the ground truth—are missing from the LLM answer. Instead, the LLM introduces 'amortization and acquisition-related charges' without quantification or direct support from the provided truth. (3) The multi-hop reasoning is partially sound: the LLM correctly links the 2022 transaction to noncontrolling interest accounting and recognizes the shift toward integration in 2023. However, it fabricates a 2023 buyout proposal, undermining the reasoning chain. The evolution from initial accounting to operational impact is conceptually addressed but not fully aligned with the evidence. (4) The correctness score is 7 due to accurate core facts about the 2022 transaction but significant omissions in 2023 financial impacts and one major factual error (the 43% acquisition proposal). Quantitative accuracy is 7 due to correct major figures but missing $550 million APIC adjustment and unverified expense claims. Qualitative accuracy is 8 because entity identification and accounting concepts are well-handled despite the fabrication. Contextual relevance is 9 as the response stays focused on the financial evolution and accounting impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 554,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "Between 2022 and 2023, IBM's treatment and disclosure of the 6.22% Debentures due 2027 remained consistent in terms of their listing and incorporation by reference in the SEC filings. In both years, the debentures were disclosed under the section listing securities registered pursuant to Section 12(b) of the Exchange Act, with the 6.22% Debentures due 2027 specifically noted as trading under the symbol \"IBM 27\" on the New York Stock Exchange. Additionally, the instrument defining the rights of the holders of the 6.22% Debentures due 2027 was referenced in both filings as being incorporated by reference from prior filings (Exhibit 3 to Form 8-K filed on August 1, 1997). There were no notable changes in the treatment or disclosure of these debentures between the 2022 and 2023 filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, claiming there were 'no notable changes' in disclosure between 2022 and 2023, which directly contradicts the ground truth. The ground truth states that IBM evolved its disclosure from a historical reference (in 2022) to a more structured, market-oriented presentation in 2023 by explicitly listing the debentures with their trading symbol (IBM 27) and including them among other NYSE-registered securities. While the LLM correctly identifies the trading symbol 'IBM 27' and the August 1, 1997 Form 8-K Exhibit 3 reference—thus getting some quantitative and entity details right—it fails to recognize the key evolution in disclosure approach. This represents a critical failure in multi-hop reasoning: the model should have compared the structure and emphasis of the disclosures across years, but instead incorrectly asserts consistency. The answer is contextually relevant to the topic and includes correct entities (IBM, 6.22% Debentures due 2027, correct dates and symbols), but the qualitative misinterpretation of the change in disclosure practice severely undermines the response. Hence, the correctness and qualitative accuracy scores are low despite acceptable quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 349,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "From 2023 to 2024, UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers has increased in complexity due to factors such as evolving regulatory environments, integration of new technologies, and expansion of value-based care models. These arrangements involve the Company assuming financial risk for medical costs in exchange for premiums, and their growth has implications for cost estimation accuracy and service delivery responsibilities. The Company's ability to manage these risks effectively is critical, as inaccuracies in estimating medical costs or challenges in maintaining provider relationships could significantly impact profitability and operational performance.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but lacks key factual details present in the ground truth, resulting in a moderate correctness score. (1) While the general trend of increasing financial risk exposure is correctly identified, the LLM fails to specify the actual evolution between 2023 and 2024 as described in the original answer. In 2023, UnitedHealth recognized premium revenues based on estimated premiums earned and participated in value-based arrangements with per-patient-per-month payments. By 2024, the company's exposure expanded to include responsibility for unpaid claims if providers failed financially—a critical new risk not mentioned in the LLM response. (2) There are no numeric values to verify, so quantitative accuracy is scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is weak: the LLM does not synthesize specific disclosures from 2023 vs 2024 filings, instead offering generic statements about regulatory changes and technology. It misses the core shift in liability for unpaid claims and increased operational risk tied to provider solvency and data reporting. (4) Contextual relevance is high because the answer addresses risk-based arrangements, cost estimation, and service delivery, but the absence of concrete, differentiating details between the two years limits its accuracy and usefulness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 376,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly in terms of investment magnitude and strategic involvement. In 2022, Emerson acquired Heritage AspenTech, gaining 55% ownership of the newly formed AspenTech. By 2023, Emerson's strategic involvement deepened as it recognized a mark-to-market gain related to foreign currency forward contracts entered into by AspenTech to hedge the Micromine purchase price. Additionally, Emerson terminated all outstanding contracts by June 2023. The investment magnitude also increased, with Emerson owning approximately 57% of AspenTech by 2024, as reflected in its proposal to acquire the remaining shares.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that Emerson acquired Heritage AspenTech and gained 55% ownership in 2022, while the ground truth confirms this major transaction occurred in 2023, not 2022. The $362 million investment in 2022 was a minority financial stake, not an acquisition. The LLM also incorrectly claims Emerson owned 57% by 2024 and was proposing to acquire remaining shares, which is not supported by the original answer. (2) Quantitative inaccuracies include misattribution of the 55% ownership to 2022 instead of 2023, and the fabricated 57% ownership in 2024. The $6.0 billion cash contribution and the $362 million 2022 investment are omitted entirely. The mention of mark-to-market gains and foreign currency contracts related to Micromine is irrelevant and not part of the original evolution described. (3) The multi-hop reasoning is flawed: the model fails to correctly sequence the evolution from financial investment (2022) to strategic control (2023), conflating timelines and events. It introduces unrelated financial instruments (forward contracts) and exit activities (contract terminations) not present in the ground truth. (4) While the answer addresses the general theme of evolving involvement, the severe factual and temporal errors, especially on key financial figures and ownership changes, undermine correctness. Contextual relevance is moderate as it attempts to discuss investment magnitude and strategic involvement, but with incorrect data and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 424,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023 by becoming a core component of Adobe's AI-driven personalization strategy, integrated with Adobe Sensei and GenAI capabilities. This evolution indicates Adobe's strategic direction of leveraging AI and machine learning to deliver hyper-personalized, real-time customer experiences across channels, emphasizing automation, intelligent decision-making, and scalable personalization.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Adobe Target from a general personalization tool in 2022 to a more strategically emphasized AI-driven personalization engine in 2023. It correctly identifies Adobe's strategic direction toward AI and machine learning for personalization. However, it introduces 'Adobe Sensei and GenAI capabilities' which, while plausible given Adobe's ecosystem, are not mentioned in the original ground truth and thus represent an unsupported enhancement. The ground truth specifies that in 2022, Adobe Target was grouped with Marketo Engage, Adobe Campaign, and Journey Optimizer as part of a broader suite, and in 2023 was explicitly labeled an 'AI- and machine learning-driven personalization engine' with AI-powered automation for omnichannel testing—details the LLM captures in spirit but not verbatim. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated). The reasoning is sound and contextually relevant, showing understanding of the strategic shift, but lacks explicit mention of the comparative context (i.e., the 2022 baseline description) and omits specific product names mentioned in the original. Thus, while semantically close and logically coherent, it misses some factual completeness and precision in entity references, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 380,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "Emerson completed the acquisition of Heritage AspenTech in the third quarter of 2022, and as of 2023, AspenTech continued to operate as a separate publicly traded company under Emerson's ownership. Emerson's financial stake in AspenTech is reflected in its integration of AspenTech's stock-based compensation plans and the assumption of outstanding equity awards. Post-acquisition integration activities included converting Heritage AspenTech equity awards into Emerson equity awards and maintaining AspenTech's own stock-based compensation programs, which are settled in AspenTech stock. Additionally, Emerson assumed responsibility for integration-related stock compensation expenses, with $58 of such costs reported in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies, particularly in quantitative details. The ground truth states that Emerson reported a balance of $8,326 million related to AspenTech in 2022, but the LLM omits this key financial figure entirely. Instead, it introduces a new number—$58 of integration-related stock compensation expenses reported in 2024—which is not present in the original answer and appears to be factually incorrect or at least unsupported by the provided ground truth. This is a significant error in quantitative accuracy. (2) The LLM correctly identifies the 2022 acquisition and AspenTech operating as a separate publicly traded company under Emerson in 2023, which aligns with the original answer. However, it incorrectly states that equity awards were converted into Emerson equity awards, while the original answer emphasizes that AspenTech maintained its own equity structure and stock-based compensation plans (e.g., stock options and RSUs settled in AspenTech stock). This misrepresents the nature of the integration. (3) The multi-hop reasoning is partially sound—linking acquisition to integration activities—but fails in accurately synthesizing the financial stake and compensation structure. The mention of performance stock units tied to metrics like annual contract value and free cash flow in the original answer is entirely missing, weakening the qualitative depth. (4) Contextual relevance is high, as the response addresses both financial stake and integration activities. However, due to the omission of the $8.326 billion figure, introduction of an unsupported $58 expense in 2024, and mischaracterization of equity conversion, the correctness score is reduced to 6—partially correct but with significant factual and quantitative flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 485,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "From 2022 to 2023, Adobe Experience Platform's role within Adobe's customer journey solutions has evolved significantly, particularly in its integration with AI-powered tools and cross-channel campaign orchestration. In 2022, Adobe Experience Platform was highlighted as a foundational infrastructure for unifying customer data and enabling AI-driven insights across Adobe Experience Cloud solutions. By 2023, the platform had further advanced, with deeper integration of Adobe Sensei and GenAI capabilities, allowing for real-time personalization, intelligent decision-making, and cross-channel campaign orchestration through tools like Adobe Journey Optimizer. This evolution enabled brands to deliver more accurate, personalized, and connected customer journeys across all channels and touchpoints.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Adobe Experience Platform from 2022 to 2023. (1) It accurately states that in 2022, the platform served as foundational infrastructure for data unification and AI-driven insights via Adobe Sensei, aligning with the ground truth. In 2023, it correctly identifies the enhanced role in cross-channel orchestration through Adobe Journey Optimizer and real-time personalization. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—dates (2022, 2023) are correct and consistent with the original answer, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes the platform’s shift from infrastructure to active orchestration. However, it omits specific 2023 innovations mentioned in the ground truth, such as Adobe Mix Modeler and its role in marketing investment optimization using machine learning. While it mentions 'GenAI' and 'intelligent decision-making,' these are not explicitly detailed in the original and slightly overreach without supporting specifics. (4) Despite minor omissions, the answer remains contextually relevant and semantically aligned with the main evolution described. The core facts are correct, but the lack of specific tool mentions (e.g., Mix Modeler) and slightly vague AI references prevent a full 9–10 on qualitative accuracy. Correctness is high but not complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 402,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In response to Medicare Advantage funding pressures from 2023 to 2024, UnitedHealth Group accelerated its transition from fee-for-service care delivery models to fully accountable value-based care models. This included enhancing care delivery through in-clinic, in-home, behavioral, and virtual care, as well as leveraging data and analytics to improve care coordination and outcomes. The company also intensified medical and operating cost management, adjusted member benefits, and implemented or increased member premiums to offset funding reductions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies UnitedHealth Group's shift toward value-based care and use of in-home, virtual, and data-driven care models in response to Medicare Advantage funding pressures, which aligns with the 2023 strategy in the ground truth. It also accurately notes cost management actions in 2024 such as benefit adjustments and premium changes. However, it omits key elements of the strategic shift described in the original answer: specifically, the retrenchment involving selective provider network changes, county-level plan withdrawals, and the framing of a shift from expansion-focused investment to cost containment. While the LLM mentions cost management, it does not fully capture the operational and geographic scaling back that characterized the 2024 response. There are no numerical inaccuracies (quantitative accuracy is high due to absence of incorrect figures), and all entities (UnitedHealth Group, Medicare Advantage, value-based care) are correctly identified. The reasoning is sound but incomplete in synthesizing the full evolution from 2023 to 2024. The answer remains contextually relevant and captures the general direction of change, but lacks the depth of multi-hop synthesis regarding strategic retrenchment decisions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 350,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "Based on the provided document pages, there is no specific information detailing the evolution of TMO's debt instruments between 2022 and 2023 or any changes regarding the 1.950% Notes due 2029. The pages primarily cover general business operations, segments, and product offerings, but do not include financial data or disclosures about changes in debt composition during the specified period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The original answer (ground truth) provides specific information about TMO's debt instruments in 2022 and 2023, including the continued presence of the 1.950% Notes due 2029 with trading symbol TMO 29 and the addition of new notes in 2023 (3.200% due 2026 and 3.650% due 2034). The LLM claims no information is available, which contradicts the provided ground truth. There are no numeric values in the LLM response to assess for quantitative accuracy, and it fails to identify any entities or perform multi-hop reasoning because it denies the existence of relevant data. While the response is contextually related to the type of information sought (debt instruments), its failure to report known facts from the ground truth severely undermines its relevance and correctness. Thus, the scores are low across all categories, with minimal credit for attempting to address the topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 266,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Between 2022 and 2023, TMO's debt instruments remained largely consistent, with the 0.500% Notes due 2028 (TMO 28A) listed in both years. However, in 2023, TMO introduced new note categories, including the 3.200% Notes due 2026 (TMO 26B) and the 3.650% Notes due 2034 (TMO 34), indicating a diversification of its debt portfolio with higher-yield, longer-term instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (0.500%, 3.200%, 3.650%) and maturity years (2026, 2028, 2034)—are correct, satisfying quantitative accuracy. The mention of the 0.500% Notes due 2028 being present in both years is factually sound. (2) The introduction of the 3.200% Notes due 2026 and 3.650% Notes due 2034 in 2023 is correctly identified, matching the original answer. (3) The reasoning correctly infers a strategic diversification of the debt portfolio, particularly toward longer-term and higher-yield instruments, which is consistent with the ground truth’s interpretation. (4) The only minor omission is that the LLM does not explicitly mention the continued presence of the 1.375% Notes due 2028 in both years, which the original answer includes as part of the stable debt structure. While this detail is relevant to completeness, its absence does not undermine the core correctness or the multi-hop synthesis. The answer remains contextually relevant, factually precise, and semantically equivalent in conveying the evolution of TMO's debt composition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 321,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "The range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses. In 2023, the excess ranged from approximately 140% to 495%, while in 2024, the range was approximately 70% to 450%. This indicates a slight decrease in the lowest end of the range, with the upper end remaining relatively stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the numerical ranges for both 2023 (140% to 495%) and 2024 (70% to 450%), matching the ground truth exactly. All percentages are accurate and properly attributed to the correct years. (2) Quantitative accuracy is perfect—no calculation errors, and the values align precisely with the original answer. Format is consistent and clear. (3) The reasoning is sound: the LLM correctly identifies a decrease in the lowest end of the range and notes stability in the upper end, which is a valid interpretation of the data. The only minor shortcoming is that it describes the change as a 'slight decrease'—while not incorrect—the original answer emphasizes a 'reduction in the lowest excess fair value percentage' and links it more clearly to a 'decline in the overall cushion before potential impairment,' which carries a slightly stronger and more precise implication about financial risk. This nuance is downplayed but not misrepresented. (4) The answer is fully contextually relevant, directly addressing how the range changed between the two years. All entities—DHR, reporting units, goodwill impairment analyses, and the correct years—are accurately referenced. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score with only a minor deduction in qualitative accuracy for slightly softer interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 394,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "From 2022 to 2023, the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan increased the available share pool. In 2022, 14.7 million RSUs were canceled and 41 million shares were withheld for taxes, while in 2023, 8.1 million RSUs were canceled and 37 million shares were withheld. Since canceled RSUs and withheld shares increase the available share pool by a factor of two times the number of shares, the reduction in cancellations and withholdals in 2023 slightly decreased the replenishment of the share pool compared to 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, the language allowing canceled RSUs and tax-withheld shares to replenish the share pool by a factor of two was *omitted*, meaning the treatment fundamentally changed. However, the LLM incorrectly assumes the 2x factor still applied in 2023, leading to a flawed conclusion about 'replenishment' based on that factor. This misrepresents the core policy change. (2) The numeric values (14.7M, 41M, 8.1M, 37M) are plausible but not confirmed in the ground truth, which does not provide specific quantities of canceled RSUs or withheld shares—only the *policy* change. Thus, the inclusion of these numbers is unsupported and likely fabricated. Calculations based on these numbers are therefore invalid. (3) The multi-hop reasoning fails: the key evolution is *policy-based* (from 2x replenishment to unknown/changed treatment), not a quantitative comparison of events. The LLM treats it as a continuation of the same rule with different inputs, missing the structural change entirely. (4) Scores reflect major factual and reasoning errors: correctness is low due to incorrect policy interpretation and invented data; quantitative accuracy is moderate only because numbers are internally consistent but unsupported; qualitative accuracy is low due to flawed logic; contextual relevance is moderate because the answer addresses the general topic but not the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 416,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "Between 2023 and 2024, Aldevron remained integrated into Danaher's Life Sciences segment, as highlighted in the 2024 10-K. There is no indication of a change in Danaher's financial stake in Aldevron during this period, as Aldevron was fully acquired in 2021 for $9.6 billion and continued to be a part of Danaher's portfolio. Aldevron's role in manufacturing plasmid DNA, mRNA, and proteins supports genomic medicine and complements Danaher's broader Life Sciences offerings, including its Genomic Medicines business and other acquisitions like IDT and Abcam.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. Most critically, it states that Aldevron was fully acquired in 2021 for $9.6 billion, which contradicts the ground truth indicating a $9,561 million (i.e., $9.561 billion) net cash consideration allocated in 2023—suggesting the acquisition or final accounting occurred in 2023, not 2021. This misstatement of the acquisition date and amount undermines factual correctness. Additionally, the LLM claims there was 'no indication of a change in financial stake,' but the ground truth explicitly notes a shift from a separately accounted stake in 2023 to full integration into the Life Sciences segment in 2024, which the LLM fails to recognize. (2) Quantitatively, the $9.6 billion figure is close to the $9,561 million in the original answer, so the dollar amount is approximately correct (within rounding), but the attribution to 2021 is wrong. The 2023 allocation is a key data point missing in the LLM response. (3) The multi-hop reasoning is flawed: the question asks about evolution between 2023 and 2024, requiring synthesis of changes in financial stake and segment integration. The LLM asserts continuity rather than change, missing the strategic shift from standalone stake to integration. It correctly identifies Aldevron’s role in plasmid DNA, mRNA, and proteins and its fit within Life Sciences, but fails to contrast 2023 vs 2024 status. (4) Contextual relevance is high—the answer discusses the right companies, segment, and strategic rationale—but correctness and qualitative accuracy are reduced due to the failure to capture the temporal evolution and misrepresentation of acquisition timing and accounting treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 462,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "Between 2023 and 2024, Microsoft 365 has evolved as a central platform for AI integration, with Copilot for Microsoft 365 combining AI with business data to enhance productivity and streamline workflows. In 2024, Microsoft 365's role in the commercial business became more prominent, contributing to a 14% revenue growth driven by Office 365 Commercial, which grew by 16%. The integration of AI technologies, such as role-based Copilots (e.g., Copilot for Sales, Service, and Finance), has further solidified Microsoft 365's position as a key driver of business transformation and operational efficiency.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of Microsoft 365 with AI integration, particularly through Copilot for Microsoft 365 and role-based Copilots, which aligns with the ground truth's emphasis on AI-first positioning. However, it introduces specific quantitative claims—'14% revenue growth' and 'Office 365 Commercial grew by 16%'—that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually incorrect or misattributed, significantly undermining quantitative accuracy. (2) The original answer does not include any revenue growth percentages; instead, it highlights a change in metric reporting—specifically, the 2024 expansion of Microsoft 365 Consumer subscribers to include Basic tier subscribers. This key strategic signal about market reach and internal alignment is entirely missing in the LLM response. (3) While the LLM demonstrates sound reasoning in connecting AI integration to commercial impact, it fails to capture the multi-hop nuance of how Microsoft's internal metric evolution reflects strategic positioning. The synthesis is partially correct but omits a core factual development. (4) The contextual relevance is high because the answer addresses AI integration and commercial role, but correctness is reduced due to unsupported numbers and omission of the subscriber metric change. Qualitative accuracy is moderate due to correct entity identification (Copilot, Microsoft 365) and plausible reasoning, but quantitative accuracy is low due to unverified percentages.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 436,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "Between 2023 and 2024, Microsoft positioned Copilot Pro as a consumer subscription service that offers enhanced AI assistance within Microsoft 365 apps and on the web. In 2023, Copilot Pro was highlighted as a tool to provide faster and more powerful AI support for productivity and collaboration. By 2024, its role expanded to emphasize broader integration with Microsoft 365 and web-based AI assistance, reflecting Microsoft's focus on leveraging AI to transform productivity and user experience across its ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Copilot Pro was introduced in 2023 as a consumer subscription service offering 'faster and more powerful AI assistance' in Microsoft 365 apps and on the web, and that by 2024, its positioning evolved to emphasize broader integration within Microsoft's AI-driven productivity ecosystem. All entities (Microsoft, Copilot Pro, Microsoft 365, 2023, 2024) are correct, and there are no numerical inaccuracies (no specific numbers involved, but temporal and descriptive accuracy is maintained). The reasoning is sound and reflects the multi-hop synthesis between the introduction in 2023 and the strategic evolution in 2024. The only minor shortcoming is that the LLM does not explicitly mention the 'retention of key language' (e.g., 'faster and more powerful') within a more expansive narrative, which slightly reduces qualitative precision. However, the core evolution in positioning and emphasis is accurately conveyed, making the answer semantically equivalent and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 309,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan had approximately 50 million shares available for issuance as of December 31, 2023, and this decreased to approximately 47 million shares available for issuance as of December 31, 2024. This reduction reflects the issuance of shares related to stock-based compensation awards during 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that approximately 50 million shares were available as of December 31, 2023, which contradicts the ground truth stating that no specific figure was provided for 2023. This is a major factual error. The 2024 figure of 47 million shares available is correct and matches the ground truth. (2) The quantitative accuracy is low because the 50 million share number for 2023 is fabricated; there is no support for this in the original answer. The reduction from 50M to 47M implies a calculation (3M shares issued) that cannot be validated due to the incorrect starting point. (3) The reasoning is partially sound in that it infers a decrease due to stock-based award issuances, which is plausible, but it fails the multi-hop requirement because it invents data for 2023 rather than acknowledging the absence of a disclosed figure. The original answer emphasizes a shift in disclosure transparency, which the LLM answer omits entirely. (4) While the LLM addresses the evolution of share availability and focuses on the right plan and years, the invention of a precise 2023 number undermines factual correctness. Contextual relevance is high because it attempts to answer the right question about changes in share availability over time, but the qualitative and quantitative inaccuracies significantly reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 381,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Microsoft did not change its accounting policy regarding the estimated useful lives of server and network equipment. The policy, which extended the useful lives from four to six years, was implemented in fiscal year 2023 following an assessment in July 2022. This change was driven by investments in software that improved operational efficiencies and technological advancements. No further updates to this policy were mentioned in the 2024 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) Quantitatively, all key details are correct: the change from four to six years occurred in fiscal year 2023, was based on a July 2022 assessment, and remained unchanged in fiscal year 2024. These match the original answer. (2) The driving factors—software investments improving operational efficiencies and technological advancements—are correctly identified. (3) The reasoning is sound: the LLM correctly infers that no mention of a change in 2024 implies policy continuity, which aligns with the ground truth's interpretation that the six-year estimate was sustained. (4) The only minor difference is that the original answer adds interpretive context about cloud and AI infrastructure investments reinforcing the rationale, which the LLM omits. However, this does not make the LLM answer incorrect—just slightly less detailed. The core multi-hop synthesis (change in 2023, no change in 2024, reasons for change) is fully accurate. Therefore, the answer earns a 9/10 for correctness and qualitative accuracy due to high factual precision and logical coherence, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 339,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "MDT's exposure to auction rate securities remained consistent in fair value at $33 million in both 2022 and 2023. In both years, these securities were classified under \"Other Assets\" on the consolidated balance sheet, with no amounts recorded under \"Investments.\"",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that MDT's auction rate securities had a fair value of $33 million in both 2022 and 2023, which matches the ground truth. However, it incorrectly claims that in 2022 the securities were classified under 'Other Assets', when in fact they were included in 'Total' within the investment portfolio without a separate classification. The ground truth indicates a shift in classification from a general investment category in 2022 to 'Other Assets' in 2023, but the LLM states there was no change and that they were classified under 'Other Assets' in both years. This is a critical factual error in entity classification and reasoning about the evolution of balance sheet treatment. (2) Quantitatively, the $33 million fair value is accurate for both years, so numerical accuracy is perfect. (3) The multi-hop reasoning fails because the model does not recognize the change in classification over time—it incorrectly assumes consistency where there was a meaningful shift in financial reporting. (4) While the answer addresses the fair value correctly and is relevant to the question, the misrepresentation of the 2022 classification undermines the qualitative accuracy and overall correctness, warranting a moderate score of 4. Contextual relevance is high as the response stays on topic and discusses the required time frame and financial instrument.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 385,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "In fiscal 2024, Cisco reported a net loss of $67 million from available-for-sale debt investments, compared to a net loss of $21 million in fiscal 2023. This indicates a worsening in the performance of Cisco's available-for-sale debt investments, reflecting either a decline in the fair value of these investments or increased volatility in the market during fiscal 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net losses for both fiscal years: $21 million in 2023 and $67 million in 2024, matching the ground truth exactly. The comparison showing an increase in loss is accurate. (2) All numeric values are correct and properly attributed to the right fiscal years. The dollar amounts are consistent with the original answer, and no calculation errors are present. (3) The multi-hop reasoning is sound—comparing performance across two fiscal years based on reported net gains/losses from available-for-sale debt investments is correctly executed. The conclusion that performance worsened is logically supported. (4) The LLM adds minor interpretive context (e.g., 'decline in fair value' or 'increased volatility'), which is reasonable and does not contradict the ground truth; however, this slight elaboration beyond the original answer does not introduce inaccuracies, so it does not reduce correctness. The core facts, numbers, and synthesis are fully aligned with the ground truth, warranting a high score. Only a perfect 10 would require exact alignment in tone and brevity, but semantic equivalence is achieved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 329,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Between 2023 and 2024, Cisco's approach to the APJC region evolved by shifting from a focus on expanding operational structures to optimizing existing operations and increasing financial investments in strategic areas such as cybersecurity and AI-driven solutions. In 2023, the emphasis was on modernizing infrastructure and enhancing network capabilities, while in 2024, the company prioritized integrating advanced technologies like AI and SASE to improve customer experiences and drive revenue growth. This shift implies a move toward a more diversified revenue model in the APJC region, with increased emphasis on subscription-based services and cloud solutions, reflecting a broader strategic alignment with digital transformation trends.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. While it mentions a shift in Cisco's approach between 2023 and 2024 in the APJC region, it fabricates specific strategic focuses—such as 'cybersecurity and AI-driven solutions,' 'SASE,' and 'subscription-based services'—that are not supported by the ground truth. The original answer states that Cisco moved from direct operational presence in 2023 to including financial investments (marketable and non-marketable equity securities, equity method investments) in 2024. The LLM answer completely misses this key financial investment shift and instead invents a narrative around technology integration and digital transformation. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, since no numbers were introduced incorrectly, this dimension does not penalize the response, hence a score of 10. (3) The multi-hop reasoning is flawed: the question requires synthesizing changes in operational structure versus financial investment across two years from SEC filings. The LLM fails to identify the actual shift from operational to investment-based engagement, instead describing a fictional evolution in tech focus. It does not reference any financial instruments or investment categories mentioned in the ground truth. (4) Contextual relevance is moderate because the answer addresses Cisco, APJC, and a temporal evolution in strategy, but it misrepresents the nature of that evolution. The implications for revenue model are partially relevant (diversification), but the basis—subscription and cloud—is speculative and unsupported by the source. Overall, major factual inaccuracies and failure to capture the core financial investment shift result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 490,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Between 2022 and 2024, Apple has adapted its App Store commission policies and regulatory compliance in response to legal and market pressures. In 2022, the Company acknowledged potential changes to its App Store practices due to litigation, competition, and regulatory requirements, but specific adjustments were not detailed. By 2024, Apple had implemented notable changes, particularly in the EU, to comply with the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures for iOS and iPadOS apps, alternative app distribution methods, and alternative payment processing. Additionally, Apple modified how developers could communicate with consumers about alternative purchasing options in the U.S. These adjustments reflect Apple's evolving approach to balancing regulatory compliance with maintaining its App Store ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Apple's 2022 acknowledgment of potential App Store changes due to legal and market pressures without detailing specific actions, and accurately describes the concrete changes implemented by 2024 in response to regulations like the DMA. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2024) and regulatory references (Digital Markets Act) are correct. (3) The multi-hop reasoning is sound: the model synthesizes Apple’s evolving stance across time and regions (U.S. and EU), correctly linking regulatory pressure (DMA) to specific policy changes such as alternative payment processing, distribution methods, and communication rules for developers. (4) The LLM includes a detail not in the original—'modified how developers could communicate with consumers about alternative purchasing options in the U.S.'—which is factually consistent with Apple’s 2024 adjustments (e.g., in response to the Open App Markets Act pressure and litigation), making it a relevant addition rather than an error. The only minor gap is that the original emphasizes the financial risk to App Store revenue more explicitly, while the LLM focuses on ecosystem balance—this nuance difference prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 415,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "Between 2022 and 2024, Texas Instruments' U.S. Retiree Health Care Plan maintained a higher allocation to fixed income securities and cash equivalents compared to equity securities. In 2022, the allocation was 64% fixed income and 36% equity, while in 2024, it was 80% fixed income and 20% equity. This shift reflects a more conservative strategy, aligning with the plan's goal to better match the interest rate sensitivity of its liabilities and mitigate market volatility risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift toward a more conservative allocation strategy favoring fixed income securities from 2022 to 2024 and accurately reports the 80%/20% split in 2024. However, it incorrectly states the 2022 allocation as 64% fixed income and 36% equity. The ground truth provides absolute values: $248 million in fixed income and cash equivalents and $137 million in equities. The correct 2022 percentages are approximately 64.4% ($248M / ($248M + $137M) = $248M / $385M) and 35.6%, which rounds to about 64%/36%. While this is numerically close and likely derived correctly, the original answer does not explicitly state percentages for 2022, so the LLM may have calculated them. The 2024 percentages (80%/20%) match the ground truth. (2) The dollar amounts from 2022 are missing in the LLM answer, which reduces completeness and quantitative accuracy. The calculation of 2022 percentages is reasonable but not explicitly confirmed in the source, so presenting them as fact without noting they are derived is a minor issue. (3) The reasoning about a more conservative posture and strategic shift is sound and aligns with the ground truth. The LLM correctly synthesizes the trend across years and infers the intent (matching liability sensitivity, reducing volatility), which is consistent with the original answer’s implication of capital preservation. However, the ground truth notes that the 80/20 split remained unchanged between 2023 and 2024, indicating stability in the later period—a nuance missing in the LLM response. (4) The contextual relevance is high as the answer directly addresses the evolution of allocation strategy. The qualitative accuracy is strong due to correct interpretation of strategic intent. Quantitative accuracy is reduced due to unverified percentage calculations and omission of dollar figures. Correctness score is 7 because core facts (direction and magnitude of shift, 2024 allocation) are correct, but some numerical representation lacks grounding in the provided data and key details are omitted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 558,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "Texas Instruments' strategic emphasis on Embedded Processing Products has seen a decline in both revenue and operating profit from 2022 to 2024. In 2022, Embedded Processing generated $3.26 billion in revenue and $1.25 billion in operating profit, but by 2024, these figures dropped to $2.53 billion in revenue and $352 million in operating profit. This decline indicates a reduced contribution to the company's competitive advantages during this period. Additionally, the segment's operating profit margin decreased significantly from 38.5% in 2022 to 13.9% in 2024, highlighting a weakening performance. Despite this, Embedded Processing remains one of TI's two reportable segments, underscoring its ongoing, though diminished, strategic importance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The revenue and profit figures provided ($3.26B revenue and $1.25B operating profit in 2022; $2.53B and $352M in 2024) are factually wrong and not supported by the ground truth. The ground truth does not provide any financial performance data for Embedded Processing for 2022 or 2024, nor does it indicate any decline. The claimed drop in operating margin from 38.5% to 13.9% is fabricated. (2) Completeness: While the question asks about evolution in strategic emphasis, competitive advantages, and segment reporting, the LLM incorrectly frames the evolution as a performance decline, which contradicts the ground truth. It fails to mention the key point that Embedded Processing was elevated to a reportable segment in 2024, which is central to the correct answer. (3) Entity Accuracy: The company (Texas Instruments) and product line (Embedded Processing) are correctly identified, and the years (2022–2024) are correct. However, the financial metrics are entirely inaccurate. (4) Reasoning: The multi-hop reasoning is flawed. The ground truth indicates a strategic elevation of Embedded Processing, while the LLM infers a strategic decline based on false financial data. The conclusion that its strategic importance has diminished directly contradicts the ground truth, which states it became more central. (5) Semantic Equivalence: The LLM answer conveys the opposite meaning of the ground truth. Despite correctly noting that Embedded Processing is a reportable segment in 2024, it misinterprets this as persistence amid decline rather than a sign of increased strategic focus. Overall, the answer is mostly incorrect with major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 480,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "TMO issued its 2.00% 10-Year Senior Notes in 2022 as part of a series of notes issued by its wholly-owned finance subsidiary, Thermo Fisher International, which were included in the Euronotes. These notes were due in 2035 as of 2022. By 2024, the 2.00% Senior Notes were reclassified as 2.00% 30-Year Senior Notes due 2051, indicating a change in their maturity date. The valuation of these notes in 2024 showed a carrying value of $777 million, with an effective interest rate of 2.06%. This evolution reflects a strategic shift in the company's long-term debt structure.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains almost no correct factual information compared to the ground truth. It incorrectly states that the 2.00% 10-Year Senior Notes were due in 2035 as of 2022, while the original answer specifies they are due October 15, 2031. It further claims these were reclassified as 30-Year Senior Notes due 2051 by 2024, which contradicts the ground truth showing no change in maturity or structure. The carrying value is stated as $777 million in 2024 with an effective interest rate of 2.06%, but the correct value is $1,200 million with a 2.23% effective rate in both years. (2) All numeric values are incorrect: principal amount ($777M vs $1,200M), maturity dates (2035/2051 vs 2031), interest rates (2.06% vs 2.23%), and timeline evolution. There is no indication of consistency between 2022 and 2024 as required by the truth. (3) The multi-hop reasoning is fundamentally flawed. Instead of identifying that the same debt instrument remained unchanged across filings, the model fabricates a reclassification and strategic shift not present in the data. It misattributes issuance to a subsidiary and Euronotes without support. (4) The answer fails on correctness due to pervasive factual errors. Quantitative accuracy is very low because all numbers are wrong. Qualitative accuracy is poor due to incorrect entities, reasoning, and synthesis. Contextual relevance is moderate because it attempts to address debt evolution, but the content is largely fabricated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 411,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "REMICADE's sales declined by 12.8% in 2024 compared to 2023, primarily due to continued biosimilar competition in the U.S. and other markets. This significant decline indicates that REMICADE is losing market share within Johnson & Johnson's Pharmaceutical segment, highlighting the increasing pressure from biosimilars in the immunology therapeutic area.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 12.8% sales decline of REMICADE in 2024 compared to 2023, aligning with the ground truth that reports a drop from $1,839 million in 2023 to $1,605 million in 2024. The percentage decrease is accurately reflected. (2) Quantitative accuracy is perfect: the 12.8% decline is correct (calculated as (1839 - 1605) / 1839 ≈ 0.1272, or ~12.7%, which rounds to 12.8%), and the years referenced (2023 to 2024) match the data used in the original answer. (3) The reasoning is sound in attributing the decline to biosimilar competition, which is a plausible and contextually appropriate explanation, though the original answer emphasizes broader factors like market saturation and newer biologics rather than specifically naming biosimilars. While biosimilar competition is a valid driver, the LLM omits mention of REMICADE’s prior role as a key product in the Immunology therapeutic area in 2022, which was part of the multi-hop synthesis required by the question. This missing context slightly weakens the qualitative completeness. (4) Despite the omission of the 2022 strategic role, the LLM answer remains highly relevant and factually accurate in addressing the financial trend and its implications for Johnson & Johnson’s Pharmaceutical segment. The focus on biosimilars adds useful specificity, even if it doesn’t fully replicate the original’s emphasis on evolving product dynamics. Thus, high scores are warranted, with a slight deduction in qualitative accuracy due to incomplete entity and temporal synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 428,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "From 2022 to 2024, REMICADE's sales declined significantly, dropping from $3,190 million in 2022 to $1,605 million in 2024, representing a total decrease of 12.8% in 2024 compared to 2023 and a cumulative decline of 50.5% over the two-year period. This sharp decline is primarily attributed to ongoing biosimilar competition in the United States and other international markets, which has eroded REMICADE's market share. The sustained pressure from biosimilars indicates a weakening market position for REMICADE within JNJ's Immunology portfolio, as newer products like STELARA and TREMFYA have shown growth and greater resilience.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies REMICADE's sales of $3,190 million in 2022 and $1,605 million in 2024, which matches the ground truth. However, it incorrectly states that the 12.8% drop occurred from 2022 to 2024, while the original answer specifies that the 12.8% decline was from 2023 to 2024. The LLM also introduces a 'cumulative decline of 50.5%' over two years, which is not mentioned in the ground truth and is factually inaccurate: the actual decline from 2022 ($3,190M) to 2024 ($1,605M) is approximately 49.7%, not 50.5%. Additionally, the ground truth references a 14.9% decline compared to 2020, which the LLM omits entirely. (2) The dollar amounts are correct, but the percentage changes are misattributed and miscalculated. The 12.8% drop should be from 2023 to 2024, not 2022 to 2024. The cumulative decline calculation is erroneous. (3) The LLM demonstrates sound multi-hop reasoning by connecting declining sales to biosimilar competition and contrasting REMICADE’s performance with growing products like STELARA and TREMFYA, which aligns with the implication of weakening market position. However, it fabricates a specific percentage decline not supported by the source and misses the 2020 comparison that provides longer-term context. (4) Despite the quantitative inaccuracies, the LLM captures the core trend—significant sales decline and weakening market position—and adds relevant qualitative context about biosimilars and portfolio dynamics, making the answer contextually strong and mostly aligned with the ground truth’s conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 431,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "REMICADE's sales declined from $3.19 billion in 2021 to $1.605 billion in 2024, representing a significant reduction of 12.8% in 2024 compared to the prior year and a cumulative decline of 43.4% over the period. The primary factor contributing to this decline is the continued competition from biosimilar versions of infliximab introduced in the U.S. and other markets, which has consistently eroded REMICADE's market share.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The ground truth states that REMICADE's sales were part of a larger Immunology segment totaling $16.8 billion in 2021, not REMICADE alone at $3.19 billion. The LLM incorrectly presents $3.19 billion as REMICADE's standalone sales in 2021, which is not supported by the original answer. The 2024 sales figure of $1.605 billion (or $1,605 million) is correct and matches the ground truth. However, the 12.8% decline is only accurate from 2023 to 2024, not as a cumulative figure, and the LLM misattributes this percentage to the full period while also calculating a 43.4% cumulative decline that is not mentioned or verifiable from the original answer. (2) Calculations: The claimed 43.4% decline from $3.19B to $1.605B is mathematically accurate ((3.19 - 1.605)/3.19 ≈ 49.7%), but this baseline sales figure is factually wrong, making the entire calculation invalid. The 12.8% year-over-year decline in 2024 is correctly cited from the original. (3) Multi-hop reasoning: The LLM correctly identifies biosimilar competition in the U.S. and global markets as the primary driver of decline, which aligns with the original answer’s reasoning. This shows sound qualitative synthesis of cause and effect across time. (4) Despite correct identification of the causal factor and the 2024 sales figure, the use of an incorrect baseline sales value in 2021 severely undermines the quantitative accuracy and overall correctness. The answer is partially correct in direction and reasoning but fails on key factual inputs, warranting a low correctness score. Contextual relevance is high as all content directly addresses the question’s focus on performance trends and contributing factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 482,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "Between 2022 and 2024, STELARA (ustekinumab) experienced a decline in sales, dropping from $9.134 billion in 2022 to $10.361 billion in 2023, and further to $6.7 billion in 2024. The decline in 2024 was primarily driven by share loss due to European biosimilar entrants and the anticipation of biosimilar competition in the U.S. in 2025. Despite this, STELARA maintained strong U.S. sales in 2024, though its overall commercial performance was negatively impacted by the entry of biosimilars.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, STELARA generated $10,858 million in 2023 and $10,361 million in 2024, representing a 4.6% decline. However, the LLM claims sales were $9.134 billion in 2022 (not provided in ground truth), $10.361 billion in 2023 (incorrect year assignment), and $6.7 billion in 2024 (massive underreporting). The correct 2024 figure is $10,361 million, not $6.7 billion. The LLM misattributes the decline to European biosimilars and anticipation of U.S. biosimilars in 2025, which is plausible context but not present in the original answer and thus cannot be verified as part of the knowledge graph truth. (2) Quantitative accuracy is very low: the LLM reverses the 2023 and 2024 figures, invents a 2022 sales number not in the original, and reports a much steeper decline than actual. The correct decline is ~4.6%, not the implied ~35% drop from 2023 to 2024 in the LLM answer. (3) Qualitatively, the LLM correctly identifies STELARA as experiencing declining sales and references biosimilar competition, but fails to mention the key 2022 regulatory status — that it was in the filing stage for pediatric use in the U.S., a critical part of the original answer. This missing information breaks the multi-hop evolution narrative from regulatory development to commercial maturity. (4) Contextual relevance is moderate because the answer discusses commercial performance over time, but the severe numerical errors and omission of the regulatory status evolution significantly undermine correctness. The answer fabricates data and misrepresents trends, leading to a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 456,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The total net revenue from Restasis in the United States decreased from $382 million in 2023 to $172 million in 2024, representing a 55.2% decrease in 2024. In 2023, the revenue decreased by 38.5% compared to 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts are accurate: $382 million in 2023 and $172 million in 2024. The percentage decreases are also correct: 38.5% decrease in 2023 (compared to 2022) and a 55.2% decrease in 2024 (compared to 2023). (2) The calculations are sound: the 55.2% decrease from 2023 to 2024 is accurate ((382 - 172) / 382 ≈ 0.552), and the 38.5% decrease in 2023 is correctly attributed as a year-over-year change from 2022. (3) The reasoning is logically structured and correctly synthesizes multi-hop information—linking two consecutive years of revenue decline with correct comparative periods. (4) All entities (Restasis, United States net revenue, years 2023 and 2024) are correctly identified and contextualized. The answer addresses both parts of the question: the change in total net revenue and the percentage decrease in each year. Wording differs slightly from the original but maintains full semantic equivalence. No errors in facts, numbers, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 300,
        "total_tokens": 1409
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "Between 2022 and 2023, the role and strategic importance of Master Lease Agreements (MLAs) for AMT evolved to become more integral in supporting international growth and strengthening tenant relationships. These agreements provide consistent, long-term revenue and reduce non-contractual churn, while also enabling faster colocation cycle times, allowing tenants to deploy equipment more efficiently. In 2023, the strategic value of MLAs was further emphasized as AMT continued to expand its international portfolio and focus on building strong partnerships with multinational carriers to drive sustainable, long-term growth across diverse markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Master Lease Agreements (MLAs) for AMT between 2022 and 2023. It correctly identifies the strategic importance of MLAs in supporting international growth, enabling faster colocation, reducing churn, and building long-term tenant relationships. The answer accurately reflects the continued emphasis on consistent revenue and tenant retention, as well as the focus on multinational carriers and sustainable growth. However, it omits specific quantitative details from the ground truth: the international portfolio size of approximately 177,000 sites in 2022 and 182,000 in 2023. While the expansion is implied, the exact figures are missing, which represents a minor but notable omission in completeness. There are no factual inaccuracies or incorrect entities—AMT, MLAs, and the correct time frame (2022–2023) are properly referenced. The reasoning is sound and synthesizes the strategic continuity and deepening focus on risk mitigation (e.g., customer consolidation, regulatory changes), though the latter point is not explicitly mentioned. Wording differs but maintains semantic equivalence on key strategic points. Quantitative accuracy is scored highly because no incorrect numbers are presented—only the absence of specific figures. Overall, the answer is contextually relevant and qualitatively strong, but loses slight points for missing precise portfolio sizes that ground the international growth claim in measurable terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 411,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "Between 2023 and 2024, the Google Marketing Platform continued to serve as a key channel for advertising revenue generation, particularly for ads placed on Google Network properties. Revenues from these ads are generally recognized on a gross basis, with the amounts billed to customers recorded as revenues and payments to Google Network partners treated as cost of revenues. In 2024, the role of the Google Marketing Platform remained consistent with prior years, as it facilitated customer purchases of advertising inventory across Google Network properties, including through AdMob, AdSense, and Google Ad Manager. No significant changes in the method of revenue recognition or management across Google Network properties were noted in the 2024 filing compared to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that no significant changes occurred in 2024, directly contradicting the ground truth which states a clear evolution in the platform's role regarding principal versus agent evaluation and gross revenue reporting justification. While the description of revenue recognition on a gross basis and treatment of partner payments as cost of revenue is accurate, the answer fails to capture the key 2024 developments in the reasoning behind gross reporting and the enhanced emphasis on control over inventory. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or formats, earning a full score by default. (3) The multi-hop reasoning is flawed: the question asks for evolution between 2023 and 2024, requiring comparison across years and synthesis of changes in accounting rationale. The LLM incorrectly asserts consistency and absence of change, missing the nuanced shift in 2024 related to principal-agent assessment and inventory control, which is central to the ground truth. (4) Correctness and qualitative accuracy are low due to the failure to report the evolution in Google Marketing Platform’s role, despite correct background context. Contextual relevance is moderate because the answer discusses the right entities and revenue recognition framework but misses the critical change in accounting judgment that was the focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 409,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "The fair value of Federal Funds Purchased and Securities Loaned increased from $144,501 million in 2023 to $133,053 million in 2024, while the volume decreased from $521,878 million to $436,340 million. This indicates that BAC likely shifted toward higher-value short-term funding instruments in 2024, possibly reflecting a strategy to optimize cost efficiency and manage liquidity risk amid changing market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2023, the volume showed a net change of $16,466 million (increase), and in 2024, the fair value was $192,859 million. However, the LLM claims the fair value decreased from $144,501 million in 2023 to $133,053 million in 2024, which contradicts the ground truth. It also states volume decreased from $521,878 million to $436,340 million, but no such volume figures are present in the original answer, and the ground truth emphasizes a net increase in volume in 2023. (2) The numbers provided by the LLM are entirely incorrect and not supported by the ground truth. There is no mention of $144.5B or $133.1B in fair value for 2023 or 2024 in the original data; instead, only the 2024 fair value is given as $192,859 million. The volume figures cited by the LLM are fabricated. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning is flawed. The original answer infers increased reliance on short-term secured funding due to a rise in fair value and prior-year volume increase. The LLM incorrectly infers a shift toward 'higher-value' instruments despite reporting a decrease in fair value, which contradicts the conclusion. The logic does not align with the data it purports to use. (4) The contextual relevance is moderate because the LLM attempts to interpret BAC's short-term funding strategy, which is relevant. However, due to severe quantitative errors and incorrect entity values, the qualitative analysis is based on false premises, leading to an incorrect overall assessment. Correctness score is low due to fundamental factual and numerical inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 461,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "Between 2022 and 2024, PepsiCo expanded its disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations. In 2022, the 10-K mentioned that the fair value of pension and retiree medical plan assets and liabilities is exposed to risks related to market fluctuations, with a reference to critical accounting policies and estimates. By 2024, the disclosure became more detailed, explicitly noting that the fair value of these liabilities is impacted by changes in market conditions, including interest rates and inflationary, deflationary, and recessionary conditions. Additionally, the 2024 filing provided specific financial impacts, such as increased pension and retiree medical benefits expense due to higher settlement charges and the purchase of a group annuity contract.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of PepsiCo's disclosures between 2022 and 2024. It accurately captures that in 2022, the company referenced market fluctuation risks in the context of critical accounting policies, and by 2024, expanded the disclosure to include broader macroeconomic conditions such as inflationary, deflationary, and recessionary environments. The mention of interest rates and specific financial impacts like higher settlement charges and the purchase of a group annuity contract adds detail not present in the original answer. However, the original ground truth does not mention specific financial impacts or the group annuity contract, so this represents an over-addition not supported by the source knowledge graph. While this extra detail may be factually accurate in a broader context, it goes beyond the provided truth and introduces elements not verified in the evaluation scope, slightly reducing qualitative accuracy. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is fully relevant to the question. The core multi-hop reasoning—comparing disclosure depth across years—is sound and correctly synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 346,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "Adobe's approach to Adobe Scan between 2023 and 2024 has evolved to emphasize its role as a seamless, mobile-first scanning solution integrated within Adobe's broader document management ecosystem. In 2023, Adobe Scan was positioned as a free mobile tool for converting paper documents into editable, searchable PDFs via Adobe Document Cloud. By 2024, Adobe Scan was further highlighted as a key component of Adobe Document Cloud, enhancing its integration with Acrobat, Acrobat Sign, and cloud-based workflows. This shift reflects Adobe's strategy to strengthen Adobe Scan's utility in automated, collaborative digital workflows, aligning it more closely with enterprise document management and e-signature solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe Scan was indeed positioned in 2023 as a free mobile scanning tool integrated with Adobe Document Cloud for converting paper into searchable PDFs. By 2024, it remained part of Document Cloud but saw increased emphasis on integration with Acrobat, Acrobat Sign, and cloud workflows—consistent with a shift toward enterprise and collaborative use. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all dates (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about Adobe Scan’s positioning across two time points and connects it to broader ecosystem trends. The only minor omission is that the LLM answer does not explicitly mention AI-driven features like Content Credentials or Firefly-powered generative AI workflows, which are highlighted in the ground truth as key 2024 developments. This slightly reduces qualitative accuracy, though the overall direction—deeper integration into enterprise workflows—is correctly captured. (4) The answer is contextually relevant, directly addressing the evolution in positioning within Adobe’s document management ecosystem. Wording differs but semantic meaning is equivalent. A score of 9 is justified due to high correctness with a minor detail omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 404,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini's role and integration across Google's products evolved significantly from its initial launch in 2023 to 2024. In 2023, Gemini was introduced as a native multimodal AI model capable of understanding and operating across text, code, audio, images, and video. By 2024, Gemini 2.0 was launched, enhancing its capabilities and expanding its integration into all seven of Google's two-billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. Specific advancements in its multimodal capabilities included the ability to process and combine different types of information seamlessly, enabling features such as AI Overviews, improved recommendations on YouTube, and enhanced productivity tools in Google Workspace.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Gemini was introduced in 2023 as a multimodal model capable of handling text, code, audio, images, and video. In 2024, Gemini 2.0 launched and was integrated into all seven of Google's two-billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—matching the original answer. (2) Quantitative accuracy is perfect: the number of products (seven), user scale (two billion), and timeline (2023 launch, 2024 evolution) are all correctly stated. Format variations are not needed as numbers are presented clearly. (3) Multi-hop reasoning is sound: the model correctly synthesizes the evolution over time and across product integrations. The mention of AI Overviews, YouTube recommendations, and Google Workspace enhancements reflects plausible applications of multimodal advancements, though these specific features are not mentioned in the ground truth. (4) The only minor shortcoming is that the LLM answer omits mention of experimental research prototypes like Project Astra and Project Mariner, which were highlighted in the original answer as part of 2024 advancements. This is a small omission in completeness but does not detract from the core factual accuracy. Overall, the answer is semantically equivalent and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 386,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "Between 2022 and 2024, Linde's global helium wholesale operations, which are included in the \"Other\" category, experienced a decline in sales and a mixed impact on operating profit. Sales for the \"Other\" segment decreased by $32 million, or 2%, in 2024 versus 2023, primarily due to lower volumes in global helium. Operating profit in the \"Other\" segment increased by $19 million, or 44%, in 2024 compared to 2023, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher costs due to helium. This suggests that while helium-related costs negatively impacted profitability, external recoveries helped mitigate the decline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 2% sales decrease in the 'Other' segment and the $32 million decline (implied 2% of ~$1.6B base) are consistent with the original answer; the $19 million (44%) increase in operating profit for the 'Other' segment is accurately reported. These figures match the knowledge graph, and the mention of LAMT insurance recovery partially offset by helium costs is factually sound. (2) The answer correctly identifies the shift in helium's impact from neutral in 2022 to negative in 2024, though it does not explicitly restate the 2022 'supply' characterization from the original answer—this is a minor omission but does not undermine the core evolution narrative. (3) Multi-hop reasoning is strong: the model correctly links helium volumes to sales decline and helium costs to profit limitation within the 'Other' segment, while contextualizing the insurance recovery. (4) Semantic equivalence is maintained—wording differs but meaning matches. The only reason for not scoring 10 is the slight incompleteness in not explicitly noting helium was a 'supply' in 2022, which slightly affects completeness in tracing the full relationship evolution. Otherwise, the answer is factually precise, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 372,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net value of acquired franchise rights decreased from $626 million in 2022 to $598 million in 2024, representing a decline of $28 million over the two-year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the numerical values. According to the ground truth, the net value of acquired franchise rights in 2022 was $789 million, but the LLM incorrectly states it as $626 million. The 2024 value is correctly reported as $598 million. (2) The calculation of the decline is therefore also incorrect: the LLM reports a $28 million decrease ($626M - $598M), but the actual decline is $191 million ($789M - $598M). This is a major quantitative error that misrepresents the magnitude of the change. (3) While the LLM correctly identifies the time frame (2022 to 2024) and the direction of change (decrease), it fails in the multi-hop synthesis of accurate values across years. The reasoning structure is sound—calculating the difference between two years—but based on incorrect input data. (4) The contextual relevance is high because the answer addresses the right metric, time period, and type of change. However, the correctness score is low due to the critical error in the 2022 value and the resulting miscalculation, which distort the core financial insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1081,
        "completion_tokens": 318,
        "total_tokens": 1400
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "Chevron's natural gas delivery commitments related to Tengizchevroil in Kazakhstan remained consistent from 2023 to 2024, with no specific changes mentioned in the provided documents. However, production volumes for Kazakhstan were stable, averaging 113 billion cubic feet in 2024 and 114 billion cubic feet in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Chevron's natural gas volumes from Tengizchevroil increased from 2023 to 2024, with specific daily volumes: 596 MMcf/d consumed and 7,148 MMcf/d sold in 2023, rising to 609 MMcf/d consumed and 7,569 MMcf/d sold in 2024. The LLM instead claims no changes were mentioned and reports annual volumes (114 Bcf in 2023, 113 Bcf in 2024) that do not appear in the original answer and are inconsistent in both magnitude and time unit (annual vs. daily). (2) The numbers provided by the LLM (113 Bcf and 114 Bcf) are not equivalent to the daily rates in the ground truth. For example, 7,148 MMcf/d over a year would be approximately 2.6 trillion cubic feet, far exceeding the LLM's reported figures. There is no indication of correct calculation or unit conversion. (3) The multi-hop reasoning failed: the LLM did not recognize that Tengizchevroil's contribution is embedded in Chevron's reported daily volumes and did not track the year-over-year increase. Instead, it incorrectly concluded stability and cited unrelated annual totals. (4) The contextual relevance is moderate because the answer addresses Chevron and Tengizchevroil in the correct time frame, but the factual inaccuracies and incorrect synthesis severely undermine the response. Hence, low scores for correctness and quantitative accuracy, slightly higher for qualitative due to correct entity mention, and moderate for relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 417,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "Between 2023 and 2024, the description of payments to Google Network partners in the 10-K filings indicates a shift in emphasis toward clarifying Google's role as the principal in advertising transactions. In 2023, payments to Google Network partners were mentioned as part of cost of revenues, without detailed explanation of the nature of these payments. By 2024, the description explicitly states that Google generally reports advertising revenues for ads placed on Google Network properties on a gross basis, with amounts paid to partners recorded as cost of revenues. This reflects a more transparent disclosure of Google's control over advertising inventory and its responsibility in setting pricing, reinforcing its principal role in these transactions.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in terms of the core evolution described. (1) What was correct: The answer correctly identifies that payments to Google Network partners are recorded as part of cost of revenues and notes a change in disclosure between 2023 and 2024, which aligns with the general direction of increased transparency. The entities (Google Network partners, 2023–2024 timeframe) and financial structure (payments as cost of revenues) are accurately referenced. (2) Quantitative accuracy: There are no numeric values in either answer, so this dimension does not apply—scored as 10 by default since no numbers were misstated. (3) Multi-hop reasoning assessment: The LLM fails to capture the key shift identified in the ground truth—reclassification and strategic framing of payments as Traffic Acquisition Costs (TAC) tied directly to revenue generation. Instead, it focuses on Google’s role as a principal in revenue reporting (gross vs. net), which, while related to accounting policy, is not the primary evolution highlighted in the original answer. This represents a significant deviation in reasoning and synthesis. (4) The answer is contextually relevant and discusses disclosure changes in partner payments, but it misidentifies the nature of the evolution—emphasizing revenue recognition principle rather than the strategic repositioning of partner costs as TAC. Thus, while semantically plausible and logically structured, it does not match the factual substance of the ground truth, warranting a moderate correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 437,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "From 2023 to 2024, Bank of America has noted an increase in the regulatory focus on climate change, with a growing number of new or heightened requirements across various jurisdictions, including state, federal, and non-U.S. regions. This has led to greater jurisdictional divergence, which is expected to elevate the bank's legal, compliance, and public disclosure risks and costs. The evolving nature of these climate-related regulatory requirements, along with the challenges in managing and disclosing climate-related data, has intensified the bank's exposure to compliance risks and uncertainties.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the increasing regulatory focus on climate change and the role of jurisdictional divergence in elevating legal, compliance, and disclosure risks for Bank of America from 2023 to 2024. It accurately reflects the multi-jurisdictional nature of the regulations (state, federal, non-U.S.) and the associated risks. However, it misses a key evolution highlighted in the ground truth: the shift from *anticipated* risks in 2023 to *actual, ongoing impacts* in 2024. The original answer emphasizes that by 2024, these requirements were not just expected but were actively impacting the bank—indicating a qualitative change in the nature of the risk (from prospective to current). The LLM answer uses forward-looking language ('expected to elevate') even for 2024, which underrepresents the progression. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the entities (Bank of America, climate regulations, jurisdictions) are correct. The reasoning is sound but incomplete in capturing the full multi-hop insight—the temporal evolution of risk from anticipation to realization. Contextual relevance is high as the response stays focused on the question and provides relevant details about compliance risks and regulatory divergence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 364,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "General Motors has increased its strategic emphasis on full-size pickup trucks from 2022 to 2024, as evidenced by stronger performance in 2024. In the GM North America (GMNA) segment, wholesale vehicle sales rose by 10.1% in 2024 compared to 2023, driven primarily by increased sales of full-size pickup trucks, mid-size pickup trucks, and other vehicles. Additionally, GMNA's EBIT-adjusted increased by 18.1% in 2024, attributed to higher volumes of full-size pickup truck sales and favorable pricing. These quantitative indicators suggest a stronger market positioning and performance for the full-size pickup truck product line in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of GM's strategic emphasis on full-size pickup trucks from 2022 to 2024, noting increased performance and market positioning in 2024. However, it introduces specific quantitative data—10.1% increase in wholesale sales and 18.1% EBIT-adjusted growth in GMNA—that are not present in the original ground truth. The ground truth does not provide year-over-year percentage changes for wholesale sales or EBIT-adjusted, nor does it mention mid-size trucks or 'other vehicles' as drivers. Instead, the ground truth emphasizes a shift from risk (2022) to strength (2024), citing net wholesale volume increases and a 160% variable profit for full-size trucks on a weighted-average basis, which the LLM answer omits entirely. (2) The numbers in the LLM answer (10.1%, 18.1%) cannot be verified against the ground truth and appear to be fabricated or sourced from outside the provided knowledge graph, failing the quantitative accuracy check. The critical profitability metric—160% variable profit—is missing, which is a key quantitative indicator in the original answer. (3) The multi-hop reasoning is partially sound: the model connects increased sales to improved performance and links full-size truck sales to EBIT-adjusted gains, which aligns with the original logic. However, it fails to capture the full evolution from 'risk factor' in 2022 to 'demonstrated strength' in 2024 based on profitability metrics, weakening the qualitative synthesis. (4) The answer is contextually relevant and addresses both parts of the question—evolution of strategy and 2024 performance indicators—but substitutes unverified metrics for the correct ones, leading to a correctness score of 7 due to accurate directionality but incorrect specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 486,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "From 2022 to 2024, the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts increased, as seen in the 2023 and 2024 filings. For example, in 2022, Georgia Power held $293 million in such securities, which rose to $349 million in 2023 and remained at a similar level in 2024. This shift indicates a strategic move toward safer, more liquid, and creditworthy investments, likely to preserve capital and ensure reliable funding for long-term decommissioning obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in Georgia Power's allocation from $293 million in 2022 to $349 million in 2024, which aligns with the ground truth. However, it omits any mention of Alabama Power's allocation, which decreased slightly from $21 million to $20 million. This omission is significant because the original answer emphasizes a shift in focus toward Georgia Power’s portfolio, implying a strategic reallocation between subsidiaries. By ignoring Alabama Power, the LLM fails to capture the comparative dynamic central to the multi-hop reasoning. (2) The LLM incorrectly states that the $349 million figure was already present in 2023 and 'remained at a similar level in 2024,' but the ground truth does not provide 2023 data—only 2022 and 2024—so asserting a 2023 value and continuity into 2024 introduces unsupported details. (3) While the LLM draws a reasonable qualitative conclusion about a move toward safer investments, it misses the more nuanced indication of internal reallocation between subsidiaries, which is a key part of the original answer’s reasoning. Thus, the multi-hop synthesis across companies and years is incomplete. (4) Despite these issues, the answer is contextually relevant and correctly interprets the directional trend for Georgia Power. The core financial figures for Georgia Power are accurate, but the lack of completeness and introduction of unverified intermediate data reduce overall correctness. Quantitative accuracy is partially compromised due to the fabricated 2023 data point. Qualitative reasoning is sound but incomplete. Contextual relevance remains high as the response addresses investment strategy appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 463,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "From 2022 to 2024, PepsiCo has maintained and slightly evolved its relationship with independent bottlers by continuing to provide annual financial incentives known as \"bottler funding.\" These incentives support trade and consumer programs, including advertising, new product launches, and equipment placement. While the 2024 filing emphasizes PepsiCo's strategic shift in some markets, such as transitioning from distribution to trademark licensing models, the core dependency on independent bottlers remains, with continued financial support to ensure effective product distribution and brand promotion. This reflects a stable yet adaptive strategic dependency.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of PepsiCo's relationship with independent bottlers, noting continued financial incentives and strategic dependency. However, it omits key quantitative details from the ground truth—specifically, that Walmart accounted for approximately 14% of consolidated net revenue in 2024, a critical data point highlighting strategic dependency. This omission significantly affects factual completeness and accuracy. (2) No numeric values are explicitly mentioned in the LLM response (e.g., 14%), so there is no direct numerical error, but the failure to include the 14% figure from the original answer constitutes a major gap in quantitative reporting. The years (2022–2024) are correctly referenced. (3) The reasoning is partially sound: the model correctly identifies the continuation of bottler funding and its allocation across trade and consumer programs. It also notes structural shifts like trademark licensing, which may reflect broader strategic changes. However, it fails to synthesize the multi-hop insight that increased revenue dependency (via Walmart’s 14% share) underscores deeper strategic reliance on bottlers—this linkage between financial incentives and growing revenue concentration is missing. (4) The contextual relevance is high because the answer addresses both financial incentives and strategic dependency. Qualitative accuracy is moderate due to correct use of terms like 'bottler funding' and 'trade programs,' but the lack of specific evidence (like the Walmart revenue contribution) limits depth. Correctness is scored at 6 due to partially accurate information with a significant omission affecting the core of the ground truth claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 468,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "Adobe Firefly's role evolved from being a newly introduced generative AI product in 2023 to a more central component of Adobe's innovation strategy in 2024. In 2023, Firefly was highlighted as a new AI offering aimed at enhancing creative workflows, but its success and adoption were uncertain. By 2024, Firefly was positioned as a key part of Adobe's broader AI integration strategy, with increased emphasis on responsible AI development and regulatory compliance, reflecting its growing strategic importance in Adobe's product roadmap.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric values, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to factual inaccuracies in the evolution of Adobe Firefly's role based on trademark listings and risk disclosures. The original answer states that in 2023, Firefly was listed among trademarks (indicating established status), while in 2024 it appeared in risk factors as a newly released generative AI product of strategic importance. The LLM incorrectly claims Firefly was 'newly introduced' in 2023 and 'highlighted as a new AI offering' that year, which contradicts the ground truth where its trademark status in 2023 implies prior establishment. Additionally, the LLM introduces unverified details about 'responsible AI development' and 'regulatory compliance' not present in the original evidence. While the general direction of increased strategic importance in 2024 is correctly inferred, the reasoning is flawed—Firefly’s appearance in 2024 risk factors reflects its growing significance, but the LLM misrepresents the 2023 positioning. The answer is contextually relevant and addresses the question's intent, but fails on key factual synthesis across years and document types (trademarks vs. risk disclosures), resulting in a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 374,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "The role of contractual rent escalations in driving tenant billing growth has been impacted by increased churn and lease cancellations in 2023, particularly in the U.S. & Canada property segment. In 2023, churn reached approximately 3% of tenant billings, driven by lease cancellations and non-renewals, notably by T-Mobile. This elevated churn has reduced the effectiveness of contractual rent escalations as a growth driver compared to prior years, as losses from cancellations offset some of the gains from escalations. Despite this, contractual rent escalations remain a key component of tenant billing growth, though their net contribution has been tempered by the higher churn environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3% churn rate in 2023, its concentration in the U.S. & Canada segment, and the attribution to T-Mobile's lease cancellations are all factually consistent with the original answer. (2) Quantitative accuracy is perfect: the 3% churn figure is correctly cited, and no other numerical data (e.g., years, dollar amounts) are misstated. Format and precision match the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the continued role of contractual rent escalations as a growth driver while acknowledging the countervailing effect of increased churn, particularly from a major tenant. It captures the nuanced shift from 2022 to 2023 in the growth dynamics. (4) The only minor shortcoming is a slight omission of the explicit mention that rent escalations were listed alongside new colocation and lease amendments in 2022 as co-drivers, which adds context to their relative importance. However, the core comparative insight—that escalations remain important but are now offset by churn—is clearly and correctly conveyed. The answer is contextually excellent, directly addressing the question’s focus on the changing role of escalations amid rising churn.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 359,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "Chevron's relationship with Tengizchevroil between 2023 and 2024 shows that the FGP/WPMP Project in Kazakhstan accounted for nearly half of the $3 billion in 2024 equity affiliate capital expenditures (Affiliate Capex). This indicates a significant and sustained capital expenditure commitment to the project in 2024. In terms of production involvement, Tengizchevroil remains a key affiliate, contributing to Chevron's net production in Kazakhstan, as reflected in the production data for affiliates in the 2024 report.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that nearly half of the $3 billion 2024 Affiliate Capex was allocated to the FGP/WPMP Project at Tengizchevroil in Kazakhstan, matching the ground truth. It also accurately reflects Chevron's ongoing production involvement through Tengizchevroil as a key affiliate in 2024. All factual elements—dollar amount, percentage, project name, location, and reporting year—are correct. (2) Quantitative accuracy is perfect: the $3 billion figure for 2024 Affiliate Capex and the 'nearly half' allocation to Tengizchevroil are both explicitly stated in the original and correctly reproduced. No calculations are required, but the synthesis of the percentage and total amount is logically sound. (3) The multi-hop reasoning is strong: the model connects Chevron’s capital expenditure commitment in 2024 to a specific project (FGP/WPMP) via its affiliate Tengizchevroil and links this to production contributions in the same year. While the original answer notes a shift from investment (2023 focus) to operational phase (2024 focus), the LLM answer does not explicitly mention the 2023 context beyond implying continuity, which slightly weakens the qualitative comparison. However, the core evolution—continued Capex commitment and sustained production role—is accurately conveyed. (4) Scores reflect near-perfect factual alignment, with only minor omission of the explicit 2023-to-2024 transition narrative preventing a full 10 on qualitative accuracy. Contextual relevance is complete as all parts of the question are addressed with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 440,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "Between 2023 and 2024, the specificity of UPS's bond matching approach for determining the discount rate for U.S. pension and postretirement benefit plans remained consistent, as it involves selecting specific bonds that would satisfy projected benefit payments. However, the discount rate itself decreased from 5.42% in 2023 to 5.88% in 2024 for U.S. pension benefits, indicating a more conservative rate due to changes in the bond market and actuarial assumptions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly focuses on the discount rate values (5.42% in 2023 and 5.88% in 2024), which are factually wrong—the rate increased from 5.42% in 2023 to 5.88% in 2024, but more importantly, the question did not ask about the rate itself but the evolution of the bond matching approach. These numbers are not relevant to the core question and are presented inaccurately (directionally misleading as 'more conservative' without proper context). (2) There are no correct quantitative elements related to the actual query—no numbers about bond selection or methodology changes were requested, but the ones provided are incorrect. (3) The multi-hop reasoning fails: the question asks for a qualitative comparison of how UPS’s description and framing of its bond matching approach evolved between 2023 and 2024. The ground truth highlights a shift in language from viewing the approach as reflective of actual settlement processes to describing it as a 'guide' for bond selection, with no material change in mechanics. The LLM misses this entirely, instead discussing discount rate changes, which reflects a failure to synthesize the correct disclosures. (4) The answer is partially contextually relevant because it mentions the bond matching approach and UPS’s use of bonds aligned with benefit payments, but it diverts into irrelevant quantitative details and misses the key qualitative evolution in disclosure language. Thus, while some entities (UPS, pension plans, bond matching) are correct, the reasoning and focus are fundamentally misaligned with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 436,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "Linde's global helium wholesale operations, included in the \"Other\" segment, experienced a 2% decrease in sales in 2024 compared to 2023, primarily due to lower volumes. Despite this decline, operating profit increased by 44%, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher helium-related costs. This indicates that while helium volumes negatively impacted sales, cost management and insurance recoveries positively influenced profitability during the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2% decrease in sales in 2024 due to lower helium volumes and attributes it to the 'Other' segment, aligning with the ground truth. It also correctly notes the increase in operating profit (44%) and cites insurance recovery for LAMT as a key driver, which matches the original answer's mention of insurance partially offsetting helium-related cost pressures. However, the LLM answer compares 2024 to 2023, while the question asks about the evolution from 2022 to 2024. The ground truth explicitly references 2022 as a period when helium was a neutral supply input, but the LLM fails to mention 2022 at all, missing a key part of the multi-hop timeline. (2) Quantitatively, the 2% sales decline is correct, but the $32 million figure associated with this decline in the ground truth is omitted in the LLM response. The 44% operating profit increase is not contradicted by the ground truth, but the ground truth does not provide this specific number, so its accuracy cannot be fully verified. The absence of the $32M figure reduces quantitative precision. (3) The reasoning is logically sound in connecting lower volumes to sales decline and insurance recovery to profit improvement, but the failure to incorporate 2022 data breaks the full multi-hop synthesis required across three years. The shift from neutral/positive (2022) to negative (2024) impact is not conveyed. (4) Despite missing the 2022 context and specific dollar amounts, the LLM captures the core financial dynamics in 2024 accurately and remains highly relevant to the question’s focus on helium’s evolving impact. Hence, correctness is reduced to 7 due to incomplete temporal coverage and missing key figures, but qualitative reasoning and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 485,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Between 2023 and 2024, Bank of America's unfunded capital contributions for renewable energy investments decreased from $6.2 billion to $4.6 billion. Correspondingly, the recognized tax credits related to these investments slightly decreased from $4.0 billion in 2023 to $3.9 billion in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: unfunded capital contributions decreased from $6.2 billion in 2023 to $4.6 billion in 2024, and recognized tax credits declined from $4.0 billion to $3.9 billion. These values exactly match the original answer. (2) The answer is complete, addressing both parts of the question: the evolution of unfunded capital contributions and the corresponding change in tax credits. (3) Entity accuracy is correct—Bank of America, the correct years (2023 and 2024), and the proper financial metrics (unfunded capital contributions and recognized tax credits) are all accurately identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis across time points and financial metrics, correctly identifying a decrease in both commitments and tax benefits. While the LLM omits the interpretive sentence about 'reduction in near-term funding commitments' and 'tax benefits remaining relatively stable,' this does not affect factual correctness, as the core data and trends are accurately reported. The answer is semantically equivalent to the ground truth for the direct question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 340,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "From 2022 to 2024, General Motors' approach to fleet sales involving commercial fleet customers has evolved in terms of sales channels and profitability considerations. In 2022, GM reported that fleet sales, including commercial fleets, were conducted through both direct channels and dealer networks, with certain fleet transactions being less profitable than retail sales. By 2024, while the specific profitability of commercial fleet sales is not explicitly detailed, the company's broader focus on EV supply chains and strategic initiatives, such as the BrightDrop electric commercial vehicles, indicates a shift toward leveraging new product offerings to enhance profitability and meet the evolving needs of commercial fleet customers. Additionally, the continued use of dealer networks for fleet sales suggests that GM has maintained a hybrid approach to sales channels during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but diverges from the ground truth in key aspects. It correctly notes that in 2022, GM used both direct and dealer channels for fleet sales and that fleet sales were less profitable than retail. However, it inaccurately states that in 2022, GM reported fleet sales were conducted through both channels—while the ground truth specifies that in 2022, daily rental fleet sales (a subset) were less profitable and sold via direct or dealer channels, not necessarily all commercial fleet sales. The LLM incorrectly implies profitability data for commercial fleets specifically was reported in 2022, when the ground truth refers more broadly to fleet transactions, particularly daily rental. (2) There are no numeric values to verify, so quantitative accuracy is not compromised—dates (2022, 2024) are correct, satisfying this criterion. (3) The multi-hop reasoning is partially sound: the model identifies a shift in strategy and mentions BrightDrop as a strategic initiative, which aligns with GM's commercial EV focus. However, the ground truth emphasizes a structural evolution in sales channels—specifically that by 2024, fleet sales were completed through dealers and sometimes directly, indicating a more structured approach. The LLM misses this nuance and instead infers profitability improvements through product innovation without direct evidence from the ground truth. The core evolution—channel optimization for profitability balance—is underdeveloped. (4) The contextual relevance is high as the answer addresses sales channels and profitability, but the qualitative accuracy is reduced due to misattribution of 2022 profitability details and reliance on inferred strategic shifts not explicitly supported in the ground truth. Thus, the answer is partially correct but lacks precision in reasoning and factual alignment on the evolution of channel strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 520,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's relationship with Sabra evolved from retaining a noncontrolling interest in a joint venture to fully exiting the relationship. In 2022, PepsiCo sold its Tropicana, Naked, and other juice brands to PAI Partners but retained a 39% noncontrolling interest in the newly formed joint venture, which included the Sabra brand. By 2024, PepsiCo had fully exited its stake in Sabra, as evidenced by the absence of any mention of Sabra in the 2024 10-K. Financially, in 2022, PepsiCo recognized a pre-tax gain of $122 million ($92 million after-tax or $0.07 per share) from the remeasurement of its previously held 50% equity ownership in Sabra at fair value. This gain was recorded in the FLNA division under selling, general, and administrative expenses. No further financial implications related to Sabra were reported in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, PepsiCo owned Sabra as part of a joint venture in 2022 and retained a 50% equity stake by 2024, not a 39% stake, and did not fully exit. The LLM incorrectly claims PepsiCo fully exited Sabra by 2024 and that Sabra was part of the Tropicana/Naked sale to PAI Partners, which is false—Sabra is a refrigerated dips business, not a juice brand. The only correct financial figure is the $122 million pre-tax gain from remeasuring the 50% equity stake, which matches the ground truth. However, the LLM misattributes this gain to the sale of juice brands and incorrectly states the retained interest was 39% in a joint venture that included Sabra. (2) Quantitative accuracy is partially correct: the $122 million pre-tax gain is accurate and correctly cited, but the 39% stake and after-tax figure of $92 million are not in the ground truth and appear fabricated. The per-share impact ($0.07) and classification in FLNA SG&A are unsupported. (3) Multi-hop reasoning is flawed: the model conflates two separate transactions—the 2021 sale of Tropicana/Naked (with a retained 39% stake) and the Sabra ownership change. Sabra was not part of that juice transaction. The model fails to correctly track PepsiCo’s ongoing 50% stake in Sabra through 2024, instead asserting a full exit with no evidence. (4) Correctness score is low due to major factual errors in entities, ownership timeline, and transaction details. Quantitative accuracy is moderate due to the correct $122M figure but incorrect ancillary numbers. Qualitative accuracy is poor due to incorrect reasoning and entity conflation. Contextual relevance is moderate as the answer addresses the general topic but misrepresents key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 486,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "Between 2023 and 2024, Adobe Scan has been increasingly integrated into Adobe's broader Document Cloud ecosystem. In 2023, Adobe Scan was mentioned primarily as a standalone mobile scanning tool that converts paper documents into PDFs. By 2024, it is highlighted as a component of Adobe Document Cloud, emphasizing its role in enabling automated, collaborative workflows and its integration with other Document Cloud services like Adobe Acrobat and Adobe Acrobat Sign. This evolution reflects Adobe's strategy to position Adobe Scan as a core, interconnected tool within its document management and digital workflow offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly identifies the evolution of Adobe Scan from 2023 to 2024: in 2023, it was referenced as a standalone scanning tool (consistent with trademark listing), and by 2024, it was integrated into Adobe Document Cloud. The entities—Adobe Scan, Adobe Document Cloud, Adobe Acrobat, and Adobe Acrobat Sign—are all correctly named and contextualized. (2) There are no numeric values requiring verification (e.g., financials, percentages), so quantitative accuracy is not applicable beyond correct use of years (2023 and 2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across time periods and product positioning, correctly inferring a strategic shift toward integration and workflow enablement. The only minor gap is that the LLM does not explicitly mention the 'trademark' status in 2023 as in the original answer, instead characterizing it as a 'standalone mobile scanning tool'—a slight recharacterization but not factually incorrect. (4) The answer is highly contextually relevant, directly addressing how Adobe Scan’s positioning evolved within Adobe’s ecosystem. Overall, the semantic meaning matches the ground truth, with only a small omission in specificity about trademark status, warranting a high but not perfect qualitative and overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 387,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "General Motors' financial exposure and nature of obligations to Stellantis from 2022 to 2024, particularly regarding indemnifications and historical liabilities, have remained largely consistent, with no significant changes noted. GM continues to indemnify Stellantis for certain losses arising from inaccuracies in representations and warranties, as well as for emissions claims, product liabilities, and recalls related to the Opel/Vauxhall business sold in 2017. In 2024, GM mentions that it indemnified Stellantis for an immaterial amount related to Takata inflator recalls in legacy Opel vehicles, but it considers further indemnification for such matters to be remote. Additionally, GM is involved in investigations by the European Commission and UK CMA concerning Opel's past conduct, but the accrued liability remains immaterial. Overall, the nature of these obligations remains conditional and difficult to estimate, with no material financial impact observed during the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and a slight mischaracterization of the evolution in GM's obligations. (1) Correct elements include: the continuation of indemnifications for emissions claims, product liabilities, recalls (including Takata), and regulatory investigations related to the Opel/Vauxhall sale; the immaterial accrued amount as of 2024; and the conditional nature of liabilities. The statement that GM considers further indemnification for Takata matters 'remote' adds nuance not contradicted by the original. (2) Quantitatively, no specific dollar figures are provided in either answer beyond 'immaterial,' so the response is consistent and accurate in that regard. Dates (2022–2024) and entities (GM, Stellantis, European Commission, UK CMA) are correctly identified. (3) The multi-hop reasoning is sound—linking the 2017 Opel sale to ongoing liabilities and recognizing the shift from operational to indemnification-based exposure. However, the LLM understates the evolution by stating obligations have 'remained largely consistent,' whereas the ground truth emphasizes a clear shift from supply-related transactions in 2022 to financial guarantees in 2024. This transformation is a key point in the original answer and is underdeveloped in the LLM response. (4) Despite this, the answer captures the core financial and legal substance accurately, with high contextual relevance and factual precision, warranting a high score but not perfect due to the downplayed evolution of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 429,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "PepsiCo's relationship with co-packers between 2022 and 2024 has remained relatively consistent in terms of operational dependency, as the company continues to rely on a distributed network of co-packers, contract manufacturers, and joint ventures to support its production and distribution operations. Both the 2022 and 2024 filings highlight that these third-party facilities are essential for manufacturing, warehousing, and distribution, particularly in regions where direct ownership is less feasible. However, there is an increased emphasis on strategic oversight and risk management, particularly in cybersecurity and third-party vendor assessments, indicating a more proactive approach to managing co-packer relationships to mitigate operational and reputational risks.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in noting PepsiCo's continued operational dependency on co-packers, which aligns with the 2022 description in the ground truth. However, it fails to accurately capture the key evolution in strategic involvement between 2022 and 2024. The ground truth highlights a clear shift in language from a 'highly distributed network' of third-party facilities in 2022 to 'strategic alliances or joint ventures in which we have an equity interest' in 2024, indicating deeper ownership and integration. The LLM answer does not mention this shift toward equity-based strategic involvement and instead emphasizes 'risk management' and 'cybersecurity' as signs of increased strategic oversight—elements not present in the original answer and not supported as the primary evolution. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; no errors in dates (2022 and 2024 are correctly referenced). (3) The multi-hop reasoning is flawed: the model should have compared the language and strategic framing across the two years and synthesized the shift from operational dependency to strategic ownership. Instead, it inferred a different kind of strategic evolution (risk management) that is not in the ground truth. (4) While the answer is contextually relevant and correctly identifies the ongoing operational role of co-packers, it misses the core factual evolution—increased equity stakes and strategic integration—making it only partially accurate. Hence, correctness is scored low despite accurate dates and entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 440,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "Between 2023 and 2024, SPG's financial relationship with ABG evolved significantly. In 2023, SPG sold a portion of its interest in ABG, resulting in a pre-tax gain of $157.1 million and a subsequent reduction in ownership to approximately 9.6%. In 2024, SPG sold all of its remaining interest in ABG for cash proceeds of $1.2 billion, generating a substantial pre-tax gain of $414.8 million. These transactions reflect a strategic divestment from ABG, with SPG recognizing significant gains in both years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, SPG recognized a $157.1 million gain from selling a portion of its ABG interests and a $59.1 million gain from deemed disposals due to ABG's capital transactions, plus a $145.8 million gain from dilution in SPARC Group. However, the LLM incorrectly states that SPG sold *all* its remaining interest in ABG in 2024 for $1.2 billion and recorded a $414.8 million gain, which is not supported by the original answer. The original answer states that in 2024, SPG disclosed an $18.8 million pre-tax gain from the sale of a portion of its ABG interest that occurred in *December 2021* (not 2024), and highlighted a strategic partnership with ABG for Reebok in the U.S., indicating deeper operational collaboration. The LLM completely misses this strategic shift and instead fabricates a large 2024 divestment that is not in the ground truth. (2) Quantitative accuracy is very low: the $414.8 million gain and $1.2 billion cash proceeds are entirely incorrect; the only correct number mentioned is the $157.1 million gain in 2023. The $18.8 million gain in 2024 (from a 2021 transaction) is omitted. (3) Multi-hop reasoning fails: the model does not connect the 2024 disclosure of a past transaction with the new strategic partnership; instead, it invents a narrative of full divestment. It misses the evolution from financial gains to operational collaboration. (4) Contextual relevance is moderate because it addresses SPG’s financial relationship with ABG and mentions gains, but the core evolution—shift from financial to strategic/operational—is misrepresented. Thus, correctness is severely compromised by false data and incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 477,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "Lockheed Martin's involvement in Sikorsky helicopter programs from 2022 to 2024 has shown growth in production volume, particularly in 2021 (as referenced in 2022 filings), with increased output on various Sikorsky helicopter programs under the Rotary and Mission Systems (RMS) segment. This growth was attributed to higher production on Black Hawk, Seahawk, and CH-53K King Stallion programs. By 2024, Sikorsky programs remained a key part of RMS's portfolio, with the final delivery of the VH-92A helicopter for the U.S. Marine One transport mission completed. The scope of involvement has expanded to include heavy lift and combat rescue capabilities, indicating a sustained and evolving focus on rotary-wing systems.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased production volume in Sikorsky helicopter programs under the RMS segment and notes the continuation and expansion of focus through 2024, aligning with the ground truth. It accurately references key programs like Black Hawk, Seahawk, and CH-53K King Stallion. However, it introduces a minor factual inaccuracy by citing '2021 (as referenced in 2022 filings)' as the period of growth, while the ground truth emphasizes 2022 cost increases due to higher production—this misaligns the timeline slightly. Additionally, the LLM mentions the 'final delivery of the VH-92A' in 2024, which is contextually relevant but not present in the original answer, making it an unverified addition. (2) Quantitatively, the LLM fails to include the $560 million increase in product costs from 2022, a key numeric fact in the ground truth. This omission significantly affects quantitative accuracy, even though no incorrect numbers are stated. (3) The multi-hop reasoning is strong: the model synthesizes information across years and connects production volume increases to strategic portfolio emphasis in 2024. The evolution from cost driver to strategic focus is implied through sustained involvement and expanded scope, though not explicitly stated as in the original. (4) The answer is highly contextually relevant, addressing both production volume and program scope evolution. The qualitative reasoning is sound and adds plausible detail (e.g., heavy lift and combat rescue), consistent with the trajectory described in the ground truth. The score reflects high accuracy with minor but notable omissions and a slight temporal misstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 461,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "Walmart acquired a 100% ownership stake in Alert Innovation during fiscal 2023 for $0.4 billion. There is no mention of any changes to this ownership stake or additional financial investment in Alert Innovation during fiscal 2024 in the provided documents. Therefore, Walmart's ownership stake and financial investment in Alert Innovation remained unchanged between fiscal 2023 and fiscal 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Walmart acquired a 100% stake in Alert Innovation in fiscal 2023 for $0.4 billion, which matches the ground truth in both ownership percentage and financial amount. However, the LLM incorrectly concludes that the ownership stake remained unchanged in fiscal 2024, directly contradicting the ground truth, which states there was no mention of Walmart retaining ownership, indicating a full exit. This is a critical factual error in interpretation. (2) Quantitative accuracy is perfect: $0.4 billion is correctly reported, and 100% ownership is accurate for fiscal 2023. No calculations were required. (3) The multi-hop reasoning failed: the model should have inferred from the absence of ownership mention in fiscal 2024 filings—especially after a major acquisition—that Walmart likely divested, as indicated in the ground truth. Instead, it assumed continuity, which is incorrect reasoning given the context. (4) Contextual relevance is moderate—the answer addresses the right companies and time periods and attempts the right analysis, but the conclusion is factually wrong on the evolution of ownership, which is the core of the question. Thus, while the first hop (2023 acquisition) is correct, the second hop (2024 status) is flawed, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 368,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "Between 2023 and 2024, SPG's utilization of the Supplemental Facility showed a strategic shift in borrowing and repayment. In 2023, the Operating Partnership borrowed €750.0 million under the Supplemental Facility, which was later repaid in full on November 17, 2023, using proceeds from the issuance of €750.0 million in senior unsecured bonds. By 2024, the Supplemental Facility had a borrowing capacity of $3.5 to $4.5 billion, but the maximum aggregate outstanding balance under all Credit Facilities during 2024 was relatively low at $325.1 million, with a weighted average outstanding balance of $311.1 million. This suggests a reduced reliance on the Supplemental Facility for short-term liquidity needs, as SPG prioritized repayment and maintained a strong cash position, with available borrowing capacity under the Credit Facilities reaching $8.2 billion by December 31, 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the €750.0 million borrowing in 2023 and its repayment on November 17, 2023, using proceeds from senior unsecured bonds, which aligns with the ground truth. However, it incorrectly states that €750.0 million in bonds were issued, while the original answer does not specify the currency or amount of the bond issuance used for repayment—only that bonds were issued. More critically, the LLM introduces new quantitative details not present in the ground truth: the Supplemental Facility's capacity of $3.5–$4.5 billion, maximum and average outstanding balances in 2024 of $325.1M and $311.1M, and available capacity of $8.2B by year-end 2024. These figures are not in the original answer and cannot be verified against the provided ground truth, suggesting potential hallucination or misattribution. (2) The ground truth emphasizes that by 2024, there was *no outstanding balance* under the Supplemental Facility and highlights a $1.0 billion *dollar-denominated* unsecured note issuance in September 2024 as part of the refinancing strategy. The LLM omits this key $1.0B issuance and instead generalizes about low utilization across *all Credit Facilities*, conflating the Supplemental Facility with broader credit facilities. This misrepresents the specificity of the original answer. (3) The multi-hop reasoning is partially sound—connecting the 2023 borrowing to bond issuance for repayment shows correct synthesis. However, the model fails to link the 2024 refinancing activity (the $1.0B note) to the reduced reliance on the Supplemental Facility, which is a core element of the original answer’s logic. Instead, it infers reduced reliance based on unrelated aggregate credit facility data. (4) While the overall direction of the conclusion (strategic reduction in reliance) is consistent, the factual inaccuracies in numbers and missing key refinancing events reduce correctness. The answer is contextually relevant and well-structured, but quantitative inaccuracies and omission of critical facts from the ground truth limit its accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 562,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Linde has increasingly positioned helium as a core component of its industrial gases business between 2023 and 2024, particularly within the merchant and on-site distribution methods. In 2024, merchant sales of helium (included in merchant argon, hydrogen, and helium) are highlighted as being capable of being shipped over longer distances, indicating a strategic emphasis on expanding helium supply capabilities beyond localized markets. Additionally, Linde's long-term supply contracts, particularly for on-site customers, include price escalation provisions, suggesting a proactive approach to managing helium pricing volatility. The company also estimates significant future revenue from long-term obligations, including those tied to helium, with approximately half expected to be realized within the next six years, reflecting a stronger focus on securing and optimizing helium supply strategies.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Linde de-emphasized helium between 2023 and 2024, removing it as a named primary product, while the LLM claims helium was increasingly positioned as a core component—this is the opposite of the truth. (2) There are no verifiable numbers in the LLM response (e.g., 'approximately half' of future revenue) that align with the ground truth; the original answer contains no quantitative data about revenue timing or distribution, making these claims unsupported. The mention of 'merchant argon, hydrogen, and helium' grouping in 2024 is plausible but used to infer increased emphasis, whereas the ground truth interprets the lack of standalone mention as reduced emphasis. (3) The multi-hop reasoning is flawed: instead of recognizing the removal of helium from explicit product listings as a sign of strategic downgrading, the model incorrectly infers enhanced strategic focus from general statements about gas distribution. It also fabricates implications about price escalation and revenue realization without grounding in the provided truth. (4) While the answer discusses relevant themes (supply strategies, contracts), its factual foundation is inverted, leading to a very low correctness score. Contextual relevance is moderate because it addresses the industrial gases business and supply strategies, but the conclusions are factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 398,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retiree Health Care Plan's asset allocation shifted toward fixed income securities and away from equity securities. In 2022, the weighted average allocation was 65% fixed income securities and cash equivalents and 35% equity securities. By 2023, this changed to 80% fixed income securities and cash equivalents and 20% equity securities. This shift reflects a more conservative investment strategy, aligning with the plan's target allocation ranges and risk management approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both dollar amounts and percentages. The ground truth states that in 2022, fixed income and cash equivalents were $248 and equity securities were $137 (total $385), and in 2023, they were $210 and $54 respectively (total $264). The LLM instead reports weighted average allocations of 65%/35% in 2022 and 80%/20% in 2023, which are not supported by the data. The actual percentages based on the ground truth are approximately 64.4% fixed income and 35.6% equity in 2022, and 79.5% fixed income and 20.5% equity in 2023—close to the LLM's figures but not exact and presented without proper derivation. More critically, the LLM omits the actual dollar values entirely, which are central to the question about 'allocation of assets'. (2) The calculations in the LLM answer are not verifiable because they introduce percentage allocations not present in the original answer. While the implied shift toward fixed income aligns directionally with the truth (as fixed income decreased less than equity), the LLM incorrectly frames it as a strategic shift rather than an absolute decline in both categories. The total plan assets decreased from $385 to $264, indicating an overall reduction, not a reallocation. The LLM fails to mention this key fact. (3) The multi-hop reasoning is flawed: the model infers a strategic reallocation toward conservatism, but the ground truth shows absolute declines in both asset classes, especially equity (from $137 to $54), suggesting asset drawdown or market impact, not just rebalancing. The LLM invents a narrative not supported by the data. (4) The contextual relevance is moderate because it addresses asset allocation trends between the two years and mentions the correct plan. However, the absence of actual dollar figures and the introduction of unverified percentages severely undermine factual correctness. The qualitative reasoning is partially sound in identifying a shift toward fixed income, but the conclusion about strategy is speculative and unsupported. Overall, the answer is misleading despite some directional alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 569,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Trodelvy's financial performance improved significantly between 2022 and 2023, with product sales increasing by 56% to $1.1 billion in 2023, driven by higher demand in new and existing geographies. Strategically, Trodelvy received FDA approval for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting, expanding its market reach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in financial figures. The ground truth states that Trodelvy generated $380 million in 2022, but the LLM claims $1.1 billion in 2023 with a 56% increase, which would imply ~$705 million in 2022—both the 2022 and 2023 figures are incorrect. No revenue data for 2023 is provided in the original answer, so stating $1.1 billion is a significant fabrication. (2) The regulatory milestones are partially correct: the FDA approval for HR+/HER2- metastatic breast cancer is accurately mentioned, though the LLM adds unnecessary detail about 'endocrine-based therapy and at least two additional systemic therapies' not present in the original, potentially misrepresenting the indication. The EC approval is omitted entirely. (3) The multi-hop reasoning is flawed—while the LLM correctly infers strategic expansion from regulatory approval, it invents quantitative performance improvements unsupported by the data. It fails to acknowledge the absence of 2023 revenue figures in the source. (4) Scores reflect severe penalties on quantitative accuracy due to invented numbers, moderate qualitative accuracy because some regulatory facts are correct, and high contextual relevance as the response addresses both financial and strategic aspects of the question despite inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 372,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron's downstream-related earnings from GS Caltex increased from $874 million in 2022 to $58 million in 2024, indicating a significant decline. This suggests that the joint venture's contribution to Chevron's earnings has diminished over the period. Despite this, the continued investment and operational ties with GS Caltex, as reflected in intercompany transactions and balances, highlight its ongoing strategic importance in Chevron's downstream operations in South Korea.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. It claims Chevron's downstream-related earnings from GS Caltex declined from $874 million in 2022 to $58 million in 2024, which is not supported by the ground truth. The original answer does not provide specific earnings figures for GS Caltex alone, only that downstream-related earnings were higher in 2022 and that Chevron reported total sales with affiliated companies (including GS Caltex) of $16,286 million in 2022 and $13,850 million in 2024. The LLM incorrectly attributes these large revenue figures to GS Caltex alone and fabricates specific earnings numbers not present in the source. (2) The quantitative inaccuracies are severe: no earnings figures of $874M or $58M appear in the ground truth, and the direction of change (sharp decline) contradicts the original answer’s implication of continued strategic importance despite slightly lower affiliated revenues. The $13.85B and $16.286B figures cited in the original are total sales with all affiliated companies, not just GS Caltex, and are revenues, not earnings—so the LLM confuses metric type, entity scope, and magnitude. (3) The multi-hop reasoning is flawed: the model fails to correctly identify that the financial figures refer to broader affiliated revenues, not GS Caltex-specific earnings, and draws an incorrect conclusion about declining strategic value, while the original answer suggests ongoing importance. (4) Scores reflect severe quantitative errors (1), weak qualitative reasoning due to incorrect entity-metric mapping (3), moderate contextual relevance as it addresses the joint venture and strategic importance (6), and a low overall correctness score (2) due to fundamentally incorrect data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 479,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "From 2022 to 2024, the CH-53K program saw an increase in production volume, contributing to higher net sales within the Rotary and Mission Systems (RMS) segment. In 2024, RMS reported increased net sales due to higher production volume on the CH-53K program. Additionally, the program experienced risk retirements, which positively impacted operating profit by improving the profit booking rate as risks related to technical, schedule, and cost aspects were successfully addressed.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but misses key factual elements from the ground truth. It correctly identifies that the CH-53K program saw increased production volume and benefited from risk retirements, which improved profit booking rates. However, it fails to mention the specific $140 million increase in operating profit in 2022, a critical quantitative detail. More importantly, the LLM incorrectly implies continued strong performance in 2024 by stating that RMS had increased net sales due to CH-53K production, while the ground truth states that RMS operating profit declined by 73% in 2024, despite higher production. This is a major factual discrepancy. (2) Quantitative accuracy is low because the answer omits the $140M profit increase in 2022 and does not reflect the 73% profit decline in RMS in 2024. No numbers are provided at all, and the claim of increased net sales in 2024 contradicts the context of declining profitability. (3) The reasoning is partially sound—risk retirements improving profit booking rate is accurate and reflects proper multi-hop understanding of how risk retirement affects financials—but it fails to reconcile this with the broader decline in RMS profitability, indicating incomplete synthesis. The model does not address the evolution from high gains in 2022 to likely diminished returns in 2024 as the program matured. (4) Contextual relevance is high because the answer focuses on the right program, time frame, and financial drivers (production volume, risk retirements, profit impact). However, due to missing key data and presenting a potentially misleading picture of 2024 performance, the overall correctness score is moderate at 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 466,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "Between 2022 and 2023, PayPal's approach to seller protection programs has evolved with a stronger strategic emphasis on enhancing risk management and expanding protections for merchants. In 2023, the company explicitly highlighted its seller protection programs as a key differentiator, emphasizing their role in reducing merchant losses and fostering trust. This reflects a more proactive stance in addressing fraud and financial risks, leveraging its two-sided network data and end-to-end platform capabilities. While risk exposure is still influenced by macroeconomic factors and transaction loss rates, PayPal's 2023 disclosures indicate a heightened focus on refining these programs to align with evolving regulatory and market demands.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though it omits specific quantitative details present in the original answer. (1) Quantitatively, the LLM does not mention the actual historical transaction loss rates (0.09% to 0.15% of TPV) cited in the 2022 report, which is a factual omission; however, it correctly references risk exposure and macroeconomic influences without introducing any incorrect numbers. (2) The answer addresses both years and the evolution in strategic emphasis—from risk management in 2022 to a competitive differentiator in 2023—accurately capturing the shift in tone and business rationale. (3) The multi-hop reasoning is sound: it synthesizes PayPal’s use of data and platform capabilities to enhance seller protection and links this to merchant trust and strategic positioning, consistent with the original answer’s emphasis on integration with analytics and broader merchant services. (4) While the LLM captures the core qualitative shift and maintains contextual relevance by directly addressing risk exposure and strategic emphasis, it falls slightly short in completeness by not including the specific loss rate metrics from 2022. This minor omission prevents a perfect score but does not undermine the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 357,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "Between 2023 and 2024, Starbucks' approach to its ready-to-drink beverages remained consistent in terms of revenue recognition, with sales primarily recognized upon shipment to customers outside of company-operated and licensed stores. Additionally, supplier dependency for these beverages was managed through long-term supply contracts with several specialty suppliers, ensuring a stable supply chain. There were no notable changes in these practices between the two years based on the provided information.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Starbucks' approach remained consistent between 2023 and 2024. The ground truth states there was a clear evolution—from a revenue-centric reporting model in 2023 (where ready-to-drink beverage sales were included in 'Other Revenues' recognized upon shipment) to a supply-chain risk management focus in 2024, emphasizing long-term contracts with specialty suppliers to ensure resilience. The LLM incorrectly asserts no notable changes occurred, which contradicts the ground truth. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily applicable; however, the years 2023 and 2024 are correctly referenced, and the description of revenue recognition upon shipment aligns with the 2023 practice, earning partial credit. (3) The multi-hop reasoning is flawed: the question asks for an evolution between two years, requiring comparison across filings. The LLM failed to identify the shift in strategic emphasis—from revenue recognition to supply chain dependency—despite both elements being present in the original answer. It conflates continuity with consistency, missing the nuanced pivot in disclosure focus. (4) While the LLM mentions correct entities (Starbucks, ready-to-drink beverages, specialty suppliers, long-term contracts), it misrepresents the temporal change, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because it addresses the right topic and mechanisms but fails to capture the evolution central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 447,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's geographic reach and regulatory approvals expanded significantly. In 2022, Trodelvy sales increased due to higher demand in new and existing geographies, and the drug had already received regulatory approvals in the U.S. and Europe for metastatic triple-negative breast cancer (TNBC) and urothelial cancer (UC). By 2023, Trodelvy sales grew by 56%, and the drug received additional regulatory approvals, including EC approval for HR+/HER2- breast cancer and expanded indications in multiple regions. These developments reflect both geographic expansion and broader therapeutic applications for Trodelvy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly identifies that Trodelvy received expanded regulatory approvals in 2023, including EC approval for HR+/HER2- breast cancer, which aligns with the ground truth. However, it introduces unverified claims not present in the original answer, such as a '56% sales growth' in 2023 and increased sales due to 'higher demand in new and existing geographies' in 2022—neither of which are supported by the ground truth. The original answer specifies exact sales figures ($370M U.S., $10M Europe) in 2022 with no international sales, but the LLM omits these and instead makes vague, unsupported statements about sales growth. (2) Quantitatively, the 56% sales growth figure is not mentioned or inferable from the ground truth and appears fabricated. There is no basis to verify this number, making it a serious factual error. The original answer does not provide 2023 sales data, so any percentage increase claim is speculative. (3) The reasoning partially captures the multi-hop aspect by connecting regulatory approvals to expanded reach and indications, which is logically sound. However, it fails to accurately synthesize the geographic reach data from 2022 (U.S. and Europe only, limited international presence) and incorrectly implies broader geographic availability in 2022. It also conflates prior approvals (for TNBC and UC) with the 2023 expansions without clearly distinguishing timelines. (4) Despite these issues, the answer remains contextually relevant, addressing both geographic reach and regulatory evolution. The core idea—that Trodelvy expanded its approvals and likely its reach—is consistent with the ground truth. Hence, a correctness score of 6 reflects partial accuracy with key omissions and one major quantitative error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 500,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's ownership stake in ABG decreased significantly. In the fourth quarter of 2023, a capital transaction diluted Simon's ownership from approximately 11.8% to 9.6%, resulting in a non-cash pre-tax gain of $10.3 million. In 2024, Simon sold all of its remaining interest in ABG for cash proceeds of $1.2 billion, generating a pretax gain of $414.8 million. Thus, Simon fully exited its ABG investment by the end of 2024, realizing substantial financial gains through both dilution and the final sale.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group (SPG) experienced multiple dilutions in 2023, reducing its stake from 12.3% to 11.8%, then 11.7%, and finally to 9.6%, with corresponding non-cash pre-tax gains of $36.4M, $12.4M, and $10.3M. The LLM only mentions one dilution (from 11.8% to 9.6%) and omits the earlier two, missing key steps in the ownership evolution. More critically, the LLM falsely claims that in 2024, SPG sold all its remaining interest in ABG for $1.2 billion, generating a $414.8 million pretax gain. This is entirely incorrect — the ground truth states that SPG did *not* report any new transactions in 2024 and instead referenced a prior 2021 transaction involving an $18.8M gain and a $100M acquisition. There is no mention of a $1.2B sale or a $414.8M gain in the original answer. (2) Quantitative accuracy is very low: the LLM invents large numbers ($1.2B, $414.8M) not present in the source, misrepresents the sequence of gains (only includes $10.3M but omits $36.4M and $12.4M), and incorrectly implies a final sale. (3) The reasoning is flawed: the LLM assumes a logical progression (stake reduction → full exit) that is not supported by the data. It fails to recognize the shift in disclosure behavior in 2024 (from active reporting to referencing past events), which is a key qualitative point in the original answer. (4) Contextual relevance is moderate because the answer addresses SPG's stake in ABG and financial gains over time, but the invented 2024 sale and associated figures severely undermine factual correctness. The answer synthesizes incorrectly across years and invents a transactional event that did not occur.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 472,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "Between the 2023 and 2024 filings, the 2012 Equity Incentive Plan underwent notable changes. In 2024, a Fourth Amendment to the plan was disclosed, filed on August 1, 2024, in addition to the previously disclosed Third Amendment from 2023. Furthermore, new forms of award agreements were added in 2024, including additional forms filed on April 25, 2024. These updates reflect ongoing modifications to the plan's structure and award administration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Fourth Amendment is correctly dated August 1, 2024, and the new award agreement forms are accurately noted as being from April 2024 (specifically April 25, 2024, in the LLM answer, which is consistent with the ground truth's 'April 2024'). The reference to the previously disclosed Third Amendment in 2023 is factually sound. (2) Quantitative accuracy is perfect: all dates and amendment numbers (Third and Fourth Amendments) match the ground truth. (3) The multi-hop reasoning is sound—comparing the 2023 and 2024 filings to identify evolution in amendments and award forms is correctly executed. The only minor limitation is that the LLM does not explicitly mention the 2012 and 2017 forms of award agreements referenced in 2023, which were part of the original answer. While this is a small omission, it slightly reduces completeness in the qualitative dimension. (4) Contextual relevance is excellent—the response directly addresses the evolution of the plan in terms of amendments and award agreements, using appropriate terminology and logical flow. Overall, the answer is factually correct and well-reasoned, warranting a high score with only a slight deduction for the omitted detail about earlier award forms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 368,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "Between 2022 and 2023, the capitalized software licenses increased from $152 million to $223 million, as noted in the consolidated balance sheets. Additionally, the amortization of capitalized software rose from $54 million in 2022 to $63 million in 2023. This increase in both the value of capitalized licenses and their amortization indicates a higher investment in software licensing by the company in 2023 compared to 2022.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in capitalized software licenses from $152 million in 2022 to $223 million in 2023, which matches the ground truth. However, it introduces a new figure—amortization increasing from $54 million to $63 million—that is not present in the original answer or implied by it. Since this data point is unverified and not part of the ground truth, it undermines quantitative accuracy. (2) The core numbers for carrying values are accurate and correctly compared, but the additional amortization figures, while plausible, are not supported by the provided ground truth and may represent hallucination or incorrect inference. (3) The reasoning is logically sound in interpreting increasing capitalized software values as indicative of greater investment, and the multi-hop synthesis between years is appropriate. However, the model adds a detail (amortization amounts) not present in the original, suggesting either external data or flawed extraction. (4) Despite the extra detail, the answer remains contextually relevant and captures the main trend—growing investment in software licensing—based on balance sheet growth. The core conclusion aligns with the ground truth, but the unsupported amortization numbers reduce confidence in full factual correctness, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 377,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "Between 2022 and 2023, PayPal increased its utilization of European customer balances for credit activities, raising the approved amount from $3.8 billion to $3.0 billion. In 2022, this represented 37% of European customer balances, while in 2023, it represented 39%. This indicates a strategic shift toward leveraging European customer balances more efficiently to fund credit products, reflecting PayPal's focus on expanding credit offerings while optimizing internal liquidity sources.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that PayPal 'increased' its utilization from $3.8 billion to $3.0 billion, when in fact the approved amount decreased from $3.8B in 2022 to $3.0B in 2023. This reverses the direction of change and misrepresents the trend. The percentages (37% in 2022, 39% in 2023) are correctly stated. However, the LLM omits the key strategic development in 2023: the new €40 billion agreement to sell consumer installment receivables, of which $5.5 billion was sold during the year. This is a major component of PayPal's shift toward external funding and is entirely missing from the LLM response. (2) Quantitative inaccuracies include the incorrect claim of an increase from $3.8B to $3.0B (should be a decrease), though the percentage figures are accurate. The omission of the $5.5B receivables sale and €40B facility further undermines quantitative completeness. (3) The reasoning is partially sound in interpreting the higher percentage (39% vs 37%) as indicating more efficient use of balances, but the flawed premise of an 'increase' in approved amount undermines the logic. The multi-hop synthesis fails by not connecting the reduced internal funding with the new external funding mechanism, which is essential to understanding PayPal's strategic shift. (4) Correctness is scored low (4/10) due to the major error in directional trend and omission of key external funding strategy. Quantitative accuracy is poor (3/10) due to the reversed dollar amounts. Qualitative accuracy is moderate (5/10) as some reasoning about efficiency is valid, but strategic synthesis is incomplete. Contextual relevance is high (8/10) as the answer addresses the general topic and timeframe appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 477,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks' investment in Valor Siren Ventures I L.P. had a total carrying value of $211.9 million as of September 29, 2024, and there were no material changes or financial impacts disclosed between fiscal years 2023 and 2024. The related financial statement activities from these private equity interests were not material during the periods presented.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the $211.9 million carrying value as of September 29, 2024, which matches the ground truth for the combined investments in Valor Siren Ventures I L.P. and II L.P. However, it incorrectly implies this was the value for Valor Siren Ventures I L.P. alone, failing to clarify that the disclosed amount is for both I and II L.P. combined. Additionally, the LLM claims 'no material changes or financial impacts disclosed' between 2023 and 2024, which oversimplifies the evolution: while the impact remained non-material, the investment relationship evolved from an unspecified stake in 2023 to a more defined and monitored position in 2024 with a disclosed combined carrying value. (2) The date (September 29, 2024) and dollar amount ($211.9 million) are accurate and properly formatted. However, the attribution of this value solely to Valor Siren Ventures I L.P. is factually incorrect per the original answer, which specifies the amount includes both I and II L.P. (3) The multi-hop reasoning is partially sound—information from both years is addressed—but the synthesis is flawed. The model fails to recognize that the 2024 figure is a combined value and misses the qualitative evolution in the nature of the investment relationship (from general equity stake to more defined monitoring). (4) The answer is contextually relevant and addresses the core question about carrying value and financial impact, but lacks completeness and precision in conveying the evolution between years, particularly regarding entity scope and qualitative changes in the investment structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 441,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Between 2022 and 2023, the strategic positioning of Analog Products at Texas Instruments (TI) shifted due to decreased demand, resulting in a 15% revenue decline and a significant 30% drop in operating profit. This was driven by lower revenue and higher manufacturing costs from planned capacity expansion and reduced factory loadings. TI continued to invest in strengthening its competitive advantages, particularly in manufacturing and technology, but the financial contribution of Analog Products weakened in 2023 compared to 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The Original Answer states that Analog Products remained a core strategic pillar in 2023, with emphasis on TI's sustainable competitive advantages (e.g., lower costs, supply chain control) and long-term free cash flow growth. In contrast, the LLM claims a strategic shift due to decreased demand, a 15% revenue decline, and a 30% drop in operating profit—none of which appear in the ground truth. These specific quantitative figures (15%, 30%) are unsupported and contradict the positive framing of continued strategic importance and financial strength in the Original Answer. (2) There are no verifiable calculations in the Original Answer to cross-check, but the LLM introduces precise numbers (15%, 30%) that are factually incorrect or at least not present in the ground truth, severely undermining quantitative accuracy. (3) The multi-hop reasoning fails: the LLM incorrectly infers declining financial performance as a driver of strategic repositioning, while the ground truth describes a consistent strategic role with evolved framing around competitive advantages and cash generation. The LLM also fails to mention the 67.5% gross margin in 2022, the role of 300mm production, or the shift toward free cash flow per share as a key metric in 2023. (4) The contextual relevance is moderate because the answer discusses Analog Products, TI’s competitive advantages, and financial contribution—but the conclusions are factually misaligned. Due to major factual and quantitative errors, the correctness score is low at 3, with similarly low scores for quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 459,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron's capital allocation strategy in the Lower 48 region from 2022 to 2023 shows an increase in depreciation, depletion, and amortization (DD&A) from $4,854 million in 2022 to $5,729 million in 2023, indicating higher capital investment or asset utilization. However, impairments decreased significantly from $735 million in 2022 to $587 million in 2023, suggesting improved asset performance or fewer write-downs. This evolution reflects a shift toward maintaining operational efficiency and capital discipline while reducing asset impairment risks in the Lower 48 region.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in DD&A from $4,854 million in 2022 to $5,729 million in 2023, which aligns with the ground truth and supports the conclusion of increased capital allocation. However, it introduces specific impairment figures ($735M in 2022 and $587M in 2023) that are not present in the original answer or implied by the ground truth. The original answer aggregates DD&A and impairments into a single total figure ($4,854M and $5,729M), without breaking them out separately. Thus, the LLM fabricates granular data not supported by the source. (2) While the total DD&A + impairments figures are accurate in sum (implied in original), the LLM incorrectly treats impairments as a separate, decreasing component, which distorts the interpretation. There is no verification that impairments decreased, and introducing this detail misrepresents the data. (3) The reasoning is partially sound—increased DD&A suggests higher investment—but the multi-hop synthesis fails because it invents a breakdown not available in the source. The original answer draws a broader strategic conclusion by comparing Lower 48 growth to other regions (Europe, MENA), which the LLM omits entirely, missing a key part of the strategic context. (4) The contextual relevance is high because the answer addresses capital allocation evolution using the right metric and timeframe. However, correctness is reduced due to unsupported numbers and incomplete reasoning. Quantitative accuracy is moderate (6) because the main totals are correct but broken down incorrectly. Qualitative accuracy is low-mid (5) due to flawed logic and missing comparative insight across regions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 461,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "Between 2023 and 2024, Verizon has positioned FWA Broadband as a core component of its next-generation Intelligent Edge Network, leveraging both 5G and 4G LTE technologies to provide high-speed, low-latency connectivity. In 2023, FWA was highlighted as an alternative to traditional landline internet access, primarily serving residential customers through the Consumer segment and small-to-medium businesses through the Business segment. By 2024, FWA had evolved further, with a stronger emphasis on its role in supporting enterprise and public sector customers, as well as enhancing Verizon's business market offerings. This shift reflects a broader strategy to integrate FWA into both Consumer and Business product portfolios, targeting a wider range of customer segments, including those requiring scalable, cost-efficient connectivity solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately reflects Verizon's use of both 5G and LTE networks for FWA broadband in 2023 and the continuation into 2024. The positioning of FWA as an alternative to traditional landline internet is correctly noted for 2023, and the integration into broader product portfolios for both Consumer and Business segments is consistent with the original answer. The expansion into enterprise and public sector customers in 2024 is a reasonable interpretation of a more strategic, integrated approach, though this specific customer expansion is not explicitly stated in the ground truth. (2) There are no numeric inaccuracies—no numbers are misstated or miscalculated. The ground truth mentions 3.1 million FWA connections in 2023, but the LLM answer does not include this figure, which is a minor omission but not a factual error. (3) The multi-hop reasoning is sound: the LLM synthesizes information about product positioning and customer segments across years and business units. However, it introduces the term 'Intelligent Edge Network' and emphasizes enterprise/public sector growth, which are not present in the ground truth, potentially reflecting inference beyond the source data. (4) The answer is highly contextually relevant, addressing both the evolution in product positioning and target customer segments. The qualitative accuracy is slightly reduced due to the addition of unverified strategic emphasis, but core facts and synthesis remain accurate. Overall, the answer is factually solid with minor over-interpretation, warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 459,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2022 to 2024, transitioning from a 55% ownership stake in the newly formed \"New AspenTech\" (created in May 2022) to proposing a full acquisition of the remaining shares in November 2024. This evolution had a mixed financial impact: the Heritage AspenTech acquisition in 2022 positively contributed to gross margin by 0.6 percentage points in 2023, but the Test & Measurement acquisition in 2024 caused a 1.3 percentage point drag on gross margin due to inventory step-up amortization. Additionally, the proposed full acquisition in 2024 would further consolidate AspenTech into Emerson’s equity structure, though the final financial implications remain contingent on the transaction's completion.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson did not hold a 55% stake in 'New AspenTech' in May 2022; rather, the strategic transaction creating 'New AspenTech' and involving the 55% ownership stake occurred in 2024, not 2022. The timeline is reversed, which is a critical error in multi-hop reasoning. Additionally, the LLM introduces a 'full acquisition of remaining shares proposed in November 2024' and a 'Test & Measurement acquisition in 2024' causing a 1.3 percentage point drag on gross margin—neither of which is supported by the original answer or ground truth. The 0.6 percentage point positive contribution to gross margin in 2023 is correctly stated and matches the ground truth. (2) Quantitative accuracy is partially correct: the 0.6 percentage point gross margin benefit in 2023 is accurate, but the 1.3 percentage point drag from a non-mentioned acquisition is fabricated. There are no dollar amounts or complex calculations to verify beyond these percentages. (3) Multi-hop reasoning is flawed: the model incorrectly sequences the evolution of the relationship (starting with 55% in 2022 instead of building to it in 2024), misidentifies key transactions, and introduces unsupported financial impacts. The equity structure impact is mentioned in the LLM answer but only in vague forward-looking terms ('would further consolidate'), whereas the ground truth specifies actual impacts via gains/losses from stock plans and asset restructuring. (4) Contextual relevance is high—the answer addresses the evolution of the relationship and financial impacts on gross margin and equity structure as asked—but the factual and temporal inaccuracies severely undermine correctness. Due to major errors in entity timelines and invented financial events, the correctness score is low despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 510,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "The financial relationship between NEE and FPL Group Capital Inc. (now NextEra Energy Capital Holdings, Inc.) from 2022 to 2023 primarily involved the issuance and management of debt instruments, including junior subordinated debentures and floating rate notes. In 2022, NEE issued Series J and K Debentures through NextEra Energy Capital Holdings, Inc., with terms extending to 2024 and 2025, respectively. In 2023, amendments and new issuances such as the Series L Debentures due 2025 and Floating Rate Notes due 2073 were recorded, indicating continued capital structure involvement through debt obligations. These activities reflect NEE's use of its subsidiary to manage long-term financing and obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, the relationship was defined by a 1998 guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc., but the LLM incorrectly frames the relationship as involving debentures issued by NEE through a subsidiary in 2022 (Series J and K with maturities in 2024 and 2025), which contradicts the original answer. The original makes no mention of Series J, K, or short-term instruments. Instead, it emphasizes a shift from a guarantee to long-term junior subordinated debentures (Series B, C, L, M, N, O, P) with maturities from 2057 to 2082—none of which are accurately reflected in the LLM answer. (2) Quantitatively, the dates and series mentioned (e.g., Series L due 2025, Floating Rate Notes due 2073) do not align with the ground truth, which specifies maturities between 2057 and 2082 for multiple series but does not mention floating rate notes or 2025 maturities. The LLM invents specific instruments not present in the truth. (3) The multi-hop reasoning is flawed: the key evolution—from a guarantee to long-term capital structure involvement via debentures—is completely missed. The LLM fails to identify the 1998 guarantee as the 2022 baseline and instead fabricates a narrative around recent debenture issuances. It also incorrectly refers to FPL Group Capital Inc. as 'NextEra Energy Capital Holdings, Inc.' without noting the name change timeline, and misattributes issuances to that entity rather than correctly identifying NEE as issuing to FPL Group Capital Inc. (4) While the answer is contextually relevant—discussing debt instruments and capital structure—it is factually incorrect in key aspects, leading to a low correctness score. The qualitative reasoning is unsound due to incorrect entities, dates, and financial instruments, undermining the core of the multi-hop analysis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 519,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "The positioning and market acceptance of the InterStim II neurostimulator evolved positively between 2022 and 2024, with continued growth in Pelvic Health therapies. In 2022, the InterStim Micro neurostimulator was highlighted as a recent launch driving Pelvic Health sales, while InterStim II was part of the broader InterStim therapy portfolio. By 2024, InterStim II was specifically noted alongside the InterStim X and InterStim Micro as a recharge-free neurostimulator for treating overactive bladder, urinary retention, and chronic fecal incontinence, indicating its established role within Medtronic’s Pelvic Health offerings. This suggests a strengthening market position for InterStim II as part of a diversified neurostimulation portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: InterStim II was part of a broader portfolio in 2022 and by 2024 was explicitly highlighted as recharge-free, alongside InterStim X and InterStim Micro. The indications—overactive bladder, urinary retention, and bowel (or fecal) incontinence—are accurately reflected. (2) There are no numeric values requiring verification (e.g., financials, percentages), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of product positioning over time and across product lines, noting the shift toward emphasizing recharge-free status and portfolio diversification. The mention of InterStim Micro as a recent launch in 2022 adds contextual accuracy consistent with market timelines. (4) The only minor gap is that the original answer emphasizes a strategic shift in *how* the products are differentiated (by recharge status), which the LLM touches on but could have articulated more explicitly. However, the core evolution in positioning and market acceptance is correctly conveyed. Wording differs slightly (e.g., 'chronic fecal incontinence' vs. 'bowel incontinence'), but these are semantically equivalent. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 378,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's utilization and management of the Supplemental Facility evolved in several key ways. The borrowing capacity of the Supplemental Facility increased from an initial $3.5 billion in 2022 to a potential $4.5 billion by 2024, subject to additional lender commitments. The interest rate strategies remained consistent, with rates based on SOFR plus a spread adjustment (72.5 basis points) reflecting the transition from LIBOR. In terms of repayment actions, the Supplemental Facility was used to support short-term liquidity needs, such as the repayment of €750.0 million in borrowings in November 2023, which were subsequently refinanced through the issuance of senior unsecured bonds. Overall, the Supplemental Facility served as a flexible tool for managing short-term liquidity and optimizing debt structures during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a few inaccuracies. The borrowing capacity description is accurate—$3.5 billion initial with potential to increase to $4.5 billion, as stated in the ground truth. The repayment of €750.0 million in November 2023 is correctly noted, though the ground truth specifies the repayment occurred on November 17, 2023, which the LLM omits. However, the LLM incorrectly states that the €750 million was refinanced via 'senior unsecured bonds,' while the ground truth specifies 'exchangeable bonds,' which is a material distinction in financial context. Additionally, the LLM introduces a 72.5 basis point spread adjustment related to SOFR, which is not mentioned in the ground truth—this detail is fabricated or misattributed. The interest rate swaps fixing the rate at 3.81% in 2023, a key point in the ground truth, is entirely missing from the LLM answer. (2) Quantitative accuracy: The $3.5B and $4.5B figures are correct. The €750.0 million amount and 2023 repayment date are correct in substance but lack precision (missing exact date). The 72.5 bps spread and bond type are incorrect or unsupported. (3) Multi-hop reasoning is partially sound—the model connects the facility usage to repayment and refinancing, but fails to incorporate the interest rate swap strategy, a critical component of the 'management' aspect of the question. It also misidentifies the refinancing instrument, weakening the synthesis. (4) Scores justified: Correctness 7 due to accurate core facts but missing key detail (swap at 3.81%) and one factual error (bond type). Quantitative accuracy 7 due to mostly correct numbers but inclusion of unsupported figure (72.5 bps). Qualitative accuracy 8 due to sound structure and logical flow, but flawed entity and strategy identification. Contextual relevance 10—answer directly addresses all aspects of the question with appropriate focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 518,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "From 2023 to 2024, Verizon transitioned away from fixed-term, subsidized service plans for Consumer customers, focusing instead on device payment plans that allow customers to pay for devices in installments over time. These plans involve non-interest-bearing installment notes, typically over a 36-month term, and include month-to-month wireless service contracts. Promotional incentives, such as billing credits contingent on service retention, are now more prominent, with these credits factored into the transaction price and allocated to performance obligations based on relative standalone selling prices. Additionally, financing components in these plans are evaluated for significance, with Verizon determining that they are not material for direct-channel contracts.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but misses key aspects of the evolution in Verizon's device payment plans from 2023 to 2024, particularly regarding the introduction of structured promotional incentives. Quantitatively, the 36-month term and non-interest-bearing installment note are correctly stated, aligning with the ground truth. However, the LLM incorrectly implies that Verizon transitioned away from 'fixed-term, subsidized service plans'—a detail not present in the original answer—and overemphasizes billing credits tied to service retention, which were not mentioned in the ground truth. The original answer highlights a specific new promotional feature: upgrade eligibility after paying a portion of the plan and trading in the device, which the LLM fails to mention. This is a significant omission in the evolution narrative. While the LLM correctly identifies the shift toward structured financing (installment notes, 36-month terms), it misrepresents the nature of promotional incentives. The reasoning is partially sound in identifying a move toward more structured financing, but the synthesis of promotional changes is inaccurate. Contextually, the response stays on topic and uses appropriate financial terminology, making it relevant. Overall, the answer is factually mixed—correct on financing structure but incorrect on the key promotional evolution, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 392,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's legal stance on liability for Aqua-Chem's asbestos-related claims remained consistent, asserting that it has no obligation for Aqua-Chem's liabilities. In 2023, the Georgia Case was still subject to the 2004 stay pending resolution of insurance coverage litigation, and the Company continued to pursue coverage agreements with insurers. By 2024, the litigation status remained unchanged, with the Georgia Case still stayed. The Company maintained its position that it is not responsible for Aqua-Chem's asbestos liabilities beyond what is covered by insurance, as outlined in the 1981 stock sale agreement and subsequent legal proceedings.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, legal status, and contractual references (e.g., 1981 stock sale agreement, 2004 stay, Georgia Case), which supports a high quantitative accuracy score. It correctly states that the litigation status remained unchanged between 2023 and 2024 and that the Georgia Case remained stayed. However, the LLM misses a key qualitative shift identified in the ground truth: Coca-Cola’s evolving stance from outright denial of liability in 2023 to a more nuanced 2024 position emphasizing insurance coverage details and shared insurer responsibility. Instead, the LLM portrays the stance as 'consistent' and 'unchanged,' which contradicts the ground truth’s assertion of a shift in emphasis. This misrepresents the multi-hop reasoning required to compare the qualitative evolution in disclosures across years. While the entities (Coca-Cola, Aqua-Chem, Georgia Case), years (2023–2024), and legal framework are correctly identified, the failure to capture the nuanced shift in narrative and strategic emphasis results in a moderate correctness and qualitative accuracy score. Contextual relevance is high because the answer addresses the core legal relationship and timeframe directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 343,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel's utilization of non-US tax credits significantly reduced its long-term income tax liabilities in 2024 compared to 2022. In 2024, non-US tax credits contributed to a $67 million tax benefit (up from $129 million in 2023 and $220 million in 2022), indicating that the company continues to leverage favorable tax rates in jurisdictions like Israel and Malaysia. This strategy reflects Intel's ongoing focus on optimizing its global tax position by structuring operations in regions with reduced tax rates and maintaining eligibility for tax holidays, which helps mitigate its overall tax burden.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Intel's long-term income taxes payable decreased from $4.3 billion in 2022 to $1.6 billion in 2024, but the LLM does not mention these figures at all. Instead, it introduces a tax benefit from non-US tax credits of $67 million in 2024, $129 million in 2023, and $220 million in 2022—values that are not present in the original answer and contradict the trend implied by the ground truth (where tax liabilities are decreasing, but the LLM claims the tax benefit from non-US credits is also decreasing, which would imply less favorable impact over time). This misrepresents both the magnitude and direction of the effect. (2) The quantitative inaccuracies are severe: the LLM invents specific tax benefit amounts not found in the ground truth, and these numbers do not align with the $2.7 billion reduction in long-term tax liabilities between 2022 and 2024 implied by the original answer. There is no evidence in the original answer that the non-US tax credit benefit was declining; on the contrary, the original suggests an increasing offsetting effect. (3) The reasoning is partially sound in that the LLM attempts to connect non-US tax credits to international tax strategy and mentions jurisdictions like Israel and Malaysia, which could be consistent with Intel's operations. However, it fails the multi-hop synthesis: it does not link the change in long-term tax liabilities to the utilization of non-US credits using the correct figures, nor does it correctly infer the strategic implication based on accurate data. (4) The contextual relevance is moderate because the answer addresses the general topic of international tax strategy and non-US tax credits, but the factual foundation is incorrect, undermining the conclusion. The qualitative accuracy is low because the entities (Intel, non-US tax credits, international strategy) are correct, but the relationships and trends are misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 540,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "Between 2022 and 2024, the treatment and risk exposure of pension risk transfers have evolved in response to interest rate sensitivity and regulatory influence. In 2022, the company experienced a net derivative loss of $445 million under a rising interest rate scenario, with adjusted earnings negatively impacted across most segments. By 2024, the net derivative loss had significantly reduced to $15 million, while the adjusted earnings impact improved to $95 million, indicating better risk management and adaptation to higher interest rates. Regulatory developments, including evolving capital requirements and reserving standards, have also influenced the company's approach to pension risk transfers, with increased focus on asset/liability management strategies and derivative usage to mitigate margin compression and interest rate volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—$445 million net derivative loss in 2022 and $15 million in 2024, with adjusted earnings impacts—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear fabricated or misattributed, as the ground truth does not mention any financial losses, derivative impacts, or earnings figures related to pension risk transfers. (2) There is no support in the original answer for any calculation or comparison of derivative losses or adjusted earnings between 2022 and 2024; thus, the quantitative claims fail verification and severely undermine factual accuracy. (3) While the LLM captures the general theme of evolving risk exposure due to interest rate sensitivity and regulatory influence, it misrepresents the nature of the evolution. The original answer emphasizes a shift in product mix toward non-guaranteed funding products due to regulatory changes affecting plan sponsor behavior, whereas the LLM focuses on improved financial performance and internal risk management, which is not supported. (4) The LLM correctly identifies interest rate sensitivity and regulatory influence as key factors but fails to accurately describe the multi-hop synthesis: it does not reference the change in regulatory environment around defined benefit plan funding or the resulting strategic shift in product mix. Instead, it invents performance metrics and implies progress in risk mitigation that isn't in the source. Thus, while contextually relevant and partially aligned in topic, the answer is factually incorrect on key details and introduces unsupported data, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 467,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "Between 2022 and 2024, Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved to emphasize broader therapeutic applications and global adoption. In 2022, the InterStim Micro was highlighted for treating overactive bladder, urinary retention, and bowel incontinence, with growth driven by recent launches and supply chain recovery. By 2024, the strategy expanded to include the InterStim X and InterStim II recharge-free neurostimulators alongside the InterStim Micro, targeting chronic fecal incontinence and non-obtrusive urinary retention. The company also emphasized continued global acceptance and growth of Pelvic Health therapies, reflecting a more comprehensive and diversified approach to neurostimulation solutions.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but exhibits significant inaccuracies in qualitative reasoning and entity representation. (1) Correctly identifies the therapeutic indications (overactive bladder, urinary retention, bowel incontinence) and mentions Pelvic Health therapies, aligning with the original answer. However, it incorrectly reverses the strategic evolution: in 2024, Medtronic did not expand the InterStim Micro's positioning to include broader applications or pair it with InterStim X and II as part of a diversified portfolio; rather, it began specifically highlighting the InterStim Micro as a 'rechargeable' device, differentiating it from the recharge-free InterStim X and II models. The original answer emphasizes a shift toward targeted differentiation, while the LLM implies a strategy of integration and expansion, which is factually incorrect. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution from a general product-line positioning in 2022 to a more distinct, rechargeable-device-focused strategy in 2024. Instead, it fabricates a narrative of expanded indications and global focus not supported by the ground truth. (4) Contextual relevance is high—the response addresses Medtronic, InterStim Micro, and the 2022–2024 timeframe—but the core strategic insight is misrepresented, leading to a moderate correctness score of 5 due to partial factual alignment but major reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 433,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's use of the Supplemental Facility showed a notable shift in terms of outstanding borrowings and repayment actions. In 2022, the Operating Partnership had $1.05 billion outstanding under the Supplemental Facility on January 12, 2022, after drawing funds in December 2021 to repay mortgages. By 2024, the company had repaid €750.0 million ($815.4 million U.S. dollar equivalent) of borrowings under the Supplemental Facility on November 17, 2023, using proceeds from the issuance of senior unsecured bonds. As of December 31, 2024, the weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) was $311.1 million, indicating a significant reduction in reliance on the Supplemental Facility compared to 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in its factual content and captures the key evolution in Simon Property Group's use of the Supplemental Facility between 2022 and 2024. It correctly identifies the €750.0 million ($815.4 million) repayment on November 17, 2023, and the $311.1 million weighted average outstanding balance under the Credit Facilities as of 2024. However, there is a discrepancy in the 2022 figure: the LLM states $1.05 billion outstanding on January 12, 2022, which is a point-in-time amount, whereas the ground truth reports a weighted average outstanding balance of $519.9 million for the full year 2022 across all Credit Facilities (including the Supplemental Facility). The LLM answer overemphasizes a single drawdown event and does not reflect the annual weighted average, leading to a partial misrepresentation of the 2022 borrowing level. (2) Quantitatively, the €750.0 million and $815.4 million figures are accurate, as is the $311.1 million 2024 balance. The $1.05 billion figure, while appearing in filings as a drawdown amount, is not the appropriate summary metric for 2022 compared to the weighted average used in the ground truth, making this a notable but not critical error. (3) The reasoning is sound: the LLM correctly infers a strategic reduction in debt, links the repayment to bond issuance, and shows a timeline of deleveraging. It synthesizes information across time and instruments (Supplemental Facility and bond issuance), demonstrating good multi-hop logic. (4) The answer is highly relevant and well-structured, addressing both outstanding borrowings and repayment actions. The minor quantitative inaccuracy prevents a top score, but overall the response is factually strong and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 480,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "COP's investment activity in the Lower 48 region, as reflected in depreciation, depletion, amortization, and impairments (DD&A) expenses, increased from 2022 to 2023. In 2023, DD&A expenses for the Lower 48 were $5,729 million, compared to $4,854 million in 2022, indicating a $875 million increase. This rise suggests higher capital investment or asset utilization in the Lower 48 region during 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $4,854 million in 2022 and $5,729 million in 2023 are correctly reported. The calculated difference of $875 million ($5,729M - $4,854M) is accurate and properly highlighted. (2) The answer is complete, addressing the evolution of investment activity from 2022 to 2023 using the specified financial metric (DD&A and impairments). (3) Entity accuracy is correct: COP (ConocoPhillips), the Lower 48 region, and the years 2022 and 2023 are all correctly identified. (4) The reasoning is sound—increased DD&A and impairments expenses are appropriately interpreted as indicators of higher capital investment or asset utilization, which aligns with standard financial interpretation in the energy sector. (5) The semantic meaning is equivalent to the original answer, with slightly more detail (explicit calculation of $875M increase), enhancing clarity without introducing error. All multi-hop elements—cross-year comparison, correct metric, correct region, and correct company—are accurately synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 317,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "From 2023 to 2024, Verizon's approach to corporate networking solutions has seen a slight shift in emphasis and service description. In 2023, the Business segment emphasized a broad portfolio of connectivity, security, and professional services tailored for large enterprises and public sector customers, with Enterprise and Public Sector accounting for 50% of Business segment revenues. By 2024, while the core offerings remain similar, there is a noted focus on enhancing IoT capabilities and leveraging business models that monetize usage across connectivity, platform, and solution layers. Additionally, the Business segment's Enterprise and Public Sector revenue slightly decreased to 48% of the Business segment's total in 2024, while Business Markets and Other saw a modest increase in relative contribution.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. Most critically, the claim that Enterprise and Public Sector revenue decreased to 48% of Business segment total in 2024 is not supported by the ground truth, which does not provide any such percentage for 2024 and only notes a more generalized service description. The ground truth does not mention IoT capabilities or monetization across connectivity, platform, and solution layers—these are fabrications or unsupported additions. The 2023 revenue figure of $15.1 billion (50%) is correctly referenced in spirit but slightly mischaracterized as '50% of Business segment revenues' without citing the dollar amount, which reduces precision. (2) Quantitative accuracy is low because the 48% figure is incorrect and unsupported; no such data exists in the original answer. The original answer does not provide 2024 revenue splits, so asserting a change to 48% is a significant factual error. (3) The multi-hop reasoning is partially sound in that it attempts to compare service descriptions across years and infer strategic shifts, but it introduces unverified details (IoT, revenue model layers) and makes up a key data point (48%), undermining the logical synthesis. The core idea of a shift in emphasis is aligned with the ground truth’s observation of a more streamlined description, but the reasoning is corrupted by hallucinated data. (4) Contextual relevance is high because the answer addresses the evolution of corporate networking solutions and segment emphasis as asked. However, correctness score is low due to major factual errors in quantitative claims and unsupported qualitative assertions, despite capturing a general trend of messaging simplification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 470,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "From 2022 to 2024, MetLife's valuation approach for FVO (Fair Value Option) securities remained consistent in terms of sensitivity to fair value changes, with the U.S. dollar appreciation having an inverse impact on short U.S. dollar net asset positions. In 2022, a 10% appreciation in the U.S. dollar resulted in a $54 million decrease in the estimated fair value of FVO securities. By 2024, the sensitivity of FVO securities to U.S. dollar appreciation remained similar, with the valuation techniques and significant unobservable inputs for Level 3 assets and liabilities, including FVO securities, unchanged. This indicates that the valuation approach and sensitivity to U.S. dollar movements for FVO securities were stable during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2022 quantitative sensitivity: a 10% U.S. dollar appreciation leading to a $54 million decrease in fair value, which matches the ground truth. However, it incorrectly states that the valuation approach and sensitivity remained stable through 2024, directly contradicting the ground truth, which indicates a clear evolution toward a more nuanced, dynamic framework based on duration and currency. The LLM claims no change in valuation techniques and unobservable inputs for Level 3 assets in 2024, but the original answer states that by 2024, MetLife emphasized a broader sensitivity framework with variation by duration and currency, signaling a shift from a static to a more complex model. (2) Quantitatively, the $54 million figure and 10% appreciation are accurate, and no incorrect calculations are made. However, the absence of a 2024 fair value figure is not acknowledged in the LLM answer, and instead used to support a claim of stability, whereas the ground truth uses this absence to infer methodological evolution. (3) The multi-hop reasoning is flawed: the question requires synthesizing changes in approach over time, but the LLM fails to recognize the shift implied by the introduction of a more granular sensitivity framework. Instead, it assumes stability due to unchanged inputs, ignoring the qualitative advancement in methodology. (4) The correctness score is low due to the central factual inaccuracy about the evolution of the valuation approach. While numbers are correct, the core conclusion is opposite to the ground truth. Quantitative accuracy is high because the cited numbers are correct. Qualitative accuracy is low due to incorrect reasoning and synthesis. Contextual relevance is moderate as the answer addresses the right topic and entities but misinterprets the trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 501,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, with its energy trading services contributing to significant changes in financial performance. In 2023, operating revenues for NextEra Energy Resources (NEER) increased by $5,952 million, driven primarily by gains from non-qualifying commodity hedges due to changes in energy prices, net increases in revenues from customer supply and gas infrastructure businesses, and revenues from new investments in wind, solar, and battery storage facilities. However, this growth was partially offset by lower revenues from existing clean energy assets, mainly due to reduced wind generation. Financially, NEER's net income less net loss attributable to noncontrolling interests rose sharply from $285 million in 2022 to $3,558 million in 2023, largely due to new investments, changes in non-qualifying hedge activity, and gains from nuclear decommissioning fund investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers are correct: the net income increase from $285 million in 2022 to $3,558 million in 2023 is accurately reported. The $5,952 million increase in operating revenues for NEER is consistent with the data in the knowledge graph, even though this specific figure was not in the original answer—it is contextually valid and does not contradict the ground truth. (2) The entities are correctly identified: NextEra Energy (NEE), its subsidiary NEER (NextEra Energy Resources), and the relevant time frame (2022–2023) are all accurate. (3) The reasoning is sound and reflects multi-hop synthesis: the answer links expanded power marketing activities to financial performance, citing specific drivers such as non-qualifying commodity hedges, customer supply revenues, and new investments in renewables. It also correctly attributes the net income surge to hedge activity and nuclear decommissioning gains, which adds depth beyond the original answer without introducing inaccuracies. (4) While the original answer emphasizes the expansion of NEER’s role and the resulting net income jump, the LLM provides additional context on revenue drivers, enhancing completeness. The only minor gap is that the LLM does not explicitly mention 'full energy and capacity requirements services' or 'load-following and ancillary services' from 2022, which were part of the original description of NEE’s activities. However, the focus on financial evolution and trading services is well-maintained. Overall, the answer is factually correct, contextually rich, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 465,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's stake in Coca-Cola FEMSA remained at 28%, with no change in ownership percentage. However, the carrying value of the investment in Coca-Cola FEMSA increased from $1,786 million in 2023 to $4,544 million in 2024, reflecting the equity method accounting for the investee's performance. The Company's equity income from Coca-Cola FEMSA also rose from $1,691 million in 2023 to $1,770 million in 2024, indicating improved financial performance of the investee and a positive impact on The Coca-Cola Company's consolidated results.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2023, The Coca-Cola Company did not report a 28% ownership stake in Coca-Cola FEMSA — rather, the relationship was described as one of indirect financial dependency due to FEMSA's role as a key bottler affecting credit ratings. The shift to a 28% ownership stake accounted under the equity method is presented as a change occurring by 2024, implying evolution from 2023. However, the LLM claims the stake 'remained at 28%' between 2023 and 2024, which contradicts the ground truth and misrepresents the nature of the relationship's evolution. (2) The quantitative figures — $1,786 million and $4,544 million carrying values, and equity income of $1,691 million and $1,770 million — are entirely absent from the original answer and not supported by the provided knowledge graph. These numbers appear fabricated or hallucinated, failing the quantitative accuracy test. There is no mention of carrying values or specific equity income amounts in the ground truth. (3) The multi-hop reasoning is flawed: the LLM assumes continuity in ownership percentage, whereas the original answer emphasizes a strategic shift from indirect dependency to direct ownership, which is a key qualitative point. The LLM misses this conceptual evolution and instead focuses on unsupported financial metrics. (4) While the LLM correctly identifies the equity method accounting and discusses equity income implications — which aligns thematically with the question — the factual foundation is incorrect. The contextual relevance is moderate because it addresses stake ownership and equity income, but the core facts and reasoning are unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 478,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "Between 2022 and 2023, the financial investment and operational focus on the Lower 48 region showed a mixed trend. Production volumes in the Lower 48 decreased from 52,921 million dollars in 2022 to 38,244 million dollars in 2023, indicating a decline in sales and other operating revenues. However, capital expenditures and investments in the Lower 48 increased from $5,630 million in 2022 to $6,487 million in 2023, reflecting a higher financial investment. Depreciation, depletion, and amortization expenses for the Lower 48 also rose from $4,854 million in 2022 to $5,729 million in 2023, suggesting increased operational focus and asset utilization in the region.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors, particularly in production volumes. The ground truth reports production in physical units—crude oil at 447 thousand barrels per day and natural gas at 1,340 million cubic feet per day in 2022—but the LLM incorrectly states production volumes as dollar amounts (e.g., '52,921 million dollars'), which is a fundamental misrepresentation of the metric. Production volume is not equivalent to revenue or dollar value, so this mischaracterization invalidates the core of the response. (2) While the LLM correctly reports the depreciation, depletion, and amortization (DD&A) expenses—$4,854 million in 2022 and $5,729 million in 2023—it incorrectly frames this as 'depreciation, depletion, and amortization' without including 'impairments,' which is part of the full metric in the original answer. However, the numerical values are accurate and correctly show an increase, supporting the conclusion of increased financial investment. (3) The LLM introduces capital expenditures ($5,630M in 2022 to $6,487M in 2023), which are not mentioned in the original answer, potentially drawing from incorrect or extraneous data. This undermines the qualitative accuracy, as the original reasoning was based on DD&A and production volumes, not capex. (4) Despite these errors, the LLM draws a reasonable qualitative conclusion that financial investment increased due to rising DD&A, which aligns with the original answer’s logic. It also attempts multi-hop reasoning by linking operational output and financial metrics, but the flawed data inputs reduce its validity. (5) Contextually, the answer addresses the evolution of financial and operational focus, so it remains relevant, but the misuse of financial figures and incorrect metrics significantly reduce correctness. Overall, partial credit is given for correct DD&A numbers and directional reasoning, but major deductions are made for incorrect production data and misused metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 535,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "Between 2023 and 2024, Verizon's 4G LTE network continued to play a foundational role in its network infrastructure, particularly as a complement to its 5G expansion. In 2024, the company emphasized leveraging its 4G LTE network alongside its advanced 5G capabilities to provide reliable connectivity, especially for Fixed Wireless Access (FWA) broadband services. While the focus shifted toward 5G deployment and densification, the 4G LTE network remained integral to supporting customer demand for mobility, capacity, and coverage, particularly in areas where 5G adoption was still evolving. Additionally, Verizon's 4G LTE infrastructure contributed to its fiber expansion strategy, enabling the company to offer integrated wireless and wireline broadband solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates (2023–2024), entities (Verizon, 4G LTE network), and core strategic themes. It correctly identifies the foundational role of 4G LTE in 2023, particularly in supporting Fixed Wireless Access (FWA), which aligns with the original answer. The evolution into 2024 is partially accurate: the LLM emphasizes 4G LTE as complementary to 5G and part of an integrated infrastructure, which is consistent with the broader multi-technology ecosystem mentioned in the ground truth. However, the LLM omits specific mention of the C-Band spectrum, millimeter wave spectrum, and fiber integration as explicit components of the strategic evolution, which are key differentiators in the original answer. Additionally, while the LLM references fiber expansion and integrated solutions, it does not fully capture the shift in strategic framing—from a service delivery mechanism to a strategic asset enabling innovation and growth. There are no numerical inaccuracies (quantitative accuracy is perfect, hence 10), and the reasoning is sound but incomplete in synthesizing all elements of the multi-hop evolution. The answer remains contextually relevant and well-structured, addressing the question’s focus on strategic evolution, but lacks full completeness in capturing the depth of the 2024 strategic shift as defined in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 386,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "Emerson's financial and strategic relationship with AspenTech evolved significantly from 2022 to 2024. In 2022, Emerson acquired the Heritage AspenTech business and contributed two of its own software businesses to form \"New AspenTech,\" owning 55% of the shares. By 2024, Emerson increased its ownership to approximately 57% and proposed a full acquisition of the remaining shares at $240 per share. This evolution positively impacted financial metrics: AspenTech's inclusion in 2022 increased its backlog significantly, and the 2023 Heritage AspenTech acquisition contributed to a 3.3 percentage point gross margin increase. However, in 2024, while gross margin remained strong at 50.8%, it was partially offset by acquisition-related inventory step-up amortization. Overall, the strategic integration of AspenTech enhanced Emerson’s Software and Control segment performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key facts. It incorrectly states that Emerson acquired Heritage AspenTech and contributed its software businesses in 2022, whereas the ground truth indicates that Emerson already held a stake in AspenTech in 2022 with a backlog of $1,042 million, and the formation of 'New AspenTech' with 55% ownership occurred by 2024, not 2022. The claim of increasing ownership to 57% in 2024 and proposing a $240 per share acquisition is not supported by the original answer and introduces unverified details. (2) Quantitative inaccuracies include the absence of the correct 2024 backlog figure ($8,053 million), which is a key metric in the original answer. The LLM mentions 'increased backlog significantly' but fails to provide the actual 2024 backlog value or the 2021 baseline ($6,533 million). While the 3.3 percentage point gross margin increase in 2023 is correctly cited, the additional detail about 50.8% gross margin and inventory step-up amortization is not in the ground truth and may be extraneous or speculative. (3) The multi-hop reasoning is partially sound—linking the AspenTech integration to margin improvement and backlog growth—but misrepresents the timeline and ownership evolution. The original answer emphasizes the 2024 completion of the transaction creating New AspenTech with 55% ownership, while the LLM backdates the 55% ownership to 2022 and adds an unsupported increase to 57%. This undermines the accuracy of the strategic evolution narrative. (4) Despite these issues, the LLM answer is contextually relevant and captures the general direction of the relationship’s evolution and financial impact. It correctly identifies the 3.3 percentage point margin boost and ties AspenTech to improved performance, earning moderate scores in qualitative accuracy and high relevance. However, the quantitative and factual errors—especially around ownership timing and missing backlog figures—prevent a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 538,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "NEE's financial commitment to the Mountain Valley Pipeline (MVP) significantly decreased between 2022 and 2023. In 2022, NEE recorded an additional impairment charge to completely write off its investment in MVP, indicating a loss of value and strategic reconsideration. By 2023, the only mention of MVP is a 20-year natural gas transportation agreement with MVP, which includes approximately $70 million per year for equity contributions in 2024. This shift from a direct investment to a more limited transportation agreement suggests a strategic pivot away from direct ownership in MVP, likely due to financial underperformance and regulatory or construction challenges.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claims. Contrary to the ground truth, it falsely states that NEE 'completely wrote off its investment' in the Mountain Valley Pipeline (MVP) in 2022 due to impairment, which contradicts the original answer indicating continued and deepening involvement. The only accurate numeric detail is the $70 million per year transportation agreement, which aligns with the ground truth. However, the claim that this includes 'equity contributions in 2024' is not supported in the original and misrepresents the nature of the agreement. (2) Quantitatively, the $70M/year figure is correct, but the characterization of the 2022 position is factually wrong—there is no mention of a write-off or impairment in the ground truth. Instead, NEE had a 32%-55% ownership stake in 2022, evolving to a precise 32.8% in 2023, which the LLM omits entirely. These percentages are critical for tracking investment evolution and are completely missing or misrepresented. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a strategic retreat from MVP based on a non-existent write-off, whereas the ground truth shows a strategic deepening via long-term contracts and sustained equity investment. The model fails to synthesize the continuity and strengthening of NEE’s commitment, instead inventing a narrative of divestment. (4) Contextual relevance is moderate because the answer addresses NEE and MVP and mentions the transportation agreement, but the overall interpretation is factually inverted. The conclusion about a 'strategic pivot away' is unsupported and directly contradicted by the evidence of increased contractual and investment ties. Thus, while some context is present, the factual foundation is incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 491,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "From 2023 to 2024, Coca-Cola's relationship with Costa Limited has remained integrated within the Global Ventures segment, as Costa's direct sales to consumers continue to be included in this segment. There is no explicit mention of significant changes in operational integration or strategic positioning in the provided pages, indicating that Costa's role and inclusion in the Global Ventures segment have remained consistent during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that there was no significant change in Costa Limited's integration or strategic positioning from 2023 to 2024. The ground truth states that by 2024, Costa was more strategically embedded within the Global Ventures segment, which now also included innocent and doğadan, indicating a broader strategic role and deeper integration. The LLM incorrectly asserts consistency, missing this key evolution. There are no numeric values to evaluate, so quantitative accuracy is not applicable but assumed correct by default (score 10). Qualitative accuracy is low because the model failed to recognize and synthesize the multi-hop information about expanded segment composition and strategic deepening. Contextual relevance is moderate—the answer addresses the right segment and company but draws an incorrect conclusion about continuity versus change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 260,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel's investment in financial institution instruments, specifically the fair value of economically hedged marketable debt investments, decreased from $17.1 billion as of December 30, 2023, to $13.5 billion as of December 28, 2024. This represents a reduction of $3.6 billion over the period. Additionally, in 2024, Intel recorded net losses of $464 million on these hedged investments, contrasting with net gains of $534 million in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant factual inaccuracies that impact overall correctness. (1) Quantitatively, the LLM correctly states the fair value decrease from $17.1 billion in 2023 to $13.5 billion in 2024 and accurately calculates the $3.6 billion reduction. However, it incorrectly claims Intel recorded net gains of $534 million in 2023, which contradicts the ground truth (and known context) that Intel recorded net losses of $748 million in 2022 and $464 million in 2024 — no 2023 gain is mentioned in the original answer, and the $534 million figure is unsupported. This is a critical error in financial performance reporting. (2) The original answer focuses on the evolution from 2022 to 2024, but the LLM omits any mention of 2022 data (the $748 million loss), which is a key part of the multi-hop comparison. Instead, it introduces a false 2023 gain, breaking the longitudinal analysis. (3) The reasoning is partially sound in tracking portfolio size reduction, but the erroneous 2023 gain undermines the trend analysis and suggests a recovery that isn't supported. (4) Entity accuracy (Intel, hedged marketable debt investments, years) is mostly correct, and the contextual relevance is high as the response addresses the evolution of investments. However, the introduction of a fabricated 2023 gain and omission of 2022 losses constitute major factual flaws. Thus, while the portfolio value trend is correctly reported, the income statement impact is wrong, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 422,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "AMT's financial focus regarding communications sites evolved from 2023 to 2024 by emphasizing recurring revenue generation through long-term leases and strategic asset management, particularly in India, where the company initiated a strategic review and entered into the Pending ATC TIPL Transaction to divest its India operations. In terms of asset retirement liabilities, AMT reported an estimated $4.5 billion in undiscounted future cash outlays for asset retirement obligations as of December 31, 2024, reflecting its ongoing commitment to site remediation and compliance with lease agreements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $4.5 billion in undiscounted future cash outlays for asset retirement obligations as of December 31, 2024, which matches the ground truth. It also correctly notes the emphasis on recurring revenue generation, aligning with the 99% of revenue from property operations mentioned in the original answer. However, the LLM introduces information not present in the ground truth—specifically the 'strategic review' and 'Pending ATC TIPL Transaction' related to India operations—which is irrelevant to the question about financial focus evolution regarding recurring revenue and asset retirement liabilities. This extraneous detail distracts from the core evolution described in the original answer. (2) Quantitatively, all numbers and dates are accurate: $4.5 billion and December 31, 2024, are correctly cited. There are no calculation errors. (3) The multi-hop reasoning is partially sound: the model connects recurring revenue and asset retirement liabilities across years, but fails to clearly articulate the shift in focus from revenue (2023) to including liabilities (2024) as a key evolution. Instead, it presents both aspects without clearly framing the change in emphasis. (4) The correctness score is 7 because core financial facts are accurate, but the answer includes irrelevant strategic transactions and lacks clarity on the conceptual shift in financial focus. Quantitative accuracy is perfect. Qualitative accuracy is reduced due to misaligned emphasis and introduction of unsupported details. Contextual relevance is high but slightly diminished by off-topic content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 445,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "Between 2023 and 2024, XOM's strategic positioning in Guyana has evolved with the introduction of the Petroleum Activities Act 2023, which provides a more structured legal operating framework. This Act authorizes the Government of Guyana to license and enter into petroleum agreements, establishing an exploration period typically up to 10 years and a production period of 20 years for oil fields (with a 30-year term for gas fields), each with a potential renewal period of up to 10 years. This legislative development enhances the clarity and stability of the operating environment, supporting XOM's business growth emphasis by providing longer-term certainty for exploration and production activities in the region.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the Petroleum Activities Act 2023 as the legal framework governing XOM's operations in Guyana and accurately describes the exploration period (up to 10 years), production period (20 years for oil, with a note on 30 years for gas), and renewal potential (up to 10 years), which aligns with the ground truth. This earns high marks for quantitative accuracy, though the ground truth does not mention gas fields having a 30-year term, so this is a minor addition not present in the original data—potentially inferred but not confirmed. The answer captures the strengthened legal operating framework, addressing the first part of the question well. However, it fails to fully address the second part regarding XOM's evolving business growth emphasis in 2024. Specifically, the LLM omits that Guyana was elevated to an 'Advantaged Asset' under the 'Advantaged Volume Growth' earnings driver in 2024—a key strategic shift indicating its role as a core growth asset. This missing element represents a significant gap in qualitative accuracy and completeness, as the evolution in strategic positioning is not fully conveyed. While the reasoning around legal stability supporting growth is logical, it does not reflect the actual multi-hop synthesis from legal framework (2023) to strategic portfolio classification (2024) present in the ground truth. Contextual relevance remains high because the answer stays focused on Guyana, XOM, legal framework, and growth implications. Overall, the answer is factually sound on the legal side but incomplete on the strategic business emphasis, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 446,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar's involvement in the diesel-electric locomotives business remained a core part of its Energy & Transportation segment in both 2023 and 2024. In 2024, the segment's sales increased by 3%, driven by favorable price realization, with Transportation sales rising due to growth in marine and rail services. The strategic positioning highlights continued focus on rail-related products and services, including remanufacturing and leasing. Operationally, the segment is responsible for diesel-electric locomotives and components, underscoring Caterpillar's ongoing commitment to this market.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key aspects of Caterpillar's strategic evolution between 2023 and 2024. While it correctly identifies Caterpillar's continued involvement in diesel-electric locomotives through its Energy & Transportation segment, it fails to capture the shift in strategic positioning described in the ground truth—specifically, the 2024 emphasis on integrated systems, electrified powertrains, and zero-emission technologies. Instead, the LLM focuses on sales growth (3%) and operational continuity (remanufacturing, leasing), which are not mentioned in the original answer and appear to be fabricated or misattributed. (2) The 3% sales increase and claim about Transportation sales growth due to marine and rail services are not supported by the ground truth and introduce unverified quantitative data, reducing quantitative accuracy. There are no calculations in the answer, but the inclusion of unsupported percentages harms factual precision. (3) The multi-hop reasoning is weak: the question asks for evolution in strategic positioning and operational responsibilities, requiring comparison across years and synthesis of strategic direction. The LLM does not demonstrate this synthesis accurately—it omits the critical shift toward electrification and environmental focus in 2024 and instead implies continuity without transformation. (4) Contextual relevance is high because the answer stays on topic, references the correct business segment, and discusses locomotives and related operations. However, correctness and qualitative accuracy are reduced due to factual inaccuracies and omission of the core strategic shift, resulting in a partial but misleading picture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 471,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "The company's reliance on securitized debt obligations as a funding source decreased from 2022 to 2024. In 2022, securitized debt obligations accounted for 4% of total funding sources, with a carrying value of $14.994 billion. By 2024, this figure dropped to 4% as well, but the carrying value decreased to $14.264 billion. This slight reduction suggests a modest shift away from securitized debt obligations in favor of other funding sources, such as deposits and other debt, indicating a more diversified funding strategy over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, the company used securitized debt obligations but did not disclose the exact amount. However, the LLM claims a carrying value of $14.994 billion in 2022, which is not supported by the ground truth. Additionally, the LLM states that securitized debt accounted for 4% of total funding in both years, but this percentage is not mentioned or inferable from the original answer. While the 2024 carrying value of $14,264 million ($14.264 billion) is correct, the 2022 figure is fabricated. (2) The quantitative accuracy is low because the model invents precise numbers (e.g., $14.994 billion in 2022, 4% shares) that are not in the ground truth. The only correct number is the 2024 carrying value. There is no basis for the claimed decrease or percentage allocations. (3) The reasoning is flawed: the original answer suggests increased clarity and possibly greater reliance on securitized debt due to its quantification in 2024, while the LLM incorrectly infers a 'decrease' and 'shift away' based on unsupported data. The multi-hop synthesis fails because the model does not correctly interpret the absence of 2022 figures as a lack of disclosure rather than an implied lower value. (4) Contextual relevance is moderate because the answer addresses the evolution of funding strategy and mentions securitized debt obligations correctly as a funding source, but the conclusions are based on false premises. The mention of deposits and other debt as alternatives is speculative and not in the original. Overall, the answer contradicts the ground truth in both data and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 461,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "Between 2023 and 2024, McDonald's treatment of developmental licensees evolved in terms of financial reporting and relationship management as follows:\n\n1. **Financial Reporting**: The number of developmental licensed restaurants increased from 8,684 in 2023 to 9,247 in 2024, indicating expansion in this segment. Financially, the Company continues to report revenues from developmental licensees as royalties based on a percentage of sales, with initial fees recognized over the franchise term. The Company also acquired additional restaurants from developmental licensees in 2024, which contributed to goodwill and intangible assets, though these acquisitions were not material to overall revenues or net income.\n\n2. **Relationship Management**: McDonald's maintains a franchising model where developmental licensees operate under license agreements and pay royalties. The Company's focus on developmental licensees is part of its broader growth strategy, including the Restaurant Development pillar introduced in 2023. This is reflected in the increased number of developmental licensed restaurants and the Company's ongoing evaluation of renewal options to support long-term growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces information not present in the ground truth. Specifically, the claim that the number of developmental licensed restaurants increased from 8,684 in 2023 to 9,247 in 2024 is not supported by the original answer, which does not mention any such figures or numerical changes in restaurant count. Additionally, the LLM states that McDonald's acquired additional restaurants from developmental licensees in 2024, contributing to goodwill and intangible assets, which is absent from the ground truth and represents a significant fabrication. (2) Quantitative accuracy is low because the key numbers (8,684 and 9,247) are incorrect and unsupported. There are no calculations in the ground truth to verify, but the introduction of false metrics undermines numerical precision. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies that royalties are based on a percentage of sales and initial fees are involved (partially aligning with 2023 disclosure), it fails to mention the key 2024 update about evaluating variable interest entities and the change in rounding policy to the nearest whole number—both central to the evolution in financial reporting. Instead, it invents details about acquisitions and growth strategy impacts not present in the source. (4) Contextual relevance is moderate because the answer addresses the general theme of financial reporting and relationship management with developmental licensees, and correctly references ongoing franchise agreements and royalty models. However, it misses the actual evolution described in the ground truth—particularly the accounting evaluation for consolidation and presentation changes—while adding irrelevant details about restaurant acquisitions and growth pillars. Overall, the answer is partially correct in broad strokes but fails on key factual and multi-hop synthesis points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 523,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "Between 2023 and 2024, Southern Company's Equity and Incentive Compensation Plan saw an increase in share availability, with 26.9 million shares available for awards under the plan as of December 31, 2023, and the plan being amended and restated effective May 26, 2021. Additionally, the 2024 filings indicate the inclusion of the ninth amendment to the Southern Company Employee Savings Plan, dated December 16, 2024, and the continued use of the 2021 Equity and Incentive Compensation Plan for executive awards.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 26.9 million shares were available as of December 31, 2023, which matches the ground truth. However, it incorrectly implies that share availability increased between 2023 and 2024 without providing any 2024 share availability number, whereas the original answer does not mention an increase in shares but rather a shift in disclosure practices. The date 'May 26, 2021' is correctly cited as the effective date of the 2021 Equity and Incentive Compensation Plan, but the LLM misattributes the amendment timing by referencing a December 16, 2024 amendment to the Employee Savings Plan — a different plan altogether — which is irrelevant to the question about the Equity and Incentive Compensation Plan. (2) Quantitatively, the 26.9 million figure is accurate, and the dates are correctly formatted and referenced where they appear in context, but the lack of a 2024 share count and introduction of an unrelated amendment hurt accuracy. (3) The multi-hop reasoning is flawed: the question asks for evolution in *share availability* and *executive award disclosures*, but the LLM fails to mention the key 2024 development — increased transparency in disclosing specific terms for Named Executive Officer awards — which is central to the ground truth. Instead, it diverts to an unrelated savings plan amendment. (4) While the LLM captures part of the factual baseline (share availability in 2023 and use of the 2021 plan), it misses the core qualitative evolution — enhanced disclosure in 2024 — and introduces irrelevant information, leading to a partial but misleading answer. Hence, correctness is moderate due to accurate numbers but incomplete and somewhat misdirected reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 469,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Inlyta's revenue increased by 3% in 2023 compared to 2022, with a 5% operational growth in the U.S. driven by the adoption of combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced RCC. However, this growth was partially offset by lower volumes and lower net price in certain European markets. Globally, the growth was primarily due to continued adoption in developed markets and growth in emerging markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Inlyta's revenue grew by 3% in 2023 with 5% operational growth, matching the ground truth. The $1,036 million global revenue figure is omitted but the percentage growth metrics are accurate. The drivers of growth—adoption of immune checkpoint inhibitor combinations for first-line advanced RCC in the U.S.—are correctly identified. It also accurately notes that lower volumes and net prices in certain European markets partially offset growth. (2) Quantitative accuracy is high: the 3% total growth and 5% operational growth are correctly reported. The only missing numeric detail is the absolute revenue value ($1,036 million), which is not repeated in the LLM answer but does not invalidate the correctness of the growth rates. No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes performance trends from 2022 to 2023 and correctly attributes the growth trajectory shift to regional dynamics and clinical adoption patterns. It links U.S. growth to specific treatment combinations and contrasts this with European headwinds. (4) The answer is contextually fully relevant and semantically equivalent to the ground truth, with only minor omission of the exact dollar amount. Wording differs slightly (e.g., 'developed and emerging markets' vs. original's focus on U.S. and international), but the core facts and synthesis are accurate. A score of 9 is justified due to the omission of the $1,036M figure, though the percentage-based analysis remains fully correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 425,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "From 2023 to 2024, McDonald's relationship with its franchisees has evolved in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms. The Company recognizes revenue from franchisees for technology platforms on a gross basis, as it is the principal in these arrangements, with related expenses recognized as incurred. This indicates that the Company is increasingly involved in providing distinct technology services to franchisees, which are separate from the franchise agreement. The financial structure reflects a shift toward the Company bearing the upfront costs of these technology platforms, with franchisees reimbursing a portion of these costs, thereby sharing in the expenses. This evolution suggests a more integrated operational and financial relationship with franchisees, leveraging technology to enhance performance while maintaining the core franchising model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the shift in revenue recognition to gross basis for technology services, McDonald's role as principal, and the recording of related expenses in operational costs (referred to as 'Other restaurant expenses' in the original). The description of increased financial and operational integration with franchisees through technology platforms is consistent. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly infers that recognizing revenue on a gross basis implies McDonald's bears upfront costs and that franchisees share in cost recovery, indicating deeper interdependence. This reflects synthesis across financial reporting concepts and business model evolution. (4) The only minor gap is that the LLM does not explicitly mention the 2023 baseline in detail (e.g., rent, royalties, initial fees), though it implies a shift from a prior model. Also, the original specifies that the change reflects a 'stronger dependency' on franchisees, while the LLM frames it as shared cost and service provision—slightly different emphasis but semantically aligned. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 400,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives held by Southern Company's subsidiaries decreased from $199 million to $55 million in assets and increased from $210 million to $358 million in liabilities. This shift indicates a growing net liability position, suggesting increased exposure to energy market fluctuations, particularly in derivative contracts used for hedging or trading purposes. The company's exposure appears to have risen, reflecting potential volatility in energy prices or expanded derivative activity during the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, in 2022, the total assets from energy-related derivatives were $59M (Mississippi Power) + $8M (Southern Power) + $28M (Southern Company Gas) = $95M, not $199M as stated. Total liabilities in 2022 were $32M + $12M + $65M = $109M, not $210M. The LLM incorrectly reports both asset and liability totals by nearly double. In 2023, the subsidiaries reporting data shifted: Alabama Power reported $15M assets and $110M liabilities, and Georgia Power reported $13M assets and $124M liabilities. Total assets = $28M, total liabilities = $234M. The LLM reports $55M in assets and $358M in liabilities—both figures are incorrect. The net liability in 2022 was $109M - $95M = $14M (not $54M as stated in the original answer, though the original answer miscalculates this as well—it should be $109M - $95M = $14M, not $54M). However, the original answer states a net liability of $54M in 2022, which appears to be based on $199M assets - $253M liabilities? This suggests possible internal inconsistency in the ground truth. Still, the LLM’s numbers do not align with any plausible sum from the provided subsidiaries. (2) Calculations are fundamentally flawed: the LLM claims assets dropped from $199M to $55M and liabilities rose from $210M to $358M, but these totals are unsupported by the data. The actual net liability increased from approximately $14M (correct calculation from ground truth components) to $206M ($234M - $28M), indicating a real increase in exposure, but the LLM’s magnitude is based on false inputs. (3) Multi-hop reasoning is partially sound—the LLM correctly infers that increasing liabilities and decreasing assets indicate greater exposure to energy market fluctuations. It identifies the directional trend (increased net liability) correctly, though based on wrong numbers. However, it fails to identify the correct subsidiaries involved (e.g., mentions no specific subsidiaries, omits Mississippi Power, Southern Power, Southern Company Gas in 2022, and misattributes 2023 data). (4) Contextual relevance is acceptable—the answer addresses the evolution of fair value and interprets the implication for market exposure. But due to severe quantitative errors and incorrect entity aggregation, the correctness score is low. The qualitative reasoning is somewhat logical but built on false premises. Final scores reflect major factual flaws in numbers and incomplete entity accuracy, despite correct general direction of interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 683,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "The Procter & Gamble 2019 Stock and Incentive Compensation Plan remained the sole active plan allowing future grants of securities in both 2022 and 2024. However, the shares available for future issuance under the plan decreased from 119 million in 2022 to 77 million in 2024, indicating increased utilization of the plan's share allocation over this period. The maximum share capacity of 187 million remained unchanged, but the reduction in available shares highlights a greater allocation of equity compensation under the 2019 Plan in recent years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces specific quantitative details not present in the ground truth. (1) The ground truth describes a qualitative evolution in disclosure context—how the 2019 Plan moved from being newly introduced in 2022 to being treated as a standard part of equity compensation by 2024. The LLM, however, asserts precise share numbers (119 million in 2022, 77 million in 2024, 187 million maximum), which are not mentioned or implied in the original answer. There is no support for these figures in the ground truth, making the quantitative claims fabricated. (2) The claim that the 2019 Plan was the 'sole active plan allowing future grants' is not supported by the original answer, which only states the plan became part of a broader set of equity compensation plans. This misrepresents the company's plan structure. (3) The multi-hop reasoning is flawed: the original answer focuses on disclosure language and integration into reporting, while the LLM shifts to unverified metrics about share utilization. (4) While the LLM attempts to show evolution (from 2022 to 2024), it does so using incorrect data and a narrow, unsupported interpretation. The contextual relevance is moderate because it addresses the time frame and plan significance, but the factual foundation is unsound. Thus, the correctness score is low due to major factual and quantitative inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 386,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "From 2023 to 2024, Southern Company's approach to managing the risk of large losses in its pension plan assets remained focused on diversification and formal rebalancing programs, as outlined in both years' disclosures. However, in 2024, there was a slight shift in risk management emphasis, with increased allocations to private credit and infrastructure, indicating a greater focus on alternative assets with stable cash flows and income generation. Additionally, the 2024 disclosures highlight a more detailed discussion of the use of Net Asset Value (NAV) as a practical expedient for valuing private investments, reflecting a stronger emphasis on liquidity management and transparency in non-publicly traded assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no numeric data, so there are no quantitative inaccuracies—this aspect is neutral. However, the qualitative content diverges significantly from the ground truth. The original answer states that Southern Company maintained diversification and rebalancing but reduced emphasis on external manager oversight in 2024, shifting focus toward market volatility and interest rate risks. In contrast, the LLM answer incorrectly claims an increased allocation to private credit and infrastructure and emphasizes NAV usage for valuation and liquidity management—details not present in the ground truth. These points represent fabricated or misattributed strategic shifts. (2) There are no numbers to verify, so quantitative accuracy is not penalized. (3) The multi-hop reasoning is flawed: the LLM fails to identify the correct evolution in risk management emphasis (from active oversight to market-driven exposure) and instead invents a narrative around alternative assets and NAV, which is unsupported by the original data. This indicates a failure in synthesizing the correct information across years. (4) While the answer addresses the general topic of risk management in pension assets and mentions continuity in diversification and rebalancing (which aligns with the original), the core shift described is factually incorrect. Thus, the correctness and qualitative accuracy scores are low despite acceptable structure and partial relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 407,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's role in the development and supply of the CUDA platform evolved from being a foundational element of its accelerated computing ecosystem to a more integrated and expanded component of its full-stack computing infrastructure. In 2022, CUDA was highlighted as a key parallel programming model that enabled performance acceleration across a wide range of applications, including AI, data analytics, and scientific computing. By 2023, CUDA was positioned as a central pillar of NVIDIA's unified architecture, underpinning not only its GPU-based solutions but also its broader data-center-scale offerings, including CPUs and DPUs. This shift indicates that NVIDIA is strategically focusing on reinforcing its leadership in AI and accelerated computing by deepening its software ecosystem and expanding the reach of CUDA across diverse markets and technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: NVIDIA's role evolved from supplier in 2022 to a more active developer role in 2023, with CUDA becoming a central part of its full-stack computing infrastructure. The mention of CUDA-X, APIs, and domain-specific frameworks is implied through 'broader software ecosystem' and 'unified architecture,' though not explicitly named—this is a minor omission. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2022 and 2023), which are accurate. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution of NVIDIA’s role and infers the strategic intent behind the shift—strengthening its full-stack platform and software ecosystem to dominate AI and data center computing. (4) The answer is contextually excellent, directly addressing both parts of the question: the evolution of NVIDIA's role and the strategic implications. The only reason for not scoring a 10 is the lack of explicit mention of CUDA-X libraries and domain-specific frameworks, which are part of the original answer and represent specific evidence of the development-focused shift. However, the LLM captures the semantic essence and strategic significance accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 379,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Between 2022 and 2023, Pfizer's financial relationship with Viatris, stemming from the 2020 separation of the Upjohn business and its combination with Mylan to form Viatris, remained largely stable in terms of supply agreements and outstanding balances. The supply and manufacturing agreements (MSAs) between the two companies, which range in initial duration from four to seven years post-separation, continued to facilitate the manufacturing, labeling, and packaging of products for each other. As of December 31, 2023, the net amounts due to Viatris under these agreements were $33 million, compared to $94 million as of December 31, 2022, indicating a reduction in outstanding balances over the period. The cash flows related to these agreements were primarily included in operating activities, with no material changes reported in operations during 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the reduction in net amounts due to Viatris from $94 million as of December 31, 2022, to $33 million as of December 31, 2023, which matches the ground truth exactly. It also accurately reflects the ongoing nature of supply agreements post-separation. However, it omits the key point from the original answer that in 2022, Pfizer reported $780 million in revenue growth from PC1 due to manufacturing legacy Upjohn products for Viatris — a significant quantitative and qualitative detail about the financial relationship’s evolution. (2) All provided numbers are accurate: $94M and $33M balances are correctly cited with proper dates; no calculation errors. (3) The reasoning is sound in noting the decline in outstanding balances and continued operation of MSAs, but fails to fully synthesize the multi-hop aspect — specifically, the shift from significant revenue generation in 2022 to reduced interdependence by 2023. The mention of TSAs being mostly completed by end of 2023 (from ground truth) is missing in the LLM answer, weakening the conclusion about reduced operational interdependence. (4) Scores reflect high factual accuracy on provided data (quantitative accuracy = 10), minor gaps in completeness and reasoning synthesis (qualitative accuracy = 8), full relevance to the question (contextual relevance = 10), and overall correctness docked slightly for missing a core revenue figure and transition context (correctness = 8).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 410,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "Between 2023 and 2024, the treatment and disclosure of communications sites in relation to debt obligations evolved with a greater emphasis on financial ratios and restrictions tied to cash flow distributions. In 2023, the focus was on securitization structures, debt repayment, and compliance with covenants, particularly around debt service coverage ratios (DSCR) and amortization periods. By 2024, the disclosures expanded to include more detailed metrics, such as specific DSCR thresholds (e.g., 1.30x for cash trap conditions and 1.15x for amortization periods), capacity for decreases in net cash flow before triggering these conditions, and the impact of these restrictions on liquidity and distributions. Additionally, 2024 disclosures highlighted the potential consequences of non-compliance, such as the diversion of excess cash flow to debt repayment and the risk of asset foreclosure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) It introduces financial ratios (e.g., DSCR of 1.30x and 1.15x), cash flow restrictions, and compliance mechanisms that are not mentioned in the original answer and have no support in the provided ground truth. These details appear fabricated or hallucinated. (2) Quantitatively, the LLM omits all correct figures from the original answer: the 3,343 communications sites, the $1.3 billion repayment via 2023 Securitization, and the $4.5 billion in asset retirement obligations as of December 31, 2024. Instead, it invents specific thresholds and metrics with no basis in the source. (3) The multi-hop reasoning is flawed: the original answer describes a shift from site-specific collateral disclosures (2023) to broader financial obligations (2024); the LLM instead pivots to debt covenants and cash flow triggers, missing the core evolution entirely. (4) While the answer is framed around debt obligations and disclosures—making it contextually relevant—the substance is factually inaccurate. The shift described in the original answer (from specific site collateral to general obligations) is completely absent. The LLM invents a narrative about evolving covenant disclosures that is unsupported by the evidence. Thus, despite addressing the general topic, the answer fails on correctness, quantitative accuracy, and qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 391,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "Comcast's approach to retransmission consent agreements between 2022 and 2023 remained consistent in terms of revenue recognition, with fees from NBC and Telemundo retransmission consent agreements being recognized as part of distribution revenue. These agreements, along with associated fees from affiliated local broadcast stations, contributed to monthly subscription-based revenue streams. In 2023, the company emphasized multiyear distribution agreements, which align with broader trends in securing long-term rights and distribution commitments. No significant changes in revenue recognition methods or distribution models were noted during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the evolution of Comcast's retransmission consent approach between 2022 and 2023. (1) It incorrectly states that there were 'no significant changes' in revenue recognition or distribution models, which directly contradicts the ground truth: in 2023, Comcast explicitly expanded retransmission fee structures to include both traditional and virtual multichannel video providers and integrated Peacock into the distribution ecosystem, indicating a strategic shift. (2) While no specific dollar amounts or percentages are mentioned in either answer, the LLM correctly notes subscription-based revenue and distribution revenue recognition, supporting a quantitative accuracy score of 8. However, the absence of numeric discrepancies does not compensate for qualitative errors. (3) The multi-hop reasoning is flawed: the question asks for an evolution between years, requiring comparison and synthesis across filings. The LLM fails this synthesis by asserting consistency where there was a documented strategic shift. It also omits key developments like the hybrid linear-streaming model and Peacock integration. (4) Contextual relevance is moderate because the answer discusses retransmission consent and revenue recognition, but it misses the core of the question—how the approach evolved. The mention of 'multiyear distribution agreements' is plausible but not supported as a change from 2022 to 2023 in the ground truth. Overall, major factual and reasoning deficiencies result in a low correctness score despite acceptable terminology and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 442,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives remained consistent from 2023 to 2024, as both the 2023 and 2024 10-K filings describe the company's continued focus on manufacturing and offering diesel-electric locomotives as part of its Energy & Transportation segment. In 2024, Caterpillar emphasized its broader strategy, including sustainability, while maintaining its role in rail-related products and services, including remanufacturing and leasing. The 2024 filing also highlighted the company's ongoing investments in electrified powertrains and zero-emission technologies, suggesting a strategic evolution toward diversifying its locomotive offerings to include more sustainable solutions alongside traditional diesel-electric models.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Caterpillar's involvement 'remained consistent' from 2023 to 2024. The ground truth shows a clear evolution: in 2023, diesel-electric locomotives were part of the ME&T segment with a focus on remanufacturing and support, while in 2024, the company explicitly stated it 'produces' diesel-electric locomotives under the Energy & Transportation segment, indicating a more direct and strategic role. The LLM incorrectly asserts consistency, missing this key shift. Additionally, the LLM introduces information not present in the ground truth, such as 'sustainability' emphasis and 'zero-emission technologies' as part of the 2024 evolution, which were not cited in the original answer. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is flawed: the model failed to correctly synthesize the change in segment structure (ME&T to Energy & Transportation) and the shift from operational inclusion to explicit production. It also failed to note the new mention of competitors (Wabtec, Siemens Mobility) in 2024, a key indicator of strategic positioning. Instead, it inferred a sustainability-driven evolution not supported in the ground truth. (4) Correctness is low (3/10) due to major factual inaccuracies in the central claim. Quantitative accuracy is 10/10 by default (no numbers). Qualitative accuracy is low (3/10) due to incorrect reasoning and entity synthesis. Contextual relevance is moderate (6/10) as the answer discusses related topics (locomotives, segments, services) but misrepresents the nature of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 470,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees in terms of revenue recognition and cost-sharing arrangements remained largely consistent, with a few notable developments. Revenue recognition continued to follow the same principles, with royalty revenues based on a percentage of franchisee sales and recognized at the time of the underlying sales. McDonald's also continued to share in the cost of certain restaurant improvements with franchisees, allocating costs between property and equipment and accounts receivable based on responsibility. However, in 2024, McDonald's acquired additional restaurants from franchisees, particularly in Israel, as part of key franchising initiatives. These acquisitions added $240 million of goodwill and did not significantly impact the Company's revenues or net income. Overall, the structure of revenue recognition and cost-sharing arrangements with franchisees remained stable, with no material changes in the financial impact of these relationships.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that McDonald's revenue recognition model remained largely consistent between 2023 and 2024, which aligns with the ground truth. However, it misses key qualitative developments in 2024, particularly the more detailed disclosures around revenue recognition, such as the treatment of technology platform fees being presented on a gross basis in the Consolidated Statement of Income. This is a significant omission in the evolution of revenue recognition practices. Additionally, while the LLM mentions cost-sharing for restaurant improvements, it fails to note that in 2024, McDonald's clarified the accounting treatment—allocating costs between Property and Equipment and Accounts Receivable during the project and finalizing upon completion—a level of detail absent in 2023 and highlighted in the ground truth as a transparency improvement. Instead, the LLM introduces information not present in the original answer: the acquisition of restaurants in Israel and $240 million of goodwill. While potentially factually accurate from another source, this information is not part of the ground truth derived from the knowledge graph and distracts from the core question about revenue recognition and cost-sharing evolution. (2) The $240 million goodwill figure is presented without context or source in the LLM answer and does not appear in the ground truth, making it unverifiable and potentially misleading. There are no calculations in the response, so quantitative accuracy is moderate—no incorrect numbers related to revenue recognition or cost-sharing are given, but the introduced $240M figure lacks support. (3) The multi-hop reasoning is partially sound—comparing 2023 and 2024 disclosures on franchisee arrangements—but fails to synthesize the correct nuances from the filings. The model identifies continuity but misses the key evolution in disclosure granularity and accounting treatment. Introducing unrelated acquisitions undermines the reasoning chain. (4) Correctness is scored at 5 due to partial factual alignment but major omissions in critical 2024 changes and inclusion of extraneous, unsupported details. Quantitative accuracy is 6 because no direct number errors in core topics, but the ungrounded $240M reduces confidence. Qualitative accuracy is 5 due to correct high-level stability claim but failure to capture nuanced improvements in transparency. Contextual relevance is 8 because the response stays focused on franchisee financial arrangements, even if it veers into unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 679,
        "total_tokens": 2189
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "Between 2023 and 2024, Southern Company updated its executive equity compensation approach by amending plan documentation, particularly in the terms of equity awards. In 2024, the company introduced the \"Ninth amendment to the Southern Company Employee Savings Plan,\" dated December 16, 2024, indicating a revision to savings plan structures. Additionally, the \"Form of Terms for Named Executive Officer Equity Awards\" under the 2021 Equity and Incentive Compensation Plan was updated, suggesting refinements in award terms for executives. These changes reflect a focus on aligning long-term incentives with company performance and retirement eligibility provisions.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct information but includes significant inaccuracies and misalignments with the ground truth. (1) Correct elements: The mention of updated 'Form of Terms for Named Executive Officer Equity Awards' under the 2021 Equity and Incentive Compensation Plan aligns with the ground truth's emphasis on more structured and documented executive award terms in 2024. The general direction of increased formalization and alignment with performance is consistent. (2) Quantitative accuracy: The date 'December 16, 2024' for the 'Ninth amendment to the Southern Company Employee Savings Plan' is problematic — it refers to a future date relative to the 2024 filing period and is unrelated to equity compensation (it concerns a savings plan, not executive equity). This is a factual error. The ground truth does not mention any ninth amendment or savings plan in this context. (3) Multi-hop reasoning: The LLM fails to correctly synthesize the evolution from 2023 to 2024. While it notes changes in 2024, it omits the key 2023 baseline (that PSUs and RSUs were granted under the plan broadly, without specific executive-level formalization). It also introduces an irrelevant document (savings plan amendment) that undermines the reasoning. The ground truth emphasizes documentation practices like specific exhibits for award terms being introduced in 2024 — a point the LLM only partially captures by referencing updated forms, but without linking it to improved transparency or exhibit designation. (4) The answer is contextually relevant to executive equity evolution but misdirects focus toward an unrelated plan. It lacks completeness by not contrasting 2023's general approach with 2024's executive-specific formalization. Overall, the core idea of increased structure is present, but factual errors and missing synthesis reduce accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 502,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "Procter & Gamble's strategic reliance on membership club stores has increased from 2022 to 2024, reflecting a broader shift toward optimizing retail channel performance and adapting to evolving consumer preferences. This shift indicates that P&G is prioritizing high-volume, cost-efficient distribution channels to enhance market reach and maintain competitive positioning amid a dynamic retail landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the increased strategic reliance on membership club stores from 2022 to 2024, aligning with the ground truth's core claim of a shift from identifying these stores as one of many channels to emphasizing dependency. There are no numeric values in the question or answer, so quantitative accuracy is not applicable in a traditional sense, but all temporal references (2022 to 2024) are accurate, warranting a full score. The answer captures the essence of P&G’s evolving retail channel strategy—prioritizing high-volume, cost-efficient channels—as a response to consumer behavior and market dynamics, which is semantically consistent with the original answer. However, it omits the specific contextual detail that in 2022, membership clubs were listed among a broad set of partners (mass merchandisers, grocery, e-commerce), which provides a clearer baseline for the evolution. While the LLM infers strategic prioritization correctly, it does not explicitly reflect the change in language used by P&G (from inclusion to emphasis/dependency), which is a key multi-hop insight from the original. This minor omission in narrative precision slightly weakens the qualitative accuracy. Nonetheless, the answer remains contextually relevant and factually sound in its overall interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 365,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "AMT's involvement with Nigeria Letters of Credit decreased between 2023 and 2024, as the 2024 filing indicates no outstanding carrying value in USD for the Nigeria Letters of Credit, whereas in 2023, they had a USD carrying value of $3.4 million. This suggests that AMT either fully settled its obligations related to these instruments or no longer had active letters of credit in Nigeria by the end of 2024, indicating a reduction in its financial exposure tied to this instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $3.4 million obligation in 2023 and $0 in 2024 are accurately reported, with acceptable phrasing variations (e.g., 'no outstanding carrying value' = $0). (2) The answer correctly identifies the reduction in financial obligation, which reflects the core evolution between the years. (3) The reasoning is sound: the conclusion that AMT either settled or exited the obligations is logically derived from the drop in carrying value, matching the multi-hop synthesis required (tracking the same instrument across two years and inferring financial implications). (4) The only minor shortcoming is that the LLM uses slightly more cautious language ('either fully settled... or no longer had active') compared to the original answer's definitive 'fully settled or otherwise exited.' However, this does not constitute an error—just a slightly more conservative interpretation—so the qualitative accuracy is still high. All parts of the question are addressed: evolution over time and implications for financial obligations. Contextual relevance is perfect, with no extraneous or missing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 342,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "Between 2022 and 2024, the valuation methodology and composition of GD's Retirement Annuity Contracts remained consistent in being classified as Level 3 assets due to the use of significant unobservable inputs. However, the fair value of these contracts decreased from $38 million in 2022 to $22 million in 2024. This reduction suggests a decline in the value of these specific retirement annuity assets over the period. The continued classification under Level 3 indicates that GD maintains a conservative and transparent approach to reporting these assets, acknowledging the uncertainty and subjectivity involved in their valuation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the fair value was $35 million as of December 31, 2021, and $38 million as of December 31, 2020 — not $38 million in 2022 as claimed. There is no mention of a $22 million value in 2024 in the original answer, making this figure entirely incorrect. (2) The quantitative inaccuracies are severe: the LLM invents a decrease from $38M to $22M with no basis in the provided truth, which does not report a 2024 fair value at all. The original answer focuses on a methodological shift, not a valuation trend. (3) The reasoning is flawed: the LLM claims the classification remained consistent without acknowledging the key change — that by 2024, the contracts were valued using NAV as a practical expedient and excluded from the formal fair value hierarchy, which is the central point of the original answer. This represents a failure in multi-hop reasoning, as the model missed the shift in reporting methodology entirely. (4) While the LLM correctly identifies that Level 3 was involved in 2022, it fails to report the critical update in 2024 about NAV usage and exclusion from the hierarchy, rendering the qualitative analysis incorrect. The contextual relevance is moderate because it discusses valuation and reporting, but misses the core insight about methodology evolution. Thus, scores are low on correctness and accuracy due to invented numbers and missed conceptual changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 408,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "The composition and value of restricted cash for securitization investors remained relatively stable between 2022 and 2024, with a slight decrease from $458 million in 2022 to $441 million in 2024. In terms of fair value hierarchy classification, restricted cash for securitization investors was consistently classified entirely under Level 1 for both years, indicating that it is valued using unadjusted quoted prices for identical assets in active markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the 2024 restricted cash value of $441 million matches the ground truth, the 2022 value of $458 million is incorrect — the original answer does not specify a dollar amount for 2022, only that restricted cash was reported as part of consolidated VIEs without explicit fair value hierarchy details. The LLM incorrectly asserts that the amount was $458 million in 2022, introducing a number not present in the source. (2) More critically, the LLM claims that restricted cash was 'consistently classified entirely under Level 1 for both years,' which directly contradicts the ground truth stating that in 2022, the fair value hierarchy was 'not explicitly detailed.' This misrepresents the evolution of valuation transparency — a key point in the original answer. The shift from unspecified hierarchy in 2022 to full Level 1 classification in 2024 is a central change, but the LLM incorrectly minimizes this development by asserting consistency. (3) The multi-hop reasoning is flawed: the model fails to recognize that absence of fair value hierarchy disclosure in 2022 implies it cannot be assumed to be Level 1. This undermines the synthesis across years. (4) Despite these errors, the answer is contextually relevant and addresses the right topic and metric. The $441 million figure for 2024 and Level 1 classification are correct, and the slight decrease narrative would follow if the 2022 number were accurate. However, the introduction of an unsupported 2022 value and the erroneous claim of consistent classification significantly reduce factual correctness. Quantitative accuracy is partially correct due to the valid 2024 number but penalized for the fabricated 2022 figure. Qualitative accuracy suffers due to incorrect reasoning about disclosure changes. Contextual relevance remains high as the structure and intent align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 520,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management through increased acquisitions of franchisee-owned restaurants and continued emphasis on franchisee cost responsibilities. In 2024, the Company acquired 228 restaurants in Israel and other locations, resulting in $240 million of goodwill and $150 million of net tangible assets, reflecting a strategic shift to support franchising initiatives. Additionally, franchisees continue to bear the majority of occupancy costs (e.g., property taxes, insurance) for franchised locations, maintaining the financial separation between Company-owned and franchised operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, McDonald's acquired restaurants from franchisees, leading to goodwill write-offs and use of discounted cash flow for valuation. In 2024, the relationship shifted to a service-based model with technology platform services provided to franchisees, with revenue recognized on a gross basis and expenses in 'Other restaurant expenses.' However, the LLM answer incorrectly claims that in 2024, McDonald's acquired 228 restaurants in Israel and other locations, resulting in $240 million of goodwill and $150 million of net tangible assets—this specific transaction is not mentioned in the ground truth and appears fabricated. There is no mention of Israel or these exact numbers in the original answer. (2) Quantitative accuracy is very low: the dollar amounts ($240M goodwill, $150M net tangible assets) and the number of restaurants (228) are not supported by the ground truth, which does not provide specific figures for acquisitions. The LLM invents precise numbers where none were given, failing basic quantitative accuracy. (3) The multi-hop reasoning is flawed. The question asks about the evolution in financial recognition and asset management. The ground truth emphasizes a shift from asset acquisition (and associated goodwill) to ongoing service-based financial interactions via technology services. The LLM completely misses this conceptual shift and instead doubles down on asset acquisition, which contradicts the actual evolution described. It fails to mention the critical change in revenue recognition (gross basis) or the expense classification in 'Other restaurant expenses,' both key qualitative shifts. (4) Contextual relevance is moderate because the answer discusses franchisee relationships, financial recognition, and asset management, which are on-topic. However, it misrepresents the nature of the evolution, focusing on fabricated acquisition data rather than the actual transition to a dependency-based service model. The core message of the original answer—shift from ownership to service provision—is entirely missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 577,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "The 2019 Stock and Incentive Compensation Plan remains the primary vehicle for equity compensation at Procter & Gamble, with no new plans introduced between 2022 and 2024. In both years, the 2019 Plan is the only active plan allowing future grants, with a maximum of 187 million shares, and full value awards like RSUs/PSUs counted more conservatively (five shares per share awarded). In 2024, the remaining shares available for future issuance under the 2019 Plan decreased from 119 million in 2022 to 77 million, reflecting increased utilization of the plan. The disclosures also confirm that older plans, such as the 2001 and 2014 plans, are no longer used for new grants, consolidating the role of the 2019 Plan as the central mechanism for equity compensation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and plan status. The ground truth indicates a shift in disclosure focus from governance (2022) to strategic ownership structure (2024), but the LLM instead emphasizes numerical changes and plan exclusivity not present in the original. Key errors include: (1) The claim that the 2019 Plan has a maximum of 187 million shares is unsupported by the ground truth, which does not mention share limits; (2) The reported decrease in available shares from 119 million (2022) to 77 million (2024) is specific but not corroborated in the original answer, which focuses on qualitative disclosure evolution, not quantitative utilization; (3) The assertion that the 2019 Plan is the 'only active plan allowing future grants' and that older plans like 2001 and 2014 are inactive goes beyond the original, which states the 2019 Plan is among active plans and references the 2014 Plan in conjunction with it, suggesting possible continued relevance. While the LLM correctly identifies the 2019 Plan as central to equity compensation and notes its continued use, it fabricates precise numbers and overstates consolidation, missing the core theme of evolving disclosure emphasis from procedural to strategic framing. The reasoning is partially sound in tracking plan usage over time but fails the multi-hop requirement to compare disclosure language and intent across years. Contextually, it addresses the question's focus on plan evolution and equity role, but with incorrect supporting data, reducing overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 436,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "Salvatore Ferragamo's presence in Simon Property Group's international outlet locations expanded between 2022 and 2023. In 2022, Ferragamo was listed at Punta Norte Premium Outlets in Mexico and Yeoju Premium Outlets in South Korea. By 2023, Ferragamo's presence expanded to additional international locations, including Las Vegas Outlets in the U.S., Siam Premium Outlets in Thailand, and Johor Premium Outlets in Malaysia. This indicates a broader geographic reach for the brand within Simon Property Group's international portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The original answer states that Salvatore Ferragamo was present in three Japanese outlets in 2022 (Gotemba, Kobe-Sanda, Sano) and only in one U.S. location (Las Vegas Outlets North) in 2023, indicating a reduction. The LLM claims expansion from Mexico and South Korea in 2022 to additional locations in the U.S., Thailand, and Malaysia in 2023—none of which aligns with the ground truth. (2) Quantitative accuracy is severely lacking: the number of locations (3 in 2022, 1 in 2023) is misrepresented (LLM implies 2 in 2022, 5 in 2023). Geographic distribution and country locations are entirely fabricated. (3) Multi-hop reasoning failed: the model did not correctly identify the entities (outlet locations, countries, years) or synthesize the change over time. Instead, it invented new locations and trends opposite to the truth. (4) Contextual relevance is low because the answer discusses international expansion, while the truth is a contraction and shift from Japan to the U.S. The only minor relevance is mentioning Las Vegas Outlets, though even that is inaccurately framed as part of international growth rather than a sole surviving presence. The conclusion about broader reach is factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 362,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region slightly decreased from 326 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024. This decline is attributed to downward revisions due to lower prices (81 BCF) and some production and sales activity, partially offset by minor upward revisions and extensions. The region's operational focus appears to be more maintenance-oriented, with limited new development or exploration activity, as reflected in the absence of significant extensions and discoveries and minimal dry exploratory wells. This suggests a strategic shift or reduced emphasis on natural gas growth in the Asia Pacific/Middle East region compared to other areas like the Lower 48 and Canada.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2023 natural gas volume: it reports 326 billion cubic feet (BCF) for 2023, whereas the ground truth states 312 BCF. This is a material discrepancy of 14 BCF that affects the accuracy of the change over time. The 2024 figure (296 BCF) is correct. (2) The calculation of the change from 2023 to 2024 is therefore incorrect: the LLM implies a decrease of 30 BCF (326 to 296), while the actual decrease is 16 BCF (312 to 296). The additional details about downward revisions due to lower prices (81 BCF), production, and minor upward revisions are not present in the ground truth and appear to be hallucinated or inferred beyond the provided data. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies a decline and infers a strategic shift in operational focus, which aligns with the ground truth’s conclusion of a 'minor reduction' indicating a potential shift or stabilization. The mention of 'maintenance-oriented' focus and limited exploration adds plausible context, though not explicitly in the original answer. (4) Despite strong contextual relevance and reasonable qualitative interpretation, the quantitative inaccuracy in the key 2023 figure significantly undermines the correctness score. The answer goes beyond the source data with unverified details, but the core direction (slight decrease, strategic shift) is consistent. Hence, partial credit is given.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 404,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "Comcast has increased its strategic emphasis on wireless gateways from 2022 to 2024, as evidenced by continued investment in deploying these devices to enhance customer connectivity. In 2022, wireless gateways were highlighted as part of the broadband services, offering combined internet modems and Wi-Fi routers with expanded coverage and xFi features. By 2024, the company explicitly included wireless gateways in its capital expenditure plans, aiming to expand deployment as part of its network upgrades to deliver multigigabit symmetrical speeds. This reflects a growing strategic focus on integrating wireless gateways to improve in-and-out-of-home connectivity and customer experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Comcast offered wireless gateways as part of broadband services with xFi features and combined modem/Wi-Fi functionality; by 2024, the strategic emphasis shifted to deeper integration into network infrastructure, including capital investment for multigigabit symmetrical speeds. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the temporal markers (2022, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the evolution from customer-facing product offering to infrastructure-level strategic investment, drawing a logical progression across years. (4) The answer captures the core evolution in strategic emphasis and investment, though it slightly downplays the explicit shift 'from offering to investing' phrasing in the original. However, mentioning inclusion in capital expenditure plans effectively conveys the same meaning. Wording differs slightly but maintains semantic equivalence. No factual errors; minor deduction in qualitative accuracy due to slightly less precise framing of the strategic shift, but overall excellent alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 351,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "Between 2022 and 2024, the G600's market presence and production have grown significantly. Cumulative deliveries of the G600 increased from nearly 150 at year-end 2021 to over 300 by year-end 2024, reflecting strong demand and successful integration into Gulfstream's product lineup. The G600, introduced in 2019 as part of Gulfstream's modernized aircraft family, has played a key role in replacing older models like the G550 and has contributed to the company's leadership in long-range, large-cabin business jets. Its performance, efficiency, and advanced features have solidified its position within Gulfstream's evolving product portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that cumulative deliveries for the G500 and G600 increased from nearly 150 at year-end 2021 to over 300 by year-end 2024, which aligns with the ground truth. While the original answer refers to the combined deliveries of G500 and G600, the LLM attributes the full increase to the G600 alone, which is a minor inaccuracy in attribution but does not misrepresent the overall trend. All numbers and timeframes are accurate. (2) Quantitatively, the figures 'nearly 150' and 'over 300' match the original answer exactly, and the years (2021 and 2024) are correctly referenced. No calculation errors. (3) The reasoning is mostly sound: the LLM correctly infers strong market adoption and integration into Gulfstream's lineup. It accurately notes the G600's role in replacing older models like the G550. However, it misses the subtle but important point from the original answer that by 2024, the G600 was no longer framed as a new product, and that Gulfstream's focus had shifted to newer models like the G800 and G400—this reflects a slight gap in qualitative synthesis across years. (4) The answer is highly relevant, directly addressing the evolution of the G600’s market presence and production. The minor omission of the shifting strategic focus prevents a perfect score, but overall, the response is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 390,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly in terms of equity ownership and income recognition. As of December 31, 2023, AIG held 52.2% of Corebridge's common stock. By June 9, 2024, AIG's ownership had decreased to 48.4%, and following the deconsolidation, AIG retained a 22.7% stake in Corebridge by December 31, 2024. In terms of income recognition, AIG recognized a $4.8 billion loss from the deconsolidation of Corebridge in 2024, primarily due to accumulated comprehensive losses. Additionally, AIG recognized $601 million in equity method income related to Corebridge in 2024, reflecting dividends received and changes in Corebridge's stock price.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several specific numbers not present in the original answer, such as AIG's ownership dropping to 48.4% by June 9, 2024, retaining a 22.7% stake by December 31, 2024, a $4.8 billion loss from deconsolidation, and $601 million in equity method income. These figures are not mentioned or implied in the ground truth and cannot be verified from the provided information, making them potentially inaccurate. The only confirmed correct number is the 52.2% ownership in 2023, which matches the original answer. (2) The dates (December 31, 2023, and June 9, 2024) are partially aligned with the original answer, which references June 9, 2024, as the point when income recognition changed, but does not specify ownership percentages on that date or year-end 2024. The $4.8B loss and $601M income figures are unsupported by the ground truth and represent significant additions that affect factual accuracy. (3) The reasoning correctly identifies the shift from majority ownership to equity method accounting, which reflects sound multi-hop understanding of the evolving relationship. The conceptual shift from control to passive investment is accurately captured, even if specific financials are over-specified. (4) While the qualitative narrative about changing ownership and income recognition aligns with the original, the inclusion of unverified quantitative details reduces correctness. The answer is contextually relevant and addresses both equity ownership and income recognition, but the unsupported numbers lower confidence in factual accuracy. Thus, correctness is partially compromised despite strong conceptual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 454,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "Between 2022 and 2024, Tesla's production strategy for the Solar Roof has evolved to emphasize localized manufacturing and operational scalability, particularly with the use of Gigafactory New York in Buffalo, New York, for development and production. However, operational challenges persist, including supplier dependencies and production ramp difficulties, as noted in both years. In 2024, Tesla continues to face risks related to supply chain constraints, hiring and training qualified personnel, and maintaining production timelines for new factories, which could impact Solar Roof production. Additionally, the need to balance localized procurement with global supply chain management remains a key challenge.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Gigafactory New York as the production site for the Solar Roof and notes ongoing operational challenges such as supplier dependencies, supply chain constraints, and production ramp difficulties, which aligns with the ground truth. It also accurately reflects that these issues persisted into 2024. However, the LLM omits key specifics from the original answer, particularly the shift in tone from active production in 2022 to increased risk and explicit delays in 2024, including the direct quote about 'delays in launching and/or ramping production.' Additionally, the LLM does not mention Tesla's financing integration strategy in 2022 or the emphasis on design tolerances, quality, and output rates in 2024, which are critical elements of the evolution in production strategy. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the model connects Solar Roof production to Gigafactory New York and infers ongoing challenges, but fails to fully synthesize the strategic shift between years—specifically the transition from a dedicated, focused setup to a risk-laden ramp-up phase. This weakens the qualitative accuracy. (4) The answer remains contextually relevant and addresses the core of the question regarding manufacturing dependencies and operational challenges, but lacks depth in capturing the nuanced strategic evolution. Hence, correctness is reduced to 7 due to missing key qualitative shifts emphasized in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 442,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "From 2023 to 2024, Qualcomm has increasingly emphasized on-device artificial intelligence (AI) as a foundational technology, integrating it into its broader strategy for growth and diversification beyond mobile handsets. In 2023, the company highlighted its investments in wireless connectivity, high-performance computing, and on-device AI, aiming to expand into industries like automotive and IoT. By 2024, Qualcomm explicitly identified on-device AI as a key area for future growth, continuing to invest in new product areas and industries by leveraging its technical expertise and pursuing strategic transactions. This evolution reflects a more focused and accelerated approach to developing and commercializing AI technologies as part of its long-term innovation roadmap.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in describing Qualcomm's evolving focus on on-device AI from 2023 to 2024, with accurate context about its expansion into automotive and IoT and continued investment in R&D and strategic transactions. The dates (2023 and 2024) and entities (Qualcomm, on-device AI, automotive, IoT) are correctly identified, satisfying entity accuracy and contextual relevance. There are no numeric values to verify, so quantitative accuracy is scored as 10 by default. However, the key qualitative difference lies in the characterization of the strategic shift: the ground truth emphasizes a move from direct product commercialization to a more investment-centric, ecosystem-enabling approach focused on third-party integration. The LLM answer instead frames the evolution as an acceleration and intensification of commercialization efforts, which misrepresents the nature of the shift. This reflects a partial failure in multi-hop reasoning and synthesis—while the surface-level facts align, the core strategic reorientation (from product to ecosystem/investment focus) is inaccurately conveyed. Thus, while the answer is factually plausible and contextually relevant, it lacks precision in capturing the nuanced strategic evolution, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 363,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "The presence of Dolce & Gabbana in SPG-operated properties increased between 2022 and 2023, as it was listed as a tenant in the Las Vegas Outlets (2023) and Punta Norte Premium Outlets (Mexico, 2023), while not explicitly mentioned in 2022 filings. This indicates SPG is enhancing its brand positioning in premium outlet locations by attracting high-end luxury brands like Dolce & Gabbana, reinforcing its focus on upscale retail experiences.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and content. The ground truth states that Dolce & Gabbana was present in multiple SPG-operated outlets in Japan in 2022 (Gotemba, Kobe-Sanda, Rinku) but only at Las Vegas Outlets North in 2023, indicating a reduction and strategic shift. The LLM incorrectly claims an increase in presence, citing Las Vegas and Punta Norte Premium Outlets in Mexico in 2023, with no mention of 2022 activity — this contradicts the ground truth which explicitly lists Japanese locations in 2022. Punta Norte is not mentioned in the original answer and appears to be fabricated. (2) Quantitatively, the LLM misrepresents the number of locations and years. It fails to report any 2022 locations despite three being documented, and invents a 2023 presence in Mexico without support. The claim of 'increased presence' is false — the actual trend is a contraction from multiple locations to one, albeit in a different region. (3) The multi-hop reasoning is flawed: the model should have compared 2022 vs 2023 tenant lists across geographies to detect a strategic shift from Japan to the U.S., but instead inferred expansion without evidence. The conclusion about SPG enhancing brand positioning by attracting luxury brands is plausible but based on incorrect premises. (4) Correctness is severely compromised due to false entities, incorrect temporal comparisons, and reversed trend analysis. Quantitative and qualitative accuracy are low due to invented data and faulty logic. Contextual relevance is moderate because the answer addresses brand positioning strategy, though based on wrong facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 449,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "COP's investment in exploration activities in the Asia Pacific/Middle East region between 2023 and 2024 remained relatively modest, with only a small number of exploratory wells completed in 2023 (0 productive and 0 dry) and no specific exploration activity noted in 2024. However, the company continued to focus on development activities in the region, with 20 development wells in 2023 and 22 in 2022. This suggests that COP's strategic focus in the region is more on developing existing reserves rather than pursuing new exploration projects.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key aspects. The ground truth states that COP spent $49 million on exploration in the Asia Pacific/Middle East region in 2023 and $0 in 2024, indicating a complete halt in exploration spending. However, the LLM answer does not mention these dollar amounts at all, instead referring vaguely to 'a small number of exploratory wells' with 0 productive and 0 dry in 2023—information not present in the original answer and potentially fabricated or misattributed. (2) The quantitative inaccuracies are severe: the $49 million expenditure in 2023 and $0 in 2024 are central facts that the LLM omits entirely. Instead, it introduces well counts (0 exploratory wells in 2023) that contradict the idea of $49 million in spending, which would imply some level of activity. There is no support for these numbers in the ground truth, and they undermine the factual basis of the response. (3) The reasoning is flawed in terms of multi-hop synthesis: while the question asks about investment evolution and strategic implications, the LLM shifts focus to development wells (20 in 2023, 22 in 2022), which are not exploration activities. This confuses development with exploration, leading to an incorrect conclusion that COP is focusing on 'developing existing reserves' rather than acknowledging a full pause in exploration. The strategic interpretation is therefore based on incorrect data and misclassification of activities. (4) Despite these issues, the answer is contextually relevant—it addresses the region, the time frame, and attempts to infer strategy. However, due to major factual and quantitative errors, especially the omission of critical financial figures and introduction of unsupported well counts, the correctness score is low. The qualitative reasoning would be stronger if based on accurate data, hence a moderate score there. Quantitative accuracy is poor due to missing and conflicting numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 528,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast's financial stake in Universal Beijing Resort remained consistent at a 30% interest from 2022 to 2024. As of December 31, 2024, Universal Beijing Resort had $3.4 billion in debt outstanding, including a $3.0 billion term loan, compared to $3.5 billion in debt, including a $3.1 billion term loan, as of December 31, 2023. The debt is secured by the resort's assets and equity interests, with Comcast's maximum risk of financial loss limited to its 30% ownership stake.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Comcast's 30% ownership stake in Universal Beijing Resort and the $3.4 billion debt outstanding as of December 31, 2024, and $3.5 billion in 2023, which aligns with the ground truth. However, it introduces specific details not present in the original answer—namely the $3.0 billion and $3.1 billion term loans—which are not mentioned in the ground truth and thus cannot be verified as accurate. This undermines quantitative accuracy. (2) The ground truth notes that no specific financial stake or debt figures were disclosed in 2022, but the LLM claims Comcast had a 30% interest starting in 2022, which is inconsistent with the original answer stating that the 30% stake was only explicitly stated in 2024. This is a factual error in timeline and disclosure. Additionally, the LLM omits key balance sheet data from the original answer: the assets and liabilities of Universal Beijing Resort ($7.3B assets / $7.0B liabilities in 2024 vs $7.8B / $7.2B in 2023), which is a significant omission in completeness. (3) The multi-hop reasoning is partially sound—linking Comcast’s ownership to its risk exposure and debt structure shows good synthesis—but incorrectly assumes continuity of disclosure from 2022 onward. The model fails to reflect the evolution of disclosure transparency over time, which is central to the question. (4) Despite these issues, the core financial figures for 2023–2024 debt levels are correct, and the contextual relevance is high as it directly addresses Comcast’s stake and debt involvement. The answer is well-structured and relevant but contains unverified specifics and a key factual misstatement about when the 30% stake was disclosed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 467,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "From 2022 to 2023, Duke Energy's net derivatives balance decreased from $29 million to $13 million, reflecting a reduction in derivative liabilities. In 2023, the company experienced $68 million in settlements compared to $32 million in 2022, indicating increased activity in settling derivative contracts. This suggests that Duke Energy is actively managing its derivative instruments, potentially reducing its exposure to market fluctuations by settling contracts and adjusting its portfolio. The overall trend implies a more conservative approach to derivative risk management in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: Duke Energy's net derivatives balance decreased from $29 million in 2022 to $13 million in 2023, and settlements increased from $32 million to $68 million. These figures match the ground truth exactly, with no calculation or number errors. (2) Quantitative accuracy is perfect—values are reported accurately, and comparisons (decrease in balance, increase in settlements) are numerically sound. (3) The multi-hop reasoning is strong: the model synthesizes data across two years for two related metrics (net balance and settlements) and draws a logical conclusion about Duke Energy's derivative management strategy. The interpretation—that increased settlements alongside a declining net balance suggest active portfolio management and reduced exposure—is consistent with and supported by the data. (4) The only minor limitation is that the LLM slightly expands on the implication by describing the approach as 'more conservative,' a characterization not explicitly stated in the ground truth. However, this is a reasonable inference and does not contradict the original answer. All parts of the question are addressed: evolution of balances and settlements, and what it indicates about exposure/management. Thus, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 387,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "From 2022 to 2023, SPG's treatment and disclosure of LTIP Units evolved in terms of their dilutive effect and valuation modeling. In 2023, SPG continued to account for LTIP units as participating securities under the two-class method of computing earnings per share, which impacts the dilutive effect. The grant-date fair values of market-based LTIP awards were estimated using a Monte Carlo model in both years, but in 2023, the valuation modeling for performance-based awards was tied to specific performance conditions based on FFO and objective criteria goals, with a maximum potential fair value of $23.6 million for the 2023 LTI Program. Additionally, the 2023 LTIP units were subject to a three-year measurement period and would vest on January 1, 2027, reflecting a longer-term incentive structure compared to prior years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies not present in the ground truth. The ground truth states that in 2022, SPG disclosed LTIP units as potentially dilutive but with no material effect for 2021–2019, and in 2023, introduced a Monte Carlo model for market-based LTIP units and confirmed their treatment as participating securities. However, the LLM incorrectly claims the Monte Carlo model was used in both years, when the ground truth implies it was newly introduced or explicitly disclosed in 2023. Additionally, the LLM introduces specific new details not in the original answer: a $23.6 million maximum fair value, a January 1, 2027 vesting date, a three-year measurement period, and FFO-based performance conditions. These specifics are absent from the ground truth and cannot be verified from the provided information, suggesting fabrication or hallucination. (2) Quantitative accuracy is low because the dollar amount ($23.6M), vesting date (2027), and performance metric (FFO) are not supported by the original answer. There are no numbers in the ground truth to compare against, so introducing them reduces accuracy. (3) The multi-hop reasoning is partially sound—LLM connects LTIP units to dilutive treatment and valuation modeling—but incorrectly assumes continuity in Monte Carlo usage and adds unverified granular details, undermining the synthesis. It fails to capture the key evolution: from minimal disclosure in 2022 to more detailed, valuation-focused disclosure in 2023. (4) Contextual relevance is high because the response addresses the question’s focus on evolution in treatment, dilution, and modeling. However, correctness and quantitative accuracy are severely impacted by unsupported specifics and misrepresentation of the timeline for valuation methods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 491,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "Between 2022 and 2024, Comcast's capital funding to Atairos Group, Inc. decreased, with contributions totaling $52 million in 2022, $73 million in 2023, and $145 million in 2024. Additionally, Comcast's remaining unfunded capital commitment was reduced from $1.5 billion in 2022 to $1.4 billion in 2024, while its annual management fee commitment remained at $40–45 million, subject to adjustments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Comcast's total capital commitment to Atairos was $5 billion in 2022, reduced to $4.5 billion by 2024, with an added $40 million annual management fee. The LLM incorrectly states actual contributions of $52M, $73M, and $145M for 2022–2024, which are not mentioned in the ground truth and contradict the nature of a capital commitment (a pledged amount, not necessarily disbursed). It also cites a remaining unfunded commitment of $1.5B in 2022 and $1.4B in 2024, which does not align with the $5B and $4.5B total commitments in the original answer. The management fee is reported as $40–45M annually, while the ground truth specifies a new $40M annual management fee commitment introduced by 2024, not maintained. (2) Quantitative accuracy is low: the core numbers (disbursements, unfunded amounts) are fabricated or misinterpreted. The $5B to $4.5B reduction is a key fact entirely missed. (3) The reasoning is flawed—instead of describing a strategic recalibration via reduced commitment and new fee structure, the model invents year-by-year funding data and implies ongoing disbursements, failing the multi-hop synthesis between years and financial instruments. (4) Contextual relevance is moderate because the answer addresses Comcast’s involvement in Atairos and discusses capital and fees, but the incorrect data and reasoning severely undermine factual correctness. The answer appears plausible but diverges fundamentally from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 427,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased slightly from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024. This modest decline, despite some upward revisions in other regions, suggests a reduced operational focus on natural gas development in the Asia Pacific/Middle East area during this period. The company appears to have prioritized other regions, such as the Lower 48 and Alaska, for natural gas extensions and discoveries in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of change: it states that reserves 'increased slightly' from 312 BCF in 2023 to 296 BCF in 2024, when in fact this is a decrease. This misrepresents the core quantitative fact. While the actual numbers (312 BCF in 2023 and 296 BCF in 2024) are correctly cited, the interpretation of the trend is reversed. (2) The numbers themselves match the ground truth—312 BCF in 2023 and 296 BCF in 2024—so numeric accuracy is high, but the comparison (increase vs. decrease) is incorrect, leading to a major error in meaning. The calculation of a 16 BCF decrease is implied but mislabeled as an increase. (3) The multi-hop reasoning about operational focus is partially sound—the conclusion that there is reduced focus in the region aligns with the decline in reserves—but it is based on flawed reasoning due to the mischaracterization of the trend. The mention of prioritization of other regions (Lower 48 and Alaska) adds context not present in the original answer; while plausible, it is not supported by the provided ground truth and introduces unverified information. (4) The correctness score is 4 due to the major error in interpreting the direction of change, despite correct input numbers. Quantitative accuracy is 3 because while the values are right, the comparative analysis is wrong. Qualitative accuracy is 5 because the logic would follow if the trend were correct, but it builds on a false premise. Contextual relevance is 8 because the answer addresses the right region, company, time frame, and attempts to interpret strategic focus appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 447,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022, Comcast focused on procuring wireless gateways to enhance in-home Wi-Fi coverage and deliver advanced features like xFi whole-home management and security. By 2024, the company shifted its investment focus toward network deployment, emphasizing scalable infrastructure and line extensions to expand capacity and deliver multigigabit symmetrical speeds. While wireless gateway procurement supported customer connectivity in 2022, the 2024 strategy centered on upgrading the broader network to meet growing demand for high-speed broadband.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately captures Comcast's 2022 focus on wireless gateway procurement to support in-home Wi-Fi and advanced features like xFi, which matches the original answer's description of purchasing customer premise equipment from limited suppliers. In 2024, the shift toward network deployment investment emphasizing scalable infrastructure and multigigabit symmetrical speeds is correctly identified. (2) There are no numeric values, dollar amounts, or percentages in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes a strategic shift from procurement (2022) to integrated network deployment (2024). However, the LLM omits a key nuance present in the ground truth: that wireless gateways themselves became a *planned capital expenditure component* in 2024, not just part of broader network upgrades. This subtle but important point about the evolving role of gateways—from procured devices to strategic infrastructure investments—is missing, slightly weakening the qualitative accuracy. (4) Despite this omission, the answer remains contextually relevant and conveys the core strategic evolution. Wording differs but semantic meaning is closely aligned. Correctness score is 8 due to the missing detail about gateways as capital investments in 2024, which is central to the original answer’s emphasis on active integration into infrastructure strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 427,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "Between 2022 and 2024, Tesla's strategic importance of the Solar Roof product appears to have diminished, as evidenced by the challenges highlighted in the 2024 10-K. The 2022 10-K mentions increased deployments of Solar Roof but notes lower gross margins due to manufacturing underutilization during product ramping. By 2024, the Solar Roof is not explicitly mentioned as a strategic focus, and production challenges, such as delays and manufacturing bottlenecks, are discussed more broadly in the context of Tesla's energy products. This suggests a shift in strategic emphasis away from Solar Roof as Tesla faces ongoing production and cost challenges in scaling the product.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately reflects Tesla's evolving stance on the Solar Roof between 2022 and 2024: in 2022, the product was actively deployed but faced margin pressure due to manufacturing underutilization, and by 2024, it was framed more cautiously due to production delays. These points are consistent with the original answer’s emphasis on a shift from growth contributor to a product with scaling risks. (2) There are no numeric inaccuracies—while no specific figures (e.g., revenue amounts) are cited, the qualitative financial references (e.g., lower gross margins, manufacturing bottlenecks) are correctly attributed to the respective years and context. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and correctly infers a strategic shift based on changing risk disclosures and emphasis in the 10-K filings. (4) The only minor shortcoming is that the LLM slightly overstates the 'diminishment' of strategic importance by saying the Solar Roof is 'not explicitly mentioned as a strategic focus' in 2024, whereas the ground truth emphasizes a shift in tone (from deployment success to caution about risks), not necessarily a de-prioritization. This nuance is missing, but the overall interpretation remains reasonable. Hence, the answer earns high marks for correctness and relevance, with a small deduction in qualitative accuracy for the slight overinterpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 417,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy's investment in \"Net pending transactions and other investments\" increased from $14 million in 2022 to $54 million in 2023. This significant increase suggests a shift in the company's strategic positioning, potentially indicating a greater focus on short-term or transitional investments, possibly to capitalize on market opportunities or to support evolving investment strategies within its retirement trust portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The original answer states that Duke Energy's investment decreased from $53 million in 2022 to $14 million in 2023, whereas the LLM claims an increase from $14 million to $54 million—reversing the years and misstating the amounts. This fundamental error undermines the entire response. (2) Quantitatively, both the starting and ending values are wrong: $14M (incorrect base) vs. $53M (correct), and $54M (incorrect end) vs. $14M (correct). The calculation of change (increase vs. decrease) is therefore also incorrect. (3) The reasoning is flawed due to incorrect data input—claiming a strategic shift toward greater investment is the opposite of the truth, which indicates a reduction or completion of prior initiatives. The multi-hop synthesis failed as the model did not correctly retrieve or align the time-series data across years. (4) Despite the factual errors, the answer addresses the right category ('Net pending transactions and other investments') and attempts to interpret strategic implications, which maintains moderate contextual relevance. However, the qualitative and quantitative inaccuracies severely limit usefulness, warranting very low scores in those domains.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 358,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "Between 2023 and 2024, the company's implementation of its liability-driven investment framework remained consistent in aligning plan assets with liabilities, maintaining a 20%/80% equity/fixed income target allocation for pension plans and a 55%/45% allocation for postretirement plans. However, the actual composition of plan assets shifted slightly, with pension plan equity securities increasing from 18% to 21% and corporate bonds rising from 57% to 63%, while U.S. Treasury and government securities decreased from 25% to 16%. For defined contribution plan expenses, the company reported increased costs, rising from $109 million in 2023 to $112 million in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces significant inaccuracies not present in the ground truth. The defined contribution plan expenses are correctly reported as $109 million in 2023 and $112 million in 2024, which matches the original answer. The 20%/80% equity/fixed income target allocation for pension assets is also correctly stated. However, the LLM adds unverified details not found in the ground truth: a 55%/45% allocation for postretirement plans, actual asset composition shifts (e.g., equity rising from 18% to 21%, corporate bonds from 57% to 63%, Treasuries falling from 25% to 16%), and specific asset class movements. These figures are not mentioned in the original answer and represent a fabrication or hallucination. (2) Quantitative accuracy is partially correct—only the expense figures and target allocation percentages are accurate. All other numbers (actual asset compositions) are unsupported and incorrect. There are no calculation errors per se, but the inclusion of false quantitative data reduces accuracy. (3) The multi-hop reasoning is flawed. While the model correctly identifies the evolution in expenses and the consistency of the target allocation, it fails to capture the key qualitative evolution noted in the ground truth: the 2024 filing introduced a new disclosure commitment to characterize the actual composition of plan assets, indicating improved transparency. Instead, the LLM falsely presents detailed actual compositions as if they were disclosed, misrepresenting the nature of the evolution. (4) Contextual relevance is high—the answer addresses the time frame, the investment framework, defined contribution expenses, and asset allocation. However, due to the introduction of fabricated data and the omission of the true qualitative advancement (enhanced disclosure practices), the overall correctness score is reduced to 4. The answer is partially aligned but contains critical factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 535,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Qualcomm's strategic focus on On-Device AI evolved as part of its broader growth and diversification initiatives beyond mobile handsets. In fiscal 2024, the company emphasized the integration of On-Device AI with 5G and high-performance, low-power computing, aiming to drive adoption in industries such as automotive and IoT. Specific investments highlighted in the disclosures include continued research and development spending, which reached $8.9 billion in fiscal 2024, and strategic transactions aimed at expanding opportunities for its technologies. The company also noted the importance of maintaining leadership in 5G and AI to sustain long-term growth, reflecting a more proactive and integrated approach to On-Device AI development and deployment.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's strategic focus on On-Device AI and its expansion into automotive and IoT in both fiscal years, aligning with the ground truth. It accurately reflects the evolution toward a more investment-driven strategy, mentioning R&D spending and strategic transactions. However, it incorrectly implies that the integration of On-Device AI with 5G was emphasized in fiscal 2024 specifically, while the ground truth states this integration was already a focus in fiscal 2023. This misrepresents the timeline of the strategic evolution. (2) The quantitative claim of $8.9 billion in R&D spending in fiscal 2024 is not present in the original answer and cannot be verified against the provided ground truth, introducing unverified data. While R&D investment is conceptually consistent with 'investments,' the specific figure is unsupported here and risks inaccuracy. (3) The multi-hop reasoning is partially sound—LLM connects On-Device AI to broader industry expansion and cites strategic actions—but fails to clearly contrast fiscal 2023's visionary stance with fiscal 2024's active investment phase, which is central to the original answer. Instead, it merges elements from both years without clarifying the shift. (4) Scores reflect mostly correct entities (Qualcomm, On-Device AI, 5G, IoT, automotive), relevant context, and good structure, but docked for timeline inaccuracies and unsupported numerical claims. The answer is contextually strong and semantically close but lacks precision in representing the evolution and specific disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 437,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "The classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members remained consistent between the 2022 and 2023 10-K filings, with both years listing the same Second Amended and Restated Voting Trust Agreement dated March 1, 2004, under Exhibit 9.1. This consistency indicates a stable governance structure, as the agreement has not been amended or reclassified, reflecting continuity in the Simon family's control and voting rights within the company.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. According to the ground truth, there was a change in the classification and presentation of the Voting Trust Agreement between the 2022 and 2023 10-K filings: the 2022 filing referred to it as the 'Second Amended and Restated' agreement, while the 2023 filing dropped that modifier, referring to it simply as the Voting Trust Agreement dated March 1, 2004. The LLM incorrectly states that the classification 'remained consistent' and that both years list it as 'Second Amended and Restated,' which contradicts the ground truth. This error undermines the entire reasoning, as the conclusion about stability is based on incorrect premises. While the date (March 1, 2004) is correctly cited, the key qualitative shift in terminology is missed, indicating a failure in multi-hop reasoning and document comparison. The conclusion about governance stability is directionally aligned with the ground truth but is based on false information, making it misleading. The answer is contextually relevant to the question and addresses governance stability, but the factual inaccuracies severely limit its correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 327,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region remained at zero for both 2023 and 2024 in the \"Developed and Undeveloped\" category, indicating no direct natural gas reserves in this region during these years. However, the region's equity affiliates, which are entirely located in Asia Pacific/Middle East, saw an increase in natural gas reserves from 5,275 billion cubic feet (BCF) at the end of 2023 to 5,870 BCF at the end of 2024. This increase, driven by purchases and extensions, suggests a growing strategic importance of the region through equity investments, even if direct reserves remain unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims COP's natural gas reserves in the Asia Pacific/Middle East region were 'zero' in both 2023 and 2024 in the 'Developed and Undeveloped' category, which directly contradicts the ground truth stating 312 BCF in 2023 and 296 BCF in 2024. These figures represent actual direct reserves, not zero. While the LLM correctly reports the equity affiliate reserves increasing from 5,275 BCF in 2023 to 5,870 BCF in 2024, this is the only accurate quantitative point. (2) The calculation of the increase in equity affiliates (5,870 - 5,275 = 595 BCF) is correct, but the core direct reserve numbers are entirely wrong. The ground truth shows a 16 BCF (5.1%) decrease in direct reserves, which the LLM fails to acknowledge. (3) The multi-hop reasoning is flawed: the model incorrectly infers that 'zero' direct reserves imply no strategic role, while the ground truth shows meaningful reserves that decreased slightly. The LLM misidentifies the nature of the data—confusing 'Developed and Undeveloped' reserves with total reserves—and fails to synthesize the correct narrative of a slight decline in direct holdings alongside growing equity investments. (4) The contextual relevance is moderate because the answer addresses strategic importance via equity affiliates, which aligns with the question’s intent, but the incorrect foundation on direct reserves severely undermines the conclusion. The qualitative reasoning about strategic importance through equity growth is partially sound but built on incorrect premises. Thus, the correctness score is low due to major factual errors in core data, despite one accurate number.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 462,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly, particularly in terms of debt structure and equity method income. In 2023, Corebridge had $9,368 million in debt, including guaranteed and non-guaranteed borrowings. By 2024, following Corebridge's deconsolidation, AIG no longer guaranteed Corebridge's debt, and Corebridge's debt was excluded from AIG's consolidated financial statements. Post-deconsolidation, AIG transitioned to accounting for its retained interest in Corebridge under the equity method, recognizing equity method income of $601 million in 2024, which included dividends received and changes in Corebridge's stock price.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AIG's relationship with Corebridge from consolidation in 2023 to equity method accounting in 2024, and correctly notes the deconsolidation impact on debt reporting. However, it omits specific breakdowns of the $9,368 million debt from the original answer—namely the $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. Instead, it vaguely refers to 'guaranteed and non-guaranteed borrowings,' which is less precise and slightly misleading since the original specifies that none of the debt was guaranteed by AIG. Additionally, the LLM introduces a specific figure of $601 million in equity method income in 2024, which is not present in the original answer. While plausible, this number is unverified and not supported by the ground truth, representing a factual addition. (2) The total debt amount ($9,368 million) is correct and properly attributed to 2023. However, the $601 million income figure is unsupported and potentially incorrect, as the original answer does not provide a numerical total for equity method income—only its components (dividends and stock price changes since June 9, 2024). (3) The multi-hop reasoning is sound: the model correctly infers that deconsolidation leads to exclusion of Corebridge's debt from AIG’s financials and a shift to equity method accounting. It also correctly associates equity method income with dividends and stock price changes, aligning with the original. (4) The answer is contextually excellent and addresses both debt structure and equity income. Due to the introduction of an unsupported numerical figure and omission of key debt composition details, the quantitative accuracy is reduced, but the qualitative and contextual reasoning remains strong, warranting an 8/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 504,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "From 2022 to 2024, NextEra Energy's investment strategy in Special Use Funds has shifted toward a greater allocation to equity securities and a reduction in fixed income securities. In 2022, the total allocation to equity securities in Special Use Funds was $5,290 million for NEE and $3,536 million for FPL, while fixed income allocations were relatively smaller. By 2024, equity securities increased to $6,164 million for NEE and $4,219 million for FPL, while fixed income allocations remained modest. This shift suggests a higher risk appetite, as equity investments typically carry more volatility than fixed income. It may also indicate a longer-term liquidity strategy, as equity investments can provide growth potential over time, aligning with the long-term nature of certain Special Use Funds like nuclear decommissioning reserves.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, NextEra Energy's (NEE) Special Use Funds were entirely composed of fixed income securities with a carrying amount of $2,505 million and no equity securities. However, the LLM claims that in 2022, NEE had $5,290 million in equity securities, which is incorrect. This misrepresents the entire evolution of the investment strategy. Additionally, the LLM introduces FPL (Florida Power & Light) figures ($3,536 million and $4,219 million), which are not mentioned in the original answer and are not part of the question's scope, adding irrelevant and unverified data. (2) The only correct quantitative figure is the 2024 equity securities amount for NEE ($6,164 million), which matches the ground truth. All other numbers, especially the 2022 equity allocation, are wrong. The ground truth states that 2022 was 100% fixed income ($2,505M), while the LLM incorrectly asserts a large equity position. There are no calculations in the answer, but the comparison over time is based on false premises. (3) The multi-hop reasoning is flawed because it fails to recognize the key transformation: from 100% fixed income in 2022 to a diversified, equity-heavy portfolio in 2024. Instead, the LLM assumes a high equity base in 2022 and a continued increase, which contradicts the ground truth. The conclusion about increased risk appetite is directionally plausible but based on incorrect data, undermining the validity of the inference. (4) The answer is contextually relevant in structure and addresses the question's components (allocation shift, risk appetite, liquidity), but the factual foundation is unsound. The introduction of FPL data adds noise and reduces accuracy. While the 2024 equity number is correct, the overall synthesis is compromised by incorrect 2022 data and extraneous entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 514,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "The risk associated with site infrastructure sharing has increased between 2022 and 2024 due to the adoption of 5G technology, which has led to greater network sharing among wireless service providers. This trend has the potential to slow new lease activity as carriers increasingly utilize shared equipment rather than deploying new infrastructure, and may result in decommissioning equipment on existing sites due to network redundancy. The evolution of 5G has thus heightened the risk of reduced demand for new leases and increased churn in existing lease agreements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of site infrastructure sharing as a growing risk from 2022 to 2024 due to 5G adoption, and accurately notes its impact on slowing new lease activity and potentially causing decommissioning of existing equipment. The dates (2022–2024) and entities (AMT, 5G technology, wireless carriers) are correct, and there are no numerical inaccuracies—this supports a high quantitative accuracy score. Contextual relevance is strong as the response directly addresses the question’s focus on risk evolution and lease activity. However, the LLM omits a key qualitative development present in the ground truth: the shift in 2024 toward more specific risk language around RAN sharing, roaming, or resale arrangements, and crucially, the lack of compensation to AMT despite carrier use of shared infrastructure. This represents a significant nuance in the risk's evolution—moving from a general concern about reduced demand to a financially explicit risk tied to revenue model erosion. While the LLM captures the general trend, it fails to convey the increased specificity and financial emphasis in the 2024 filing, which weakens the qualitative accuracy. Thus, the answer is factually sound but lacks depth in multi-hop synthesis regarding how the nature of the risk matured. This justifies a correctness score of 7 rather than higher.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 378,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Chevron's investment in Angola LNG Limited remained relatively stable between 2022 and 2023, with the carrying value of its investment decreasing slightly from $1,963 million in 2022 to $1,762 million in 2023. Under equity method accounting, Chevron's share of Angola LNG Limited's net income decreased from $513 million in 2022 to $513 million in 2023, indicating consistent returns despite the reduction in investment value. This suggests that Chevron continues to maintain a 36.4% stake in Angola LNG Limited, and its financial relationship with the entity remains a steady contributor to its upstream equity earnings.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that the key evolution in Chevron's relationship with Angola LNG Limited between 2022 and 2023 was a reclassification from 'Depends_On' to 'Invests_In'—a structural and strategic shift in the nature of the investment—while maintaining the same 36.4% ownership. However, the LLM answer fabricates financial figures not present in the original answer, such as a carrying value of $1,963 million in 2022 and $1,762 million in 2023, and Chevron's share of net income being $513 million in both years. These numbers are not supported by the ground truth and appear to be hallucinated. (2) There is no mention in the original answer of carrying values or net income figures, so all numeric claims in the LLM response fail verification. The only correct number is the 36.4% stake, which the LLM correctly identifies. (3) The multi-hop reasoning is flawed: the question asks about evolution in investment structure and equity method accounting, but the LLM focuses on fabricated financial performance metrics instead of the relationship classification change. It completely misses the core qualitative shift from 'Depends_On' to 'Invests_In', which is the central point of the ground truth. (4) The contextual relevance is moderate because the answer discusses Chevron’s investment in Angola LNG Limited and mentions equity method accounting, but it fails to address the actual structural evolution. Due to major factual inaccuracies and omission of the key conceptual shift, the correctness score is low at 2. Quantitative accuracy is 3 because one percentage is correct but all dollar amounts are fabricated. Qualitative accuracy is 2 due to complete misinterpretation of the nature of the evolution. Contextual relevance is 5 because the topic is generally on point but misses the critical details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 517,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "From 2022 to 2023, the G600 aircraft continued to solidify its role as a high-performance, large-cabin business jet within Gulfstream's product lineup. Performance metrics highlight its status as one of the fastest and most fuel-efficient aircraft in its class, with over 90 city-pair speed records by the end of 2023 and cumulative deliveries exceeding 250 units. While the G600 remains a key model, Gulfstream's focus in 2023 shifted toward newer aircraft like the G700 and G800, with the G600's production status stable as part of a mature product line.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the G600's evolving role from a recent addition to a mature product, noting over 250 cumulative deliveries by end of 2023, which aligns with the ground truth. It accurately reflects the shift in Gulfstream's focus toward newer models like the G700 and G800. However, the mention of '90 city-pair speed records' is not present in the original answer and cannot be verified from the provided ground truth, introducing unconfirmed information. (2) The number 'over 250 deliveries' is correctly stated and matches the ground truth. The year 2023 is appropriately referenced. No calculation errors are present. The '90 city-pair speed records' is an unsupported quantitative claim, but other numbers are accurate. (3) The reasoning correctly captures the multi-hop evolution: from introduction (2022) to maturity (2023), and the technological influence of the G600 (e.g., Symmetry Flight Deck) being extended to newer models is implied through the shift in focus, though the LLM does not explicitly state that the G600's technologies became foundational for newer models—a key point in the original answer. This omission slightly weakens the qualitative synthesis. (4) The answer is highly relevant to the question, addressing both performance metrics and production status. While it adds a detail (speed records) not in the original, it remains contextually appropriate. The core evolution of the G600’s role is accurately conveyed, warranting a high correctness score despite minor omissions and an unverified metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 430,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize greater strategic collaboration and financial co-investment. The Company has increasingly partnered with franchisees to fund restaurant improvements and modernization initiatives, aiming to enhance customer experiences and drive revenue growth. Additionally, McDonald's has reinforced collaboration through shared standards and innovation, ensuring consistency and quality across all locations while supporting franchisee success.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in McDonald's relationship with franchisees from 2022 to 2024, emphasizing increased financial co-investment and strategic collaboration. It accurately reflects the shift from a more traditional franchising model to a co-investment approach focused on modernization and customer experience. There are no numeric values in the original or LLM answer, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced because the LLM omits specific details present in the ground truth, such as the fact that McDonald's did not typically invest in restaurant capital under developmental licenses in 2022, which highlights the significance of the shift. The answer also does not explicitly mention rent, royalties, and initial fees as part of the 2022 financial structure. However, the core reasoning and multi-hop synthesis—comparing the company's role across two time points to show a strategic shift—are sound and factually aligned. The response is fully contextually relevant, directly addressing the question about financial involvement and strategic collaboration. Semantic equivalence is largely maintained, though some granularity from the original answer is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 349,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a decline in both net revenues and operating income. Net revenues for smokeable products decreased from $22,476 million in 2022 to $21,756 million in 2023. Similarly, operating income remained nearly flat, decreasing slightly from $10,688 million in 2022 to $10,670 million in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects. (1) The numbers for net revenues and operating income in both 2022 and 2023 are correct: $22,476 million and $21,756 million for net revenues, and $10,688 million and $10,670 million for operating income, respectively. These match the original answer exactly, with acceptable formatting. (2) The calculations implied by the comparison (a slight decrease in both metrics) are accurate: net revenues decreased by $720 million, and operating income declined by $18 million, which aligns with the 'slight' or 'marginal' characterization in the ground truth. (3) The multi-hop reasoning is sound—information from two years is correctly synthesized across both financial metrics. (4) The only minor shortcoming is that the LLM describes operating income as 'nearly flat' and 'decreasing slightly', which is accurate, but the original answer more precisely characterizes the overall trend as a 'small decrease in both revenue and profitability', providing slightly better synthesis. However, the LLM conveys the same essential conclusion. All entities (smokeable products, net revenues, operating income, years) are correct. The answer is fully relevant and responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 355,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within BMY's strategy has evolved to emphasize expanded therapeutic approvals and continued collaboration in key markets. In 2024, Opdivo received multiple approvals, including FDA and EC approvals for new indications such as urothelial carcinoma and NSCLC, and Japan's approval for unresectable urothelial carcinoma. Collaboratively, BMY continues its joint development and commercialization of Opdivo with Ono in Japan, South Korea, and Taiwan, maintaining profit-sharing and supply responsibilities. Additionally, the launch of Opdivo Qvantig in 2024, a subcutaneous formulation, reflects BMY's focus on improving patient access and convenience, reinforcing Opdivo's central role in BMY's immunotherapy leadership.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continuation of the BMY-Ono collaboration in Japan, South Korea, and Taiwan, including profit-sharing and supply responsibilities, which aligns with the 2022 framework in the ground truth. It also accurately notes Opdivo's evolving role with new approvals in 2024, particularly the FDA approval for urothelial carcinoma—though it generalizes this as 'multiple approvals' including NSCLC and EC without specifying that the March 2024 FDA approval was specifically for urothelial carcinoma in combination with cisplatin and gemcitabine. The launch of Opdivo Qvantig in 2024 is factually accurate and relevant, but not mentioned in the ground truth, so it neither adds nor detracts from correctness. (2) Quantitatively, the answer correctly references 2022 and 2024 as key years and implies the correct timeline. However, it omits the specific structure of cost/profit sharing (e.g., 80-20 vs. 50-50 splits) detailed in the original answer, which is a meaningful omission in the collaborative framework. It also does not specify that the 2024 approval was FDA-specific in March 2024, instead listing FDA, EC, and Japan approvals broadly, which introduces some ambiguity. (3) The multi-hop reasoning is partially sound: the model connects collaboration (2022) to expanded approvals (2024), but fails to fully synthesize the strategic shift from co-development dependency to BMY-led independent expansion emphasized in the ground truth. The answer emphasizes collaboration continuity but underrepresents the strategic evolution toward BMY-led commercialization. (4) The contextual relevance is high—topics are on point, and the answer addresses both collaboration and new approvals. However, the qualitative accuracy is reduced due to incomplete synthesis of the strategic shift and lack of specificity on approval details and collaboration mechanics. Thus, the answer is mostly correct but lacks precision on key strategic and structural details, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 546,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, with a continued reliance on LIBOR and EURIBOR as referenced rates in 2024, but with no explicit mention of transition plans to alternative benchmarks like SOFR. In 2022, AMT's debt instruments referenced LIBOR or EURIBOR with applicable margins, and covenants included compliance with financial metrics and restrictions on additional indebtedness. By 2024, similar rates were still in use, but covenants became more detailed, emphasizing debt service coverage ratios (DSCR), reserve account requirements, and amortization triggers tied to performance thresholds. Additionally, new securitization structures in 2024 included specific repayment terms and interest rates (e.g., 5.490% and 5.735% for 2023 Securities), reflecting a more nuanced approach to managing interest rate exposure and liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in several key areas. (1) Quantitatively, the LLM introduces specific interest rates like 5.490% and 5.735% for 2023 securities, which are not present in the original answer and lack support from the provided truth. These numbers appear fabricated. (2) The core factual claim—that AMT continued using LIBOR and EURIBOR in 2024 with no mention of SOFR—is directly contradicted by the ground truth, which states that by 2024, new drawings in Nigeria bore interest at SOFR plus a spread, indicating a clear transition away from LIBOR. The original answer emphasizes a shift in benchmarks; the LLM denies it. (3) Regarding covenants, the LLM claims they became 'more detailed' in 2024 with DSCR, reserve accounts, and amortization triggers, but the ground truth states that 2024 disclosures focused on consequences of non-compliance without specifying renewal terms or interest rate structures—suggesting simplification, not increased detail. (4) The multi-hop reasoning fails: the question asks for evolution between 2022 and 2024, requiring synthesis across years and disclosures. The LLM incorrectly portrays continuity in rates and increasing covenant complexity, missing the transition to SOFR and the shift in disclosure style. (5) While the answer is framed around the right topic (interest rate benchmarks and covenants), its factual inaccuracies severely undermine correctness. The contextual relevance is moderate because it addresses the general theme, but the substance is wrong. Overall, the answer reflects a fundamental misunderstanding of the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 452,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with franchisees evolved to emphasize co-investment strategies and modernization of franchise locations. The Company increasingly collaborates with franchisees to fund improvements through co-investment, aiming to enhance consumer appeal and restaurant performance. Additionally, McDonald's continues to own or secure long-term leases on land and buildings for conventional franchise locations, ensuring alignment with its real estate strategy to maintain brand consistency and operational control.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying McDonald's real estate ownership model (owning or securing long-term leases on land and buildings) and the co-investment strategy with franchisees for equipment, signs, and décor. It accurately reflects the evolution toward a more structured co-investment approach by 2024. There are no numeric values to verify, so quantitative accuracy is scored as 10. The answer captures the core shift described in the ground truth: from general collaboration in 2022 to a clearly defined co-investment and real estate strategy in 2024. However, it omits a specific mention of the 2022 emphasis on ESG initiatives and systemwide alignment, which provided important context for the earlier stage of franchisee relationship development. While the evolution is correctly characterized, this missing element slightly weakens the completeness of the multi-hop synthesis across 2022 and 2024. The reasoning is sound and semantically equivalent in key aspects, but the absence of ESG and systemwide coordination in 2022 prevents a perfect score. Contextual relevance is strong as all provided information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 337,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective October 26, 2022, as noted in the 2022 10-K (page 110). By 2023, this plan remained in effect, with no further amendments indicated in the 2023 10-K (page 107). This continuity suggests that Altria's governance approach to director compensation emphasizes stability and long-term alignment, maintaining a structured and shareholder-approved framework for non-employee director equity compensation.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the October 26, 2022 amendment date and references the correct filing (2022 10-K, page 110), which aligns with the ground truth. However, it omits the key quantitative detail from 2022—703,256 shares available for issuance—which is a significant factual component of the original answer. This omission reduces completeness and quantitative accuracy. (2) The LLM claims the plan remained in effect in 2023 with no further amendments, but the ground truth states the amended plan was incorporated by reference from the September 30, 2022 Form 10-Q, indicating the 2023 documentation reflects the updated plan, not just continuity. The LLM misinterprets the lack of new amendments in the 2023 10-K as stability, when in fact the plan had been formally restated. (3) The multi-hop reasoning is partially sound—linking 2022 amendment to 2023 status—but fails to recognize that the incorporation by reference constitutes an important documentation update. The conclusion about 'stability' contradicts the ground truth's interpretation of active refinement in governance. (4) While the LLM addresses both parts of the question (status change and governance implication), its factual omissions and incorrect inference on governance approach reduce correctness. Quantitative accuracy is moderate due to missing share number; qualitative accuracy suffers from flawed reasoning; contextual relevance is high as it stays on topic and cites appropriate sources.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 413,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "The impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity has intensified from 2022 to 2024, as these arrangements increasingly serve as alternatives to leasing infrastructure directly from AMT. In 2022, the filings noted that such arrangements could slow new lease activity or lead to decommissioning of equipment on existing sites. By 2024, the filings emphasize that extensive sharing of infrastructure, including through roaming or resale, is a growing concern, particularly with the deployment of 5G, and is directly linked to competitive pressures that are affecting new lease growth. This evolution indicates that wireless providers are increasingly relying on shared networks rather than expanding their own infrastructure, which is reducing demand for AMT's leasing services and constraining its growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: the evolution from 2022 to 2024 is properly captured, with roaming and resale arrangements initially posing a risk to new lease activity and later expanding to include RAN sharing and potential decommissioning. The mention of 5G deployment as a driver is consistent in both answers. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10 since no numbers are misstated. (3) The multi-hop reasoning is sound—information is correctly synthesized across years (2022 to 2024) and concepts (roaming/resale → infrastructure sharing → impact on leasing and decommissioning). The only minor shortcoming is that the LLM answer combines 'roaming or resale' with decommissioning in 2022, while the original answer specifies that decommissioning became a more explicit risk by 2024 due to RAN sharing. This slightly overstates the 2022 risk, but the overall trajectory is correct. (4) The answer is fully relevant, addressing both the evolution of the impact and the implication for competitive pressures on lease growth. Wording differs but semantic meaning is equivalent. Thus, correctness is 9 due to minor imprecision in timing of decommissioning risk, but all other aspects are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 375,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize strategic investment and operational alignment. The company has increased collaboration with franchisees to modernize restaurants and enhance customer experiences through technology and digital initiatives. Additionally, McDonald's has reinforced operational expectations by requiring franchisees to meet rigorous standards and invest in their businesses, ensuring consistency and quality across the system. This approach reflects a stronger partnership model aimed at driving long-term growth and profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in McDonald's relationship with franchisees from 2022 to 2024. It correctly identifies the shift toward strategic investment and operational expectations, including restaurant modernization, technology adoption, and franchisee reinvestment. While it does not explicitly mention the 'Accelerating the Arches' strategy or the pandemic-related challenges emphasized in 2022 (such as labor shortages and supply chain disruptions), it accurately reflects the 2024 shift toward co-investment and higher operational standards. The answer lacks specific reference to structured co-investment initiatives or the strategic pivot from pandemic response to growth, which are key nuances in the ground truth. However, the overall reasoning is sound, and the qualitative description aligns with the direction of change. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no numbers were cited), and the response is fully relevant to the question. Minor omissions prevent a top score, but the core message is factually consistent and well-synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 320,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "NextEra Energy's investment strategy in equity securities within its Special Use Funds evolved from 2022 to 2024 by increasing the fair value of these investments. In 2022, the carrying amount of Special Use Funds was $8,922 million, and by 2024, it had increased to $1,342 million for NEE and $915 million for FPL, with corresponding estimated fair values of $1,343 million and $916 million, respectively. This indicates a strategic growth in the value of equity securities held in these funds over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, NextEra Energy held $8,922 million in Special Use Funds with no explicit breakdown of equity securities. By 2024, $6,164 million was specifically allocated to equity securities within those funds. However, the LLM incorrectly states that the carrying amount increased to $1,342 million for NEE and $915 million for FPL in 2024, which contradicts the ground truth. These numbers do not reflect the total Special Use Funds or the equity allocation as reported. Additionally, the LLM implies growth in equity investments, but the total Special Use Funds actually decreased from $8,922 million to a disclosed equity portion of $6,164 million, not an increase. (2) The quantitative values are largely incorrect: the LLM introduces NEE and FPL splits not present in the original answer and fabricates fair value figures ($1,343M, $916M) that are unsupported by the ground truth. There is no mention in the original answer of fair value estimates or separate reporting for NEE and FPL in this context. (3) The multi-hop reasoning is flawed. The original answer infers a shift in transparency and strategy based on the emergence of a detailed equity breakdown in 2024 versus none in 2022. The LLM fails to capture this nuance and instead invents a narrative of value growth that is not supported. It does not recognize that the 2022 filing lacked a breakdown while 2024 provided one—a key qualitative shift. (4) The contextual relevance is moderate because the LLM addresses investment strategy evolution in Special Use Funds over time, but the factual foundation is incorrect, undermining the analysis. Due to major errors in numbers, entities, and reasoning, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 488,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a slight decline in net revenues, which decreased from $22,476 million in 2022 to $21,756 million in 2023. However, operating income remained relatively stable, decreasing only slightly from $10,688 million in 2022 to $10,670 million in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: net revenues decreased from $22,476 million in 2022 to $21,756 million in 2023, and operating income declined from $10,688 million to $10,670 million. These values match the ground truth exactly, with acceptable formatting ($X million). (2) Quantitative accuracy is perfect—both revenue and income figures are correct, and the description of a 'slight' or 'marginal' decline is consistent with the small absolute changes (e.g., $720M revenue drop, $18M income drop). (3) The reasoning is sound and synthesizes the correct metrics across two years for the smokeable products segment. The conclusion of a slight decline in revenues and stable operating income is logically supported. (4) The only minor deviation from the original answer is the characterization of operating income as 'relatively stable' rather than explicitly stating it 'declined,' though the correct numbers are provided and the word 'slightly' is used. This does not constitute a factual error but a slight softening of tone. All parts of the question (net revenues and operating income across 2022–2023) are addressed. Thus, the answer is factually complete and accurate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 349,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "Between 2022 and 2023, the utilization of Accenture plc Class A Ordinary Shares through share purchase programs remained focused on open-market repurchases and employee-related activities. In fiscal 2022, Accenture repurchased 12,180,917 Class A shares for $4.11 billion, primarily through open-market purchases, with shares intended for use in employee benefits and equity awards. By fiscal 2023, while specific repurchase figures are not provided in the given pages, the company continued its share repurchase programs under the existing authorization, which had increased to $6.13 billion by the end of fiscal 2022. Shares were also used for employee share plans, including share withholding for tax obligations and equity awards under the 2010 Share Incentive Plan and Employee Share Purchase Plan.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Accenture had an aggregate available authorization of $3,129,296 (approximately $3.13 million), not $6.13 billion as claimed by the LLM. The LLM incorrectly reports that 12,180,917 shares were repurchased for $4.11 billion in fiscal 2022, which is not supported by the original answer and contradicts the disclosed authorization amount. There is no mention of such specific repurchase volume or value in the ground truth. Additionally, the increase to $6.13 billion by end of fiscal 2022 is false and inconsistent with the provided data. (2) The original answer does not provide any repurchase volume or dollar amount beyond the remaining authorization; thus, the LLM fabricated precise figures without basis. The only correct number implied is the $3.13 million authorization in 2022 (though the LLM misstates it), and no quantitative data is provided for 2023. (3) The qualitative reasoning partially aligns with the shift toward employee benefits: the LLM correctly identifies that shares were used for employee equity awards and tax withholding, which matches the ground truth’s mention of share withholding in fiscal 2024. However, it misattributes these activities to 2023 and conflates them with the broader buyback program, failing to distinguish between authorized open-market repurchases and separate employee-related share withholdings. The multi-hop synthesis is flawed because it invents data rather than accurately tracing the evolution from 2022 to 2023 based on disclosed authorizations and usage intent. (4) Contextual relevance is moderate because the LLM addresses share purchase programs and employee usage, which are central to the question, but the severe quantitative errors and invented details undermine factual reliability. Correctness score is low due to major factual and numerical inaccuracies despite some alignment in thematic elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 533,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "Between 2022 and 2024, AMT's operating covenants have evolved to include more structured securitization arrangements and refinements in interest rate benchmarks. In 2022, the covenants primarily involved traditional debt instruments such as term loans and credit facilities, with interest rates tied to LIBOR or EURIBOR plus a fixed margin (e.g., 1.125%). By 2024, AMT expanded its use of securitized debt, including the 2023 and 2018 Securitizations, which feature fixed interest rates (e.g., 5.490% and 5.735% for the 2023 Securities) and deferred principal repayment until specific dates (e.g., March 2028). Additionally, the covenants now emphasize debt service coverage ratios (DSCR) and reserve account requirements to ensure liquidity and compliance with financial metrics, reflecting a more structured and risk-mitigated approach to debt management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of AMT's operating covenants between 2022 and 2024, particularly regarding interest rate benchmarks. (1) The ground truth states that in 2022, AMT's covenants were tied to LIBOR and EURIBOR-based facilities such as the 2021 Multicurrency Credit Facility and 2021 Credit Facility, with no mention of securitizations or fixed-rate instruments like the '2023 and 2018 Securitizations'—these are not supported by the original answer and appear fabricated. (2) The LLM claims specific fixed interest rates (5.490%, 5.735%) and a repayment date (March 2028), which are entirely absent from the ground truth and cannot be verified; these numbers are therefore incorrect. (3) The key evolution identified in the original answer—the shift from LIBOR/EURIBOR to SOFR for Nigerian letters of credit by 2024—is completely missing from the LLM response. Instead, the LLM incorrectly suggests a shift toward securitized debt and DSCR-based covenants, which is not mentioned in the ground truth. (4) The multi-hop reasoning is flawed: the LLM invents new debt instruments and metrics rather than correctly synthesizing the transition in interest rate benchmarks. While the general theme of 'evolution in debt structure' is contextually relevant, the specific details are factually wrong. The answer is partially relevant in discussing covenant changes but fails on correctness and completeness. Minor credit is given for recognizing a shift in debt management approach, but core facts, entities, and benchmarks are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 439,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Between the 2023 and 2024 SEC filings, Disney+ Hotstar's subscriber base grew from approximately 36 million in 2024 to the same figure in 2023, indicating no significant change in the number of paid subscribers. However, the consolidation of Star+ into Disney+ in Latin America during June 2024 streamlined Disney's international streaming strategy by unifying its offerings, enhancing content breadth, and improving operational efficiency. This move allowed Disney to better compete in the region by providing a more cohesive and comprehensive service.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the subscriber evolution: it states that Disney+ Hotstar grew from 36 million in 2024 to the same figure in 2023, which reverses the timeline and implies no change but with incorrect year ordering. The original answer states that as of September 28, 2024 (in the 2023 filing), Disney+ Hotstar had 36 million subscribers. This phrasing is confusing but reflects that the 2023 filing reported data for the year ending September 28, 2024. However, the LLM misinterprets the timeline, suggesting growth between 2023 and 2024 when no change in number is indicated and reversing the years. (2) The consolidation date is partially correct — the original specifies that the merger occurred by the end of June 2024, which the LLM correctly identifies as June 2024. However, the LLM incorrectly implies that this affected Disney+ Hotstar’s subscriber count or was part of its evolution, when in fact the consolidation refers to Latin America, not the Hotstar market (primarily India and Southeast Asia). (3) The qualitative reasoning about the strategic impact — streamlining offerings, improving efficiency, enhancing competitiveness — aligns well with the original answer’s interpretation of the consolidation as a move toward unified branding and operational efficiency. This shows sound multi-hop reasoning in interpreting strategic intent, though it misapplies the geography. (4) The contextual relevance is high because the answer addresses both parts of the question and attempts synthesis, but the quantitative inaccuracy — especially the reversed timeline and incorrect linkage of Star+ consolidation to Hotstar — significantly undermines factual correctness. Hence, correctness score is 5 (partially correct with major errors), quantitative accuracy is low due to timeline reversal, qualitative reasoning is reasonable but flawed, and relevance remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 520,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "In 2022, approximately one-fifth of the company's employees were covered under collective labor agreements, with 21 agreements covering around 3,000 employees set to be renegotiated. By 2023, this number decreased slightly, with 20 agreements covering approximately 2,100 employees expected to be renegotiated. This indicates a reduction in the number of employees under collective labor agreements, suggesting a potential shift toward more direct labor management or a strategy to streamline labor negotiations, which the company believes will not disrupt operations or have a material financial impact.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in the number of employees covered under collective labor agreements from 3,000 in 2022 to 2,100 in 2023, aligning with the ground truth. However, it introduces the detail that 'approximately one-fifth of the company's employees' were covered, which is not present in the original answer and cannot be verified from the provided ground truth, making it an unsupported addition. The number of agreements (21 in 2022, 20 in 2023) is also not in the original answer and appears to be fabricated or inferred without basis. (2) The core numbers—3,000 and 2,100 employees expected to be renegotiated in the following year—are accurate and correctly compared, showing a decrease. Calculations or comparisons based on these numbers are sound, though the added specifics about agreement counts reduce quantitative precision. (3) The multi-hop reasoning is generally sound: the model correctly infers a strategic shift from the decline in employees involved in upcoming negotiations. The conclusion about streamlined negotiations or operational stability is consistent with the original's suggestion of a strategic shift, though it adds interpretation (e.g., 'direct labor management') not explicitly in the ground truth. (4) The answer is contextually relevant and addresses both parts of the question—change in employee numbers and strategic implication. While the core facts and direction of change are correct, the inclusion of unverified details (agreement counts, percentage of workforce) prevents a top score. Overall, the answer is factually aligned on the key metrics and reasoning, but with minor inaccuracies in ancillary details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 463,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "NextEra Energy's investment in U.S. Government and municipal bonds increased from 2022 to 2024. In 2022, the total value was $757 million (NEE: $700 million + FPL: $583 million). By 2024, the total value rose to $722 million (NEE: $663 million + FPL: $561 million). Thus, the change in total value was a decrease of $35 million over the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that NextEra Energy's investment in U.S. Government and municipal bonds was $137 million in 2022 and increased to $161 million in 2024, representing a $24 million increase. However, the LLM claims the investment decreased from $757 million in 2022 to $722 million in 2024, which is both numerically and directionally wrong. (2) The numbers cited by the LLM are fabricated: it incorrectly sums NEE and FPL values ($700M + $583M = $1.283B, not $757M), and the 2024 sum ($663M + $561M = $1.224B) also does not equal the stated $722M. These calculations are mathematically inconsistent and factually unsupported. The claimed decrease of $35M is therefore based on erroneous inputs and flawed aggregation. (3) The multi-hop reasoning fails completely: instead of pulling the correct 'Other investments' line for NEE alone, the model erroneously combines NEE and FPL (a subsidiary) data, misaggregates across years, and reports a trend opposite to the truth. It also introduces entities (FPL) and calculations not relevant to the specific metric asked. (4) The contextual relevance is low because the answer discusses a different financial figure and trend, despite addressing the general topic of bond investments. The qualitative reasoning is deeply flawed due to incorrect entity selection and synthesis. Only minimal credit is given for attempting to address investment trends over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 413,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "Between 2022 and 2024, Opdivo's role in Bristol-Myers Squibb's product portfolio has evolved with significant therapeutic approvals and a shift in manufacturing strategy. In 2024, Opdivo received multiple approvals, including FDA approval for first-line treatment of unresectable or metastatic urothelial carcinoma in combination with chemotherapy and EC approval for similar indications in Europe. Additionally, Opdivo Qvantig, a subcutaneous formulation, was approved in December 2024 for multiple previously approved indications, enhancing patient accessibility. In terms of manufacturing, the company has increasingly relied on third-party manufacturers for Opdivo, while maintaining internal production capabilities to ensure supply stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2024 FDA approval for Opdivo in combination with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, aligning with the ground truth. It adds value by mentioning the EC approval in Europe and the December 2024 approval of Opdivo Qvantig, a subcutaneous formulation, which are factually consistent with BMY's 2024 developments, though not included in the original answer. However, the original answer specifies the March 2024 FDA approval date, which the LLM omits, instead generalizing to '2024'. This minor imprecision affects quantitative accuracy slightly. (2) The manufacturing strategy is accurately described: the LLM correctly states that BMY uses both third-party and internal manufacturing, consistent with the 2022 context and ongoing strategy. There are no numerical figures requiring calculation, but the temporal references (2022, 2024) are correct. The mention of 'increasingly relied' on third parties introduces a subtle interpretive shift not present in the original, which neutrally states 'reliance on third-party manufacturers' without implying a trend. (3) Multi-hop reasoning is sound: the LLM synthesizes manufacturing strategy (from 2022 context) with new 2024 approvals, correctly linking evolution in both clinical and operational dimensions. The addition of Opdivo Qvantig and EC approval shows broader knowledge, though not required for correctness. (4) The answer is contextually excellent, fully addressing both manufacturing and therapeutic evolution. The correctness score is 8 due to minor omission of the March 2024 specificity and slight interpretive language around manufacturing reliance, but core facts, entities, and reasoning are accurate and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 489,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, National Geographic magazine has remained part of Disney's Entertainment segment, specifically under Content Sales/Licensing, with Disney owning 73% of the business. There is no indication of structural changes to Disney's ownership or positioning of National Geographic magazine during this period. The magazine continues to be reported within the Entertainment segment alongside other content-related activities, such as film and television distribution. No major strategic repositioning or divestiture of National Geographic magazine is noted in the provided documents.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. While it correctly states that National Geographic magazine was 73% owned by Disney and part of the Entertainment segment under Content Sales/Licensing in 2023, it fails to identify the key change in 2024. The ground truth indicates a shift in how Disney reports its relationship—moving from emphasizing 73% ownership to describing the magazine as merely 'published' by the company, with no mention of ownership percentage. The LLM incorrectly asserts there was 'no indication of structural changes' and 'no major strategic repositioning,' which directly contradicts the ground truth that shows a clear shift toward a more operational, less ownership-focused relationship. (2) Quantitatively, the 73% ownership figure is accurate for 2023, and the years (2023–2024) are correct. However, the answer does not note the absence of the ownership percentage in 2024, which is a critical data point. (3) The multi-hop reasoning is flawed: the model should have compared the language and framing of National Geographic's role across the two years’ reports and inferred a strategic shift in reporting emphasis, which implies a change in business structure perception. Instead, it assumed no change due to continued segment classification, missing the nuance in ownership disclosure. (4) Despite accurate numbers and relevant context, the answer misses the central evolution in Disney's strategic positioning of National Geographic, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer discusses the right entities and segment but draws the wrong conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 460,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "Between 2023 and 2024, PayPal's description of its transaction management databases' capabilities related to global payment processing in different currencies has shown slight but notable evolution. In 2023, PayPal stated that consumers could send payments in approximately 150 currencies and withdraw funds in 56 currencies. By 2024, this was updated to 140 currencies for sending payments and 57 currencies for withdrawals, indicating an expansion in the number of supported currencies. This evolution reflects PayPal's ongoing efforts to enhance its global payment processing capabilities and support a broader range of international transactions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that PayPal supported 56 currencies for withdrawals in 2023 and 57 in 2024 (matching the ground truth), it introduces unsupported claims about sending payments in 'approximately 150 currencies' in 2023 and '140 currencies' in 2024. The ground truth does not mention sending capabilities or these specific numbers, making this a major factual error. There is no indication in the original answer that PayPal reduced the number of sendable currencies from 150 to 140, which contradicts the narrative of expansion. (2) The quantitative accuracy is low because the core numbers related to sending payments are fabricated or misattributed. The withdrawal figures (56 to 57) are correct and align with the ground truth, but the addition of sending currency data — especially with a decrease from 150 to 140 — undermines the accuracy. No such regression is indicated in the original answer, which only notes an increase in withdrawal currencies. (3) The reasoning is partially sound in identifying a trend of evolution in PayPal's capabilities, but it fails on multi-hop synthesis. The original answer emphasizes a shift in language (consumer-centric framing, order change from merchants to consumers), which the LLM completely omits. This missing qualitative nuance represents a failure to capture a key aspect of the evolution described in the ground truth. (4) Contextual relevance is high because the answer addresses the core topic — evolution of transaction management databases in relation to multi-currency processing — and attempts to compare years and capabilities. However, the inclusion of incorrect metrics and omission of key descriptive shifts result in a partially correct but misleading response. The answer gives the impression of a broader data set than supported, reducing overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 515,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The interest rate terms associated with the Series K Debentures increased significantly between 2023 and 2024, with the rate resetting to 6.051% per year in March 2023 and remaining unchanged in 2024. This indicates that NEE is adapting to rising interest rates by locking in higher fixed rates for long-term financing, which suggests a strategy to manage interest rate risk and stabilize its debt costs over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key fact that the Series K Debentures were reset to 6.051% per year in March 2023, which matches the ground truth. It also accurately states that the rate remained unchanged in 2024, which is consistent with the original answer noting that updated terms from the March 1, 2023 letter were effective and continued into 2024. (2) All numeric values (6.051%, March 2023) are correct and precisely match the ground truth. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes the timing and nature of the rate reset and infers continuity into 2024 based on the effective terms. However, it omits mention of the March 1, 2023 letter that formalized the terms, which is a minor but relevant procedural detail in the financing strategy. (4) The qualitative interpretation about NEE locking in higher rates to manage interest rate risk and stabilize debt costs is logically sound and aligns with the ground truth's conclusion about adjusting financing strategy in response to market conditions. The answer is semantically equivalent and contextually appropriate, with only a slight omission of a procedural detail preventing a perfect 10 on qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 352,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil continued to apply the Unit-of-Production (UOP) depreciation method for most upstream assets, using proved reserve volumes as the basis for calculating depreciation rates. The method remained consistent, with depreciation calculated as the ratio of asset cost to total proved reserves or proved developed reserves, applied to actual production. However, the Corporation noted that changes in proved reserves—due to factors such as price fluctuations, development strategies, or technical revisions—could impact the UOP rates. In cases where UOP did not equitably allocate costs over the asset's economic life, the Corporation used the straight-line method for certain assets with shorter useful lives than their associated reserves. In 2023, the Corporation emphasized that it would adjust depreciation calculations using the most recent SEC price when reserves were substantially de-booked, ensuring a more meaningful allocation of costs. This approach reflects a continued reliance on reserve estimates and market conditions to guide depreciation practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: ExxonMobil used the Unit-of-Production (UOP) method based on proved or proved developed reserves in both 2022 and 2023, switched to straight-line when asset life didn't align with reserves, and applied SEC price-based reserves when reserves were substantially de-booked. The evolution in 2023—greater emphasis on using the most recent SEC price in depreciation calculations after significant reserve reductions—is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages, reserve volumes) in either answer, so quantitative accuracy is not compromised; all references to time (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information about depreciation methodology, triggers for method changes, and the impact of reserve changes and pricing assumptions across two years. The only minor shortcoming is that the LLM answer frames the 2023 change as a general 'emphasis' rather than explicitly stating it as a refinement to align with updated economic conditions and production realities, which slightly reduces qualitative precision. (4) The response is fully contextually relevant, directly addressing the evolution of UOP application in response to reserve and asset life assumptions. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 412,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "Between 2023 and 2024, Netflix has increasingly scaled its internal studio operations to produce original programming, as highlighted by its acquisitions of companies like Scanline and Animal Logic. This shift reflects a strategic move to reduce reliance on third-party production partners and enhance in-house capabilities for content creation. While third-party collaborations remain part of the ecosystem, the emphasis on internal studio growth underscores Netflix's aim to maintain greater control over production quality, costs, and creative output to sustain its competitive edge in original content.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies Netflix's strategic shift toward internal studio scaling through acquisitions like Scanline and Animal Logic in both 2023 and 2024, and notes the reduced reliance on third-party production partners. The answer captures the core evolution: a move toward greater internal control over original content production. However, it omits a specific detail present in the original answer — the explicit mention in 2023 of risks associated with third-party partners (e.g., legal violations, insolvency, fraud) and the fact that this risk language was dropped in 2024, which strengthens the inference of reduced dependency. While the LLM implies this shift, it does not fully reflect the change in disclosure tone between years, which is a subtle but important part of the multi-hop reasoning. All entities (Netflix, Scanline, Animal Logic), timeframes (2023–2024), and strategic themes (internal scaling, reduced third-party reliance) are correct. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and the answer remains highly relevant to the question. The reasoning is sound but slightly less nuanced than the ground truth in capturing the shift in risk disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 364,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "Between 2022 and 2023, Mastercard's Cyber and Intelligence Solutions evolved to become a more integral part of its value-added services, emphasizing fraud prevention, transaction security, and data-driven insights. The 2023 filing highlights these solutions as essential for enabling secure and confident transactions across all stakeholders, reflecting a strategic shift toward enhancing security and leveraging data analytics to support the broader payments ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Mastercard's Cyber and Intelligence Solutions from 2022 to 2023 with high factual accuracy. (1) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM accurately reflects the strategic shift: in 2022, the solutions were part of 'Other revenues' focused on fraud prevention; by 2023, they were elevated to a value-added service enabling secure transactions across the broader payments ecosystem. The core elements—fraud prevention, transaction security, data-driven insights, and expanded role—are all present. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and correctly infers the strategic elevation of the service. The only minor omission is that the LLM does not explicitly mention that in 2022, Cyber and Intelligence Solutions were categorized under 'Other revenues', which is a small but relevant contextual detail from the ground truth. However, this does not undermine the overall correctness. (4) The answer is semantically equivalent to the original, uses appropriate terminology, and directly addresses the question with relevant and accurate context, warranting full marks for contextual relevance. The qualitative accuracy is slightly reduced due to the omitted detail about revenue classification in 2022, but the strategic evolution is correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 398,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "From 2023 to 2024, Tesla's approach to energy storage products has evolved with a stronger focus on scaling production and addressing supply chain dependencies. In 2023, Tesla emphasized the modular design of its energy storage systems and the integration of vehicle technologies to optimize manufacturing, while also highlighting the importance of battery cell supply from partners like Panasonic and CATL. By 2024, Tesla expanded its production capabilities, including the development of new Gigafactories, and acknowledged the need to grow its access to battery cells through both supplier partnerships and in-house manufacturing. Additionally, Tesla faced production challenges, such as supplier constraints and the need for localized procurement, which required significant investment and management of global supply chain risks. Strategic dependencies on raw materials like lithium and nickel also remained a concern, with Tesla working to mitigate these through vertical integration and cost control initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's evolving focus from modular design and integration in 2023 to scaling production and supply chain management in 2024, which aligns with the ground truth. However, it introduces details not present in the original answer, such as specific partnerships with Panasonic and CATL, development of new Gigafactories, and vertical integration efforts for raw materials like lithium and nickel. While plausible, these specifics are not supported by the ground truth and represent over-enrichment. The core evolution in strategy—modular design and in-house software/power electronics in 2023 shifting to production ramp and supply chain bottlenecks in 2024—is accurately captured. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised; the years 2023 and 2024 are used correctly. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift over time and synthesizes production challenges and dependencies. However, it adds unverified entities (Panasonic, CATL, Gigafactories) and specific mitigation strategies (localized procurement, vertical integration) that were not in the original, reducing qualitative accuracy. (4) The correctness score is 7 because the central theme and timeline are accurate, but the added details introduce potential inaccuracies. Quantitative accuracy is 10 due to absence of numerical errors. Qualitative accuracy is 7 due to correct reasoning but unsupported additions. Contextual relevance is 9 as the response stays focused on the question and covers the key evolution, challenges, and dependencies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 458,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "From 2023 to 2024, NextEra Energy Capital Holdings (NEECH) expanded its issuance strategy for floating rate debentures by significantly increasing the principal amount and extending the maturity structure. In 2023, NEECH issued $400 million in floating rate debentures due in 2024. By 2024, the principal amount increased to $600 million, with a maturity date of 2026, indicating a longer-term approach. Additionally, in January 2024, NEECH issued $600 million of floating rate debentures due in 2026 as part of a broader issuance strategy that included a mix of fixed and floating rate instruments with maturities extending to 2054. This evolution reflects a shift toward diversifying maturity dates and increasing the scale of floating rate debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. However, the LLM incorrectly states that in 2023, NEECH issued $400 million due in 2024, which is factually wrong on both amount and maturity. The LLM correctly notes a $600 million issuance in 2024 due in 2026, aligning with the ground truth, but incorrectly frames it as an 'increase' from $400 million in 2023. (2) The quantitative inaccuracies are severe: the 2023 principal amount is wrong ($400M vs $600M), and the 2023 maturity date is incorrect (2024 vs 2026). The LLM also fabricates a broader issuance strategy in 2024 with maturities extending to 2054, which is not mentioned in the original answer. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the continuity of the issuance strategy from 2023 to 2024. The ground truth emphasizes consistency in maturity (2026) and no significant change in strategy, while the LLM incorrectly infers an expansion and diversification. (4) The contextual relevance is moderate because the answer addresses the topic of issuance strategy evolution and mentions relevant instruments and dates, but the core facts are incorrect, undermining the analysis. The qualitative reasoning is weak due to incorrect premises leading to invalid conclusions about strategic shifts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 405,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "From 2023 to 2024, Intel's approach to industry initiatives related to supply chain responsibility has evolved by expanding collaboration and supplier engagement. In 2023, the focus was on directly engaging suppliers to verify compliance and build capacity to address risks such as forced labor and human rights issues, with periodic audits and capability-building programs for critical direct suppliers. By 2024, Intel significantly expanded the number of suppliers covered by its engagement activities and began actively measuring and reducing suppliers' greenhouse gas emissions to support its net-zero upstream Scope 3 emissions goal by 2050. Additionally, the company increased its commitment to supplier diversity by setting new spending targets with women-owned and minority-owned suppliers globally.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly references Intel's RISE strategy, net-zero upstream Scope 3 emissions goal by 2050, and supplier engagement, it misrepresents the evolution from 2023 to 2024. The ground truth states that in 2023, Intel announced an expansion of supplier engagement and set the net-zero goal, while in 2024 the focus shifted to deeper collaboration on responsible minerals, climate, and water transparency—without explicit mention of expanding the number of suppliers. The LLM incorrectly claims that in 2024 Intel 'significantly expanded the number of suppliers covered,' which contradicts the ground truth indicating a shift away from expansion announcements. Additionally, the LLM introduces new information—'setting new spending targets with women-owned and minority-owned suppliers globally'—which is not present in the original answer and cannot be verified. (2) There are no specific numerical values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not heavily penalized, but the misrepresentation of strategic direction (expansion in 2024) constitutes a factual error. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift from announcing strategic expansions (2023) to reinforcing existing partnerships (2024), instead portraying a continued expansionist approach. This mischaracterizes the evolution of Intel's strategy. (4) Contextual relevance is high because the answer addresses supply chain responsibility, collaboration focus, and supplier engagement scope. However, correctness and qualitative accuracy are low due to factual misstatements and introduction of unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 478,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "Between 2022 and 2023, XOM's framing of its dependency on first-day-of-the-month average prices in the standardized measure of discounted future cash flows remained consistent in acknowledging that these prices represent discrete points in time and may cause significant variability in cash flows. However, in 2023, the company emphasized more explicitly its belief that the standardized measure does not provide a reliable estimate of its expected future cash flows or the value of its proved reserves, reinforcing its critique of the methodology's limitations.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in XOM's disclosure tone and emphasis between 2022 and 2023. (1) What was correct: The answer correctly notes that XOM acknowledged the use of first-day-of-the-month prices as discrete points that may cause variability, and it accurately reflects XOM's 2023 critique of the standardized measure as unreliable for estimating future cash flows. These points align with the broader context of the company's skepticism. (2) Quantitative accuracy: There are no numerical values in the question or answer requiring verification (e.g., discount rates, prices), so this aspect is neutral. The 10% discount factor, year-end costs, and tax rates mentioned in the ground truth are not referenced in the LLM answer, but since they weren't the focus of the LLM's claim, this is a completeness issue rather than a quantitative error. (3) Multi-hop reasoning assessment: The LLM fails to capture the core evolution highlighted in the ground truth — the shift from describing the assumptions as 'prescribed' (2022) to stating the measure 'depends on' them (2023), which signals a stronger acknowledgment of sensitivity and dependency. This is a critical omission in the qualitative shift. Instead, the LLM focuses on XOM's general critique of the methodology's reliability, which, while present in the 2023 filing, does not directly address the change in framing around dependency on pricing assumptions. (4) Justification for scores: Correctness is scored 5 because the answer gets some context right (XOM’s skepticism) but misses the central point about evolving language from 'prepared on the basis of' to 'depends on' — a key semantic and strategic shift. Qualitative accuracy is 5 due to flawed reasoning in capturing the evolution. Quantitative accuracy is 10 because no numbers are misstated. Contextual relevance is 8 because the answer stays on topic and discusses relevant disclosure trends, even if it misidentifies the primary change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 537,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "Between 2022 and 2023, Mastercard's digital identity solutions evolved significantly, particularly in their integration with open banking capabilities and reach across financial institutions. In 2023, Mastercard expanded its open banking platform to provide connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks in Europe, directly and through partners. This expansion enabled seamless and secure consumer bill payments via a new ACH payment solution. Additionally, Mastercard enhanced its digital identity solutions by incorporating device intelligence, behavioral biometrics, document proofing, and IP intelligence to strengthen and secure digital payments across individuals, devices, and accounts. These advancements reflect Mastercard's commitment to providing secure, consent-centric, and privacy-by-design solutions that support financial inclusion and improved customer experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of MA's digital identity solutions between 2022 and 2023, with accurate emphasis on open banking integration and expanded reach. It correctly states that in 2023, MA achieved connectivity to over 95% of U.S. deposit accounts and approximately 3,000 banks in Europe—matching the ground truth exactly. The mention of the ACH payment solution using open banking infrastructure is also factually correct and contextually aligned. (2) Quantitative accuracy is perfect: the percentages and numbers (95%, 3,000 banks) are correctly reported, and no erroneous figures are introduced. (3) The multi-hop reasoning is sound—linking the expansion of open banking to enhanced digital identity reach and new payment solutions demonstrates synthesis across capabilities and time. However, the LLM omits explicit mention of 2022's foundational launch of the digital identity solutions on an open banking platform, instead starting the narrative in 2023. While it implies progression, the absence of a direct reference to 2022's initiative slightly weakens completeness in the year-over-year evolution. Additionally, the LLM adds details about 'device intelligence, behavioral biometrics, document proofing, and IP intelligence' not present in the ground truth, which, while plausible, are not verifiable from the original data and introduce unconfirmed enhancements. (4) Despite minor omissions and slight over-enrichment, the core facts, numbers, and synthesis are accurate and highly relevant to the question. The answer effectively conveys the expanded reach and deeper integration of digital identity via open banking, justifying a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 467,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to the Solar Roof product has evolved with a focus on addressing production challenges and strategic dependencies. In 2023, Tesla emphasized improving installation capability and efficiency, including collaborations with real estate developers and builders on new homes. By 2024, the company faced ongoing production ramp challenges, as noted in risk factors, including potential supplier issues and the need to scale localized manufacturing. Additionally, Tesla's strategic dependencies on suppliers for components and the development of in-house battery cell capabilities became more pronounced, highlighting the need to secure supply chains and reduce reliance on external partners to meet production goals.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and entity representation compared to the ground truth. (1) Correct elements: The mention of production ramp challenges in 2024 aligns with the original answer, and the general theme of strategic dependencies is relevant. However, the specific details about 'collaborations with real estate developers and builders' in 2023 are not present in the ground truth, which instead emphasizes design maturity, aesthetic appeal, and integration with Powerwall. (2) Quantitative accuracy is high because there are no numerical values or dates that are incorrect—only qualitative misrepresentations. (3) Multi-hop reasoning is flawed: the original answer highlights a strategic prioritization shift due to Tesla's dependence on mass-market vehicle production, which indirectly affects Solar Roof. The LLM instead invents supplier dependencies and in-house battery cell development as central to Solar Roof’s challenges, which is not supported in the ground truth. This misattributes strategic dependencies to supply chain and component suppliers rather than the correct emphasis on internal resource allocation toward vehicle production. (4) Contextual relevance is moderate—the answer addresses production challenges and strategic dependencies as asked, but misrepresents the nature and source of those issues, leading to a misleading conclusion about Tesla's evolving approach. The core evolution described in the ground truth—shifting from product maturity emphasis to acknowledging delays and indirect deprioritization—is not captured accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 443,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "NextEra Energy, Inc. introduced new Pledge Agreements in both 2023 and 2024. In 2023, a Pledge Agreement dated September 1, 2022, was listed, involving Deutsche Bank Trust Company Americas as Collateral Agent and The Bank of New York Mellon as Purchase Contract Agent. In 2024, a new Pledge Agreement dated June 1, 2024, was added, maintaining the same counterparties. Additionally, another Pledge Agreement dated October 1, 2024, was introduced, continuing with the same entities as Collateral Agent and Purchase Contract Agent. These agreements reflect ongoing arrangements with consistent counterparties but with updated effective dates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2023 disclosure of a Pledge Agreement dated September 1, 2022, and the introduction of two new agreements in 2024 dated June 1, 2024, and October 1, 2024, with the same counterparties—Deutsche Bank Trust Company Americas and The Bank of New York Mellon—are accurately reported. (2) Quantitative accuracy is perfect: all dates are correct and match the original answer. The LLM even adds slightly more detail by specifying the roles of the counterparties (Collateral Agent and Purchase Contract Agent), which is consistent with typical SEC filing language and adds value without introducing error. (3) The reasoning is sound: the answer correctly synthesizes information across years and identifies the evolution in timing and structure of the agreements. The only minor shortcoming is that the original answer emphasizes the 'evolution' and 'expansion over time' more explicitly, while the LLM focuses on 'ongoing arrangements'—a slight difference in emphasis but not in substance. (4) The answer is fully contextually relevant, addressing both the dates and counterparties as asked. No irrelevant information is included. Overall, this is a strong, factually correct response with only a negligible difference in framing, warranting a 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 378,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "From 2023 to 2024, Intel strengthened its strategic positioning in Edge AI by expanding its software platform offerings and deepening ecosystem partnerships. In 2024, Intel emphasized open software frameworks and edge-native platforms to enable developers to build, deploy, and manage distributed edge infrastructure and AI applications. This included modular, flexible software solutions optimized for network, IoT, and hybrid AI workloads. Additionally, Intel expanded collaborations with over 500 ecosystem partners, including major players like Ericsson, Nokia, and Microsoft, to drive software-defined transformations in edge and network infrastructure. These efforts reflect a shift toward a more integrated, software-driven edge AI strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Intel's Edge AI strategy from 2023 to 2024 with accurate qualitative details. (1) It correctly identifies Intel's focus on edge-native software platforms and modular building blocks in 2024, aligning with the ground truth's description of flexible, developer-focused infrastructure. The mention of open software frameworks and support for hybrid AI, network, and IoT workloads reflects the horizontal, scalable approach described in the original answer. (2) There are no explicit numbers in the ground truth, so quantitative accuracy is not compromised—the claim of 'over 500 ecosystem partners' is plausible and consistent with Intel's known ecosystem scale, though not explicitly verifiable from the provided ground truth. Since the ground truth mentions 'broader ecosystem partnerships' without a number, the LLM's inclusion of a specific count is an acceptable elaboration, not a factual error. (3) The multi-hop reasoning is sound: the LLM synthesizes Intel's software evolution and partnership expansion across time, correctly framing the shift toward a software-driven, integrated strategy. However, it omits the specific 'NEX initiative' and the strategic pivot from fixed-function hardware to cloud-native, programmable systems—a key differentiator in the 2024 strategy. This missing element slightly weakens the qualitative accuracy, as the NEX initiative is central to the transformation described in the ground truth. (4) Despite this omission, the answer remains contextually relevant and semantically aligned with the original, conveying the essence of Intel's strategic evolution. The use of terms like 'software-defined transformations' and 'cloud-native' aligns well with the ground truth's emphasis on programmability and collaboration. Thus, the answer is strong overall but loses minor points for missing a critical strategic initiative (NEX) that anchors the 2024 shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 526,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "The composition and value of CVS's long-term debt related to the 1.75% senior notes due August 2030 remained unchanged between 2023 and 2024, with both years reporting a value of $1,250 million. This indicates that there was no issuance, redemption, or material change in the value of these specific senior notes during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the value of the 1.75% senior notes due August 2030 remained unchanged at $1,250 million between 2023 and 2024, which matches the ground truth. All numeric values (percentage, maturity date, dollar amount, years) are accurate. (2) Quantitative accuracy is perfect: $1,250 million in both years, correct interest rate (1.75%), and correct maturity month and year (August 2030) are all correctly reported. (3) The reasoning is sound for the specific notes in question. However, the LLM does not mention other senior notes due in 2030 (e.g., the 3.75% notes due April 2030), which were included in the original answer to provide broader context on the composition of long-term debt. While the question focuses on the 1.75% notes, the original answer includes comparative information about other 2030 notes to illustrate overall debt composition trends. The LLM omits this comparative context, making its response less complete in terms of multi-hop synthesis across all 2030 senior notes. (4) Despite this omission, the core of the question—about the 1.75% senior notes due August 2030—is fully and accurately addressed with correct data and reasoning. The answer is semantically equivalent in scope to what was asked, though slightly less comprehensive than the original. Hence, a high score of 9 is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 395,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "Between 2023 and 2024, Netflix's ad-supported subscription plan evolved from being a newly introduced, lower-priced option to a more integrated component of its pricing strategy aimed at meeting diverse consumer needs and driving membership growth. In 2023, the plan was highlighted as a new addition to the company's offerings, while by 2024, it was positioned as part of a broader strategy to enhance accessibility and attract a wider audience, reflecting its growing importance in Netflix's approach to expanding its membership base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Netflix's ad-supported subscription plan from 2023 to 2024, accurately stating that it was introduced as a lower-priced option in 2023 and became a more integrated part of the pricing strategy by 2024. The core facts—its role in expanding membership, addressing diverse consumer needs, and improving accessibility—are consistent with the ground truth. (2) There are no numeric values, percentages, or financial figures in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2023 and 2024), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes the plan’s introduction in 2023 and its strategic integration by 2024, reflecting a shift from experimental to core offering. The only minor shortcoming is that the LLM answer does not explicitly mention the 'competitive pressures' or the 'value perception' aspect noted in the original answer, slightly reducing completeness in qualitative nuance. (4) Despite this, the LLM conveys the same essential information with high fidelity, uses semantically equivalent phrasing, and fully addresses the question’s focus on pricing strategy and membership growth objectives. Hence, correctness and contextual relevance are high, with only a slight deduction in qualitative accuracy for missing subtle strategic context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 390,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "Tesla's approach to the Tesla Semi evolved between 2023 and 2024, with the vehicle transitioning from early production to pilot production, as noted in the 2024 document. In 2023, the Tesla Semi was in early production and delivery stages, while by 2024, it had advanced to pilot production in Nevada, indicating progress in manufacturing readiness. Strategically, Tesla emphasized leveraging its proprietary technologies, such as battery cells and powertrain systems, to support the Semi's development and align it with broader goals of sustainable energy and manufacturing innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: in 2023, Tesla Semi was in early production and deliveries; by 2024, it advanced to pilot production at the Nevada facility. These details match the original answer exactly. (2) There are no numeric values requiring calculation (e.g., financial figures or dates), so quantitative accuracy is not compromised—dates (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two time points and infers a strategic progression in Tesla’s manufacturing approach. It appropriately identifies the evolution from initial rollout to a more structured scaling phase. (4) The LLM adds a small amount of contextual interpretation—mentioning proprietary technologies like battery cells and powertrains—which is plausible and consistent with Tesla’s broader strategy, though not explicitly stated in the ground truth. This addition does not introduce inaccuracies but slightly extends beyond the provided information. Therefore, while the core facts, entities, and timeline are fully accurate and the reasoning is logical, the slight expansion on strategic rationale (without contradicting the original) prevents a perfect 10. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 375,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 indicates a deliberate and strategic effort to ensure leadership continuity and reinforce the company's commitment to retaining key executive talent. By extending and adding new agreements for executives such as Brian Bolster in 2024, the company emphasizes the importance of stabilizing its leadership team, which is critical for executing long-term strategic goals. This suggests that NextEra Energy views its executive talent as a core asset and is proactively investing in retention mechanisms to maintain experienced leadership amid evolving business demands.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic implication of NextEra Energy's expansion of Executive Retention Employment Agreements from 2023 to 2024, emphasizing leadership continuity and talent retention. It accurately references the addition of Brian Bolster in 2024, which aligns with the ground truth. However, it omits specific details about the 2023 agreements with Mark Lemasney (January 1, 2023) and Armando Pimentel, Jr. (February 15, 2023), which were part of the original answer and provide important context for the expansion. (2) There are no numerical values or calculations in this question, so quantitative accuracy is based on correct dates and entity references. The LLM correctly identifies the 2024 agreement with Brian Bolster (dated May 6, 2024 in ground truth), though it does not specify the exact date. The absence of the 2023 signatories and dates reduces quantitative precision slightly. (3) The multi-hop reasoning is sound: the model infers from the expansion of agreements that NextEra is prioritizing leadership stability and talent retention, which is consistent with the ground truth's interpretation. It synthesizes the implication of adding new executives under retention plans as a proactive strategy. However, the lack of mention of the 2023 executives weakens the completeness of the cross-temporal comparison. (4) The answer is highly contextually relevant and well-articulated, focusing directly on leadership continuity and strategic emphasis on retention. The qualitative reasoning is strong, but the omission of key 2023 individuals prevents a perfect score. Overall, the answer is factually aligned in meaning but lacks full completeness in entity coverage across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 473,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "From 2023 to 2024, Intel's approach to xPU products has evolved with a stronger strategic focus on product competitiveness and ecosystem expansion. In 2024, Intel emphasized the x86 ecosystem and announced the formation of an advisory group to enhance compatibility and simplify software development across platforms. The company is advancing a broad xPU portfolio, including client and data center GPUs, IPUs, FPGAs, and accelerators, to address diverse computing needs. Additionally, Intel is integrating AI into its xPU strategy, aiming to deliver solutions across the AI continuum, from large language models to edge computing, leveraging its silicon, platforms, and packaging technologies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution from 2023 to 2024. (1) It accurately captures the shift toward product competitiveness and the formation of an advisory group to expand the x86 ecosystem, which matches the original answer. The inclusion of xPU components—GPUs, IPUs, FPGAs, and accelerators—is factually consistent. (2) There are no numeric inaccuracies; the LLM does not introduce any incorrect figures, though it omits the specific $16.0 billion R&D expenditure mentioned in 2023. This omission affects completeness but not quantitative accuracy, as no numbers are wrong. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift and connects xPU development to broader ecosystem and AI initiatives. However, it adds a detail about 'AI continuum' and 'large language models' not present in the ground truth, which, while plausible, is not supported by the provided data and slightly extends beyond the original answer. (4) The answer is highly contextually relevant and addresses both strategic focus and product development priorities. The main shortcoming is the omission of 2023 R&D spending and the associated challenges (delays, cost overruns), which were part of the original answer’s baseline for comparison. Despite this, the core evolution in strategy is correctly conveyed, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 392,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "Between 2023 and 2024, Netflix has focused on developing and expanding its advertising technology infrastructure to support its growing advertising business. In 2023, the company highlighted the need to build the technology and related infrastructure to support advertising and drive value for advertisers. By 2024, this effort had evolved to include a stronger emphasis on organizational development, specifically the expansion of an advertising sales and advertising technology organization team. This indicates a strategic shift toward not only building the technical capabilities for ad delivery and measurement but also strengthening the internal team responsible for managing and scaling the advertising business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Netflix's advertising technology approach between 2023 and 2024. (1) It correctly identifies the shift from infrastructure development in 2023 to organizational expansion in 2024. The key elements—building technology infrastructure and expanding the advertising sales and tech team—are accurately reflected. (2) There are no numeric values, dates, or calculations in the question or ground truth beyond the years 2023 and 2024, which are correctly used. (3) The multi-hop reasoning is sound: the model synthesizes Netflix’s changing focus across two years, correctly inferring a strategic shift from external reliance to internal capability building, even though the LLM answer slightly reverses the emphasis (it states infrastructure was a 2023 focus and organization in 2024, while the original answer notes that in 2023, Netflix emphasized its lack of experience and dependency on third parties, and in 2024 highlighted proactive development of both tech and teams). This is a minor nuance—the overall trajectory is correctly captured. (4) The answer is contextually excellent, directly addressing both organizational development and infrastructure investment as asked. The only reason for not scoring a 10 is that the LLM slightly misrepresents the 2023 emphasis: the original answer stresses Netflix's limited experience and risks in 2023, not active infrastructure building. Thus, the qualitative accuracy is slightly reduced, but the overall correctness remains high due to accurate portrayal of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 435,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "Between 2023 and 2024, Tesla's free Supercharging program has remained a component of deferred revenue related to automotive sales, with no significant structural changes indicated. In both years, deferred revenue related to free Supercharging, along with other features like FSD and over-the-air updates, showed a slight increase in the deferred revenue balance, from $3,536 million in 2023 to $3,599 million in 2024. Revenue recognition for free Supercharging continues to be recognized over time, typically on a straight-line basis over the expected ownership life of the vehicle, as Tesla maintains a stand-ready obligation to provide the service. There is no indication of a material shift in the program's structure or revenue recognition approach during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that there was no significant structural change in Tesla's free Supercharging program between 2023 and 2024. The ground truth states a clear shift: in 2023, free Supercharging was bundled into Automotive Sales Revenue, but in 2024, Tesla began deferring revenue for such features as liabilities to be amortized over time, indicating a formalized segmentation. The LLM incorrectly asserts continuity, contradicting the documented change in accounting treatment. (2) The quantitative data about deferred revenue balances ($3,536M in 2023 and $3,599M in 2024) is plausible but not present in the ground truth, making it unverifiable. More critically, these figures are used to support an incorrect conclusion, suggesting stability when the real change is in accounting classification, not necessarily balance size. The numbers may be accurate in isolation, but their use misrepresents the underlying shift. (3) The multi-hop reasoning fails: the model does not recognize that a change in revenue recognition method (from immediate bundling to deferral and amortization) constitutes a structural evolution, even if deferred balances appear stable. It misses the conceptual shift in how Tesla accounts for free Supercharging as a distinct performance obligation. (4) The contextual relevance is moderate because the answer discusses deferred revenue and Supercharging, which are relevant topics, but it directly contradicts the key evolution described in the ground truth. Thus, while the terminology is appropriate, the factual and conceptual foundation is flawed, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 455,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, with the company shifting from long-term maturities (e.g., 2079 in 2019) to shorter-term maturities (e.g., 2054 in 2024). Additionally, the coupon structures in 2024 included fixed rates (e.g., 5.90%) and floating rates, whereas earlier issues had lower fixed rates or floating-rate structures. This shift may indicate a strategic move to optimize capital structure, reduce long-term interest rate exposure, and align financing with more immediate capital needs or market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that in 2023, the maturity was in 2079 'in 2019', conflating years and misrepresenting the timeline. The 2023 issuance did have a May 1, 2079 maturity, but the LLM incorrectly references 2019, which is not part of the question or ground truth. More critically, the LLM claims the 2024 issuance has a maturity of 2054 and a coupon of 5.90%, while the ground truth states the 2024 Series O Debentures have a maturity of November 1, 2029 and a coupon of 5.55%. These numbers are entirely incorrect. (2) The quantitative inaccuracies are severe: the maturity date is off by 25 years (2054 vs correct 2029), the coupon rate is wrong (5.90% vs 5.55%), and the reference to a 2019 issuance is fabricated. No calculations are performed, but the core numbers are invalid. (3) The multi-hop reasoning is flawed. The model fails to correctly identify the evolution between 2023 and 2024, instead introducing a false timeline and incorrect instrument terms. It does recognize a strategic shift toward shorter maturities and defined coupons, which aligns with the qualitative interpretation, but this reasoning is based on incorrect data. (4) The contextual relevance is moderate because the answer addresses the right topic—evolution in debenture terms and financing strategy—and attempts to interpret strategic intent. However, due to major factual and numerical errors, the correctness score is low. The qualitative accuracy is partially preserved due to correct directional interpretation, but quantitative accuracy is very poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 442,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "From 2022 to 2023, ExxonMobil's consideration of OPEC investment activities in its impairment assessment framework remained consistent in acknowledging their impact on long-term oil supply dynamics. The Corporation emphasized that OPEC's investment and production policies influence global oil supply, which is a key factor in its long-term supply projections. However, in 2023, there was a more explicit mention of incorporating estimated greenhouse gas emission costs into future cash flow assessments, reflecting a broader consideration of regulatory and environmental factors alongside OPEC's role in shaping supply dynamics.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately captures that ExxonMobil continued to acknowledge OPEC's influence on long-term oil supply dynamics from 2022 to 2023 and correctly notes the increased emphasis on greenhouse gas emission costs in 2023. The answer reflects the shift toward integrating environmental factors into cash flow assessments, which is consistent with the original answer. However, the LLM slightly underrepresents the depth of the conceptual shift described in the ground truth: while it mentions the inclusion of emission costs, it does not fully convey that by 2023, OPEC's role was embedded within a broader, more comprehensive framework that included macroeconomic and net-zero targets as central components of the impairment assessment—suggesting a move away from direct focus on OPEC toward a systems-level view. This nuance in reasoning and framing is partially missing, making the synthesis less complete than the original. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (ExxonMobil, OPEC, 2022–2023 timeframe, greenhouse gas costs) are correctly identified. The response is highly relevant to the question and addresses both years and the evolution in framework. Thus, while factually sound, the qualitative accuracy is slightly reduced due to incomplete conceptual synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 384,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "Netflix's approach to its ad-supported subscription plan shows increased strategic emphasis in 2024 compared to 2023. In the 2023 filing, the ad-supported plan is mentioned briefly as part of a range of pricing plans aimed at meeting consumer needs, with limited detail. By 2024, the plan is highlighted more prominently within the core business strategy, reflecting its growing importance as part of Netflix's efforts to diversify revenue streams and attract a broader audience. This evolution suggests a shift toward treating the ad-supported tier as a more central component of Netflix's financial and operational strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Netflix's ad-supported plan from 2023 to 2024 with correct entities (Netflix, ad-supported plan, 2023, 2024) and no numeric inaccuracies (no specific numbers involved, so quantitative accuracy is 10). However, the qualitative analysis contains a key factual error: the LLM states that in 2023, the ad-supported plan was mentioned as part of a range of pricing plans aimed at meeting consumer needs — this misrepresents the ground truth. According to the original answer, in 2023 the plan was discussed in the context of risk and uncertainty, not as a strategic offering. The shift described in the LLM answer (from limited detail to more prominence) is directionally correct, but the characterization of the 2023 filing is inaccurate. The ground truth emphasizes a shift from risk disclosure to strategic integration, whereas the LLM incorrectly suggests the plan was already part of the pricing strategy in 2023. This undermines the multi-hop reasoning, as the contrast between the two years is misrepresented. While the conclusion about growing strategic emphasis in 2024 aligns with the original, the flawed premise reduces qualitative accuracy. Contextual relevance is high as the response addresses the evolution over time and strategic emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 361,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon's approach to shipping offers between 2022 and 2024 has shifted toward greater fulfillment efficiency and cost optimization. In 2022, shipping costs were driven by increased investments in the fulfillment network, higher wage rates, and supply chain inefficiencies. By 2024, Amazon had made progress in reducing shipping costs through fulfillment network efficiencies and lower transportation costs, even as sales and shipping usage continued to grow. The strategic focus remained on maintaining low prices for customers through shipping offers while improving operational scalability and leveraging technology to enhance fulfillment productivity.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic shift toward fulfillment efficiency and cost optimization between 2022 and 2024, which aligns with the ground truth. However, it omits the specific $76.7 billion shipping cost figure from 2021 mentioned in the original answer and incorrectly implies that shipping costs were reduced by 2024, whereas the ground truth states that fulfillment costs increased due to sales and network investments but were partially offset by efficiencies. The LLM suggests a net reduction in shipping costs, which is not supported by the original. (2) Quantitatively, no incorrect numbers are introduced, but the key $76.7 billion figure is missing, and there is no mention of the anticipated continued growth in shipping costs from 2022. The LLM does not include any false numerical claims, so quantitative accuracy is relatively high. (3) The multi-hop reasoning is partially sound—Amazon’s shift toward efficiency is correctly identified—but the synthesis is incomplete. The original answer emphasizes a transition from customer-driven cost increases (faster delivery adoption) in 2022 to operations-centric efficiency gains in 2024, a nuance not fully captured. The LLM overstates the outcome by implying cost reductions rather than cost growth offset by efficiencies. (4) Contextual relevance is strong as the response directly addresses the evolution in shipping strategy, cost drivers, and efficiency focus. However, the qualitative accuracy is reduced due to misrepresentation of the financial outcome (cost reduction vs. cost growth with partial offset). Correctness score reflects partial accuracy with significant but not fundamental errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 462,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "Between 2023 and 2024, Duke Energy's utilization and reporting of the Master Retirement Trust showed notable changes in asset allocation and disclosure practices. In terms of asset allocation, the RCBP assets shifted from a 35% liability hedging and 65% return-seeking allocation in 2023 to a 35% liability hedging and 65% return-seeking allocation in 2024, maintaining the same structure. However, the actual allocation for RCBP assets in 2024 showed a slight deviation, with Global equity securities at 44% compared to the target of 45%, and Real estate and cash at 10% compared to the target of 7%. \n\nFor the DELPP assets, the target allocation remained at 80% liability hedging and 20% return-seeking, with actual allocations in 2024 closely aligning with the targets. Additionally, Duke Energy's disclosure practices became more detailed in 2024, including a reconciliation of Level 3 assets and a more comprehensive breakdown of fair value measurements.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct elements about Duke Energy's Master Retirement Trust and increased disclosure in 2024, particularly mentioning Level 3 fair value disclosures and more detailed reporting. However, it introduces specific asset allocation details (e.g., RCBP and DELPP targets, Global equity at 44%, Real estate and cash at 10%) that are not present in the ground truth and cannot be verified from the provided original answer. These specific percentages and plan names (RCBP, DELPP) appear to be fabricated or hallucinated. (2) The quantitative accuracy is compromised because while the 35/65 and 80/20 allocations are plausible, they are not mentioned in the ground truth, making them factually unsupported. The ground truth emphasizes subsidiary allocations (e.g., Duke Energy Progress at 15%, Duke Energy Florida at 18%) and a reconciliation of beginning and ending balances—details entirely missing from the LLM response. (3) The multi-hop reasoning is partially sound in identifying a trend toward more detailed disclosure, especially around Level 3 assets, which aligns with the original answer. However, the model fails to synthesize the correct evolution—shifting from general investment objectives in 2023 to subsidiary-level allocation breakdowns and balance reconciliations in 2024—and instead invents a different narrative based on unverified asset categories. (4) Contextual relevance is high because the answer addresses asset allocation and disclosure changes, which are central to the question. However, correctness and quantitative accuracy are significantly reduced due to the inclusion of unsupported specifics, leading to a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 462,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "The provided documents do not include specific details on the evolution of Google's financial relationship with Google Network Partners between 2022 and 2024, particularly regarding cost structure and payment obligations. The information available focuses on broader financial performance, such as revenue breakdowns and operating income, but does not specify changes in terms or financial arrangements with Network Partners.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is incorrect and fails to reflect the ground truth information. (1) It claims that no specific details are available in the documents, but the original answer (ground truth) clearly states that there is information about Google's financial relationship with Network Partners in both 2022 and 2024, including cost structure (TAC as part of cost of revenues in 2022) and payment obligations (operating cash outflows in 2024). (2) There are no numeric values in the LLM response to assess for quantitative accuracy, and it does not reference any financial metrics like Traffic Acquisition Costs (TAC), which are central to the question and present in the ground truth. (3) The multi-hop reasoning is entirely missing: the model should have synthesized information across years (2022 vs 2024) and concepts (cost of revenue → operating cash flow) to show evolution in the financial relationship, but instead defaults to a 'no information' response. (4) Contextual relevance is low because the answer avoids addressing the core question about evolution in cost structure and payment obligations, despite the ground truth providing a clear narrative of shift from cost-of-revenue to cash flow obligation. The LLM’s failure to retrieve or synthesize this key evolution results in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 365,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "Between 2022 and 2023, the financial impact of non-designated derivative instruments, particularly offsetting swap positions, showed a significant improvement. In 2022, UPS reported a loss of $69 million from fair value changes and settlements of these instruments, primarily foreign currency exchange contracts, which were recognized in \"Investment income and other.\" In contrast, in 2023, the loss was significantly reduced to $7 million, indicating a more favorable outcome in terms of fair value changes and settlements during the year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that UPS reported net gains in 2021 ($163M) and 2020 ($124M), but does not provide a specific net loss of $69M in 2022 or $7M in 2023. These figures are entirely fabricated and not present in the original answer. The original explicitly notes that the financial impact in 2023 was *not quantified* in the excerpt, directly contradicting the LLM's claim of a $7M loss. (2) Quantitative accuracy is very low: the LLM invents precise dollar amounts for 2022 and 2023 that are not supported by the ground truth. There is no mention of a $69M loss in 2022 or a $7M loss in 2023 in the original answer. The only actual numbers referenced are from 2020 and 2021, which the LLM omits entirely. (3) The multi-hop reasoning is flawed. The original answer emphasizes a shift in disclosure focus and reduced transparency in 2023, not an improvement in financial performance. The LLM incorrectly interprets the trend and introduces non-existent data to support a narrative of improvement. It fails to capture the key point about changing transparency and instead asserts a false quantitative comparison. (4) Contextual relevance is moderate because the LLM addresses derivative instruments, fair value changes, and settlements—relevant topics—but misrepresents the core information. The qualitative accuracy is low due to incorrect entities (specific losses), faulty logic, and failure to reflect the actual evolution in reporting practices. The correctness score is low because the answer is factually wrong on the key quantitative claims and misses the central point about disclosure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 458,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures compared to 2023 indicates a greater emphasis on deferred compensation for directors as part of the company's overall compensation strategy. This suggests Duke Energy may be prioritizing long-term alignment of director interests with shareholders by encouraging deferral of compensation into plans tied to company stock performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures compared to 2023 and infers a strategic shift toward deferred compensation. It accurately captures the directional change in disclosure emphasis and links it to director compensation strategy. However, it omits specific details from the ground truth, such as the fact that in 2023 the plan was only referenced through exhibit amendments (e.g., Exhibit 10.12) without substantive description, while in 2024 there is a detailed explanation of deferral mechanics, phantom investment options, and balance adjustments. These omissions reduce completeness and qualitative accuracy. (2) There are no numerical values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift based on increased disclosure, but does not fully synthesize the specific nature of the change in disclosure format and content across years as required. The ground truth relies on comparing the *type* of mention (historical exhibit vs. substantive description), which the LLM overlooks. (4) The answer is contextually relevant and conveys a plausible interpretation, but lacks the granular, evidence-based contrast present in the original answer, which limits its factual completeness and reasoning depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 411,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "Between 2022 and 2024, American Express has evolved its approach to developing value propositions by emphasizing innovation in premium products, digital integration, and customer-centric benefits to address competitive pressures and shifting consumer behaviors. The company has focused on expanding its leadership in the premium consumer space, particularly with younger demographics like Millennials and Gen Z, by offering differentiated services, rewards programs, and enhanced digital experiences. Additionally, American Express has prioritized building a multiproduct digital ecosystem and investing in technologies like artificial intelligence and machine learning to improve customer engagement and operational efficiency. These strategies aim to strengthen customer loyalty, drive spending growth, and maintain a competitive edge in a rapidly evolving payments landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of American Express's value proposition strategy between 2022 and 2024, highlighting key themes such as competitive pressures, focus on premium products, digital innovation, and targeting younger demographics. All entities—American Express, Millennials, Gen Z, AI/ML investments—are accurately identified and contextually appropriate. The time frame (2022 to 2024) is correctly referenced. (2) There are no numeric values, percentages, or financial figures in either the original or LLM answer, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers supports a full score here. (3) The multi-hop reasoning is sound: the LLM synthesizes the shift from reactive competition concerns in 2022 to a proactive, innovation-driven strategy by 2024. However, it omits specific strategic elements mentioned in the ground truth, such as strategic partnerships, expansion of dining platforms (Tock and Rooam), and global merchant coverage growth—details that enrich the original answer. While the core reasoning and direction are correct, these omissions prevent a perfect qualitative score. (4) The answer is highly contextually relevant, directly addressing how Amex evolved its value propositions in response to competition and changing customer behaviors. The emphasis on digital ecosystems, AI, and youth demographics aligns well with the original. The correctness score is 8 because the answer is factually accurate and captures the main strategic shift, but lacks some specific, concrete initiatives that were part of the 2024 strategy, resulting in minor incompleteness despite strong overall alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 463,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Between 2022 and 2024, Exxon Mobil's long-term debt financing approach evolved with the addition of new long-term notes issued as part of its acquisition of Pioneer Natural Resources Company in May 2024. Specifically, the 2024 10-K indicates that ExxonMobil issued 545 million shares of common stock and assumed $5 billion in debt as part of the $63 billion fair value transaction. While the exact composition of long-term notes is not detailed in the provided pages, the 2024 filing lists several long-term notes, including 0.524% Notes due 2028, 0.835% Notes due 2032, and 1.408% Notes due 2039, suggesting a continued focus on low-interest, long-term debt instruments to finance operations and strategic acquisitions.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but misses key aspects of the ground truth and introduces information not supported by the original answer. (1) Correctly identifies the continuation of certain long-term notes in 2024 (0.524% due 2028, 0.835% due 2032, 1.408% due 2039), which aligns with the original answer. However, it fails to note the absence of the 0.142% Notes due 2024 in the 2024 filing—a critical point in the evolution of debt composition. (2) The quantitative accuracy is partially correct: the $5 billion in assumed debt and $63 billion fair value transaction are plausible figures related to the Pioneer acquisition, but these details were not present in the ground truth and introduce external information that cannot be verified from the provided context. The original answer does not mention the Pioneer acquisition or stock issuance, so including this shifts focus away from the actual evolution in debt composition. (3) The reasoning is flawed in that it attributes changes in debt structure to the Pioneer acquisition, which is not mentioned in the ground truth. The real evolution highlighted is the natural maturation of the 2024 notes and continued reliance on long-dated debt, not new issuances from an acquisition. The model fails to make the correct multi-hop inference: that removing a near-term note (due 2024) while retaining longer-term ones (e.g., 2039) indicates a strategic shift toward extended maturities. (4) Contextual relevance is high because the answer discusses long-term notes and their composition, but the emphasis on an unmentioned acquisition reduces factual alignment. Overall, the answer captures part of the trend but misattributes the cause and omits the key evidence of debt maturity progression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 476,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "Between 2022 and 2024, American Express has evolved its approach to corporate card solutions by emphasizing innovation and differentiation in commercial payments. The company has focused on enhancing its corporate card and accounts payable expense management solutions, designing innovative products and features such as financing, banking, and payment solutions tailored for business customers. This strategic emphasis reflects a broader goal to strengthen its position in the commercial payments space by delivering more value and flexibility to corporate clients.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies American Express's strategic emphasis on corporate card solutions and commercial payments between 2022 and 2024, and accurately notes the focus on product differentiation and innovation in expense management solutions. However, it omits the key evolution highlighted in the ground truth: the shift from internal product development in 2022 to a more externally integrated global network strategy by 2024, including increased merchant acceptance, fraud protection, and marketing insights. This missing element represents a significant gap in capturing the full strategic evolution. (2) There are no numeric values, dates, or calculations in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes American Express’s ongoing focus on commercial payments and product enhancement, but fails to contrast the 2022 and 2024 strategies as required by the question, particularly the ecosystem shift in 2024. (4) The answer is contextually relevant and well-phrased but lacks the critical comparative insight that defines the evolution, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 351,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "Amazon's financial relationship with AWS Services has strengthened significantly between 2022 and 2024, with AWS contributing 16% of total net sales in 2022 and increasing to 17% in 2024. AWS demonstrated robust growth, with a 13% increase in 2022 and a 19% increase in 2024, outpacing growth in other segments. In terms of cash flow generation, AWS supported Amazon's overall operating cash flow, which rose from $84.9 billion in 2023 to $115.9 billion in 2024. The strategic emphasis on AWS is evident in Amazon's capital expenditures, with significant investments in technology infrastructure to support AWS business growth, reflecting its critical role in the company's long-term financial strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in Amazon's operating cash flow from $84.9 billion in 2023 to $115.9 billion in 2024, which aligns with the ground truth. However, it introduces specific AWS net sales percentages (16% in 2022, 17% in 2024) and AWS growth rates (13% in 2022, 19% in 2024) that are not present in the original answer and cannot be verified from the provided ground truth. These additions, while plausible, are factually unsupported in this context and reduce quantitative accuracy. (2) The cash flow numbers are accurate and correctly attributed to 2023 and 2024, but the original answer does not state AWS's exact contribution to net sales or its year-over-year growth in those years—this information is extraneous and potentially misleading. (3) The reasoning is sound in linking AWS to increased cash flow and strategic emphasis via capital expenditures, reflecting a correct multi-hop synthesis of AWS’s evolving role from a competitive risk to a core financial driver. The shift in strategic emphasis is qualitatively well captured. (4) Despite the inclusion of unverified percentages and growth rates, the core narrative—that AWS became a stronger financial contributor and strategic priority between 2022 and 2024—is consistent with the ground truth. The answer addresses both cash flow and strategic emphasis, though with some overreach in specificity. Hence, correctness is reduced primarily due to unsupported quantitative claims, but qualitative and contextual accuracy remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 423,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "Between 2023 and 2024, the scope and focus of trend analyses used in evaluating the historical consistency of regulatory asset balances expanded. In 2023, trend analyses were mentioned as part of procedures to evaluate the historical consistency of regulatory asset balances. By 2024, the focus broadened to include not only trend analyses but also comparisons of recorded balances to independently developed expectations, assessments of regulatory developments, and detailed testing of deferred costs, indicating a more comprehensive and forward-looking approach to evaluating regulatory asset recoverability.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about the evolution of trend analyses. The ground truth states that in 2024, the scope of trend analyses remained focused on regulatory asset balances but expanded to include a specific evaluation of the recoverability of asset retirement obligations related to coal ash. In contrast, the LLM claims that the focus broadened to include comparisons to independently developed expectations, assessments of regulatory developments, and testing of deferred costs—none of which are mentioned in the original answer and which describe different audit procedures, not trend analyses. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are correctly referenced, earning full points here. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the specific evolution in focus—from general regulatory asset balances to including coal ash-related asset retirement obligations—indicating a failure to accurately synthesize the key development. Instead, it invents a broader procedural expansion not supported by the ground truth. (4) While the answer is relevant to audit procedures around regulatory assets, it misrepresents the nature and scope of trend analyses specifically, leading to a low correctness and qualitative accuracy score despite correct date references and contextual proximity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 404,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Between 2022 and 2023, Costco increased the penetration of private-label items as part of its strategy to manage cost and pricing pressures. In response to higher merchandise costs and inflation, Costco adjusted its merchandising and pricing strategies, which included increasing the share of private-label items to maintain competitive pricing and preserve member value. This approach helped Costco balance cost challenges while maintaining its pricing authority and member perception of value.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core claims and conveys that Costco increased private-label penetration in response to cost and pricing pressures between 2022 and 2023. It accurately reflects the strategic shift toward private-label items as a means to maintain competitive pricing and member value. However, it omits a key nuance present in the original answer: the distinction between Costco's 2022 reactive tactics (absorbing costs, bulk purchasing, selective price passing) versus the more strategic, sustained emphasis on private-label growth in 2023. This missing contrast slightly weakens the multi-hop reasoning component, which should synthesize changes across years. There are no numerical inaccuracies (quantitative accuracy is perfect, as no specific numbers were involved and no false figures were introduced). The entities (Costco, private-label items, cost and pricing pressures) and time periods (2022–2023) are correct. The answer is highly contextually relevant and semantically aligned with the ground truth, but lacks full completeness in capturing the evolution of strategy. Thus, while the qualitative reasoning is strong, it misses a layer of strategic progression, warranting a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 352,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "The financial outlook for Paxlovid has significantly declined between 2023 and 2024 based on Pfizer's remaining performance obligations. As of December 31, 2024, the remaining performance obligations for Paxlovid totaled approximately $1 billion, compared to $2.5 billion in deferred revenues (noncurrent liabilities) as of December 31, 2023. This decrease reflects the transition of Paxlovid from government contracts to commercial markets and reduced demand, as well as the recognition of $2.9 billion in revenue from prior deferred balances in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) Quantitatively, the LLM claims $2.5 billion in deferred revenues as of December 31, 2023, and states that $2.9 billion in revenue was recognized from prior deferred balances in 2024—neither of which appears in the original answer or is supported by the ground truth. The original answer explicitly states that Pfizer did not disclose specific remaining performance obligations (RPOs) for Paxlovid in 2023, making the LLM's numerical comparison invalid. (2) The only correct number is the $1 billion in RPOs as of December 31, 2024, which matches the ground truth. However, the rest of the financial data is fabricated or misattributed. (3) The reasoning is flawed: the original answer indicates increased contractual certainty and improved financial outlook due to newly reported $1B in RPOs in 2024, while the LLM incorrectly infers a 'significant decline' based on non-existent 2023 figures. This misrepresents the trend entirely. (4) The LLM introduces 'deferred revenues (noncurrent liabilities)' as a proxy for RPOs, which may not be equivalent and is not mentioned in the ground truth, showing poor entity and metric alignment. (5) Contextually, the answer addresses the right topic (Paxlovid's financial outlook via RPOs) and timeframe (2023–2024), so it maintains moderate relevance, but the factual inaccuracies and incorrect conclusion severely undermine its validity. The multi-hop synthesis fails because it invents data for 2023 rather than acknowledging the absence of disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 428,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "Between 2022 and 2024, American Express has maintained a structured and data-driven approach to estimating credit loss reserves, with the R&S Period remaining a central assumption in its models. In 2022, the reserves for credit losses on Card Member loans were $3.3 billion, while in 2024, they increased to $5.7 billion, reflecting a more cautious stance amid evolving economic conditions. The company continues to incorporate historical loss experience, current economic trends, and future projections within the R&S Period, reverting to long-term average loss rates beyond it. This evolution indicates a proactive and adaptive approach to financial risk management, emphasizing transparency, model validation, and the inclusion of qualitative reserves to address uncertainties not captured by quantitative models.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. While the 2022 reserve figure of $3.3 billion is correct (matching the ground truth as of December 31, 2021, referenced in the 2022 filing), the claim that reserves increased to $5.7 billion in 2024 is unsupported by the provided ground truth, which does not mention any 2024 reserve amount. This introduces a major factual error. (2) The ground truth does not provide a 2024 reserve number, so asserting $5.7 billion is a fabrication or hallucination. There is no verification of this figure in the context given, making the quantitative accuracy low. Additionally, the ground truth does not state that American Express 'reverts to long-term average loss rates beyond the R&S Period'—this detail is absent and cannot be confirmed. (3) On qualitative reasoning, the LLM correctly identifies that the R&S Period remained a key assumption and that American Express uses historical, current, and forward-looking inputs. It also appropriately infers a maturing risk management approach. However, it misses the core evolution highlighted in the ground truth: the shift from explicitly introducing the R&S Period as a new concept in 2022 to treating it as an embedded, standard component in 2024. This conceptual evolution is the central point of the original answer and is underemphasized in favor of unsupported numerical comparisons. (4) Contextual relevance is high because the answer addresses credit loss reserves, the R&S Period, and risk management approach. However, the hallucinated $5.7 billion figure and missing emphasis on the methodological maturation significantly reduce correctness. The answer substitutes a plausible narrative for the actual documented evolution, leading to a partial but materially flawed response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 499,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "Amazon issued the 0.800% Note due 2025 as part of its debt financing strategy, as disclosed in its 2024 10-K. Specifically, this note was issued under an Officers' Certificate dated June 3, 2020, and is part of Amazon's broader approach to managing its capital structure through a variety of debt instruments with varying maturities and interest rates. Between 2022 and 2024, Amazon continued to issue and manage multiple debt instruments, including the 0.800% Note due 2025, to support its financial operations and investment needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 0.800% Note due 2025, its issuance under the Officers' Certificate dated June 3, 2020, and its continued presence in Amazon's debt structure through 2024. These factual elements match the ground truth. However, the LLM answer omits a key evolution highlighted in the original answer: the introduction of new debt instruments like the 4.600% Note due 2025, which demonstrates a strategic shift toward a broader range of interest rates and maturities. This omission weakens the qualitative accuracy, as the multi-hop synthesis of Amazon's evolving strategy is incomplete. (2) All numbers and dates are accurate: '0.800% Note due 2025' and 'June 3, 2020' are correctly cited. No calculations are involved, but the factual data points are precise and consistent with the ground truth. (3) The reasoning is sound in describing Amazon's use of multiple debt instruments, but it fails to explicitly contrast 2022 and 2024 to show evolution—specifically, the addition of higher-interest debt in 2024. The answer describes continuity but not strategic change, which is central to the question about 'evolution.' (4) The correctness score is 7 because core facts are accurate (hence high quantitative accuracy), but the answer lacks the full qualitative depth needed to demonstrate the shift in strategy. Contextual relevance is high as the response stays focused on Amazon's debt financing and the specified note, but it misses a critical comparative insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 413,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "The Twenty-third Supplemental Indenture, dated June 1, 1978, is consistently referenced in both the 2022 and 2024 SEC filings, indicating its historical inclusion as part of Duke Energy Progress' mortgage and deed of trust documentation. However, there is no new disclosure or amendment related to this specific indenture in the 2024 filing, suggesting it has remained unchanged and is no longer the subject of active updates. This implies that the indenture is part of the historical record and is not currently relevant to ongoing operations or recent corporate actions.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it claims the Twenty-third Supplemental Indenture is 'consistently referenced in both the 2022 and 2024 SEC filings,' but the ground truth explicitly states that there is *no direct mention* of this indenture in the 2024 filing. This is a major inaccuracy that undermines the entire response. The date of the Twenty-third Supplemental Indenture (June 1, 1978) is correctly stated, which is consistent with the original answer, so some quantitative accuracy is preserved. (2) The quantitative accuracy is partially correct—only the 1978 date is accurate. However, the claim of continued reference in 2024 is false, and no other dates (e.g., the Forty-ninth Supplemental Indenture dated March 14, 2024) are mentioned, missing key comparative data. (3) The multi-hop reasoning fails: the model incorrectly assumes presence due to historical relevance rather than verifying actual disclosure in the 2024 filing. It does not recognize the absence of the indenture in the later filing as a meaningful change, nor does it note the shift in focus to newer indentures, which is central to the ground truth’s conclusion. (4) While the answer attempts to interpret the lack of updates as diminished relevance, it does so based on incorrect premises. The contextual relevance is moderate because it addresses the right topic and attempts to assess ongoing significance, but the flawed factual foundation leads to an incorrect overall conclusion. The answer would have been stronger if it acknowledged the removal of the reference and inferred reduced reporting importance accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 448,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "From 2022 to 2024, the total value of Class C Capital Stock repurchases increased slightly. In 2022, $52.868 billion worth of Class C shares were repurchased, in 2023 it was $50.192 billion, and in 2024, $50.192 billion as well. The number of shares repurchased also decreased from 450 million in 2022 to 306 million in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Alphabet repurchased $59.3 billion in 2022, $62.2 billion in 2023, and $62.0 billion in 2024 across Class A and C shares. However, the LLM claims $52.868 billion in 2022, $50.192 billion in 2023, and $50.192 billion in 2024—these figures are incorrect and inconsistent with the truth. Additionally, the LLM incorrectly isolates Class C repurchases, while the original answer combines Class A and C, which is standard in Alphabet's disclosures. (2) The numbers provided by the LLM do not match the ground truth in any year, with discrepancies of billions of dollars. The claim that repurchase value remained flat from 2023 to 2024 at $50.192 billion contradicts the truth showing a slight decline from $62.2B to $62.0B. The mention of 450 million and 306 million shares repurchased is unsupported by the provided truth and introduces unverified granular data. (3) The reasoning is flawed: the LLM fails to correctly synthesize the multi-hop information across years and misattributes the repurchase amounts specifically to Class C, while the original answer correctly notes the combined nature of the repurchases. It also mischaracterizes the trend—ground truth shows an increase then slight decrease, while LLM suggests a decrease followed by stability. (4) Scores are low due to major quantitative errors and incorrect entity breakdown (Class C only vs. combined). Contextual relevance is moderate because the answer addresses repurchase trends over time, but factual correctness is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 440,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "The American Express Company Salary/Bonus Deferral Plan is referenced in both the 2022 and 2024 SEC filings, but there is no indication of any substantive amendments or changes to the plan itself between these years. The 2022 filing includes references to the plan and its amendments up to 1997, while the 2024 filing does not list the plan explicitly, suggesting it may have been superseded or integrated into broader deferred compensation or incentive plans, such as the 2016 Incentive Compensation Plan. No new amendments or restatements specific to the Salary/Bonus Deferral Plan are disclosed in the 2024 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims the 2024 filing does not list the plan explicitly, but the ground truth states that the 2024 filing reintroduces the plan through Exhibits 10.13, 10.14, and adds Exhibit 10.16 for the 1997 amendments—this is a direct factual error. (2) The LLM incorrectly asserts that the 2022 filing includes amendments up to 1997, but the original answer specifies that only the 1988 plan (Exhibit 10.16) and 1994 amendment (Exhibit 10.17) were referenced in 2022—there is no mention of 1997 amendments in 2022, so this is a significant misstatement. (3) The LLM concludes the plan may have been superseded or integrated into other plans like the 2016 Incentive Compensation Plan, which is speculative and unsupported by the ground truth; instead, the 2024 filing expands disclosure with additional exhibits. (4) The reasoning fails on multi-hop synthesis: it should have compared specific exhibits across years and noted the reintroduction and expansion of documentation, especially the addition of the 1997 amendments via Exhibit 10.16 in 2024. (5) While the question asks about changes in treatment and documentation, the LLM focuses on absence and possible integration, missing the core fact that the 2024 filing enhanced historical disclosure. Quantitative accuracy is low due to incorrect dates and missing exhibit numbers. Qualitative accuracy is poor due to flawed logic and entity/timing misattribution. Contextual relevance is moderate because it addresses the general topic but draws wrong conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 431,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Starbucks' exposure to interest rate swaps between 2022 and 2024 has shifted in both magnitude and classification. In 2022, the interest rate swap liability was $34.0 million, classified under \"Other long-term liabilities,\" while by 2024, the liability had decreased to $19.2 million, still classified under \"Other long-term liabilities.\" Additionally, the carrying amount of the hedged item related to interest rate swaps dropped significantly from $1,047.7 million in 2022 to $332.2 million in 2024, indicating a reduction in the scale of these hedging activities.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 interest rate swap liability of $34.0 million and the 2024 liability of $19.2 million, both classified under 'Other long-term liabilities', which matches the ground truth. However, it introduces new information not present in the original answer — specifically, the 'carrying amount of the hedged item' decreasing from $1,047.7 million in 2022 to $332.2 million in 2024 — which was not part of the ground truth and cannot be verified from the provided data. This addition misrepresents the scope of the original answer and may confuse the user. (2) The core numbers for the swap liabilities in 2022 and 2024 are accurate, but the absence of any mention of the 2023 liability of $41.4 million (which is critical to understanding the evolution and context of the 2024 figure) is a significant omission. The ground truth emphasizes a multi-year shift including 2023 data to show trend and transformation; the LLM skips this entirely. (3) The reasoning is partially sound — it correctly infers a reduction in liability and links it to decreased hedging exposure — but fails the multi-hop requirement by not incorporating the 2023 data point, which is essential for a complete evolution analysis. The classification consistency is correctly noted, but the transformation mentioned in the original answer (shift in classification and magnitude) is not fully reflected since classification remained the same. (4) The contextual relevance is high as the answer addresses the core question about evolution in magnitude and classification. However, the quantitative accuracy and qualitative accuracy are reduced due to missing data (2023 liability) and introduction of unverified metrics, undermining full factual alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 486,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "Between 2022 and 2024, the Directors' Savings Plan at Duke Energy has remained a key component of director compensation governance, allowing outside directors to defer all or a portion of their annual compensation, typically in the form of retainers. The plan continues to credit deferred amounts to an unfunded account adjusted for the performance of phantom investment options, including Duke Energy Common Stock Fund. This suggests a consistent approach to deferral mechanisms, emphasizing long-term alignment with shareholder interests and flexibility for directors to manage compensation timing. The lack of material changes to the plan's structure indicates a stable governance strategy focused on deferral and non-cash compensation mechanisms for directors.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entities, structure, and key mechanisms of the Directors' Savings Plan, such as deferral of retainers, unfunded accounts, and phantom investment options including the Duke Energy Common Stock Fund. There are no numeric inaccuracies, and the time frame (2022–2024) is correctly referenced, earning a perfect quantitative accuracy score. However, the LLM portrays the evolution as one of 'stability' and 'lack of material changes,' which contradicts the ground truth that emphasizes a meaningful evolution from formal policy introduction in 2022 (with a December 16, 2021 amendment) to greater operational transparency in 2024 regarding how deferrals are invested. This shift reflects a move from establishment to detailed disclosure, suggesting active governance refinement rather than static consistency. The LLM underplays this development, missing the nuance that increased transparency around phantom investments and stock fund linkage indicates a maturing governance approach aligned with shareholder interests. While the core facts are correct, the reasoning and synthesis of the plan’s evolution are partially inaccurate, reducing qualitative accuracy. The response remains highly relevant to the question, hence a high contextual relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 367,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "Between 2022 and 2023, Costco's Kirkland Signature brand has maintained its positioning as a high-quality, cost-effective private-label offering, but with a heightened focus on navigating evolving market and operational risks. The 2022 filing emphasizes Kirkland Signature's role in differentiating merchandise offerings and earning higher margins, while the 2023 filing reflects increased attention to risks such as supply chain disruptions, inflation, and supplier reliability, which could impact the brand's ability to maintain quality and pricing advantages. This suggests a more cautious risk profile in 2023, as Costco seeks to balance growth and member value against external uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2022 emphasis on Kirkland Signature as a high-quality, margin-enhancing private label is accurately described, as is the 2023 shift toward highlighting risks. The key risks mentioned—supply chain disruptions, inflation, and supplier reliability—are consistent with the broader risk categories in the original answer (supply chain, foreign exchange, catastrophic events), with 'inflation' and 'supplier reliability' being reasonable interpretations or subsets of the disclosed risks. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations, but all references to years (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifying both the strategic positioning and the evolution in risk disclosure. The conclusion that the risk profile became more cautious in 2023 is logically supported. (4) The only minor gap is that the LLM answer does not explicitly mention 'foreign exchange fluctuations' or 'catastrophic events' from the 2023 filing, instead summarizing risks with slightly different phrasing (e.g., 'inflation'). However, this does not distort the meaning and remains semantically equivalent in spirit. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 409,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region declined from 764 BCF at the end of 2021 to 326 BCF at the end of 2022, then further decreased to 312 BCF by the end of 2023, before slightly increasing to 296 BCF by the end of 2024. Key changes in 2022 included downward revisions of 2 BCF and sales of 385 BCF, primarily from the disposition of Indonesia assets. In 2023, the region saw minor upward revisions of 9 BCF and downward adjustments due to production and sales. In 2024, there were small upward revisions of 6 BCF and minor additions from extensions and discoveries in the Middle East and Australia, but overall volumes remained low due to ongoing production and limited new additions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that COP's natural gas reserves in the Asia Pacific/Middle East region were 326 BCF in 2022 and decreased to 296 BCF in 2024. However, the LLM claims reserves were 764 BCF in 2021 (not mentioned in the original), 326 BCF in 2022 (correct), 312 BCF in 2023 (not in original), and 296 BCF in 2024 (correct). The 2023 figure is unsupported by the original answer, and the 2021 number is irrelevant and incorrect. (2) The original answer does not mention any sales of 385 BCF or downward revisions of 2 BCF in 2022, nor does it reference asset dispositions in Indonesia. These details are fabricated. Similarly, the LLM's claims of 9 BCF upward revisions in 2023 and 6 BCF in 2024 with minor additions from extensions and discoveries contradict the original, which explicitly states 'no sales or significant reserve additions in this region' in 2024 and minimal contributions overall. (3) The multi-hop reasoning is flawed: the LLM invents year-by-year breakdowns and causal factors (e.g., Indonesia asset sales) not present in the source. It fails to accurately synthesize the trend as one of slight decline due to production and revisions with minimal additions, instead creating a narrative of major sales and fluctuations. (4) While the final 2024 number (296 BCF) matches and the general direction of decline is correct, the inclusion of unsupported intermediate values, incorrect drivers, and fabricated transactions severely undermines factual accuracy. The contextual relevance is moderate because it addresses the region and time frame, but the qualitative reasoning and quantitative precision are poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 465,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "Between 2022 and 2024, FedEx's strategic relationship with the Boeing 767F has evolved with a focus on fleet modernization. As of May 31, 2022, FedEx owned 114 Boeing 767F aircraft and had committed to purchasing 38 more through 2027. By May 31, 2024, the company had adjusted its commitments, with 14 Boeing 767F aircraft scheduled for delivery in 2025 and 3 in 2026, totaling 17 planned purchases. This shift reflects a continued emphasis on modernizing the fleet with more fuel-efficient aircraft, as the 767F is part of FedEx's broader modernization programs aimed at achieving long-term operating savings and replacing older aircraft.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies not supported by the ground truth. The original answer states that FedEx owned 114 Boeing 767F aircraft in 2022, which the LLM correctly reports. However, the LLM adds specific forward purchase commitments (38 more through 2027, with 14 in 2025 and 3 in 2026) and delivery schedules that are not present in the original answer. The ground truth explicitly states that no updated ownership figures were disclosed for 2024 and does not mention any specific number of planned deliveries or purchase adjustments. These added details are unsupported and likely hallucinated. (2) Quantitative accuracy is low because the LLM introduces precise numbers (38 total purchases, 17 planned) and delivery years (2025, 2026) that do not appear in the original answer. The only correct number is the 114 owned aircraft in 2022. (3) The reasoning partially captures the modernization focus and fuel efficiency benefits mentioned in the original answer, showing correct qualitative understanding of the strategic direction. However, it fails on multi-hop synthesis because it fabricates specific procurement timelines instead of acknowledging the lack of updated ownership data in 2024. The original emphasizes the necessity of expenditures for long-term savings and limited flexibility to delay, which the LLM mentions in spirit but distracts with incorrect specifics. (4) Contextual relevance is high because the answer addresses fleet ownership and modernization as asked, and correctly identifies the Boeing 767F's role in efficiency and replacement strategy. However, the inclusion of fabricated delivery schedules undermines factual correctness. The core evolution—shift from ownership reporting to modernization emphasis—is partially captured but distorted by incorrect quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 501,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "From 2022 to 2024, Starbucks' inventory value for roasted coffee increased from $310.3 million to $310.3 million (no change in the provided data), while unroasted coffee inventory rose from $1,018.6 million to $1,018.6 million. In terms of production infrastructure, Starbucks maintained and expanded its roasting facilities globally, including locations in the U.S., China, and other key markets, ensuring capacity for roasting, warehousing, and distribution to support its operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the 2022 roasted coffee inventory value of $310.3 million, which matches the ground truth. However, it incorrectly claims there is no change in data for 2024, stating the same $310.3 million without confirming whether this is accurate for 2024. The original answer implies a strategic shift by 2024 but does not provide a 2024 inventory figure, so the LLM's repetition of the 2022 number as if it were confirmed for 2024 is misleading and unsupported. Additionally, the mention of unroasted coffee inventory values ($1,018.6 million in both years) is not relevant to the question and was not part of the original answer, suggesting possible hallucination or inclusion of extraneous data. (2) Quantitatively, the 2022 roasted coffee inventory is correct, but the assertion that it remains unchanged in 2024 lacks evidence in the provided ground truth, which does not specify the 2024 inventory value. Thus, presenting it as unchanged is an unsupported inference. The unroasted coffee figures are not mentioned in the ground truth and appear to be incorrect in context. (3) The qualitative reasoning partially captures the expansion of roasting infrastructure, correctly identifying global facilities, but lacks the specific locations named in the original answer (York, PA; Minden, NV; Kunshan, China; Kent, WA). Instead, it generalizes to 'U.S., China, and other key markets,' which omits precision and weakens the multi-hop synthesis. The key insight in the original answer—that Starbucks shifted from holding inventory to actively producing roasted coffee at scale—is underdeveloped in the LLM response. (4) The contextual relevance is high because the answer addresses both inventory value and production infrastructure over the 2022–2024 period. However, the correctness score is reduced due to unsupported numerical repetition, inclusion of irrelevant unroasted coffee data, and failure to accurately reflect the strategic evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 540,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "Based on the provided document pages, PepsiCo's utilization of the 2.750% Senior Notes due 2025 remained consistent between 2023 and 2024. In both years, the notes were referenced in the context of authorizations for issuance, with no indication of changes in their terms or redemption status. Specifically, the 2.750% Senior Notes due 2025 were included in the list of authorized notes in 2023 (PEP_10k_2023.pdf) and similarly referenced in 2024 (PEP_10k_2024.pdf), suggesting no material change in their utilization during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of the entities and dates mentioned—the 2.750% Senior Notes due 2025 were indeed referenced in both the 2023 and 2024 filings, and no changes to their terms or redemption status are indicated. Thus, quantitative accuracy is high: the percentages, years, and document references (PEP_10k_2023.pdf, PEP_10k_2024.pdf) are correct. However, the qualitative reasoning and completeness are significantly lacking. The original answer identifies a key evolution: in 2024, PepsiCo introduced a new 2.750% Senior Notes due 2030, signaling a strategic extension of its use of this interest rate to longer-term debt. The LLM answer fails to mention this critical development, which directly reflects a strategic evolution in utilization of the 2.750% rate. Instead, it concludes there was 'no material change' in utilization, which contradicts the ground truth interpretation that PepsiCo expanded its use of this rate to a new instrument. This omission represents a failure in multi-hop reasoning—connecting the continued authorization of the 2025 notes with the introduction of the 2030 notes as part of a broader financing strategy. While the LLM response is contextually relevant and factually accurate on surface-level details, it misses the deeper strategic shift, resulting in a partially correct but ultimately misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 380,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "FedEx's planned utilization of the B777F aircraft decreased from 2022 to 2024, with deliveries dropping from 8 aircraft in 2022 to just 2 in 2024. This reduction indicates a diminished strategic role for the B777F in the fleet during this period, likely reflecting a shift in focus to other aircraft types such as the B767F and regional freighters like the Cessna SkyCourier 408 and ATR 72-600F, which are more aligned with FedEx's long-term modernization and fuel efficiency goals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the plan was revised to 2 B777Fs operating in 2025 with no further plans beyond. The LLM incorrectly states that deliveries dropped from 8 aircraft in 2022 to 2 in 2024, which contradicts the original data—there is no mention of 8 aircraft or deliveries in 2022 in the ground truth. The numbers are therefore factually wrong. (2) The quantitative inaccuracies are severe: the LLM invents a figure of 8 aircraft in 2022 that does not appear in the original answer, and misrepresents the timeline by focusing on 'deliveries' rather than 'planned operations.' The correct data shows a reduction from 4 (planned for 2024 in the 2022 plan) to 2 (planned for 2025 in the 2024 plan), not an 8-to-2 drop. Calculations or comparisons based on incorrect base figures invalidate the quantitative reasoning. (3) The multi-hop reasoning is partially sound in that the LLM infers a strategic shift from reduced utilization, which aligns with the ground truth's conclusion about reduced strategic emphasis. However, the synthesis is based on fabricated data rather than accurate cross-temporal comparison. The mention of B767F, Cessna SkyCourier 408, and ATR 72-600F is extraneous and not supported by the original answer, introducing unsupported details. (4) The correctness score is low (3) due to major factual and numerical errors. Quantitative accuracy is very poor (2) because the core numbers are incorrect. Qualitative accuracy is moderate (4) as the general direction of inference (reduced role) is correct, but reasoning is based on false premises. Contextual relevance is acceptable (6) because the answer addresses the question’s theme and attempts strategic interpretation, even if misinformed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 508,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI decreased from $55.3 million in 2022 to $11.5 million in 2023 and further to a net gain of $9.5 million in 2024. This decline suggests a reduced exposure to foreign currency fluctuations or more effective hedging strategies over the period. The trend indicates that Starbucks may have improved its risk management practices or experienced a more stable foreign exchange environment, leading to smaller swings in gains and losses related to foreign currency exposures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million, not $55.3 million as stated by the LLM. Additionally, the LLM incorrectly reports a value of $9.5 million for 2024 net gains in AOCI, while the ground truth states $11.5 million. The LLM also introduces a 2023 figure ($11.5 million) not present in the original answer, which lacks any data for 2023. (2) The quantitative inaccuracies are severe: the 2022 liability is off by over 180x ($55.3M vs $0.3M), and the 2024 gain is incorrect ($9.5M vs $11.5M). There is no support for a 'decline' trend as claimed, since the ground truth shows a shift from a small liability to a significant unrealized gain, suggesting increased, not reduced, exposure or hedging activity. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a decreasing trend and concludes reduced exposure or better hedging, while the ground truth suggests increased exposure or hedging due to a move from minimal liability to a large unrealized gain. The synthesis across years is invalid due to incorrect data. (4) Despite incorrect numbers and reasoning, the LLM addresses the general topic—foreign currency derivative liabilities and AOCI impacts—and attempts to interpret the implications for foreign exchange exposure, maintaining moderate contextual relevance. However, the core facts and conclusions are misaligned with the ground truth, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 427,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 2.625% Senior Notes due 2026 remained consistent in terms of broader debt instrument disclosures. In both years, the notes were referenced as part of PepsiCo's extensive list of senior notes, with the 2024 disclosures including the 2.625% Senior Notes due 2026 among newly authorized and issued debt instruments. Notably, in 2024, PepsiCo expanded its debt disclosures to include additional senior notes issued in 2024, such as the 4.500% Senior Notes due 2029 and the 4.800% Senior Notes due 2034, indicating a broader diversification of its debt portfolio while maintaining the 2.625% Senior Notes due 2026 as part of its ongoing obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the specific senior notes issued in 2024. The ground truth states that PepsiCo disclosed the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029 in 2024, but the LLM incorrectly claims the 4.500% Senior Notes due 2029 and 4.800% Senior Notes due 2034 were added, which contradicts the original data. These incorrect rates and maturities represent major quantitative and entity-level errors. (2) The percentage rates and maturity years are critical numeric identifiers in debt instruments; even small deviations constitute serious inaccuracies. The LLM’s version introduces entirely different financial instruments not present in the ground truth, failing the quantitative accuracy check. (3) The reasoning about broader diversification and continued inclusion of the 2.625% Senior Notes due 2026 is logically sound and aligns with the multi-hop synthesis required—recognizing both continuity and expansion in debt disclosures. However, the flawed entity identification undermines the validity of the conclusion. (4) Despite the incorrect specifics, the answer addresses the question's focus on evolution and broader debt disclosures, maintaining contextual relevance. The core idea of portfolio diversification is consistent with the ground truth, but the use of wrong notes limits correctness. Thus, the correctness_score is 5—partially correct with significant factual flaws; quantitative_accuracy is low due to wrong rates/dates; qualitative_accuracy is moderate due to sound logic but incorrect entities; contextual relevance is high as the response stays on-topic and interprets the intent correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 464,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "Cisco's exposure to and reliance on overcoming technical hurdles from 2022 to 2024 has increased, particularly as the company has intensified strategic investments in key priority areas such as AI, cloud, cybersecurity, and observability. In 2022, the focus was on realigning resources and addressing challenges in product development timelines, with risks tied to market transitions and the need to develop programmable and virtual networks. By 2024, the company emphasized the acceleration of software subscription offerings and the integration of acquired technologies, such as Splunk, which added complexity to its product development and technical execution. The evolution reflects a greater emphasis on timely innovation and overcoming technical challenges to maintain competitiveness in rapidly evolving markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: Cisco's evolving exposure to technical hurdles from 2022 to 2024 is accurately portrayed, with correct emphasis on strategic investments in AI, cloud, cybersecurity, and observability. The integration of Splunk in 2024 is a valid detail that reflects increased technical complexity, consistent with the knowledge graph's indication of more complex software subscription offerings. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes Cisco’s shifting risk profile from internal execution challenges (2022) to broader strategic dependencies (2024), including consequences like competitive positioning and customer retention. The LLM captures the evolution in risk scope—though it does not explicitly mention 'reputational damage' or 'legal liability' from the original answer, it does convey the heightened stakes in competitiveness and innovation, which implies similar consequences. (4) The answer is contextually excellent, directly addressing the evolution in exposure and reliance on overcoming technical hurdles in relation to strategic investments and product timelines. The only minor gap is the omission of the specific risks of reputational damage and legal liability in 2024, which slightly reduces completeness but does not undermine the core accuracy. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 463,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "Based on the provided information, Google Ad Manager played a significant role in driving growth for Google Network revenues in 2021, as it was highlighted as a key contributor to the $8.6 billion increase from 2020 to 2021, along with AdMob and AdSense. However, in the 2023 10-K filing, there is no direct mention of Google Ad Manager's performance or contribution to Google Network revenues, suggesting that its specific role or impact may have diminished or become less emphasized compared to 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that Google Ad Manager was a key contributor to the $8.6 billion increase from 2020 to 2021, while the ground truth specifies the increase was from 2021 to 2022 (i.e., in the 2022 fiscal year). This misalignment of years and periods undermines the core of the response. Additionally, the LLM claims there is 'no direct mention' of Google Ad Manager in the 2023 10-K, but the ground truth confirms it was mentioned as part of a suite of platforms, just without explicit revenue attribution—this is a notable omission and misrepresentation. (2) Quantitatively, the $8.6 billion figure is correct, but its temporal assignment is wrong (2020–2021 vs. 2021–2022), and the years referenced in the analysis (2021, 2023) do not align with the question’s focus on 2022 vs. 2023. This results in a major error in time-based reasoning and context. (3) The multi-hop reasoning fails because the model does not correctly identify the relevant filings for 2022 and 2023, conflating prior-year data. It also fails to recognize that Google Ad Manager was still mentioned in 2023, albeit in a broader context, which is a key nuance in assessing its changing role. (4) While the general direction of the conclusion (reduced emphasis in 2023) is partially aligned, the incorrect timeline, misattribution of data, and omission of key details (e.g., integration into a broader platform suite) severely limit accuracy. The answer is contextually relevant to the topic but factually flawed in execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 431,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks' derivative liabilities related to foreign currency - other increased from $8.3 million in 2022 to $4.7 million in 2024 under accrued liabilities, and from $8.2 million in 2022 to $4.1 million in 2024 under other long-term liabilities. The total magnitude of change was a decrease of $10.1 million from 2022 to 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, Starbucks' derivative liabilities related to foreign currency - other were $0.3 million in 2022 and increased to $4.7 million in 2024 under accrued liabilities. The LLM incorrectly states the 2022 amount as $8.3 million (accrued liabilities) and $8.2 million (other long-term liabilities), which contradicts the ground truth. Additionally, the LLM claims a total decrease of $10.1 million, which is factually wrong—the correct change is an increase of $4.4 million ($4.7M - $0.3M). (2) The quantitative inaccuracies are severe: the starting value is off by over 27x ($0.3M vs $8.3M), and the direction of change is reversed (decrease vs actual increase). Calculations are also incorrect—the claimed $10.1 million decrease does not align with either the LLM's own numbers (combined 2022: $16.5M; 2024: $8.8M; actual difference: $7.7M decrease) or the ground truth. (3) The multi-hop reasoning fails: the model introduces a second liability category (other long-term liabilities) not mentioned in the original answer, fabricating data rather than synthesizing correctly. It also misrepresents the trend, failing to recognize the significant increase. (4) Despite addressing the general topic (evolution of derivative liabilities and magnitude of change), the answer is mostly incorrect due to wrong numbers, incorrect direction of change, and invented data. Contextual relevance is moderate because it attempts the right question structure but with entirely inaccurate content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 430,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "PepsiCo issued the 4.600% Senior Notes due 2045 as part of its broader debt issuance strategy, with no new issuance of these specific notes between 2023 and 2024. However, in 2024, PepsiCo expanded its debt portfolio by issuing new notes such as the 4.650% Senior Notes due 2027 and 4.700% Senior Notes due 2034 through its Singapore subsidiary. This evolution indicates a strategic shift toward diversifying its long-term debt structure, extending maturities, and leveraging international financing platforms to manage interest costs and liquidity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 4.600% Senior Notes due 2045 were authorized in 2023 via Board Resolutions and remained part of the debt structure in 2024, but the LLM incorrectly implies an actual issuance occurred and claims new notes like the 4.650% due 2027 and 4.700% due 2034 were issued in 2024 through a Singapore subsidiary—information not present in the original answer and unsupported by the knowledge graph. These specific notes and the Singapore subsidiary are fabrications. (2) Quantitative accuracy is low: the percentages (4.650%, 4.700%), maturities (2027, 2034), and issuance vehicle (Singapore subsidiary) are all incorrect or unverified. The original answer references a 4.000% Senior Note due 2047 and Floating Rate Notes due 2026 as new instruments, not the ones cited by the LLM. (3) The multi-hop reasoning is partially sound in that the LLM identifies a trend toward diversification in debt strategy, which aligns with the original conclusion. However, the reasoning is based on false premises, undermining the validity of the synthesis. (4) Contextual relevance is moderate—the response addresses the evolution of PepsiCo's debt strategy and attempts to interpret strategic intent, but uses incorrect instruments and dates, reducing factual reliability. While the general direction of interpretation (diversification, extended maturities) is consistent, the lack of factual grounding in the specific notes and transactions limits correctness. Minor credit is given for recognizing continuity in the 4.600% note and inferring strategic diversification, even if based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 459,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region remained relatively stable between 2022 and 2024, with slight fluctuations in proved natural gas reserves. In 2022, the region experienced upward revisions due to higher prices and improved LNG market dynamics, while in 2024, the region saw minimal changes, with only minor upward revisions in equity affiliates. This suggests that COP's strategic focus in the region has shifted toward maintaining and optimizing existing reserves rather than pursuing significant new developments or acquisitions, indicating a more conservative approach to its Asia Pacific/Middle East operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that COP's natural gas reserves in the Asia Pacific/Middle East region decreased from 326 billion cubic feet in 2022 to 296 billion cubic feet in 2024—a reduction of 30 billion cubic feet. The LLM answer incorrectly frames this as 'slight fluctuations' and 'minimal changes' with 'minor upward revisions,' which contradicts the actual decline. There is no mention of the 30 Bcf decrease, and instead, the model falsely claims upward revisions in both 2022 and 2024, which is not supported by the data. (2) The numbers are entirely inaccurate: the LLM does not report the actual reserve figures (326 Bcf and 296 Bcf), nor does it acknowledge the downward trend. This is a critical failure in quantitative accuracy. (3) The reasoning is partially sound in that it attempts multi-hop synthesis by discussing strategic focus based on reserve trends, but because the underlying data is wrong, the conclusion is flawed. The model infers a 'conservative approach' due to 'stable' reserves, but the actual decline suggests a more nuanced strategic shift that may involve drawdowns or divestments, not just optimization. (4) Contextual relevance is fair because the answer addresses the region, time frame, and strategic implications, and uses appropriate terminology (e.g., proved reserves, LNG dynamics). However, the qualitative accuracy is limited by incorrect data interpretation. The answer fabricates revisions and market responses not present in the ground truth. Thus, while the structure and intent are relevant, the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 462,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "From 2022 to 2023, Google Play's role in Google's non-advertising revenue strategy remained consistent as a key contributor, generating revenue primarily from the sales of apps, in-app purchases, and digital content through the Google Play store. However, in 2023, there was a slight shift in emphasis, with increased attention to the broader ecosystem of non-advertising revenue sources such as YouTube subscriptions and hardware, suggesting that while Google Play remained important, it was part of a more diversified strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Google Play as a source of non-advertising revenue involving apps, in-app purchases, and digital content, which aligns with the 2022 description in the ground truth. However, it fails to accurately reflect the evolution in 2023. The ground truth states that in 2023, Google Play's revenue was more narrowly described as coming from 'apps and in-app purchases' only, and was grouped under the broader 'platforms' category. The LLM instead suggests a 'slight shift in emphasis' due to growth in other areas like YouTube subscriptions and hardware, which is not supported by the original answer and misrepresents the nature of the evolution. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—score reflects no factual errors in numbers (by default correct). (3) The multi-hop reasoning is partially sound—LLM recognizes that Google Play remains important and that non-advertising revenue is diversifying, but it fails to correctly synthesize the specific change in how Google Play’s revenue sources were described in the filings from 2022 to 2023. The key shift is in the narrowing of stated revenue sources and re-categorization under 'platforms', which the LLM omits. (4) Correctness and qualitative accuracy are penalized for missing this key strategic repositioning; contextual relevance is high because the answer stays on topic and discusses relevant revenue streams, even if the synthesis is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 415,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "From 2022 to 2024, the projected utilization of the Cessna SkyCourier 408 by FedEx has decreased, with planned deliveries shifting from 49 aircraft through 2027 in 2022 to only 31 aircraft by 2025 in 2024. This reduction suggests a diminished strategic reliance on the Cessna SkyCourier 408, as FedEx appears to be prioritizing other aircraft models such as the ATR 72-600F, B767F, and B777F for its fleet modernization and operational needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a reduction in projected aircraft numbers from 49 to 31, which aligns with the ground truth. However, it misrepresents the timeframes: the 2022 projection was for '2023 to thereafter' (not through 2027), and the 2024 projection covers 2025–2029 (not 'by 2025'), making the date characterization inaccurate. (2) The numbers 49 and 31 are correct, but the implied calculation of a reduction 'to 31 aircraft by 2025' is misleading—the 31 aircraft are planned over a multi-year period (2025–2029), not completed by 2025. This distorts the utilization timeline. (3) The LLM fails to mention the critical qualitative shift in strategic relationship from 'Increases' to 'Depends_On' as noted in the original answer, which indicates a nuanced change in reliance rather than a simple reduction. Instead, it concludes a 'diminished strategic reliance,' which contradicts the ground truth's implication of 'moderated but still significant' reliance. This misrepresents the multi-hop synthesis of both quantitative and qualitative strategic indicators. (4) While the answer addresses the evolution of utilization and strategic reliance, it omits key contextual nuance and misstates timeframes, leading to an oversimplified and partially incorrect conclusion. Quantitative accuracy is partially correct but flawed in context; qualitative reasoning is weakened by missing entity relationships; contextual relevance is high as it directly addresses the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 415,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "AIG's use of expected loss ratio methods between 2022 and 2023 evolved with a greater emphasis on segmentation and analysis of specific casualty lines. In 2022, the focus was on using expected loss ratio methods for at least the three latest accident years due to low credibility of reported losses, with segmentation by attachment point bands and between automobile and non-automobile claims. By 2023, the methodology expanded further, with more detailed segmentation of non-automobile claims into subsets like construction defects and mass torts, which have unique emergence patterns. Additionally, the analysis for excess casualty lines incorporated more nuanced adjustments for rate changes, loss trends, inflation, and market conditions, reflecting a more refined approach to capturing the impact of external factors and underwriting strategies.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AIG's use of expected loss ratio methods in 2022 with segmentation by attachment point and automobile vs. non-automobile claims, and references the three latest accident years, which aligns with the ground truth. However, it incorrectly states that in 2023 the focus remained on excess casualty lines and further segmented non-automobile claims into construction defects and mass torts. In reality, AIG shifted its focus in 2023 from U.S. Excess Casualty to U.S. Workers' Compensation, which the LLM answer completely misses. This is a major factual error in entity and context. (2) Quantitatively, the answer gets the years (2022, 2023) correct and correctly references the three latest accident years. There are no numerical calculations, so accuracy here is high based on available data. (3) The multi-hop reasoning is flawed: the model fails to recognize the shift in casualty line focus from Excess Casualty to Workers' Compensation, a key evolution. Instead, it assumes continuity in the same line with deeper segmentation, contradicting the ground truth. It also incorrectly attributes the special treatment of latent exposures (construction defects, mass torts) as a 2023 development, when they were already part of 2022 analysis. (4) The answer is contextually relevant and uses appropriate terminology, but the core factual error—misidentifying the casualty line analyzed in 2023—severely undermines correctness. While the qualitative details on segmentation and external adjustments are plausible, they do not reflect the actual strategic shift documented in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 448,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "Between fiscal years 2022 and 2024, the classification of unallocated products within Nike's consumer construct evolved as part of the Consumer Direct Acceleration strategy. Beginning in fiscal 2022, unisex products were classified within Men's, and the Jordan Brand was separately reported. By fiscal 2024, the \"Others\" category included products not allocated to Men's, Women's, Kids', and Jordan Brand, reflecting a more refined consumer-focused structure. This shift aimed to align reporting with consumer segments, enhancing transparency and strategic decision-making.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that in fiscal 2022, unisex products were classified within Men's and that 'Others' included unallocated products not assigned to major consumer segments, including Jordan Brand. It also correctly notes that by fiscal 2024, the 'Others' category continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—no errors in dates or fiscal years (2022 and 2024 correctly referenced). (3) The reasoning is sound and reflects a multi-hop synthesis across fiscal years and reporting categories. However, the LLM adds the claim that this shift was 'part of the Consumer Direct Acceleration strategy' and aimed to 'enhance transparency and strategic decision-making,' which, while plausible, is not present in the original answer and introduces unsupported strategic rationale. Additionally, the original answer highlights the absence of explicit mention of unisex classification in Men's by 2024 as a potential shift—this nuance is missing in the LLM response, which fails to note the lack of explicit unisex classification in 2024. (4) Despite these minor omissions and the addition of unverified strategic context, the core facts about classification evolution are correct, warranting a high correctness score of 8. Qualitative accuracy is slightly reduced due to the unsupported inference, but contextual relevance remains high as the answer directly addresses the evolution in reporting structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 437,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 3.500% Senior Notes due 2025 remained consistent, as these notes were issued in 2020 and are set to mature in 2025. No new issuance or refinancing of these specific notes occurred during this period. This indicates that PepsiCo is managing its debt maturity schedule by maintaining existing obligations while potentially preparing for refinancing or repayment closer to the maturity date, reflecting a strategy of disciplined debt management and maturity alignment.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 3.500% Senior Notes due 2025 remained outstanding between 2023 and 2024, which aligns with the ground truth. The dates (2020 issuance, 2025 maturity) and coupon rate (3.500%) are factually accurate, satisfying quantitative accuracy. However, the LLM fails to mention the key evolution noted in the original answer: the introduction of new long-term debt instruments in 2024 such as the 3.500% Senior Notes due 2040 and 3.550% due 2034. This omission is significant because it undermines the multi-hop synthesis required to assess PepsiCo’s broader debt management strategy. (2) There are no calculation errors, and all numeric values (percentages, years) match or are consistent with the ground truth. (3) The reasoning is partially sound—while it's plausible that PepsiCo is preparing for repayment or refinancing, the LLM does not recognize the strategic diversification of maturities indicated by the issuance of new long-term notes. Instead, it concludes a conservative 'disciplined debt management' strategy without evidence from the 2024 filing showing active portfolio expansion. This misrepresents the strategic shift highlighted in the original answer. (4) The answer is contextually relevant and addresses the question about debt management, but it lacks completeness and depth in synthesizing the evolution across years. It focuses narrowly on the absence of change in the 2025 notes, missing the broader strategic context of debt diversification, which is central to the ground truth conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 430,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "Between 2022 and 2024, COP's financial disclosures for the Lower 48 region showed significant changes in capital expenditures and future cash inflow revisions. In 2022, capital expenditures for the Lower 48 were $3,129 million, increasing to $29,952 million in 2024, primarily driven by higher investments in development and proved property acquisitions. Future cash inflows for the Lower 48 also increased from $195,605 million in 2022 to $164,264 million in 2024, reflecting revised estimates based on updated pricing and production assumptions. These changes highlight a strategic shift toward higher capital allocation and updated reserve valuations in the Lower 48 region.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, COP reported capital expenditures of $3,129 million for the Lower 48 region, which is correct. However, the LLM claims that capital expenditures increased to $29,952 million in 2024, which is false — the original answer explicitly states that no new capital expenditure figure was provided for 2024. This is a critical error. Additionally, the LLM fabricates future cash inflow figures: it states $195,605 million in 2022 and $164,264 million in 2024, but these numbers are not present in the ground truth, which only mentions that future cash inflows and production costs were revised in 2024 without providing specific values. The direction of change (increase/decrease) is also unsupported. (2) Quantitative accuracy is extremely low: one number correct ($3,129M in 2022), but two major fabricated figures for 2024 with no basis in the source. The claim of an increase to $29,952M is off by an order of magnitude and completely invalidates the response. (3) Multi-hop reasoning is flawed: the model fails to recognize that the evolution is from reporting actual capex in 2022 to disclosing revisions in financial projections (not new capex) in 2024. Instead, it invents a narrative of growing investment and changing cash inflows, contradicting the ground truth’s indication of a shift from active investment to projection refinement. (4) Contextual relevance is moderate — the answer addresses the Lower 48 region, capital expenditures, and future cash inflows as asked, and attempts a comparative analysis across years, but the substance is factually wrong. Due to severe quantitative and qualitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 477,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "Between 2023 and 2024, Comcast's financial commitments and governance arrangements with Atairos Group remained largely consistent, with a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. Comcast accounts for its investment in Atairos using the equity method, as it does not have the power to direct the activities that most significantly impact Atairos' economic performance due to lacking voting rights. Comcast's economic interests entitle it to approximately 86% of residual returns but obligate it to absorb about 99% of losses. In 2024, Comcast contributed $73 million in cash capital to Atairos, and its total investment, including advances, was $5.1 billion as of December 31, 2024, compared to $5.5 billion in 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. Correct elements include: the equity method accounting in 2024, Comcast absorbing approximately 99% of losses and receiving 86% of residual returns, and the fact that Comcast lacks voting rights (retained by Atairos’ management). However, key inaccuracies exist: the LLM states a remaining unfunded commitment of $1.4 billion as of 2024, which contradicts the ground truth that the total capital commitment was reduced to $4.5 billion (from $5 billion), with annual capital calls limited to $400 million and $40 million for management fees. The $1.4 billion figure is not supported by the ground truth and appears to be either fabricated or misinterpreted. Additionally, the LLM claims total investment was $5.5 billion in 2023 and $5.1 billion in 2024, implying a decrease, but this contradicts the narrative of continued investment and is inconsistent with the ground truth, which does not specify cumulative totals. The $73 million contribution in 2024 is not mentioned in the ground truth and cannot be verified. (2) Quantitative accuracy is compromised: while percentages (86%, 99%) are correct, the dollar figures ($1.4B unfunded, $5.1B/$5.5B total) are either unverified or inconsistent with the stated $4.5B commitment cap. The ground truth specifies structural limits, not actual drawdowns, so reporting a precise unfunded amount suggests overprecision or error. (3) Multi-hop reasoning is partially sound—LLM correctly infers lack of control due to no voting rights and uses equity method accounting—but fails to capture the evolution from the 2023 amended shareholders agreement to the 2024 recalibrated framework, including the formal reduction in commitment and annual funding caps. The answer omits the June 2023 amendment and the structural changes in capital calls, which are central to the question. (4) Contextual relevance is high—the response addresses financial commitments and governance—but correctness suffers due to factual inaccuracies and omission of key structural changes. The answer gives a false impression of stability rather than the recalibration described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 587,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "FedEx's projected utilization of the Cessna SkyCourier 408 decreased between 2022 and 2023, with the total number of aircraft to be purchased dropping from 49 to 31. This reduction indicates a diminished strategic role for the Cessna SkyCourier 408 in FedEx's fleet compared to other aircraft, such as the ATR 72-600F, B767F, and B777F, which also saw changes in their projected utilization but retained a more prominent position in the company's future fleet planning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the reduction in projected Cessna SkyCourier 408 aircraft from 49 in the 2022 filing to 31 in the 2023 filing, matching the ground truth. The years (2022 and 2023 filings) and the time horizons (through 2027 vs. through 2029) are not explicitly mentioned in the LLM answer, but the core numerical projection change is accurate. (2) Quantitatively, the numbers 49 and 31 are correct, and the direction of change (decrease) is properly conveyed. There are no calculation errors. (3) The reasoning is sound: the LLM correctly infers that the reduction indicates a diminished strategic role for the SkyCourier. It appropriately compares the aircraft to others like the B767F and B777F, though it adds the ATR 72-600F, which was not mentioned in the ground truth. This addition does not contradict the truth but slightly extends it without confirmation. The core multi-hop synthesis—comparing changes in projections across filings and drawing strategic implications—is valid. (4) The answer is contextually relevant and addresses both parts of the question: the change in utilization and the strategic implication. The only minor omission is the lack of detail on the extended timeline (2027 vs. 2029), which slightly affects completeness but not overall correctness. Hence, a high score is warranted, with a small deduction in qualitative accuracy for the unverified addition of ATR 72-600F in the comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 401,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "Nike's approach to the Air Max product line from 2022 to 2024 shows a shift in both revenue transparency and technological innovation emphasis. In 2022, Air Max is listed among other technologies like Zoom, Flyknit, and React in the context of leveraging innovations across product categories, but there is no specific revenue breakdown for Air Max. By 2024, while Air Max is still highlighted as a key technology, there is a stronger emphasis on innovation in product design and consumer experiences, particularly with a focus on sustainability and performance. However, no specific revenue figures or transparency for Air Max are disclosed in 2024, indicating that Nike continues to aggregate such data within broader product lines or categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: in 2022, Air Max was listed among other technologies without specific revenue disclosure; in 2024, it was emphasized as a key innovation driver without standalone financials. The absence of specific revenue figures in both years is correctly noted. (2) There are no numeric values requiring calculation, but the temporal references (2022 and 2024) are accurate and consistent with the original answer. (3) The multi-hop reasoning is sound—comparing Nike’s treatment of Air Max across years in terms of transparency and innovation emphasis. The LLM correctly infers a strategic shift despite lack of financial disaggregation. (4) The only minor gap is that the original answer explicitly frames the evolution as a move from 'passive acknowledgment' to positioning Air Max as a 'central example' of innovation strategy, which the LLM captures in substance but slightly under-articulates in strategic framing. However, the mention of 'stronger emphasis on innovation in product design and consumer experiences' conveys semantic equivalence. Wording differences do not detract from factual correctness. Thus, the answer is fully contextually relevant and qualitatively strong, meriting a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 365,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "In 2023, Comcast's capital expenditures for Epic Universe focused on acquiring land for potential theme park expansion opportunities. By 2024, the strategy shifted to direct investment in theme park attractions, with increased spending on the construction of Epic Universe in Orlando. Specific 2024 expenditures included costs associated with developing this new attraction, reflecting a prioritization of advancing the project's physical development over land acquisition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that in 2023, Comcast's capital expenditures for Epic Universe were focused on 'acquiring land for potential theme park expansion opportunities,' which contradicts the ground truth stating that $8.2 billion was allocated to Connectivity & Platforms, including scalable infrastructure and line extensions—specifically for Epic Universe development, not land acquisition. The LLM also fabricates specific 2024 expenditures on construction without citing any dollar amounts, while the original answer notes that no specific figures for Epic Universe were disclosed in 2024. (2) Quantitative accuracy is very low: the $8.2 billion figure from 2023 is entirely omitted, and no correct numerical data is presented in the LLM response. There are no verifiable calculations or accurate financial figures provided. (3) The multi-hop reasoning is flawed—the LLM incorrectly characterizes the strategic evolution, inventing a land-to-construction shift not supported by the source. The actual evolution is from infrastructure-focused investment in 2023 to sustained, experience-enhancing investment in 2024, not a shift from land acquisition to construction. The LLM fails to reflect the correct synthesis across years and investment categories. (4) Despite the factual errors, the answer is contextually relevant—it addresses the question's focus on capital expenditure strategy evolution and thematic park priorities. However, due to major factual and quantitative inaccuracies, the correctness score is low at 3, with similarly low scores for quantitative (2) and qualitative accuracy (3). Contextual relevance is moderate (6) because the structure and intent align with the question, even if the content does not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 486,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "Between 2022 and 2023, FedEx's utilization of the ATR 72-600F aircraft in its fleet projections decreased. In 2022, FedEx was committed to purchasing 24 ATR 72-600F aircraft, with deliveries scheduled from 2023 to 2026. By 2023, this commitment was reduced to 10 ATR 72-600F aircraft, with deliveries planned for 2023 and 2024 only. This indicates a significant reduction in the planned acquisition of this aircraft type in 2023 compared to the prior year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that in 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and 1 in 2026. In 2023, the projections changed to 7 for 2025 and 3 for 2026. The LLM instead claims FedEx was committed to purchasing 24 ATR 72-600F aircraft in 2022 and reduced that to 10 by 2023, with deliveries only in 2023 and 2024. These numbers and timelines are not supported by the ground truth. (2) The quantitative inaccuracies are severe: the original answer contains no mention of a 24-aircraft commitment or a reduction to 10; instead, it discusses fleet projections for specific years, not total purchases. The LLM invents numbers and delivery schedules not present in the ground truth. (3) The reasoning is flawed: the question asks about the evolution of 'utilization' as reflected in 'fleet projections' over planning periods. The correct answer requires comparing how projected fleet sizes for overlapping future years (2023–2026) changed between the 2022 and 2023 planning documents. The LLM misinterprets this as a change in total purchase commitments, failing to perform the correct multi-hop comparison across years and projections. (4) While the LLM captures the general direction (reduction in planned use), it gets the data, scope, and reasoning wrong. Hence, correctness is low (3/10), quantitative accuracy is very poor (2/10), qualitative reasoning is weak (3/10), but contextual relevance is moderate (6/10) as it addresses fleet planning trends for the ATR 72-600F.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 437,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Nike's approach to estimating product return reserves remained consistent in its methodology, which involves using historical rates, specific identification of outstanding returns, and estimates of future returns. However, the reserve balances decreased from $1,015 million in 2022 to $53 million in 2024, indicating a significant reduction in anticipated returns. This suggests a potential improvement in customer satisfaction, stronger demand for products, or a shift in sales mix toward lower-return channels like Direct to Consumer, reflecting a more optimistic revenue recognition outlook.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that in fiscal 2022, Nike's product return reserve was $269 million, recorded in Prepaid expenses and other current assets. The LLM incorrectly claims the reserve was $1,015 million in 2022 and dropped to $53 million in 2024—values not supported by the original answer and factually wrong. No dollar amount was disclosed for 2024 in the ground truth, whereas the LLM asserts a specific figure, which is a major factual error. (2) The quantitative inaccuracies are severe: the claimed amounts ($1,015M and $53M) do not appear in the original answer and contradict it. There is no mention of a decrease in reserves in the ground truth, nor any 2024 dollar value. Calculations or comparisons based on these numbers are therefore invalid. (3) The reasoning is flawed: the original answer describes a methodological shift in Nike’s approach—from a disclosed reserve amount in 2022 to a more formalized, probabilistic 'most likely amount' estimation method by 2024, aligning with variable consideration under revenue recognition standards. The LLM incorrectly claims the methodology 'remained consistent' and attributes changes to business performance (e.g., customer satisfaction), which is not supported by the source. This misses the core point about an evolution in accounting methodology toward forward-looking, probabilistic estimation. (4) The contextual relevance is moderate because the answer addresses product return reserves and revenue recognition, but the factual foundation is so incorrect that the response misleads rather than informs. The multi-hop synthesis failed: it did not connect the change in disclosure practice and estimation technique across years as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 489,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "In 2022, FedEx was committed to purchasing 49 Cessna SkyCourier 408 aircraft in total, with 12 planned for delivery in 2025. By 2023, the total number of planned purchases was reduced to 31, with no deliveries scheduled for 2025. This indicates a significant reduction in the company's strategic reliance on the Cessna SkyCourier 408 model for its fleet composition beyond 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, FedEx planned for 12 Cessna SkyCourier 408 aircraft by 2025 and intended to maintain that number through 2026. In 2023, the plan changed to 17 for 2025 and 14 for 2026. However, the LLM claims that in 2022, FedEx committed to purchasing 49 total aircraft with 12 planned for 2025, and by 2023, reduced total purchases to 31 with no deliveries in 2025—this contradicts the ground truth on all key numbers and trends. (2) The quantitative inaccuracies are severe: the total fleet numbers (49, 31), the 2025 delivery count (12 vs. 'no deliveries'), and the 2026 plan are all incorrect. The ground truth shows an increase to 17 in 2025, not zero. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning is flawed—the question asks for changes in planned fleet composition between 2022 and 2023 for 2025 and beyond. The LLM fails to correctly retrieve or synthesize the actual planned numbers across years and instead introduces unsupported figures and a narrative of reduction, whereas the truth indicates a short-term increase followed by a slight decrease. (4) The contextual relevance is moderate because the answer addresses the right topic (FedEx’s fleet plans for the Cessna SkyCourier 408) and attempts to interpret strategic reliance, but the incorrect data leads to a completely reversed conclusion. Correctness and quantitative accuracy are very low due to fundamental factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 420,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "Mastercard expanded its real-time account-based payments infrastructure from 2023 to 2024 by increasing its operational scale, implementing real-time clearing and settlement infrastructure in 13 markets by December 31, 2023, and enhancing integrated security capabilities through a multi-layered approach. This includes robust programs to protect against cyber and information security threats, incorporating multiple layers of protection, third-party assessments, and collaboration with industry stakeholders to establish secure transaction standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Mastercard was operating or implementing real-time payments infrastructure in 13 markets by the end of 2023, which aligns with the ground truth. It also accurately reflects the enhancement of security capabilities through a multi-layered approach. However, the LLM answer does not explicitly mention the 2024-specific expansion of ACH and real-time account-based systems or the emphasis on intelligent routing and value-added services like fraud scoring and tokenization in real time, which are key developments noted in the original answer. (2) The number '13 markets' and the date 'December 31, 2023' are factually correct and match the ground truth; no calculations were required. (3) The reasoning is mostly sound—correctly linking infrastructure scale and security evolution—but misses the full multi-hop synthesis of how capabilities evolved from 2023 to 2024, particularly the strategic shift toward smarter, more secure global solutions. (4) Scores reflect high factual accuracy, minor omissions in qualitative details, and strong relevance to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 319,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Between 2022 and 2024, Nike's use of foreign exchange forwards and options saw a reduction in both derivative assets and liabilities, reflecting adjustments in their hedging strategy. In 2024, total derivative assets related to these instruments dropped to $343 million from $557 million in 2023, while total derivative liabilities decreased to $151 million from $180 million. This decline suggests a more conservative approach to hedging, potentially due to reduced exposure or improved currency stability. Additionally, the notional amounts of cash flow hedges decreased from $18.2 billion in 2023 to $16.2 billion in 2024, indicating a slight reduction in the scale of hedged transactions. Nike continued to use these instruments primarily to hedge against foreign currency fluctuations, with a focus on major currency pairs like Euro/U.S. Dollar and Chinese Yuan/U.S. Dollar.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2024, liabilities from foreign exchange forwards and options were $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, totaling $115 million in liabilities. However, the LLM claims total derivative liabilities decreased to $151 million from $180 million between 2023 and 2024, which contradicts the ground truth and introduces data not present in the original answer. Additionally, the LLM mentions derivative assets dropping from $557 million to $343 million and notional hedges decreasing from $18.2B to $16.2B, none of which appear in the original answer. (2) The only numeric alignment is indirect: the original mentions a net gain of $8 million after tax in 2022, but the LLM does not reference this at all. All other numbers in the LLM response (e.g., $343M, $151M, $18.2B) are unsupported by the ground truth and appear fabricated or misattributed. (3) The multi-hop reasoning is flawed. The question asks about evolution in use and impact on financial liabilities and hedging strategy. The original answer focuses on a shift in liability reporting and post-tax impact, indicating strategic evolution. The LLM instead infers a 'more conservative approach' based on fabricated asset/liability trends and notional amounts, failing to reference the actual shift in liability classification or the 2022 net gain. (4) The contextual relevance is moderate—the LLM stays on topic regarding hedging strategy and foreign exchange instruments—but the factual foundation is incorrect, severely undermining correctness. The qualitative reasoning is partially sound in intent (assessing strategy evolution) but based on false premises. Quantitative accuracy is very low due to unsupported figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 500,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "The product category classification of Puffs within the Baby, Feminine & Family Care segment remained consistent between 2022 and 2023, as it was listed under the Family Care sub-category in both years. In 2022, Family Care included \"Paper Towels, Tissues, Toilet Paper,\" and in 2023, it was similarly categorized under Family Care with the same description.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key qualitative change in the reporting of the Family Care sub-category between 2022 and 2023. (1) What was correct: The LLM correctly identifies that Puffs remained in the Family Care sub-category in both years and that in 2022, Family Care included 'Paper Towels, Tissues, Toilet Paper.' The entities (Puffs, Baby, Feminine & Family Care segment, Family Care) and years (2022, 2023) are accurate. (2) Quantitative accuracy is high because there are no numerical values to report, and all stated facts are consistent with the ground truth in terms of category names and time periods. (3) Multi-hop reasoning is partially sound: the model correctly tracks Puffs' classification across years but fails to recognize the shift in disclosure detail—specifically, that in 2023, the breakdown was simplified and 'Tissues' was no longer explicitly listed as a distinct component, indicating a consolidation in reporting. The LLM incorrectly states that the 'same description' was used in 2023, which contradicts the ground truth. (4) This omission reduces the qualitative accuracy, as the evolution in classification reporting—though not a change in actual category—is a central part of the answer. The answer is contextually relevant and addresses the question's focus, but lacks the nuance of reporting changes, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 385,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Between 2022 and 2023, Tampax remained within the Baby, Feminine & Family Care segment of P&G's product portfolio. In 2022, Tampax was listed under the \"Feminine Care\" product category, which also included \"Adult Incontinence\" and \"Family Care.\" By 2023, the categorization was slightly refined, with \"Feminine Care\" explicitly divided into \"Adult Incontinence\" and \"Menstrual Care\" subcategories. Tampax was specifically positioned under the \"Menstrual Care\" subcategory in 2023, reflecting a more detailed classification of the product line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Tampax remained within the 'Baby, Feminine & Family Care' segment from 2022 to 2023 and accurately describes the reclassification from 'Feminine Care' in 2022 to a more specific 'Menstrual Care' subcategory in 2023. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—no errors in dates or financials. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of categorization across years and infers a more refined classification structure. The only minor discrepancy is that the original answer mentions 'Family Care' as a separate sub-category alongside 'Baby Care' and 'Feminine Care' in 2022, while the LLM answer incorrectly includes 'Family Care' under 'Feminine Care' rather than as a peer category. Additionally, the LLM mentions 'Adult Incontinence' as part of 'Feminine Care' in 2022, which is not stated in the ground truth—this is a small factual overreach. (4) Despite these minor inaccuracies in subcategory composition, the core insight about Tampax’s repositioning into 'Menstrual Care' is correct and well-reasoned, warranting a high score. Contextual relevance is perfect as all parts of the question are addressed with appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 368,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "Oracle's strategy for Oracle Engineered Systems shifted between fiscal 2022 and 2023, with a continued de-emphasis on nonstrategic hardware products, leading to a decline in hardware revenue contribution. In fiscal 2022, hardware revenues totaled $3.18 billion, a -5% decrease compared to fiscal 2021, and Oracle anticipated this trend to continue as it focused on cloud-based infrastructure. In fiscal 2023, Oracle reiterated its focus on cloud offerings, with hardware representing 6% of total revenues. Research investment expectations for Oracle Engineered Systems were not explicitly detailed, but Oracle committed to ongoing R&D investments in cloud and license offerings, with research and development expenses expected to grow to support cloud expansion and capacity needs.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces significant inaccuracies not present in the ground truth. While it correctly states that hardware represented 6% of total revenues in fiscal 2023 — matching the original answer — it fabricates a specific dollar amount for fiscal 2022 hardware revenue ($3.18 billion) and a -5% year-over-year decline, which are not mentioned or supported in the ground truth. These figures may be plausible but are not part of the verified knowledge base and thus constitute factual overreach. (2) The ground truth does not provide any revenue figures for fiscal 2022 or comparisons to fiscal 2021, nor does it mention a 'decline' in hardware revenue or a 'de-emphasis on nonstrategic hardware products.' This narrative of decline and de-emphasis is absent from the original and represents an unsupported interpretation. (3) On qualitative accuracy, the LLM correctly identifies Oracle’s increased R&D commitment in fiscal 2023, though it incorrectly frames this as focused on 'cloud and license offerings' rather than explicitly including hardware improvements as stated in the ground truth. The original answer emphasizes continued R&D investment to improve *existing hardware products* and develop new ones — a key strategic evolution that the LLM underrepresents. (4) Contextually, the answer addresses the question about strategy evolution, revenue contribution, and R&D expectations, so it remains relevant. However, the inclusion of unverified quantitative data and misalignment on strategic emphasis (e.g., de-emphasis vs. continued investment) reduces factual reliability. The multi-hop synthesis is partially sound but flawed by incorrect assumptions and fabricated metrics. Overall, the answer captures a fragment of the truth but distorts the strategic narrative with unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 505,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Between 2022 and 2023, Honeywell's Non-U.S. pension plans saw a significant increase in investments in private funds. In 2022, the fair value of private funds was $115 million, classified as $41 million in Level 2 and $74 million in Level 3. By 2023, this amount rose to $131 million, with $74 million in Level 2 and $57 million in Level 3. The overall allocation to private funds increased, reflecting a shift in strategy or performance within the Non-U.S. pension portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth in multiple critical ways. (1) Quantitative Accuracy: The LLM falsely claims that Non-U.S. pension plan investments in private funds increased from $115M in 2022 to $131M in 2023. However, the ground truth states that in 2022, $1,105M was invested in private funds—but for U.S. pension plans, not Non-U.S.—and that by 2023, Non-U.S. plans had $115M total ($41M Level 2 + $74M Level 3). The LLM incorrectly assigns the 2023 Non-U.S. number to 2022 and fabricates a 2023 figure of $131M. The breakdowns for 2023 are also wrong: LLM says $74M Level 2 and $57M Level 3, but truth is $41M Level 2 and $74M Level 3. (2) Completeness: The question asks about the evolution of Non-U.S. pension plan investments between 2022 and 2023. The LLM fails to report any correct 2022 figure for Non-U.S. plans (it misuses the 2023 Non-U.S. number as 2022), and incorrectly implies growth when the truth shows a major decrease in overall private fund allocation (from $1,105M in U.S. plans in 2022 to $115M in Non-U.S. in 2023). (3) Entity Accuracy: The LLM confuses U.S. and Non-U.S. pension plans. The $1,105M figure for 2022 applies to U.S. plans, but the LLM incorrectly applies a $115M figure to Non-U.S. in 2022 without mentioning the actual 2022 Non-U.S. data (which may not exist in the ground truth). (4) Reasoning: The multi-hop synthesis is fundamentally flawed. The LLM should have contrasted the 2022 U.S. plan investment ($1,105M Level 3) with the 2023 Non-U.S. plan investment ($115M split across Level 2 and 3), noting the shift in geography and classification. Instead, it fabricates a trend of growth in Non-U.S. plans, which is unsupported. (5) Semantic Equivalence: The LLM's conclusion of 'increased allocation' is the opposite of the truth—there was a significant decrease. The only correct number is $74M in Level 3 for 2023, but even that is misassigned to 2022 in the LLM's narrative. Overall, the answer fails on factual accuracy, reasoning, and entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 549,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "The 2014 USD Notes, which had a principal amount of $1,000 million and a maturity date of April 2024, were fully repaid in April 2024. This repayment marked the conclusion of this debt obligation. No further actions or extensions related to the 2014 USD Notes were taken in 2024, as the debt was fully settled upon maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 2014 USD Notes had a $1 billion principal (stated as $1,000 million), matured in April 2024, and were fully repaid at maturity. This matches the ground truth, which confirms the $1 billion principal payment in April 2024. The status evolution from short-term debt in 2023 to settled in 2024 is accurately implied by the repayment upon maturity, though the explicit classification in 2023 as short-term debt (net of discount and issuance costs) is omitted. (2) All quantitative elements are correct: $1,000 million = $1 billion, and the April 2024 maturity and repayment are precisely stated. No calculation errors. (3) The multi-hop reasoning is sound—connecting the 2023 classification (implied by maturity in 2024) to the 2024 repayment action—but slightly less explicit about the 2023 accounting classification compared to the ground truth. However, the core synthesis across years and debt status is accurate. (4) The answer is contextually fully relevant, directly addressing the evolution and 2024 actions. The minor deduction in qualitative accuracy is due to the omission of the 2023 short-term debt classification detail, but the overall factual correctness and completeness remain high. Hence, a 9/10 correctness score is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 364,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "Between 2022 and 2024, Lowe's Officer Indemnification Agreements have been consistently documented in the 10-K filings, with the 2024 filing (page 79) referencing the same form agreement as in 2022 (page 80). This continuity suggests that the company has maintained a stable indemnification framework for its officers, indicating a consistent approach to executive risk management and governance. The lack of material changes in the documentation implies a focus on preserving legal protections for executives, ensuring continuity in corporate governance practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Lowe's maintained the same form of Officer Indemnification Agreement between 2022 and 2024, with no amendments, and references the continuity in documentation (citing page numbers from the respective 10-Ks: 2024, p.79; 2022, p.80), which matches the original answer’s assertion of re-filing without changes. The date of initial filing (April 2, 2019) and exhibit number (10.43) are omitted, but this does not detract from the core factual accuracy regarding the lack of changes and the implication for governance. Quantitative accuracy is perfect—no numerical or date errors. The reasoning is sound: the model correctly infers that unchanged documentation indicates stable executive risk management and governance continuity. The answer addresses both parts of the question: evolution (no change) and implications (consistency in governance). The only minor gap is the absence of the original filing date and exhibit number, which were included in the ground truth but not strictly necessary for correctness. Semantic equivalence is maintained, and the response is highly relevant. Thus, a score of 9 is warranted—excellent but not fully exhaustive of all documented details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 357,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "Between 2022 and 2023, the market share and category positioning of Always Discreet in the adult incontinence market remained relatively stable. In 2022, Always Discreet held over 10% market share in key markets, while in 2023, it maintained a position with about 15% market share in the markets where it competed. This indicates a slight increase in market share and continued presence as a key player in the adult incontinence sub-category under the Baby, Feminine & Family Care segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Always Discreet had approximately 15% market share in 2023. The ground truth explicitly states that no market share figure was provided in the 2023 filing—only that the brand remains listed as a major brand in the Feminine Care category. The 2022 figure (over 10%) is correctly cited, but the 2023 number is fabricated. (2) Quantitative accuracy fails because the 15% figure does not appear in the source and is not supported by any calculation or inference from the provided data. There is no basis for claiming an increase in market share. (3) The multi-hop reasoning is flawed: the model should have recognized the absence of a market share disclosure in 2023 as a change in reporting, not assumed growth. Instead of noting the shift from quantitative to qualitative presentation, it incorrectly infers performance improvement. (4) Contextual relevance is moderate because the answer addresses the right brand, segment, and product category, and correctly identifies the segment (Baby, Feminine & Family Care), but misrepresents the core fact—market share change—due to unsupported numerical claims. The conclusion about 'slight increase' is invalid, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 353,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "Oracle's strategic positioning of Engineered Systems between 2022 and 2023 has evolved to emphasize their role as a foundational element in both cloud and on-premise infrastructure, reinforcing Oracle's cloud transformation narrative. In 2022, Engineered Systems were described as pre-integrated solutions that deliver performance, scalability, and operational efficiency, with flexible deployment options including on-premise, cloud, and hybrid models. By 2023, the focus expanded to highlight their integration with Oracle Cloud Infrastructure (OCI), particularly through offerings like Oracle Exadata Cloud Service, which supports Oracle's push toward hybrid and multi-cloud environments. This evolution underscores Oracle's strategy to position Engineered Systems as a bridge between traditional on-premise infrastructure and cloud adoption, supporting customers' hybrid IT needs and enhancing Oracle's cloud narrative.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Oracle's Engineered Systems from 2022 to 2023, noting their role in both cloud and on-premise infrastructure and the increased strategic emphasis on integration with Oracle Cloud Infrastructure (OCI), particularly through hybrid offerings like Exadata. This aligns with the ground truth's narrative of Engineered Systems becoming more central to Oracle's hybrid and cloud transformation strategy. However, the LLM answer omits key quantitative and structural details present in the original answer. Specifically, it fails to mention that hardware revenues (including Engineered Systems) accounted for 6% of total revenues in both fiscal 2023 and 2024, a critical data point for assessing the business impact. It also does not reference the broader hardware business expansion to include servers, storage, and operating systems as combined performance obligations, nor the continued R&D investments. (2) There are no numerical inaccuracies—since the LLM does not introduce any incorrect numbers, and the only numbers in the ground truth (6% revenue share) are simply omitted—the quantitative accuracy is scored highly. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward hybrid cloud integration and links Engineered Systems to Oracle’s cloud narrative. However, it misses the financial context and organizational changes in how hardware is reported and managed, weakening the completeness of the synthesis. (4) The contextual relevance is high because the response directly addresses the strategic evolution and cloud transformation angle. The qualitative accuracy is reduced due to missing key elements of the strategic repositioning beyond technical integration, such as financial performance and reporting changes. Overall, the answer is factually consistent but incomplete in capturing the full scope of Oracle’s strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 525,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "In the 2022 10-K (page 59), the 2020 Stock Plan is described as the \"successor to the 2011 Stock Plan,\" with 5,530,106 shares from the 2011 Plan available for grants under the 2020 Plan. By the 2023 10-K (page 61), the 2011 Stock Plan is no longer explicitly referenced, and the 2020 Stock Plan is presented as the sole active plan, with no mention of shares from the 2011 Plan being carried over. This indicates that the 2020 Stock Plan fully replaced the 2011 Plan by 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 10-K explicitly referenced the 2011 Stock Plan as the predecessor and stated that 5,530,106 shares were carried forward to the 2020 Stock Plan, and this detail was omitted in the 2023 10-K. The LLM correctly identifies this change in disclosure. (2) Quantitative accuracy is perfect: the number 5,530,106 is correctly cited, and no calculations are required. (3) The reasoning is sound: the LLM correctly infers that the 2020 Plan replaced the 2011 Plan and that the company shifted its disclosure to present the 2020 Plan as the sole active plan without referencing the prior plan. The only minor shortcoming is the addition of the interpretation that the 2020 Plan 'fully replaced' the 2011 Plan 'by 2023'—while logically plausible, the ground truth does not confirm the timing of the replacement, only the change in disclosure. This slightly extends beyond the provided data. (4) The answer is contextually relevant, directly addressing the evolution of disclosure between the two filings. Overall, the response is factually correct, well-reasoned, and complete with only a minor interpretive overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 342,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell's allocation strategy toward private funds increased between 2022 and 2023, particularly in its U.S. pension plans, where private fund investments rose from $1,258 million in 2022 to $1,265 million in 2023. In non-U.S. plans, private fund allocations also increased from $90 million in 2022 to $115 million in 2023. This suggests a slight shift in capital deployment priorities toward alternative investments, potentially to diversify risk and enhance returns in response to evolving market conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Honeywell's total investment in private funds was $1,244 million in 2022 and $1,265 million in 2023, representing a 1.7% increase. However, the LLM incorrectly breaks this down into U.S. and non-U.S. plans with figures not present in the original answer ($1,258M and $90M in 2022 for U.S. and non-U.S., respectively). These sub-components do not sum to the correct total ($1,258M + $90M = $1,348M, which exceeds the true 2022 total), and there is no mention of such a breakdown in the ground truth. The 2023 non-U.S. figure of $115M is also unsupported. (2) The only correct number is the 2023 total of $1,265M, which matches the ground truth. The 2022 figure of $1,258M in the LLM answer is incorrect and contradicts the verified $1,244M. No calculation of the 1.7% increase is provided, and the implied increase from $1,258M to $1,265M would be only ~0.56%, further misrepresenting the trend. (3) The reasoning about a strategic shift toward alternative investments aligns semantically with the ground truth’s interpretation, showing sound qualitative logic. However, the multi-hop synthesis is flawed because it introduces unverified disaggregated data (U.S. vs. non-U.S.) not present in the source, suggesting possible hallucination or incorrect parsing of the filings. (4) Despite the incorrect numbers, the overall direction (slight increase) and strategic interpretation (diversification, return enhancement) are consistent with the ground truth, preserving some contextual and qualitative value. Hence, partial credit is given for reasoning and relevance, but major deductions apply for factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 472,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "Between 2023 and 2024, Class B-2 Common Stock emerged as a new class of stock following an exchange offer in May 2024, where 241 million shares of Class B-1 Common Stock were exchanged for approximately 120 million shares of Class B-2 Common Stock and 48 million shares of Class C Common Stock. Prior to this exchange, no shares of Class B-2 Common Stock were outstanding. Class B-2 Common Stock has a conversion rate into Class A Common Stock that is subject to adjustments, with double the impact of adjustments compared to Class B-1 Common Stock. The Class B-2 Common Stock is also subject to transfer restrictions and conversion conditions tied to the resolution of litigation matters.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Class B-2 Common Stock was not newly created in May 2024 via an exchange offer involving 241 million Class B-1 shares; rather, it existed in 2023 with disclosures about conversion rate adjustments tied to the U.S. litigation escrow account and dilution impacts. The ground truth states no shares were outstanding prior to the Class B-1 exchange offer, but does not confirm such an exchange actually occurred in May 2024 or that 241 million Class B-1 shares were exchanged for 120 million Class B-2 and 48 million Class C shares—these numbers are entirely fabricated and not supported by the original answer. (2) Quantitative accuracy is very low: the specific figures (241 million, 120 million, 48 million) and the May 2024 date appear in no way in the ground truth and contradict it by implying a transaction that the original answer does not confirm. There are no calculations in the original answer to verify, but the LLM invents precise numbers without basis. (3) Multi-hop reasoning is flawed. The LLM incorrectly frames Class B-2 as emerging from a 2024 exchange, whereas the original answer emphasizes its 2023 disclosure around conversion mechanics and dilution, followed by reduced emphasis in 2024. The relationship to other stock classes is misrepresented—there is no mention in the ground truth of Class C Common Stock or a conversion ratio comparison with Class B-1 having 'double the impact.' While the point about no Class B-2 shares being outstanding before the exchange offer aligns with the original, the broader context and evolution are misrepresented. (4) The contextual relevance is moderate because the LLM addresses Class B-2's outstanding status and relationship to other classes, but the factual foundation is incorrect, leading to a misleading narrative. Due to major factual and quantitative errors, the correctness score is low at 3, with similarly low scores for quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 547,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The financial obligations related to the Target Circle program significantly decreased between 2022 and 2024, with deferred revenue dropping from $89 million in 2022 to $19 million in 2025. This decline suggests that the program may have evolved to recognize revenue more quickly, possibly due to increased member activity, changes in reward structures, or improved redemption rates. The reduction in deferred liabilities indicates a shift toward more immediate revenue recognition, reflecting a more mature or optimized loyalty program.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that deferred revenue dropped from $89 million in 2022 to $19 million in 2025, but the question asks about changes between 2022 and 2024. The ground truth shows that deferred revenue actually increased from $89 million (as of January 29, 2022) to $117 million (as of February 3, 2024), before dropping to $19 million by February 1, 2025. The LLM incorrectly frames the trend as a decrease between 2022 and 2024, when it was in fact an increase. (2) The numbers cited are partially correct—$89 million and $19 million are accurate endpoints—but the LLM misattributes the $19 million figure to 2024 when it is from 2025, and omits the critical $117 million figure for 2024. This leads to a fundamentally flawed quantitative narrative. (3) The reasoning is partially sound in interpreting what a decline in deferred revenue might mean (e.g., faster redemption or revenue recognition), but it fails the multi-hop synthesis by ignoring the intermediate 2024 data point that shows growth in obligations before the drop. The conclusion about program evolution is speculative and based on incorrect trends. (4) Contextual relevance is high because the answer addresses financial obligations and program evolution, but correctness is severely undermined by incorrect timeframes and directional trends. The omission of the 2024 increase renders the answer misleading despite some accurate data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 407,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million at December 31, 2022, to $996 million at December 31, 2023, despite a par value of $1,000 million in both periods. This slight increase in fair value suggests a modest improvement in investor perception or more favorable market conditions for Netflix's debt in 2023 compared to 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that the fair value of Netflix's 4.375% Senior Notes 'decreased from $980 million to $996 million', which is logically impossible—$996 million is higher than $980 million, so this is an increase, not a decrease. The original answer correctly identifies the movement from $980M to $996M as an increase (though it mistakenly calls it a 'decrease' as well, which appears to be a typo in the ground truth). However, the LLM compounds the error by using 'decreased' while citing numbers that show an increase, indicating a failure in basic numerical reasoning. (2) The numbers themselves—$980 million on December 31, 2022, and $996 million on December 31, 2023—are factually correct and match the ground truth. The par value of $1,000 million is also correctly referenced in the LLM answer, though not in the original answer. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that a rise in fair value toward par suggests improved investor perception or better market conditions, which is a valid financial interpretation. However, due to the incorrect use of 'decreased' when the value actually increased, the reasoning is undermined. (4) The contextual relevance is moderate—the answer addresses both parts of the question (change in fair value and its implication), but the core quantitative misstatement (decrease vs. increase) severely compromises factual correctness. A score of 3 is justified due to correct numerical values but major errors in interpretation and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 431,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "Between 2023 and 2024, the equity structure related to Class C Common Stock remained largely unchanged in terms of share issuance, with 10 shares issued and outstanding in both years. However, equity classification was impacted by adjustments in accumulated other comprehensive income (loss), primarily due to changes in foreign currency translation adjustments and derivative instruments. Additionally, the conversion rates of Class B-1 and B-2 common stock were adjusted under the U.S. retrospective responsibility plan, indirectly affecting the earnings per share calculations for Class A common stock but not directly altering the equity classification of Class C shares.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it falsely states that Class C Common Stock had 10 shares issued and outstanding in both 2023 and 2024. The ground truth confirms that in 2023, approximately 48 million Class C shares were issued as part of an exchange offer involving 241 million Class B-1 shares. Only in 2024 did the balance reduce to 10 shares outstanding. The LLM omits this major issuance event entirely and incorrectly asserts stability across both years. (2) The claim about 'accumulated other comprehensive income adjustments' and 'conversion rates of Class B-1 and B-2' affecting equity classification is unsupported by the original answer and distracts from the actual restructuring event. (3) The multi-hop reasoning fails: the question asks about evolution between 2023 and 2024, requiring synthesis of the 2023 exchange offer and the 2024 stabilization. The LLM misses the key 2023 transaction and incorrectly implies no change in share issuance. (4) While the mention of Visa and Class C stock shows some contextual relevance, the core facts—issuance of ~48M shares in 2023—are missing, and the answer fabricates indirect effects on earnings per share and classification. The only correct detail is the 2024 figure of 10 shares outstanding. Due to major factual inaccuracies and failure to capture the key equity restructuring event, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 398,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "Lowe's engagement with Rough Plumbing from 2022 to 2024 has remained consistent in terms of business classification, as it is included within the Building Products division, which also encompasses categories like Building Materials, Electrical, Lighting, Lumber, Millwork, and Rough Plumbing. In terms of service offerings, Rough Plumbing is highlighted as one of the key categories for installation services and extended protection plans, indicating that Lowe's continues to provide both product and service support for this category. There is no indication of a significant change in the classification or expansion of service offerings specific to Rough Plumbing during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that there was no significant change in classification or service offerings for Rough Plumbing from 2022 to 2024. The ground truth states a clear evolution: in 2022, Rough Plumbing was classified under 'Building Products' as a product-only offering, but by 2024 it was integrated into installation services and protection plans, marking a strategic shift toward a service-oriented model. The LLM incorrectly claims consistency, directly contradicting the documented evolution. (2) There are no numeric values in the LLM answer, but it does not contradict the 5% installed sales figure mentioned in the ground truth—however, it also fails to mention it, missing a key quantitative anchor. Since no numbers are misstated, quantitative accuracy is not penalized. (3) The multi-hop reasoning is flawed: the question requires synthesizing changes over time in both classification and service offerings, but the LLM fails to detect the shift from product-only to bundled service model, indicating a failure in temporal and categorical reasoning across the two years. (4) Contextual relevance is moderate because the answer discusses the right entities (Lowe's, Rough Plumbing, Building Products, installation services) and time frame, but draws the wrong conclusion about change (or lack thereof), undermining the core of the question. The answer is plausible-sounding but factually inverted relative to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 409,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "The introduction of Class B-2 common stock occurred in May 2024 through an exchange offer, where 241 million shares of Class B-1 common stock were exchanged for 120 million shares of Class B-2 common stock and 48 million shares of Class C common stock. This indicates that Class B-2 common stock was created as part of a restructuring initiative to release transfer restrictions and facilitate liquidity for certain shareholders. The Class B-2 common stock has a similar per-share earnings allocation as Class B-1 common stock but with conversion rate adjustments that have double the impact compared to Class B-1. This suggests that Class B-2 plays a specialized role in the capital structure, likely tied to litigation and conversion mechanics, while still providing higher earnings per share compared to Class A but lower than Class C.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Class B-2 common stock was introduced in 2023 with 77 million shares outstanding, but the LLM claims it was introduced in May 2024 via an exchange offer involving 241 million Class B-1 shares for 120 million Class B-2 and 48 million Class C shares—none of which appears in the original answer and directly contradicts it. The ground truth states that by 2024, no Class B-2 shares were outstanding prior to the Class B-1 exchange offer, implying they were either retired or restructured, not newly created in 2024 as the LLM claims. (2) Quantitative accuracy is poor: the LLM invents specific numbers (241M, 120M, 48M) not present in the ground truth, and the timeline is reversed—introduction in 2023 vs. 2024. The original answer only mentions 77 million shares in 2023 and zero prior to an exchange in 2024; no exchange mechanics or conversion ratios are provided. (3) Multi-hop reasoning is flawed: the LLM fabricates a narrative about conversion rates, earnings allocation, and litigation roles unsupported by the original answer. The actual inference should be that Class B-2 was introduced in 2023 and then seemingly eliminated or restructured by 2024, indicating a transitional or temporary role in capital structure. The LLM instead constructs a detailed but fictional restructuring event. (4) Contextual relevance is moderate because the answer discusses capital structure evolution and shareholder mechanics, which are relevant themes, but the specifics are entirely incorrect. The conclusion about a 'specialized role' is speculative and not aligned with the ground truth’s indication of strategic shift or replacement. Overall, the answer fails on factual correctness and synthesis, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 497,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The financial liability associated with the Target Circle program decreased significantly from $117 million in 2022 to $19 million in 2024. This decline suggests that the program may have evolved to a point where more revenue is being recognized in line with customer activity, potentially indicating improved predictability or changes in how rewards and benefits are structured and deferred.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that no liability was disclosed in 2022, but by 2024 it had grown to $117 million, indicating an increase. The LLM incorrectly claims the liability decreased from $117 million in 2022 to $19 million in 2024—both the starting value and the trend are wrong. (2) Quantitative accuracy is severely lacking: the $117 million figure is attributed to the wrong year (2022 instead of 2024), and the $19 million figure is entirely fabricated with no support in the original answer. There are no correct calculations because the inputs are false. (3) The multi-hop reasoning fails—the model should have inferred growth from the introduction of a disclosed liability in 2024 where none existed in 2022, but instead it invented a downward trend. The conclusion about improved predictability or structural changes is unsupported and contradicts the evidence of program expansion. (4) Contextual relevance is moderate because the answer addresses the Target Circle program and financial liability, but the incorrect data renders the analysis irrelevant. Correctness and quantitative accuracy are near zero due to complete factual inversion and fabrication of numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 354,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "NVDA's exposure to and concern about pollution limits and their regulatory impact on operations and customer data center expansion evolved between 2023 and 2024, with increased emphasis on climate-related risks and sustainability. In 2023, the company highlighted the potential for new regulations on pollution limits, carbon taxes, and energy taxes to increase compliance costs and alter operations. By 2024, the discussion expanded to include the direct and indirect financial impacts of such regulations, including higher capital expenditures for facilities and equipment, increased energy costs, and potential supply chain disruptions. Additionally, in 2024, NVDA noted that data centers depend on access to clean water and predictable energy, and that regulations limiting energy or water availability could impair customers' ability to expand data centers, which in turn could negatively impact NVDA's business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: in 2023, NVDA noted increased costs and operational changes due to pollution regulations; by 2024, concerns expanded to include capital expenditures, energy costs, supply chain issues, and critically, constraints on customer data center expansion due to resource availability (land, water, energy). The answer correctly identifies the evolution in NVDA's risk disclosures. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes how regulatory pollution limits affect not only NVDA's own operations but also its customers' ability to expand data centers, thereby impacting demand for NVDA's products. The mention of water and energy dependencies adds contextual detail consistent with the broader concern about permitting and land use. (4) The only minor gap is that the LLM does not explicitly mention 'land and permitting constraints' as stated in the original answer, instead framing it as resource (water/energy) availability. However, this is semantically close and does not distort the meaning. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 371,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "Between 2023 and 2024, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary totaled $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120% and maturities from 2033 to 2043. In July 2024, $77 of these Guaranteed Senior Notes were repaid. These notes are valued using Level 3 inputs, indicating they rely on unobservable inputs and internal assumptions for valuation. No further issuances or repayments of these specific Guaranteed Senior Notes were reported in 2024 beyond the initial issuance and partial repayment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $500 issuance of Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 at fixed interest rates from 1.400% to 2.120%, and the $77 repayment in 2024. It accurately states that these notes are valued using Level 3 inputs. The dates (November 2023 issuance, July 2024 repayment) are consistent with the ground truth. (2) All numeric values—$500 issuance, $77 repayment—are correct. While the ground truth does not specify exact months, the LLM adds plausible detail (November 2023, July 2024) that does not contradict the original and may reflect additional context from the filing. The fair value figures ($5,738 in 2023 and $5,412 in 2024 for total long-term debt) are not mentioned in the LLM answer, which is a minor omission. However, the answer focuses specifically on the Guaranteed Senior Notes rather than the overall long-term debt, so this omission does not invalidate the response. (3) The multi-hop reasoning is sound: the model connects the issuance, repayment, valuation inputs, and time periods across years and entities (Costco, Japanese subsidiary). It correctly synthesizes that no further issuances occurred in 2024, which aligns with the ground truth. (4) The answer is contextually relevant and semantically equivalent to the ground truth, with slightly more detail (maturities: 2033–2043) that may come from the actual filing. The only reason for not scoring a 10 is the omission of the overall fair value trend of long-term debt, which was part of the original answer’s concluding insight. However, since the question focuses on 'composition and valuation of the company's Guaranteed Senior Notes,' the LLM stays on point. Thus, a score of 9 is justified for high accuracy with a minor completeness gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 486,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "From 2022 to 2024, Netflix increased its investment in streaming service improvements, as reflected in higher personnel-related costs and cybersecurity measures. In 2022, technology and development expenses rose by 24% due to increased headcount supporting production and streaming improvements. By 2024, the company had strengthened its cybersecurity program, appointing a Vice President of Security and Privacy Engineering with extensive experience and implementing regular risk assessments, penetration testing, and third-party security programs. These efforts indicate a more proactive approach to managing cybersecurity risks and supporting operational resilience.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Netflix's investment from personnel growth in 2022 to enhanced cybersecurity in 2024, which aligns with the ground truth. However, it introduces a 24% increase in technology and development expenses in 2022 that is not present in the original answer; instead, the ground truth specifies a $384 million increase in personnel-related costs. This is a significant quantitative discrepancy. (2) The $384 million figure is missing from the LLM response, and the 24% figure is unsupported by the original data, reducing quantitative accuracy. No other numbers are provided for verification. (3) The qualitative reasoning is sound: the model correctly identifies a strategic shift from streaming service headcount growth to cybersecurity maturity, including third-party risk and security leadership (e.g., VP of Security and Privacy Engineering), which reflects accurate multi-hop synthesis across years and risk domains. (4) Contextually, the answer is highly relevant, addressing both personnel and cybersecurity developments as asked. While the core narrative is correct, the incorrect substitution of a percentage for a disclosed dollar amount prevents a higher score. Semantic equivalence is partially met, but the lack of the specific $384M figure and introduction of unverified data lowers factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 381,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "Between 2023 and 2024, The Bank of New York Mellon Corporation updated its restricted stock unit (RSU) agreements by introducing the 2024 Form of RSU Agreement, as noted in the 2024 filing (Exhibit 10.29). This reflects a continued evolution in the lifecycle management of equity instruments, with a focus on aligning executive compensation with long-term performance and governance standards. The amendments and restatements to related executive compensation plans, such as the Executive Severance Plan (Exhibit 10.30), indicate a strategic effort to refine and standardize equity award structures and post-employment terms for executives.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the introduction of the '2024 Form of Restricted Stock Unit Agreement' in the 2024 filing and references it as Exhibit 10.29, which aligns with the ground truth. It also appropriately notes related amendments to executive compensation plans like the Executive Severance Plan (Exhibit 10.30), indicating awareness of broader governance updates. However, the answer misses key temporal and procedural details that are central to the evolution described in the original answer. Specifically, it fails to note that the 2024 Form was first introduced and marked 'Filed herewith' in the 2023 filing—not the 2024 filing—as a forward-looking document. This misrepresents the timeline: the 2024 Form was already in place before the 2024 fiscal year and was then referenced as 'Previously filed' in the 2024 filing, while the '2025 Form' was newly introduced ('Filed herewith') in 2024. This nuance is critical for understanding the annual, iterative lifecycle management of RSU agreements, which the LLM answer does not capture. While the general strategic intent (aligning compensation with long-term goals) is reasonably inferred, the absence of this multi-hop synthesis—tracking the status change of forms across filings—undermines the qualitative accuracy. The answer is contextually relevant and uses correct entities (correct form names, exhibit numbers, company), and there are no numerical inaccuracies (no incorrect dates or dollar amounts, and no flawed calculations). Thus, quantitative accuracy is high, but qualitative reasoning and completeness are partially deficient.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 438,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90% Senior Notes due April 15, 2029 were issued in November 2023 with a carrying amount of $750 million as of January 28, 2024. By February 2, 2025, the carrying amount remained unchanged at $743 million. The maturity timeline remains consistent, with the notes maturing in fiscal 2029. No repayments or redemptions of these notes occurred between 2023 and 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the carrying amount was $750 million as of January 28, 2024, when the ground truth specifies the carrying amount was $743 million as of that date. The principal was $750 million at issuance, but the carrying amount was reduced by the $3.4 million discount, resulting in $746.6 million initially, and further amortization brought it to $743 million by January 28, 2024. The LLM also references a date 'February 2, 2025,' which is outside the 2023–2024 scope of the question and not mentioned in the ground truth. Additionally, stating the carrying amount 'remained unchanged at $743 million' by 2025 misrepresents the timeline and implies no change from issuance, which contradicts the amortization process. (2) Quantitative accuracy is compromised: the $750 million figure is mislabeled as the 2024 carrying amount instead of the initial principal, and the $743 million is incorrectly presented as stable rather than the result of amortization. The maturity date (April 15, 2029) is correctly cited, and the issuance in November 2023 is accurate. (3) The reasoning partially captures the structure and status of the notes but fails in multi-hop synthesis: it does not correctly link the initial discount, amortization, and resulting change in carrying amount over time. The claim of 'no repayments or redemptions' is reasonable and consistent, but the explanation lacks depth on how the carrying amount evolved. (4) Contextual relevance is high—the answer addresses the notes’ maturity timeline and carrying amount as asked. However, due to significant numerical and temporal errors, the correctness score is moderate. The qualitative accuracy is slightly higher because the overall structure and intent are sound, but quantitative accuracy is low due to critical number mismatches.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 510,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "Between 2023 and 2024, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 in November 2023 at fixed interest rates ranging from 1.400% to 2.120%. In July 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. No further repayments of these notes were mentioned for the remainder of 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of four Guaranteed Senior Notes totaling approximately $500 in 2023 at fixed interest rates between 1.400% and 2.120%, and the repayment of $77 in 2024. It adds specific months (November 2023 and July 2024) not present in the original answer, which are plausible and do not contradict the ground truth. The statement that no further repayments were mentioned in 2024 is consistent with the original answer’s limited scope. (2) All numeric values—$500 issuance, $77 repayment, interest rate range—are accurate and match the ground truth. The formatting is consistent and acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about issuance in 2023 and repayment in 2024, linking both events to the same instrument (Guaranteed Senior Notes) issued by Costco's Japanese subsidiary. The addition of months suggests precise sourcing, though not required, and does not detract from accuracy. (4) The answer is semantically equivalent to the original, with slightly more detail (specific months) and a minor omission of the mention about proceeds being referenced as a financing activity in the 2024 filing. This contextual detail is present in the original but missing in the LLM answer, justifying a 9 instead of 10 on qualitative accuracy. However, the core facts, numbers, and timeline are fully correct and relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 397,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "The risk associated with competitors developing after-market parts for DHR's products is mentioned in both the 2022 and 2023 filings, but there is no explicit indication of a significant evolution in this risk from 2022 to 2023. In both years, the risk is described as a potential factor that may detract from DHR's sales. However, in the 2023 filing, the mention of the Inflation Reduction Act of 2022 and its potential impact on pricing and government-established pricing for certain products suggests a broader regulatory context that could indirectly influence the competitive landscape, including the development of after-market parts.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative shifts in how DHR framed the risk of competitors developing after-market parts from 2022 to 2023. (1) What was correct: The LLM correctly identifies that the risk was mentioned in both years and could detract from sales, and it appropriately notes the introduction of the Inflation Reduction Act in 2023 as part of a broader regulatory context, which aligns with the increased emphasis on external pricing pressures. (2) Quantitative accuracy: There are no numerical values in the question or ground truth, so this aspect is not applicable; the LLM does not introduce any incorrect figures, earning full marks by default. (3) Multi-hop reasoning assessment: The model fails to capture the core evolution — in 2022, the risk was presented as a direct threat to sales and competitive position due to commoditization and private-label competition, while in 2023, it was reframed as one of several external factors under the umbrella of 'Impacted By' cost containment and pricing pressures, indicating a relative de-emphasis. This shift in framing and contextualization is central to the ground truth but is not adequately reflected in the LLM response. The LLM downplays the evolution by stating there is 'no explicit indication of a significant evolution,' which contradicts the documented change in language and strategic emphasis. (4) Justification for scores: Correctness is scored at 5 due to missing the key shift in risk characterization despite some accurate contextual elements. Qualitative accuracy is low because the reasoning and synthesis across years are insufficient. Contextual relevance is high as the answer addresses the right topic and filings, and quantitative accuracy is 10 by default.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 478,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "From 2022 to 2024, Netflix's membership plans evolved with a focus on pricing adjustments and introducing new service features to address business challenges such as slowing membership growth and increasing competition. The company implemented price increases across various regions to boost average monthly revenue per paying membership, which rose from $9.56 in 2021 to $11.67 by 2024. Additionally, Netflix introduced an ad-supported subscription plan to attract price-sensitive consumers while generating additional revenue through ads. These changes aimed to enhance profitability, retain existing members, and compete more effectively in a crowded entertainment market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Netflix's strategic shifts from 2022 to 2024, including price increases and the introduction of an ad-supported plan to address slowing membership growth and competition. These points align with the original answer and address the core of the question. However, the LLM introduces specific dollar amounts—$9.56 in 2021 and $11.67 by 2024—that are not present in the ground truth and cannot be verified from the provided data, making them factually unsupported. The original answer mentions a 7% rise in average monthly revenue per membership but does not provide exact figures or a multi-year breakdown, so these precise numbers represent an overreach. (2) While the 7% increase in average revenue per membership is consistent with the ground truth, the LLM extrapolates this into unsupported numerical precision. There is no mention of 2021 or 2024 exact ARPU values in the original, so these figures are likely fabricated or inferred beyond available data. (3) The reasoning is logically sound: the model correctly synthesizes pricing strategy and new service features (ad-supported tier) as responses to membership and competitive challenges. It captures the multi-hop intent—linking business challenges to strategic responses—even if it adds unverified specifics. (4) The contextual relevance is high because the answer directly addresses the evolution of membership plans, pricing, features, and business rationale. The qualitative accuracy is strong due to correct entity identification (Netflix), time frame (2022–2024), and strategic drivers. However, the quantitative accuracy is reduced due to the inclusion of unverified dollar amounts not present in the ground truth, which affects factual correctness. Hence, a score of 7 is justified: core facts and reasoning are correct, but there are significant quantitative additions that lack support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 515,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "Between 2022 and 2023, Boeing's approach to in-orbit incentive payments has shown increased risk exposure and financial recognition challenges. In 2023, the company highlighted that in-orbit incentive payments, tied to satellite performance for up to 15 years post-acceptance, expose it to financial risks if satellites fail to meet contractual criteria. This is particularly relevant for commercial and government satellite contracts, where failure could lead to loss of incentive payments, refund obligations, and significant charges. In contrast, the 2022 disclosures did not explicitly address in-orbit incentives, focusing instead on general development program risks. Thus, Boeing's 2023 disclosures reflect a more explicit recognition of the long-term financial risks associated with in-orbit performance obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution in Boeing's risk disclosure regarding in-orbit incentive payments, correctly noting increased emphasis on long-term performance risks in 2023 compared to more general risk disclosures in 2022. However, it fails to include the critical quantitative detail from the ground truth: Boeing recorded $1,585 million in additional losses on its five major fixed-price development programs in 2023. This omission significantly undermines the factual completeness and accuracy of the response. (2) The ground truth includes a precise dollar amount ($1,585 million) and links it directly to the programs at risk (Commercial Crew, KC-46A Tanker, VC-25B), which the LLM omits entirely. No other numbers are present in either answer, so the quantitative accuracy is low due to this major missing figure. (3) The multi-hop reasoning is partially sound—the model correctly infers a shift from general risk discussion in 2022 to more specific performance-linked risks in 2023. It also correctly identifies the 15-year post-acceptance performance period and the financial consequences of failure. However, it does not synthesize the key connection between revenue recognition (net present value recognized during construction) and increased financial exposure, which is a core element of the ground truth and essential to understanding the evolution in financial recognition practices. (4) Contextual relevance is high because the answer addresses the question’s focus on risk exposure and financial recognition trends. Qualitative accuracy is moderate due to correct conceptual framing but missing key program names and the revenue recognition mechanism. Correctness score is 6 because while the directional insight is accurate, the absence of the $1.585B loss figure and incomplete explanation of revenue recognition constitute significant factual gaps that prevent full alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 525,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "Between 2023 and 2024, the Directors' Code of Conduct for The Bank of New York Mellon Corporation remained accessible on the company's website, as disclosed in both years. In 2023, the Code was referenced in the 10-K on page 13 under \"ITEM 10,\" and in 2024, it was similarly referenced on page 3 under \"Available Information.\" There is no indication of substantive changes to the Code's content or accessibility during this period, suggesting continuity in its disclosure and availability to stakeholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in stating that the Directors' Code of Conduct remained accessible on the company's website in both 2023 and 2024, and it correctly notes the continuity of disclosure. However, it fails to capture the key evolution in disclosure approach highlighted in the ground truth. In 2023, the Code was explicitly posted with a direct URL and a clear statement about disclosing amendments or waivers. In 2024, the disclosure shifted to a more general reference within a broader list of governance materials without repeating the URL, indicating a move toward consolidation and less direct access. The LLM answer incorrectly implies no change in disclosure style, missing this important nuance. While there are no numerical inaccuracies (hence a high quantitative score), the qualitative accuracy is low because the model fails to synthesize the multi-hop detail about how the accessibility was communicated. The answer is contextually relevant but incomplete in addressing the evolution aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 295,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "Between 2022 and 2023, Mobileye Drive™ evolved from being primarily a Level 4 self-driving system for fleet deployment to a more scalable and commercially advanced autonomous driving solution. In 2022, Mobileye positioned Mobileye Drive as part of its dual business model, targeting both Robotaxi services and Vehicle-as-a-Service (MaaS) partnerships. By 2023, Mobileye expanded its deployment strategy by launching Mobileye SuperVision, which provided highway Navigate-on-Pilot capabilities and was deployed in 22 cities, up from two at its launch. Additionally, Mobileye secured production design wins for its consumer-focused Chauffeur product and further integrated its self-driving system with Moovit's mobility platform to enhance MaaS offerings. This reflects a shift toward broader commercialization and integration into both fleet and consumer markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that Mobileye Drive™ is an L4 self-driving system and that Mobileye targeted fleet and MaaS partnerships. However, it introduces Mobileye SuperVision and highway Navigate-on-Pilot capabilities as part of the 2023 evolution of Mobileye Drive™, which is factually incorrect—SuperVision is a separate L2/L3 system, not part of Mobileye Drive™ (an L4 system). The claim about deployment in 22 cities (up from 2) is not supported by the ground truth and appears to conflate SuperVision with Drive. Additionally, the mention of 'consumer-focused Chauffeur product' design wins in 2023 is not mentioned in the original answer and misrepresents the focus on fleet and MaaS. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily penalized, but the city count (22 vs 2) is a fabricated detail with no grounding, reducing confidence in factual precision. (3) The multi-hop reasoning is partially sound—Mobileye’s shift toward MaaS and integration with Moovit is correctly noted—but the synthesis is flawed by introducing unrelated products (SuperVision, Chauffeur) and misattributing their deployment to Mobileye Drive™. The original answer emphasizes partnerships with Udelv, Transdev, and Geely in 2022 and a strategic pivot to bundle Drive with Moovit in 2023, which the LLM only partially captures. (4) The correctness score is 5 due to significant factual inaccuracies in product differentiation and deployment details, despite capturing the general strategic direction. Quantitative accuracy is 6 because while no financials are wrong, the invented city numbers reduce precision. Qualitative accuracy is 5 due to incorrect entity mapping and reasoning errors. Contextual relevance is 8 because the answer stays on topic and addresses the evolution of deployment strategy, even if with inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 532,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "From 2022 to 2024, the structure and distribution rate of the Tower Preferred Interests evolved as follows: In 2022, Tower Holdings had two series of preferred interests—Class A-1 (5.0%) and Class A-2 (4.75%)—with distributions resetting every five years. In 2024, the 2019 Tower preferred interests were amended to restructure them into Fixed Rate and Floating Rate Class A Limited Membership Interests. The Fixed Rate Interests carry a 5.90% distribution, while the Floating Rate Interests pay SOFR plus 250 basis points, with a portion transitioning to floating rates annually over five years. This restructuring reflects an adjustment to market conditions and provides more flexibility in distribution terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: in 2022, there were two series—Class A-1 with $1,500 at 5.0% and Class A-2 with $4,500 at 4.75%, both resetting every five years. In 2024, the restructuring into Fixed Rate (5.90%) and Floating Rate (SOFR + 250 bps) interests is correctly described. The August 2024 amendment date is missing, but the year is correct. (2) Quantitatively, all percentages and dollar amounts are accurate. The LLM omits the exact dollar totals ($1,500 and $4,500) but correctly identifies the existence and structure of the two series. This is a minor omission, not an error. (3) The multi-hop reasoning is sound—correctly linking the 2022 structure to the 2024 amendment and explaining the evolution in both structure and rate. The mention of annual transition to floating rates aligns with the ground truth. (4) The answer is contextually relevant and directly addresses how the structure and distribution rates evolved. The only minor shortcoming is the lack of specificity on the August 2024 timing and the exact dollar amounts, but these do not undermine the overall correctness. Wording differences (e.g., 'Tower Holdings' vs 'Tower') are acceptable and do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 360,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "From 2022 to 2023, the investment approach for Level 3 assets related to the Balanced Index Fund remained consistent, as the majority of OPB plan assets continued to be invested in a balanced index fund comprising approximately 60% equities and 40% debt securities, valued using a market approach based on quoted prices. However, the unrealized gains/(losses) for Level 3 assets showed improvement, with a total of $14 in 2023 compared to a significant loss of ($90) in 2022. This indicates a positive shift in the performance of these assets during 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, in 2022, the unrealized losses were ($16) million for corporate fixed income and ($11) million for mortgage-backed/asset-backed securities, totaling ($27) million—not ($90) million as stated. In 2023, the gains were $2 million and $6 million respectively, totaling $8 million—not $14. The LLM incorrectly aggregates and fabricates these numbers, leading to major quantitative errors. (2) The investment approach description is partially correct: the 60/40 equities/debt allocation is accurately noted for both years. However, the LLM incorrectly states that Level 3 assets were valued using a market approach based on quoted prices (Level 1) in both years. The ground truth specifies that this market approach was explicitly referenced only in 2023, not 2022, which is a key evolution in valuation methodology. (3) The multi-hop reasoning is partially sound—LLM recognizes the need to compare performance across years and notes a shift from losses to gains. However, due to incorrect figures and misattribution of valuation methods, the synthesis is flawed. The conclusion about improved performance is directionally correct but based on wrong data. (4) Contextual relevance is high—the answer addresses both investment approach and unrealized gains evolution. However, the severe quantitative inaccuracies and misrepresentation of valuation methodology significantly undermine factual correctness, warranting a low correctness score despite some structural and directional accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 442,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "Between 2023 and 2024, BNY Mellon's emphasis on accounting developments in its forward-looking statements has shifted to reflect a more explicit acknowledgment of their strategic and operational impact. In 2023, accounting developments were mentioned as one of several external factors that could influence the company's business. By 2024, the discussion expanded to highlight how changes in accounting standards could have a \"material impact\" on reported financial metrics, including financial condition, results of operations, and capital planning. This evolution suggests that accounting standards are increasingly being integrated into BNY Mellon's strategic considerations, indicating a growing recognition of their influence on financial reporting and decision-making.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and interpretation. (1) It accurately captures the evolution in BNY Mellon's forward-looking statements between 2023 and 2024: from a general mention of accounting developments among other factors in 2023 to a more prominent, strategic role in 2024. The key shift—increased emphasis on the material impact of accounting standards on financial reporting and capital planning—is correctly identified. (2) There are no numeric values, dates, or financial figures in the original or LLM answer beyond the years 2023 and 2024, which are correctly used; thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure language across years and infers increasing strategic importance. However, the LLM slightly overstates the 2024 language by claiming accounting developments could have a 'material impact'—a phrase not present in the ground truth. The original specifies expanded language linking accounting developments to 'businesses, regulatory, technology, market, economic or accounting developments' and ties them to 'capital plans including dividends and repurchases' and 'efficiency savings,' which the LLM omits. These specifics are important for completeness. (4) Despite this omission, the overall reasoning and conclusion about growing strategic integration are valid and contextually appropriate. The answer is highly relevant and well-framed, earning high marks, but loses a point for missing key details present in the ground truth that refine the understanding of how accounting changes are now linked to operational decisions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 460,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "In 2023, the evolution of risks related to store safety and cybersecurity introduced challenges that could negatively impact the associate experience by increasing operational costs, reducing margins, and potentially diminishing associate morale and retention due to unsafe environments or data security concerns. This contrasts with the engagement-focused initiatives in 2022, which emphasized creating an inclusive and supportive workplace through programs like the Voice of the Associate survey, diversity and inclusion efforts, and competitive compensation and benefits to foster emotional commitment and engagement among associates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All entities are correct: HD (Home Depot) is implied contextually, years 2022 and 2023 are accurately referenced, and the focus on associate experience, store safety, cybersecurity, and engagement initiatives aligns with the original. (2) There are no numeric values (percentages, dollar amounts, etc.) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM correctly contrasts 2022's engagement initiatives (e.g., Voice of the Associate survey, inclusion efforts, compensation) with 2023's emerging risks (store shrink from organized retail crime, cybersecurity threats) and their potential negative impact on morale, retention, and trust. While the original answer explicitly mentions 'four out of five associates emotionally committed,' this detail is omitted in the LLM response—this is a minor omission but does not undermine the core accuracy. (4) Contextual relevance is perfect: the response directly addresses how the evolution of risks in 2023 could impact associate experience compared to 2022 initiatives. The LLM captures the contrast and implications (eroded trust, lower morale) using slightly different phrasing. Overall, the answer is highly accurate with only a minor loss in completeness, warranting a 9 in qualitative accuracy and 9 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 390,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "The role of the 'learning curve' in influencing cost and production estimates between 2022 and 2023 has remained a critical factor in program profitability and risk management, particularly for complex programs like the 777X, 787, and KC-46A Tanker. In 2022, the learning curve was explicitly mentioned as a factor affecting production costs, change incorporation, and achieving anticipated cost reductions. By 2023, the learning curve continued to play a key role in estimating program costs and gross margins, with ongoing challenges in production stability, supplier performance, and regulatory requirements impacting profitability. The evolution reflects a heightened focus on managing these variables to mitigate risks and improve long-term program outcomes.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses the key evolution described in the ground truth. (1) What was correct: The answer correctly identifies that the learning curve influenced cost and production estimates in both 2022 and 2023 and ties it to program profitability and risk management, mentioning relevant programs like the 787. It also correctly notes ongoing challenges in supplier performance and production stability. (2) Quantitative accuracy: There are no numeric values in either the ground truth or the LLM answer, so this dimension is neutral; no inaccuracies present. (3) Multi-hop reasoning assessment: The critical failure is in reasoning—the ground truth describes a conceptual shift: in 2022, the learning curve was a risk factor; by 2023, it was integrated into cost estimation as a predictable, managed element. The LLM answer does not capture this evolution. Instead, it suggests continuity ('continued to play a key role') and emphasizes ongoing challenges without acknowledging the strategic reframing of the learning curve as a managed variable. This misrepresents the core transformation in how Boeing treated the learning curve. (4) Justification for scores: Correctness is 5/10 because key facts (programs, general influence) are accurate, but the central evolution is missing. Qualitative accuracy is 5 due to flawed reasoning and failure to synthesize the shift in treatment of the learning curve. Quantitative accuracy is 10 by default (no numbers). Contextual relevance is 8 because the answer stays on topic and references relevant programs and themes, even if the conclusion is incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 443,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "Between the 2023 and 2024 SEC filings, the disclosure regarding the Dividend Reinvestment Plan remains consistent in acknowledging that certain officers or directors participate in the plan. However, in the 2024 filing, there is a more specific reference to these arrangements in **ITEM 9B**, where it clarifies that such transactions may either be structured under Rule 10b5-1 or constitute non-Rule 10b5-1 trading arrangements, as defined in Regulation S-K. This added specificity in 2024 provides greater transparency about the nature of the trading arrangements associated with officer and director participation in the plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. According to the ground truth, the 2024 filing *omitted* the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements that was present in the 2023 filing, indicating a simplification. However, the LLM states the opposite—that the 2024 filing includes a 'more specific reference' and 'added specificity' in ITEM 9B regarding these trading arrangements. This misrepresents the evolution of disclosure and inverts the direction of change. There are no numeric values to assess, so quantitative accuracy is not applicable (scored 10 by default for absence of errors). Qualitatively, the reasoning is flawed because it fails to correctly synthesize the multi-hop comparison between the two years’ disclosures; instead, it asserts a heightened level of detail in 2024 that contradicts the ground truth. Contextually, the answer addresses officer/director participation and trading arrangements, which is relevant, but the incorrect characterization of the disclosure trend severely undermines its validity. The mention of 'ITEM 9B' also does not appear in the original answer and may be a fabrication or misattribution. Overall, the answer conveys the opposite of the true disclosure evolution, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 362,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "The Home Depot's investment in creating an interconnected shopping experience increased from $2.6 billion in fiscal 2021 to $3.2 billion in fiscal 2023. Specific changes to tailor this experience to customers included enhancing digital capabilities for a seamless blend of online and in-store interactions, introducing mobile app features like store-specific maps, implementing self-service tools such as lockers and curbside pickup, and leveraging data-driven merchandising tools to personalize product offerings based on customer intent and location. Additionally, the company focused on improving store navigation, checkout efficiency, and associate engagement to enhance the in-store experience.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative claim that The Home Depot's investment increased to $3.2 billion in fiscal 2023. The ground truth only confirms $2.6 billion in capital expenditures in fiscal 2021 and does not provide any specific dollar amount for fiscal 2023. This unsupported increase claim undermines the factual accuracy. Other details about enhanced digital capabilities, mobile app features, self-service tools, and data-driven personalization are plausible elaborations but are not present in the original answer and cannot be verified from the provided ground truth. (2) The quantitative accuracy is low because the $3.2 billion figure is fabricated. The original answer does not mention any capital expenditure figure for 2023, so asserting an increase is incorrect. The $2.6 billion figure for 2021 is accurate. (3) The qualitative reasoning partially captures the evolution from general investment to a more tailored, data-driven experience, which aligns with the ground truth’s emphasis on leveraging enhanced merchandising IT tools to personalize based on shopping intent and location. However, the LLM invents specific initiatives (e.g., lockers, curbside pickup, store maps) that are not in the original answer, going beyond the provided information. While these may be real initiatives, they are not part of the knowledge graph ground truth and thus introduce hallucinated details. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution over time and specific changes in tailoring—and stays focused on The Home Depot’s interconnected shopping experience. However, the correctness score is moderate due to the critical error in financial data and the inclusion of unverified specifics, which compromise overall factual reliability despite reasonable reasoning structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 510,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "Between 2022 and 2023, DHR's financial relationship with Aldevron primarily involved acquisition-related expenditures. In 2021, DHR acquired Aldevron for approximately $9.6 billion, financing the acquisition using cash on hand and proceeds from commercial paper. The acquisition added approximately $6.1 billion in goodwill to DHR's balance sheet. In 2023, DHR incurred $27 million in transaction-related costs associated with the Abcam Acquisition, but no further material capital investments or acquisition expenditures related to Aldevron were reported. Thus, the financial relationship remained static post-acquisition, with no new capital investments or acquisition activities involving Aldevron in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that DHR acquired Aldevron in 2021 for $9.6 billion, while the ground truth indicates the acquisition was completed in 2023 with net cash consideration of $9,561 million ($9.561 billion), which is close in magnitude but wrong in timing. The $9.6 billion figure is a reasonable approximation of $9,561 million, so the amount is approximately correct, but the year is critically wrong. Additionally, the LLM claims no further material expenditures related to Aldevron occurred in 2023, which directly contradicts the ground truth that the acquisition payment itself occurred in 2023. The mention of $27 million in transaction costs for the Abcam Acquisition is irrelevant and distracts from the Aldevron focus. The $6.1 billion goodwill addition is not mentioned in the ground truth and cannot be verified, making it potentially fabricated or misattributed. (2) Quantitative accuracy fails on key points: the year of acquisition (2021 vs 2023) is incorrect, and the answer omits the $1.5 billion anticipated capital expenditures in 2022 tied to Aldevron capacity, which is a major component of the original answer. The only partially correct number is the acquisition cost (~$9.6B vs $9.561B). (3) Multi-hop reasoning is flawed: the model fails to connect 2022 capital investment plans to the 2023 acquisition, instead portraying the acquisition as a past event (2021) with no subsequent financial activity, which inverts the timeline and misrepresents the evolution. The shift from capital investment to full acquisition is completely missed. (4) Contextual relevance is moderate because the answer discusses financial expenditures related to Aldevron, but the incorrect timeline and inclusion of unrelated Abcam costs reduce relevance. The core evolution of the financial relationship is misrepresented, leading to a low correctness score despite some thematic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 530,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "From 2022 to 2024, the total value of Telco LLC's preferred interests increased from $7,250 million as of December 31, 2023, to $9,500 million by October 2024, following the planned issuance of an additional $2,250 million in Telco Class A-4 preferred interests in early 2025. The structure evolved with the introduction of the Telco Class A-4 interests, which carry an initial distribution rate of 5.94% annually, subject to a reset on November 1, 2028, and every four years thereafter. The earlier classes (A-1, A-2, and A-3) had initial distribution rates of 4.25% and 6.85%, with reset schedules every seven years. The new Class A-4 interests have a shorter reset interval and a higher initial rate compared to the older classes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Telco LLC had $2,000 in preferred interests (Class A-1), and in April 2023, it issued an additional $5,250 in Class A-2 and A-3 interests, bringing the total to $7,250 by 2024. The LLM incorrectly states the 2022/2023 total as $7,250 million (adding 'million' erroneously) and claims a further $2,250 million issuance of Class A-4 in early 2025 (which is future and not within the 2022–2024 scope), inflating the total to $9,500 million by October 2024—none of which is supported by the original answer. (2) The numbers are fundamentally wrong: the original answer does not mention Class A-4, any issuance in 2025, or a $2,250 million issuance. The distribution rates for A-2 and A-3 are correctly noted as 6.85% in the LLM answer, and A-1 as 4.25%, which matches the ground truth. However, the LLM invents a 5.94% rate for non-existent Class A-4 and a reset every four years, whereas the original specifies seven-year resets for all existing classes. (3) The multi-hop reasoning fails: the LLM misrepresents the timeline, introduces fictional instruments, and misstates totals. It also references events in 2025 when the question is about 2022–2024. (4) The contextual relevance is moderate because it discusses structure, value, distribution rates, and reset schedules as asked, but the factual foundation is incorrect. Due to major quantitative and qualitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 418,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "Between 2022 and 2024, AIG's use of Expected Loss Ratio Methods has evolved in terms of application and rationale. In 2022, the Expected Loss Ratio method was primarily used for short-tail classes like U.S. Property and for the latest accident year in aviation exposures, where claim severity and variability made frequency/severity methods less effective. By 2024, the Expected Loss Ratio method was still applied to short-tail and long-tail lines, including U.S. Workers' Compensation, where loss emergence is long-term and historical data may be inconsistent. The rationale for its use expanded to include adjusting for rate changes, loss trends, and market conditions, particularly in recent accident years. Additionally, it was weighted more heavily in business written in excess of deductibles, reflecting its reliability in scenarios with limited loss history or inconsistent development patterns.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of factual content and context, with accurate dates (2022 and 2024) and correct identification of AIG as the entity. It correctly notes the use of Expected Loss Ratio (ELR) methods in 2022 for short-tail lines like aviation and implies their use in the latest accident year, aligning with the ground truth. The expansion to U.S. Workers' Compensation by 2024 is accurately mentioned, which is a key long-tail line, matching the ground truth. However, the LLM introduces 'U.S. Property' as a short-tail class used in 2022, which is not mentioned in the original answer and lacks support in the ground truth, representing an unsupported addition. Additionally, while the original answer emphasizes the combination of ELR with loss development and frequency/severity methods in 2024 for Workers' Compensation, the LLM focuses more on rationale like adjusting for rate changes and loss trends—details not present in the ground truth. These additions, while plausible, go beyond the documented evolution and introduce speculative reasoning. The core multi-hop synthesis—comparing AIG’s use of ELR across years and lines of business—is sound and relevant, but the extra details reduce qualitative accuracy. Quantitatively, there are no numbers to verify, so accuracy is rated as 10 by default. Contextual relevance is high as the response directly addresses the evolution in application and rationale. Overall, the answer captures the main evolution but adds unverified specifics, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 423,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "Target's approach to its owned brands evolved from 2023 to 2024 by placing a stronger strategic emphasis on expanding and strengthening its owned brands portfolio as a key element of its overall strategy to delight customers with newness, style, and value. In 2023, the focus was on leveraging owned brands to differentiate its offerings and provide value, while in 2024, the strategy explicitly highlighted strengthening the owned brands portfolio alongside curating national brands and expanding signature partnerships. Additionally, the 2024 document provides a more detailed list of owned brands and emphasizes the importance of global sourcing operations in developing and procuring these brands, indicating a more structured and expanded approach to product portfolio development.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities—Target, 2023, 2024, owned brands, strategic emphasis, product portfolio development—are correctly identified and addressed. (2) There are no numeric values in the original or LLM answer requiring quantitative verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; the mention of 'over 40 distinct brands' in the ground truth is consistent with the LLM’s reference to a 'more detailed list of owned brands,' though the LLM does not explicitly state the number '40+', which is a minor omission. (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic evolution from 2023 (focus on differentiation and value) to 2024 (strengthening portfolio, structured development via global sourcing, and integration with partnerships), reflecting a progression from strategic intent to execution. (4) The LLM adds contextual detail not in the ground truth (e.g., 'global sourcing operations', 'signature partnerships') that is plausible and enhances the explanation without contradicting facts. The core evolution—strategic emphasis shifting toward more concrete, diversified execution—is accurately conveyed. The answer is fully contextually relevant. A score of 9 is given because while all key facts are correct, the LLM does not explicitly mention the 'over 40' brands, a specific data point in the ground truth that reflects the scale of portfolio development in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 413,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggests a strategic approach to diversify its long-term debt structure and potentially access more favorable borrowing conditions. The issuance of the higher-yield 2.900% Notes may indicate that IBM is capitalizing on current market conditions to secure additional financing at a relatively attractive rate, while retaining the lower-yield 0.875% Notes to maintain a balanced maturity profile and manage interest costs over time. This reflects confidence in stable long-term borrowing markets and IBM's proactive management of its debt portfolio to optimize financial flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two notes (0.875% and 2.900% Notes due 2030) and their continued listing in 2024, which aligns with the ground truth. All numeric values—interest rates (0.875% and 2.900%) and maturity year (2030)—are accurate, satisfying quantitative accuracy. (2) However, the LLM misinterprets the market conditions: it suggests IBM issued the 2.900% Notes to capitalize on 'attractive' borrowing conditions, while the ground truth indicates the higher rate likely reflects *less favorable* interest rate environments in 2024 compared to when the 0.875% Notes were originally issued (in 2023). This is a significant qualitative error in reasoning. (3) The multi-hop synthesis is partially sound—linking the two notes and inferring a debt diversification strategy is valid—but the conclusion about favorable market conditions contradicts the implied economic reality of rising rates. The ground truth emphasizes that the rate increase suggests deteriorated borrowing conditions, not improved ones. (4) The answer is contextually relevant and well-structured, addressing both debt strategy and market conditions, but the flawed interpretation of interest rate trends undermines the qualitative accuracy. Hence, correctness is reduced to 6 due to this key misinterpretation, despite correct entities and numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 376,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "The 4.000% Global Notes due June 1, 2049 (T 49A) were listed in both the 2022 and 2024 filings, indicating continuity in this long-term debt instrument. Between 2022 and 2024, AT&T added new long-term notes, including the 3.950% Global Notes due April 30, 2031 (T 31F) in 2024, reflecting a shift toward issuing notes with shorter maturities and varying coupon rates to manage its debt portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that the 4.000% Global Notes due June 1, 2049 (T 49A) were present in both 2022 and 2024, it incorrectly identifies the newly added note as the 3.950% Global Notes due April 30, 2031 (T 31F). According to the ground truth, the new note added was the 4.300% Global Notes due November 18, 2034 (T 34C), not the T 31F. This is a critical error in both coupon rate and maturity date. (2) Quantitative accuracy is low: the coupon rate (3.950% vs 4.300%), maturity date (April 30, 2031 vs November 18, 2034), and security symbol (T 31F vs T 34C) are all incorrect. These are not formatting differences but distinct financial instruments. (3) The reasoning is partially sound—recognizing that AT&T added new notes and maintained long-dated obligations—but fails the multi-hop requirement because it synthesizes incorrect data. The conclusion about a 'shift toward shorter maturities' is speculative and not supported by the specific comparison in the ground truth, which highlights the addition of a 2034 note alongside the 2049 note. (4) Contextual relevance is fair because the answer addresses the evolution of debt composition and attempts to interpret strategy, but the incorrect instrument details undermine the validity. Correctness is scored low due to core factual errors in the newly added debt instrument, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 399,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The financial impact of the Heritage AspenTech acquisition evolved between 2023 and 2024, with intangibles amortization increasing from $258 million in 2023 to $560 million in 2024, primarily due to the full-year impact of the acquisition and the addition of the National Instruments acquisition in 2024. Restructuring costs related to the Heritage AspenTech acquisition were minimal, at $1 million in 2023 and $8 million in 2024, reflecting ongoing integration and operational adjustments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, intangibles amortization decreased from $258 million in 2023 to $97 million in 2024, but the LLM claims it increased to $560 million in 2024—this is a major factual error. Similarly, restructuring costs in the ground truth rose from $72 million to $228 million, but the LLM states they were only $1 million and $8 million, respectively—another severe inaccuracy. (2) All numeric values are wrong: amortization figures are inverted in direction and magnitude; restructuring costs are off by orders of magnitude. Calculations or trends based on these numbers are therefore invalid. (3) The reasoning is flawed and introduces unrelated information: the mention of the 'National Instruments acquisition' is extraneous and not referenced in the original context, indicating a hallucination. The model fails to correctly synthesize the actual financial evolution of the Heritage AspenTech acquisition, misrepresenting both cost trends and their drivers. (4) Despite addressing the right question structure (evolution of amortization and restructuring costs), the complete lack of factual alignment with the ground truth results in a correctness score of 1. Contextual relevance is moderate (5) because the answer attempts the right comparison, but accuracy scores are near zero due to pervasive quantitative and qualitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 399,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods for workers' compensation between 2022 and 2024 has evolved with a greater emphasis on segmentation by business types and the impact of large deductible accounts. In 2022, the proportion of large deductible business continued to increase, which slowed claim reporting patterns. By 2024, AIG further refined its segmentation, analyzing subsets of the portfolio with unique characteristics and segmenting excess of deductible business by deductible size and claim handling (AIG vs. third-party administrators). Additionally, expected loss ratio methods for excess of deductible business were given significant weight in the most recent five accident years, reflecting the evolving approach to account for the delayed emergence of claims in this structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AIG's use of expected loss ratio methods between 2022 and 2024. (1) All factual elements are correct: the increasing proportion of large deductible business slowing claim reporting in 2022, the use of expected loss ratios for guaranteed cost in the most recent accident year (implied context), and the significant weight given to the most recent five accident years for excess of deductible business. By 2024, the segmentation by deductible size and claim handling (AIG vs. third-party administrators) is correctly identified. (2) There are no numeric inaccuracies—dates (2022, 2024), timeframes (most recent five accident years), and business types (guaranteed cost, excess of deductible) are all correctly stated. (3) The multi-hop reasoning is sound: the answer synthesizes changes over time, connects the impact of large deductible accounts to claim emergence, and reflects increased segmentation. (4) The only minor omission is that the 2024 disclosures' emphasis on limitations in claim count data due to aggregation and reinsurance exclusions—explicitly noted in the ground truth—is not mentioned in the LLM answer. This is a contextual detail that adds depth but does not undermine the core accuracy. Overall, the answer is semantically equivalent to the ground truth with high completeness and precise qualitative and quantitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 391,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "From 2023 to 2024, Target enhanced its Cyber Fusion Center operations by strengthening threat investigation and response capabilities, leveraging industry-leading tools and in-house technologies. In 2024, the company emphasized deeper integration of cybersecurity into its enterprise risk management and expanded collaboration with external organizations across industries to share threat intelligence, best practices, and regulatory insights. Additionally, Target continued to invest in developing in-house cybersecurity expertise and training programs, such as the Cyber Plus Institute, to further bolster its response strategies and preparedness.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct and relevant but misses key factual developments from the ground truth, particularly around the structured incident response program and third-party assessments in 2024. (1) Correct elements include: maintaining and enhancing the Cyber Fusion Center, cross-industry collaboration for threat intelligence sharing, and investment in training (e.g., Cyber Plus Institute mentioned aligns with expanded training in 2024). (2) Quantitative accuracy is high—no specific numbers, dates, or financials are misstated; all timeframes (2023 to 2024) are correctly referenced. (3) Multi-hop reasoning is partially sound: the model correctly infers evolution in cybersecurity posture and external collaboration, but fails to accurately synthesize the specific 2024 enhancements such as the coordinated escalation model for Board reporting and use of third-party vendors to test the cybersecurity program—both critical differentiators in the ground truth. Instead, it substitutes with plausible but unverified details like 'enterprise risk management integration' and 'industry-leading tools' not present in the original. (4) The answer is contextually relevant and well-structured, but lacks precision in reflecting the actual documented changes, resulting in a moderate correctness score due to significant omissions in operational evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 377,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "Eli Lilly recognized $677.6 million in revenue from Baqsimi in 2023, a significant increase from $139.3 million in 2022, as noted in the 2023 10-K. By 2024, the 10-K indicates that Baqsimi was included in the revenue from the sale of product rights, though specific figures for 2024 are not provided. This suggests that the contractual arrangement involving Baqsimi likely concluded in 2023, with the majority of revenue recognized during that year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Eli Lilly recognized $579.0 million in revenue from the sale of Baqsimi rights in 2023, but the LLM claims $677.6 million, which is incorrect. Additionally, the LLM references $139.3 million in 2022 revenue for Baqsimi, which is not mentioned or supported in the original answer and appears to be fabricated or misattributed. (2) The quantitative inaccuracies are severe—both the 2023 and 2022 figures are wrong, and no 2024 figure was provided in the original, but the LLM incorrectly implies one might exist. The original answer emphasizes a shift in revenue recognition methodology, not ongoing product sales. (3) The reasoning is flawed: the original describes a shift from direct revenue to inclusion in broader collaboration revenue in 2024, indicating continued strategic relevance, whereas the LLM incorrectly infers that the arrangement 'likely concluded' in 2023. This misrepresents the evolution as a termination rather than an integration, failing the multi-hop synthesis between accounting treatment changes across years. (4) While the LLM attempts to address revenue recognition and contractual evolution, it does so with incorrect data and flawed logic, leading to a low correctness score. Contextual relevance is moderate because it discusses the right topic and timeframe but draws incorrect conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 394,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "From 2023 to 2024, AT&T repurchased all outstanding Mobility Preferred Interests, completing the process in April 2023 by repurchasing the remaining 213 million interests for $5,414, which was primarily funded through the issuance of Telco LLC preferred interests. In terms of expansion, AT&T restructured and reset the Tower Holdings preferred interests in August 2024, transitioning them to Fixed and Floating Rate Class A Limited Membership Interests, with distributions of 5.90% and SOFR + 250 basis points, respectively. Additionally, in October 2024, AT&T agreed to issue $2,250 of new Telco Class A-4 preferred interests in 2025, paying an initial distribution of 5.94%, to fund the redemption of preferred equity securities.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core events correctly—AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414 in 2023, funded primarily by issuing Telco LLC preferred interests. It also correctly notes the restructuring of Tower Holdings preferred interests into fixed and floating rate classes with 5.90% and SOFR + 250 bps, respectively. However, the LLM introduces a new issuance of $2,250 in Telco Class A-4 interests in October 2024, which is not present in the ground truth. The ground truth states that total Telco LLC preferred interests reached $7,250, including the original $2,000 and 2023 issuance of $5,250—this implies no additional $2,250 issuance in 2024. This is a significant quantitative error. (2) The date of the Tower Holdings restructuring is given as August 2024 in the LLM answer, but the ground truth does not specify a date—only that it occurred by 2024—so this over-precision is a minor issue. The $5,414 repurchase amount and 213 million interests are accurate. The 5.90% and SOFR + 250 bps rates for Tower Holdings are correct. The 6.85% rate on the 2023 Telco issuance is missing in the LLM answer, which weakens completeness. (3) The multi-hop reasoning is generally sound: the LLM connects the repurchase of Mobility interests to funding via Telco issuance and identifies the strategic shift toward Tower and Telco preferred expansions. However, it fabricates a future $2,250 issuance not supported by the ground truth, undermining quantitative accuracy. (4) Despite this, the overall narrative of a strategic pivot from repurchasing legacy interests to expanding structured preferred interests is preserved, and the answer remains contextually relevant and qualitatively strong. Hence, correctness is reduced to 7 due to the incorrect new issuance figure, but other dimensions remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 504,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "From 2023 to 2024, Emerson's relationship with AspenTech evolved significantly, culminating in a proposal to acquire the remaining shares of AspenTech not already owned by Emerson for $240 per share in cash. By 2024, Emerson already owned approximately 57% of AspenTech's outstanding shares. This transformation had notable financial impacts: Emerson's gross margin increased by 1.8 percentage points to 50.8% in 2024, primarily due to the Test & Measurement acquisition (which included AspenTech), despite a negative impact from acquisition-related inventory step-up amortization. Additionally, Emerson's ownership structure was affected, with the proposed acquisition aiming to consolidate full control over AspenTech, enhancing Emerson's position as a global automation leader.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Emerson proposed to acquire the remaining shares of AspenTech for $240 per share in cash—this detail is not present in the ground truth and appears fabricated. Second, the ownership stake is reported as 'approximately 57%' in 2024, whereas the ground truth specifies a 55% ownership in 'New AspenTech' post-transaction. Third, the LLM attributes the 1.8 percentage point gross margin increase in 2024 primarily to the 'Test & Measurement acquisition (which included AspenTech)', but the ground truth states that AspenTech contributed a 3.3 point increase in 2023 and was part of broader changes leading to a 1.8 point increase in 2024—this misattributes causality and timing. Additionally, the LLM omits the $6.0 billion cash transaction, a key financial figure. (2) Quantitative accuracy is low: the $240/share price, 57% ownership, and attribution of margin impact to Test & Measurement are all incorrect or unsupported. The 1.8 percentage point margin increase in 2024 is correctly mentioned, but the context and driver are misrepresented. The 2023 margin impact (3.3 points) is entirely omitted. (3) The multi-hop reasoning is partially sound—Emerson’s deepening relationship and ownership shift are acknowledged—but the synthesis is flawed. The model conflates events, introduces unverified details (e.g., $240/share), and misattributes financial impacts. It fails to correctly link AspenTech’s margin contribution across both years as per the ground truth. (4) Contextual relevance is high—the answer addresses the evolution of the relationship and its financial impacts on margin and ownership—but correctness is undermined by significant factual and quantitative errors. Overall, the answer captures the general direction of change but fails on key details and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 509,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "Between 2022 and 2024, AIG's Japan pension plans contributed approximately 50-67% of the total non-U.S. pension obligations. The weighted average discount rate for these plans increased from 0.52% at December 31, 2021, to 1.81% at December 31, 2024, reflecting a significant upward shift in the interest rate environment during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and timeframes. The claim that Japan pension plans contributed '50-67%' to non-U.S. pension obligations between 2022 and 2024 is incorrect. Ground truth shows a decline from 61% in 2022 (not 50-67%) to 50% in 2024, with an intermediate value of 54% in 2023. The LLM omits the 2023 figure and misrepresents the range. Additionally, the LLM incorrectly cites a discount rate of 0.52% as of December 31, 2021, which is not supported by the ground truth. The ground truth states the discount rate increased to 1.81% in 2024 from 1.48% in 2023; the 2021 rate is irrelevant and distracts from the required 2022–2024 analysis. (2) The only correct quantitative value is the 1.81% discount rate in 2024. The 2023 rate (1.48%) and 2022 rate (not provided in ground truth) are missing or incorrect. The LLM introduces a rate from 2021 not mentioned in the original answer, which undermines accuracy. (3) The multi-hop reasoning is partially sound in that the model attempts to track changes over time and link discount rate shifts to market conditions. However, it fails to correctly synthesize the evolution across 2022–2024, especially the year-over-year decline in Japan's share of obligations and the correct discount rate trajectory. The use of 2021 data introduces a logical error in scope. (4) Despite inaccuracies, the answer remains contextually relevant by addressing both parts of the question—contribution to obligations and discount rate changes—and drawing a reasonable qualitative conclusion about market conditions. This justifies moderate scores in qualitative accuracy and contextual relevance, but the quantitative errors severely limit correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 475,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "Between 2022 and 2023, Amazon's framing of the impact of competitive stores on its business evolved to emphasize the intensifying competition in international markets and the challenges posed by evolving business models. In 2022, the disclosure highlighted that local companies had a competitive advantage due to their understanding of local customers and established brand names. By 2023, the framing expanded to include the broader context of geopolitical events and economic conditions, reflecting a more global and dynamic view of external market pressures.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies a shift in Amazon's framing of competitive stores between 2022 and 2023 toward broader external conditions, which aligns with the ground truth. However, it introduces content not present in the original filings: specifically, the claim that in 2022 Amazon highlighted 'local companies had a competitive advantage due to their understanding of local customers and established brand names' is not supported by the provided ground truth. The original answer states that competitive stores were mentioned as one of many factors affecting sales, alongside internal capabilities and other external factors like price decreases, but does not mention local companies or international markets at all. Similarly, the 2023 framing in the LLM answer references 'intensifying competition in international markets' and 'evolving business models,' which are not in the original disclosure summary. While the general direction of the evolution—toward a broader, more global and external risk context—is correctly captured, the specific supporting details are fabricated or misattributed. There are no numerical inaccuracies (hence high quantitative accuracy), but the qualitative accuracy suffers due to incorrect entity and contextual attribution. The answer is relevant to the question and attempts the right kind of comparison, but fails on factual fidelity in key details, warranting a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 392,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "Between 2023 and 2024, Target's exposure to port security risks remained a concern, particularly due to its reliance on global supply chains and sourcing a significant portion of merchandise from outside the U.S., with China as its largest source. In 2023, the company highlighted disruptions at major U.S. ports, including closures, ship diversions, labor disputes, and congestion, which could increase costs and affect inventory availability. By 2024, the company reiterated these risks, emphasizing that geopolitical conflicts, labor unrest, and port security issues continued to pose threats to its supply chain. Operationally, Target has made alternative arrangements to mitigate disruptions, but recurring events could still lead to higher costs and inventory challenges. The geographic focus remained on U.S. ports, especially California ports, and the operational impact centered on potential delays, increased costs, and inventory shortages.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that port security risks remained a concern for Target in both 2023 and 2024, and accurately notes the operational impacts such as increased costs, inventory issues, and supply chain disruptions. It also correctly references U.S. ports and mentions California specifically, which aligns with the 2023 ground truth. However, it fails to capture a key evolution: in 2024, Target broadened its geographic focus from specifically naming California ports to referring more generally to 'major U.S. ports.' The LLM incorrectly states that the geographic focus 'remained on U.S. ports, especially California ports,' which contradicts the ground truth that the emphasis shifted away from singling out California. Additionally, the answer misrepresents the change in operational emphasis — in 2023, Target noted it had already made alternative arrangements due to past disruptions, while in 2024 the focus was on potential future impacts. The LLM conflates these by suggesting alternative arrangements are still in response to recurring events, missing the shift from retrospective mitigation to prospective risk. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, all non-numerical factual references (years, events, risks) are otherwise accurate, earning full marks here. (3) The multi-hop reasoning is partially sound — the model synthesizes information across years and identifies continuity, but fails to correctly infer the evolution in geographic specificity and risk framing, which is central to the question. (4) Contextual relevance is high because the answer addresses supply chain risks, ports, and operational impacts directly related to the question, but the failure to accurately reflect the shift in geographic focus and temporal framing of operational impact limits its correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 514,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "Between 2023 and 2024, Emerson's financial relationship with Heritage AspenTech evolved in terms of acquisition-related amortization and restructuring costs as follows: \n\nAmortization of intangibles related to the Heritage AspenTech acquisition increased from $258 million in 2023 to $560 million in 2024, reflecting the ongoing amortization of intangible assets from the 2022 business combination. Restructuring costs attributed to AspenTech rose from $1 million in 2023 to $8 million in 2024, indicating incremental restructuring activities within the AspenTech segment during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, amortization related to the Heritage AspenTech acquisition was $258 million in 2023 but was no longer reported in 2024, indicating it had ended or was no longer significant. However, the LLM claims it increased to $560 million in 2024, which is factually incorrect. Similarly, restructuring costs in the ground truth rose from $72 million in 2023 to $228 million in 2024, but the LLM states they were only $1 million in 2023 and $8 million in 2024—dramatically underreporting the actual figures and misrepresenting the trend. (2) Number verification: The 2023 amortization figure ($258M) is correct in the LLM answer, but the 2024 value ($560M) is wrong. Restructuring costs are entirely incorrect in both years (LLM: $1M and $8M vs. truth: $72M and $228M). No calculations are performed, but the comparisons drawn are invalid due to incorrect inputs. (3) Multi-hop reasoning is attempted—linking amortization and restructuring costs to the AspenTech acquisition over time—but fails because the underlying data is wrong. The LLM incorrectly implies ongoing significant amortization and minimal restructuring, whereas the truth shows amortization ceased being highlighted and restructuring surged, suggesting deeper integration or strategic shifts. (4) Scores are low due to major quantitative errors and flawed qualitative interpretation. Contextual relevance is moderate because the answer addresses the right topics (amortization, restructuring, AspenTech), but with incorrect data, the analysis is misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 442,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "AIG's use of Expected Loss Ratio methods between 2022 and 2024 has evolved to place increased weight on these methods for recent accident years, particularly in lines of business characterized by long-tail exposures and low-frequency, high-severity losses. In 2022, the Expected Loss Ratio method was emphasized for newer accident years due to inconsistent loss development patterns and limited historical data. By 2024, this approach was further refined, with significant weight given to Expected Loss Ratio methods for the most recent five accident years across U.S. Workers' Compensation and U.S. Excess Casualty lines. This shift reflects a strategic adaptation to evolving underwriting practices, including higher deductible structures and risk-sharing features, which delay claim emergence and increase reliance on forward-looking assumptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of AIG's use of Expected Loss Ratio (ELR) methods from 2022 to 2024 and correctly notes increased reliance on ELR for recent accident years and in low-frequency, high-severity lines. However, it introduces specific claims not present in the ground truth, such as 'the most recent five accident years' and 'U.S. Excess Casualty,' which are not mentioned in the original answer. The expansion into U.S. Workers' Compensation is correctly noted, but the original does not specify a five-year window or mention U.S. Excess Casualty. (2) There are no explicit numerical values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not compromised—no incorrect numbers are introduced. The use of 'five accident years' is a fabricated detail, but since the ground truth doesn't specify a number, this is a qualitative inaccuracy rather than a numerical one. (3) The multi-hop reasoning is partially sound: the model correctly infers that ELR methods are used more broadly over time and connects this to long-tail and low-frequency/high-severity lines. However, it incorrectly adds U.S. Excess Casualty as a line where ELR gained weight in 2024, which is not supported by the original. The synthesis is plausible but not fully accurate. (4) The answer is contextually relevant and captures the general trend of expanded ELR use. However, the addition of unsupported details (Excess Casualty, five-year window) and omission of the original's mention of D&O, E&O, EPLI, and professional liability in 2022 reduces qualitative accuracy. The core evolution is captured, but with significant factual overreach, warranting a score of 6 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 471,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Between 2022 and 2023, Amazon's monetization strategy for its film groups evolved with an increase in capitalized video and music content costs and associated expenses. The total capitalized costs of video and music content rose from $16.7 billion in 2022 to $17.4 billion in 2023, while total video and music expenses increased from $16.6 billion in 2022 to $18.9 billion in 2023. This suggests a continued investment in content production and licensing to enhance the value proposition of Amazon Prime memberships, with a focus on monetizing these film groups as integrated units across major geographies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: capitalized costs increased from $16.7 billion in 2022 to $17.4 billion in 2023, and associated expenses rose from $16.6 billion to $18.9 billion. These figures match the original answer exactly, with no calculation or reporting errors. (2) Quantitative accuracy is perfect—each dollar amount and year is correctly cited, and the direction of change (increase) is accurately described. Format consistency is also appropriate. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that rising capitalized costs and expenses indicate a more aggressive investment and monetization strategy. It adds contextual insight about enhancing Prime membership value and geographic expansion, which is reasonable and consistent with the trend, though slightly more interpretive than the original. This does not contradict the ground truth but extends it slightly, which is acceptable. (4) The answer is fully relevant to the question about evolution in monetization strategy based on cost and expense changes. All parts of the question are addressed with accurate data and logical interpretation. The only reason for not scoring a 10 in correctness is the slight addition of interpretive elements (e.g., 'integrated units across major geographies') not explicitly present in the ground truth, but these do not detract from factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 403,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges (RBH) evolved significantly, particularly in terms of its stake and associated impairment. In 2024, PMI recorded a non-cash impairment charge of $2,316 million (diluted EPS charge of $1.49 per share) due to the proposed CAD 32.5 billion settlement in Canadian tobacco litigation, which raised concerns about the allocation of the settlement amount among RBH and other parties. This impairment reflected a decline in the estimated fair value of PMI's investment in RBH below its carrying value, indicating a substantial financial impact on PMI's stake in RBH.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $2,316 million impairment charge in 2024 and links it to the CAD 32.5 billion Canadian tobacco litigation settlement, which matches the ground truth. The numeric values (amounts, EPS impact) are accurate and properly formatted. (2) Quantitative accuracy is perfect: $2,316 million impairment and CAD 32.5 billion settlement amount are correctly reported. (3) The multi-hop reasoning is mostly sound—PMI’s financial relationship with RBH evolved from a brand licensing arrangement to an equity investment facing impairment. However, the LLM omits the key detail from 2022 about PMI's trademark relationship and reporting of RBH's sales volume (e.g., HEETS units), which is part of the evolution. This missing context slightly weakens the qualitative accuracy. (4) Despite this omission, the answer captures the core financial evolution—equity stake impairment due to litigation uncertainty—and remains highly relevant and factually correct on the main point. Hence, correctness is reduced slightly to 8 for incompleteness, but quantitative and contextual scores remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 321,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "The sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities remained relatively stable between 2023 and 2024. In both years, a 5 percent change in these liabilities would result in a change in revenue of approximately $600 million in 2024 and $615 million in 2023. Additionally, the portion of these liabilities attributable to U.S. sales remained consistent at approximately 90 percent for both years.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that a $600 million sensitivity figure was disclosed in 2024. The ground truth explicitly states that LLY did not provide an updated sensitivity figure in 2024, making the $600 million number fabricated. The 2023 figure of $615 million is correct. (2) The quantitative accuracy is low because the 2024 number is wrong, and the claim of 'approximately $600 million' implies a disclosure that did not occur. The 90% U.S. sales attribution is not mentioned in the ground truth and appears to be an unsupported addition. (3) The multi-hop reasoning is flawed: the model fails to recognize that the absence of a 2024 sensitivity disclosure is a key part of the answer. Instead, it assumes continuity and invents a comparable figure, which contradicts the original answer's emphasis on the omission. (4) Contextual relevance is moderate because the answer addresses the right topic (sensitivity of revenue to liabilities) and correctly recalls the 2023 number, but introduces false information for 2024 and misses the critical point about disclosure discontinuity, undermining overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 328,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "Based on Union Pacific's disclosures, the role and revenue contribution of Bulk shipments evolved from 2022 to 2024 as follows: In 2022, Bulk shipments contributed to freight revenue growth due to increased volume and pricing gains, recovering from the 2020 pandemic impact. By 2024, Bulk shipments accounted for 32% of the company's freight revenues, reflecting continued demand for commodities like grain, fertilizer, and coal, supported by the railroad's extensive network connecting key production and export areas.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Bulk shipments accounted for 32% of freight revenues in 2024, which matches the ground truth. However, it omits the specific 2022 reference to average revenue per car of $3,305 (from the 2021 data cited in the 2022 filing) and the 6% year-over-year increase from 2020 to 2021. While the LLM mentions recovery from the pandemic and pricing gains, it does not include the quantitative benchmark from the earlier period, which is a minor omission. (2) The only numeric value provided in the LLM answer—32% contribution in 2024—is accurate and correctly attributed. The absence of the $3,305 revenue per car and 6% growth figure reduces completeness but does not introduce inaccuracy. (3) The reasoning is sound: the LLM correctly infers increased strategic importance through network connectivity and commodity demand, aligning with the ground truth’s emphasis on grain, fertilizer, coal, and international access. It synthesizes the evolving role of Bulk shipments, though with less detail on the multi-year financial trajectory. (4) The answer is contextually fully relevant, addressing both the revenue contribution and strategic evolution. Scores reflect high accuracy with minor gaps in completeness regarding early-period quantitative metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 363,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "The interest rate for IBM's Notes due 2028 remained at 0.300% in both 2023 and 2024. This consistency in the interest rate suggests that IBM has maintained a stable debt strategy for this particular bond issue, likely locking in a low rate to manage financing costs over the long term. It also indicates that IBM did not issue new Notes due 2028 during this period, and the existing issuance continued under the same terms.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the interest rate of IBM's Notes due 2028. The ground truth states the rate was 1.750% in both 2023 and 2024, but the LLM claims it was 0.300%, which is a significant error. This incorrect rate undermines the entire response. (2) Quantitative accuracy is very low because the core percentage (0.300% vs 1.750%) is wrong, and no correct figures from the ground truth are present. The years (2023–2024) and maturity (2028) are correctly referenced, but the key metric is inaccurate. (3) The reasoning is partially sound in structure—discussing stability in debt strategy and lack of new issuance—but it is based on false data. The LLM fails to mention IBM’s introduction of new higher-rate notes in 2024 (e.g., 2.900% due 2030, 3.150% due 2033), which is a critical part of the ground truth indicating a broader debt strategy shift. Thus, the multi-hop synthesis is incomplete and misdirected. (4) Contextual relevance is moderate because the answer addresses the question’s structure (rate evolution and strategy implication), but due to factual inaccuracy and missing key strategic moves, the response is misleading. Correctness is severely penalized due to the wrong interest rate and omission of new debt issuances that define IBM’s actual strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 367,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "From 2023 to 2024, AT&T's capital structure strategy regarding preferred interests evolved by retiring the Mobility Preferred Interests, which were fully repurchased by April 2023, and introducing new preferred instruments such as the Tower Holdings and Telco LLC preferred interests. The Tower Holdings preferred interests were restructured in August 2024, transitioning to a mix of fixed and floating rate distributions, while the Telco LLC expanded its preferred interests with the planned issuance of additional Telco Class A-4 interests in early 2025. These changes reflect a shift toward more structured, long-term preferred instruments with flexible redemption and distribution terms.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the retirement of Mobility Preferred Interests in 2023 and the strategic shift toward new preferred instruments like Tower Holdings and Telco LLC. It accurately captures the core evolution in AT&T's capital structure strategy. However, it introduces a forward-looking event—'planned issuance of additional Telco Class A-4 interests in early 2025'—which is not mentioned in the ground truth and falls outside the 2023–2024 scope, introducing inaccuracy. (2) Quantitative accuracy issues: the ground truth specifies the redemption value of Mobility Preferred Interests as $5,340 million and annual distributions of $373 million, but the LLM omits these specific figures entirely. Similarly, the $7,250 million total for Telco LLC preferred interests is omitted. The restructuring of Tower Holdings is correctly described as involving fixed and floating rate components, but the August 2024 date is not in the original and appears to be fabricated or assumed. (3) Multi-hop reasoning is generally sound—the model connects the elimination of Mobility Preferred Interests with the introduction of new instruments tied to infrastructure, showing strategic evolution. However, the addition of unverified details (2025 issuance, August 2024 restructuring date) undermines full factual synthesis. (4) Scores reflect high qualitative understanding and relevance to the question, but deductions are made for missing key quantitative data and introducing unsupported specifics, preventing a top score on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 434,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Between 2022 and 2023, Amazon's characterization of the competitive threat from websites evolved to reflect a more nuanced and dynamic landscape. In 2022, the focus was primarily on traditional competitive pressures, such as the introduction of competitive stores, websites, products, and services. By 2023, the language expanded to emphasize evolving business models and intensified competition, particularly in international markets, as well as the growing influence of local companies with deeper market understanding and established brand presence. This shift in language indicates a recognition of the increasing complexity and localized nature of the competitive environment.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no numbers involved, the absence of errors earns a 10. The qualitative accuracy is low because the LLM misrepresents Amazon's actual language shift between 2022 and 2023. According to the ground truth, in 2022 Amazon mentioned competitive websites as part of a general list of fluctuating business factors, but the LLM incorrectly states that in 2022 Amazon already focused on 'competitive stores, websites, products, and services'—which actually reflects the 2023 language. This reversal of the timeline undermines the core reasoning. Additionally, the LLM introduces elements not present in the original answer—such as 'evolving business models,' 'international markets,' and 'local companies with deeper market understanding'—which are unsupported by the ground truth and represent a significant factual deviation. The contextual relevance is moderate because the answer addresses the general theme of evolving competition and language shifts, but it fails to accurately reflect the specific evolution documented in the filings. The multi-hop reasoning is flawed: instead of identifying a shift from general to more specific and strategic language around digital competition, the model fabricates a narrative about international and localized competition. Thus, while the structure and intent of the response are relevant, the factual content and reasoning do not align with the ground truth, warranting a correctness score of 4 for partial accuracy on theme but major errors in substance and direction of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 442,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "PMI's relationship with KT&G has evolved from 2022 to 2024, with increased strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free portfolio. In 2022, PMI announced a global collaboration agreement with KT&G to commercialize KT&G's smoke-free products outside South Korea, and by 2024, PMI had launched commercial initiatives for these products in select markets. KT&G's heat-not-burn products, such as LIL Mini and LIL Plus, are now included in PMI's smoke-free product offerings, reflecting a growing integration of KT&G's innovations into PMI's broader strategy to expand its heat-not-burn product portfolio globally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 global collaboration agreement between PMI and KT&G, the exclusive commercialization of KT&G's heat-not-burn products (LIL Mini, LIL Plus) outside South Korea, and the integration of these products into PMI's smoke-free portfolio by 2024. The evolution from a distribution partnership to deeper integration is correctly conveyed. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct mention of years (2022, 2024), which are accurate. (3) Multi-hop reasoning is sound: the model synthesizes information across time (2022 agreement → 2024 integration) and entities (PMI, KT&G, product lines), correctly inferring increased strategic reliance. The only minor omission is that the original answer specifies the agreement was for three years, which adds context about the planned duration and strategic intent—this detail is missing in the LLM response, slightly reducing completeness. (4) Despite this, the LLM captures the core evolution in the relationship and its strategic implications, with excellent contextual relevance and semantic equivalence to the ground truth. Wording differs but meaning is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 367,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "Between 2022 and 2024, IBM's use of the PWCC Plan remained consistent in terms of administration and scope. The PWCC Plan continued to be used solely to fund awards for employees of PricewaterhouseCoopers Consulting (PwCC) who became IBM employees following the 2002 acquisition. It did not fund awards for senior executives, and its terms and conditions remained substantively identical to those of the 2001 Plan. No significant changes in administration or scope were noted during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly states that the PWCC Plan was used solely to fund awards for former PwCC employees who joined IBM after the acquisition, and that the plan's administration and terms remained substantively identical to the 2001 Plan—both of which are consistent across 2022 and 2024. The answer correctly notes no significant changes in scope or administration, which matches the original answer's conclusion of reaffirmed usage without expansion. The only minor shortcoming is that the LLM does not mention the evolution in language tone from 2022 to 2024 (from 'will continue to be used' to a more definitive 'has been and will continue to be'), which the ground truth highlights as indicating a stronger commitment. While this nuance is qualitative and does not affect the core facts, its omission prevents a perfect score. All entities (PwCC, IBM, 2001 Plan) and timeframes (2022–2024) are correct. There are no numerical inaccuracies, and the reasoning is sound, demonstrating proper synthesis of multi-hop information across years and plan terms. The answer is highly relevant and fully addresses the question’s focus on administration and scope evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 345,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "Between 2023 and 2024, AT&T fully repurchased its Mobility Preferred Interests, which were outstanding as of December 31, 2022, with the final redemption occurring in April 2023. This marked a significant shift in AT&T's capital structure management, as the company eliminated a liability that had previously been reclassified from equity to a liability at fair value. In 2024, AT&T focused on restructuring and issuing new preferred interests in its Tower Holdings and Telco LLC subsidiaries, including resetting rates and introducing floating-rate components to align with market conditions. These actions indicate a strategic approach to optimizing capital structure by managing debt obligations, enhancing flexibility, and aligning long-term financing with evolving market dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core facts: AT&T repurchased all Mobility Preferred Interests in 2023, with the final redemption in April 2023, effectively eliminating the obligation. It accurately contrasts this with the continued presence and restructuring of Tower Holdings and Telco LLC preferred interests in 2024. The strategic interpretation about capital structure optimization is consistent with the ground truth. (2) Quantitatively, the LLM does not mention the exact repurchase amount of $5,414 million, which is present in the ground truth. This is a minor omission but does not distort the overall accuracy. All other temporal details (December 31, 2022, outstanding status; April 2023 redemption) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and entities (Mobility vs. Tower Holdings/Telco LLC), identifying a strategic shift in treatment. It correctly infers that eliminating Mobility Preferred Interests while restructuring others reflects a selective capital management strategy. (4) The answer is contextually excellent—directly addresses the evolution between 2023 and 2024 and interprets the broader capital structure implications. The omission of the precise dollar figure prevents a perfect 10, but all other elements are factually correct and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 380,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "Between 2022 and 2024, IBM's regulatory exposure for its debt securities remained largely consistent, with exposure stemming from factors such as interest rates, exchange rates, governmental and stock exchange regulations, and credit ratings. However, the 2024 filing highlights an increasingly complex global regulatory environment, particularly around cybersecurity, data privacy, and AI, which could indirectly affect the company's compliance obligations and, consequently, the value and liquidity of its debt securities. There is no indication of a material change in the direct regulatory exposure for debt securities during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, which directly contradicts the ground truth. The original answer states that IBM's language evolved from describing stock exchange regulations as an influencing factor in 2022 to being 'subject to' them in 2024—indicating a stronger, more direct regulatory exposure. In contrast, the LLM claims there was 'no indication of a material change in direct regulatory exposure,' which misrepresents the shift in IBM's disclosure tone and regulatory self-characterization. While the LLM correctly identifies general regulatory factors (e.g., interest rates, credit ratings), it fails to capture the key qualitative shift in IBM's framing of stock exchange regulations specifically. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—however, no numbers are misstated, warranting a full score. The reasoning is internally logical but based on a flawed interpretation of the source material, failing the multi-hop requirement to compare the evolution of language across years. Contextually, the answer addresses the topic of regulatory exposure but misses the central evolution in IBM's relationship with stock exchange regulations, focusing instead on indirect impacts from cybersecurity and AI, which are not mentioned in the ground truth. Thus, while relevant, it lacks the necessary precision and factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 391,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "Disney's equity income contribution from A+E declined significantly from 2022 to 2024. In 2022, A+E was a major equity investment with 50% ownership, generating income through its cable channels. By 2024, equity income from investees, including A+E, dropped by 26% to $575 million from $782 million in 2023, primarily due to lower income from A+E. This decline reflects a worsening financial contribution from A+E to Disney's consolidated results over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a decline in Disney's equity income from A+E between 2022 and 2024 and attributes it to lower income from A+E, which aligns with the ground truth. However, key quantitative details are inaccurate. The ground truth states a $207 million decrease in equity income specifically due to lower income from A+E, but the LLM claims a 26% drop from $782 million (2023) to $575 million (2024), which is a $207 million decrease but misattributes the years and omits 2022 data. The original answer does not mention 2023 figures or a percentage decline, so this introduces unsupported data. (2) The LLM invents a $782 million figure for 2023 and a 26% decline, which are not present in the ground truth. While the $207 million difference matches numerically, the ground truth does not specify the base year as 2023, nor does it provide absolute values for A&E's contribution. The 50% ownership detail is plausible but not confirmed in the original answer. (3) The multi-hop reasoning is partially sound—recognizing a decline in A+E's contribution over time—but the synthesis is flawed due to fabricated intermediate data. The model extrapolates a trend using unsupported year-specific figures, undermining factual reliability. (4) Despite incorrect numbers, the core qualitative insight—a material decline in A+E's financial contribution—is consistent with the ground truth, warranting a moderate score. Contextual relevance is high as the response directly addresses the evolution of Disney's financial relationship with A&E.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 429,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations increased from $16,973 million in 2022 to $18,043 million in 2023. This increase indicates that the company is actively utilizing securitized debt as a long-term funding strategy to support its operations and manage liquidity needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that the carrying value of securitized debt obligations decreased to $18.043 billion by December 31, 2023, from a prior level (implied in 2022) that was part of a total long-term funding of $42.3 billion as of December 31, 2021, with securitized debt being a significant portion. The LLM incorrectly claims an increase from $16,973 million ($16.973 billion) in 2022 to $18.043 billion in 2023, which contradicts the downward trend indicated in the original answer. (2) The quantitative values are inconsistent with the ground truth: the starting value for securitized debt in 2022 is fabricated ($16.973 billion), and no such increase is supported; the $18.043 billion figure for 2023 is correct but presented as an increase rather than a decrease. (3) The multi-hop reasoning fails: the original answer implies a strategic reduction in securitized debt obligations as part of long-term funding, but the LLM concludes the opposite—increased reliance—based on incorrect data. The model did not correctly synthesize the trend or contextualize it within the broader funding strategy shift. (4) While the LLM addresses the question's structure (change in value and interpretation), the factual errors in numbers and direction of change severely undermine correctness. The conclusion is therefore diametrically opposed to the truth, warranting a low score despite some contextual framing being present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 418,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "Between 2022 and 2024, Disney has shifted its focus from international general entertainment channels to prioritize its Direct-to-Consumer (DTC) platforms. The company has consolidated services, such as merging Star+ into Disney+ in Latin America, and plans to launch an ESPN tile on Disney+ in the U.S. This shift reflects a strategic move to monetize content primarily through DTC services rather than licensing linear channels, which is expected to negatively impact the International Channels business. Additionally, Disney has expanded its DTC offerings, including Disney+, Disney+ Hotstar, and ESPN+, with a focus on localized and sports content to drive subscriber growth in key international markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Disney's strategic shift from international general entertainment channels to DTC platforms between 2022 and 2024, which aligns with the ground truth. It accurately references key developments such as the merger of Star+ into Disney+ in Latin America and the planned ESPN tile on Disney+, both of which reflect the broader pivot toward DTC. However, the LLM omits specific quantitative details from the original answer—namely, the number of international general entertainment channels (approximately 220) in 2022 under Fox, National Geographic, and Star brands—which is a notable factual omission affecting completeness. (2) There are no numerical inaccuracies in the LLM response because it avoids citing specific numbers; thus, quantitative accuracy is high by default. The absence of incorrect figures earns it full marks here. (3) The reasoning is sound in identifying the strategic shift and citing concrete examples like service consolidation and new DTC features. However, it misses the multi-hop element involving the Venu Sports joint venture with Fox Corporation and Warner Bros. Discovery, which is a key indicator of the broader industry shift toward DTC sports distribution. This omission weakens the synthesis across entities and timeframes. (4) The answer remains contextually relevant and captures the essence of Disney’s evolving strategy, particularly around localization and sports content on DTC platforms. While the core direction is correct, the lack of specific supporting facts and partnerships from the ground truth reduces qualitative and overall correctness, warranting a 7/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 453,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "From 2022 to 2023, Tesla faced evolving financial and operational challenges related to energy storage products, particularly in accounts receivable and production scaling. In 2022, accounts receivable were impacted by fluctuations in customer payments and government rebate collection timelines, with long-term government rebates reaching $627 million by year-end. By 2023, production scaling dependencies remained a key concern, as Tesla highlighted ongoing challenges in securing sufficient battery cell supply and managing raw material costs and availability, which could hinder production ramping for energy storage products. Additionally, delays in launching and scaling new manufacturing processes and dependencies on suppliers for components continued to pose risks to production efficiency and cost control.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $627 million long-term government rebates receivable as of year-end 2021 (disclosed in the 2022 filing), which aligns with the ground truth. However, it inaccurately states this balance was 'by year-end' of 2022, when the $627M figure is explicitly from December 31, 2021. This is a minor temporal misattribution but affects quantitative precision. The shift in focus from financial (receivables) to operational (production scaling) challenges in 2023 is accurately captured. (2) The number $627 million is correct in amount but misassigned to the wrong reporting year in context—should be 'as of 2021, disclosed in 2022,' not 'by year-end 2022.' No other figures are provided or miscalculated. (3) The multi-hop reasoning is largely sound: the model connects financial disclosures about receivables in 2022 to operational risks in 2023, synthesizing information across time and domains (financial vs. operational). It correctly identifies supplier constraints, manufacturing ramp delays, and input cost dependencies as key 2023 risks, consistent with Tesla’s 2023 10-K. However, it omits specific mention of factory locations (Nevada, Texas) cited in the ground truth, slightly weakening completeness. (4) The answer is contextually highly relevant and conveys the core evolution in Tesla’s challenges. Despite minor inaccuracies in timing and missing specific facility names, the qualitative narrative matches the ground truth’s intent. Hence, correctness is high but not perfect—warranting an 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 427,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "The role of syrups in Coca-Cola's business model remained central in 2022 and 2023, primarily serving as a key component of its concentrate operations. Syrups, including fountain syrups, are sold to bottling partners who then produce finished beverages or sell them directly to fountain retailers. In 2023, concentrate operations accounted for 58% of net operating revenues, up from 56% in 2022, indicating a slight increase in the importance of syrups and concentrates relative to finished product operations. This reflects Coca-Cola's continued focus on leveraging its bottling partners and fountain retailers to distribute its products efficiently, particularly in the foodservice and retail channels.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses the core evolution described in the ground truth. It correctly identifies that syrups are central to Coca-Cola's business and sold to bottling partners and fountain retailers. However, it fails to capture the key shift between 2022 and 2023 in revenue recognition logic and the strategic repositioning of syrups within the operational framework. The ground truth emphasizes a change in accounting and strategic emphasis—from a volume-driven model with differential revenue recognition based on bottler ownership (consolidated vs unconsolidated) in 2022 to a more integrated, operationally embedded role in 2023, particularly with direct sales to fountain retailers. This nuanced shift is entirely missing in the LLM response. (2) Quantitatively, the LLM introduces percentages (58% in 2023 vs 56% in 2022) that are not present in the original answer and cannot be verified from the provided ground truth. While these numbers may be factually accurate in external context, they are not supported by the knowledge graph provided and thus represent unverified additions. No other numbers are present, so the quantitative accuracy is partially correct but based on unsupported data. (3) The multi-hop reasoning is weak: the question asks for an evolution in the role of syrups in relation to bottling partners and fountain retailers across two years, requiring synthesis of changes in business model logic. The LLM does not address the change in revenue recognition policy or the shift from volume-driven to operationally embedded roles. Instead, it focuses on revenue share changes without explaining the underlying structural shift. (4) Contextual relevance is high because the answer discusses syrups, bottling partners, and fountain retailers in the correct timeframe. However, the absence of the key conceptual shift significantly undermines factual correctness, warranting a mid-range score of 5 for correctness. Quantitative accuracy is scored 6 due to plausible but unsupported percentages. Qualitative accuracy is 5 due to partial but incomplete reasoning. Contextual relevance is 8 because the topic and entities are well-aligned with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 595,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) decreased from fiscal year 2022 to fiscal year 2024. In fiscal 2022, the fair value of Other MBS & ABS was $84 million (1% of total plan assets), while in fiscal 2024, it was $166 million (1% of total plan assets). Despite the slight increase in absolute value, the proportion relative to the overall fair value hierarchy remained consistent at 1% for both years.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, Disney's investment in Other MBS & ABS was $96 million in fiscal year 2022 and $120 million in fiscal year 2024. However, the LLM incorrectly states $84 million for 2022 and $166 million for 2024. While the percentage (1%) is correctly reported for both years, the absolute values are wrong, which undermines the quantitative accuracy. Additionally, the LLM claims the investment 'decreased' from 2022 to 2024, which contradicts both its own numbers (since $84M to $166M is an increase) and the ground truth (which shows an increase from $96M to $120M). (2) The calculation of proportional representation is correct—1% in both years—but the absolute values and directional trend are incorrect. The model fails to accurately reflect the evolution of the investment, misreporting both the starting and ending values. (3) The multi-hop reasoning is partially sound in that the model attempts to compare two fiscal years and assess both absolute and relative changes. However, due to incorrect data retrieval or synthesis, the conclusion about the trend is flawed. The model does recognize that the proportion remained stable, which shows correct qualitative understanding of relative weighting, but this is overshadowed by the numerical errors. (4) The contextual relevance is high because the answer addresses the right metric, time frame, and comparative structure (absolute value vs. proportion). However, the correctness score is low due to major quantitative errors that change the interpretation of the trend. A correct answer should state a moderate increase from $96M to $120M with stable 1% allocation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 474,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Between 2022 and 2023, Skunk Works' advanced development programs (ADP) at Lockheed Martin expanded their focus on next-generation military aircraft capabilities, emphasizing unmanned and manned aerial systems, air dominance, hypersonics, intelligence, surveillance, reconnaissance (ISR), situational awareness, and air mobility. The evolution highlighted a stronger emphasis on integrating network-enabled technologies and advancing hypersonic capabilities, reflecting the growing importance of speed, agility, and interconnected systems in modern military operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the focus areas of Skunk Works' advanced development programs in general terms, including hypersonics, ISR, situational awareness, air mobility, and both manned and unmanned systems. However, it misrepresents the evolution between 2022 and 2023. The ground truth states that in 2022, the focus included unmanned and manned systems and next-gen capabilities across several domains, and by 2023, the emphasis shifted to highlight 'air dominance' more prominently, while maintaining other areas. The LLM answer suggests an 'expansion' and increased focus on 'network-enabled technologies' and 'integrating interconnected systems,' which are not mentioned in the original answer and represent an addition not supported by the ground truth. Additionally, the original answer emphasizes that the change was a 'refinement of priorities' rather than a broad expansion, which the LLM fails to capture. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound—the model correctly identifies continuity in focus areas across years but fails to accurately characterize the nature of the shift (from broader future systems to a sharpened focus on air dominance). The introduction of 'network-enabled technologies' as a key evolution is unsupported and reflects a reasoning gap. (4) The contextual relevance is high because the answer addresses Skunk Works, the time frame, and relevant military capability domains. However, the qualitative accuracy is reduced due to the mischaracterization of the strategic shift. Correctness is scored at 6 due to core factual alignment with focus areas but significant deviation in describing the evolution between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 498,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "From 2022 to 2023, Tesla's approach to the Powerwall product evolved by emphasizing integration with residential solar energy systems and increasing cross-selling efforts. In 2022, the company noted growing customer interest in Powerwall driven by better availability and grid stability concerns, while also highlighting the importance of maintaining adequate battery cell supply. By 2023, Tesla explicitly stated its focus on emphasizing cross-selling with residential solar energy products and improving installation capabilities for Solar Roof, which suggests a more integrated strategy to bundle Powerwall with solar offerings. This shift reflects a stronger emphasis on leveraging synergies between energy generation and storage solutions to drive adoption and scale.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's evolving approach to Powerwall from 2022 to 2023, noting increased integration with solar products and cross-selling efforts. It accurately reflects growing customer interest due to grid stability concerns and availability in 2022, and a strategic push toward integration in 2023. However, it misses a key evolution highlighted in the ground truth: by 2023, Tesla had *designed* Solar Roof and solar systems to specifically integrate with Powerwall, indicating a deeper engineering-level integration. The LLM instead states Tesla 'emphasized cross-selling' and 'improving installation capabilities,' which were already part of the 2022 strategy, thus failing to clearly distinguish the shift from sales focus to technical integration. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model connects Powerwall with solar integration across years and recognizes strategic shifts, but it conflates 2022 and 2023 priorities, failing to fully capture the progression from availability and installation improvements to engineered product synergy. (4) The answer is contextually relevant and well-structured, but lacks precision in conveying the depth of integration strategy evolution, warranting a 7 for correctness and qualitative accuracy. Contextual relevance is high as it directly addresses the question's focus on integration and production emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 435,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "Between 2022 and 2024, Gilead has maintained Biktarvy as a cornerstone of its HIV portfolio, emphasizing its role as a once-daily, single-tablet regimen for the treatment of HIV-1 infection. However, the company faces increasing commercial risks, including competition from generic and branded alternatives, pricing pressures due to legislative actions such as the Inflation Reduction Act (IRA), and reimbursement challenges from government and third-party payers. These factors could impact Biktarvy's market share and profitability, necessitating ongoing strategic adaptations to sustain its position in the HIV treatment landscape.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, addressing Gilead's strategic positioning of Biktarvy and commercial risks between 2022 and 2024. However, it diverges from the ground truth in key qualitative aspects of the strategic evolution. The original answer emphasizes a shift in Gilead’s strategic vulnerability due to overreliance on TAF-based therapies (like Biktarvy) and a transition from innovation focus to increased exposure to class-wide risks in HIV treatment. This specific multi-hop insight—linking Biktarvy’s centrality to growing dependence on TAF and systemic risk from potential shifts away from nucleoside-based regimens—is missing in the LLM response. Instead, the LLM cites generic competition, IRA pricing pressures, and reimbursement challenges, which, while valid commercial risks, are not mentioned in the ground truth and represent a different risk profile. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), but the qualitative reasoning does not fully align with the documented strategic evolution in the knowledge graph. The answer is well-structured and relevant to the question’s scope, hence high contextual relevance, but lacks the precise cause-effect linkage between Biktarvy’s role and Gilead’s narrowing therapeutic base, which is central to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 381,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retrospective Responsibility Plan saw notable changes in the U.S. Litigation Escrow Agreement. In 2022, the balance in the U.S. litigation escrow account was $1,449 million, with $850 million in deposits and $295 million in payments. By 2023, the balance increased to $1,764 million at the beginning of the period, with $1,000 million in deposits and $685 million in payments, resulting in an end-of-period balance of $3,089 million in 2023. Additionally, the 2023 disclosures introduced new mechanisms such as makewhole agreements, which were not mentioned in 2022, adding complexity to the plan's structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The original answer states that the composition of the U.S. Retrospective Responsibility Plan evolved by adding 'makewhole agreements relating to the Class B-1 common stock exchange offer' in 2023 while retaining prior mechanisms, including the U.S. Litigation Escrow Agreement. However, the LLM answer incorrectly shifts focus to numerical changes in the escrow account balance (e.g., $1,449 million, $1,764 million, $3,089 million), which are not mentioned in the ground truth and appear fabricated. These figures and associated deposits/payments have no support in the original answer and represent a complete misrepresentation of the information. (2) There are no valid calculations or accurate numbers in the LLM response because all financial figures are absent from the ground truth. The mention of deposits and payments in specific dollar amounts fails the quantitative accuracy test entirely. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies the addition of 'makewhole agreements' in 2023 as a new element, it fails to mention the full list of retained mechanisms (e.g., indemnification obligations, interchange judgment sharing, omnibus agreement) and instead invents a financial narrative around the escrow account that is not present in the original. The core of the question—how the composition changed—is misrepresented by focusing on non-existent financial flows rather than structural additions. (4) The contextual relevance is partially preserved because the LLM addresses the timeframe (2022–2023), mentions the U.S. Litigation Escrow Agreement, and correctly notes the introduction of makewhole agreements. However, the emphasis on unverified financial data severely undermines correctness. Due to major factual errors and invention of data, the correctness score is low despite partial recognition of one new mechanism.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 529,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "The strategic importance of Biktarvy for GILD has increased from 2022 to 2024, as it remains a key HIV treatment with robust patent protection through 2033 in both the U.S. and the European Union, providing long-term exclusivity. This extended patent life helps mitigate the risk of generic competition, which is a critical concern given GILD's heavy reliance on HIV products for revenue. The 2024 filing emphasizes the continued importance of maintaining market leadership in HIV therapies, particularly as patent protections for other HIV products have started to expire or face litigation, making Biktarvy a central asset for sustaining revenue and competitive positioning.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly notes Biktarvy's U.S. patent expiration in 2033, it incorrectly states that this protection extends to the European Union, whereas the ground truth explicitly states that no E.U. expiration was listed in 2022—this does not equate to confirmed protection through 2033 in the E.U. More critically, the LLM misrepresents the evolution of strategic importance: it claims Biktarvy's strategic importance has increased, while the original answer indicates growing vulnerability due to heightened risk disclosures in 2024 around competition and treatment shifts. This is a major qualitative error in interpretation. (2) Quantitatively, the 2033 U.S. patent date is accurate, but the extension of that date to the E.U. is unsupported by the ground truth and thus incorrect. There are no calculations in the response, so scoring focuses on date accuracy. (3) The multi-hop reasoning is flawed: the model fails to synthesize the key shift from strong patent protection (2022) to increased risk disclosure (2024), instead portraying continued strength without acknowledging the rising competitive and regulatory threats emphasized in the 2024 filing. The model also omits the nuance that patent protection alone does not insulate Biktarvy from strategic risk. (4) Contextual relevance is high—the response addresses patent timelines and HIV product dependency—but correctness and reasoning are undermined by key factual and interpretive errors, warranting a moderate score of 4 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 434,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "Based on the provided document pages, there have been no modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023. The referenced guarantees, including the guarantee of certain obligations of Illinois Bell Telephone Company, are detailed in Exhibit 4-c of the 2023 10-K filing, and there is no indication of structural changes or updated documentation for these guarantees during the specified period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly concludes that there were no modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, which aligns with the ground truth. The reasoning about structural consistency and lack of updated documentation is accurate and relevant. However, there is a discrepancy in the exhibit number: the LLM cites Exhibit 4-c in the 2023 10-K, while the ground truth confirms the guarantee is referenced under Exhibit 4-d to the Form 10-K for the period ending December 31, 2011, with no change in exhibit number. This misidentification of the exhibit number affects entity accuracy and suggests potential confusion in source tracing. While the core conclusion (no changes) is correct, the incorrect exhibit reference undermines the precision of the documentation claim. The answer is semantically close and contextually appropriate, but the error in a key identifier (exhibit number) prevents a higher score. Quantitative accuracy is high as no numerical data is involved. Qualitative accuracy is impacted by the exhibit mismatch, though the multi-hop reasoning (comparing across years and filings) is sound in intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 332,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggests that there has been no dilutive adjustment during this period, which implies stability in the potential voting power of Class A common stockholders in significant corporate transactions. Since the conversion rate remains unchanged, the number of Class A shares that would be issued upon conversion of Class C shares has not increased, preserving the relative voting power of existing Class A common stockholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It correctly identifies the consistent conversion rate of Class C to Class A common stock between 2022 and 2023, though it does not explicitly state the numerical rate (4.0000), which is a minor omission. However, the core quantitative fact—that the rate remained unchanged—is accurately conveyed. (2) The answer correctly infers that no increase in the conversion rate means no additional dilution of voting power for Class A stockholders, which matches the ground truth's conclusion about stable relative voting power. (3) The reasoning is sound: the LLM correctly synthesizes that a stable conversion rate implies no structural change in voting influence during significant corporate transactions, even if underlying values (like as-converted share counts) slightly increased. (4) While the ground truth includes additional context (e.g., as-converted Class A value rising from 38M to 39M shares), this detail is not necessary to answer the specific question about what the stable rate suggests regarding voting power. The LLM focuses on the key implication—stability in dilution and voting power—making the response contextually relevant and semantically equivalent. The only reason for not scoring a 10 is the omission of the specific 4.0000 rate, which, while not critical to the conclusion, is part of the full factual picture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 389,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "From 2022 to 2023, Tesla's relationship with the Solar Roof shifted in production focus and strategic dependencies. In 2022, the Solar Roof was explicitly mentioned as a product developed and produced at Gigafactory New York, indicating a dedicated manufacturing focus. By 2023, however, there was no direct mention of Solar Roof production at Gigafactory New York, suggesting a potential reallocation of resources or reduced emphasis on the product. Additionally, strategic dependencies on Gigafactory New York's operations were noted in 2022, but by 2023, the company's focus appeared to shift toward scaling vehicle production and battery cell development, indicating a reduced strategic reliance on the Solar Roof in favor of core automotive growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment and captures the shift in Tesla's relationship with the Solar Roof from 2022 to 2023. It correctly identifies that in 2022, Tesla produced the Solar Roof at Gigafactory New York and had strategic dependencies on that facility. The absence of direct mention of Solar Roof production in 2023 is accurately noted. However, the LLM infers a 'reduced strategic reliance on the Solar Roof in favor of core automotive growth' and a 'potential reallocation of resources or reduced emphasis'—details not explicitly supported by the ground truth. The original answer emphasizes a shift in disclosure tone—from active production to highlighting risks and challenges in scaling (e.g., supply chain constraints, delays)—rather than a strategic deprioritization. The LLM overinterprets the absence of production mentions as a strategic shift away, whereas the ground truth reflects a change in risk communication, not necessarily a change in strategic focus. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (Tesla, Solar Roof, Gigafactory New York, 2022–2023) are correct. The reasoning is sound but slightly overreaches in conclusion, missing the nuance of risk disclosure versus strategic de-emphasis. Contextual relevance is high as it directly addresses production focus and strategic dependencies as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 386,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "Between 2022 and 2023, syrups remained a core component of Coca-Cola's business model, primarily serving as intermediate products in the beverage manufacturing process. Syrups are produced by combining concentrates with water and sweeteners and are sold to bottling partners and fountain retailers, who use them to create finished beverages for retail or immediate consumption. In 2023, concentrate operations (which include syrups) accounted for 58% of net operating revenues, up from 56% in 2022, while finished product operations decreased slightly to 42% from 44%. This suggests a continued emphasis on syrups and concentrate sales as a revenue driver. Distribution channels remained largely consistent, with bottling partners and fountain retailers playing key roles in delivering Coca-Cola's products to consumers globally.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention any percentage breakdown of net operating revenues between concentrate and finished product operations for 2022 or 2023 (e.g., 56% vs 58%), nor does it state that concentrate operations include syrups as a distinct revenue category in that context. These figures are entirely fabricated or misattributed, severely undermining factual correctness. (2) There are no verifiable calculations or numeric data in the original answer to support the 56% and 58% claims; thus, the quantitative accuracy is very low. The original answer focuses on structural and operational changes—not revenue splits—making these numbers unsupported. (3) The qualitative reasoning partially captures the role of syrups as intermediate products and their use in fountain systems, which aligns with the ground truth. However, it misses the key evolution highlighted in the original: the shift in 2023 toward direct management of fountain syrup sales in the U.S. by Coca-Cola and the inclusion of fountain syrup operations in the North America operating segment. This reflects a strategic reorganization that the LLM answer fails to mention, indicating a failure in multi-hop synthesis across years and operational segments. (4) Contextual relevance is moderate because the answer discusses syrups, bottling partners, and distribution channels, which are relevant, but it introduces incorrect metrics and omits the core strategic shift described in the original. The answer gives the impression of precision through false numbers, which harms overall correctness. While the general business model description is plausible, the lack of accurate detail and invented statistics results in a partially correct but misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 501,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "Between 2022 and 2024, the company's operational focus on Africa/Eurasia remained relatively stable in terms of geographic reporting structure, as it continued to be a reportable operating segment under the Oral, Personal and Home Care product segment. However, its financial contribution showed a slight increase in operating profit, rising from $228 million in 2022 to $253 million in 2024. Additionally, net sales for Africa/Eurasia grew from $1,082 million in 2022 to $1,095 million in 2024, indicating modest growth in the region's financial performance over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Africa/Eurasia had an operating profit of $203 million in 2022, but the LLM claims $228 million in 2022 and $253 million in 2024—both figures are incorrect and unsupported by the original answer, which does not provide 2024 operating profit or any data for 2024 beyond structural changes. Additionally, the LLM introduces net sales figures ($1,082M in 2022, $1,095M in 2024) that are not mentioned in the ground truth, making them fabricated or misattributed. (2) Quantitative accuracy is very low because all financial numbers provided by the LLM are incorrect or unverified. There is no mention of net sales or updated operating profits in the original answer, and the only financial figure given is $203 million in 2022. The LLM also implies a trend (growth in profit and sales), which is not supported by the source. (3) The reasoning is partially sound in identifying that Africa/Eurasia remained a reportable segment, but it fails the multi-hop synthesis required: the key evolution in 2024 was the realignment of the skin health business from Europe to North America, which the LLM omits entirely. This strategic shift is central to the company’s geographic reporting refinement and was a critical part of the original answer. (4) Contextual relevance is moderate because the LLM addresses the region and time frame and attempts to discuss financial contribution and reporting structure, but it invents data and misses the key organizational change, leading to a misleading conclusion about 'modest growth' and stability when the ground truth emphasizes structural realignment and strategic refinement. Thus, while the topic is relevant, the substance is largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 484,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's Orthopaedics business, under the MedTech segment, showed modest global sales growth, with a 4.1% increase in worldwide sales in 2023 compared to 2022. The U.S. market saw a 3.8% growth, while international sales increased by 4.6%. The strategic emphasis on enabling technologies is evident in the expansion of the Orthopaedics portfolio, which includes products and technologies supporting hips, knees, trauma, spine, sports, and other areas. This reflects a continued focus on innovation and advanced solutions to address patient needs across various orthopaedic applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the 2023 global sales growth of 4.1%, U.S. growth of 3.8%, and international growth of 4.6%, all of which match the ground truth. The dollar amounts ($8,942M, $5,525M, $3,417M) are not mentioned in the LLM answer, but the percentages are accurate. (2) Quantitative accuracy is high—percentages are correct and consistent with the original data. However, the absence of actual revenue figures reduces completeness, though not correctness. (3) The LLM captures the emphasis on enabling technologies in 2024 but fails to highlight the strategic shift *from* financial metrics in 2023 *to* qualitative innovation focus in 2024. This omission weakens the multi-hop reasoning that underpins the question—comparing the evolution in presentation strategy. The answer implies continuity rather than a pivot, missing the core contrast. (4) Contextual relevance is strong—the response addresses sales performance and enabling technologies directly. However, the failure to articulate the shift in strategic framing (from quantitative to qualitative emphasis) results in a partially incomplete qualitative analysis, justifying a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 335,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Between 2022 and 2023, Visa's approach to managing litigation liabilities through loss sharing agreements remained consistent in terms of liability allocation, with the scope of U.S. covered litigation expanding to include actions brought by merchants that opted out of the Rule 23(b)(3) settlement class in MDL 1720. The liability allocation mechanism under the loss sharing agreement continued to distribute obligations based on each bank's membership proportion as defined in Visa U.S.A.'s certificate of incorporation. Additionally, the U.S. litigation escrow account balance increased significantly in 2023, reflecting larger deposits ($1,500 million in 2023 vs. $1,000 million in 2022) and reduced payments to opt-out merchants, indicating a more active management of funds to address potential liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and omits key aspects of the evolution in Visa's approach. While it correctly identifies the inclusion of opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 as part of U.S. covered litigation, it fails to mention the specific October 2015 amendment referenced in the ground truth, which is central to the 2022 context. More critically, the LLM incorrectly states that liability allocation is based on 'each bank's membership proportion as defined in Visa U.S.A.’s certificate of incorporation,' which contradicts the ground truth specifying fixed percentages: Visa assuming 66.6667% and Mastercard 33.3333% under the omnibus agreement. This is a major qualitative and quantitative error. (2) The LLM introduces dollar amounts for the 'U.S. litigation escrow account' ($1,500 million in 2023 vs $1,000 million in 2022) that are not present in the original answer and cannot be verified against the ground truth; these figures appear fabricated or misattributed, severely undermining quantitative accuracy. There is no mention of an escrow account or deposits/payments to merchants in the ground truth. (3) The multi-hop reasoning is flawed: the answer does not capture the strategic shift from a focus on bilateral loss sharing with Mastercard in 2022 to the 2023 consolidation under the U.S. Retrospective Responsibility Plan, which now includes settled or resolved matters. This evolution toward a more comprehensive, retrospective framework is the core of the original answer but is entirely missing in the LLM response. Instead, the LLM implies continuity rather than transformation. (4) Despite these issues, the answer is contextually relevant, addressing litigation scope and liability management, and correctly notes the expansion of covered litigation to opt-out merchants. However, due to significant factual errors in liability allocation, introduction of unsupported financial data, and failure to identify the key strategic pivot in 2023, the overall correctness score is low at 4, with moderate qualitative and relevance scores due to partial alignment with the topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 581,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "Between 2022 and 2024, CL's investment in Guaranteed Investment Contracts (GICs) within its pension plans shifted from $34 million in 2023 to $30 million in 2024, indicating a slight reduction in allocation to GICs. This shift suggests a potential diversification or reallocation of pension plan assets toward other investment categories, such as fixed income or multi-asset funds, as part of the company's strategy to manage risk and optimize returns in its defined benefit plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative details. According to the ground truth, in 2022, CL held $1 million in GICs under U.S. Pension Plans and $55 million under International Pension Plans. By 2024, the U.S. allocation was fully phased out (0), and the international allocation dropped to $34 million. The LLM incorrectly states investments were $34 million in 2023 and $30 million in 2024, which misrepresents both the amounts and the timeline. It omits the U.S./international breakdown entirely, failing to capture the complete structure of the pension plans. (2) The numbers cited ($34M in 2023, $30M in 2024) are factually wrong—there is no support for these figures in the ground truth. The actual total in 2022 was $56 million ($1M + $55M), and in 2024 it was $34 million (all international), so the reduction is from $56M to $34M—not $34M to $30M. The LLM also introduces a non-existent 2023 figure. (3) The reasoning is flawed because it fails to perform the required multi-hop synthesis: distinguishing between U.S. and International plans, tracking changes over 2022–2024, and recognizing the complete elimination in the U.S. The conclusion about 'slight reduction' contradicts the ground truth, which shows a significant strategic shift, especially in the U.S. where GICs were fully exited. (4) While the general idea of reallocation is directionally plausible, the factual inaccuracies and missing breakdowns severely undermine correctness. The answer is contextually relevant in discussing pension asset strategy but fails on core accuracy and completeness, warranting a low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 446,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "Between 2022 and 2024, the Mastercard Developer Platform evolved from a tool for simplifying access to digital assets and APIs into a more strategic enabler of integration for digital assets and new technologies. In 2022, the platform focused on providing a single access point for customers and partners to leverage digital assets and services. By 2024, it had expanded its role to support blockchain-based business models, programmable payments via the Mastercard Multi-Token Network™, and enabling consumers to buy and spend cryptocurrencies seamlessly. The platform also facilitated integration with emerging technologies and fintech innovations, reinforcing Mastercard’s commitment to a future-ready payments ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: the platform's 2022 role as a single access point for digital assets and services is accurately described, and the 2024 evolution to support blockchain, programmable payments, and the Mastercard Multi-Token Network™ is correctly identified. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes the platform’s evolving strategic role across two time points and correctly links it to new technologies like blockchain and digital currencies, including the specific integration with the Multi-Token Network™. The mention of enabling consumers to 'buy and spend cryptocurrencies seamlessly' is a slight expansion beyond the original answer, which focuses on interoperable blockchain transactions and programmable payments, but this is a reasonable inference and not factually incorrect. (4) The answer is contextually fully relevant, addressing both the evolution in strategic positioning and functionality regarding digital assets and emerging technologies. The only minor gap is that the original emphasizes 'secure, scalable, and interoperable' blockchain transactions, which adds specificity slightly missing in the LLM version. However, the core facts, entities, timeline, and technological evolution are accurately conveyed, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 427,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "The company's investment in U.S. common stocks within its pension plans remained minimal between 2022 and 2024, with only $1 million in U.S. common stocks reported in 2024 and none in 2022 and 2023. This indicates that the company's strategic asset allocation continues to prioritize fixed income securities and other investments over direct holdings in U.S. common stocks, aligning with its target allocation of 21% equity securities for U.S. plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, there was no investment in U.S. common stocks in the U.S. pension plan in 2022 or 2024, and the international pension plan had a consistent $2 million investment in both years. The LLM incorrectly states there was $1 million in 2024 and none in 2022 and 2023, which misrepresents both the amount and timing. Additionally, the LLM introduces a 'target allocation of 21% equity securities for U.S. plans' that is not present in the original answer and unsupported by the provided data. (2) Quantitative accuracy is low: the dollar amounts ($1 million vs. $2 million) and years (2024 only vs. both years) are incorrect. The claim of 'none in 2022 and 2023' contradicts the consistent $2 million in the international plan. (3) The multi-hop reasoning is flawed—the LLM fails to distinguish between U.S. and international pension plans, conflating them into a single narrative. It also invents strategic rationale (21% target) not present in the source, indicating poor synthesis. (4) Contextual relevance is moderate because the answer addresses the general topic of asset allocation and minimal investment in U.S. stocks, but the incorrect figures, missing plan distinction, and fabricated details severely undermine factual correctness. The core message about low exposure is partially aligned, but the specifics are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 395,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "Between 2022 and 2023, Disney's strategic focus on cruise ships evolved with plans for additional expansion of its fleet, as noted in the 2023 filing. Capital investment plans included significant spending on new cruise ships as part of broader investments in the Parks, Experiences and Products segment. Operationally, Disney Cruise Line faced risks related to global economic conditions, travel disruptions, and the need to align with consumer preferences for out-of-home entertainment experiences, particularly in the context of recovering from the impacts of the pandemic and ensuring profitability amid rising costs and competitive pressures.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct contextual elements but fundamentally misrepresents the evolution of Disney's strategic focus between 2022 and 2023. While it correctly identifies that cruise ships were part of capital investment plans in the Parks, Experiences and Products segment, it incorrectly states that Disney maintained an expansionary focus in 2023. The ground truth shows a clear strategic shift from growth and capital investment in 2022 to operational risk mitigation in 2023, particularly due to external disruptions like hurricanes. The LLM answer fails to capture this pivot and instead implies continued expansion, which contradicts the documented shift in tone and focus. (2) There are no specific numbers, dollar amounts, or percentages in either the original or LLM answer, so quantitative accuracy is not compromised—minor references to 'significant spending' are vague but not factually incorrect. (3) The multi-hop reasoning is flawed: the question requires synthesizing a change in strategic emphasis over time (from investment to risk), but the LLM does not contrast 2022 and 2023 appropriately. It omits the key 2023 risk framing (e.g., Hurricane Milton) and fails to acknowledge the repositioning of cruise ships from growth engines to operational exposures. (4) Contextual relevance is moderate because the answer discusses cruise ships, capital investment, and operational risks, but the qualitative inaccuracy in portraying the strategic evolution severely undermines correctness. The answer reflects a static view rather than the dynamic shift described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 444,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Between 2022 and 2024, Mastercard has continued to use short duration foreign exchange derivative contracts to manage foreign exchange risk arising from daily settlement activities. These contracts are employed to offset potential changes in the value of monetary assets and liabilities due to foreign exchange fluctuations, particularly given the short-term nature of settlement exposure, which typically lasts only a few days. The gains and losses from these non-designated derivative contracts are recorded in general and administrative expenses on the consolidated statements of operations, net of foreign currency gains and losses on related monetary assets and liabilities. The data shows that general and administrative expenses related to these contracts increased from $21 million in 2022 to $32 million in 2024, indicating a growing role for these instruments in managing settlement-related currency risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Mastercard used short duration foreign exchange derivative contracts between 2022 and 2024 to manage foreign exchange risk in daily settlement activities, which aligns with the ground truth. It also accurately notes the non-designated nature of these contracts and their accounting treatment in general and administrative expenses. However, the key factual issue lies in the introduction of specific dollar amounts—$21 million in 2022 and $32 million in 2024—which are not present in the original answer or implied by the ground truth. There is no mention in the ground truth about expense figures or trends in spending related to these contracts, making these numbers unsupported and likely incorrect. (2) The quantitative claims about general and administrative expenses increasing from $21M to $32M are entirely absent from the original answer and cannot be verified from the provided context. This represents a significant factual overreach or hallucination, severely undermining quantitative accuracy. (3) The qualitative reasoning is partially sound: the model correctly infers the purpose of short-duration contracts in managing short-term settlement risk and maintains continuity in their use. However, it fails to mention the key evolution in Mastercard’s broader FX strategy—specifically the de-designation and re-designation of euro-denominated debt in 2023 and 2024—which is central to the ground truth’s narrative of a more dynamic hedging approach. This omission limits the depth of multi-hop synthesis. (4) Contextual relevance is high because the answer addresses the core topic—use of short-duration FX derivatives in settlement risk management—and provides relevant operational and accounting context. However, the inclusion of fabricated financial figures and the absence of key strategic developments result in a partially correct but misleading overall response. Correctness score is 5 due to a mix of accurate conceptual understanding and serious factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 550,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "From 2023 to 2024, Salesforce's strategic relationship with enterprise cloud companies has evolved with a stronger focus on AI integration and ecosystem expansion. In 2023, the company emphasized investments in enterprise cloud companies, technology startups, and system integrators, aiming to digitally transform industries and expand its solution ecosystem. By 2024, Salesforce had further integrated AI into its offerings, exemplified by the launch of Agentforce, an agentic layer for deploying autonomous AI agents across business functions. The company also enhanced its ecosystem integration through platforms like AppExchange and by deepening partnerships with developers, ISVs, and SIs to expand into new markets and industries. This shift reflects a strategic move toward leveraging AI and strengthening its ecosystem to drive innovation and customer value.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Salesforce's strategic relationships from 2023 to 2024, noting the shift from investment focus to broader ecosystem integration. It accurately reflects the 2023 emphasis on investing in enterprise cloud companies, startups, and system integrators to drive digital transformation and ecosystem expansion. The 2024 shift toward deeper integration with partners via AppExchange and third-party developers is also correctly conveyed. However, the LLM introduces 'Agentforce' and a specific focus on AI as a central element of the 2024 strategy, which is not mentioned in the ground truth. While Salesforce may have launched AI initiatives, the original answer does not reference AI or Agentforce, making this an addition not supported by the provided knowledge graph. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is mostly sound: the model correctly synthesizes information across years and strategic focuses, identifying the transition from financial investment to ecosystem dependency. The core logic aligns with the ground truth, though the introduction of AI as a driver adds unsupported detail. (4) The correctness score is 8 because the central factual trajectory is accurate and complete regarding investment evolution and ecosystem integration, but the inclusion of unverified AI-centric developments slightly detracts from factual fidelity. Qualitative accuracy is 8 due to strong reasoning with minor overreach. Quantitative accuracy is 10 (no numbers, no errors), and contextual relevance is 10 as the response directly addresses the question's focus on strategic evolution, investment, and integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 491,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the company maintained a consistent methodology for developing accrual rates for vendor funding programs, but there was increased emphasis on sensitivity to projected purchase volumes. In both years, accrual rates were based on vendor agreement provisions, historical purchase trends, and periodic adjustments. However, in fiscal 2024, the documentation highlighted a greater awareness of the potential impact of actual purchase volumes differing from projections, particularly for graduated volume-based programs, which could affect amounts accrued and recorded financial results. This reflects a heightened focus on aligning accruals more closely with evolving purchase activity.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of the company's approach to accrual rates, despite being contextually relevant and free of numerical errors. (1) The original answer states that the methodology remained consistent and that the explicit mention of 'graduated purchase volumes' was *omitted* in fiscal 2024, suggesting a potential simplification or stabilization. In contrast, the LLM claims there was a 'greater awareness' and 'heightened focus' on projected purchase volumes in fiscal 2024, implying increased sensitivity—this directly contradicts the ground truth. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the absence of numbers does not excuse factual misrepresentation. (3) The multi-hop reasoning is flawed: the model incorrectly infers increased emphasis in 2024 when the evidence (removal of specific language) suggests the opposite or at best no change. The synthesis misreads the implication of omitted disclosure. (4) While the answer addresses the right topic and references relevant factors (vendor agreements, historical trends), it reverses the directional change implied by the filing language, leading to a substantively incorrect conclusion. Hence, the correctness and qualitative accuracy scores are low, though the response remains contextually relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 387,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "From 2022 to 2024, the strategic relationship between Eli Lilly (LLY) and Boehringer Ingelheim (BI) regarding the Jardiance product has seen increased legal involvement and regulatory challenges. In 2022, BI initiated U.S. patent litigation against generic companies seeking to market generic versions of Jardiance, with Lilly not being a party to this litigation. By 2024, Jardiance was selected by the U.S. Department of Health and Human Services under the Inflation Reduction Act (IRA) to face a government-set price, effective in 2026, which will result in a 66% discount from the 2023 list price. Additionally, Jardiance has faced product liability lawsuits, with BI responsible for defending and indemnifying Lilly under their collaboration agreement. These developments highlight heightened legal and regulatory pressures impacting their collaborative dependency on Jardiance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, BI led the Hatch-Waxman litigation without LLY as a party; by 2024, Jardiance was selected under the IRA for a 66% price discount from the 2023 list price, effective in 2026. The LLM correctly identifies the financial and strategic implications for LLY. (2) Quantitative accuracy is perfect: the 66% discount, 2023 list price reference, and 2026 effective date are all factually correct and match the knowledge graph. Format and context are appropriately handled. (3) Multi-hop reasoning is sound—LLM synthesizes legal (patent litigation, product liability), regulatory (IRA pricing), and strategic (collaborative dependency) developments across 2022–2024. It correctly notes BI's responsibility for legal defense under the collaboration agreement, adding depth not in the original but consistent with it. (4) The only minor gap is that the original emphasizes LLY’s growing 'dependency' and 'strategic entanglement' as a central theme, while the LLM focuses more on external pressures. This nuance is implied but not explicitly highlighted, slightly reducing qualitative alignment. However, all factual and contextual elements are present and correctly interpreted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 357,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "From 2022 to 2023, Disney's capital investment strategy for cruise ships remained a significant component of its Parks & Experiences business, with continued emphasis on cruise ship acquisitions and fleet expansion. In 2022, the strategy included capital spending for new cruise ships and capital improvements, while in 2023, the focus remained on cruise ships as a principal area of investment, reflecting the broader strategy to enhance and expand the Disney Cruise Line offerings within the Parks & Experiences segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding Disney's 2022 capital investment strategy. The ground truth states that in 2022, Disney did not specifically emphasize capital investment in cruise ships, instead discussing general macroeconomic risks affecting business plans broadly. However, the LLM incorrectly claims that in 2022, Disney's strategy 'included capital spending for new cruise ships and capital improvements,' which is not supported by the 2022 10-K as per the original answer. In contrast, the 2023 shift—where Disney explicitly listed cruise ships as part of significant capital investments—is correctly reflected in the LLM answer. (2) There are no numeric values, dollar amounts, or percentages in either the question or answers, so quantitative accuracy is not applicable; no errors here. (3) The multi-hop reasoning is partially sound: the LLM recognizes a continuity in strategy between 2022 and 2023, but fails to capture the key evolution—elevation of cruise ships from a non-emphasized component to an explicitly prioritized one. This misrepresents the nature of the strategic shift. The model treats cruise ships as consistently emphasized, whereas the ground truth shows a clear change in emphasis. (4) Contextual relevance is high because the answer addresses Disney’s capital investment in cruise ships within the Parks & Experiences segment across both years. However, the qualitative inaccuracy in representing the 2022 strategy undermines the correctness. The answer would score higher if it had correctly framed 2022 as lacking specific emphasis on cruise ship investments, contrasting with the explicit prioritization in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 463,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "Between 2022 and 2024, Mastercard Foundry has evolved from a platform for innovation experimentation to a more integrated and strategic driver of emerging technologies and fintech partnerships. In 2022, it focused on providing access to early-stage fintech players and innovation methodologies, while by 2024, it had expanded its role to support blockchain ecosystems, digital currencies, and the integration of future technologies into payment solutions, reflecting a stronger emphasis on scaling innovation and fostering deeper collaboration with fintechs and digital partners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Mastercard Foundry between 2022 and 2024. (1) It correctly identifies the shift from a platform focused on early-stage fintech access and innovation methodologies in 2022 to a more strategic, integrated driver of emerging technologies by 2024. The mention of blockchain ecosystems, digital currencies, and programmable payments aligns with the ground truth's emphasis on the Mastercard Multi-Token Network™ and blockchain-based business models. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022, 2024) are correct, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes Foundry’s changing role across two time points and connects it to technological focus areas and partnership strategies. The only minor omission is the lack of explicit mention of the rebranding from 'Mastercard Labs' to 'Foundry' and the specific branding of the Multi-Token Network™, which slightly reduces qualitative completeness but does not affect factual correctness. (4) The answer is fully contextually relevant, directly addressing the evolution in innovation role, engagement with emerging tech, and fintech partnerships. Overall, the response is semantically equivalent to the ground truth with only slight detail gaps, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 386,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "The financial and strategic nature of the collaboration with Boehringer Ingelheim evolved notably between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures. In 2022, Jardiance, part of the collaboration, received regulatory designations such as Breakthrough Therapy and Fast Track for heart failure and chronic kidney disease. By 2024, the collaboration faced significant pricing pressures due to the Inflation Reduction Act (IRA), which set government prices for certain drugs under Medicare. Jardiance was selected as one of the first medicines subject to these price controls, with a 66% discount from its 2023 list price effective in 2026. This regulatory development marked a shift from focusing on accelerated approvals to addressing the financial impact of mandated price reductions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Jardiance received Breakthrough Therapy and Fast Track designations in 2022 (specifically for heart failure and CKD, which adds detail beyond the original but does not contradict it), and in 2024, it was selected under the Inflation Reduction Act for a 66% discount from its 2023 list price, effective in 2026. These numbers, dates, and percentages match the ground truth exactly. (2) Quantitative accuracy is perfect: the 66% discount, 2023 price reference, and 2026 effective date are all correctly stated. (3) The multi-hop reasoning is sound—linking the 2022 regulatory support to 2024 pricing pressures shows a clear evolution in the collaboration's strategic and financial nature. The answer synthesizes information across time and regulatory contexts appropriately. (4) The only minor shortcoming is that the original answer emphasizes the shift from 'regulatory facilitation to regulatory-driven financial constraints,' while the LLM frames it as a shift from 'accelerated approvals to mandated price reductions'—a slightly narrower interpretation but semantically equivalent. The LLM adds specificity (indications: heart failure, CKD) not in the original, which enhances rather than detracts. All entities—Boehringer Ingelheim, Jardiance, LLY (implied), FDA, IRA—are correctly identified. The answer fully addresses both regulatory designations and pricing pressures as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 414,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "The strategic positioning of the CH-53K King Stallion heavy lift helicopter within Lockheed Martin's Rotary and Mission Systems (RMS) segment has evolved to emphasize its role in meeting international demand for heavy-lift capabilities. In 2023, the CH-53K program saw significant international interest, highlighted by the Israeli Ministry of Defense's procurement of 12 helicopters, with deliveries progressing through 2023. By 2024, the CH-53K continued to be a key component of RMS's international portfolio, supporting global customers and aligning with the segment's focus on expanding its presence in international markets through advanced, multi-mission platforms.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific international developments—namely, the Israeli Ministry of Defense's procurement of 12 CH-53K helicopters—that are not present in the original ground truth. While such information may be factually accurate in external contexts, it is not supported by the provided knowledge graph, which makes no mention of international sales, Israel, or delivery timelines. The original answer focuses on the internal strategic evolution within RMS, emphasizing a shift from near-to-mid-term growth element to integration within a broader, technology-driven portfolio including AI/ML and autonomy. The LLM answer completely omits this technological and strategic reframing. (2) There are no numeric values in either answer that conflict—both avoid specific revenue figures or quantitative performance metrics—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is flawed: the question asks for evolution in strategic positioning within RMS from 2023 to 2024 based on internal corporate framing, but the LLM substitutes this with a narrative about international market expansion not present in the ground truth. This reflects a failure to synthesize the correct conceptual shift across years. (4) While the LLM answer is contextually relevant to the CH-53K and RMS, it diverges significantly in substance, replacing the core theme of technological integration and portfolio evolution with an unverified emphasis on international demand. Thus, correctness and qualitative accuracy are low despite acceptable structure and no numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 438,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicates a strategic shift toward focusing on innovative therapies and expanding indications for existing products. For example, Jardiance's expanded use for heart failure and cardiovascular risk reduction reflects a move toward broader therapeutic applications beyond diabetes. This shift suggests both companies are prioritizing value-added differentiation in a competitive market, aiming to maintain market relevance amid biosimilar and generic competition.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the strategic shift and contextual reasoning, but it omits key details about the specific products removed from the portfolio (Trajenta, Jentadueto, Basaglar), which are central to the multi-hop synthesis required by the question. Quantitatively, there are no numbers, dates, or calculations in either answer, so accuracy is not compromised in that regard—scored as 10. The LLM correctly identifies a strategic refocusing on higher-value, innovative therapies like Jardiance with expanded indications, which aligns with the ground truth's implication of prioritizing products with stronger commercial performance or longer patent life. However, the answer introduces a plausible inference (expansion into heart failure and cardiovascular risk reduction) that, while accurate for Jardiance, is not explicitly supported by the provided ground truth data and thus adds unverified detail. The core reasoning about shifting priorities due to market competition and differentiation is sound and relevant, but the failure to mention the specific product withdrawals limits completeness and precision in entity-level accuracy. Thus, qualitative accuracy is scored a 7 due to partial omission of factual entities and introduction of external knowledge. Contextual relevance is high as the response directly addresses the strategic implications of the portfolio change. Overall, the answer captures the essence but lacks full completeness on the factual composition changes, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 429,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "The JASSM program's financial performance and strategic importance grew between 2023 and 2024. In 2023, JASSM contributed to a $145 million increase in MFC's net sales due to production ramp-up, and its operating profit benefited from favorable profit adjustments. By 2024, JASSM's production ramp-up continued, contributing to a $1.2 billion sales increase in tactical and strike missile programs. However, MFC's operating profit declined significantly in 2024 due to large losses on a classified program, though JASSM's contribution to backlog increased as orders for the program rose.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The claim that JASSM contributed to a $145 million increase in MFC's net sales in 2023 is not supported by the ground truth, which states there was no specific mention of significant changes in production or backlog for JASSM in 2023. This number is fabricated. The $1.2 billion increase in 2024 is correctly attributed to tactical and strike missile programs, aligning with the ground truth, though it incorrectly frames this as a 'sales increase' rather than an increase in backlog contribution. (2) The quantitative accuracy is low because the $145M figure is incorrect and unsupported. The $1.2B figure is directionally correct but mischaracterized as a sales increase rather than part of backlog growth. The mention of operating profit impacts from a classified program, while possibly true, is irrelevant to the question and distracts from the focus on JASSM's performance and backlog. (3) The multi-hop reasoning is partially sound in that it identifies JASSM as gaining strategic importance in 2024 and links it to increased production and backlog. However, it fails to accurately represent the baseline in 2023, inventing financial impact where none was stated, and misattributes financial outcomes. The synthesis across years is flawed due to the introduction of false data. (4) Contextual relevance is high because the answer addresses production activity, backlog contribution, and strategic importance across both years, and correctly identifies JASSM as a key contributor in 2024. However, the inclusion of unrelated financial details (classified program losses) reduces precision. Overall, the answer shows understanding of the program's rising importance but undermines credibility with incorrect figures and misattributions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 501,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPM's focus in evaluating credit risk for Business Banking Loans has shifted between 2023 and 2024 to place greater emphasis on early-stage delinquency trends and geographic distribution as indicators of borrower distress. In 2023, the firm primarily relied on delinquency rates and LTV ratios to assess risk, with late-stage delinquencies (150+ days past due) being a strong indicator of potential defaults. By 2024, the firm highlighted that early-stage delinquencies (30+ days past due) serve as a more immediate warning sign of borrower distress, enabling earlier intervention. This shift implies a more proactive approach to identifying and addressing potential credit issues before they escalate, improving risk management and loss mitigation.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly identifies a shift toward early-stage delinquency (30+ days past due) in 2024 as an early warning sign—aligning with the ground truth—its description of 2023 practices is inaccurate. The ground truth states that in 2023, JPM focused on loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment, not on delinquency rates and LTV ratios as claimed by the LLM. Additionally, the LLM introduces 'geographic distribution' and 'LTV ratios' as key factors, which are not mentioned in the original answer and lack support from the knowledge graph. The mention of '150+ days past due' as a 2023 indicator is also unsupported. (2) There are no explicit numerical values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy hinges on correct timeframes and thresholds. The 30+ days past due metric in 2024 is correctly cited, but the 150+ days and LTV references are factually incorrect, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift toward earlier intervention—but it synthesizes incorrect or extraneous elements (e.g., LTV, geographic distribution, late-stage delinquency focus in 2023) not present in the source. This undermines the qualitative accuracy. (4) The answer is contextually relevant and addresses the evolution of credit risk focus and implications for borrower distress, but factual inaccuracies in the baseline (2023) description and introduction of unsupported metrics reduce correctness and qualitative scores. The implication of earlier intervention is correctly interpreted, supporting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 479,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Based on the provided document pages, there is no explicit mention of changes to the terms of Target Corporation's SPP II (Stock Purchase Plan II) plan between the 2022 and 2023 filings. Both filings list the SPP II as \"Target Corporation SPP II (2016 Plan Statement) (as amended and restated effective April 3, 2016)\" without indicating any further amendments in 2023. This suggests that the company maintained a stable executive compensation framework during this period, with no material changes to the SPP II structure. It reflects a continuity in Target's approach to executive compensation, relying on previously established plans rather than introducing new terms in 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. According to the ground truth, the SPP II plan was updated from the 2016 Plan Statement (effective April 3, 2016) in the 2022 filing to the 2022 Plan Statement (effective May 1, 2022) in the 2023 filing. The LLM incorrectly states that both filings reference the same 2016 version with no changes, which contradicts the factual evolution documented in the knowledge graph. This error affects all aspects of the response: the quantitative accuracy fails because the key dates (May 1, 2022 vs April 3, 2016) are wrong; qualitative accuracy fails because the reasoning is based on a false premise of no change, leading to an incorrect conclusion about stability; and while the answer is contextually relevant in discussing executive compensation, it draws the opposite conclusion of the ground truth. The multi-hop synthesis failed—instead of identifying the plan update across two filings, it asserted continuity. Thus, the correctness score is very low due to complete factual inaccuracy despite addressing the question's structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 304,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "The financial obligations related to Incyte under the Olumiant collaboration evolved as follows from 2022 to 2024: In 2022, Incyte was eligible to receive up to $100.0 million in additional regulatory milestone payments and up to $100.0 million in sales-based milestones. By 2024, no new material milestone payments to Incyte were recognized, indicating that either the potential future milestones had not been triggered or the amounts involved were not significant. Royalty payments to Incyte continued, with tiered rates up to 20% on worldwide net sales of Olumiant, including an additional royalty for COVID-19 treatments exceeding a specified sales threshold.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $100.0 million in regulatory milestones and $100.0 million in sales-based milestones for 2022, matching the ground truth exactly. The royalty structure in 2024 is accurately described with tiered rates up to 20% and an additional royalty for COVID-19 sales exceeding a threshold. However, the LLM states that 'no new material milestone payments...were recognized' rather than explicitly noting the absence of regulatory milestones in 2024 filings, which slightly weakens the inference that they were either paid out or no longer applicable. This nuance is present in the original answer but only implied in the LLM version. (2) All numeric values—$100.0 million (twice), royalty up to 20%, and reference to low teens for COVID-19—are factually correct and match the ground truth. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes over time between 2022 and 2024, comparing milestone structures and identifying the shift toward sales-based compensation. However, it stops short of explicitly stating the 'shift' in structure, which is a key conclusion in the original answer. (4) Scores reflect high accuracy in numbers and relevance, with a minor deduction in qualitative accuracy due to less precise reasoning articulation and omission of the explicit structural shift conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 386,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco's financial exposure in the APJC region increased between fiscal 2022 and fiscal 2023. In fiscal 2022, APJC revenue was $8,027 million, rising to $8,208 million in fiscal 2023, reflecting growth in the region. Additionally, goodwill attributed to the APJC segment increased from $5,382 million in fiscal 2022 to $8,208 million in fiscal 2023, primarily driven by acquisitions, including the Splunk acquisition in fiscal 2024. This indicates an expanded financial commitment and strategic investment in the APJC region.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, no specific financial figures for APJC were disclosed in fiscal 2022, but the LLM claims APJC revenue was $8,027 million in 2022 and $8,208 million in 2023—these numbers are not supported by the provided data. Additionally, the LLM incorrectly states that goodwill in APJC was $5,382 million in 2022 and rose to $8,208 million in 2023. In reality, $5,382 million refers to total APJC assets as of July 29, 2023 (fiscal 2023), not goodwill, and there is no mention of goodwill values in the ground truth. The Splunk acquisition is also misattributed to fiscal 2024, which is outside the scope of the comparison between fiscal 2022 and 2023. (2) All numeric values in the LLM answer are incorrect or misassigned. The only correct number is $5,382 million, but it is wrongly labeled as goodwill in 2022 instead of assets in 2023. The revenue figures and goodwill increases are entirely fabricated. (3) The multi-hop reasoning is flawed. The LLM assumes revenue and goodwill data are available for both years, but the ground truth explicitly states that APJC segment figures were not disclosed in 2022. It fails to recognize that the key evolution is improved disclosure (from no itemized assets in 2022 to $5,382M in 2023), not revenue or goodwill growth. (4) The answer is contextually relevant in that it attempts to assess financial exposure in APJC over time, but the incorrect data and reasoning severely undermine its validity. The conclusion about increased investment might seem plausible, but it is based on false premises, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 456,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "The strategic collaboration between LLY and Boehringer Ingelheim regarding Jardiance has evolved in response to regulatory changes, particularly the Inflation Reduction Act of 2022 (IRA). In 2023, the U.S. Department of Health and Human Services selected Jardiance for government-set pricing, effective in 2026, with a 66% discount from the 2023 list price. This regulatory development, part of broader pricing reforms, has influenced LLY's business strategies, accelerating revenue erosion for Jardiance prior to the expiration of its exclusivity. The collaboration remains critical as both companies navigate the impact of reduced Medicare pricing and potential effects on Medicaid and 340B drug pricing programs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several key inaccuracies. While it correctly identifies the Inflation Reduction Act (IRA) and its impact on Jardiance pricing, it incorrectly states that the government-set pricing is effective in 2026, whereas the ground truth specifies that the 66% discount was applied in August 2024. This is a critical error in timing that affects the interpretation of revenue impacts. Additionally, the LLM claims the selection occurred in 2023 by HHS, but the ground truth specifies August 2023 as the selection date and August 2024 as the implementation—details the LLM misrepresents. (2) The 66% discount figure is accurate and correctly tied to the 2023 U.S. list price, which aligns with the ground truth. However, the LLM omits the 2022 revenue growth data (30% in U.S., 28% outside U.S.) entirely, which was a required part of the evolution from 2022 to 2024. This omission reduces completeness and quantitative accuracy. (3) The reasoning partially captures the multi-hop nature of the question—linking regulatory change (IRA) to pricing action and then to strategic impact—but fails to fully synthesize the timeline and business evolution across 2022–2024. The omission of early-stage growth context weakens the narrative of evolution. (4) Despite these issues, the answer remains contextually relevant, correctly identifying the collaboration, the drug, the regulatory driver, and the general direction of impact. The qualitative reasoning is sound in structure but flawed in factual precision, particularly on dates and implementation timing. Hence, correctness is partially compromised, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 453,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "Between 2022 and 2023, GM's emphasis on the financial and reputational risks of product safety recalls, particularly concerning global platforms like the Chevrolet Bolt EV, showed a heightened focus on the broader implications of recalls on its EV/AV positioning. In 2022, the risks were discussed in the context of general product safety and the potential for recalls to impact brand equity and consumer trust, especially with advanced technologies. By 2023, the discussion expanded to explicitly reference the Chevrolet Bolt EV recall as an example of how global platform recalls can exacerbate costs and reputational damage. Additionally, GM emphasized the challenges of managing safety and security risks in AVs and connected vehicles, reflecting a more strategic alignment with its evolving role in the EV/AV market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in GM's risk disclosure between 2022 and 2023 regarding product safety recalls, particularly in relation to the Chevrolet Bolt EV and EV/AV technologies. It accurately notes the increased focus on reputational damage and strategic positioning by 2023. However, it reverses the timeline slightly: the ground truth states that in 2022, GM specifically cited the Bolt EV recall in the context of financial and logistical costs of global platforms, while in 2023 the emphasis expanded to include reputational risks. The LLM answer incorrectly implies that in 2022 the discussion was more general (about 'advanced technologies') and that the Bolt was only explicitly referenced in 2023, which contradicts the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model connects GM, Bolt EV, recalls, and EV/AV strategy across years, but misattributes when the Bolt example was first highlighted (2022 vs. 2023), weakening the accuracy of the synthesis. (4) Despite the timeline inversion, the overall trend described—increased emphasis on reputational and strategic risks by 2023—is correct, and the answer remains contextually relevant and well-articulated, hence a score of 7 for correctness and qualitative accuracy, with high contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 416,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "Between 2022 and 2024, Costco's Japanese subsidiary issued Guaranteed Senior Notes totaling approximately $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120% and maturities extending to 2043. In July 2024, the subsidiary repaid $77 of these notes. This evolution indicates that Costco is utilizing long-term financing through its international operations, likely to manage debt maturities and optimize its capital structure by accessing favorable interest rates in foreign markets. The repayment of a portion of the debt also suggests active management of its liabilities to maintain financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of $500 in Guaranteed Senior Notes in November 2023 at fixed interest rates from 1.400% to 2.120% with maturities extending to 2043, and the repayment of $77 in July 2024—all of which align with the ground truth. The only minor omission is that the original answer specifies four separate notes were issued (a detail not included in the LLM response), but this does not affect the overall accuracy of the financial figures or timeline. (2) All numeric values—$500 total issuance, $77 repayment, interest rate range, and maturity dates—are factually correct and match the ground truth. Date references (November 2023 issuance, July 2024 repayment) are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across 2022 (implied baseline of less disclosure) and 2024 (detailed disclosure), and infers a strategic long-term financing approach. The LLM attributes the strategy to managing maturities, optimizing capital structure, and maintaining financial flexibility—reasoning that is logically consistent with the ground truth’s conclusion about transparency, fixed-rate debt, and extended maturities. (4) The LLM slightly under-elaborates on the evolution in disclosure transparency between 2022 and 2024 (e.g., Level 3 inputs in 2022), but captures the core evolution in financing activity and strategic intent. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 440,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "The value of Cisco's available-for-sale debt investments decreased from $15,592 million in 2023 to $9,865 million in 2024, a reduction of $5,727 million. This significant decline indicates that Cisco likely liquidated a portion of its investment portfolio, potentially to fund the acquisition of Splunk and other strategic initiatives, reflecting a shift in capital allocation toward major acquisitions and operational needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in dates and direction of change. The original answer states that the drop occurred between 2022 and 2023 (from $15,592M to $9,865M), but the LLM incorrectly claims the change was from 2023 to 2024, which is not supported by the ground truth. This misalignment in fiscal years undermines the quantitative accuracy. While the dollar decrease of $5,727 million is correctly calculated, it is applied to the wrong time period. (2) The numbers themselves ($15,592M, $9,865M, and $5,727M difference) are numerically accurate and correctly formatted, but their temporal assignment is incorrect. The LLM also omits the 2022 gain of $9 million mentioned in the original answer, which provides context about the prior year’s investment activity. (3) The reasoning about a strategic shift is plausible and aligns with the general implication of the original answer, but the LLM introduces unverified specifics—namely, the Splunk acquisition and 'operational needs'—which are not present or inferable from the ground truth. This reflects overinterpretation and introduces unsupported external context. (4) Despite the incorrect timeline and unsupported strategic rationale, the answer does recognize a significant reduction in available-for-sale debt investments and infers a strategic shift, which is thematically relevant. However, the multi-hop reasoning fails because it misaligns the data across years and adds speculative motivations. The contextual relevance remains moderate because the overall topic and direction of interpretation (portfolio reduction = strategic shift) are consistent, even if details are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 458,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "JPMorgan Chase's exposure to system damage risks, particularly from third-party vendor attacks and data recovery challenges, has evolved from 2023 to 2024 with increased emphasis on proactive measures and heightened awareness of emerging threats. In 2023, the company highlighted the risks of third-party vendor vulnerabilities and the potential for operational disruptions due to cyberattacks or system failures. By 2024, JPMorgan Chase expanded its focus to include more specific strategies for mitigating these risks, such as enhancing early detection of attacks on third-party vendors, improving oversight of vendor cybersecurity, and strengthening controls for secure software development and identity management. Additionally, the company emphasized the need for ongoing adaptation to evolving threats, including ransomware and zero-day vulnerabilities, and the importance of integrating acquired businesses with robust cybersecurity frameworks to address data recovery challenges effectively.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies when compared to the ground truth. While it correctly identifies JPMorgan Chase and the years 2023 and 2024, it misrepresents the nature of the evolution in system damage risks. The original answer emphasizes an increased focus on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage in 2024, as well as challenges in preventing fraudulent transaction processing. However, the LLM answer incorrectly frames the evolution as a shift toward 'proactive measures' and 'strategies for mitigating risks' such as improved detection and vendor oversight, which is not supported by the ground truth. The ground truth does not mention any new mitigation strategies or controls implemented in 2024, but rather a heightened awareness and expansion of risk disclosures. (2) There are no numeric values, percentages, or financial amounts in either answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound in that the LLM connects third-party vendor risks and data recovery across years, but it fails to accurately synthesize the actual content from the knowledge graph. Instead of reflecting increased exposure and financial risk (e.g., losses exceeding insurance), the LLM portrays a more optimistic narrative of improved defenses, which contradicts the original answer’s emphasis on growing vulnerabilities. (4) Contextual relevance is moderate—the response addresses system damage risks, third-party vendors, and data recovery, so it stays on topic. However, the qualitative inaccuracy in representing the direction of change (from increased risk to improved mitigation) significantly undermines factual correctness, warranting a correctness score of 5—partially correct but with significant factual misrepresentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 510,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "Costco has made operational investments in processing, packaging, and manufacturing facilities to support the production of private-label items, as mentioned in the 2024 filing. These investments align with the private-label growth strategy outlined in the 2022 filing, which emphasized increasing the penetration of private-label products as part of its merchandising and pricing strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies the operational investments Costco made by 2024—processing, packaging, and manufacturing facilities—for private-label production, as stated in the 2024 filing. It correctly links these investments to the private-label growth strategy mentioned in the 2022 filing, demonstrating proper multi-hop reasoning across time and documents. All entities (Costco, 2022 and 2024 filings, private-label strategy) are correctly identified. There are no numeric inaccuracies; the answer does not include specific numbers but correctly references qualitative operational investments. The only minor shortcoming is that it does not explicitly mention the strategic shift from external sourcing to internal production capabilities, which is a key nuance in the original answer about the evolution of the strategy. However, the core facts, timeline, and reasoning are sound and semantically equivalent. Thus, the answer is highly accurate and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 327,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's approach to Medicaid managed care contract bidding remained centered on assumptions regarding enrollment, utilization, medical costs, and other factors. However, the 2023 filing highlights increased risks associated with bid accuracy, including unforeseen changes to programs, implementation of material policy changes after bid submission, and competitive pressures from lower bids by competitors. These risks could lead to material adverse effects on the company's results of operations, financial position, and cash flows. The evolution reflects a growing emphasis on the potential volatility and uncertainty in the bidding environment, particularly as state Medicaid programs continue to refine their processes and payment mechanisms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in UnitedHealth Group's approach from 2022 to 2023, noting a shift toward greater emphasis on bid assumptions and associated risks. While the original answer explicitly mentions the 2022 focus on risk of losing Medicaid members due to non-renewal of contracts, the LLM answer omits this specific point but correctly emphasizes the increased focus in 2023 on assumptions (enrollment, utilization, medical costs) and external risks (program changes, competitor pricing). The core factual elements—increased risk disclosure around bid accuracy, reliance on assumptions, and potential material impact—are all present and accurate. (2) There are no numeric values, percentages, or dollar amounts in either the question or answers, so quantitative accuracy is not applicable; however, the years 2022 and 2023 are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the model synthesizes a change over time in risk disclosure strategy from two different years’ filings, correctly identifying the evolving nature of UnitedHealth’s risk factors related to Medicaid bidding. The omission of the 2022 contract renewal risk as a primary concern slightly weakens the completeness of the comparison, but the 2023 emphasis is accurately detailed. (4) The LLM answer is semantically very close to the original, with slightly different framing but consistent meaning. It scores highly on contextual relevance and qualitative accuracy, with only minor loss in completeness for not explicitly contrasting the 2022 renewal focus with 2023 bid assumption focus. Thus, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 460,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "Based on the provided information, MET's investment in Municipals remained relatively stable in terms of estimated fair value from 2022 to 2023. In 2022, the estimated fair value of Municipals was $14,212 million, and in 2023, it was $14,212 million as well. In terms of valuation hierarchy classification, Municipals were primarily classified under Level 2 in both 2023 and 2022, with no significant Level 3 components reported for either year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. According to the ground truth, MET's investment in Municipals decreased dramatically from $14,212 million in 2022 to $159 million in 2023, but the LLM claims the value remained stable at $14,212 million in both years. This is a major factual error. Additionally, the ground truth states that in 2022, there was no detailed breakdown of valuation hierarchy levels (only 'Estimated Fair Value'), while in 2023 it was explicitly classified as 'Level 2'. The LLM incorrectly claims that Municipals were classified under Level 2 in both years with no significant Level 3 components. (2) Quantitative accuracy is extremely low: the 2023 value is off by over $14 billion, and the characterization of stability is false. The numbers cited are factually wrong. (3) The multi-hop reasoning failed completely: the model did not detect the significant drop in investment value or the change in transparency of valuation hierarchy classification. Instead, it fabricated consistent values and classifications across years. (4) Scores are low because the core facts—both numerical and conceptual—are incorrect. The answer contradicts the ground truth on every key point. Contextual relevance is slightly above zero because the answer addresses the right topic (Municipals investment and valuation hierarchy), but with entirely wrong data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 388,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "From fiscal year 2022 to 2024, Microsoft has enhanced licensing flexibility and customer agreement models for Office 365 by introducing more streamlined and customer-centric options. In 2022, Office 365 revenue was recognized ratably over the contract period, with licensing tied to volume agreements and Software Assurance (SA). By 2024, Microsoft expanded its Microsoft Customer Agreement (MCA) and Microsoft Online Subscription Agreement (MOSA) to provide simplified, non-expiring digital agreements, enabling seamless subscription management for small, medium, and large organizations. These changes reflect a shift toward flexible, scalable, and digitally accessible licensing models to better meet evolving customer needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution from volume licensing and ratable revenue recognition in FY2022 to more flexible, customer-centric models by FY2024. The mention of Software Assurance (SA) adds contextual detail not in the original but is factually consistent with Microsoft's licensing practices. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the fiscal years (2022 and 2024) are correctly used as reference points. (3) The multi-hop reasoning is sound: the answer synthesizes changes in licensing models over time, correctly identifying the shift from traditional volume licensing to digital agreements like MCA and MOSA. It accurately reflects the move toward monthly/annual subscriptions and reduced organizational commitments, though it does not explicitly mention the 'no organization-wide commitment' aspect, which is a minor omission. (4) The answer is semantically equivalent to the original, with slightly different phrasing but full preservation of meaning. The introduction of 'non-expiring digital agreements' and 'seamless subscription management' captures the essence of enhanced flexibility. Only a perfect score is withheld due to the slight lack of specificity around commitment terms, but overall, the response is factually correct, complete, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 388,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "Between 2022 and 2023, the composition of MET's Level 3 Fixed Maturity Securities AFS changed from $967 million in 2022 to $904 million in 2023, indicating a reduction in investments in assets with little or no price transparency, such as private equity and real estate funds. This shift suggests a potential adjustment in the company's investment strategy toward reducing exposure to less liquid and more volatile assets, possibly to enhance portfolio stability and align with long-term funding objectives for employee benefit plans.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both quantitative and qualitative aspects. According to the ground truth, MET's Level 3 Fixed Maturity Securities AFS in 2022 consisted of $1M Corporate bonds, $1M Foreign Bonds, and $11M Equity Securities (totaling $13M), not $967M as claimed. In 2023, it was $54M Corporate bonds, $2M Foreign Bonds, and $828M Other Investments (totaling $884M), not $904M. The LLM reports incorrect totals and completely misrepresents the composition. (2) The dollar amounts are grossly inaccurate—$967M and $904M are over 70x and 70x higher than the actual 2022 total, respectively. The LLM also fabricates a narrative about private equity and real estate funds, which are not mentioned in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to identify the actual components of Level 3 securities and incorrectly infers a reduction in illiquid assets, when in fact the company significantly increased its 'Other Investments' within Level 3—from $0 reported in 2022 to $828M in 2023. This indicates a shift toward, not away from, potentially less transparent or more diverse investments. (4) The correctness score is 1 due to complete factual inaccuracy in numbers, entities, and reasoning. Quantitative accuracy is 1 because all numbers are wrong. Qualitative accuracy is 1 because the interpretation contradicts the actual strategic shift. Contextual relevance is 3 because the answer addresses investment strategy in a general sense but misrepresents the data entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 424,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "Between 2022 and 2024, Microsoft has further integrated Office 365 into its broader cloud services portfolio, emphasizing its role as a core component of its AI-driven strategy. Office 365 is now deeply interdependent with cloud services, with revenue recognized ratably over the service period due to its integration with desktop applications and cloud infrastructure. In response to competitive pressures from AI-driven offerings, Microsoft has infused generative AI capabilities into Office 365 and other products, positioning it as a key platform for productivity and collaboration in the AI era. This evolution reflects Microsoft's focus on leveraging AI to enhance cloud-based services and maintain competitiveness in a rapidly evolving market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Office 365's evolution from a standalone cloud offering in 2022 to an AI-integrated component by 2024 is accurately described. The integration with Microsoft's broader cloud portfolio and the strategic response to AI-driven competition are correctly captured. (2) There are no numeric values (e.g., revenue figures, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the shift in strategic positioning over time and links it to competitive pressures and AI integration. The only minor omission is that the original answer specifically names Azure, Dynamics 365, and Xbox as peer offerings in 2022, and explicitly references Microsoft's response to free/ad-funded or open-source AI models—details not fully elaborated in the LLM response. However, the core strategic shift and AI infusion are correctly identified. (4) The answer is contextually excellent—directly addresses the evolution of Office 365’s role, its integration into cloud/AI strategy, and competitive dynamics. Wording differs but semantic meaning matches. Thus, correctness is 9 due to slight incompleteness in contextual details, but still highly accurate overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 381,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group maintained a consistent approach to evaluating credit-related impairments, primarily focusing on the present value of expected cash flows relative to amortized cost, the issuer's financial condition, and the Company's intent to hold or sell impaired securities. In both years, the Company noted no significant credit deterioration in its investment portfolio and did not record material credit-related impairments. The methodology for identifying and measuring impairments remained unchanged, with unrealized losses attributed largely to interest rate fluctuations rather than credit quality issues. As a result, the financial impact of credit-related impairments remained immaterial in both periods.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that UnitedHealth Group maintained a consistent approach between 2022 and 2023. The ground truth states that the company evolved its methodology in 2023 by formalizing a distinction between credit-related and non-credit-related impairments and changing how these are recorded in financial statements—credit-related impairments are now recorded as an allowance against investment income, while non-credit-related impairments go through other comprehensive income. The LLM incorrectly asserts that the methodology 'remained unchanged,' which contradicts the documented evolution in approach. (2) There are no specific numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—minor details like 'not material' or 'immaterial' are consistent across both answers, hence a score of 8 is justified. (3) The multi-hop reasoning is flawed: the question asks about evolution, implying change over time, but the LLM fails to detect and report the shift in methodology, instead asserting consistency. This represents a failure in synthesizing the temporal change in policy and reporting structure. (4) Contextual relevance is moderate—the answer discusses the right topic (impairment evaluation), company, and time frame, and correctly notes that impairments were immaterial in both years. However, it misses the key qualitative shift in framework and reporting treatment, which is the central point of the original answer. Thus, while some contextual elements are correct, the failure to capture the evolution severely undermines correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 458,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "From 2022 to 2023, the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans showed slight changes. For pension benefits, the total estimated fair value of Fixed Maturity Securities AFS decreased from $6,802 million in 2022 to $6,714 million in 2023. In terms of allocation, the Level 2 category (primarily liquid and marketable securities) decreased from $5,091 million in 2022 to $4,924 million in 2023, while Level 1 (directly held investments) decreased from $1,653 million to $1,726 million. For other postretirement benefits, the total estimated fair value of Fixed Maturity Securities AFS remained relatively stable, decreasing slightly from $1,256 million in 2022 to $1,274 million in 2023, with most assets categorized under Level 2.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Fixed Maturity Securities AFS were reported as percentages of total allocations (84% for U.S. Pension Benefits and 95% for U.S. Other Postretirement Benefits), not as absolute dollar values. However, the LLM answer incorrectly asserts specific dollar amounts for 2022 ($6,802 million for pensions and $1,256 million for other postretirement benefits), which are not present in the original answer and contradict the structure of the ground truth. The 2023 values ($6,714 million and $1,274 million) are correct per the ground truth. (2) The LLM introduces granular details about Level 1 and Level 2 fair value categories and their changes from 2022 to 2023, which are entirely absent in the original answer and not supported by the provided ground truth. These numbers cannot be verified and appear fabricated. (3) The multi-hop reasoning is flawed because the model fails to recognize that the 2022 data was allocation-based (percentage of total) while 2023 was valuation-based (absolute fair value), which is the key evolution highlighted in the original answer. Instead, it assumes both years reported dollar values and computes changes, which misrepresents the nature of the data shift. (4) While the LLM attempts to address the evolution over time and mentions correct 2023 valuations, its incorrect portrayal of 2022 data and addition of unsupported details severely undermine factual accuracy. The contextual relevance is moderate because it discusses the right topic and time frame, but the core quantitative claims are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 450,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "Between 2022 and 2023, Lowe's strategic positioning of the Kitchens & Bath product category evolved by integrating it more deeply into its omnichannel and Pro customer strategies. In 2022, Kitchens & Bath was highlighted as part of the installed sales model and protection plans, emphasizing its role in complex, customer-focused projects. By 2023, the category was further emphasized in product assortment and localization efforts, reflecting its importance in serving both DIY and DIFM customers. This evolution suggests that Kitchens & Bath has become a more central part of Lowe's product portfolio, supporting its Total Home strategy and enhancing customer solutions across channels.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying that Kitchens & Bath gained strategic importance between 2022 and 2023 and is tied to Lowe's Total Home strategy, which aligns with the ground truth. However, it misses the key factual repositioning detail: in 2022, Kitchens & Bath was grouped under Home Décor (with Appliances, Décor, Flooring, Paint), and in 2023 it was moved to a construction/remodeling grouping (with Lumber, Building Materials, Rough Plumbing). Instead, the LLM focuses on omnichannel and Pro customer integration, installed sales, and localization—details not supported by the ground truth. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; no errors in dates or formats. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the correct organizational categorization shift across years, which is central to the question. While it infers increased strategic importance correctly, it bases this on inaccurate structural reasoning. (4) Correctness is scored 5 due to partial factual alignment (importance increasing, Total Home strategy) but major omission of the actual reclassification. Qualitative accuracy is 5 because entity names (Lowe's, Kitchens & Bath, Total Home) are correct, but the reasoning and synthesis are based on incorrect premises. Contextual relevance is 8 because the answer addresses the evolution and strategic importance, though with inaccurate supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 410,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez International's strategic focus on Cheese & Grocery between 2022 and 2024 has remained part of its broader portfolio of adjacent, locally relevant categories, but it has not been highlighted as a primary growth driver. The 2024 10-K emphasizes the company's core focus on chocolate, biscuits, and baked snacks, with Cheese & Grocery mentioned as a supporting category. The company's strategic priorities continue to center on accelerating consumer-centric growth and operational excellence across its core snacking businesses. This suggests that while Cheese & Grocery is part of Mondelez's diversified offerings, the company is prioritizing its high-growth core snack categories—such as baked snacks and confectionery—for long-term value creation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cheese & Grocery is not a primary growth driver and that Mondelez prioritizes core snack categories like biscuits and chocolate. It also accurately reflects the strategic context of focusing on core snacking for long-term growth. However, it omits critical quantitative and structural changes between 2022 and 2024 that are central to the question. Specifically, the LLM fails to mention that Mondelez generated $1,990 million in net revenues from direct production of Cheese & Grocery in 2022 and that by 2024, it no longer reported direct production, instead holding only a strategic stake. This shift—from direct involvement to an adjacent, non-core category—is a key factual transformation that the LLM answer does not capture. (2) Quantitatively, the answer completely misses the $1,990 million revenue figure and the discontinuation of direct reporting, which are essential data points in the ground truth. There are no numerical inaccuracies per se, but the absence of these figures severely undermines quantitative accuracy. (3) The reasoning is partially sound: the conclusion that core snacks are prioritized aligns with the ground truth, and the mention of adjacent categories is consistent. However, the multi-hop synthesis is incomplete—it fails to connect the financial data from 2022 with the structural change in 2024 and the strategic repositioning. The answer treats the category’s role as static rather than evolving, missing the dynamic shift. (4) Contextual relevance is high because the response addresses the strategic focus and long-term prioritization as asked. The qualitative accuracy is moderate because while the general direction of strategy is correct, the lack of key facts about divestment or reduced operational footprint weakens the analysis. The correctness score is 6 due to significant omissions in critical financial and operational changes, despite accurate general strategic framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 533,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "Between the 2022 and 2023 10-K filings, Abbott's presentation of its enteral feeding product lineup remained largely consistent, with both years listing Jevity and Freego™ products as part of the Nutritional Products segment. However, in the 2023 filing, Freego™ is explicitly mentioned as an enteral pump and its associated sets, whereas in 2022, it was grouped more generically with other enteral feeding products without specific emphasis on the pump functionality. This subtle shift in 2023 highlights Freego™'s role as a more distinct and technologically specific offering within Abbott's enteral feeding portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in noting that Abbott included Freego™ products in both the 2022 and 2023 10-K filings and that the 2023 filing provides more specific detail about Freego™ as an enteral pump and sets. However, it misses the key factual change highlighted in the ground truth: the shift in *presentation order* of products. In 2022, Jevity was listed first, followed by Glucerna and Osmolite lines before Freego™, whereas in 2023, Freego™ (Enteral Pump) and Freego™ sets were moved immediately after Jevity, indicating a more prominent positioning. The LLM incorrectly states the presentation was 'largely consistent,' when the reordering represents a meaningful change in emphasis. While there are no numeric inaccuracies (hence a high quantitative accuracy score), the qualitative accuracy is low because the model fails to identify and report the critical multi-hop detail—the change in listing order—which is central to the question. The reasoning is flawed as it infers a shift based on specificity of description rather than the actual structural change in product listing. Contextually, the response is relevant and addresses Abbott's product lineup, but it misidentifies the nature of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 348,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "From 2022 to 2023, MET's investment in municipals showed an increase in fair value, rising from $14,212 million in 2022 to $14,642 million in 2023, as reflected in the fair value of fixed maturity securities AFS. The classification of municipals remained as available-for-sale (AFS) in both years, with no allowance for credit losses reported. This suggests that MET's credit risk management strategy involves maintaining a diversified portfolio of investment-grade securities, with municipals being a stable component with low credit risk. The absence of credit losses and the consistent AFS classification indicate that the company is managing its credit risk by investing in securities with strong credit quality and holding them for long-term value.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It claims MET's investment in municipals increased from $14,212 million in 2022 to $14,642 million in 2023, which directly contradicts the ground truth showing a dramatic decrease to just $159 million in 2023. This fundamental error invalidates the entire response. Additionally, the LLM states there was no allowance for credit losses and that municipals remained a stable component, but the ground truth indicates a strategic divestment, suggesting active risk reduction. (2) Quantitative inaccuracies are severe: the 2023 value is off by over $14 billion. The claimed fair value increase of $430 million ($14,642M - $14,212M) is the opposite of the actual 98.9% reduction. The ground truth also mentions $2,464M in gross unrealized gains and only $13M in losses in 2022, which the LLM omits entirely. (3) The multi-hop reasoning is flawed: instead of recognizing the sharp decline as a strategic move to reduce credit risk exposure, the LLM incorrectly infers stability and low risk based on fabricated data. It fails to note the reclassification entirely to Level 2 of the fair value hierarchy in 2023, a key detail indicating changed valuation transparency. (4) The contextual relevance is low due to factual inaccuracy, though the answer does address the general topic of credit risk management. However, the conclusion is based on false premises, leading to a completely incorrect interpretation of MET's strategy. Scores reflect near-total failure in factual correctness and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 427,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Between 2022 and 2023, Abbott's use of interest rate hedge contracts decreased from approximately $2.9 billion to $2.2 billion, primarily due to the maturity of $700 million of contracts in 2023 alongside corresponding long-term debt maturities. These contracts, designated as fair value hedges, were used to manage exposure to changes in the fair value of fixed-rate debt caused by fluctuations in long-term benchmark interest rates. The reduction in notional value reflects a strategic adjustment in fixed-rate debt management, aligning hedge positions with the company's evolving debt profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Abbott's notional value of interest rate hedge contracts remained consistent at approximately $2.2 billion in both 2022 and 2023. However, the LLM incorrectly states that the value decreased from $2.9 billion in 2022 to $2.2 billion in 2023, introducing a $700 million reduction not supported by the original data. This misrepresents the quantitative trend entirely. (2) The calculation of a $700 million decrease is therefore incorrect, as no such change occurred. The ground truth confirms stability in notional value, not a reduction. (3) While the LLM correctly identifies the purpose of the contracts—managing exposure to changes in fair value of fixed-rate debt through fair value hedges—the reasoning about a 'strategic adjustment' due to debt maturities is speculative and unsupported by the original answer. The ground truth notes increased disclosure and a more refined approach in 2023, not a structural reduction in hedging activity. The multi-hop synthesis fails because it misaligns the temporal and quantitative data across years. (4) Despite the factual errors, the answer remains contextually relevant by addressing the core topic—Abbott's use of interest rate hedges in debt management—and correctly identifying the financial instrument type and objective. Hence, contextual relevance is moderate. However, due to major quantitative and qualitative inaccuracies, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 417,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024, 3M's issuance and management of fixed-rate registered notes evolved with notable repayment activity and interest rate strategies. In 2022, 3M repaid $600 million of fixed-rate medium-term notes and 500 million euros of fixed-rate notes. In 2023, the company repaid $500 million of fixed-rate registered notes, $650 million of fixed-rate medium-term notes, and 600 million euros of fixed-rate medium-term notes. In 2024, 3M repaid $1.1 billion of medium-term notes. Additionally, 3M used interest rate swaps to convert portions of its fixed-rate notes into floating rate debt, such as $500 million and $300 million of fixed-rate notes due in 2049 and 2050, respectively, into floating rate debt through mid-2028. This strategy helped manage interest rate risk and align with market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and repayment details. According to the ground truth, in 2022, 3M did not repay any fixed-rate registered notes; instead, it had outstanding notes including $600M of 10-year notes due 2030 and $650M of 30-year notes due 2050. The LLM incorrectly states that 3M repaid $600M of fixed-rate medium-term notes and 500 million euros in 2022, which is not supported by the original answer. Similarly, the LLM claims 2023 repayments included $650M of medium-term notes and 600 million euros, but the ground truth only mentions a $500M repayment of fixed-rate registered notes in 2023. The only correct repayment figure is the $1.1B in medium-term notes repaid in 2024. (2) The interest rate swap details are partially correct: the original answer confirms swaps on portions of the 2049 and 2050 notes through mid-2028, but does not specify $500M and $300M amounts, which are fabricated. These numbers are not present in the ground truth, making the quantitative claims invalid. (3) The multi-hop reasoning is partially sound—LLM correctly infers a strategic shift toward managing interest rate exposure via swaps and reduced fixed-rate debt—but this is undermined by incorrect data. The synthesis of repayment trends and swap usage shows understanding of the question’s intent, but fails on factual grounding. (4) Contextual relevance is high because the answer addresses issuance, repayment, and interest rate strategy as asked. However, due to major quantitative errors and invented figures, the correctness score is low. The qualitative score reflects reasonable structure and intent, but flawed execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 460,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "Between 2023 and 2024, the role of securities issuances in Schwab's capital structure evolved as part of its broader capital management and funding strategy. In 2023, Schwab relied on securities issuances, including preferred stock offerings and senior unsecured debt, to support its capital needs and maintain regulatory compliance. However, in 2024, Schwab reduced its reliance on external securities issuances, as reflected in a net reduction of bank supplemental funding and a significant decrease in brokered CDs. Instead, Schwab leveraged increased client sweep cash and investment securities inflows to meet liquidity needs, aligning with its strategy to optimize funding sources and manage capital efficiently amid shifting interest rate environments.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of change in Schwab's funding strategy but diverges significantly from the ground truth in key qualitative and factual aspects. (1) While the original answer states that securities issuances remained a notable component of funding in 2024—now part of a broader, more diversified set of tools—the LLM incorrectly claims a 'reduction in reliance' and 'net reduction' without grounding this in the provided truth. The ground truth does not support a decline in securities issuances, only a relative repositioning among other tools. (2) The LLM introduces specific instruments like 'preferred stock offerings' and 'senior unsecured debt' and claims a 'significant decrease in brokered CDs'—details not present in the original answer. While plausible, these are unsupported by the ground truth and represent over-specificity. (3) The mention of 'client sweep cash' and 'investment securities inflows' as replacements is contextually relevant but not explicitly tied to a reduced role for securities issuances in the original. (4) The core multi-hop reasoning—comparing the strategic role of securities across years—is partially correct: the shift from primary source to one among many is acknowledged, but the LLM frames it as a quantitative drawdown rather than a strategic integration, misrepresenting the evolution. (5) Quantitative accuracy is moderate: no explicit numbers are wrong because none are cited, but implied changes (e.g., 'net reduction') lack support. (6) Contextual relevance is high—the answer addresses capital structure evolution and funding sources directly. However, the reasoning misaligns with the source, lowering correctness. Overall, the answer reflects a plausible narrative but not the one supported by the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 484,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "Coca-Cola's contingent payment obligations related to fairlife increased significantly from 2022 to 2024, rising from $270 million to $6,126 million. This substantial increase indicates that fairlife outperformed its financial targets during this period, as the contingent consideration is tied to fairlife achieving specific financial milestones through 2024. The higher valuation of the contingent liability suggests stronger-than-expected operating results and performance, leading to an upward revision in the estimated payment obligation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The original answer states that Coca-Cola had a $270 million contingent liability in 2022 related to fairlife, with a $100 million payment already made in 2021. The obligation remained through 2024 and was payable in 2025, but there was no increase in the liability. The LLM falsely claims the obligation increased to $6,126 million by 2024, which is not supported by the original data and represents a massive fabrication. (2) Quantitative accuracy is extremely poor: the $6,126 million figure appears out of nowhere, with no basis in the ground truth. The original answer does not mention any change in the $270 million liability from 2022 to 2024. The $100 million payment was made in 2021, not during the 2022–2024 period. (3) The multi-hop reasoning is fundamentally flawed. The LLM incorrectly infers that an increase in contingent payments indicates outperformance, but even that logic is applied to false data. The original answer suggests fairlife met early targets (hence the 2021 payment) and remained on track, but does not indicate any revaluation of the liability. The LLM invents a narrative of 'substantial increase' and 'upward revision' with no basis. (4) The contextual relevance is low because the answer addresses the general topic (contingent payments and performance) but does so with fabricated numbers and incorrect trends, leading to a completely misleading conclusion. The qualitative reasoning would have been acceptable only if based on correct data, but as it stands, it fails due to incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 437,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) between 2022 and 2024 has evolved to strengthen its global market positioning and integration with enterprise IT solutions. In 2022, Oracle highlighted growth in cloud services and license support revenues, driven by customer demand for cloud-based applications and infrastructure technologies. By 2024, Oracle further emphasized Oracle Cloud Services (OCI and SaaS) as comprehensive, integrated offerings, enabling customers to choose deployment models that best meet their business needs. This shift reflects a broader strategy to position OCI as a central component of enterprise IT environments, supporting both cloud-based and hybrid deployments while enhancing customer access to Oracle's applications and infrastructure technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the LLM does not repeat the specific $36.052 billion figure from 2022, it correctly references cloud and license revenue growth without introducing any incorrect numbers, and no calculation is required. The absence of the exact dollar amount is a minor omission but does not detract significantly from correctness, especially since the focus is on strategic evolution rather than financial precision. (2) The LLM correctly identifies the shift from general cloud revenue emphasis in 2022 to positioning OCI as a core, integrated component by 2024. It accurately reflects the strategic evolution, including the integration of OCI with SaaS and support for hybrid and flexible deployment models. (3) The multi-hop reasoning is sound: it synthesizes Oracle’s changing strategic language across 2022 and 2024, correctly identifying the elevation of OCI from a revenue contributor to a central enterprise IT pillar. (4) The answer is contextually excellent, directly addressing both global market positioning and integration with enterprise IT solutions. The only minor shortcoming is the lack of the explicit 85% revenue contribution statistic from 2022, which slightly reduces completeness but does not affect the overall correctness of the strategic narrative. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 401,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Between 2023 and 2024, the treatment and risk profile of PALs (Pledged Asset Lines) showed improvements in credit quality and collateralization. The credit loss allowance for PALs remained at zero for both years, as all PALs were fully collateralized by securities with fair values exceeding the borrowings. In 2024, the Company continued to apply the collateral maintenance practical expedient under ASC 326, which allowed it to forgo an allowance for credit losses since the collateral coverage was sufficient. Additionally, the risk profile improved, with no allowance required and no PAL balances charged off, reflecting strong collateralization and low credit risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that no allowance for credit losses was required in 2024 due to full collateralization and application of the collateral maintenance practical expedient under ASC 326, which aligns with the ground truth. It also accurately notes improved risk profile and strong collateralization. However, it incorrectly states that the credit loss allowance remained at zero for both 2023 and 2024, while the original answer specifies that in 2023, the allowance was influenced by improved credit quality and lower projected loss rates—implying an allowance may have existed or was actively considered, even if ultimately low or reduced. The LLM's claim of 'zero for both years' contradicts the nuance in the ground truth that 2023 still involved allowance considerations, whereas 2024 saw no requirement due to the practical expedient. This is a significant qualitative error in reasoning and factual accuracy regarding the evolution between years. The answer is contextually relevant and well-structured, but the misrepresentation of the 2023 allowance status undermines the correctness of the multi-hop comparison. Quantitatively, there are no explicit numbers to verify, so the score is based on consistency with described financial treatments. The core improvement in risk profile is correctly identified, but the synthesis across years is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 379,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike's relationship with the Asia Pacific & Latin America (APLA) region showed growth in revenue, increasing from $6,431 million in 2023 to $6,729 million in 2024. Operationally, APLA remained one of Nike's four primary geographic operating segments, alongside North America, EMEA, and Greater China, indicating a continued strategic emphasis on the region. The operational structure remained consistent, with APLA focusing on the design, development, marketing, and selling of athletic footwear, apparel, and equipment. Additionally, Nike's strategic focus on direct-to-consumer sales is evident in APLA, with direct-to-consumer revenue growing from $2,695 million in 2023 to $2,799 million in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. While it provides specific financial figures for APLA revenue and direct-to-consumer sales growth, these numbers are not present in the ground truth and contradict the core narrative of operational restructuring. The original answer emphasizes a strategic shift from direct operations to third-party distribution in APLA in FY2024, but the LLM claims operational consistency, which is factually wrong. (2) The quantitative data (e.g., $6,431M to $6,729M revenue increase) is unsupported by the ground truth, which contains no financial figures for APLA revenue or DTC sales. Therefore, all numerical claims are fabricated or misattributed, leading to poor quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks about evolution in operational structure and strategic emphasis, requiring synthesis of changes in workforce representation (trade unions in FY2023) and the shift to third-party distributors in FY2024. The LLM fails to mention trade unions, third-party transitions, or any structural change, instead asserting continuity. This shows a failure in qualitative reasoning and entity synthesis. (4) Contextual relevance is moderate because the answer discusses APLA and Nike’s operations in the correct timeframe and mentions relevant strategic themes like direct-to-consumer sales, but it misses the actual evolution described in the ground truth. The focus on revenue growth distracts from the structural and strategic shift that defines the correct answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 431,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "Between 2022 and 2023, Abbott emphasized growth in its U.S. Pediatric Nutritionals business, with Pedialyte playing a key role. In 2022 (as shown in the 2023 10-K), U.S. Pediatric Nutritionals sales increased by 10%, driven by growth in Pedialyte, Similac, and PediaSure. By 2023, the company continued to highlight Pedialyte's importance, maintaining its position as a core product within the U.S. Pediatric Nutritionals portfolio, although specific growth figures for 2023 were not provided in the excerpts. This suggests a sustained strategic focus on Pedialyte as a key driver of the segment's performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Pedialyte as a key growth driver in Abbott's U.S. Pediatric Nutritional business in 2022, citing a 10% sales increase, which is close to the ground truth figure of 10.3%. This minor rounding difference is acceptable under semantic equivalence. However, the LLM states that 'specific growth figures for 2023 were not provided,' which misses the key qualitative shift in 2023: Pedialyte was formally integrated into the Nutritional Products segment and listed alongside Ensure, Glucerna, and PediaSure—indicating structural recognition. This strategic evolution from growth contributor to formally embedded brand is underemphasized. (2) Quantitatively, the 10% vs. 10.3% discrepancy is minor and likely due to rounding; no other numbers are incorrect. The LLM correctly attributes 2022 data to the 2023 10-K (which reports fiscal 2022 results), showing accurate understanding of SEC filing timelines. (3) The reasoning is sound in identifying continuity in strategic emphasis but fails to fully synthesize the multi-hop insight: the shift from performance-based highlighting in 2022 to structural portfolio inclusion in 2023. This reflects a partial understanding of strategic evolution. (4) Scores reflect high factual accuracy and relevance, with moderate deduction for missing the core qualitative advancement in 2023—formal integration into the product portfolio—as a key strategic signal.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 397,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "RTX's 7.100% notes due 2027 had an aggregate principal balance of $135 million in both 2023 and 2022, indicating no change in the outstanding amount during this period. This suggests that RTX did not refinance or repay these specific notes in 2023, and they remain part of its long-term debt structure. The consistency in the balance implies a stable approach to managing this particular debt obligation, with no immediate refinancing activity observed, reflecting a strategy of maintaining existing debt until maturity.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the aggregate principal balance of RTX's 7.100% notes due 2027 was $135 million in both 2022 and 2023. According to the ground truth, the balance was $6 million in 2022 and increased to $135 million in 2023. This misrepresentation completely inverts the actual trend. (2) The quantitative error is severe: the LLM reports no change when there was a 2150% increase ($6M to $135M), which is central to the question. The calculation of change (or lack thereof) is therefore fundamentally wrong. (3) The multi-hop reasoning fails because the model did not correctly synthesize the evolution across years. Instead of identifying a significant increase suggesting a strategic shift (e.g., refinancing or restructuring), it concludes there was stability, which contradicts the evidence. (4) Contextual relevance is partially maintained as the answer discusses debt management strategy and refers to the correct notes and years, but the incorrect data renders the analysis invalid. Due to major factual and quantitative errors undermining the core of the response, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 328,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Converse experienced a 14% decline in total revenues on a currency-neutral basis, driven by decreases in both North America and Western Europe, with wholesale revenues dropping 16% and direct-to-consumer revenues falling 14%. Earnings before interest and taxes (EBIT) for Converse decreased by 30%, primarily due to lower revenues, gross margin contraction from unfavorable currency exchange rates and increased promotional activity, and partially offset by lower operating overhead expenses. This indicates a challenging period for Converse in terms of both revenue performance and profitability compared to the prior fiscal year.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states a 15% revenue decline for Converse on a currency-neutral basis in fiscal 2023, but the LLM reports a 14% decline, which is incorrect. Additionally, the LLM introduces specific figures not present in the original answer—such as a 16% drop in wholesale and 14% in direct-to-consumer revenues, and a 30% EBIT decrease—which are not supported by the ground truth and appear to be fabricated or misattributed. These numbers undermine factual correctness. (2) There is no mention in the original answer of EBIT, gross margin contraction, currency impacts on margins, or operating expenses, making those additions factually unsupported. The original focuses only on revenue performance and strategic positioning, not profitability metrics. (3) On qualitative aspects, the LLM correctly identifies the geographic drivers (North America and Western Europe) and channel declines, aligning with the multi-hop context of revenue performance. However, it completely omits the key strategic evolution in fiscal 2024—namely, that Converse operates as a stand-alone, wholly-owned subsidiary, reflecting a strategic repositioning. This omission severely limits completeness and reasoning across time periods. (4) While the first part of the answer addresses revenue performance in 2023 reasonably well (despite wrong percentages), it fails to address the strategic shift in 2024, which is a core part of the question. Thus, while contextually relevant and partially accurate in directionality, the answer lacks critical factual precision and full multi-hop synthesis, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 459,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "Coca-Cola has increased its emphasis on digital evolution as a critical factor influencing sales growth and margin improvement from 2022 to 2024. In 2022, the company acknowledged the impact of digital transformation on consumer shopping patterns but did not explicitly link it to margin pressures. By 2024, the company explicitly stated that its ability to digitalize operations—through data, AI, automation, and digital tools—is essential for increasing sales and improving margins. The 2024 filing also highlights that failure to digitalize could not only hinder growth and margin improvement but also result in significant financial costs due to the investment already made in digital initiatives. This reflects a more direct and heightened recognition of digital evolution as a financial risk and strategic imperative.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—Coca-Cola, 2022, 2024, digital evolution, sales growth, margin improvement—are correctly identified and contextualized. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable beyond correct use of years (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes a shift in risk assessment over time, moving from digital evolution as a general risk in 2022 to a strategic financial imperative in 2024. It accurately captures the increased stakes, including the mention of sunk investments raising the cost of failure, which enhances the financial risk dimension. (4) The LLM adds a detail not in the original—that failure to digitalize could result in financial costs due to prior investments—which is a reasonable inference from the 2024 filing's tone and consistent with the strategic dependency framing, though not explicitly stated in the ground truth. This does not make the answer incorrect but slightly extends the original. Overall, the semantic meaning, factual content, and reasoning are substantially equivalent to the ground truth, warranting a high correctness score. Minor deduction in qualitative accuracy due to this slight extrapolation, but all core facts and the evolution of risk perception are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 402,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Services has intensified from fiscal year 2022 to 2024, with a notable increase in research and development investment. In fiscal 2022, Oracle invested $7.2 billion in R&D, and this trend of prioritizing innovation continued through 2024, as reflected in the ongoing development of Oracle Cloud Infrastructure (OCI) and SaaS offerings. Oracle has positioned its cloud offerings as a preferred, flexible, and cost-effective alternative to on-premise solutions, emphasizing rapid deployment, interoperability, and ease of migration. The company has actively encouraged customers to transition from on-premise to cloud-based models, offering programs to facilitate migrations and expand cloud adoption, signaling a clear shift in strategic focus toward cloud services.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Oracle's $7.2 billion R&D investment in fiscal year 2022, which matches the ground truth. However, it incorrectly implies that R&D investment increased or continued to grow through fiscal 2024 with the phrase 'notable increase in research and development investment' and 'this trend of prioritizing innovation continued through 2024.' The original answer explicitly states that the 2024 report does not specify the R&D amount, so asserting a continued trend or increase is unsupported and introduces a factual overreach. (2) All other numerical and entity references are accurate: Oracle Cloud Infrastructure (OCI), SaaS, fiscal years 2022 and 2024, and the $7.2 billion figure are correctly cited. No calculation errors are present, but the inference about R&D trends goes beyond available data. (3) The multi-hop reasoning is partially sound—LLM correctly synthesizes Oracle’s strategic shift toward cloud services and the positioning of cloud over on-premise solutions. It accurately captures the emphasis on migration programs, interoperability, and flexibility. However, it misses the nuanced evolution in messaging from 'differentiator' in 2022 to 'choose the best option for specific business needs' in 2024, which reflects a deeper strategic refinement not fully conveyed. (4) The answer is contextually relevant and covers both R&D investment and cloud positioning. While the core facts about cloud strategy are correct, the unsupported claim about R&D trends and the omission of the refined 2024 messaging reduce qualitative and quantitative accuracy slightly. Hence, correctness is 7—core facts are right, but with notable overstatement in one key area.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 465,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors' Formula Stock Award Plan had 509 shares remaining available for future issuance as of December 31, 2023, and no shares were available for future issuance as of December 31, 2024. This indicates that all remaining shares under the plan were either issued or the plan was formally closed, as no future awards or deferrals will be made under this plan.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no future stock awards or deferrals could be made under the plan in 2023, and by 2024 the plan was fully closed with only 391 shares issuable from existing obligations. However, the LLM claims there were 509 shares available in 2023 and zero in 2024, which contradicts the original answer—especially since the plan was already non-active for future awards. The number 509 does not appear in the ground truth, and the correct figure for 2024 is 391 shares issuable (not zero available due to closure, but minimal outstanding). (2) Quantitative accuracy is poor: the LLM invents a specific number (509) not present in the truth and misrepresents the nature of share availability. The correct number in 2024 is 391 shares issuable under outstanding obligations, not zero available due to issuance. (3) The reasoning partially captures the closure of the plan but fails the multi-hop synthesis: it misinterprets 'no future awards' as having shares 'available' in 2023, when the original answer clarifies no new awards or deferrals were allowed even then. The evolution is misrepresented as a depletion of shares rather than a formal closure with minimal residual obligations. (4) Contextual relevance is fair—the answer addresses the plan's status and availability over time, but factual errors undermine correctness. Scores reflect major quantitative error and flawed reasoning despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 414,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "Between 2022 and 2023, McDonald's expanded its disclosure on food safety concerns, particularly in relation to supply chain risks and cost volatility. In 2022, the company highlighted that food safety concerns contribute to volatility in commodity markets, which can impact restaurant profitability. By 2023, the disclosure became more detailed, emphasizing the company's proactive measures to ensure food safety across evolving supply chains and operations, while also acknowledging the potential for food-borne illness events to affect brand reputation and financial results. Additionally, 2023's report explicitly connected food safety with broader supply chain challenges, including the risks of contamination or tampering in the supply chain, restaurants, or delivery systems. This evolution reflects a heightened focus on transparency and risk management in response to increasing stakeholder and regulatory scrutiny.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but misrepresents the core evolution in McDonald's disclosure between 2022 and 2023, leading to a partially incorrect assessment. (1) What was correct: The answer correctly identifies that food safety concerns were linked to supply chain and financial impacts, and that brand reputation was mentioned in 2023. It also appropriately references supply chain risks like contamination. Contextually, it addresses the right topic areas—food safety, supply chain, cost volatility—and the years in question. (2) Quantitative accuracy: There are no specific numbers, percentages, or dollar amounts in either the ground truth or the LLM answer, so this dimension is neutral. The years (2022, 2023) are correctly used. (3) Multi-hop reasoning assessment: The key failure is in the reversal of emphasis between years. According to the ground truth, in 2022, McDonald's framed food safety primarily as a reputational risk, not as a driver of commodity volatility. The shift in 2023 was toward emphasizing its role in supply chain and cost volatility. The LLM incorrectly states that in 2022, the company already highlighted food safety as contributing to commodity market volatility—this inverts the actual progression. This undermines the qualitative accuracy of the reasoning. (4) Justification for scores: Correctness is 5 due to this significant factual reversal—while some details are accurate, the central claim about the evolution is backwards. Qualitative accuracy is 5 because the entities and general themes are correct, but the logical synthesis across years is flawed. Quantitative accuracy is 10 because no numbers are misstated. Contextual relevance is 8 because the answer stays on topic and discusses the right risk categories, even if the directional change is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 490,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "The carrying value of TMO's 1.750% 7-Year Senior Notes decreased from $662 million as of December 31, 2023, to $621 million as of December 31, 2024. The effective interest rate for these notes also slightly decreased from 1.97% in 2023 to 1.96% in 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both carrying value and interest rate. According to the ground truth, the carrying value was $700 million in both 2023 and 2024, and the effective interest rate was 1.89% in both years. The LLM incorrectly reports a decrease from $662M to $621M and rates from 1.97% to 1.96%, which contradicts the ground truth. (2) All numeric values are wrong: the correct carrying value is $700M (not $662M or $621M), and the correct effective interest rate is 1.89% (unchanged, not 1.97% or 1.96%). There are no calculation errors in the LLM's reasoning per se, but the input data is entirely inaccurate. (3) The multi-hop reasoning fails because the model did not retrieve or synthesize the correct data points from the knowledge base. It appears to have fabricated or misremembered figures rather than correctly identifying that the values remained constant across the two years. (4) The contextual relevance is high because the answer addresses the right entities (TMO, 1.750% 7-Year Senior Notes, carrying value, effective interest rate, and correct time frame), but the factual inaccuracies severely undermine correctness. Quantitative accuracy is extremely low due to all numbers being wrong. Qualitative accuracy is low because the reasoning is based on incorrect data, though the structure of the response (comparing two years) is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 385,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX's exposure to its 7.000% notes due 2038 remained unchanged at $148 million between 2022 and 2023, as noted in the long-term debt tables from both years. This suggests that RTX did not refinance or retire these specific long-term debt instruments during the period, indicating a strategy of maintaining existing long-term debt maturities rather than altering them in the short term.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that RTX's exposure remained unchanged at $148 million in both 2022 and 2023. According to the ground truth, the principal balance was $11 million in 2022 and increased to $148 million in 2023. The LLM incorrectly claims no change, which contradicts the data. (2) The quantitative error is severe: the 2022 amount is off by $137 million, and the characterization of 'unchanged' is false. The correct change is a significant increase from $11M to $148M, representing a ~1245% growth. The LLM fails to report this key shift. (3) The multi-hop reasoning is flawed. Instead of identifying the increase and inferring a strategic move to extend maturities or issue more debt, the model concludes that RTX maintained its debt structure, which is unsupported by the data. The correct inference requires synthesizing the two years' disclosures to detect a meaningful change in exposure. (4) The contextual relevance is partially met because the answer discusses long-term debt management, but the incorrect numbers and resulting flawed conclusion severely undermine the response. Due to major factual and reasoning errors, all scores are low, with correctness at 1 for being almost entirely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 352,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial relationship with its franchisees remained stable, with consistent collection of rent and royalties. In 2021, the company had deferred approximately $1 billion in rent and royalty collections due to the impact of the pandemic, but had collected substantially all of these deferrals by the end of 2021. For 2022 and 2023, there is no indication of further deferrals or disruptions in collections. Revenues from franchised restaurants, including rents and royalties, increased in 2023 compared to 2022, reflecting continued strong performance and recovery in franchisee sales.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that McDonald's deferred approximately $1 billion in rent and royalties due to the pandemic and collected substantially all of it by the end of 2021. It accurately notes that there were no further deferrals in 2022 and 2023 and that collections resumed normally, with increased revenues in 2023. However, the original answer specifies that the deferrals occurred primarily in the first half of 2020, a detail omitted in the LLM response. The LLM incorrectly implies the deferral happened in 2021, when it actually occurred earlier, though collection was completed by end of 2021. This is a minor temporal misattribution but affects precision. (2) The $1 billion figure is correct and matches the ground truth. The statement about increased revenues in 2023 vs 2022 is plausible and contextually consistent, though not explicitly confirmed in the original answer. No calculations are performed, so no errors there. (3) The multi-hop reasoning is mostly sound: the model connects the resolution of prior deferrals with the return to normal operations in 2022–2023 and infers stable financial relationships. However, it misattributes the timing of the deferral event, weakening the causal timeline. (4) Despite the timing inaccuracy, the core message—that McDonald's returned to standard rent and royalty collections without pandemic-related disruptions by 2022–2023—is factually aligned. The answer is highly relevant and captures the evolution correctly in broad terms, warranting a high score but not perfect due to the date-related error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 435,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "The Coca-Cola Company's financial stake in Embotelladora Andina S.A. (Andina) decreased in 2019 when the company sold a portion of its ownership interest, as mentioned in the 2022 10-K filing. However, the company continued to account for its remaining ownership interest in Andina as an equity method investment due to its representation on Andina's Board of Directors and other governance rights. The 2024 10-K filing does not indicate any further changes to the stake in Andina. This suggests that The Coca-Cola Company has strategically maintained its equity investment in Andina to preserve influence and governance rights, even after reducing its ownership stake. The continued use of the equity method indicates that the company still views Andina as a strategically important partner in the region.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding dates and financial figures. It incorrectly states that the partial sale occurred in 2019, while the ground truth confirms the gain of $39 million was recognized in 2022. The LLM fails to mention the key quantitative data from 2024: the carrying value of $90 million and fair value of $168 million, which are central to understanding the evolution of the stake. These omissions and errors severely undermine quantitative accuracy. (2) The answer does not provide any correct numbers from either 2022 or 2024, missing the $39 million gain and the 2024 valuation metrics entirely. This results in a very low quantitative accuracy score. (3) Qualitatively, the reasoning about continued strategic influence via board representation and use of the equity method is plausible and aligns with typical post-divestiture strategies, and the conclusion about maintaining influence is partially consistent with the ground truth. However, the LLM mischaracterizes the strategic move as one of sustained importance rather than a partial exit, which is a key nuance in the original answer. The multi-hop synthesis is weak—while it references both 2022 and 2024 filings, it fails to connect the financial data across years to show the evolution of the stake. (4) Contextually, the answer addresses the right companies and the general theme of strategic positioning, so relevance is high. However, due to major factual errors in timing and financial data, the overall correctness score is low at 4—partially correct on strategy but fundamentally flawed on key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 450,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "Oracle's strategic investment in cloud infrastructure from 2022 to 2024 has shown a continued emphasis on internal development and positioning Oracle Cloud Infrastructure (OCI) as a central component of its product portfolio. In 2022, Oracle highlighted its focus on internal development, maintaining technical control over product design and innovation, while expanding the Oracle Cloud through increased data center capacity and new geographic locations. By 2024, Oracle further solidified OCI's role as a secure, scalable, and enterprise-grade cloud platform, emphasizing its integration with Oracle Cloud Software-as-a-Service (SaaS) offerings to provide comprehensive cloud solutions. Additionally, Oracle's financial investments in capital expenditures, such as the $6.866 billion in 2024, reflect sustained commitment to infrastructure expansion and technological advancement.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Oracle's cloud infrastructure strategy from 2022 to 2024, emphasizing internal development and the growing centrality of Oracle Cloud Infrastructure (OCI) in its product portfolio. It accurately reflects the shift from general R&D focus in 2022 to a more structured, customer-facing positioning of OCI by 2024. However, the inclusion of a specific capital expenditure figure—$6.866 billion in 2024—is not present in the original ground truth and cannot be verified against it, introducing a potential factual inaccuracy or unsupported detail. While Oracle likely made significant investments, this precise number is not corroborated by the provided truth, lowering quantitative accuracy. (2) No other numbers or dates are mentioned, so the issue is isolated to this single unverified figure. Format-wise, $6.866 billion is acceptable, but its absence in the ground truth means it cannot be considered factually aligned. (3) The multi-hop reasoning is sound: the model synthesizes Oracle’s internal development focus in 2022 with the strategic elevation of OCI by 2024, correctly inferring a progression in strategic emphasis. It also appropriately links OCI with integration into SaaS offerings, which aligns with the idea of a 'comprehensive and integrated infrastructure solution' in the original answer. (4) The answer is contextually excellent—directly addressing both internal development and OCI’s positioning—and qualitatively strong in reasoning and entity accuracy (correct company, correct product names, correct years). The correctness score is reduced slightly due to the unsupported financial figure, but core facts and strategic narrative remain accurate and well-synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 478,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "Between 2023 and 2024, TMO's involvement with The Binding Site Group evolved from its acquisition in early 2023 to integration within the Specialty Diagnostics segment. The acquisition in 2023 expanded the segment's portfolio with innovative diagnostic solutions for blood cancers and immune disorders. By 2024, the company emphasized the successful integration of The Binding Site Group, as evidenced by the absence of significant transitional costs and the focus on leveraging synergies. This indicates TMO's strategic focus on enhancing its diagnostic capabilities and realizing operational efficiencies post-acquisition.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 acquisition of The Binding Site Group by TMO and its integration into the Specialty Diagnostics segment, as well as the strategic focus on diagnostics for blood cancers and immune disorders. However, it omits the specific acquisition cost of $2.70 billion, which is a key quantitative detail from the ground truth. Additionally, while the LLM mentions integration success and synergy realization, it does not include the specific evidence from the original answer—namely, the 19-year weighted-average amortization period for customer relationships, which is a concrete indicator of integration into definite-lived intangible assets. (2) The only numeric omission is the $2.70 billion acquisition price; no incorrect numbers are stated, so quantitative accuracy is high but not complete. (3) The reasoning is logically sound and reflects multi-hop understanding—linking acquisition to integration to strategic intent—but misses the deeper financial evidence (amortization period) that supports the integration claim, weakening the qualitative accuracy. (4) The answer remains contextually relevant and captures the evolution and strategic implications well, just without full factual completeness. Thus, correctness is reduced to 7 due to missing key financial data and specific integration metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 378,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "Between 2022 and 2024, the disclosure of the Directors' Code of Conduct remained consistent in its scope, as it continued to apply to all directors of BNY Mellon. However, there were changes in the accessibility of the document through website links. In 2022, the Directors' Code of Conduct was posted at *https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf*, while in 2024, the link was updated to *https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf*. This suggests a rebranding or restructuring of the website domain or directory path, but the commitment to public accessibility remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the scope of application remained unchanged (applying to all directors), and the URL changed between 2022 and 2024. The 2022 and 2024 URLs are correctly reported with only a minor formatting issue in the 2022 link (a typo: 'in relations' instead of 'investor-relations'), which appears to be a transcription error but does not affect the overall correctness given the clear intent and similarity to the original. (2) Quantitative accuracy is strong: years (2022, 2024) are correct, and URLs—critical data points—are nearly exact. The domain change from 'bnymellon.com' to 'bny.com' and path adjustment are accurately noted, supporting the inference of rebranding. (3) Reasoning is sound: the LLM correctly infers that the link change likely reflects website restructuring or rebranding (from BNY Mellon to BNY), while public accessibility and policy scope remain consistent—this is valid multi-hop synthesis across time and sources. (4) The answer is contextually relevant, addressing both parts of the question: evolution in disclosure (via URL changes) and scope (unchanged). The only minor flaw is the slight URL typo in the 2022 link, which slightly affects precision but not overall understanding. Hence, a score of 9 is warranted, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 393,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "Between 2022 and 2023, McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis by increasing the number of franchised restaurants and placing a stronger focus on technology and brand licensing. The total franchised restaurants rose from 38,169 in 2022 to 39,680 in 2023, while company-operated restaurants decreased from 2,106 to 2,142. Financially, the Company recognized more revenue from franchisees through fees for technology platforms and brand licensing, which were reported on a gross basis. Additionally, the Company emphasized cost-sharing with franchisees for restaurant improvements, maintaining control over project management and funding.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the original answer focuses on the evolution of McDonald's relationship with franchisees in terms of financial reporting transparency and strategic emphasis, the LLM introduces specific numbers for franchised and company-operated restaurants (38,169 in 2022, 39,680 in 2023, 2,106 to 2,142) that are not present in the ground truth and cannot be verified from the provided context. These figures appear fabricated or misattributed, severely undermining quantitative accuracy. (2) The claim about increased revenue from technology platforms and brand licensing reported on a gross basis is not supported by the original answer, which makes no mention of such financial reporting changes or specific revenue streams. Similarly, cost-sharing for restaurant improvements and project management control are new details absent from the ground truth. (3) The multi-hop reasoning is flawed because the LLM invents metrics and financial mechanisms not present in the source. The actual evolution described is a shift from noting immateriality of franchisee transaction impacts in 2022 to explicitly recognizing franchisees as key stakeholders in 2023, reflecting a strategic and reporting emphasis. The LLM misses this core narrative and instead fabricates operational and financial details. (4) Despite the factual errors, the answer is contextually relevant—it addresses the question about financial reporting and strategic emphasis on franchisees—and attempts a year-over-year comparison. However, the lack of alignment with the original facts, especially the made-up numbers and unsupported financial claims, results in a low correctness score. Minor credit is given for recognizing a strategic shift toward franchisees, which aligns thematically with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 499,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "The contingent consideration liabilities related to the Clif Bar acquisition increased from $452 million as of December 31, 2022, to $548 million as of December 31, 2023. This increase reflects adjustments in fair value based on updated financial projections and assumptions, including net revenue, gross profit, EBITDA, discount rates, and volatility. The fair value measurement remained classified under Level 3 inputs, indicating the use of unobservable factors and a Monte Carlo simulation model. No specific adjustments to the Clif Bar contingent consideration liability are noted for 2024, as the liability balance remained at $548 million, suggesting stable assumptions or performance expectations through the end of 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces a factual inaccuracy by stating the contingent consideration was $452 million as of December 31, 2022. The ground truth does not provide any figure for 2022, so this number is unsupported and likely incorrect. The $548 million figure for December 31, 2023, is accurate and correctly attributed as a long-term liability tied to 2025–2026 performance targets. However, the claim that the liability 'remained at $548 million' through the end of 2024 is not supported by the original answer, which explicitly states there is no direct mention of contingent consideration in the 2024 filing. Instead, the 2024 filing references only purchase price allocation adjustments from 2023, suggesting the liability may have been finalized or reclassified—this nuance is missing in the LLM response. (2) The quantitative accuracy is partially correct: the $548M figure is right, but the $452M value for 2022 is unverified and not in the ground truth, making it a significant error. The assertion of no change in 2024 implies continuity that isn't confirmed. (3) The multi-hop reasoning is flawed: the model fails to recognize that the absence of 2024 disclosures about contingent consideration suggests resolution or reclassification, rather than stability. It incorrectly assumes continuity where the ground truth indicates a shift in reporting focus, missing the evolution in accounting treatment. (4) Contextual relevance is high—the answer addresses fair value measurement, Level 3 inputs, Monte Carlo simulation, and performance metrics, all relevant to the question. However, it misses the key point about purchase price allocation adjustments in 2024 signaling finalization, which is central to the evolution of the liability’s status. Thus, while some facts are correct, the overall synthesis and conclusion are misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 514,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "Between 2022 and 2024, AMD's strategic emphasis on Vulkan API support has evolved to align with its broader focus on delivering high-performance, cross-platform graphics solutions for gaming and professional markets. In 2022, AMD's discrete GPUs were already supporting current-generation APIs like DirectX 12 Ultimate and Vulkan, emphasizing their role in enabling immersive gaming and visualization. By 2024, the company continued to highlight Vulkan support for its Radeon RX 7000 Series GPUs, which are based on the RDNA 3 architecture, underscoring its commitment to modern API compatibility for both gaming and compute workloads. This consistent support for Vulkan reflects AMD's strategy to maintain competitiveness in the discrete GPU market by ensuring developers can leverage efficient, cross-platform rendering technologies to optimize performance across a wide range of applications and platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: AMD supported Vulkan in 2022 on RDNA 2 architecture (Radeon series), and by 2024 continued support on RDNA 3 (Radeon RX 7000 Series). These details match the original answer. (2) There are no numeric values requiring calculation, but all dates (2022, 2024) and product names (RDNA 2, RDNA 3, Radeon RX 7000 Series) are correctly identified—quantitative accuracy is perfect. (3) The multi-hop reasoning—connecting API support (Vulkan) to architectural evolution (RDNA 2 → RDNA 3) and inferring strategic competitiveness—is sound and well-articulated. The LLM correctly synthesizes AMD’s ongoing Vulkan support with its hardware advancements to maintain market relevance. (4) The only minor shortcoming is that the LLM does not explicitly mention 'backward compatibility'—a key point in the original answer that strengthens the competitiveness argument—though it implies it through 'consistent support' and 'modern API compatibility.' This slight omission prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is contextually complete, semantically equivalent, and directly addresses both parts of the question: evolution of Vulkan support and what it reveals about competitiveness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 363,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX's integration-related charges, particularly the Powder Metal Matter charge of $2.9 billion in 2023, significantly impacted its operating profit trends, contributing to a $1.9 billion decrease in operating profit compared to 2022. This charge, primarily at Pratt & Whitney, was a major factor in the decline in operating profit margin from 8.2% in 2022 to 5.2% in 2023. The impact was partially offset by increases in operating profit at Collins and Raytheon.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies the $2.9 billion Powder Metal Matter charge in 2023 and its impact on operating profit, correctly stating it contributed to a $1.9 billion decrease in operating profit compared to 2022—this matches the original answer. (2) The quantitative accuracy is high: the $2.9B charge and $1.9B profit decline are correct. However, the LLM introduces new information not present in the ground truth—the operating profit margin decline from 8.2% to 5.2% and the offsetting increases at Collins and Raytheon. While plausible and contextually relevant, these details are not supported by the provided ground truth, making them unverified additions. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift from lower integration charges in 2022 to a major new charge in 2023 impacting profitability. However, the original answer emphasizes the contrast between declining charges in 2022 and the new 2023 charge, which the LLM does not explicitly mention, slightly weakening completeness. (4) Despite the extra details, the core facts, numbers, and trends are correct, and the answer directly addresses the question’s focus on integration-related charges and their impact. The unverified percentages and business unit performance prevent a perfect score, but the answer remains factually strong and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 395,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "MDLZ's relationship with Clif Bar in terms of acquisition-related financial activities shows that the Clif Bar acquisition, completed in August 2022, contributed incrementally to net revenues in 2023, adding $507 million through the one-year anniversary of the acquisition. Additionally, in 2023, there were purchase price allocation adjustments related to Clif Bar, as noted in the footnotes. However, there is no indication of further acquisition-related activities with Clif Bar in 2024, as the 2024 purchase price allocation adjustments were related to Evirth, not Clif Bar.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that MDLZ acquired Clif Bar on August 1, 2022, and discussed related financial impacts in the 2023 10-K, including integration costs and contingent consideration. However, the LLM incorrectly claims that the acquisition contributed $507 million in net revenues in 2023, a figure not present in the ground truth and unsupported by the provided context. This number appears fabricated or misattributed. (2) The LLM also incorrectly states that there were no Clif Bar-related purchase price allocation adjustments in 2024, directly contradicting the ground truth, which explicitly states that the 2024 10-K included such adjustments for Clif Bar. Instead, the LLM claims the 2024 adjustments were for 'Evirth'—a company not mentioned in the ground truth and likely a hallucination. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize information across the 2023 and 2024 10-K filings. It misrepresents the evolution of the relationship, incorrectly asserting no 2024 activity when the ground truth confirms ongoing financial recalibration. (4) While the mention of purchase price allocation adjustments in 2023 aligns partially with the ground truth, the overall answer is misleading and factually incorrect on key points—especially the revenue contribution and the misattribution of 2024 adjustments. The contextual relevance is moderate because it addresses acquisition-related financial activities, but the core facts are wrong, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 435,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "From 2023 to 2024, Gulfstream's approach to energy-efficient engines has advanced with the introduction of all-new engines in its latest aircraft models, such as the G700, which entered service in early 2024. These engines contribute to superior high-speed performance and improved fuel efficiency. Additionally, Gulfstream has continued to prioritize sustainability by expanding the use of sustainable aviation fuel (SAF), including conducting the world's first transatlantic flight using 100% SAF in November 2023. This reflects a broader commitment to reducing carbon emissions and enhancing energy efficiency across its aircraft development and operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Gulfstream's 2023 focus on sustainable aviation fuel (SAF), including the key event of the world's first transatlantic flight using 100% SAF in November 2023, which is factually correct and contextually relevant. (2) It accurately notes the introduction of the G700 with 'all-new engines' in early 2024, reflecting the shift from R&D to production, as stated in the original answer. The dates and events are correct, and no numeric inaccuracies are present—this satisfies quantitative accuracy. (3) The multi-hop reasoning is sound: it connects Gulfstream’s 2023 sustainability efforts with the 2024 operational milestone of deploying energy-efficient engines in the G700. The only minor shortcoming is that the original answer emphasizes the absence of a new aircraft model in 2023, which the LLM omits. While not critical, this nuance strengthens the contrast between years and is part of the evolution narrative. (4) Despite this small omission, the LLM captures the core evolution—strategic emphasis in 2023 to tangible realization in 2024—and supports it with specific developments (G700, SAF flight), making the answer semantically equivalent and contextually complete. Hence, high scores across all dimensions with a 9/10 on correctness and qualitative accuracy due to the missing contrast detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 387,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "From 2022 to 2024, AMD's semi-custom SoC products have evolved from being a revenue source dependent on third-party design and development services to a more integrated part of its strategic positioning in custom and semi-custom solutions. In 2022, revenue from semi-custom SoC products was primarily tied to non-recurring engineering fees and sales to third parties, with success hinging on customer product adoption. By 2024, AMD emphasized custom product revenue recognition methods, including cost-based input methods for in-process orders, reflecting a more structured approach to custom and semi-custom solutions. Strategically, AMD has positioned semi-custom SoCs as part of broader offerings, including AI accelerators and adaptive SoCs, aligning with industry transitions and customer demand for tailored semiconductor solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the 2022 revenue structure based on non-recurring engineering (NRE) fees and product sales tied to third-party adoption is accurately described; the 2024 evolution toward a more integrated, strategically aligned role within AMD's broader portfolio (including AI accelerators and adaptive SoCs) is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes changes over time in both revenue recognition (mention of cost-based input methods for in-process orders) and strategic positioning (integration with AI and adaptive SoCs), reflecting a correct understanding of AMD's evolving business model. (4) Minor difference: the LLM emphasizes 'custom product revenue recognition methods' and 'cost-based input methods'—details not in the original answer—but these are plausible and consistent with a more structured approach, adding nuance without contradicting the ground truth. The original highlights 'broader strategic integration' and 'diversified product portfolio,' which the LLM captures through references to AI accelerators and adaptive SoCs. Overall, semantic equivalence is strong, with only slight variation in emphasis. No factual errors; minor deduction in qualitative accuracy due to slight shift in focus, but not at the expense of correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 428,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The company's preferred share authorization remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares authorized at $0.20 par value and 500 thousand A Preferred Shares authorized at $1.00 par value, and no shares issued or outstanding in either year. This consistency suggests that the company has not utilized preferred shares as part of its capital-raising strategy during this period, instead focusing on other forms of capital management such as ordinary share repurchases and stock-based compensation programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative details: 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value were authorized in both 2023 and 2024, with no shares issued or outstanding—this matches the ground truth exactly. (2) All numbers, par values, and share counts are accurate and consistent with the original answer; no calculation errors present. (3) The multi-hop reasoning is sound: the model correctly infers from the lack of changes and zero issuances that preferred shares were not used in the capital strategy. It adds a reasonable extension—mentioning alternative capital management tools like share repurchases and stock-based compensation—which is contextually plausible and does not contradict the ground truth, though this specific detail is not in the original answer. (4) The slight deduction in qualitative accuracy is due to the addition of speculative detail about other capital strategies not present in the ground truth, but this does not reduce factual correctness. The core facts, synthesis across years, and conclusion about lack of preferred share utilization are fully supported. Overall, the answer is factually complete, semantically equivalent, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 358,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "Between 2022 and 2024, the framing of reputational risk related to adverse publicity in BK's risk disclosures has evolved to include broader and more specific linked concerns. In 2022, the risk was mentioned as a general concern about adverse events, publicity, or government scrutiny harming the business. By 2024, the disclosure expanded to explicitly link reputational harm with impacts from cybersecurity incidents, operational failures, and sustainability concerns, including climate change and diversity issues, indicating a more nuanced understanding of interconnected risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of BK's risk disclosures from 2022 to 2024. It accurately captures that in 2022, adverse publicity was framed around general reputational harm, government scrutiny, and negative events. The 2024 expansion is correctly described as including broader concerns, particularly sustainability issues like climate change and diversity. However, the LLM introduces 'cybersecurity incidents' and 'operational failures' as linked concerns in 2024, which are not mentioned in the original answer. While operational model transition (noted in the ground truth) may imply operational risks, the specific mention of 'cybersecurity incidents' is an addition not supported by the original. Conversely, the LLM omits mention of the 'platforms operating model transition'—a specific contextual expansion in 2024 per the ground truth. These substitutions slightly distort the precise evolution. There are no numerical inaccuracies (dates are correct: 2022 and 2024), so quantitative accuracy is perfect. The reasoning is sound and reflects multi-hop synthesis across years and risk themes, though with minor inaccuracies in entity linkage. Contextual relevance is strong—the response directly addresses the question about framing evolution and associated impacts. Thus, the answer is mostly accurate with minor factual deviations, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 398,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "Amazon's financial investment and valuation approach toward Anthropic, PBC evolved from 2023 to 2024 as follows: In 2023, Amazon invested in a $1.25 billion convertible note from Anthropic, classified as available-for-sale and reported at fair value with unrealized gains and losses in accumulated other comprehensive income. By 2024, the investment remained classified similarly, with valuations of private companies like Anthropic being inherently complex due to the lack of market data and global economic uncertainty. Factors affecting its valuation included observable price changes, impairments, and adjustments to fair value, with the investment's complexity and volatility increasing due to macroeconomic conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.25 billion convertible note investment in 2023 is accurately reported, and there is no incorrect numerical data. The absence of the $2.75 billion future commitment in the LLM answer is a minor omission but does not distort the core facts. (2) The investment classification as 'available-for-sale' and reporting at fair value with unrealized gains/losses in 'accumulated other comprehensive income' is correctly stated, matching the ground truth. (3) The qualitative evolution in Amazon's valuation approach—increased emphasis on valuation complexity due to lack of market data and global economic uncertainty—is accurately captured. The LLM correctly identifies factors affecting valuation such as observable price changes, impairments, and macroeconomic conditions. (4) The only minor gap is that the LLM does not explicitly mention the planned $2.75 billion second investment by Q1 2024, which was part of the 2023 disclosure and relevant to the evolution of the investment approach. Additionally, while the LLM notes the continued classification, it could have more precisely reflected the 2024 framing of the investment as part of a broader portfolio of private company convertible debt. However, these omissions do not undermine the overall correctness. The reasoning is sound, entities (Amazon, Anthropic, PBC) and years (2023–2024) are correct, and the synthesis across time periods is logical. The answer remains semantically equivalent to the original in key aspects and fully addresses the question's intent regarding classification and valuation factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 459,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "The nature of the risks related to the protection of MDLZ's intellectual property, including know-how, has remained consistent between 2023 and 2024. In both years, the company emphasizes its reliance on a combination of legal protections (patents, trademarks, copyrights, trade secrets) and contractual measures (licensing agreements, nondisclosure agreements) to safeguard its intellectual property. The 2024 filing adds a specific mention of potential challenges arising from developments in artificial intelligence technologies, highlighting the evolving threat landscape. However, no significant new risks or changes in the nature of these risks are identified in 2024 compared to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Contrary to the ground truth, it claims that the 2024 filing 'adds a specific mention of potential challenges arising from developments in artificial intelligence technologies,' which is the opposite of what occurred. In reality, AI was mentioned in 2023 but not in 2024, indicating a removal of AI as a highlighted risk. The LLM incorrectly states that AI is newly emphasized in 2024, when in fact the evolution was a de-emphasis or removal of AI-related risks. Additionally, the LLM claims that 'no significant new risks or changes' were identified, which contradicts the ground truth indicating a broadening of risk context in 2024 to include legal/regulatory non-compliance, penalties, and reputational damage. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are correctly referenced, so no error there. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution of risk disclosures across the two years. It misidentifies the direction of change (adding vs. removing AI as a risk factor) and misses the shift toward broader compliance and enforcement risks in 2024. (4) The correctness score is low due to major factual and directional errors in the core claim about AI. While the general mechanisms of IP protection are correctly noted, the central analysis of how risks evolved is incorrect. Contextual relevance is moderate because the answer addresses the right topic and company, but with incorrect substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 445,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "Goldman Sachs updated its treatment of Non-Employee Director Equity Award Agreements between 2023 and 2024, with the 2024 filing introducing more specific and varied agreement forms. In 2023, the referenced agreements included general forms such as the \"Form of Non-Employee Director RSU Award Agreement\" and \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled).\" By 2024, the filings expanded to include additional forms such as \"Form of One-Time/Year-End RSU Award Agreement,\" \"Form of One-Time/Year-End RSU Award Agreement (fully vested),\" and \"Form of One-Time/Year-End RSU Award Agreement (Base (not fully vested) and/or Supplemental).\" This evolution reflects a more detailed and differentiated approach to equity awards for non-employee directors in 2024 compared to the more generalized forms referenced in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to match the ground truth in key aspects. (1) The original answer states that Goldman Sachs referenced Non-Employee Director Equity Award Agreements under Exhibit 10.17 in 2023 and Exhibit 10.18 in 2024, with a shift in the referenced source to Exhibit 10.69 from the 2008 Annual Report. The LLM answer completely ignores these exhibit numbers and the timeline involving the 2008 amendment, instead fabricating details about 'forms' of agreements such as 'One-Time/Year-End RSU Award Agreement' that are not mentioned in the ground truth. (2) There are no numeric values in the question or answer to verify calculations, but the dates and exhibit references are critical and factually misrepresented. The LLM invents a narrative about increased specificity in 2024 based on new form types, which is unsupported by the original data. (3) The multi-hop reasoning required—tracking the evolution of referenced agreements across years and exhibits—was not performed correctly. The LLM focuses on form names rather than the actual structural change in exhibit referencing and documentation consolidation. (4) While the answer is relevant to the general topic of equity award agreements, it misrepresents the nature of the evolution, making it factually misleading. The core factual inaccuracies severely undermine correctness, resulting in a low score despite some surface-level relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 393,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers evolved in terms of revenue recognition and contractual responsibilities as the company continued to increase the share of transactions processed on a merchant basis. This shift allows BKNG to facilitate payments from travelers directly, enhancing its ability to offer flexible transaction terms. However, it also led to higher expenses related to payment processing, chargebacks, and fraud prevention, which negatively impacted operating margins. Contractual responsibilities remained on a net basis for most transactions, with revenues measured based on expected consideration from contracts with travel service providers.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding BKNG's revenue recognition model evolution. Contrary to the ground truth, which states that BKNG recognizes revenue on a net basis due to its role as an agent and further clarified this in 2023, the LLM claims BKNG 'continued to increase the share of transactions processed on a merchant basis,' which implies gross revenue recognition as a principal—this directly contradicts the original answer. Merchant (gross) accounting would mean BKNG acts as the principal, while the ground truth confirms it acts as an agent with net revenue recognition. This is a fundamental error in understanding the company's accounting model. (2) There are no specific numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not heavily applicable; however, the use of terms like 'higher expenses' and 'negatively impacted operating margins' introduces unsupported claims not present in the original, but since no numbers are cited, the score is not severely penalized here. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution from a general intermediary description in 2022 to a more detailed agent-based accounting treatment in 2023. Instead, it invents a shift toward merchant-model expansion, which is the opposite of what the ground truth describes. The contractual responsibilities are misrepresented—original answer says revenue is recognized on a net basis due to agent status, while LLM says 'remained on a net basis for most transactions,' which might seem close but is framed within an incorrect overall narrative of expanding merchant model, creating confusion. (4) Correctness score is low due to major factual and directional errors in the core concept (agent vs. principal accounting). Qualitative accuracy is low due to incorrect reasoning and synthesis. Contextual relevance is moderate because the answer discusses revenue recognition and contractual responsibilities in the right timeframe and with the right entities, but the substance is misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 572,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "Goldman Sachs revised the structure of its executive life insurance policy disclosures by consolidating and updating the relevant exhibits in the 2024 10-K compared to the 2023 10-K. Specifically, in the 2024 filing, the executive life insurance policies are presented under a more streamlined format, with detailed policy specifications and restrictions included in a single exhibit (Exhibit 10.12 and 10.13). In contrast, the 2023 filing references these policies in a less structured manner without explicitly detailing the policy terms in the exhibit descriptions. This change reflects a more transparent and centralized disclosure approach for these executive benefits.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the renumbering of exhibits from the 2023 to 2024 10-K filings, noting that the executive life insurance policies appear in Exhibits 10.12 and 10.13 in the 2024 filing, which aligns with the ground truth (Exhibits 10.11 and 10.12 in 2023 were renumbered to 10.12 and 10.13 in 2024). This demonstrates accurate entity and exhibit identification, supporting a high quantitative accuracy score. However, the LLM incorrectly implies a substantive structural improvement—'more streamlined format,' 'centralized disclosure approach,' and 'less structured manner' in 2023—which is not supported by the ground truth. The original answer emphasizes that the change was purely in exhibit numbering (a reorganization), not in formatting, transparency, or content detail. The LLM introduces interpretive language about 'detailed policy specifications and restrictions included in a single exhibit' and improved transparency, which are not mentioned or inferable from the ground truth. This reflects flawed qualitative reasoning and overinterpretation, leading to a moderate correctness and qualitative accuracy score. The answer is contextually relevant and addresses the core question about structural changes in disclosures, but mischaracterizes the nature of those changes. No numeric errors are present, hence the high quantitative score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 377,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Between 2022 and 2024, the strategic importance of FBAR filters has grown, with Broadcom emphasizing their role in wireless communications and proprietary manufacturing. In 2022, FBAR filters were highlighted as products made in internal fabrication facilities to protect IP and accelerate time-to-market. By 2024, the company further underscored the strategic value of FBAR filters, noting their use in innovative and proprietary processes, and their competitive positioning was reinforced by Broadcom’s broad product portfolio, design expertise, and customer relationships. This evolution reflects a stronger focus on internal fabrication for high-value, mission-critical components to maintain a competitive edge.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic importance and manufacturing approach for FBAR filters between 2022 and 2024. It accurately captures that in 2022, FBAR filters were fabricated internally to protect IP and accelerate time-to-market, and that this internal fabrication strategy continued into 2024 as a means to maintain competitive advantage. The answer correctly identifies the continuity in internal fabrication and the emphasis on proprietary processes. However, it omits a key element from the original answer: the explicit expansion of the competitive landscape by 2024 to include Qorvo, Qualcomm, and Skyworks. While the LLM mentions 'competitive positioning' and Broadcom’s broader strengths, it does not reflect the increased competitive pressure due to these named rivals, which is a significant qualitative shift in context. This omission affects completeness and reasoning depth, particularly in the multi-hop aspect of assessing how the competitive environment evolved. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the answer remains contextually relevant and well-reasoned overall. The semantic meaning is largely equivalent but lacks the specific competitive benchmarking that strengthens the original conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 373,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "Between 2023 and 2024, BMY's strategic positioning of Krazati evolved significantly, particularly through the acquisition of Mirati in January 2024, which added Krazati to BMY's portfolio. In 2023, Krazati was in clinical development for second-line non-small cell lung cancer (NSCLC) and colorectal cancer. By 2024, Krazati had received FDA and EMA approvals for second-line NSCLC and advanced KRAS-mutated colorectal cancer, and it was further advancing in clinical trials for first-line NSCLC in combination with a PD-1 inhibitor. Financially, the acquisition of Mirati, valued at $4.8 billion, reflected BMY's commitment to expanding Krazati's development and commercial potential, with the asset contributing to BMY's indefinite-lived IPRD and R&D technology valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY acquired Mirati in 2024 for $4.8 billion, securing full rights to Krazati; Krazati received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer; and it advanced into first-line NSCLC development in combination with a PD-1 inhibitor. The clinical focus evolution from 2023 to 2024 is accurately summarized. (2) Quantitative accuracy is perfect: the $4.8 billion acquisition value is correctly stated, and no other numerical errors exist. Date (January 2024) is consistent with known public timeline. (3) Multi-hop reasoning is sound—LLM correctly synthesized information across time (2023 vs 2024), clinical development stages, regulatory milestones, and financial implications. The only minor omission is that the original answer specifies exact trial names (KRYSTAL-17, KRYSTAL-10, KRYSTAL-12*) in 2023, which the LLM does not mention, slightly reducing completeness. However, the clinical indications described are equivalent. (4) The financial valuation aspect is well addressed through the $4.8B acquisition and its reflection in IPRD/R&D valuation, capturing the strategic intent. Wording differs but semantic meaning matches. Thus, correctness is excellent—minor detail omission prevents a perfect 10, but all core facts, numbers, and reasoning are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 393,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "Between 2022 and 2023, BKNG has continued to evolve its relationship with travel service providers by maintaining and expanding its platform to facilitate bookings and payments, while managing financial obligations and incentives through structured programs. The Company manages financial obligations primarily through deferred merchant bookings, where cash received from travelers is held until performance obligations are fulfilled, with amounts payable to travel service providers. Incentive programs, such as referral bonuses and loyalty points, are recognized as a reduction of revenue at the time they are granted. Additionally, BKNG has focused on enhancing its Connected Trip vision, aiming to streamline the travel experience by integrating various travel services, which further strengthens its partnerships with travel service providers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in describing BKNG's financial obligations via 'deferred merchant bookings' and the treatment of incentive programs (referral bonuses, loyalty points) as a reduction of revenue, which aligns with the ground truth. It correctly identifies the structural mechanisms BKNG uses to manage relationships with travel service providers. However, it omits a key qualitative shift emphasized in the original answer: the evolution from a competitive relationship in 2022 to a more dependent, partnership-oriented model in 2023. This strategic shift is central to the question and is supported by the increase in deferred merchant bookings liability and expanded incentives. While the LLM mentions incentive programs and financial obligations, it does not explicitly frame the relationship evolution—competing in 2022 vs. depending on and incentivizing in 2023—thus missing a critical multi-hop inference. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and the context about Connected Trip adds relevant detail. The answer is well-structured and contextually relevant, but the absence of the competitive-to-dependent narrative reduces qualitative accuracy. Semantic equivalence is partially achieved, but the core transformation in the business relationship is underemphasized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 371,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "From 2022 to 2024, Broadcom's involvement in the development of Custom Touch Controllers has remained consistent, with their role primarily focused on the design and integration of these controllers as part of their broader semiconductor solutions for mobile device connectivity. In both years, Custom Touch Controllers are listed as a key product offering under the Wireless segment, indicating a stable position in their product lifecycle. There is no indication of a significant shift in their role or strategic emphasis regarding Custom Touch Controllers during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. While the ground truth states that Broadcom evolved from a supplier in 2022 to an active producer involved in design and creation by 2024—indicating a strategic shift—the LLM asserts there was no significant change in role or strategic emphasis, which directly contradicts the original answer. This fundamental disagreement on the evolution of Broadcom's involvement undermines the correctness of the response. (2) There are no numeric values, dates, percentages, or financial amounts in either the question or answers, so quantitative accuracy is not applicable; however, the years 2022 and 2024 are correctly referenced, earning full marks here. (3) The multi-hop reasoning is flawed: the question requires synthesizing Broadcom’s changing role across two time points, but the LLM fails to detect the shift from supplier to producer, missing the key inference of deeper engagement in the product lifecycle. Instead, it incorrectly concludes stability in role and strategy. (4) Contextual relevance is moderate—the answer addresses Broadcom, Custom Touch Controllers, and the correct time frame, and correctly identifies them as part of the Wireless segment, so it stays on topic—but it fails to capture the essential evolution described in the ground truth, resulting in a mostly incorrect qualitative assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 385,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "Union Pacific's approach to freight cars from 2023 to 2024 remained relatively consistent in terms of asset acquisition strategy. In both years, the company invested in locomotives and freight cars as part of its broader capital investment plan, with expenditures of $728 million in 2023 and $788 million in 2024. These investments included lease buyouts and were aligned with the company's goals to modernize its fleet, replace older assets, and support growth opportunities. The 2024 capital plan also emphasized continued investments in freight cars to enhance operational efficiency and meet demand from intermodal customers.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses the key shift in strategy from leasing to acquiring freight cars, which is central to the ground truth. Instead, it claims the approach 'remained relatively consistent,' which contradicts the documented strategic shift. While it correctly notes capital expenditures on freight cars and lease buyouts, it fails to emphasize the significant increase in buyouts ($57M in 2023 vs $143M in 2024) as a signal of strategic change. (2) Quantitatively, the LLM provides capital expenditure figures of $728M (2023) and $788M (2024), which may be accurate in context but are not directly relevant to the specific question about freight car acquisition strategy. The critical numbers—lease buyouts of $57M in 2023 and $143M in 2024—are omitted, undermining the quantitative accuracy despite no incorrect numbers being stated. (3) The multi-hop reasoning is flawed: the model fails to synthesize the evolution in asset strategy—shifting from reliance on leasing to increased ownership via buyouts—despite having some underlying data. It conflates general capital spending with specific freight car acquisition strategy, missing the nuance of changing financial commitments to ownership. (4) Contextual relevance is high because the answer discusses freight cars, capital investment, and growth goals, but the core conclusion about consistency contradicts the ground truth of a strategic shift, significantly reducing factual correctness. Thus, while some data points align, the overall interpretation and key details are inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 434,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike's structural changes in APLA between FY2022 and FY2023, particularly the transition of certain businesses to third-party distributors, had mixed financial and operational impacts. Revenues for APLA increased slightly from $5,955 million in FY2022 to $6,431 million in FY2023, reflecting stable performance despite the transition. However, EBIT for APLA rose from $1,896 million in FY2022 to $1,932 million in FY2023, indicating improved profitability, likely due to cost efficiencies from the structural changes. Operationally, the shift reduced Nike's direct control and asset exposure in APLA, as evidenced by a decline in inventories from $894 million in FY2022 to $810 million in FY2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—revenues, EBIT, and inventories—for APLA in FY2022 and FY2023 that are not present in the original ground truth answer. The ground truth does not provide any numerical data on revenue, EBIT, or inventory levels, nor does it mention any improvements in profitability or cost efficiencies from the transition. Therefore, these numbers appear to be fabricated or hallucinated, severely undermining factual accuracy. (2) There is no verification possible for the claimed $5,955M to $6,431M revenue increase or EBIT rise from $1,896M to $1,932M, as the original answer contains no such data. Similarly, the inventory decline from $894M to $810M is unsupported by the ground truth. These quantitative claims are entirely absent from the source knowledge, making the quantitative accuracy very low. (3) While the LLM correctly identifies the core structural change—transitioning certain APLA businesses to third-party distributors and reducing direct operational involvement—it incorrectly frames the impact as quantitatively positive (higher EBIT, lower inventories), which is not supported by the original answer. The ground truth emphasizes non-recurring impairment charges due to foreign currency translation losses and a strategic shift toward brand management via a strategic stake, not direct operations. The reasoning around cost efficiency and improved profitability is speculative and not grounded in the provided facts. (4) Despite the hallucinated numbers, the LLM captures the general direction of the operational shift—reduced direct control and asset exposure—which aligns with the strategic intent described in the original answer. Thus, while contextually relevant and partially accurate in qualitative direction, the inclusion of false quantitative data results in a low correctness score. The answer fails the fundamental requirement of factual fidelity to the source knowledge.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 528,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "Broadcom's involvement with InP lasers has remained consistent in terms of internal fabrication strategy from 2022 to 2024, as both filings indicate that InP lasers are manufactured internally for fiber optic communications. However, in 2024, there is a slight emphasis on competitive positioning, with broader mention of competitors in the semiconductor market, including firms like Lumentum and II-VI Incorporated, suggesting increased market dynamics. Broadcom continues to leverage its proprietary InP laser technology to maintain a competitive edge in high-speed communications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that Broadcom maintained internal fabrication of InP lasers from 2022 to 2024 for fiber optic communications, which matches the original answer's claim about continued use of internal facilities and proprietary processes. (2) There are no numeric values requiring calculation, so quantitative accuracy is fully satisfied—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years and identifies a strategic shift in competitive positioning. The mention of Lumentum and II-VI Incorporated (now Coherent Corp. following merger) is accurate; while the original answer lists 'Coherent Corp., Lumentum Holdings Inc.', the LLM refers to 'II-VI Incorporated', which is contextually correct as II-VI merged with Coherent. This does not constitute an error but reflects naming variation over time. (4) The LLM captures the core evolution: consistent internal fabrication strategy with increased emphasis on competitive differentiation in 2024. The only minor shortcoming is that it does not explicitly name Coherent Corp. in the same form as the original, though II-VI is a valid reference pre-merger. Overall, the answer is semantically equivalent, factually correct, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 372,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "Between 2022 and 2023, Swoosh, LLC maintained its significant ownership of approximately 77% of NIKE's Class A Common Stock, which grants disproportionate voting power as holders of Class A stock elect three-quarters of the Board of Directors. In 2022, it was noted that if all Class A shares were converted to Class B, Swoosh, LLC's ownership of Class B Common Stock would be about 16%. The 2023 filing reaffirms this ownership structure without indicating material changes. This concentration of ownership through Class A shares provides Swoosh, LLC with substantial influence over corporate governance and decision-making, potentially limiting shareholder influence and discouraging hostile takeovers or unsolicited bids.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 77% ownership of Class A Common Stock and the 16% equivalent ownership in Class B Common Stock if converted are accurately reported for both 2022 and 2023. There are no calculation errors, and the percentages match the original answer exactly. (2) The answer correctly identifies that there was no material change in ownership structure between 2022 and 2023, which is consistent with the ground truth's assertion of consistency. (3) The qualitative reasoning is sound: the LLM correctly infers the implications of concentrated ownership in Class A shares, including disproportionate voting power (electing three-quarters of the Board) and the resulting influence over corporate governance, which aligns with the original answer’s emphasis on sustained influence. While the original answer specifically names Travis Knight as having a significant role, the LLM omits this detail but still captures the broader implication of concentrated control. This is a minor omission that does not undermine the core accuracy. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the evolution (or lack thereof) in ownership structure and the implications for shareholder influence. The LLM appropriately explains how Class A ownership translates into governance power and potential market effects like deterring hostile takeovers. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a slight gap in specificity regarding Travis Knight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 450,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "From 2022 to 2023, PMI's strategic positioning of Reduced-Risk Products (RRPs) evolved significantly through portfolio integration and expanded market availability. In 2022, the acquisition of Swedish Match AB strengthened PMI's oral nicotine offerings, particularly in the U.S. with the ZYN brand, complementing its heat-not-burn products like IQOS. By 2023, PMI integrated Swedish Match into its regional structure and reorganized its operating segments, including a new Wellness and Healthcare segment. This integration enhanced PMI's smoke-free portfolio, with RRPs available in 84 markets by year-end, reflecting a strategic shift toward becoming a smoke-free company.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in PMI's strategic positioning from 2022 to 2023, including the integration of Swedish Match AB enhancing oral nicotine offerings and the expansion to 84 markets by 2023, which matches the ground truth. The market number (84) is accurate and correctly attributed to year-end 2023. However, the LLM does not explicitly state that RRPs were reclassified into a broader category called Smoke-Free Products (SFPs) that now includes wellness and healthcare—instead, it mentions a new 'Wellness and Healthcare segment' as part of reorganization, which is related but less precise. The ground truth emphasizes a re-categorization of RRPs into SFPs as a portfolio integration move, while the LLM focuses on organizational integration via segments. (2) Quantitatively, all numbers are correct: '84 markets' is accurately cited with no conflicting data in 2022. There are no calculations, so accuracy is preserved. (3) The multi-hop reasoning is sound—LLM connects the Swedish Match acquisition (2022) to portfolio expansion and links 2023 reorganization to strategic smoke-free goals. It synthesizes information across time and business units correctly, though it misses the explicit rebranding of RRPs into SFPs as a category-level change. (4) Scores reflect high factual accuracy and relevance, with a minor deduction in qualitative accuracy for not fully capturing the nature of portfolio integration (category redefinition vs. operational integration). Contextual relevance is perfect as it directly addresses both portfolio and market availability aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 448,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "Caterpillar's strategic role in the reciprocating engines business from 2022 to 2024 has shifted toward emphasizing high-margin applications such as data center power generation and gas compression, while experiencing declines in lower-margin areas like well servicing. This shift is evident in the 2024 10-K, which notes flat sales in reciprocating engines for well servicing but increased sales in gas compression and turbines. As a result, the Energy & Transportation segment's profit margin rose to 19.9% in 2024 from 17.6% in 2023, indicating improved gross margin potential due to a more favorable product mix and price realization.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of Caterpillar's strategic evolution in the reciprocating engines business from 2022 to 2024. The ground truth states that Caterpillar evolved from selling engines through its dealer network and Perkins to including remanufacturing of its own and third-party engines by 2024. However, the LLM answer instead claims a shift toward high-margin applications like data centers and gas compression, with declines in well servicing—information not supported by the ground truth. (2) The quantitative elements—such as the Energy & Transportation segment margin rising from 17.6% in 2023 to 19.9% in 2024 and flat sales in well servicing—are not present in the original answer and cannot be verified against the provided ground truth. These figures may be factually accurate in another context but are irrelevant here, as the ground truth does not mention them. (3) The multi-hop reasoning is flawed: the LLM fails to connect Caterpillar’s strategic shift to remanufacturing and lifecycle services, which is the core evolution. Instead, it fabricates a narrative around product mix and margin improvement based on application areas not referenced in the ground truth. (4) While the LLM answer discusses gross margin potential and revenue composition—relevant themes—it does so using incorrect reasoning and unsupported data. The contextual relevance is moderate because it addresses the general topic of margin improvement and revenue shifts, but the factual basis is misaligned with the provided truth. Thus, the correctness score is low due to major factual and directional inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 449,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon maintained its commitment to disclosing amendments to the Directors' Code of Conduct by posting updates on its website, as outlined in both years' filings. However, in 2023, there was a slight enhancement in transparency, as the company explicitly reiterated its intention to disclose amendments or waivers of the Directors' Code of Conduct on its website, reinforcing its commitment to stakeholder communication. No specific new mechanisms were introduced, but the reaffirmation of existing disclosure practices highlighted a continued emphasis on transparency.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces a claim not supported by the ground truth. (1) The ground truth states that BNY Mellon's approach 'remained consistent' between 2022 and 2023 with no change in mechanism or transparency commitment. However, the LLM answer asserts a 'slight enhancement in transparency' in 2023 due to the company 'explicitly reiterating' its intention, which implies a qualitative improvement. This contradicts the ground truth, which emphasizes stability and no change. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are involved. (3) The multi-hop reasoning is partially sound: the model correctly identifies that disclosures were made via the website in both years and that no new mechanisms were introduced. However, it incorrectly infers increased transparency from the reaffirmation of existing policy, failing to recognize that repetition does not equate to evolution or enhancement. (4) Contextually, the answer is relevant and addresses the question about mechanisms and transparency. But due to the erroneous claim of enhanced transparency, the qualitative and overall correctness scores are reduced. The core facts are present, but the interpretation misrepresents the consistency described in the ground truth as a subtle improvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 384,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Between FY22 and FY23, Nike's strategic approach to the APLA market evolved through a shift in operational structure, particularly with the planned transition of legal entities in Argentina, Uruguay, and Chile to third-party distributors. This move aimed to transition from a wholesale and direct-to-consumer model to a distributor model, which is expected to reduce selling and administrative expenses and mitigate foreign exchange volatility. Additionally, Nike continued to strengthen its market participation in APLA through its NIKE Direct operations, which saw growth in digital sales and owned retail channels, aligning with the broader Consumer Direct Acceleration strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the shift in Nike's operational structure in APLA between FY22 and FY23, noting the transition of certain markets (Argentina, Uruguay, Chile) to third-party distributors, which matches the ground truth's description of a strategic shift toward a partner-driven model. (2) There are no numeric values (percentages, dollar amounts, etc.) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes Nike’s prior direct presence (implied by continuation of NIKE Direct growth) with the new distributor strategy, correctly framing it as a structural evolution. It adds contextual detail not in the original—expected benefits like reduced expenses and FX risk mitigation—which is consistent with strategic logic and does not contradict the ground truth. (4) The only minor gap is that the original emphasizes APLA’s contribution to the 14% growth in NIKE Direct in FY22, which the LLM mentions only generally through 'growth in digital sales and owned retail.' While not omitted entirely, this specific data point is underemphasized. However, the core facts, entities (Nike, APLA, FY22–FY23, third-party distributors), and strategic narrative are correct and well-synthesized. The answer remains semantically equivalent and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 397,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "From 2022 to 2024, the impact of favorable price realization on Caterpillar's sales and profitability has evolved as follows: In 2022, favorable price realization contributed to a 22% sales increase compared to 2021, driven by higher demand and inventory changes. By 2024, while sales decreased slightly by 3% compared to 2023, favorable price realization partially offset the impact of lower sales volume and improved operating profit margin to 20.2%. In 2025, however, Caterpillar expects unfavorable price realization in Construction and Resource Industries to negatively impact profitability, though Energy & Transportation is expected to see favorable price realization.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces information not present in the ground truth. While it correctly identifies that favorable price realization played a role in offsetting lower sales volume in 2024, it fabricates a 22% sales increase in 2022 compared to 2021, which is not supported by the original answer (which states a $9.223 billion increase in sales but does not provide a percentage). The 3% sales decrease in 2024 and 20.2% operating profit margin are not mentioned in the ground truth and appear to be invented. Additionally, the LLM incorrectly projects into 2025, which is outside the requested 2022–2024 timeframe and not supported by the original answer. (2) The only correct quantitative element is the conceptual role of favorable price realization in offsetting volume declines in 2024, but no actual numbers from the ground truth are accurately reflected: the $9.223 billion sales increase in 2022, the $2.251 billion volume decrease, and the profit increase from $10.335B to $10.792B in 2024 are all missing or replaced with incorrect figures. (3) The multi-hop reasoning is partially sound in recognizing that pricing helped maintain profitability despite volume declines, but it fails to synthesize the actual financial data across years and introduces speculative forward-looking statements not in the source. (4) The contextual relevance is moderate because the answer addresses the general theme of price realization’s impact on sales and profitability, but correctness is severely undermined by fabricated numbers, incorrect timeframes, and omission of key ground truth data. Hence, the correctness score is low despite some conceptual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 466,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "Between 2023 and 2024, General Motors' approach to EV manufacturing capacity evolved by refocusing its strategy on scaling EV production and developing a resilient, North America-centric EV supply chain. In 2024, GM emphasized strategic sourcing initiatives, including investments in raw material suppliers and multi-year supply agreements, to secure materials and reduce costs, particularly for battery cells and packs. Additionally, GM shifted its autonomous driving focus to personal vehicles and integrated technical efforts with Cruise to prioritize ADAS development, aligning with its long-term EV strategy. These actions reflect a stronger commitment to addressing supply chain challenges and advancing EV technology to meet evolving consumer and regulatory demands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: GM's 2023 focus on EV capacity investments amid demand uncertainty and fixed cost risks is implied through the contrast with 2024 actions, and the 2024 shift toward a resilient, North America-centric supply chain with strategic sourcing, raw material supplier investments, and multi-year agreements is explicitly stated. (2) There are no numeric values, dates, or calculations in the question or answers that conflict—the years 2023 and 2024 are used correctly. (3) The multi-hop reasoning is sound: the LLM synthesizes GM’s evolving strategic focus across time, correctly identifying the pivot from broad capacity investment to supply chain resilience and scalability. (4) The only minor shortcoming is the inclusion of information about autonomous driving and Cruise, which, while contextually related to GM’s broader strategy, is not directly relevant to the question about EV manufacturing capacity and supply chain development. This slightly dilutes focus but does not introduce inaccuracy. Overall, the answer captures the core evolution in GM’s strategy with strong qualitative and contextual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 341,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Based on the remaining performance obligations disclosed in the 10-K filings, Pfizer's financial commitment to Paxlovid has significantly decreased from 2022 to 2024. As of December 31, 2022, the remaining performance obligations for Paxlovid were approximately $1 billion, which decreased to $4 billion as of December 31, 2023, and further reduced to $1 billion by December 31, 2024. This decline reflects the transition of Paxlovid from government contracts to commercial markets and the recognition of revenue as obligations were fulfilled.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that Pfizer did not disclose specific performance obligations for Paxlovid in 2022, but by 2024, the obligation was quantified at $1 billion. The LLM falsely claims that obligations were $1 billion in 2022, rose to $4 billion in 2023, then dropped to $1 billion in 2024—this data is entirely inaccurate. (2) Quantitative accuracy is severely lacking: no $1B or $4B figures for 2022 or 2023 exist in the ground truth; the only valid number ($1B in 2024) is coincidentally correct but misinterpreted as a reduction rather than an emergence of disclosure. (3) The multi-hop reasoning is flawed: instead of recognizing the evolution from no disclosed amount to a defined $1B commitment, the model fabricates a decreasing trend unsupported by data. It also incorrectly attributes the change to a transition to commercial markets, which is not in the original answer. (4) Scores are low because the core facts, numbers, and logical conclusion are wrong. Contextual relevance is moderate since the answer addresses Paxlovid and performance obligations, but with incorrect data and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 337,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Between 2022 and 2023, Caterpillar's approach to monitoring supplier financial viability has evolved with a stronger emphasis on contractual agreements and risk mitigation strategies. The company continues to expect suppliers to maintain industry-leading quality and delivery performance while using agreements to protect intellectual property and monitor risks, including supplier financial viability. However, in 2023, Caterpillar explicitly expanded its risk mitigation strategies to include a more structured focus on business continuity, production flexibility, and supplier financial resilience, particularly in response to ongoing supply chain disruptions and fluctuating demand. These enhancements reflect a more proactive stance in safeguarding against potential business disruptions caused by supplier instability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment that Caterpillar maintained its monitoring of supplier financial viability and placed greater emphasis on it in 2023, with a more proactive risk mitigation stance. The answer correctly identifies the continuity of contractual protections for intellectual property and risk monitoring. However, it introduces elements not present in the ground truth: specifically, the claim that Caterpillar 'explicitly expanded its risk mitigation strategies to include a more structured focus on business continuity, production flexibility, and supplier financial resilience' in 2023 is not supported by the original answer. The ground truth notes a more explicit *emphasis* on supplier financial viability as a listed risk and reinforcement of strategic sourcing models, but does not mention business continuity or production flexibility as new 2023 additions. Additionally, while the LLM captures the increased focus on financial viability, it misses the specific detail that in 2023, supplier financial viability was listed as the *first* risk in supply chain disclosures—a key indicator of prioritization. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is contextually relevant and well-reasoned, but the qualitative accuracy is slightly reduced due to unsupported elaboration and omission of a key differentiator (ranking of risk). The core evolution—increased emphasis on financial viability—is correctly conveyed, warranting a solid but not top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 423,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's approach to Risk and Identity Solutions evolved by expanding its AI and machine learning capabilities to enhance fraud prevention and authentication. In 2024, Visa introduced three new products—Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic Visa Advanced Authorization—to address fraud in A2A and card-not-present (CNP) transactions, both on and off Visa's network. This reflects a strategic shift toward providing more comprehensive, network-agnostic fraud prevention tools that support Visa's broader vision of being a \"network of networks.\"",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but diverges from the ground truth in key aspects of strategic positioning and integration. (1) Correct elements: The answer correctly identifies a strategic evolution in Visa's Risk and Identity Solutions between 2022 and 2024 and highlights an expansion into network-agnostic services, aligning with the ground truth's second pillar. The mention of AI/ML enhancements and fraud prevention tools is contextually plausible and relevant. (2) Quantitative accuracy: There are no specific numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so no factual discrepancies exist in this regard—score is 10. (3) Multi-hop reasoning: The LLM introduces specific product names (Visa Deep Authorization, Visa Protect for A2A Payments, Visa Risk Manager) and features not present in the ground truth. While these may reflect real developments, they are not supported by the knowledge graph and shift focus from the structural, strategic reorganization (three-pillar framework) emphasized in the original answer. The concept of 'network of networks' is interpretive and not mentioned in the ground truth. (4) The core omission is the failure to describe the three-pillar strategic framework—especially the third pillar (services beyond payments)—which is central to the 2024 evolution. Instead, the LLM focuses narrowly on fraud products and technological enhancements, missing the broader integration into value-added services. Thus, while contextually relevant and factually plausible in parts, the answer lacks alignment with the documented strategic repositioning, resulting in a correctness score of 6 for partial accuracy with significant omissions in strategic context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 468,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "The company's exposure to shelf space limitations as a risk factor remained significant in 2023, with continued challenges from retail customer policies such as inventory destocking, fulfillment requirements, and limitations on shelf space access. However, the expansion of alternative retail channels, particularly e-commerce and direct-to-consumer models, provided some mitigation by diversifying distribution pathways. In 2023, the company emphasized adapting to evolving consumer preferences and expanding into higher-growth channels, suggesting a strategic shift to reduce dependency on traditional retail shelf space.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately reflects that shelf space limitations remained a significant risk in 2023 and were tied to retail customer policies, consistent with the 2022 disclosure. The mention of alternative channels like e-commerce and direct-to-consumer models as mitigating factors matches the original answer's emphasis on the growth of such channels. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is sound: the model correctly infers a continuity of risk from 2022 to 2023 and contextualizes it within evolving retail dynamics. However, it slightly misses the explicit evolution from 'potential risk' in 2022 to 'actively impacted' in 2023, which is a key nuance in the ground truth. Additionally, the original answer notes a specific strategic response—investment in digital and analytics capabilities—which is not mentioned in the LLM response, representing a minor omission. (4) Despite this, the LLM captures the core progression and strategic adaptation, and all entities (retail policies, shelf space, alternative channels) are correctly identified and contextualized. The answer is highly relevant and conveys a semantically close interpretation, warranting a high correctness score with a small deduction for missing the shift in risk status and specific mitigation plans.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 425,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "Oracle's approach to hybrid deployments between fiscal years 2023 and 2024 has shown a continued strategic emphasis on providing flexible and interoperable solutions. In 2023, Oracle highlighted its hybrid deployment models, including Oracle Exadata Cloud@Customer and Dedicated Region offerings, which allow customers to use Oracle Cloud within their own data centers. By 2024, Oracle expanded on this by emphasizing the integration of AI and machine learning capabilities within its hybrid offerings, such as the Oracle Autonomous Database, and by introducing programs to help customers migrate existing workloads to the Oracle Cloud. This evolution reflects a stronger push toward modernizing hybrid environments with advanced technologies and facilitating seamless transitions for customers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its portrayal of Oracle's evolving approach to hybrid deployments between fiscal years 2023 and 2024, with accurate entity identification (Oracle, Exadata Cloud@Customer, Dedicated Region) and correct timeframes. It correctly notes Oracle’s continued strategic emphasis on hybrid deployments and flexibility. The quantitative accuracy is perfect—no numerical data is misstated, and no incorrect figures are introduced. However, the qualitative accuracy is slightly lower because the LLM introduces elements not present in the ground truth: specifically, the mention of 'AI and machine learning capabilities' and 'programs to help customers migrate existing workloads' are not supported by the original answer. While these may be plausible developments, they are not part of the documented evolution in the knowledge graph, which instead emphasizes deeper product integrations and services tailored for hybrid environments, improved interoperability, and extensibility. The original answer does not mention AI integration or migration programs as focal points in 2024. Thus, while the LLM captures the general direction of Oracle’s strategy, it adds speculative details that shift the emphasis. The reasoning is sound but not fully aligned with the source, and the answer remains contextually relevant and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 375,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid has significantly decreased between 2022 and 2024. In 2022, Paxlovid contributed $18,933 million in revenues, which dropped to $1,279 million in 2023 due to a non-cash revenue reversal of $3.5 billion related to expected returns of EUA-labeled U.S. government inventory. By 2024, Paxlovid revenues increased to $5,716 million, partly due to a $771 million favorable adjustment from returned treatment courses and the transition to commercial markets. Remaining performance obligations for Paxlovid were $1 billion as of December 31, 2024, with expected delivery through 2028.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the revenue figures and their interpretation. While the $1 billion remaining performance obligations as of December 31, 2024, matches the ground truth and is correctly tied to revenue recognition through 2028, the revenue numbers for 2022, 2023, and 2024 are not supported by the original answer. The original answer does not provide specific revenue figures for Paxlovid in 2022 or 2023, nor does it mention a $3.5 billion non-cash reversal or a $771 million favorable adjustment. These specific numbers and explanations appear to be hallucinated or incorrectly inferred. (2) The quantitative accuracy is low because the LLM introduces precise dollar amounts (e.g., $18,933 million in 2022, $1,279 million in 2023, $5,716 million in 2024) that are not present in the ground truth and cannot be verified from the provided context. The only correct number is the $1 billion in remaining performance obligations as of end-2024. (3) The multi-hop reasoning is partially sound in that the LLM attempts to trace the evolution of Pfizer’s financial commitment over time and incorporates the forward-looking performance obligations. However, it fails to accurately represent the 2022 context, which in the ground truth is qualitative (expectation of reduced post-pandemic revenue), not quantitative. The synthesis is flawed due to the insertion of unsupported figures. (4) Contextual relevance is high because the answer addresses the timeline (2022–2024), discusses revenue trends, and correctly identifies the $1 billion obligation with delivery through 2028. However, the correctness score is low due to the critical inclusion of unverified financial data that distorts the actual evolution of Pfizer’s commitment as described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 496,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "Between 2022 and 2023, Caterpillar's relationship with its independent dealers remained centered on contractual agreements that grant dealers the right to sell and service Caterpillar products within specified geographic territories. These agreements, which include obligations for dealers to promote Caterpillar products, maintain adequate support personnel, and uphold quality standards, were consistent in both years. However, in 2023, there was a greater emphasis on leveraging dealer networks to support Caterpillar's global sales strategy, particularly in developing markets. Additionally, the company continued to strengthen its strategic focus on dealer support through financing and technical assistance, as highlighted by the role of Cat Financial in providing inventory and sales financing to dealers worldwide.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the ongoing contractual nature of Caterpillar's dealer relationships and mentions key obligations such as promoting products, maintaining support personnel, and geographic territories, which aligns partially with the ground truth. However, it fails to accurately capture the core evolution highlighted in the original answer: the shift from a general partnership model in 2022 to a formalized, standardized contractual framework in 2023. The LLM implies continuity in the contractual structure between 2022 and 2023, whereas the ground truth emphasizes a significant change in 2023 with the introduction of more detailed and standardized agreements. This misrepresents the nature of the evolution. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are involved. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information about dealer obligations and strategic emphasis but misses the critical shift from informal to formal agreements, which is central to the question about evolution in contractual obligations. The mention of Cat Financial and financing support adds contextual detail not present in the ground truth, but this is not directly responsive to the question about contractual changes. (4) The correctness score is 5 due to significant factual inaccuracy in portraying the evolution of the contractual relationship, despite some correct elements about dealer roles. Qualitative accuracy is low because the reasoning mischaracterizes the nature of the change. Contextual relevance is high as the answer stays on topic and discusses relevant aspects of dealer relationships, even if the core transformation is missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 493,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "From 2022 to 2023, the company's financial allocation and operational focus related to Africa/Eurasia, as part of the 2022 Global Productivity Initiative, shifted from 11% of restructuring charges in 2022 to 5% in 2023, indicating a reduced emphasis on this region. Additionally, capital expenditures for Africa/Eurasia increased from $13 million in 2022 to $33 million in 2023, reflecting a modest rise in investment despite the declining share of restructuring efforts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that restructuring charges for Africa/Eurasia were 11% in 2022 and 5% in 2023; the original answer states that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative (not annual charges) relate to Africa/Eurasia, with no breakdown by year. Second, the LLM reverses the capital expenditure trend: it claims capex increased from $13M in 2022 to $33M in 2023, but the ground truth shows $33M in 2022 (up from $13M in 2021), with no 2023 capex data provided. (2) The numbers are therefore quantitatively incorrect: capex for Africa/Eurasia was $33M in 2022, not 2023, and $13M in 2021, not 2022. The percentages for restructuring charges (11% and 5%) are fabricated and not supported by the original answer. (3) The multi-hop reasoning is flawed: the model fails to correctly interpret that the 2022 Global Productivity Initiative's regional allocation (10% to Africa/Eurasia) was disclosed in 2023, indicating a shift from capital investment to restructuring. Instead, it invents a year-on-year comparison of restructuring charges that does not exist in the source. (4) The contextual relevance is moderate because the answer addresses financial allocation and operational focus in Africa/Eurasia, but the incorrect data and reasoning severely undermine the conclusion. The qualitative accuracy is low due to incorrect entity relationships and synthesis. The correctness score is very low because the core facts—capex timing and restructuring percentages—are wrong, leading to an inverted and misleading narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 451,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "From 2022 to 2024, Qualcomm has deepened its strategic focus on 5G technologies by increasing investment in AI integration, expanding commercialization into new industries, and enhancing product performance. In 2022, the company emphasized 5G modem-RF platform development and foundational 5G NR technologies. By 2024, Qualcomm had integrated AI into its Snapdragon 5G modem-RF products to optimize performance and battery life, while also expanding 5G adoption into automotive, IoT, and industrial applications. Commercialization outcomes include the global rollout of 5G technologies and over 200 5G license agreements, reflecting stronger market penetration and diversification beyond mobile handsets.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Qualcomm's 5G strategy from development to broader commercialization, correctly identifying expansion into automotive, IoT, and industrial applications. However, it introduces AI integration into Snapdragon 5G modem-RF products as a key 2024 development, which is not supported in the ground truth and represents an unverified enhancement. The claim of 'over 200 5G license agreements' is specific but not present in the original answer and cannot be verified against the knowledge graph; thus, it introduces a potentially inaccurate quantitative outcome. (2) The original answer does not mention AI integration or a specific number of license agreements, instead emphasizing the shift from investment to monetization via QTL revenues from OFDMA-based products and a leading 5G NR patent portfolio. The absence of revenue figures or licensing counts in the ground truth makes the LLM's inclusion of 'over 200' agreements a factual overreach. (3) The multi-hop reasoning is partially sound—Qualcomm’s shift from R&D to commercialization across industries is correctly inferred—but the synthesis adds elements (AI, exact licensing numbers) not present in the source data, weakening the factual foundation. (4) The contextual relevance is high as the answer addresses investment emphasis and commercialization outcomes across the 2022–2024 timeframe. Qualitative accuracy is moderate due to correct framing but incorrect specifics. Quantitative accuracy is reduced due to unsupported numbers. Correctness score reflects partially correct information with significant additions not grounded in the truth data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 456,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Pfizer's financial and strategic positioning of Paxlovid evolved significantly between 2022 and 2024. In 2022, Paxlovid contributed $18,933 million in revenue, which dropped to $1,279 million in 2023 due to a non-cash revenue reversal of $3.5 billion associated with expected returns of EUA-labeled U.S. government inventory. By 2024, Paxlovid revenue rebounded to $5,716 million as the product transitioned to commercial markets. Contractual commitments also shifted, with amended agreements allowing for continued access through government programs and a U.S. Strategic National Stockpile (SNS) of 1.0 million treatment courses supplied at no cost for pandemic preparedness. Deferred revenues related to Paxlovid decreased from $5.1 billion in 2023 to $2.2 billion in 2024, reflecting product deliveries and a favorable adjustment of $771 million in Q1 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states Paxlovid generated $76 million in revenue in 2022, but the LLM claims $18,933 million (over $18 billion), which is off by two orders of magnitude. The LLM introduces a $3.5 billion non-cash reversal in 2023 and a 2024 revenue of $5,716 million, none of which are supported by the original answer. The ground truth does not provide 2023 or 2024 revenue figures—only 2022 revenue and 2024 remaining performance obligations of ~$1 billion. The LLM fabricates detailed financials not present in the source. (2) The only partially correct element is the mention of contractual commitments in 2024, but even here, the LLM invents specifics like a '1.0 million treatment courses' stockpile and 'amended agreements' not found in the original. The original mentions $1 billion in remaining performance obligations, which the LLM does not reference. Deferred revenue figures ($5.1B to $2.2B) and a $771M Q1 2024 adjustment are entirely fabricated. (3) The multi-hop reasoning is flawed: the LLM incorrectly synthesizes non-existent data across years and misrepresents the strategic shift. While it attempts to frame a narrative of transition from government to commercial markets, this is not supported in the original, which emphasizes contractual obligations despite market challenges. (4) Scores reflect severe quantitative inaccuracy (1), poor qualitative reasoning due to hallucinated details (3), moderate contextual relevance as it addresses revenue and contracts (6), and a low overall correctness score (2) due to almost entirely fabricated financials despite attempting the right themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 459,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "The company's exposure to credit market tightness as a supply chain risk increased between 2022 and 2023, as both years mention the impact of tighter credit or capital markets on suppliers. However, the 2023 filing explicitly highlights the ongoing challenges of geopolitical conflicts (e.g., the war in Ukraine and the Israel-Hamas war) and climatic events exacerbating these risks. This evolution indicates a heightened vulnerability to external financial conditions, as tighter credit markets are now compounded by broader macroeconomic and geopolitical pressures, potentially disrupting supplier operations and increasing the company's reliance on contingency planning.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that credit market tightness was a supply chain risk in both 2022 and 2023, which aligns with the ground truth. However, it incorrectly implies an increase in exposure due to new geopolitical and climatic factors explicitly tied to credit market tightness, which is not supported in the original answer. The ground truth emphasizes a shift in framing—from suppliers being 'negatively impacted' in 2022 to the company's operations being 'impacted by' these conditions in 2023—indicating a broader internal recognition of vulnerability, not an expansion of risk due to external events. The LLM introduces geopolitical conflicts (e.g., war in Ukraine, Israel-Hamas war) and climatic events as compounding factors in 2023, but these are not mentioned in the original answer as linked to credit market tightness. (2) There are no numerical values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly infers ongoing concern across years but fails to accurately represent the nature of the evolution. Instead of focusing on the company’s changing perspective (from supplier-level to operational-level impact), it fabricates external risk amplifiers not present in the ground truth, undermining the qualitative accuracy. (4) The correctness score is 5 because while the core idea of continued concern over credit markets is correct, the explanation of how the risk evolved is factually inaccurate. The contextual relevance is 7 because the answer addresses the question’s intent but adds unsupported details that distort the actual evolution of risk perception.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 471,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid significantly decreased from 2022 to 2024. In 2022, Paxlovid generated $18,933 million in revenue, but by 2024, this dropped to $5,716 million. This decline reflects the transition from government contracts to commercial market sales, particularly in the U.S., and the recognition of deferred revenues. Additionally, deferred revenues related to Paxlovid decreased from $5.1 billion in 2023 to $2.2 billion in 2024, primarily due to product deliveries and a favorable adjustment from returned EUA-labeled treatment courses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly references Paxlovid and the general timeline of shifting from government to commercial sales, it fabricates key financial figures not present in the ground truth. The claim that Paxlovid generated $18,933 million in revenue in 2022 and $5,716 million in 2024 is unsupported by the original answer, which does not provide annual revenue figures for those years. Similarly, the deferred revenue figures of $5.1 billion in 2023 and $2.2 billion in 2024 are not mentioned in the ground truth and appear to be invented. The only partially correct element is the reference to a favorable adjustment related to returned EUA-labeled treatment courses, but even this lacks the specific $771 million figure from the original answer. (2) Quantitative accuracy is very low: none of the major dollar amounts match the ground truth. The original answer states that remaining performance obligations were ~$1 billion as of December 31, 2024, not declining revenues or deferred revenue balances. The $771 million favorable adjustment is omitted entirely in the LLM’s numerical narrative. (3) The reasoning is flawed—while the idea of a shift from government to commercial sales may be contextually plausible, the LLM incorrectly frames the evolution as a decline in financial commitment, whereas the ground truth shows a continued strong commitment via $1 billion in future performance obligations through 2028. The model fails to capture the multi-hop synthesis of regulatory status (2022) evolving into long-term contractual obligations (2024), instead focusing on fabricated revenue trends. (4) Scores reflect major factual errors in numbers and conclusions, though the answer is contextually relevant in discussing Paxlovid’s contractual evolution and touches on correct themes like EUA returns. However, absence of correct figures and misrepresentation of the financial trajectory severely undermine accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 536,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "From 2023 to 2024, the financial liability related to Aearo Technologies' respirator mask/asbestos litigation decreased from $62 million to $51 million. This reduction reflects the resolution of certain claims and ongoing management of liabilities through an informal arrangement with co-defendants. However, the risk exposure remains significant due to uncertainties in future claims, legal costs, and potential changes in liability allocation or co-defendant financial viability. The Company continues to monitor and adjust its accruals based on developments in litigation and claims trends.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that Aearo's liability decreased from $62 million in 2023 to $51 million in 2024, but the ground truth states that in 2023, 3M (MMM) had a $574 million accrual for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy with litigation stayed. There is no mention of a $62 million figure for Aearo in 2023 in the ground truth. The only accurate number is the $51 million in 2024 for Aearo-related claims, which matches the original answer. (2) The calculation of a $11 million decrease is therefore incorrect and based on fabricated data. The ground truth does not support any reduction from $62M to $51M. Additionally, the LLM omits the critical detail about Cabot's assumption of pre-1997 liability and the $100,000 quarterly fee arrangement, which is central to understanding the 2024 liability framework. (3) The multi-hop reasoning is flawed: the model fails to synthesize the relationship between MMM, Aearo, and Cabot, and incorrectly frames the 2023 situation by inventing a specific Aearo accrual that is not in the source. It also misses that Aearo’s 2023 status was defined by bankruptcy and litigation stay, not an active accrual. (4) While the LLM correctly notes ongoing risk exposure and monitoring of accruals, this generic risk commentary does not compensate for the core factual errors. The answer is partially relevant to the question’s intent but fails on key facts, calculations, and entity relationships. Hence, low scores for correctness, quantitative, and qualitative accuracy; moderate relevance due to addressing litigation risk conceptually.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 458,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline of 1.7 share points. In contrast, between 2020 and 2021, Skoal's retail share decreased from 13.9% to 12.6%, a decline of 1.3 share points. Thus, the decline in Skoal's retail share was more pronounced in 2024 compared to the 2020–2021 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the retail share decrease for Skoal from 9.3% in 2023 to 7.6% in 2024, which matches the ground truth. However, it incorrectly claims that Skoal's retail share was 13.9% in 2020 and 12.6% in 2021, which is factually wrong—the original answer does not provide any retail share data for 2020–2021. Instead, the ground truth discusses shipment volume during that period, not retail share. The LLM confuses metrics by applying retail share to 2020–2021 when the correct metric is shipment volume. (2) The numbers for 2023–2024 are accurate, but the 2020–2021 retail share figures (13.9% and 12.6%) are fabricated and not supported by the ground truth. Additionally, the correct shipment volumes—208.5 million packs/cans in 2020 and 197.4 million in 2021—are entirely omitted. (3) The multi-hop reasoning fails because the model does not synthesize the correct metrics across time periods: it should compare 2023–2024 retail share trend with 2020–2021 shipment volume trend, but instead compares retail share across both periods, using false data. This breaks the logical and factual foundation of the comparison. (4) Due to major factual errors, incorrect data insertion, and failure to address the shipment volume trend, the correctness and accuracy scores are low. Contextual relevance is moderate because the answer addresses the general topic and timeframes but with wrong data and metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 398,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm's approach to multimedia technologies has evolved with a stronger emphasis on integration into diverse product offerings and a broader engineering focus. In 2022, the company highlighted its expertise in multimedia technologies such as camera, video, display, and computer vision, as part of its research and development efforts aimed at expanding beyond mobile handsets into automotive and IoT. By 2024, Qualcomm expanded its engineering focus to include AI, generative AI, and power efficiency, emphasizing on-device AI capabilities and scaling across industries. Additionally, multimedia technologies were increasingly integrated into product offerings such as automotive systems for digital cockpit and ADAS/AD, as well as IoT applications, reflecting a strategic shift toward diversification and innovation in emerging markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Qualcomm's multimedia technology approach from 2022 to 2024. It accurately identifies the 2022 focus on camera, video, display, and computer vision as part of R&D expansion into automotive and IoT. It also correctly notes the 2024 shift toward AI, generative AI, and on-device AI, aligning with the ground truth. The strategic diversification and integration into automotive (digital cockpit, ADAS/AD) and IoT are accurately reflected. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; all time references (2022, 2024) are correct and consistent with the original answer. (3) The multi-hop reasoning is sound: the model synthesizes information across time periods (2022 vs 2024), identifies shifts in engineering focus, and connects integration into product offerings across industries. The only minor omission is that the original answer emphasizes a shift from 'hardware-centric' to 'platform-oriented' innovation, which the LLM answer implies but does not explicitly state. This nuance slightly affects qualitative completeness. (4) The LLM answer is factually accurate, contextually complete, and semantically equivalent to the ground truth, with only slight under-articulation of the platform-oriented strategic shift. Hence, a correctness score of 9 is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 406,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "Between 2023 and 2024, 3M's financial relationship with the Aearo Entities evolved significantly. In 2023, 3M reconsolidated the Aearo Entities after the dismissal of their bankruptcy proceedings, resulting in the removal of a $0.7 billion equity investment and a $0.6 billion intercompany liability from the consolidated balance sheet. In 2024, there is no specific mention of changes to the equity investment or intercompany balances, suggesting that the reconsolidation remained in effect and no material adjustments occurred during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $0.7 billion equity investment and $0.6 billion intercompany liability removed from 3M's balance sheet in 2023, which matches the ground truth numerically and contextually. However, it incorrectly states that 3M 'reconsolidated' the Aearo Entities in 2023, when in fact the reconsolidation marked a reversal of prior deconsolidation—this is a subtle but important distinction. More critically, the LLM answer claims that 'no specific mention of changes' occurred in 2024 and that 'the reconsolidation remained in effect,' which directly contradicts the ground truth: by 2024, the Aearo Entities were *no longer consolidated*, and 3M only retained a stake. This misrepresents the core evolution of the financial relationship. (2) Quantitative accuracy is high—the $0.7B and $0.6B figures are correct in amount and context. (3) The multi-hop reasoning fails: the model does not correctly synthesize the transition from reconsolidation in 2023 to deconsolidation with retained equity interest in 2024. Instead, it assumes continuity, missing the key shift described in the original answer. (4) While the context and numbers for 2023 are accurate, the conclusion about 2024 is factually wrong, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer addresses the right entities and time frame but draws an incorrect conclusion about the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 402,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions have evolved to become a more integral part of the company's broader value-added services portfolio. In 2022, these solutions were primarily described as tools to help prevent fraud and protect account holder data through products like Visa Consumer Authentication Service and Visa Advanced Authorization. By 2024, the strategic positioning had expanded significantly, with the introduction of new AI-powered tools such as Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic Visa Advanced Authorization. These enhancements reflect a stronger emphasis on leveraging AI and machine learning to address fraud across a broader range of payment types, including card-not-present and account-to-account transactions, both on and off Visa's network.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Visa's Risk and Identity Solutions from a fraud prevention focus in 2022 to a more advanced, AI-driven suite by 2024, and addresses the strategic positioning within value-added services. It accurately references core 2022 products like Visa Advanced Authorization and correctly identifies a shift toward broader capabilities. However, it introduces specific product names not present in the ground truth—'Visa Consumer Authentication Service' (not mentioned in original), 'Visa Deep Authorization', 'Visa Protect for A2A Payments', and 'Visa Risk Manager with scheme-agnostic Visa Advanced Authorization'—which are not supported by the provided knowledge graph. These additions, while plausible, represent hallucinated details that undermine factual accuracy. The ground truth emphasizes structural evolution—Risk and Identity Solutions becoming one of five core categories in a 200+ product ecosystem by 2024—but the LLM omits this key organizational and portfolio-scale context. While the qualitative direction of evolution (AI, broader payment types) is reasonable, the answer substitutes specific, unsupported product claims for the actual evidence of strategic integration (e.g., portfolio expansion to over 200 services, inclusion of Open Banking and Advisory Services). Quantitatively, there are no numbers, dates, or calculations in either answer, so no errors here. Contextually, the response is highly relevant and addresses the evolution and strategic positioning theme. The reasoning is partially sound but fails the multi-hop synthesis test by not connecting Risk and Identity Solutions to the broader reorganization of the value-added services portfolio as described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 474,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "RTX's Acquisition Accounting Adjustments' impact on operating profit remained relatively consistent between 2023 and 2024, with adjustments of $1,998 million in 2023 and $2,058 million in 2024. The adjustments primarily stemmed from amortization of acquired intangible assets, property, plant, and equipment fair value adjustments, and customer contractual obligations. The slight increase in 2024 was driven by a modest rise in amortization of acquired intangibles and a decrease in amortization of property, plant, and equipment fair value adjustments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM claims RTX disclosed a $2,058 million adjustment in 2024, which is false according to the ground truth—RTX did not provide any updated quantitative figures for 2024. The only correct number is the $1,998 million impact in 2023, which matches the ground truth. However, the 2024 figure is fabricated. (2) Completeness: The question asks about the evolution of disclosure and quantification between 2023 and 2024. The LLM fails to note the key shift from quantitative to qualitative disclosure in 2024, which is the central point of the ground truth. Instead, it falsely asserts continued numerical disclosure. (3) Entity Accuracy: While the company (RTX) and the metric (Acquisition Accounting Adjustments) are correctly identified, the years and financial data for 2024 are incorrect. (4) Reasoning: The LLM assumes a continuation of quantitative reporting and even provides a detailed breakdown of drivers (e.g., amortization changes), which are not present or verifiable in the ground truth. This reflects a complete failure in multi-hop reasoning—the model should have recognized the absence of 2024 data and the shift in disclosure strategy. (5) Semantic Equivalence: The LLM’s answer suggests consistency and numerical evolution, while the truth is a discontinuation of quantification. These are semantically opposite. The answer is therefore mostly incorrect, with only a single accurate number from 2023, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 429,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Between fiscal years 2022 and 2023, Microsoft's Office 365 Commercial revenue grew from $44.97 billion to $48.85 billion, representing an increase of $3.88 billion or approximately 8.6%. This growth indicates a steady but moderate expansion of Office 365 Commercial within the broader Microsoft Cloud ecosystem, which saw its total revenue rise from $91.4 billion to $111.6 billion during the same period. While Office 365 Commercial remains a significant contributor, the faster growth of Azure and other cloud services suggests a diversification of the cloud revenue base.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not provide specific revenue figures for Office 365 Commercial in FY2022 or FY2023—only that it was a key growth driver in FY2022 and was subsumed into the consolidated Microsoft Cloud revenue of $111.6 billion in FY2023 (up from $91.4 billion). The LLM invents precise figures of $44.97B and $48.85B for Office 365 Commercial, which are not present in the original answer and cannot be derived from the provided data. This makes the $3.88B increase and 8.6% growth rate fabricated. (2) While the Microsoft Cloud revenue numbers ($91.4B to $111.6B) are correctly cited, the LLM incorrectly treats Office 365 Commercial as having standalone disclosed revenue in FY2023, when in fact it was included in the new consolidated Microsoft Cloud figure without a separate breakout. This misrepresents Microsoft's reporting change. (3) The reasoning is partially sound in noting that Office 365 Commercial remains important and that Azure and other services are growing faster, but this conclusion is drawn from incorrect data. The multi-hop synthesis fails because it assumes granular revenue disclosures continued in FY2023 when they were actually consolidated. (4) The contextual relevance is fair because the answer addresses the evolution and growth trajectory within the cloud ecosystem, but the core quantitative claims are false, severely undermining correctness. The qualitative score reflects some accurate conceptual understanding, but the quantitative inaccuracy is severe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 431,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Merck's alliance revenue related to Lynparza increased by 9% in 2024 compared to 2023, primarily driven by higher demand in most international markets. This growth was supported by Lynparza's approval in new indications and expanded market adoption. Additionally, in January 2025, Lynparza received approval in China for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, further contributing to its growth potential.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the 9% growth in alliance revenue for Lynparza from 2023 to 2024, which matches the ground truth. The driver of higher demand in international markets is also accurately reported. However, the LLM adds information about Lynparza's approval in new indications and expanded market adoption, which are plausible but not present in the original answer. Most notably, the mention of a January 2025 approval in China is factually problematic because it refers to a future event beyond the 2024 timeframe being evaluated and is not supported in the ground truth. (2) Quantitatively, the 9% growth figure is accurate and correctly attributed to the 2023–2024 period. No calculations are required, and the percentage aligns with the original. (3) The multi-hop reasoning is partially sound—correctly linking Lynparza to alliance revenue growth and identifying international demand as a driver. However, the addition of unverified approvals and the forward-looking China approval introduces unsupported elements, weakening the reasoning fidelity. (4) The answer is contextually relevant and addresses both parts of the question—evolution of revenue and contributing factors—with mostly accurate information. The core facts are correct, but the extra details reduce qualitative accuracy slightly. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 381,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "The Procter & Gamble 2014 Stock and Incentive Compensation Plan remains referenced in both the 2023 and 2024 10-K filings, indicating continuity in its inclusion within the company's equity compensation reporting. However, the 2024 filing emphasizes that only the 2019 Stock and Incentive Compensation Plan allows for future grants of securities, with the 2014 Plan no longer serving as an active vehicle for new awards. This shift reflects the company's regulatory and strategic focus on newer plans for ongoing equity compensation, while older plans like the 2014 Plan are maintained for historical and administrative purposes.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that the 2014 Plan is no longer used for new grants and that only the 2019 Plan allows future awards, which aligns with the regulatory and strategic evolution implied in the ground truth. The dates (2014, 2019, 2023, 2024) and entity (Procter & Gamble) are correct, and there are no numerical inaccuracies—thus, quantitative accuracy is perfect. Contextual relevance is high, as the response directly addresses the evolution of the plan’s treatment between 2023 and 2024. However, the LLM answer diverges from the ground truth in emphasis: while the original answer highlights a shift from regulatory disclosure to inclusion in equity compensation transparency and ownership structure reporting, the LLM focuses on the plan’s inactivity for new grants. This is a valid point but represents a different dimension of evolution—not the one emphasized in the ground truth. The multi-hop synthesis is sound (linking plan status to reporting context), but the qualitative emphasis on 'no future grants' over 'integration into broader equity reporting' means it captures a related but not fully aligned aspect of the plan’s evolving role. Thus, while factually correct and relevant, it misses the core nuance of the original answer regarding reporting integration and transparency focus, leading to a moderate deduction in qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 388,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "The 1992 Stock Plan is mentioned in both the 2023 and 2024 10-K filings as one of the equity compensation plans under which securities may be issued. However, in both filings, it is clear that the 1992 Stock Plan no longer allows for future grants of securities. The 2019 Stock and Incentive Compensation Plan is the only active plan allowing for future equity grants, indicating that the 1992 Stock Plan has been superseded and no longer plays an active role in the company's current equity compensation structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but diverges from the ground truth in key qualitative aspects. (1) Quantitatively, there are no numeric inaccuracies—no specific numbers were cited in either answer, and dates (1992, 2023, 2024, 2019 plan) are correctly referenced. (2) The LLM correctly identifies that the 1992 Stock Plan is no longer active for future grants and that the 2019 Stock and Incentive Compensation Plan is the current active plan. However, it fails to capture the evolution highlighted in the ground truth: the shift in *presentation and treatment* of the 1992 Stock Plan between the 2023 and 2024 filings—from being referenced by incorporation in 2023 to being included in a consolidated table of equity plans in 2024. This representational shift is central to the question and is entirely omitted in the LLM response. (3) The reasoning is sound in concluding the plan is inactive, but it does not perform the required multi-hop synthesis between the two years’ filings to describe how its *role within the disclosure structure* evolved. Instead, it generalizes the plan’s inactivity without contrasting the reporting differences. (4) While contextually relevant and factually consistent on the plan’s current status, the answer misses the nuance of evolving disclosure treatment, which is the core of the question. Hence, correctness and qualitative accuracy are reduced, though quantitative accuracy remains high due to correct entity and date usage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 403,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "Between 2023 and 2024, the company has observed that clients continue to prioritize large-scale transformations, which convert to revenue over a longer period. In 2024, economic and geopolitical uncertainties slowed the pace and level of client spending, particularly for smaller, shorter-duration contracts and consulting services, reinforcing a shift toward larger, long-term engagements. This indicates an evolving emphasis on sustained, complex projects as clients focus on strategic, long-term digital and technological transformations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in the company's emphasis on large-scale transformations between 2023 and 2024. It correctly identifies that clients continued to prioritize large-scale, long-duration projects that convert to revenue over extended timelines, which aligns with the ground truth. The answer accurately reflects the reduction in spending on smaller, shorter contracts and consulting services, particularly in 2024 due to economic and geopolitical uncertainties. While the original answer explicitly mentions that this trend was observed in both 2023 and 2024 filings, the LLM answer synthesizes this well but slightly underemphasizes the 2023 context, focusing more on 2024. However, it still conveys the continuity of the trend. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers were involved), and the reasoning correctly synthesizes multi-hop information across years and client behavior patterns. The terminology and entities (e.g., 'large-scale transformations', 'longer-duration contracts', 'consulting services') are used accurately. The answer is fully contextually relevant and addresses both client spending patterns and revenue conversion timelines. The only minor shortcoming is the lack of explicit mention that the 2023 filing already noted the prioritization of large-scale transformations, making the evolution slightly less clear—hence a 9 instead of 10 on qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 411,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "In fiscal 2024, Accenture issued $7,869 million in Class A Ordinary Shares for employee share programs, compared to $7,970 million in fiscal 2023, representing a slight decrease of $101 million. This issuance contributed to an increase in additional paid-in capital by $2,280,198 million and impacted retained earnings negatively by $131,133 million. Overall, it affected the equity structure by increasing total shareholders' equity by $1,416,945 million in fiscal 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Accenture issued $7,869 million and $7,970 million in Class A Ordinary Shares in fiscal 2024 and 2023 respectively, which misrepresents both the units and the direction of change. The ground truth indicates that in fiscal 2024, Accenture issued 7,970 *shares* (not millions of dollars) for employee programs, while in 2023, the company did not issue shares but instead *acquired* shares via withholding for tax obligations. The LLM flips this dynamic and treats it as a monetary issuance, which is fundamentally incorrect. Additionally, the LLM claims a decrease from 2023 to 2024, but the ground truth shows a shift from share acquisition to issuance, not a decrease in issuance. (2) The numerical values are entirely wrong: the LLM reports dollar amounts in the billions (e.g., $7,869 million = ~$7.9B), whereas the actual number is 7,970 shares. The additional paid-in capital and retained earnings figures (e.g., $2,280,198 million = ~$2.28 trillion) are implausibly large and not supported by the ground truth. The equity structure changes cited (e.g., increase in total shareholders' equity by $1.4 trillion) are also fabricated. (3) The multi-hop reasoning is flawed: the model fails to recognize the shift from share acquisition (2023) to share issuance (2024) and misinterprets the nature of the transaction (equity compensation via withholding vs. new issuance). It does not mention the purchase of 12,181 treasury shares or the change in treasury stock value from $(3,408,491) million to $(6,678,037) million, which are key to understanding the equity impact. (4) The contextual relevance is moderate because the answer discusses employee share programs and equity impact, which are relevant topics, but the factual and quantitative errors severely undermine correctness. The qualitative reasoning is poor due to incorrect entity interpretation (shares vs. dollar value) and missing synthesis of treasury activity and share count changes. Thus, the correctness score is low at 2 due to major factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 571,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ's exposure to Canadian-denominated debt instruments decreased between 2022 and 2023, as the notional amount of Canadian dollar notes dropped from $443 million in 2022 to $453 million in 2023, indicating a slight reduction in direct exposure. However, the after-tax losses related to Canadian notes increased from $25 million in 2022 to $8 million in 2023, suggesting a shift in the impact of currency fluctuations on these instruments. This contrasts with the company's broader trend of managing foreign currency-denominated debt, where overall notional amounts for net investment hedges increased, and the company continued to hedge against exchange rate risks through derivative contracts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude. According to the ground truth, MDLZ's Canadian-denominated debt *increased* by $8 million in 2023, reversing a prior downward trend. The LLM incorrectly states that exposure *decreased*, citing notional amounts of $443M in 2022 and $453M in 2023 — which are not only fabricated but also imply an *increase* of $10M, contradicting its own claim of a reduction. This shows internal inconsistency. (2) The numbers are completely wrong: the actual Canadian note balances were $3M in 2022 and increased by $8M in 2023 to $11M (implied), not hundreds of millions. The after-tax loss figures cited ($25M to $8M) are also incorrect and not mentioned in the ground truth. (3) The multi-hop reasoning fails: the LLM does not recognize the reversal in trend (from decreasing to increasing) as described in the original answer, and instead fabricates a false narrative of reduction. It also incorrectly contrasts this with broader hedging trends using made-up data. (4) The contextual relevance is low because it addresses the general topic of foreign currency debt, but with entirely inaccurate data and conclusions. The qualitative reasoning is flawed due to incorrect entity values and misrepresentation of trends. The answer fails on all core dimensions: numbers, direction of change, trend interpretation, and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 390,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024 by enhancing strategic involvement and increasing investment activity through its innovation ecosystem. In 2023, Accenture Ventures was already partnering with and investing in growth-stage companies focused on innovative enterprise technologies. By 2024, the company emphasized a more structured and forward-looking innovation approach, supported by increased R&D spending ($1.2 billion in 2024) and a global network of over 100 innovation hubs. This evolution reflects a stronger commitment to incubating emerging technologies and scaling innovative solutions for clients, particularly in areas like AI, blockchain, and quantum computing.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Accenture's R&D spending as $1.2 billion in 2024, consistent with the ground truth (which also notes $1.3 billion in 2023). However, the LLM incorrectly states that in 2023, Accenture Ventures was already 'investing in' growth-stage companies, while the ground truth specifies that in 2023 the model was primarily 'partnering with' such firms and only shifted to direct 'investment' in 2024. This misrepresents a key evolution in strategy—the shift from partnership to investment—which is central to the question. (2) Quantitatively, the $1.2 billion R&D figure for 2024 is accurate, and the mention of over 100 innovation hubs, while not contradicted by the ground truth, is additional context not present in the original answer and cannot be verified from the provided data. No calculation errors are present. (3) The multi-hop reasoning is partially flawed: the model fails to correctly identify the change in engagement model (from 'partnering' to 'investing') as the core evolution, instead suggesting both activities were already occurring in 2023. This undermines the qualitative accuracy of the strategic shift. (4) Despite this, the answer remains contextually relevant, discussing innovation strategy, R&D, and technology focus areas, and conveys a plausible narrative of increased strategic involvement. Hence, correctness is reduced due to a significant factual misstatement about the nature of Accenture’s 2023 activities, even though supporting details like R&D spending are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 425,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca from 2022 to 2024 shows growth in alliance revenue and ongoing amortization of intangible assets. Alliance revenue related to Lynparza grew 9% in 2024 compared to 2023, driven by higher international demand. As of 2021, the intangible asset balance related to Lynparza was $1.1 billion, which is being amortized over its estimated useful life through 2028. This reflects continued value from the collaboration, supported by regulatory approvals and market expansion, including a new approval in China in January 2025.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% growth in alliance revenue in 2024 and attributes it to higher international demand, which matches the ground truth. It also accurately states the $1.1 billion intangible asset balance related to Lynparza and its amortization through 2028. However, it incorrectly states that the $1.1 billion balance was as of 2021, while the ground truth specifies 2022. This is a factual error in timing, though the number itself is correct. The mention of the January 2025 China approval is accurate and contextually relevant. (2) Quantitatively, the 9% revenue growth and $1.1 billion asset value are correct. The amortization period (through 2028) is also accurate. The only error is the misattribution of the $1.1 billion balance to 2021 instead of 2022, which affects precision but not the overall financial trajectory. (3) The multi-hop reasoning is sound: the model connects asset amortization, revenue growth, and strategic expansion via regulatory approval. It synthesizes financial and strategic elements across time, though the incorrect year for the asset balance slightly weakens the temporal accuracy of the evolution narrative. (4) The answer is highly contextually relevant, addressing both financial (amortization, revenue) and strategic (approvals, market expansion) dimensions of Merck's involvement. The core facts are correct, with only a minor error in the reference year for the asset balance, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 414,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "AVGO's strategic emphasis on ValueOps has shifted from a focus on enabling work lifecycle management and alignment between business and development teams in 2023 to a more integrated role within the Distributed Software portfolio in 2024. In 2024, ValueOps is positioned as a key component of solutions that optimize the planning, development, and delivery of business-critical services, working alongside DevOps and AIOps to deliver end-to-end visibility across the digital lifecycle. This evolution indicates that ValueOps is becoming more central to AVGO's strategy for driving operational efficiency and business outcomes in distributed environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core strategic shift in AVGO's emphasis on ValueOps between 2023 and 2024. It correctly identifies that in 2024, ValueOps became a key component alongside DevOps and AIOps, with an emphasis on 'end-to-end visibility across the digital lifecycle,' matching the ground truth. The answer conveys the evolution from a supporting offering to a more central, integrated role in the Distributed Software portfolio, reflecting its growing strategic importance. While the original answer specifies that ValueOps was elevated to be one of the three 'core domains' the portfolio is organized around, the LLM uses similar phrasing ('key component') and captures the foundational shift. The mention of 'enabling work lifecycle management' in 2023 is slightly more specific than the ground truth, which notes it was listed among other offerings without elaboration—this is a minor addition but not factually incorrect. There are no numeric values to verify, so quantitative accuracy is 10. The reasoning is sound, synthesizing the change in strategic positioning across years. The answer is contextually fully relevant and addresses both parts of the question: the change in emphasis and what it indicates about ValueOps' evolving role. The only reason for not scoring a 10 is the slight lack of precision in articulating the structural reorganization of the portfolio into three domains, though the semantic meaning is close.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 402,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "Between 2023 and 2024, FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolved by consolidating operations, such as merging FedEx Ground and FedEx Services into Federal Express, and redesigning the international air network through the Tricolor initiative. While the new legal structure was completed in June 2024, integration and optimization were ongoing. The expected benefits included improved efficiency, asset utilization, and cost savings, but the company acknowledged risks such as higher-than-anticipated costs, potential disruptions, and challenges in integrating networks and labor relations. The actual amount and timing of cost savings and savings to the permanent cost structure remained uncertain and subject to change based on the progress of integration and external factors.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of qualitative developments and correctly identifies the evolution of FedEx's strategic approach to Network 2.0 between 2023 and 2024, particularly around integration efforts and risks. It correctly notes the June 2024 completion of the legal restructuring (merger of FedEx Ground and FedEx Services into Federal Express) and the ongoing nature of integration and optimization, which aligns with the 2024 risk focus. The mention of uncertain timing and amount of cost savings matches the 2024 filing's caution. However, the LLM answer omits key details from the original answer that reflect a deeper multi-hop synthesis: specifically, the 2023 emphasis on strategic investment justification (operational efficiencies, network flexibility, cost base alignment) and the explicit shift in risk profile from execution timing/cost in 2023 to integration complexities in 2024 (harmonizing operating practices, labor and cultural differences, tax impacts, litigation, and asset impairments). While the LLM mentions 'challenges in integrating networks and labor relations,' it misses the broader scope of integration risks and financial contingencies highlighted in the ground truth. There are no numerical inaccuracies—dates (June 2024) are correct, and no incorrect figures are introduced. The reasoning is sound but incomplete in capturing the full strategic transition from planning to risk mitigation. The answer remains contextually relevant and conveys a largely accurate picture, but lacks completeness in reflecting the full evolution of risk disclosure and strategic emphasis across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 447,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "The financial impact from equity method investment contracts increased from 2022 to 2023, with pre-tax gains recorded in net earnings rising from $0 million in 2022 to $7 million in 2023. This indicates a modest but positive shift in MDLZ's engagement with these investments, reflecting improved performance or favorable valuation changes in the related equity method investments during 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative description of the 2022 financial impact. The ground truth states that MDLZ reported a net *liability* of $3 million in 2022, which is a negative financial position. However, the LLM incorrectly states that pre-tax gains were $0 million in 2022, which misrepresents the financial reality. The 2023 figure of $7 million gain is correct and matches the ground truth. (2) The calculation or comparison between years is therefore flawed: the actual change is from a $3 million liability (i.e., -$3M) to a $7 million gain, representing a $10 million swing, not an increase from $0 to $7 million. This undermines the quantitative accuracy. (3) The reasoning about MDLZ's engagement being more favorable or active is partially sound and aligns with the ground truth’s interpretation of a reversal indicating strategic shift. The LLM correctly infers improved performance or favorable valuation changes, which is a reasonable qualitative interpretation, though it misses the full significance of the reversal from liability to gain. (4) The entities (MDLZ, equity method investment contracts, years 2022 and 2023) are correctly identified, and the answer addresses both parts of the question—evolution of financial impact and what it indicates—so contextual relevance is high. However, due to the critical error in the 2022 financial figure, the correctness score is reduced to 5, as the core quantitative claim is partially wrong, affecting the overall accuracy despite correct directionality and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 436,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases decreased from fiscal year 2023 to fiscal year 2024, dropping from $38 million to $0, as the project was released during fiscal year 2024. This indicates that the development progress met or exceeded expectations, with the project completed on schedule.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the estimated cost to complete decreased from $38 million to $0. The ground truth confirms the cost remained unchanged at $38 million in both fiscal years 2023 and 2024. The claim that the cost dropped to $0 implies project completion, which contradicts the original answer stating the development was ongoing and progressing as planned, not completed. (2) Quantitatively, the $38 million figure is correct for fiscal year 2023 but falsely reported as dropping to $0 in fiscal year 2024. This introduces a major error in both value and interpretation—no such decrease occurred. (3) The multi-hop reasoning fails because the model incorrectly infers completion from unchanged cost, whereas the correct inference (per ground truth) is that stable costs reflect on-track progress without overruns or delays. The model misunderstands the meaning of 'estimated cost to complete'—a drop to $0 would indicate full expenditure, but the knowledge graph confirms it remained at $38M, meaning the project was still active. (4) Scores are low due to critical factual and reasoning errors, though the answer remains contextually relevant by addressing the right project, company (AVGO), and timeframe. The qualitative reasoning is flawed, and quantitative accuracy is poor despite one correct number.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 377,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "Between 2023 and 2024, the strategic positioning of FedEx Office's Ship and Go kiosk has evolved by emphasizing convenience and integration with e-commerce logistics and returns management. The kiosk allows customers to generate shipping labels via mobile devices or QR codes and drop off packages securely, streamlining the shipping process. Additionally, FedEx Office facilitates e-commerce returns through FedEx Returns Technology, enabling in-store printing of return labels and offering consolidated returns with no box or label required. This evolution indicates that FedEx is enhancing its retail logistics infrastructure to better support e-commerce growth, improve customer experience, and provide seamless returns management solutions for both consumers and businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in the strategic positioning of FedEx Office's Ship and Go kiosk between 2023 and 2024. It correctly identifies the kiosk's functionality—generating labels via mobile/QR code and secure drop-off—and notes the enhanced integration with FedEx Returns Technology and Consolidated Returns in 2024, including in-store printing of return labels and the ability to return items without a box or label. While the original answer specifies that the kiosk was present in approximately 1,300 locations in both years (a detail omitted in the LLM response), this quantitative point is not central to the strategic interpretation. No incorrect numbers, dates, or entities are used (quantitative accuracy is perfect). The reasoning correctly synthesizes the shift from a shipping-focused tool to a returns infrastructure node, indicating sound multi-hop logic. The answer is contextually excellent, directly addressing e-commerce logistics and returns management. The only minor gap is the lack of explicit mention of the continuity in kiosk count (1,300 locations), which slightly affects completeness but not the overall correctness of the strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 341,
        "total_tokens": 1772
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 1000,
    "failed_evaluations": 0,
    "average_correctness_score": 5.71,
    "average_quantitative_accuracy": 6.69,
    "average_qualitative_accuracy": 6.03,
    "average_contextual_relevance": 8.21,
    "score_distribution": {
      "excellent": 233,
      "good": 196,
      "fair": 304,
      "poor": 267
    }
  },
  "original_experiment_metadata": {
    "model": "qwen3-32b",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 2741.18,
    "timestamp": "2026-02-03T21:11:43.108013"
  }
}